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this is part 1 of 3.Table 1 (abstract A1). Endophenotypes versus clinical characteristics
Impassive
endophenotype
N=383 Intermediate
endophenotype
N=224 Reactive
endophenotype
N=164 P-value
Age 63 (53.5-72) 61.5 (51.8-72) 58 (45-66) <0.001
Male 252 (65.8) 129 (57.6) 107 (65.2) 0.1
APACHE IV
Score
72 (58-92) 83 (67.5-102) 104.5 (84-124) <0.001
SOFA:
Total score
7 (5-9) 9 (7-11) 11 (9-14) <0.001
PaO2/FiO2 191.1 (138-260) 183.2 (146-234) 173.3 (124-225) <0.001
PEEP 8 (5-11) 9 (6-12) 12 (10-15) <0.001
Days free
of MV at
day 28
20 (8-25) 18 (0-24) 0 (0-18) <0.001 <0.001
ICU
Mortality
61 (15.9) 60 (26.8) 76 (46.3) <0.001
30-Day
Mortality
75 (19.6) 70 (31.2) 78 (47.8) <0.001Oral Sessions. ARDS: CLINICAL STUDIES
A1
Identification of distinct endophenotypes in patients with acute
respiratory distress syndrome by unbiased cluster analysis, and
their association with mortality
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Introduction: Pharmacological immunomodulatory interventions in
'acute respiratory distress syndrome' (ARDS) have been unsuccessful
in clinical trials [1-3] despite promising results in preclinical studies
using animals [4-5]. Poor phenotyping of patients could be respon-
sible for these disappointing results.
Objectives: We hypothesized that ARDS patients can be clustered
based on concentrations of plasma biomarkers and that such bio-
logical endophenotypes are association with clinical outcomes.
Methods: Patients were screened for presence of ARDS. Unbiased clus-
ter analysis of plasma concentrations of 20 biomarkers of inflammation,
coagulation and endothelial activation at diagnosis of ARDS provided
the endophenotypes. A decision tree was then used to predict cluster
membership based on a more restricted set of biomarkers. The inde-
pendent association of endophenotypes with ICU mortality was studied
by multivariate logistic regression.
Results: Three endophenotypes of ARDS were identified in 771 pa-
tients, which we named 'impassive' (N = 383), 'intermediate' (N = 224)
and 'reactive' (N = 164), had mortality rates of 16 %, 26 % and 47 %,
respectively (P < 0.01). Patients with a 'reactive' endophenotype were
younger, had higher disease severity scores, more failing organs and
more frequently had an indirect cause for ARDS than patients with
an 'impassive' or 'intermediate' endophenotype. A 'reactive endophe-
notype' was independent from confounders associated with ICU
mortality (OR 1.18 [95 % confidence interval: 1.09-1.28]). The concen-
tration of interleukin 10, interleukin 8 and matrix metalloproteinase 8
were sufficient to predict the three endophenotypes.
Conclusions: ARDS patients can be clustered into three biological
endophenotypes, with different mortality rates. Three easy to measure
biomarkers can be used to predict the endophenotype.
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Introduction: Patients meeting the Berlin definition criteria for the
acute respiratory distress syndrome (ARDS) might lack exposure to
one or more “common” risk factors. Such patients might exhibit dif-
ferent clinical phenotype and outcomes than others and constitute
an individualized subgroup of patients.
Objectives: To compare the clinical presentation and outcome of pa-
tients having ARDS with vs without risk factors, to determine whether
the lack of ARDS risk factor is associated with hospital mortality, andis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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of ARDS patients with no risk factors.
Methods: Ancillary study of an international, multicenter, prospective
cohort study (LUNG SAFE study[1]). Patients meeting ARDS criteria
(Berlin definition) on day 1 or 2 of acute hypoxemic respiratory fail-
ure onset were included in the study and categorized as having
“common” risk factors or not.
Results: Among the 2813 patients presenting ARDS in the first 48 h,
266 patients (9.4 %) had no ARDS risk factor identified at admission.
Table 2 shows the final ARDS risk factor identified in patients with or
without initial risk factor identified.
The patients with no risk factor were older, had more frequent previ-
ously known chronic diseases and presented with less severe SOFA
(8.7 ± 3.9 vs 9.5 ± 4.1, p < 0.001) and non-pulmonary (5.4 ± 3.9 vs 6.3
± 4.1, p < 0.001) SOFA scores. ICU mortality was lower in ARDS pa-
tients with no risk factor than in others (28.6 % vs 34.9 %, p = 0.047),
but in-hospital mortality was not (35.7 % vs 39.8 %, p = 0.20). The lack
of ARDS risk factor was not associated with hospital mortality (ad-
justed OR = 0.86 [0.65-1.13], p = 0.29). In the subgroup of patients
with no ARDS risk factor, age, SOFA, concomitant heart failure, and
administration of steroids within 72 hours of ARDS onset were associ-
ated with hospital mortality (Table 3).
Conclusions: Almost ten percent of patients with ARDS had no risk
factor identified and exhibit a different clinical phenotype than
others. Future research aimed at studying management strategies in
this subgroup of patients is warranted.
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The LUNG SAFE study was supported by the ESICM.Table 2 (abstract A2). Risk factors eventually identified N(%)
ARDS patients with ≥1
risk factor identified upon
ARDS diagnosisa (n=2547)
ARDS patients with no
risk factor identified upon
ARDS diagnosis (n=266)
Pneumonia 1670 (65.6) 13 (4.9)
Non-pulmonary Sepsis 453 (17.8) 2 (0.8)
Aspiration of gastric
contents
400 (15.7) 0 (0.0)
Non cardiogenic shock 214 (8.4) 0 (0.0)
Trauma 199 (7.8) 0 (0.0)
Blood transfusion 111 (4.4) 0 (0.0)
Pulmonary vasculitis 24 (0.9) 14 (5.3)
Others 264 (10.4) 16 (6.0)
No risk factor identified 0 (0.0) 219 (82.3)
Table 3 (abstract A2).
OR 95%CI p-value
Age (for 1 year) 1.03 1.01-1.05 0.003
SOFA score (for 1 point) 1.11 1.03-1.19 0.004
Concomitant heart failure 1.96 1.07-3.63 0.030
Steroids in the 1st 72 h of ARDS 2.66 1.37-5.25 0.004A3
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Introduction: The Acute Respiratory Distress Syndrome (ARDS) is a
serious complication following major surgery1. ARDS frequently com-
plicates oesophagectomy. The Beta Agonist Lung Injury Prevention
Trial (BALTI-P)2 provided a large cohort of patients having undergone
oesophagectomy who had been systematically screened for ARDS.
Objectives: To characterise patients developing ARDS following oeso-
phagectomy and identify risk factors for ARDS in this group.
Methods: Data were collected as part of the BALTI-P trial, which in-
cluded daily assessment of oxygenation. Chest x-rays were assessed
by an expert panel. A comparison of Early ARDS (first post-operative
72 hours) and Late ARDS (after 72 hours) was undertaken using uni-
variate and multivariate analysis. Differences in outcome were deter-
mined and risk factors for ARDS in this group were identified.
Results: There were 83 cases of ARDS, 59 (71 %) were Early and 24
(29 %) were Late. ARDS with associated with longer ICU (Difference
7.18 days (Confidence Interval 5.53, 8.82)) and hospital stay (Differ-
ence 5.72 days (CI 4.05, 7.40)), fewer organ failure-free days (Differ-
ence -3.23 days (CI -4.36, -2.10)) and fewer ventilator-free days
(Difference -6.50 days (CI -7.90, -5.10)). There was no difference in
mortality or quality of life score. Late ARDS had the worst outcomes.
Early ARDS was associated with increased age (Odds Ratio 1.06 (CI
1.00 to 1.13), p = 0.05) and mid-oesophageal tumours (OR 7.48 (CI
1.62-34.5), p = 0.01), whereas gastro-oesophageal tumours were pro-
tective (OR 0.21 (CI 0.05, 0.85), p = 0.03). ARDS was associated with
more adverse events.
Conclusions: ARDS is associated with adverse patient outcomes and in-
creased healthcare resource utilisation. Patients with mid-oesophageal
tumours may be at especially high risk. Further investigations aimed at
reducing perioperative ARDS are warranted3. The high risk of ARDS fol-
lowing oesophagectomy makes the patient group useful for conduct-
ing trials into preventative therapies, as the incidence of ARDS high
and the onset is predictable, therefore patients can be approached pre-
operatively.
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Table 4 (abstract A4). Characteristics of trauma patients in LUNG SAFE
Trauma with AHRF
N=229 (5.7%)
Non-Trauma with
AHRF N=3812 (94.7%)
P value
Age, years, mean ±SD 51.4±19 62±16 <0.001
Male patients, No (%) 175 (76.4) 2336 (61.3) <0.001
Day 1 SOFA score ,
mean ±SD
8.5±4.0 9.3±4.1 0.004
P/F ratio , mmHg,
mean ±SD
187±66 167±67 <0.001
Vt, mL/kg PBW, mean
±SD
7.6±1.5 7.8±2.1 0.127
Set PEEP, cmH2O,
mean ±SD
7.3±2.8 7.8±3.1 0.007
Table 5 (abstract A4). Management and outcome of trauma patients
Trauma with AHRF
N=229 (5.7%)
Non-Trauma with
AHRF N=3812 (94.7%)
P value
NIV during the 48 first
hours, No (%)
8 (3.5) 585 (15.4) <0.001
Use of Neuromuscular
Blockade, No. (%)
28 (12.2) 553 (14.5) 0.340
Use of Prone positioning,
No. (%)
1 (0.4) 165 (4.3) 0.017
Duration of invasive
mechanical ventilation,
median [IQR], days
9 [4-14] 7 [4-14] 0.187
Duration of ICU Stay,
median [95%IQR], days
11 [7-20] 9 [5-14] 0.004
ICU Survival, No. (%) 189 (82.5) 2570 (67.4) <0.001
Duration of Hospital Stay,
median [IQR], days
22 [10-39] 16 [8-30] <0.001
Hospital Survival, No. (%) 186 (81.2) 2335 (61.3) <0.001
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Introduction: There is limited information about the epidemiology,
recognition, management, and outcomes of trauma patients with the
acute hypoxemic respiratory failure (AHRF).
Objectives: To assess the demographics, clinician recognition, venti-
lation management, use of adjunctive measures, and outcome of
trauma patients with AHRF that were enrolled into the LUNG SAFE
study.
Methods: LUNG SAFE was an international, multicenter, prospective
cohort study of patients undergoing invasive or noninvasive ventila-
tion, conducted during four consecutive weeks in the winter of 2014
in a convenience sample of 459 ICUs from 50 countries across 5 con-
tinents. In this analysis, we compared data from patients with AHRF
secondary to trauma to the general AHRF patient population. We de-
fined this cohort as that group of patients in whom the presence of
trauma and/or a pulmonary contusion was considered a risk factor
for their AHRF.
Results: Of 4,041 patients admitted to participating ICUs with AHRF,
229 (5.7 %) had sustained a trauma and/or a pulmonary contusion
[Table]. Trauma patients were younger, and had a higher male pre-
dominance, and less comorbidities and lower illness severity com-
pared to the general AHRF patient population. Of the trauma
patients that developed ARDS, clinician recognition was 35 %, which
lower than that that overall. In regard to ventilator management,
tidal volumes and PEEP levels were comparable to that seen in the
general AHRF group. The use of non-invasive ventilation was lower,
neuromuscular blockade use was comparable (12.2 % versus 14.5 %),
while there was less use of prone positioning (0.4 % versus 4.3 %).
Outcome of trauma patients with AHRF was better than that in the
overall AHRF population, with greater ICU (82.5 % versus 67.4 %) and
hospital (81.2 % versus 61.3 %) survival compared to the general
AHRF population. Trauma was independently associated with a re-
duced risk of death in a multivariable analysis.
Conclusions: Trauma patients constituted a distinct cohort, being
younger, predominantly male, and with less comorbidities, and im-
proved outcome compared to the general AHRF cohort
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Introduction: Prognostication in patients with ARDS improves when
patients are reclassified after 24 hours using PaO2/FiO2 and PEEP
cutoffs [1,2]. It is uncertain if SpO2/FiO2 [3] could serve as a non-
invasive and continuous surrogate of PaO2/FiO2 in prognostication
of ARDS patients. We hypothesized that SpO2/FiO2, in combination
with PEEP, is a reliable alternative for PaO2/FiO2 in prognostication
of patients with moderate or severe ARDS.
Objectives: To investigate whether classification at onset and re-
classification after 24 hours using SpO2/FiO2 and PEEP cutoffs allow
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 4 of 607outcome prognostication in patients with moderate or severe ARDS
according to the Berlin definition [4].
Methods: A secondary analysis of a large prospective observational
study in the mixed intensive care unit of a university hospital in the
Netherlands. First, the relation between PaO2/FiO2 and SpO2/FiO2 was
determined. Then patients were assigned to four groups, at onset of
ARDS and after 24 hours: group I (SpO2/FiO2 ≥ 190 and PEEP < 10 cm
H2O), group II (SpO2/FiO2 ≥ 190 and PEEP ≥ 10 cm), group III (SpO2/
FiO2 < 190 and PEEP < 10 cm H2O), and group IV (SpO2/FiO2 < 190 and
PEEP ≥ 10 cm H2O). The primary outcome was all-cause in-hospital
mortality. Secondary outcomes were ICU-, 30-, 90-day- and 1 year mor-
tality and the number of ventilator-free days and alive at day 28.
Results: The analysis included 456 patients with moderate or severe
ARDS who stayed in the ICU > 24 hours. The relation between PaO2/
FiO2 and SpO2/FiO2 was good (R2 = 0.62). Using the predefined
cutoffs for SpO2/FiO2 and PEEP, prognostication improved with re-
classification after 24 hours (Tables 6 and 7).
Conclusions: The SpO2/FiO2 is a reliable alternative for PaO2/FiO2 in
prognostication at 24 hours after onset of moderate or severe ARDS.
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(grant 04I-201).Table 6 (abstract A5). Distribution and Outcomes at baseline
Group I Group II Group III Group IV p value OR (95% CI)
group IV vs
group IBaseline ARDS diagnosis SpO2/FiO2
≥ 190 and
PEEP < 10
SpO2/FiO2
≥ 190 and
PEEP ≥ 10
SpO2/FiO2
< 190 and
PEEP < 10
SpO2/FiO2
< 190 and
PEEP ≥ 10
Number of patients (N) 87 43 100 226
ICU mortality (%) 19.5 23.3 18.0 30.1 0.042 1.77 (0.99 - 3.30)
In-hospital mortality (%) 44.8 30.2 36.0 41.2 0.897 0.85 (0.52 - 1.40)
30-day mortality (%) 27.6 27.9 24.0 33.2 0.276 1.30 (0.75 - 2.23)
90 days mortality (%) 47.1 34.9 41.0 42.0 0.636 0.81 (0.50 - 1.34)
1 year mortality (%) 60.9 41.9 47.0 49.6 0.182 0.63 (0.38 - 1.04)
VFD-28 (days-IQR) 19 (7-24) 22 (6.5-25) 20.5 (6-25) 18 (0-23) 0.070* -
Data are medians [IQR] or percentages
Abbreviations: ARDS acute respiratory distress syndrome, VFD-28 ventilator free
days and alive at day 28
P-value is p-for trend or p for Kruskall-Wallis test*
Table 7 (abstract A5). Distribution and Outcomes after 24 hours
After 24h Group I Group II Group III Group IV p value OR (95% CI)
group IV vs
group ISpO2/FiO2
≥ 190 and
PEEP < 10
SpO2/FiO2
≥ 190 and
PEEP ≥ 10
SpO2/FiO2
< 190 and
PEEP < 10
SpO2/FiO2
< 190 and
PEEP ≥ 10
Number of patients (N) 213 145 17 81
ICU mortality (%) 15.5 24.1 35.3 48.2 <0.001 5.06 (2.99 - 9.04)
In-hospital mortality (%) 34.7 35.9 52.9 56.8 <0.001 2.52 (1.50 - 4.25)
30-day mortality (%) 23.9 26.9 47.1 45.7 <0.001 2.64 (1.54 - 4.52)
90 days mortality (%) 38.0 38.6 52.9 56.8 0.003 2.14 (1.28 - 3.62)
1 year mortality (%) 47.4 45.5 58.8 65.4 0.006 2.10 (1.24 - 3.60)
VFD-28 (days - IQR) 23 (15-26) 18 (0-23) 6 (0-17) 0 (0-17) <0.001* –
Data are medians [IQR] or percentages
Abbreviations: ARDS acute respiratory distress syndrome, VFD-28 ventilator free
days and alive at day 28
P-value is p-for trend or p for Kruskall-Wallis test*SEPSIS DIAGNOSIS IN 2016
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Introduction: The differential diagnosis of acute respiratory failure
(ARF) in hospitalized patients is extensive and includes congestive
heart failure, atelectasis, nosocomial pneumonia, ARDS and sepsis. A
novel diagnostic test based on the expression of four RNAs in periph-
eral blood (SeptiCyte LAB, Immunexpress, Seatle, WA) may facilitate
discrimination between infectious and non-infectious causes in this
setting [1].
Objectives: To explore the diagnostic and prognostic value of Septi-
Cyte LAB in ARF patients admitted to the ICU from hospital wards.
Methods: We enrolled consecutive patients with ARF who had been
hospitalized >48 hrs and required prompt intubation in the ICUs of
two Dutch university hospitals from 2011 to 2013. All patients ful-
filled ≥2 SIRS criteria and/or had an early warning score >5. We ex-
cluded patients having an established diagnosis of infection >2 days
before ICU admission as well as those with airway obstruction, circu-
latory arrest, and other pertinent reasons for mechanical ventilation.
Blood samples were collected in PAXgene tubes for RNA extraction
upon ICU admission and subsequently analyzed on an Applied Bio-
systems® 7500 fast Dx Real-Time PCR instrument. Test results were
categorized into 4 probability bands according to the manufacturer´s
specification. Post-hoc infection likelihood of sepsis events within
2 days after ICU admission were based on physician assessments ac-
cording to validated definitions [2].
Results: Sample preparation or processing issues resulted in exclu-
sion of 14 patients, leaving 467/481 (97 %) for final analysis. Of these,
359 (77 %) subjects received antibiotics upon ICU admission, whereas
therapy was initiated on a later date in an additional 14 (3 %) pa-
tients. Test results correlated with the probability of infection (p <
0.001) (Fig. 1). Among the 415 patients in whom the test classified
sepsis as 'likely´, the false positive rate decreased from 17/39 (44 %)
to 36/195 (18 %) with higher probability bands. In the 52 patients in
whom the test suggested infection to be unlikely we observed 8
cases of confirmed infection (false negative rate 15 %). As 135 pa-
tients could not be categorized with certainty (“undetermined”) for-
mal calculation of sensitivity and specificity was precluded. SeptiCyte
test results were not affected by age, prior ICU stay, or immune defi-
ciency. Higher scores of the test were indicative of increased severity
of disease and mortality (Fig. 2).
Conclusions: SeptiCyte LAB is a biomarker assay which may aid clini-
cians in separating infectious from non-infectious causes of acute
respiratory failure in hospitalized patients. In addition, the test may
have prognostic utility.
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interest.Fig. 1 (abstract A6). SeptiCyte LAB result versus post-hoc infection
likelihood in 467 critically ill patients with acute respiratory failure,
stratified by receiving or not receiving antibiotic treatment on the
first day in ICU
Fig. 2 (abstract A6). Patient characteristics by SeptiCyte LAB result
Table 8 (abstract A7). Demographic characteristics
Total N=928 Survived n=697
(75.1%)
Died n=231
(24.9%)
p value
Age 70.1 (69.3-71.0) 69.2 (68.2-70.2) 72.9 (71.3-74.5) <.001
Male sex 552 (59.5%) 402 (57.7%) 150 (64.9%) .051
Infection site <.001
Respiratory 404 (43.5%) 271 (38.9%) 133 (57.6%)
Hepatobiliary 186 (20.0%) 152 (21.8%) 34 (14.7%)
Genitourinary 173 (18.6%) 148 (21.2%) 25 (10.8%)
Gastrointestinal 67 (7.2%) 52 (7.5%) 15 (6.5%)
Others 98 (10.6%) 74 (10.6%) 24 (10.4%)
Table 9 (abstract A7). qSOFA and 28-day mortality
qSOFA
28-d mortality 0 1 2 3 Total
Survived 90 (84.9%) 315 (81.4%) 226 (72.4%) 66 (53.7%) 697 (75.1%)
Died 16 (15.1%) 72 (18.6%) 86 (27.6%) 57 (46.3%) 231 (24.9%)
Subtotal 106 387 312 123 928
Fig. 3 (abstract A7). ROC curve to predict 28-d mortalityA7
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Introduction: Recently, the 3rd international consensus definitions for
sepsis and septic shock have launched. According to the guideline,
quick Sequential Organ Failure Assessment (qSOFA) score 2 or more
was recommended as clinical criteria to identify sepsis patients outside
the ICU. Emergency department (ED) is the major source of ICU admis-
sion for sepsis. Therefore, an early recognition of sepsis is essential for
the application of bundle therapy in time.
Objectives: We wanted to investigate the predictive value of qSOFA
for 28-day mortality in ED patients with sepsis.
Methods: Patients suspected for old definition of severe sepsis and
septic shock were retrospectively identified in 3 urban tertiary hos-
pital EDs from May 2014 to April 2015. Demographic findings, initial
vital signs, Glasgow coma scale (GCS), site of infection, initial lactate
levels, systemic inflammatory response syndrome criteria (SIRS),
qSOFA score, SOFA score, and 28-day mortality were abstracted.
Area under the receiver operating characteristics (AUROC) of SIRS,
qSOFA, and SOFA to predict 28-day mortality were compared and
diagnostic performance of qSOFA 2 or more to predict 28-day mortality
was calculated.Results: Total 942 patients were identified during study periods.
Among them, 14 patients were excluded because of missing values.
Demographic characteristics were described in Table 8.
Patients with qSOFA less than 2 accounted for over half of enrolled
patients (493/928, 53.1 %) and over one third of mortality cases (88/
231, 38.1 %) (Table 9).
AUROC of SIRS, qSOFA, and SOFA to predict 28-day mortality were
0.540 (0.500-0.580), 0.627 (0.587-0.667), and 0.687 (0.646-0.727), re-
spectively. (SIRS vs qSOFA [p < 0.001], qSOFA vs SOFA [p = 0.009])
(Fig. 3).
Diagnostic performance of qSOFA 2 or more to predict 28-day mor-
tality was as follows: sensitivity, 61.9 % (55.3 %-68.2 %); specificity,
58.1 % (54.3 %-61.8 %); positive predictive value, 32.9 % (28.5 %-
37.5 %); negative predictive value, 82.2 % (78.5 %-85.4 %). Diagnostic
performance of SOFA score 2 or more to predict 28-day mortality
was as follows: sensitivity, 99.1 % (96.9 %-99.9 %); specificity, 4.2 %
(2.8 %-5.9 %); positive predictive value, 25.5 % (22.7 %-28.5 %); negative
predictive value, 93.5 % (78.6 %-99.2 %).
Conclusions: The current clinical criteria using qSOFA have a better
predictive value than SIRS for 28-day mortality in ED patients with
sepsis. However, criteria of qSOFA 2 or more can miss one third of
mortality cases. Therefore, further assessment of organ failure by
SOFA score would be helpful in ED patients with infection.
Table 10 (abstract A8). Discrimination performance
Scores Baseline risk model + Scores
Variable AUC (95% CI) Variable AUC (95% CI)
Baseline model 0.74 (0.72-0.76)
SIRS criteria 0.58 (0.55-0.60) Baseline + SIRS 0.75 (0.73-0.77)
qSOFA 0.70 (0.68-0.72 Baseline + qSOFA 0.79 (0.77-0.81)
CRB 0.71 (0.69-0.74) Baseline + CRB 0.80 (0.78-0.82)
SOFA 0.80 (0.78-0.82) Baseline + SOFA 0.84 (0.83-0.86)
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 6 of 607A8
Validation of quick SOFA in a large population of patients with
community-acquired pneumonia
O.T. Ranzani1,2,3, E. Prina1,2, R. Menendez4, A. Ceccato1,2,5, R. Mendez4, C.
Cilloniz1,2, A. Gabarrus1,2, M. Ferrer1,2, A. Torres1,2
1Department of Pulmonology, Hospital Clinic of Barcelona, University of
Barcelona, Institut D'investigacions August Pi I Sunyer (IDIBAPS),
Barcelona, Spain; 2Centro de Investigación Biomedica En Red-
Enfermedades Respiratorias (CibeRes, CB06/06/0028), Barcelona, Spain;
3Respiratory Intensive Care Unit, Pulmonary Division, Heart Institute,
Hospital das Clínicas, University of Sao Paulo, São Paulo, Brazil;
4Pneumology Department, ISS/Hospital Universitario y Politecnico La Fe,
CIBER Enfermedades Respiratorias (CIBERES), Valencia, Spain; 5Seccion
Neumologia, Hospital Nacional Prof. Alejandro Posadas, Palomar, Argentina
Correspondence: O.T. Ranzani – Department of Pulmonology, Hospital
Clinic of Barcelona, University of Barcelona, Institut D'investigacions
August Pi I Sunyer (IDIBAPS), Barcelona, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A8
Introduction: The new sepsis consensus introduced the quick SOFA
score (qSOFA) as a simple screening tool for the early detection of pa-
tients with infection at risk for worse outcome [1]. Community-acquired
pneumonia (CAP) is the most common infection responsible for sepsis
and external validation of qSOFA is necessary [2]. Interesting, CRB (Con-
fusion, Respiratory rate and Blood pressure), a consolidate score used for
CAP, weighs the same variables used in qSOFA with different cut-offs.
Objectives: Our aim was to evaluate the performance of qSOFA in
patients with CAP and to compare the qSOFA with SIRS, CRB and
SOFA scores in predicting mortality.
Methods: We included patients with clinical diagnosis of CAP from
Hospital Clinic (Barcelona) and Hospital La Fe (Valencia), Spain. Using
variables at diagnosis, we calculated SIRS, qSOFA, CRB and SOFA scores.
We evaluated the performance of these scores and their additional pre-
diction contribution to a baseline risk model estimated by a logistic re-
gression model including demographic (age, gender) and comorbidity
variables (chronic respiratory disease, chronic neurologic disease, liver
disease, heart failure, diabetes mellitus, active neoplasia, chronic renal
disease, HIV status and etiologic diagnosis). Our primary outcome was
in-hospital mortality, and secondary outcomes were in-hospital mortal-
ity and/or 3 days of ICU stay and 30 days mortality. We used multiple
imputation to deal with missing data.
Results: We evaluated 6,874 patients with CAP, mean age 66 (±19)
and in-hospital mortality of 442 patients (6.4 %). Discrimination eval-
uated through the area under the curve (AUC) is in Table 10. SIRS
criteria had the worse discrimination performance compared with
qSOFA, CRB and SOFA. Calibration plots were comparable among the
scores, although overestimation was more pronounced for qSOFA
and SOFA scores. When adding the scores to the baseline risk model,
the discrimination of Model + SIRS has no change, although improved
with qSOFA, CRB and SOFA. Baseline model calibration improved
similarly by adding each score in it. Using the cut-off of two points, the
sensitivity/specificity for SIRS was 88/22 %, qSOFA 50/82 %, CRB 39/
87 % and SOFA 97/23 %. Similar patterns were observed for secondary
outcomes and for other measures of performance (Brier Score, IDI).
Conclusions: qSOFA, CRB and SOFA were more accurate than SIRS
to detect CAP patients with risk to unfavourable outcomes. In this
external validation, the cut-off of 2 points for qSOFA had lower
sensitivity than expected for a screening tool. CRB outperformed
qSOFA and SOFA in terms of calibration and higher specificity in
this population.
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Introduction: Previous studies have linked various cytokine levels
and clinical traits to organ failure and mortality, but few have used
this data to cluster patients and classify distinct endotypes
Objectives: To determine whether clinical biomarkers can define
endotypes of sepsis with different rates of 14-day mortality and
organ failure
Methods: The multicenter, randomized Protocol-Based Care for Early
Septic Shock (ProCESS) trial enrolled 1341 patients with septic shock
and showed a 16.3 % 14-day mortality. We used hierarchical bi-
clustering as an approach to cluster patients using cytokine levels,
their early trends and other baseline clinical variables as features.
Cytokine levels measured at 0, 6, and 24 hours were included. Vari-
ables with high coefficients of variation and significant univariate lo-
gistic regression p-values with organ failure outcomes were included
as candidate clustering variables. Patient variables were standardized
and differences in cluster mortality were examined using the log-
rank test. Only patients with complete variable profiles were included
in the heat map analysis. After clustering was performed, the associ-
ation between these clusters, organ failure, defined as a SOFA score
of 2 or greater, and 14-day mortality was examined.
Results: Unsupervised clustering yielded several subgroups, or endo-
types, of interest. Increasing the potential number of subgroups dis-
closed the emergence of subgroups with distinct clinical feature. At
the highest level, patient with high cytokinemia (HC) are proximally
distinguished from those with low cytokinemia (LC). Patient with HC
further segregated in those with elevated lactate (HCL) (figure),
which often had higher than average platelet count. Although HC
was associated with generally higher MOF and mortality, HCL por-
tended a particularly poor prognosis. As the dotted line is moved
down the top dendrogram, additional subgroups appear, such as pa-
tients with acute kidney injury (high blood urea nitrogen (BUN) with
low urine output), hyperglycemia, and patients with high systolic
blood pressure, high temperature, and high heart rate.
Conclusions: Hierarchical clustering identified endotypes of patients
at particularly high (or low) risk of organ failure and 14-day mortality.
Heat map bi-clustering of septic patients including several domains
of information (serum markers, clinical features) is a promising method
to group patients into distinct endotypes. Classification of these endo-
types can act as a basis for personalized therapies.
Grant acknowledgement
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Fig. 4 (abstract A9). Sepsis endotype heat map
Fig. 5 (abstract A10).
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Introduction: The new sepsis definitions (sepsis-3) are supposed to
„offer greater consistency“ for research classification of septic pa-
tients [1]. However, it remains to be determined, how sepsis-3 will
change the patient population formerly identified by criteria of se-
vere sepsis and septic shock [2].
OBJECTIVE. To investigate the changes in mortality and length of stay
data by applying sepsis-3 criteria to a previous patient cohort identi-
fied by the former sepsis criteria.
Methods: A patient population derived from a previous prospective
cohort study performed at the tertiary University Hospital of Greifs-
wald, Germany (ethical approval: BB 133/10) including adult patients
with sepsis onset after ICU admission was reanalyzed. Sepsis-3 cri-
teria were applied to the patients previously classified as severe sep-
sis or septic shock by the consensus conference criteria of 1992.
Mortality rates and length of stay data were compared between severity
subgroups defined by the former definitions and sepsis-3, respectively.
Results: 196 patients with severe sepsis or septic shock were included.
Applying sepsis-3 criteria resulted in 3 subgroups: sepsis, septic shock
and patients with neither SOFA increase nor shock. Results are pre-
sented in Fig. 5.
Conclusions: Sepsis-3 criteria identified patients with a higher risk of
mortality. However, results were not significant. Further investiga-
tions are needed to determine the impact of sepsis-3 on sepsis classi-
fication. Interpreting future research using sepsis-3 should carefully
consider potential changes when comparing the results of future
trials with previous studies.
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Introduction: Fluid administration to maintain organ perfusion is a
common practice in critically ill patients. Reliable assessment of fluid
responsiveness is difficult. Carotid artery flow is easy to measure
bedside.
Objectives: To test the hypothesis that changes in carotid artery flow
time (corrected flow time, FTc) induced by PLR can predict volume
responsiveness in MV patients.
Methods: A prospective observation study conducted in MV patients
admitted in a mixed ICU between 1st Nov.2013 to 31st Decemeber
2015. All adult patients considered eligible for fluid resuscitation as
decided by the attending physician were included. Exclusion criteria:
Pregnant patients, head injury , intra-abdominal hypertension, ampu-
tees, those with rhythm and known cardiac abnormalities.
Protocol: Linear transducer with pulse wave doppler was used on
common carotid artery for recording carotid artery FTc. Flo trac
(Vigileo Edwardlife sciences-TM) monitor was used to detect changes
in stroke volume (SV). All recordings taken at baseline in semi-
recumbent positions. Patients were put supine and after 5 minutes,
PLR was done. The maximum SV during the PLR was recorded.
Carotid FTc was measured at 1, 2 and 3 minutes. Maximum carotid
FTc value was considered. Fluid responsiveness was defined as
>15 % in SV after volume expansion (VE).
Results: Total of 260 patients were taken for the study. Mean age was
58 .5(sD11.2 )years; Male:Female 190:70, BMI (kg/m2) 22.4 (sd 4.2),
mean APACHE II score 19 (sD 4.8) with mean mechanical ventilation
days of 11.4 (sD 8.2) and mean ICU days of 12.6 (sD9.4). Disease types :
62.5 % Respiratory, 18.5 % Acute febrile illness, 12.50 % CNS and
6.25 % with pancreatitis. Fluid responsiveness were seen in 56.25 %
with changes in stroke volume >15 % after VE. Change in Carotid FTc
of 24.4 % in response to PLR to predicted volume responsiveness-
Sensitivity was 76.8 %, Specificity 89.5 % and ROC Curve of 0.872 (95 %
CI 0.56- 1.0).
Conclusions: The Carotid FTc increase of 24.4 % during PLR is a reliable
predictor of fluid responsiveness in MV patients.
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Parameters All patients
n=260
Responders
n=146
Non-responders
n=114
p value
Age in years 58.5 (sD 11.2) 58.2 (sD 12.4) 57.9 (sD 10.2) 0.42
Male : Female 145:115 88:58 52:62 0.53
APACHE II 19.0 (sD 4.8) 19.4 (sD 3.9) 19.1 (sD 5.2) 0.84
BMI in Kg/m2 22.4 (sD 4.2) 22.2 (sD 3.2) 23.4 (sD 2.4) 0.47
M V in days 11.4 (sD 8.2) 11.2 (sD 7.4) 11.5 (sD 9.6) 0.85
ICU stay in days 12.6 (sD 9.4) 12.5 (sD 7.5) 12.8 (sD 10.1) 0.89
Table 12 (abstract A11). Hemodynamics post PLR and Volume
Expansion (VE)
Parameters Step 1
(base line-
recimbent)
Step 2
(PLR-passive
leg raising)
P (2, 1) Step 4
(VE-voulme
expansion)
P ( 4, 1) P (4,2)
RESPONDERS
HR beats/min 89.4 (sD 19.4) 88.7 (sD 20.4) 0.84 87.8 (sD 19.8) 0.72 0.83
MAP mmHg 68.7 (sD 11.2) 78.4 (sD 11.8) 0.01 83.5 (sD 11.2) 0.001 0.04
SVI ml/m2 34.4 (sD 12.4) 40.1 (sD 18.1) 0.02 45.1 (sD 17.2) 0.005 0.25
FTc millisec 335.15 (sD 23.5) 359.55 (sD 25.46) 0.001 360.52 (sD 26.5) 0.000 0.35
HR beats/min
(NON-RESPONDRS)
110.2 (sD 16.4) 115.6 (sD 15.4) 0.76 110.4 (sD 16.8) 0.89 0.82
MAP mmHg 84.6 (sD 14.4) 86.2 (sD 15.7) 0.48 87.3 (sD 14.9) 0.52 0.70
SVI ml/m2 35.4 (sD 11.5) 36.2 (sD 11.6) 0.88 37.2 (sD 11.5) 0.74 0.82
FTc millisec 372.62 (sD 11.7) 381.57 (sD 11.4) 0.03 382.63 (sD 11.6) 0.02 0.74
Fig. 6 (abstract A11). ROC curve for carotid flow timeA12
Stroke volume targeted resuscitation may be superior to cardiac
output or mean arterial pressure based resuscitation in
hemorrhagic shock: an animal experiment
N. Öveges1, I. László1, K. Tánczos1, M. Németh1, G. Lebák1, B. Tudor2, D.
Érces3, J. Kaszaki3, W. Huber4, D. Trásy1, Z. Molnár1
1University of Szeged Faculty of Medicine, Anaesthesiology and Intensive
Therapy, Szeged, Hungary; 2Medical University of Vienna, Anaesthesiology
and General Intensive Care Medicine, Vienna, Austria; 3University of Szeged
Faculty of Medicine, Surgical Research, Szeged, Hungary; 4Technische
Universität München, Gastroenterology, Munich, Germany
Correspondence: N. Öveges – University of Szeged Faculty of
Medicine, Anaesthesiology and Intensive Therapy, Szeged, Hungary
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A12
Introduction: Fluid resuscitation forms the mainstream to ameliorate
impaired oxygen delivery during hemorrhagic shock. However, it is a
“double-edged-sword” as both over-, and under-filling can be harm-
ful, therefore it should be performed according to adequate physio-
logical end-points. According to a recent survey most physicians still
use hypotension as their main target to guide fluid resuscitation (1).
Objectives: Our aim was to compare stroke volume (SVI), cardiac out-
put (CI) and mean arterial pressure (MAP) guided fluid resuscitation
in a hemorrhagic shock-resuscitation experiment performed on Viet-
namese mini pigs.
Methods: 39 anaesthetised, mechanically ventilated pigs were random-
ized into SVI (n = 17), CI (n = 12) and MAP-groups (n = 10). After instru-
mentation (tbsl) the animals were bled till the initial SVI dropped by
50 % (t0), and then in each group fluid replacements were performed
in 4 equivalent steps (by dividing the tbsl-t0 values into 4 equal inter-
vals: t1-t4) by Ringer fundin (RF) solution to reach the baseline values of
SVI, CI and MAP, respectively. Invasive hemodynamic measurements
and blood gas analyses were undertaken after each step. For statistical
analysis General Linear Model, Independent samples T-test and Mann-
Whitney U tests were used in SPSS® 23.
Results: Similar amounts of blood were drained in all groups (SVI: 17
± 2, CI: 17 ± 4, MAP: 22 ± 6 ml/kg). There were significant differences
among the 3 groups in fluid-replacement ratio: SVI = 3.86 ± 1.21, CI =
2.63 ± 1.31, MAP = 4.51 ± 0.80, p = 0,001. In the SVI-group all variables
returned to their baseline or physiological values. Animals in the CI-
group remained under-resuscitated as indicated by SVI, central ven-
ous oxygen saturation (ScvO2), global end diastolic volume (GEDI)
and VO2/DO2 ratio at t4 as compared to tbsl (SVI: 31 ± 5 vs. 22 ± 6 ml/
m2; ScvO2: 79 ± 8 vs. 64 ± 12 %; GEDI: 313 ± 33 vs. 243 ± 47 ml/m2;
VO2/DO2 = 17 ± 10 vs. 47 ± 8 %, p < 0.05, respectively). In the MAP-
group most hemodynamic variables (including SVI, CI, pulse pressure
variation) returned to their baseline values by t2. However, at t4
ScvO2 and VO2/DO2 remained significantly lower than at tbsl: ScvO2
= 83 ± 5 vs. 64 ± 12 %, VO2/DO2 = 17 ± 7 vs. 36 ± 14, p < 0.05, respect-
ively. In this group the experiment was terminated when volume re-
placement exceeded 4.5-times of the drained blood regardless
whether the end-point of baseline MAP was reached or not.
Conclusions: According to our results, using SVI as goal of resuscita-
tion resulted end-points closest to the physiological baseline values,
whilst CI-based resuscitation ended up with under-, and MAP-guided
fluid replacement caused over-resuscitation in this experiment.
Hence most physicians still use MAP to guide resuscitation, based on
these results our practice should carefully be revised.
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Introduction: Reperfusion injury plays a major role after the resuscita-
tion of hemorrhagic shock. Microcirculatory alterations, however, have
not been completely described in this setting.
Objectives: To characterize the sublingual and intestinal microcircula-
tion during hemorrhagic shock and retransfusion.
Methods: We performed a progressive bleeding followed by
retransfusion in anesthetized and mechanically ventilated sheep
(n = 10). We also studied a sham group (n = 7). Sublingual and in-
testinal microcirculation were quantitatively assessed by means of
SDF-videomicroscopy. Measurements were performed at baseline
(B), first and last step of hemorrhage (H1 and H2), and 30' after
retransfusion (R).
Results: During hemorrhagic shock, all microcirculatory variables
were affected. Blood reinfusion restored intestinal mucosal total and
perfused vascular density, and red blood cell velocity (Panels A, B,
and D). Proportion of perfused vessels, microvascular flow index, and
heterogeneity flow index (Panels C, E, and F) remained altered. A
similar pattern was observed in sublingual mucosa except for red
blood cell velocity, which was reduced.
Conclusions: Reperfusion microvascular injury was mainly character-
ized by decreased perfusion velocity and increased heterogeneity. In
contrast, vascular density was preserved. Sublingual microcirculatory
changes mirrored those from intestinal mucosa.
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Introduction: Septic patients may require large amount of intravas-
cular fluid in the initial resuscitation. Intravascular volume can be di-
vided into unstressed and stressed volume (Vs). Vs represents the
volume haemodynamically active. The systemic vascular compliance
(Csys) quantifies the relationship between the change in volume per
unit of pressure in the compliance vessels.
Objectives: The aim of this study is to compare the Csys and Vs between
patients after cardiac surgery and septic patients after a fluid challenge.
Methods: Patients admitted to the intensive care unit were moni-
tored with invasive arterial blood pressure, a calibrated LiDCOplus
(LiDCO, UK). Mean systemic filling pressure (Pmsf-arm) was measured
using the stop-flow arterial-venous equilibrium method [1]. A fluid
challenge of 4 - 5 mL/kg of Hartmann´s solution was performed over
5 minutes. Csys was calculated as Δvolume/ΔPmsf-arm. Vs was calcu-
lated multiplying Csys times Pmsf-arm at the end of the fluid chal-
lenge. Sepsis was defined by the presence of at least 2 systemic
inflammatory response syndrome criteria and strong suspicion or evi-
dence of infection. Data are presented as median and interquartile
range, and compared using Mann-Whitney U test. p values less than
0.05 were considered statistically significant.
Results: 18 septic and 19 post-cardiac surgery patients were included
in the study. Csys in septic patients was 160.0 (95.8, 240.6) mL/mmHg
while in post-cardiac surgical patients was 86.4 (64.7, 144.0) mL/
mmHg (U = 237.5, p = .04). Vs was 2785 mL (1951, 5625) in septic pa-
tients and 2312 mL (1810, 4650) in post-cardiac surgical patients.
There is no evidence of differences in Vs (U = 195, p = .46) between
septic and post-cardiac surgical patients.
Conclusion: Csys is twice greater in septic patients compared to
cardiac surgical patients but Vs is similar between these two groups.
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Introduction: No method is currently available to predict the effect
of a fluid challenge on tissue perfusion. Capillary refill time (CRT) has
a prognostic value and can assess tissue perfusion during septic
shock (1). Passive leg raising simulates a fluid load with the great
advantage to be reversible.
Objectives: Our hypothesis is that the variation of a digitalized capil-
lary refill time during a passive leg raising could predict the variation
of the CRT after a 500 ml fluid load.
Methods: Hemodynamic variables [CRT, systolic, diastolic and mean
arterial pressure (PAS, PAD, PAM), heart rate (HR), cardiac index (CI)
by transpulmonary thermodilution] were recorded, before and after
a passive leg raising. And after a 500 ml fluid load. Capillary refill
time was recorded with a video camera after a calibrated compres-
sion of the skin using a piston. Four CRT acquisition was made at
each hemodynamic condition and a posteriori analyzed by two
readers ( MR and MJL). The least significant change of the measure
was 25 %. Consequently, responders (CRT-R) were defined as pa-
tients showing a reduction of CRT after the fluid load of at least
25 %. Others were defined as CRT-NR. Variations were calculated
after passive leg raising and after the fluid load. CI responsiveness
was define as an increase of 15 % of the CI after the fluid load.
Spearman correlation test was used. Mann-Whitney-Wilcoxon tests
were used to compare nonparametric independent variables. ROC
curve was build and area under the curve were calculated
(AUCROC). Confidence intervals (CI) were calculated using a 1000
repetitions bootstrap. The best threshold was determined using the
Youden index.
Results: Our institution review board (Comité de Protection des Per-
sonnes Lyon Sud-Est III) approved the study protocol, 29 patients with
circulatory failure were recruited. 11 patients (38 %) were CRT-R, 18
CRT-NR. Passive leg raising induced CRT variations decreased by -41 %
(-30 ;-48) in CRT-R and by -4.5 % (-10 ; 19) in CRT-NR (p < 0.001). Correl-
ation between CRT variation after passive leg raising and after the fluid
load was r = 0.74 (p < 0.001). AUCROC was 0.93 (CI: 0.83 ; 1.0). The best
threshold was -27 %. Sensitivity was 73 (CI: 45-100)%. Specificity was
100 (CI:100-100)% . Among the 13 patients diagnosed with a CI respon-
siveness, seven patients were also CRT-R.
Conclusions: Our method enables a precise and reproducible meas-
urement of the CRT and the detection of a moderate variation of the
CRT. Digitalized CRT variation during a passive leg raising predict CRTvariation after a fluid load. Our method is, in our knowledge, the first
to predict the effect of a fluid load on tissue perfusion.
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Introduction: Adequate empiric antimicrobial therapy is crucial in
terms of survival in patients with severe infections. However, the use of
broad-spectrum antimicrobial treatment is not without its drawbacks.
Objective: The aim of this study was to evaluate factors associated
with no de-escalation therapy in a cohort of patients admitted to the
ICU with severe sepsis.
Methods: Prospective and observational study of patients admitted
to the ICU with severe sepsis or septic shock January 2008 to July
2013. Appropriate cultures were obtained before initiating broad
spectrum antimicrobial therapy and supportive measures were per-
formed following Surviving Sepsis Campaign guidelines. Modification
of the antimicrobial regimen after culture results was left at the
decision of physician in charge of the patient. The following variables
were recorded: demographic characteristics, underlying diseases,
severity of illness at admission (APACHE II and SOFA scores), ad-
equacy of empirical antimicrobial therapy, SOFA score at the day of
culture results, worst SOFA score in the ICU, development of noso-
comial infection, leght of stay and mortality. We also analyzed clin-
ical characteristics, sepsis source, presence of bacteremia and type
of pathogen. We used Student´s T test, Mann-Whitney U test or Chi
square (as appropriate) to compare the variables. A multivariate
analysis was also performed to control for confounding variables in
order to asses the factors associated with no de-escalation.
Results: Eight hundred and fifty two patients were enrolled and de
escalation therapy was performed on two hundred and sixty seven
(31,3 %). The median APACHE II and SOFA scores at admission were
18 (13-24) 7 (5-10) respectivily. Up to 648 (76,1 %) patient of total
cohort had microbiological documentation. The multivariate ana-
lysis showed that the variables associated with not de-escalation
therapy were SOFA score the day of culture results (OR 0,942 IC
95 %), previous antimicrobial therapy (OR 0,555 IC 95 %), liver SOFA
score (OR 0,213 IC 95 %), pulmonar focus (OR 0,491 IC 95 %) and
abdominal focus of infection (OR 0,500 IC 95 %). Blood cultures
possitives, microbiological documentation and combination of anti-
biotic therapy were independent factors associated with de-escalation
therapy.
Conclusions: De-escalation is a feasible strategy in critically ill pa-
tients admitted to the ICU with microbiological documentation,
blood cultures positive and those with combination of antibiotic
therapy.
References
1.- Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, et al.
Deescalation of empirical therapy is associated with lower mortality in
patients with severe sepsis and septic shock. Intensive Care Med 2014;
40:32-40.
2.- Leone M, Bechis C, Baumstarck K, et al. Deescalation versus continuation
of empirical antimicrobial treatment in severe sepsis: a multicenter non-
blinded randomized noninferiority trial. Intensive Care Med 2014;
40:1399-1408.
Fig. 11 (abstract A17). Probability of target attainment efficacy/
toxicity
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 11 of 607A17
Influence of renal replacement therapy modalities on population
pharmacokinetics of amikacin in critically ill patients undergoing
continuous veno-venous haemofiltration and haemodiafiltration
C. Roger1,2, L. Muller1, L. Elotmani1, J. Lipman2,3, J.Y. Lefrant1, J.A. Roberts2,3
1Nimes University Hospital, Department of Anaesthesiology, Critical Care,
Pain and Emergency Medicine, Nimes, France; 2University of
Queensland, Burns Trauma Critical Care Research Centre, Brisbane,
Australia; 3Royal Brisbane & Womens Hospital, Department of Intensive
Care Medicine, Brisbane, Australia
Correspondence: L. Muller – Nimes University Hospital, Department of
Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes, France
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A17
Introduction: Few data are available to guide amikacin dosing regi-
mens in critically ill patients undergoing continuous renal replacement
therapy.1 The aim of the study was to describe amikacin pharmacokin-
etics during continuous veno-venous haemofiltration (CVVH) and
continuous veno-venous haemodiafiltration (CVVHDF). We also used
Monte Carlo simulations to determine the optimal dosing regimens.
Methods: Patients receiving amikacin and undergoing CVVH or
CVVHDF were eligible. Blood samples were collected at ten sampling
times during a dosing interval and assay using a validated LC-MS/MS
method. Population pharmacokinetic analysis and Monte Carlo simu-
lation were undertaken using Pmetrics.
Results: Sixteen patients (four patients received both CVVH and CVVHDF)
were included and twenty sampling profiles (9 CVVH, 11 CVVHDF) were
analysed. A two-compartment linear model best described the data. Pa-
tient weight was the only covariate that was associated with drug clear-
ance. The mean (SD) parameter estimates were 25.2 ± 17.3 L for central
volume, 0.89 ± 1.17 L/h for rate constant for drug distribution from the
central to the peripheral compartment, 2.38 ± 6.60 L/h for rate constant
for drug distribution from the peripheral to the central compartment,
4.45 ± 2.35 L/h for haemodiafiltration clearance and 4.69 ± 2.42 for hae-
mofiltration clearance. After accounting for patient weight, CVVH and
CVVHDF clearance were 5.19 (±0.74) L/h and 4.08 (±0.50) L/h (p = 0.21),
respectively. Dosing simulations for amikacin supported the use of high
dosing regimens (≥25 mg/kg) and extended intervals (36 to 48 h) for
most patients to achieve the pharmacodynamics/pharmacokinetics target
of peak/MIC≥ 8 for efficacy and the lowest probability of target attain-
ment (PTA) of a minimal concentration≥ 2.5 mg/L for toxicity.
Conclusions: A strategy of extended-interval high doses of amikacin
(25 mg/kg 48-hourly) associated with therapeutic drug monitoring
(TDM) should be the best approach for aminoglycoside administration
in critically ill patients receiving continuous renal replacement therapy.
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Introduction: Linezolid (LNZ) is a widely used antibiotic in critically ill
patients as a treatment of infections in which it is certain or suspected
the presence of Gram-positive cocci methicillin or vancomycin resistant
(CGP -MR).
Objectives: To identify clinical factors associated with subtherapeutic
concentrations of LNZ (defined as plasma concentrations [Cmin] < 2
ug / ml) or with its overexposure (defined as plasma concentrations
[Cmin] > 7.5 ug / ml).
Table 13 (abstract A19). Risk Factors for MRB
RZ CHECK LIST OR (IC 95%)
UNIVARIATE
OR (IC 95%)
MULTIVARIATE
Hospitalization >5 days in past 3 months 3,1 (2,1-4,4) 1,7 (1,1- 2,6)
Institutionalized patient 4,2 (2,1-8,6) 3,0 (1,3- 6,9)
Prior MRB colonization/ infection 17,8 (9,4-33,8) 11,3 (5,5-23,2)
Antibiotherapy >7 days in the past month 4,2 (2,9-6,2) 2,1 (1,3- 3,6)
Chronic kidney disease with dialysis 2,0 (0,4-9,3) NS
Colonization susceptibility (bronchiectasis,
cystic fibrosis)
2,4 (1,0-5,4) NS
Table 14 (abstract A19). Relation between comorbidities and MRB
COMORBIDITY OR (IC 95%) UNIVARIATE OR (IC 95%) MULTIVARIATE
DM type II 1,5 (1,1-2,2 NS
COPD 1,9 (1,3-3,0) NS
Malnutrition 1,8 (1,2-2,6) NS
Cirrhosis 3,9 (2,1-7,1) 2,7 (1,4-5,4)
APACHE II >25 2,46 (1,6-3,8) 2,2 (1,4-3,6)
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ICU. All patients who received intravenous LNZ (60-minutes infusion)
at doses of 600 mg every 12 hours, for treatment of a suspected or
confirmed CGP-MR infection in which it was possible to obtain a
blood sample (5 ml) after the third day (steady state) for the deter-
mination of the Cmin, just before administering the next dose, were
included. Patients under renal replacement therapy were excluded.
Demographic variables, comorbidities, severity on admission and
analytical data were evaluated. LNZ quantification was performed
using a high performance liquid chromatography technique (HPLC).
Differences between groups were assessed using chi-square for
categorical variables and Student's t-test or Mann-Whitney test for
continuous variables. Significant variables in the univariate analysis
were included in a multivariate model (logistic regression) to identify
the variables related to sub/supratherapeutic levels. We considered
p < 0.05 to be significant. The predictive value of each formula was
calculated using a receiver operator characteristic curve (ROC), and
the area under the curve (AUC) was also computed.
Results: A total of 103 patients were included. In 58 of them (56.3 %)
the Cmin was < 2 ug / ml and in 30 (29.1 %) the Cmin was >7.5 ug / ml.
Glomerular filtration rate (OR 1.01, 95 % CI 1.00- 1.02; p = 0.002) and
diabetes mellitus (OR 0.24, 95 % CI 0.07-0.83; p = 0.02) were independ-
ently variables associated with subtherapeutic concentrations. The
discrimination ability model obtained an AUC (95 % CI) of 0.808 (0.72
to 0.89). Liver cirrhosis (OR 14.51, 95 % CI 1.35-156.40; p = 0.03) and
glomerular filtration rate (OR 0.98, 95 % CI 0.97 to 0.99 p = 0.002) were
independently variables associated with supratherapeutic concentra-
tions. The discrimination ability model obtained an AUC (95 % CI) 0.81
(0.72 to 0.898).
Conclusions: Variables related to sub and supra-therapeutic LNZ
concentrations in critically ill patients admitted to the ICU have been
identified. Presence of these variables would require the determin-
ation of plasma levels of LNZ. Glomerular filtration rate is the variable
that influences both groups.
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Introduction: Multirresistant bacteria (MRB) development is a grow-
ing phenomenon. In 2013, the “Zero Resistance” (RZ) program was
launched in Spain, to help prevent the emergence of MRB in critically
ill patients. One of its recommendations is to complete a checklist
upon patient admission in Intensive Care Unit (ICU) to identify those
patients at high risk for colonization or infection by MRB.
AIMS. To analyse the effectiveness of the checklist for risk factors
(RF) proposed by the RZ project as a way of MRB early detection.
Methods: A prospective study from March/2014 to January/2016. All
patients admitted to a polyvalent ICU of a general hospital were
submitted to the checklist proposed, with the application of contact
precaution (CP) strategies for patients with RF for MRB. Bacteriologic
swabs (nasal, pharyngeal, axillary and rectal) were routinely performed
on all patients admitted, besides diagnostic cultures when necessary.
Furthermore, we analysed other pathological variables and comor-
bidities (diabetes, renal failure, immunosuppression state, neoplasia,
cirrhosis, chronic obstructive pulmonary disease -COPD-, organ
transplantation, malnutrition or type of admission to ICU - urgent
or programmed). Univariate and multivariate analysis of RF for MRB
with binary logistic regression were performed. Statistical signifi-
cance was set at CI 95 %.
Results: 1651 patients were admitted. 532 (32,2 %) met some CP cri-
teria. In 136 (8,2 %) were detected one or more MRB, 87 of these
(64 %) presented CP criteria according to the checklist. 37 met 1criteria, 31 met 2 criteria and 19 met 3 or more criteria with accumu-
lation of risk (p < 0,001). In 49 (36 %) MRB carriers it was not identi-
fied any of the RF from the checklist. Tables 13 and 14 show risk
factors and comorbidities that were significant as added risk for MRB.
Conclusion: After comparing to previous analysis, it was seen that,
increasing the sample size, almost all RF included in the RZ checklist
were predictors of MRB. Despite this, it could not detect 36 % of the
patients infected or colonized by MRB. Because of that, we should
consider other factors to predict the presence of a MRB on admitted
patients to ICU.
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Introduction: Development of candidemia and bacteremia caused by
multidrug-resistant (MDR) pathogens in hospitalized patients signifi-
cantly increases the risk of adverse outcome [1-3]. The main task of
the antibiotic stewardship program (ASP) is to reduce the microbial
resistance and decrease incidence of infectious complications caused
by MDR pathogens.
Objectives: To estimate the etiological structure and clinical outcome
in patients with bacteremia in a multidisciplinary hospital in the
period before and after the implementation of ASP.
Methods: Interventional study with historical controls. The intervention:
ASP, including a group of experts on antimicrobial therapy (AMT), AMT
and prophylaxis protocols, infection control, internal audit. Study onset:
June 2013. Analysis of pre-intervention (Jan. 2011-June 2013) and
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 13 of 607intervention (July 2013-Dec. 2015) periods was carried out. We assessed
incidence of bacteremia caused by methicillin-resistant S. aureus
(MRSA), vancomycin-resistant Enterococci (VRE), ESBL-producing Entero-
bacteriaceae, MDR Gram-negative non-fermenting bacteria (MDR-
NFGB), incidence of candidemia. The hospital length of stay (LOS) and
mortality of patients with bacteremia were secondary end-points.
Results: In the pre-intervention period 2905 blood samples were
analyzed, 448 (15.4 %) positive blood cultures from 206 patients
were obtained; in the interventional period 2742 blood samples
were analyzed, 470 (17.1 %) positive blood cultures from 230
patients were obtained.
In the intervention period a significant decrease in the incidence of
bacteremia caused by MDR-NFGB from 55 (12.3 %) to 20 (4.3 %), p <
0.001, VRE from 10 (2.2 %) to 0, p = 0.0011 and incidence of candidemia
from 29 (6.5 %) to 13 (2.85), p < 0.01, was detected. The frequency of
bacteremia caused by ESBL-producing Enterobacteriae did not signifi-
cantly change [91 (20.3 %) vs. 108 (23.0 %), p > 0.05]. Number of MRSA
bacteremias remained low [6 (1.3 %) vs. 4 (0.9 %), p > 0.05]. There was
a significant reduction of mortality from 30.6 % to 20.3 %, p < 0.025 in
the group of patients with bacteremia. The LOS did not change signifi-
cantly [29 (IQI 19-52) vs. 27 (IQI 17-53), p > 0.05].
Conclusions: Implementation of ASP in multidisciplinary surgical
hospital allows significantly decrease incidence of candidemia and
bacteremia caused by MDR-NFGNB and VRE. As a result - reduction
in mortality in patients with bacteremia.
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Rationale: Poor sleep is common in intensive care unit (ICU) patients
and environmental factors contribute to sleep deprivation and alter-
ations of sleep architecture. The objective of the present study was
to evaluate the impact of earplugs and eye masks on sleep architec-
ture in ICU patients.
Patients and methods: A single center randomized controlled trial of
64 ICU patients was conducted from July 2011 to December 2013.
Patients were randomly assigned to sleep with or without earplugs
and a facemask. A polysomnography was performed on the first day
and night following inclusion. The primary end point was the propor-
tion of sleep stage 3 + 4. Secondary end points were other descrip-
tors of sleep and major outcome variables.
Results: In the intervention group, 33 % of patients did not wear
earplugs all night long. The proportion of sleep stage 3 + 4 was 11
[3-23]% in the control group and 13 [6-23]% in the protective
group (p = 0.72). Other descriptors of sleep were not different be-
tween the two groups except the number of long awaking that was
lower in the protective group than in the control group (21 [19-26] vs.
31 [21-47], p = 0.02). There was no difference among the two groups in
terms of sleep quality, occurrence of a delirium, ICU length of stay andmortality, anxiety and depression on ICU discharge and day-90 and the
incidence of post-traumatic stress disorder.
Conclusion: In ICU patients, earplugs and eye mask are not well
accepted by patients, do not increase the proportion of sleep stage
3 + 4 but decrease the number of prolonged awakenings. They had
no impact on the outcome.
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Introduction: Postoperative pulmonary dysfunction after cardiac
surgery with the use of cardiopulmonary bypass (CPB) is common,
ranging from transient hypoxemia to acute respiratory distress syn-
drome (ARDS). It is triggered by an inflammatory response, disrupted
coagulation, ischemia-reperfusion injury, and oxidative stress. How-
ever, as the nadir of partial pressure of arterial oxygen (PaO2) appears
on the second to third postoperative day, it is of paramount import-
ance to identify patients at risk at an early stage. Determining the
progression into hypoxemia is challenging, as no early diagnostic test
exists. We hypothesized that metobonomics can provide new insights
into the pathogenesis of pulmonary dysfunction, thus potentially enab-
ling the identification of specific biomarkers of lung injury.
Objectives: To use a human model of cardiac surgery to study the
progression into postoperative hypoxemia by means of blood
metabonomics.
Methods: Fifty consecutive patients undergoing cardiac surgery were
included. Arterial blood samples were collected the day before sur-
gery, and 48 and 72 hours (h) postoperatively. In addition, samples
from the pulmonary artery and the left atrium were collected at
seven different time points: just before CPB, straight after CPB (0 h),
and 2, 4, 8, 20, 48, and 78 h after CPB. Samples were analyzed by
nuclear magnetic resonance (NMR) spectroscopy. Statistical methods,
including principal component analysis (PCA), partial least-square
regression (PLS) and discriminant analysis (PLS-DA), were applied to
find metabolite patterns related to surgical trauma and postoperative
hypoxemia. Venetian-Blinds cross-validation and permutation testing
were used for validation.
Results: All patients had a normal preoperative PaO2; 11.3 ± 1.3 kPa
(mean ± SD). PaO2 decreased to 7.9 ± 1.5 kPa at 48 h, and to 7.8 ± 1.4
kPa at 72 h, respectively. Twenty-three patients developed moderate
hypoxemia (PaO2 ≤ 8 kPa) and 9 patients had severe hypoxemia
(PaO2 ≤ 6 kPa). NMR showed major shifts in the metabolome during
and after surgery. Different metabolites were identified at different
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 14 of 607timepoints, of which several were directly correlated to the progres-
sion into hypoxemia. PLS-DA modeling predicted postoperative hyp-
oxemia at 72 h with 72.2 % sensitivity and 81.0 % specificity based
on blood samples collected just before CPB, while PLS models revealed
a correlation of r2 equal to 0.7. Higher predictive values (>88 % sensitiv-
ity, >92 % specificity, and r2 > 0.91) were achieved when analyzing
blood collected 0, 2, 4, 8, and 20 h postoperatively, demonstrating the
ability of metabonomics in early diagnosis.
Conclusion: We found that metabonomics may contribute to the
detection of early signs of pulmonary dysfunction two-three days
before significant postoperative hypoxemia. The study provides
novel insights into the underlying mechanisms that trigger progres-
sion into hypoxemia, facilitating new hypotheses and treatment
options.
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Introduction: Gravity plays a pivotal role in the pathogenesis of
ventilator-associated pneumonia (VAP) (1). In previous laboratory
studies (2) the semi-lateral Trendelenburg position (LTP) hindered
gravity-driven pulmonary aspiration and avoided VAP.
Objectives: To determine whether the LTP vs. the semi-recumbent
position (SRP) would reduce the incidence of microbiologically con-
firmed VAP and to appraise patient's compliance and safety.
Methods: We conducted a randomized, single-blind, controlled study
in 17 European centers and 1 in North America. A total of 2019 adult
patients were screened between 2010 and 2015. 395 patients were
randomized - 194 in LTP and 201 in SRP - and analyzed in an intention
to treat approach. Patients in LTP were placed in semi-lateral (60°) -
Trendelenburg position to achieve an orientation, from the sternal
notch toward the mouth, slightly below horizontal, and turned from
one side to the other every 6 hours. LTP was encouraged during the
first days of mechanical ventilation, but always in compliance with the
patient's wish. In the SRP group, the head of the bed was ele-
vated ≥ 30°. Primary outcome was VAP incidence rate, based on
quantitative bronchoalveolar lavage fluid culture with ≥ 104 colony-
forming units/mL. Secondary outcomes were compliance to the
randomized position, length of intubation, duration of intensive
care unit and hospital stay, mortality, and adverse events.
Results: The trial was stopped after the planned interim analysis for
achieving efficacy endpoints and owing to safety concerns. Patientsin the LTP and SRP group were kept in the randomized position for
38 % and 90 % of the study time, respectively (p = 0.001). Yet, during
the first 48 hours, LTP patients were kept in the randomized position
for 50 % of the study time, and SRP patients for 88 % (p = 0.001). In
the LTP, the bed was angulated 5.6° in Trendelenburg; while, the
head of the bed was elevated 34.1° in the SRP group. Incidence rates
of microbiologically confirmed VAP were 0.88 (1/1136 patient-days;
95 % confidence interval [CI], 0.12-6.25) in the LTP group, and 7.19
(8/1113 patient-days; CI 95 %, 3.60-14.37) in the SRP (p = 0.020),
relative risk reduction of 0.12 (95 % CI, 0.01-0.91). No statistically
significant differences were observed in durations of mechanical
ventilation, intensive care unit and hospital stay, and mortality.
Vomiting was more common in LTP patients (8.3 % vs. 2.5 % in the
SRP, p = 0.013).
Conclusions: Critically ill patients positioned in the LTP had a statis-
tically significant reduction in the incidence of VAP, compared with
those positioned in the SRP. A comprehensive evaluation of poten-
tial LTP contraindications is warranted to enhance safety.
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Introduction: Ventilator Associated Pneumonia (VAP) is the most
common nosocomial infection in Intensive Care Units (ICUs), which
increases the length of ICU stay, duration of mechanical ventilation,
and mortality.
Objectives: The present study used an oral care protocol and com-
pared the effects of two different concentrations of chlorhexidine on
reduction of oropharyngeal colonization and VAP.
Methods: This study was performed on 114 patients from trauma,
surgery, neurosurgery, and general ICUs randomly allocated to two
groups under oral care with 0.2 % and 2 % chlorhexidine solution. A
multidisciplinary team approved the oral care protocol. The data
were collected using a demographic information form, Apache IV
form, Beck oral assessment scale, mucosal-plaque assessment scale,
and oropharyngeal swab culture.
Results: The results showed a significant reduction in VAP (p = 0.007)
and oropharyngeal colonization (p = 0.007) in the group under oral
care with 2 % chlorhexidine solution compared to the other group.
However, no significant difference was found between the two
groups in terms of oropharyngeal adverse effects (p = 0.361).
Conclusions: Oral decontamination with 2 % compared to 0.2 %
chlorhexidine is a more effective method in prevention of VAP and
reduction of oropharyngeal colonization (especially gram-positive).
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Table 15 (abstract A25). Ventilation pattern and gas exchange
Right embolization
+ lavage + high
Vt (n= 5)
Left embolization
+ lavage + high
Vt (n= 4)
Lavage + high
Vt (n= 5)
Right embolization
+ low Vt ventilation
(n= 3)
Low Vt
ventilation
(n=3)
P-value
ANOVA
Vt (ml/kg) 20.1 ± 2.5°# 18.7 ± 2.7°# 23.5 ± 2.3*°# 8.1 ± 0.2 8.0 ± 0.3 <0.001
PEEP
(cmH2O)
0 ± 0°# 0 ± 0°# 0 ± 0°# 5 ± 0 5 ± 0 <0.001
PaO2/FiO2 460 ± 95* 102 ± 74 489 ± 121* 477 ± 7* 568 ± 10* <0.001
PaCO2
(mmHg)
35.8 ± 4.3* 52.5 ± 10.1 34.2 ± 10.3* 41.3 ± 3.0 41.3 ± 5.0 <0.05
pH 7.52 ± 0.05 7.39 ± 0.09 7.55 ± 0.09 7.50 ± 0.02 7.51 ±
0.03
<0.05
*p <0.05 vs. left emb. + lavage + high Vt; ° p <0.05 vs. right emb. + low Vt; #p
<0.05 vs. low Vt; all by Tukey test
Table 16 (abstract A25). Severity of lung injury
Right embolization
+ lavage + high
Vt (n= 5)
Left embolization
+ lavage+ high
Vt (n= 4)
Lavage + high
Vt (n= 5)
Right embolization
+ low Vt (n= 3)
Low Vt
(n=3)
P-value
ANOVA
PawPlat
(cmH2O)
36 ± 9°# 43 ± 4°# 38 ± 4°# 18 ± 1 19 ± 2 <0.001
Crs (ml/
cmH2O)
34 ± 6 26 ± 6 39 ± 8* 38 ± 2 38 ± 5 <0.05
CT-scan total
lung tissue (g)
222 ± 124 369 ± 160 193 ± 166 43 ± 5 117 ±
28*
<0.05
CT-scan right
lung tissue (g)
103 ± 58 270 ± 119 101 ± 88 27 ± 2* 90 ±
31
<0.001
CT-scan left
lung tissue (g)
119 ± 68 98 ± 44 91 ± 78 15 ± 3 26 ± 3 0.09
*p <0.05 vs. left emb. + lavage + high Vt; °p <0.05 vs. right emb. + low Vt; #p
<0.05 vs. low Vt; all by Tukey test
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Introduction: Previous studies showed that, in the presence of pre-
served ventilation, interruption of regional pulmonary blood flow
rapidly leads to severe ventilation-induced lung injury (VILI) [1-2].
These data suggest that tissue alkalosis might be a multiplication
factor for VILI [3], especially in the presence of high tidal volume (Vt)
ventilation and/or pre-existing lung injury.
Objectives: We investigated the alterations in blood gases, respira-
tory mechanics and CT-scan imaging in an animal model of con-
trolled unilateral lobar pulmonary artery occlusion followed by lung
lavage and high Vt ventilation.
Methods: We report data from 20 pigs (weight 61 ± 2 Kg). Animals
were randomly assigned to the following 5 study groups: 1. Five
animals underwent right lower lobar endovascular embolization,
lung lavage with 500 ml of normal saline solution and high Vt ven-
tilation for 8 hours; 2. Four animals underwent left lower lobar
embolization, lavage and high Vt ventilation; 3. Five pigs received
lung lavage and high Vt ventilation; 4. Three animals received
right lower lobar embolization and low Vt ventilation; 5. Three
animals received only low Vt ventilation. In groups 1, 2 and 4 se-
lective embolization of the pulmonary artery branch perfusing the
lower lobe of the right or left lung was performed under fluoros-
copy guidance by expert radiologist; in group 1-3, Vt was set at
20-25 ml/Kg with plateau pressure ≤40 cmH2O and peak pressure
≤50 cmH2O, without positive end-expiratory pressure (PEEP) and
respiratory rate of 7-9 breaths/minute to control pH. In groups 3
and 5, Vt was 6-8 ml/Kg with PEEP 5 cmH2O. After 8 hours, the ani-
mals underwent physiologic data collection and chest CT scan at
zero PEEP. CT images were analysed offline by custom-made soft-
ware. Data were analysed by one-way ANOVA and Tukey post-hoc
tests.
Results: Main parameters describing pathophysiological character-
istics of each group after 8 hours are reported in Tables 15 and
16. Lung lavage and high Vt ventilation following regional
embolization led to more severe impairment of oxygenation (p <
0.001), especially in the left embolization group. Lung mechanics
at the end of the experiment showed similar trend: plateau pres-
sure was higher and respiratory system compliance lower (p <
0.05) in the embolization + lavage + high Vt groups. Finally, CT-
scan revealed higher lung weight in groups 1 and 2 (p < 0.05).
Interestingly, in the same groups, the non-embolized lungs were
heavier, as if embolization triggered more severe ventilation-
induced lung oedema that could develop mainly where perfusion
was preserved.
Conclusions: Regional block of lung perfusion might amplify lung in-
jury due to lavage and high Vt ventilation.
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Introduction: Acute kidney injury (AKI) is a multifactorial syndrome,
but knowledge regarding its pathophysiology and possible genetic
background is limited. Recently the first hypothesis free genetic asso-
ciation studies have been published to explore the individual suscep-
tibility to AKI.
Objectives: We aimed to replicate the previous associations of candi-
date polymorphisms (N = 5) with development of AKI (1) using a pro-
spectively collected cohort of septic critically ill patients in Finland.
Methods: We included all septic patients with genetic samples
among the 2968 FINNAKI study patients. After exclusion of 401 pa-
tients (due to underlying chronic kidney disease, lack of DNA or
genotyping quality) 837 (of the remaining 2567) had sepsis. AKI was
defined according to the KDIGO criteria, considering stages 2 and 3
affected and KDIGO 0 unaffected.
The genotyping was done using iPLEX™ Assay (Agena Bioscience).
The genotyped SNPs were rs8094315 and rs12457893 in the intron
of the BCL2 gene, rs2093266 in the SERPINA4 gene, rs1955656 in the
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 16 of 607SERPINA5 gene and rs625145 in the SIK3 gene. Association analyses
were performed using logistic regression with PLINK software.
Results: We found no significant associations between SNPs rs8094315
(OR 1.10, p 0.4827), rs12457893 (OR 1.02, p 0.8736), rs2093266 (OR 0.77,
p 0.1525), rs1955656 (OR 0.77, p 0.1525) and rs625145 (OR 0.89, p
0.3967) and AKI comparing 354 AKI patients and 299 non-AKI patients
(Table 17). AKI patients were significantly older, had higher BMI, more
often diabetes and COPD, had received more often colloids before
admission to ICU, and had lower platelet count. Multivariate logistic re-
gression analysis with adjustment for sex and these baseline differences
did not change our findings.
Conclusions: We could not confirm the previously reported associa-
tions between five SNPs and development of AKI KDIGO 2/3 in critic-
ally ill septic patients.
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Sigrid Juselius Foundation (V.P.).Table 17 (abstract A26). Associations in univariate and multivariate
analysis between SNPs and AKI
SNP Gene Genotype
available
Major allele/
Minor allele
Minor Allele
Frequencya
Univariate p Adjusted p b
rs625145 SIK3 653 A/T 0.20/0.21 0.3967 0.4455
rs1955656 SERPINA5 653 G/A 0.10/0.12 0.1525 0.1981
rs2093266 SERPINA4 653 G/A 0.10/0.12 0.1525 0.1981
rs8094315 BCL2 650 A/G 0.24/0.22 0.4827 0.5187
rs12457893 BCL2 653 A/C 0.37/0.37 0.8736 0.7715
aCases/controls, bAdjusted for age, BMI, diabetes, COPD, receiving colloids pre
ICU, minimum platelet count and sex
Fig. 12 (abstract A27). RRI for each AKI stage (mean+95% CI)
Fig. 13 (abstract A27). ROC curves for AKI stage 2 and 3A27
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Introduction: Acute kidney injury (AKI) is a severe complication of crit-
ical illness, often accompanied by vasoconstriction in the renal arteries
and microcirculation. Its diagnosis is mainly based on a rise in serum
creatinine, which is a late phenomenon. The Renal Resistive Index (RRI),
measured with Doppler ultrasound, represents a new non-invasive
diagnostic tool assessing flow resistance in the renal circulation, early
after admission.(1)
Objectives: To determine whether RRI measured on intensive care
unit (ICU) admission is an early predictor and discriminator of AKI de-
velopment and severity, developing within the first week after ICU
admission, and if RRI predicts AKI independently of other AKI risk
factors.
Methods: Prospective observational cohort study in ICU patients. AKI
development and stage were defined by the KDIGO criteria. To
increase the likelihood of including patients developing AKI, two
cohorts of patients were included within 24 h after ICU admission:
Patients with shock and without shock. Patients with eGFR < 30 ml/
min were excluded. Besides routine ICU measurements, including risk
factors for developing AKI, three study measurements were performed
at inclusion: RRI, sublingual sidestream dark field imaging (SDF) to visu-
alise microcirculation, and Bioelectrical Impedance Analysis (BIA) as amarker of fluid status. Uni- and multivariate and ROC curve analyses
were performed to assess predictive and discriminative value of RRI
and other variables for the development of AKI.
Results: We included 99 patients, mean age 65, mean APACHE III score
73. 49 patients (49 %) developed AKI within the first week (mean
2.2 days after inclusion). Patients who developed AKI had a significantly
higher RRI on inclusion than those who did not: 0.708 (0.687-0.730) vs
0.654 (0.631-0.677), p = 0.001. Compared to patients without AKI, RRI
was significantly higher in patients with AKI stage 2 and 3, but not in
patients with AKI stage 1 (Fig. 12).
We therefore chose AKI stage 2 and 3 as endpoint in further analysis.
On univariate analysis, RRI was a significant predictor of AKI (OR 1.012,
95 % CI 1.006-1.019), along with other parameters including: APACHE
III, fluid balance and BIA derived reactance, but not sublingual microcir-
culation. On multivariate analysis, RRI, APACHE III and fluid balance
remained significant. The AUC of RRI for AKI stage 2 and 3 was 0.721
(95 % CI 0.612-0.831). The composite AUC of the multivariate predictors
was 0.825 (Fig. 13).
Conclusions: In this observational study, RRI on ICU admission was a
significant independent early predictor for development of AKI stage 2
and 3 during the first week, but not for AKI stage 1. Of all evaluated
predictors, APACHE III, as a marker of severity of disease, and fluid bal-
ance were additional independent predictors of AKI, suggesting that
other factors than vasoconstriction contribute to AKI development.
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Introduction: Post-sepsis syndrome describe the group of long-
term problems that some people with sepsis experience. Acute
kidney injury (AKI) is associated with increased short-term mor-
tality of septic patients; however, the exact influence of AKI on
long-term mortality has not yet been determined. Herein, we
sought to evaluate the impact of sepsis on kidney structures of
survivors.
Methods: Adult Wistar rats (200 g) were submitted to sepsis [iv.
2 mL E. coli 108 (S8) or 109 CFU/ mL (S9), DL60 and DL80, re-
spectively, in 26 hours].Under general anesthesia, the microcircu-
lation of the renal cortex area was monitored by Sidestream Dark
Field Imaging (SDF) video-microscopy, at 6 hours (T6h, n = 3/
group) and 30 days (T30d, n = 3/group) after sepsis. The kidney
samples were evaluated by histology (T0, T6h, T30d) using H.E
and PAS dyes.
Results: SDF findings (Fig. 14) of S8-T6h showed broadly distrib-
uted microcirculation dysfunction. The outlining of tubules be-
came blurred by their enlargement leading to the compression
of tubular lumen and of the peritubular microvessels, suggesting
an ongoing obstructive phenomenon in a progressive manner by
tubular wall edema. The heterogeneous dysfunction pattern was
disseminated in entire screen. S9-T6h showed similar findings,
however more intensely. The histology (Fig. 15) confirmed the
ongoing obstructive phenomena at S8-T6h, and also showed gen-
eralized peritubular microvessels congestion, multiple glomerulus
without mesangial area, inflammatory infiltrate in the connective
tissue and hyaline degeneration suggestive of ongoing cellular
dysfunction/death. The histological results of S9-T6h showed simi-
lar pattern with the enlargement of the epithelial cells of convo-
luted tubules with reduced lumen, and with compressed or
dilated peritubular microvessels. In addition, numerous tubular
epithelial cells showed membrane injury, nuclear pycnosis and
necrosis. At S8-T30d, although the general findings were better,
as compared to the early phase sepsis (T6h), the histological find-
ings demonstrated a persistence of significant peritubular and
glomerular congestions with intense inflammatory infiltrate in the
connective tissues, nucleus contractions suggestive of cell death,
and collecting ducts injuries. PAS staining demonstrated wide-
spread hyaline degeneration. The more severe sepsis, S9-T30d
group, showed a widespread congestion around the collecting
tubules and peritubular congestion of the small and large vessels.
Also was observed glomerulus without mesangial areas, intense
congestion and hyaline degeneration of the collecting tubules
and of the cortex tubules region. The general findings were of
the ischemic renal injury pattern. These findings showed that
renal dysfunction persists at 30 days after sepsis, and that the
presence of any pathological stimuli, may decay the renal physio-
logical capacity quickly, justifying the fragility of renal physiology
in patients who survived sepsis.
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Fig. 16 (abstract A30). LED phophorimeter schematic drawing
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demonstrated beneficial effects on acute kidney injury (AKI) and/or
cardiac function, after coronary angiography (CA), in high risk patients.
However, the protective effects by RIPC may be attenuated in diabetic
patients
Objectives: The purpose of this study was to evaluate the effects of
RIPC on the myocardial and renal function as measured by plasma
Troponin I and proBNP, and creatinine and cystatin C levels (as an
early marker of glomerular function), before and after CA in diabetic
patients.
Methods: A prospective randomized, single centre pilot trial was
conducted at University Hospital Sta. Lucia, Spain. We analyzed 50
diabetic adult patients with acute coronary syndrome admitted to a
medical intensive care unit, with a diagnosis of diabetes before
admission, undergoing standard CA.
We established two groups: standard CA with remote RPIC (RIPC
group) trough intermittent upper-arm ischemia before CA, or without
RIPC (control group). We recorded demographical, clinical, and ana-
lytical data of the patients, before and after 72 hours of procedure.
We analyzed qualitative variables with percentages by categories
and square Chi; quantitative variable with mean, standard deviation
and T Student; or median, interquartile rank and U Mann Whitney; or
regression, depending on the statistical distribution.
Results: Patients receiving RIPC showed lower troponin I peak (ng/ml)
3.3 (0.98-13.5) compared to control group 18 (1.76-31.15); p = 0.053;
and the NT-proBNP (pg/ml) increasing after 72 hours was -946
(-2977—20); compared to control group 73 (-426- 2210); p = 0.005.
Regarding to renal function, basal and after 72 hours, creatinine
and cystatine-C plasma levels were similar in both groups. The crea-
tinin (mg/dl) increments after 24 hours were (RIPC; 0(-14-10; control
-5.5(-16-8) p > 0.05 and cystacin C (mg/L) RIPC, 3 (-7-11) and control
-4 (-9-13) p > 0.05.
The calculated mean Mehran score for both groups in the present
study was8 in RIPC group and 8.5 (control group), thus determining
the present study population as a group at medium risk of develop-
ing AKI. No adverse effects were related to RIPC maneuver in any
patient.
Conclusions: The RIPC maneuver in diabetic patients before CA dem-
onstrated beneficial on cardiac function without affecting renal pa-
rameters. The mechanisms underlying these effects merit further
investigation
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A30Introduction: Quantitative measurement of microcirculatory and of
tissue oxygen concentration is of prime importance in experimental
research. Non-invasive time resolved quenching of Palladium-porphyrin
phosphorescence injected into experimental animals has given much
fundamental insight in mechanisms of oxygen transport to tissue in
health and models of disease. Until now, most of the phosphorimeters
used flash lamps as a light excitation source. However, a major draw-
back of flash lamps is the plasma glow that persists for tens of micro-
seconds after the primary discharge. When a flash lamp produces a
pulse, a tail remains causing unwanted further excitation to the initial
pulse of the phosphor in a time dependent manner. This generates a
complex excitation pulse pattern, which if not taken into account using
deconvolution analysis, can lead to inaccurate PO2 readings.
Objectives: To design and calibrate a new LED-based phosphori-
meter (LED-P) that address previous drawbacks of flash-lamp phos-
phorimeter (FL-P). We validate the LED-P with in vitro and vivo
experimental studies
Methods: We designed the LED-P using 4 LEDs of different colours
(blue, green, yellow, red), each with a narrow-band wavelength
(20 nm), providing excitation light pulses within the range of several
phosphorescent dyes often use in experimental studies.
We calibrated in vitro the device using the Palladium-porphyrin
phosphorescent dye at different temperatures ( 19, 25, 28, 32, 34, 37
and 39 °C) and adjusted pH (6.8, 7.0, 7.2, 7.4, 7.6) with an enzymatic
reaction producing step by step decrease of oxygen content and
analysing the decay times of phosphorescence (τ). The oxygen con-
tent was measured with a solid-state polymer optical fiber sensor
oxygen optode (POF, Oxy-Mini, World Precision Instruments, USA). In
vivo calibration was performed in a rat model by exposing the kid-
ney. We ventilated the animal in different hypoxic conditions (15, 7
and 4 % O2) and performed renal ischemia/reperfusion injury by
clamping the renal artery.
Results: The LED-P exhibited a block shape light pulse without after-
glow eliminating the need for deconvolution of the light emission
signal coming from the tissue under analysis. A perfect linear regres-
sion was observed after plotting decay times ratio (τ0/τ) and in vitro
oxygen concentration (r2 = 0.99). In vivo, the LED-P showed similar
kidney microvascular PO2 compared to previously published works,
in hypoxia or ischemia conditions.
Conclusions: This new LED-P provides minimally-invasive, accurate
and reliable measurements of microvascular PO2 in the kidney, with-
out the need of complex mathematical deconvolution of the light
emission signal coming from the tissue. LEDs are much cheaper, with
a smaller sized and simpler electronics, are more energy efficient,
have a longer lifetime. This LED-P provides the ability to choose
which LED to enable/disable to excite different phosphorescent dyes
within the same measurement.
Fig. 17 (abstract A30). Trends in kidney μPO2 during hypoxia and
ischemia
Fig. 18 (abstract A31). Leukocytes count in systemic and
microcirculation
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Introduction: Systemic inflammatory response is a complication that
occurs frequently in cardiac surgery patients with extracorporeal circu-
lation (EC). Leucocytosis is a common outcome after cardiac surgery
due to surgical trauma, blood contact to nonendothelial surfaces in the
EC, endotoxaemia and ischemia reperfusion injury due to aortic cross
clamping and release. This induces an activation of complement fac-
tors, coagulation pathways and cellular immune response. Leucocyte
(Lc) adhesion to the endothelial followed by diapedesis is a key compo-
nent of the inflammatory response. In the context of cardiac surgery
therefore Lc adhesion is expected especially following release of cross
clamp. Currently there is no direct method of identifying this behavorof Lc in the microcirculation. This study describes the use of Cytocam
IDF imaging (handheld video microscope) as a tool to identify and
quantify the behavior of Lc in the sublingual microcirculation of pa-
tients during surgery.
Objectives: The introduction and application of an algorithm as a
method to count non-invasively Lc in the microcirculation.
Methods: In this prospective observational study videos of the sublin-
gual microcirculation during, coronary artery bypass surgery with EC,
were recorded with the use of the CytoCam (Braedius Medical,
Amsterdam, The Netherlands). Two time points were measured, baseline
(T0) after induction of anesthesia before CPB, second time point (T1)
after release cross clamp.25 patients were recruited, of which 10 were in-
cluded in this study based on evaluation of the sublingual video images
using a quality criteria in order to identify at least one post capillary
venule (PCV) where focus of the red blood cells is primarily important.
Patients in this group received blood transfusions during surgery.3 clips
for each time point with duration of 4 sec (25 frames/sec) in different
spots were captured. Identifying a PCV to count the activated Lc: sticking
and rolling Lc on the wall of the PCV. Converting these clips into movies
with a lower frame rate in order to match the velocity of the leukocytes
to that of the frame speed allowed the movement of the rbc's to look
unclear. Selecting 2-5 PCV good quality for each clip ( at least one PCV).
Results: The rolling/sticking Lc from T0 (7.3 ± 1.5 Lc/PCV/4 sec) to T1
(14.5 ± 0.7 Lc/PCV/4 sec) increased significantly (P = < 0.0001). The
systemic leukocytes before (7.2 ± 0.9 x10^9/L ) and after (10.6 ± 1.5
x10^9/L ) surgery also increased significantly (p = 0.0002).
Conclusions: This study introduces a bedside methodology using
CytoCam IDF imaging for quantifying Lc activation of sublingual
microcirculation. Application of this methodology to cardiac surgery
identified an increase in microcirculatory activated Lc in parallel to
an increase in Lc numbers in the systemic circulation.
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Fig. 19 (abstract A32). Effects of GM-CSG, INFγ on mHLA-DR geo-
metric mean intesity in post-operative serum. Results are depicted in
a dot plot with media and IQR, n=12, 3 independent experiments
Fig. 20 (abstract A32). mRNA levels in monocytes incubated with
post-operative serum containing either GM-CSF or INFγ. Dot plots,
with median and IQR represented, n=12
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Introduction: We have previously demonstrated that the incidence
of infection following major abdominal surgery is 35 %1 and is asso-
ciated with the extent of post-operative immune suppression2. It
remains unclear which clinically available immune stimulant may
best suited as an adjunct to prevent post-operative infection.
Objectives: To determine whether Granulocyte macrophage colony-
stimulating factor (GM-CSF) and interferon gamma (IFNγ) act through
different pathways in reversing defects in monocyte antigen presen-
tation following major abdominal surgery.
Methods: Serum was collected from 12 patients undergoing elect-
ive abdominal surgery (Research ethics approved). The median
patient age was 68 years (IQR 48-74), median operation time was
270mins (IQR 207-320) and 50 % (6) developed nosocomial
infection.
Pooled healthy peripheral blood mononuclear cells (PMBCs) were
incubated with media containing 30 % serum taken either pre-
operatively or 24 hrs post operatively and then with the addition of
GM-CSF (10 ng/ml) and INFg 250 IU/ml).
Monocyte human leucocyte antigen-DR (mHLA-DR) membrane
density (geometric mean fluorescent intensity) was characterised
using flow cytometry following a 20-hour incubation. Cells were
then sorted on a BD FACS ARIA IIIu system using CD14 positive
selection. Messenger RNA (mRNA) was extracted from the sorted
population (>90 % purity post sorting). Genes of interest were
quantified using polymerase chain reaction (PCR) using TaqMan®
labelled primers and real time PCR (ABI HT7900).
Flow cytometry data was analysed using FlowJo. Continuous vari-
ables were analysed using a Wilcoxin signed-rank test (JMP (version
11) statistical software).
Results: PMBCs incubated with post-operative serum demon-
strated a significant reduction in mHLA-DR membrane density
(Fig. 19, p = 0.001). The reduction in mHLA-DR density was pre-
vented when co-incubated with GM-CSF and IFNγ (Fig. 19).
Incubation with IFNγ but not GM-CSF increased expression of
HLA-DRα chain (p = 0.01), Cathepsin S (CTSS) (p = 0.001), suppres-
sor of cytokine signalling 3 (SOCS3) (p = 0.01) and March 1 (p =
0.002) (Fig. 20).
Conclusions: These results suggest that these immune stimulants,
GM-CSF and IFNγ, exert their effects on monocyte antigen pres-
entation through different signalling pathways. The increased
gene expression associated with IFNγ may be indicative of po-
tential therapeutic benefit in reversing post-operative immune
suppression.
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Table 18 (abstract A33). Implementation strategies useda
Category Guideline implementation
Professional 1. Distribution of educational materials 2. Educational meetings
3. Local consensus processes 4.Outreach visits 5.Local opinion
leader 6. Patient-mediated intervention 7. Audit and feedback
8. Reminders 9.Marketing / Tailored interventions 10.Mass media
Organizational 11. Provider oriented interventions 12. Patient oriented interventions
13. Structural interventions
Financial 14.Provider or patient interventions
Regulatory 15.Changes in medical liability 16.Peer review or Licensure
a Implementation strategies used are described according to EPOC (Cochrane
Effective Practice and Organization of Care) classification system. Only
"Management of patients complaints" strategy was not used in this study
Table 19 (abstract A33). Adherence to guideline recommendations
Performance indicator Period I Before
Implementation
Period II
After Screening
Implementation
Period III
After Guideline
Implementation
OR or RR
(95% CI)
p
no. patient-days (n= 4727
patients)
8005 8207 7746
Delirium screening
(assessments / patient-days)
0.80 2.4 2.6 4.6 (4.4, 4.9) <0.01
Sedation assessments
(assessments / patient-days)
0.67 0.76 0.77 5.8 (4.3, 7.9) <0.01
no. total sedation days
(n=2044 patients)
3368 3210 3489
Light sedation (days / total
sedation days)
0.61 0.76 0.74 3.1 (2.5, 3.9) <0.01
Use of benzodiazepines
(days / total sedation days)
0.33 0.31 0.19 0.1 (0.1, 0.2) <0.01
no. patient-days in patients
(n=1766) admitted>48
hours
5978 5868 5834
Performing Physical Therapy
(physical therapy days /
patient-days)
0.2 0.44 0.45 5.3 (4.3, 6.6) <0.01
Performing mobilization
(mobilization days / patient-
days)
0.1 0.13 0.18 2.3 (1.8, 3.1) <0.01
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Introduction: Delirium in critically ill patients is associated with in-
creased mortality and long-term cognitive decline. The recent Pain,
Agitation and Delirium (PAD) guidelines include recommendations
for delirium screening, prevention and management, which may
help to improve clinical outcomes and reduce delirium burden.
Objectives: We aimed to measure the effectiveness of a multifaceted
implementation program for improved adherence to the PAD guide-
lines and associated changes in delirium incidence and duration,
length of ICU stay and hospital mortality.
Methods: A prospective multicenter before-after study was conducted
in six ICUs in the Netherlands between March 2012 and April 2015. The
intervention consisted of a two-phase multifaceted tailored implemen-
tation of the PAD guidelines. Multiple implementation strategies were
applied to change clinical practice (Table 18). Data of all adult ICU
patients were collected during three four-month periods:
1) before implementation,
2) after implementation of delirium screening, and
3) after implementation of other PAD guidelines.
The difference in adherence and clinical outcomes between the three
periods was assessed with random effects Poisson and logistic
regression with a random intercept for patients for outcomes on
patient-day level and with logistic and linear regression for out-
comes on patient level, adjusted for APACHE II, hospital, age and
admission type. Differences were expressed as adjusted rate ratios
(aRR), odds ratios (aOR) or beta's with the “before”-period as the
reference.
Results: A total of 4727 patients were enrolled in the study with a
total of 23958 ICU days. Adherence to most PAD guideline recom-
mendations improved significantly whereas early mobilization and
reduced benzodiazepine sedation improved only in the last period
(Table 19). The incidence of delirium increased from 22 % before to
30 % after implementation (aOR = 1.5, p < 0.01) whereas delirium
duration decreased from 6.3 before to 3.6 days after implementa-
tion (aBeta = -2.6, p < 0.01). There were no statistically significant
differences in ICU length of stay (aBeta = 0.001, p = 0.99); ICU
mortality (aOR = 1.2, p = 0.17); and hospital mortality (aOR = 1.2, p =
0.21) after vs. before the implementation. Only length of mechan-
ical ventilation increased with half a day (aBeta = 0.55, p = 0.01).
Conclusions: This multifaceted implementation program was effective
in improving adherences to multiple key PAD guideline recommenda-
tions. Delirium duration decreased significantly in spite of increased in-
cidence probably due to improved screening. We observed differential
effects of screening vs. further guideline implementation. However,
these improved adherences to guideline recommendations did not
translate into measurable improvements of short-term clinical out-
comes. To improve clinical outcomes, future investigations on PADguideline implementation should consider focusing on specific recom-
mendations or targeting long-term outcomes.A34
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Introduction: Propofol infusion syndrome is a rare, but serious ad-
verse effect of a commonly used drug with a very high mortality rate
(˃50 %) [1]. The symptoms can occur in various combinations and
include: unexplained metabolic acidosis, arrhythmia, Brugada like
pattern on electrocardiograph (elevated ST-segment and coved-T
wave), cardiac and/or renal failure, rhabdomyolysis, hyperkalaemia,
hepatomegaly and hyperlipidaemia. The mechanism of the syndrome
is still unknown: experimental studies performed on animal models
and clinical features of the syndrome are suggestive of its mitochon-
drial origin.
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capacity, inhibits fatty acid oxidation and induces inner mitochon-
drial membrane uncoupling in a dose-dependent manner. Our study
aims to test this hypothesis in vitro by exposing human skeletal
muscle-derived cells to a range of propofol concentrations for
4 days.
Methods: Skeletal muscle cells were isolated from biopsies obtained
from patients (n = 16) undergoing hip replacement surgery and sub-
sequently exposed to a range of propofol resembling clinical concen-
trations in human plasma during propofol infusion (0, 1, 2.5, 5 a
10 μg/ml) and to lipid vehicle (Intralipid® - IL). After 96 hours of ex-
posure, mitochondrial metabolism was assessed by extracellular flux
analysis (Seahorse Biosciences). Oxygen consumption rate (OCR) was
measured at baseline and after addition of ATPase inhibitor, mito-
chondrial uncoupler and complex III inhibitor. Injection of these
agents enables to calculate baseline OCR, ATP turnover rate, proton
leak through inner mitochondrial membrane and respiratory chain
capacity (uncoupled respiration). The capacity of fatty acid oxidation
was measured as etomoxir-inhibitable OCR after adding of uncoupler
and palmitate. Values presented in Table 20 are expressed as % of
baseline OCR.
Results: In human skeletal muscle cells exposed to propofol, respira-
tory chain capacity was decreased and uncoupling of inner mito-
chondrial membrane was increased. The most significant result was
propofol-induced inhibition of fatty acid oxidation to 15 %, respect-
ively 11 % of baseline values (see Table 20). Data are presented as
median (interquartile range). Statistically significant results are signed
as * if p-value < 0.05, ** p-value < 0.001.
Conclusions: Propofol, in clinically relevant concentrations, is a po-
tent inhibitor of fatty acid oxidation and induces changes in a func-
tion of respiratory chain in an in vitro model of human skeletal
muscle.
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Propofol
concentration
[μg/ml]
0 1.0 2.5 5.0 10.0 Intralipid
control
Basal OCR
[pmol/min]
114 (91.5-181) 89 (52-159) 112 (87-155) 104 (58-179) 123 (63-207) 100 (73-124)
Proton leak
(% OCR)
23 (16-36) 25* (16-53) 26* (17-44) 35* (16-45) 20 (12-28) 26 (13-40)
ATP turnover
(% OCR)
77 (64-84) 76* (47.1-84) 74* (56-83) 65* (56-84) 80 (72-88) 74 (60-87)
Maximal
respiratory
capacity
(% OCR)
311 (251-
383)
190** (44.3-
375)
175** (78.8-
290)
260** (150-
305)
244 (196-
358)
370 (293-
433)
Fatty acid
oxidation
[pmol/min]
75 (40-134) - 11** (2-34) - 8** (1-27) -
Table 21 (abstract A35). Outcomes suitable for meta-analysis
Outcome Trials Participants Effect estimate
Requirement for allogeneic
RBC transfusion
5 613 RR 0.88 (95% CI 0.74 - 1.06, p=0.18)
Mean number of RBC
units transfused
2 183 MD -2.06 units (95% CI -8.24 - 4.12, p=0.51)
Mean Hb (g/dL) at
short-term follow-up
3 242 MD -0.25 g/dL; 95% CI -0.79 - 0.28, p=0.35
Mean Hb (g/dL) at
mid-term follow-up
3 238 MD 0.21 g/dL; 95% CI -0.13-0.55, p=0.23
Mortality 4 454 RR 1.04 (95% CI 0.43 - 2.52, p=0.92)
Infection 2 347 RR 0.89 (95% CI 0.74 - 1.08, p=0.23)
Mean ferritin (ng/ml) at
short-term follow-up
3 241 MD 193.61 ng/ml (95% CI -122.39 - 509.61,
p=0.23)
Mean ferritin (ng/ml) at
mid-term follow-up
3 235 MD 358.79 ng/ml (95% CI 169.85 - 547.74,
p=0.0002)A35
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A35Introduction: Anaemia affects 60-80 % of patients admitted to crit-
ical care (ICU).1 Allogeneic red blood cell (RBC) transfusions remain
the mainstay of treatment for anaemia but are associated with risks1
and are costly. Some patients may have true iron deficiency and
could benefit from iron replacement, reducing the need for transfu-
sions. However, diagnosing iron deficiency in ICU patients is difficult
due to the unreliability of serum ferritin in the context of co-existing
inflammation.
Objectives: To assess the efficacy and safety of iron supplementation,
by any route, in anaemic patients in adult ICUs.
Methods: We searched multiple databases (CENTRAL, MEDLINE,
EMBASE) for RCTs comparing iron by any route with placebo/no iron.
Two investigators independently assessed eligibility and extracted
data. The primary outcomes were RBC transfusion requirement, mean
number of transfused RBCs and mean haemoglobin (Hb) concentra-
tion. Secondary outcomes included mortality, infection, length of
hospital stay, health-related quality of life (QoL), mean difference in
iron biomarkers (e.g. ferritin) and adverse events. Outcomes were
assessed at two time points: (i) short-term - up to 10 days and (ii)
mid-term - last measured time point in hospital or end of the trial.
Risk of study bias was assessed using Cochrane methodology. Meta-
analyses were performed in RevMan v5.3 using random effects
models. Continuous variables were reported as mean difference (MD)
with 95 % confidence interval (CI); dichotomous variables were re-
ported as relative risk (RR) with 95 % CI.
Results: Five trials consisting of 613 patients were included for
meta-analysis.2,3,4,5,6 Four trials were set in surgical ICUs and one
in a mixed ICU. Only one trial was rated at low risk of bias in all
domains. There was variation in dosage regimes, from 3x/weekly
administration of intravenous iron to daily oral iron for up to
30 days post discharge. Results are shown in Table 21. No trials re-
ported on QoL.
Conclusions: Iron supplementation does not reduce RBC transfu-
sion requirements in adult ICU patients. Larger, well-designed
trials are needed to investigate the benefits and risks of iron, opti-
mal dosing regimes and strategies to identify patients likely to
benefit together with patient-focused outcomes such as QoL after
discharge.
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Fig. 21 (abstract A36). Basic illness narrative across three
consultations
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Introduction: Intensive care is lifesaving, but associated with the de-
velopment of physical, mental and cognitive problems in survivors.
Intensive care aftercare has emerged to help patient recovery and re-
turn to normal life. Guidelines focus on promoting recovery and im-
proving quality of life. More insight is needed into the mechanisms
of intensive care recovery.
Objectives: To describe the patient experience of recovery from a
longitudinal perspective by analyzing follow-up consultations at three
time-points.
Methods: The study had a descriptive multicenter longitudinal
qualitative design. We selected strategically a sub-sample of 36
consultations with 12 patients from a randomized controlled trial
on intensive care recovery from ten Danish intensive care units
(ICUs). Data were prospectively collected through the intervention
and were audio-recordings of three follow-up consultations (at 3,
5 and 10 months), patient photographs during ICU-stay, and re-
flection sheets. First consultation focused on patient's narratives of
ICU supported by photographs to aid memory. Second and third
consultations focused on patient-centred dialogs of what was
most important by guided by patients reflection sheets. Thematic
analysis and narrative theory were used to explore the mecha-
nisms of recovery after intensive care (1).
Results: The basic narrative of recovery was “toward a trajectory of
new orientation”. The narrative at 3 months described mortal illness
in ICU (Being at Death's door), the narrative at 5 months described
ongoing fear of relapse (Still not out of the Woods), and the narrative
at 10 months had three potential outcomes: downhill (detour on the
road), steady-state (end of the road), or progress (The Road to Recov-
ery). New orientation was obtained in steady-state or progressive re-
covery, Fig. 21.
Conclusions: This study provides a contemporary understanding of the
process of intensive care recovery. Recovery evolves through narratives
of mortal danger, fear of relapse and different types of progress toward
a new orientation in life. Nurse-led follow-up consultations help patients
to obtain a sense of coherence during the first year after critical illness.
These findings enable healthcare professionals to understand what pa-
tients experience during stages of recovery by offering dialogue and
supporting the construction of a coherent illness narrative with ICU staff
and close relatives. This shared understanding is important to improve
nursing and healthcare professionals in the assessment of long-term
outcome, and management of patients after intensive care.
References
1. Braun V CV (2006) Using Thematic analysis in psychology in Qualitative
research in psychology. Universiy of West England, London, http://
dx.doi.org/10.1191/1478088706qp063oa, Accessed Feb. 14th, 2015.
Grant acknowledgement
The Danish Nursing Organization, The Novo Nordisk Foundation and
Nordsjællands Hospital, University of Copenhagen, DKA37
Effect of a skin ointment creating a polymer protective film
beneath transparent catheter dressings on skin integrity and risk
of dressing disruption
A. Pivkina1, V. Gusarov1, I. Zhivotneva2, N. Pasko1, M. Zamyatin2
1N.I. Pirogov National Medical Surgical Center, Anestesiology and
Intensive Care, Moscow, Russian Federation, 2N.I. Pirogov National
Medical Surgical Center, Moscow, Russian Federation
Correspondence: A. Pivkina – N.I. Pirogov National Medical Surgical
Center, Anestesiology and Intensive Care, Moscow, Russian Federation
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A37
Introduction: Skin breakdown caused by adhesive dressings is a risk
factor for central line-associated bloodstream infection (CLABSI).
Protective skin products are developed, but it is uncertain whether
the use of such products is not associated with a higher rate of
dressing disruption, which is also a risk factor for CLABSI [1]. On the
other hand, a transparent dressing with a chlorhexidine gluconate
(CHG) containing gel pad at the insertion site prevents CLABSI.
Objectives: To compare transparent catheter dressings either with or
without the application of a protective skin ointment for skin integ-
rity, dressings disruptions and dwell time; in addition, we assessed
rates of catheter colonization and CLABSI in transparent dressing
either with or without a CHG-pad.
Methods: We conducted a monocentric, open-label, randomized, con-
trolled trial (Aug.-Dec./2014) to compare transparent CHG-dressings
with use of a skin ointment creating a polymer protective film (Cavi-
lon®) (intervention group) with standard transparent dressings without
the skin product (control group). Standard catheter care included 0.5 %
CHG in 70 % ethanol for skin preparation before CVC insertion and
maximal sterile barriers. Dressings were changed /7 days, or in case of
full dressing disruption (revealing the insertion site) or if moisture was
present under the dressing.
Results: Sixty patients with a central venous catheter (CVC) were en-
rolled accounting for 60 CVCs and a total of 533 CVC days. Study
groups did not differ in sex, age, insertion site and the number of
CVC lumens, comorbidities, severity of condition, length of hospital
stay before enrollment, or concomitant therapy. Dressing dwell time
was higher in the intervention group: 6.3 (SD 1.5) vs 2.0 (SD 1.1) days
(p < 0.001). The Table describes reasons for dressing changes and
skin integrity after dressing removal.
CVC dwell time did not differ between the groups: 9.7 (SD 3.5) days
in the intervention group and 8 (SD 3.9) days in the control group
(p > 0.05). Rates of CVC colonization were not different (37.9/1000
CVC days in the intervention group vs. 37.0/1000 CVC days in the
control arm [relative risk 1.22, 95 % confidence interval 0.59-2.5]) as
were CLABSI rates (6.9/1000 vs 20.6/1000 CVC days [relative risk 0.4,
95 % confidence interval, 0.08-1.9]).
Conclusions: The use of a skin ointment creating a polymer protect-
ive film beneath transparent dressings results in longer dressing
dwell times and less skin breakdown. The application of the skin
product does not alter the risk of infection, at least not when used
combined with a CHG-impregnated dressing.
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Table 22 (abstract A37). Reasons for dressing change and skin
condition at
Feature Control group
(n=30)
Intervention group
(n=30)
p
Reasons for dressing change
Partial dressing disruption, n (%) 4 (13.3) 7 (23.3) >0.05
Full dressing disruption (revealing
insertion point), n (%)
17 (56.7) 2 (6.7) <0.001
Moisture presence under the
dressing, n (%)
6 (20) 0 0.0093
Skin condition at the CVC site after the dressing removal
Hyperemia of the insertion site,
n (%)
4 (13.3) 1 (3.3) >0.05
Presence of skin irritations under the
dressing, n (%)
1 (3.3) 0 >0.05
Residues of adhesive on the skin
around the catheter, n (%)
0 0 >0.05
Presence of discharge from the
insertion site, n (%)
2 (6.7) 0 >0.05
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Introduction: More ICU programs are emerging to promote psycho-
logical recovery after a stay in intensive care unit (ICU) (1). In the
Scandinavian countries, patients' discharge rehabilitation plan usually
includes physical training, but seldom psychological rehabilitation. To
address this gap, we developed a post-ICU recovery program to im-
prove psychological health after intensive care. We hypothesized that a
nurse-led recovery program, that helped to construct a coherent illness
narrative including person-centered communication, would improve
health-related quality of life (HRQOL), sense of coherence (SOC), reduce
symptoms of anxiety, depression, and post-traumatic stress (PTSD) in
the first year after ICU discharge.
Objectives: To investigate the effectiveness of a post-ICU recovery
program compared to standard care in improving quality of life in
the first year after ICU.
Methods: We randomly assigned 386 patients adult (≥18 years) survi-
vors after receiving mechanical ventilation (≥48 hours) to standard
care (SC) plus a recovery program or SC alone after discharge from
intensive care. It was a nurse-led intervention consisted of patient
photographs, three follow-up consultations and reflection sheets.
Results: Primary outcome was HRQOL, and secondary outcomes were
SOC, anxiety, depression, PTSD assessed at 3 and 12 months after inten-
sive care discharge using t-tests. We supplemented outcomes with re-
habilitation services within the first year. At 12 months after intensive
care the HRQOL scores were unchanged by the intervention (mean dif-
ference in the Mental Component Summary score, 0.9 [95 % CI, −1.5 to
3.3; P =0.47]; and in the Physical Component Summary score, 1.1 [95 %CI, −1.3 to 3.5; P = 0.37]). No differences were found for the total score on
self-reported SOC, anxiety, depression, and PTSD. The intervention
showed a potential effectiveness on the rate of anxiety, when a cutoff
score ≥11 was applied, in the complete analysis at 3 months. However,
all patients received high level of rehabilitation services as SC within the
first year after intensive care.
Conclusions: Overall, no beneficial or detrimental effects were found
on either primary or secondary outcomes, but the symptoms were
generally lower that found in similar studies. Patients maintained
good mental health and a strong sense of coherence, but the PTSD
score was consistently high. The high quality of standard care in Danish
ICUs might help explain the lack of improvement in this study.
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Introduction: Enabling clinicians to prospectively identify patients who
will later become unstable would enable targeting resources to patients
most in need as well as potential application of preventive care.
Objectives: To determine the incremental contribution of information
progressively available within the first 4 hours of (SDU) admission to
improve models forecasting later development of cardiorespiratory
instability (CRI), including a novel CRI relative risk score.
Methods: Continuous noninvasive vital sign (VS) monitoring data (heart
rate [HR], respiratory rate [RR; bioimpedance], oscillometric blood pres-
sure [BP], peripheral oximetry [SpO2]) were collected from 1971 step-
down unit (SDU) patients, and CRI episodes defined as VS deviation
beyond stability thresholds. Patients with any CRI (cases, n = 918) and
those never displaying CRI (controls, n = 1053) were identified. We com-
puted a minute-by-minute integrated CRI risk score based on the method
described in [1], using features computed from VS data streams during
trailing 15 minute rolling windows and a trained random forest machine
learning model. We then computed for each patient a mean risk score
aggregated from the risk scores during first 4 hours of SDU stay. Next we
built a logistic regression model to forecast whether or not there will be
a CRI event in the future. To mimic the temporal availability of data fol-
lowing patient admission, we first entered demographics available at pa-
tient admission (age, gender, Charlson Comorbidity Index score) into the
model, and then the initial VS (5-minute average of continuous VS data
accrued from minutes 10 to 15 after admission), and finally the relative
risk score derived in the first 4 hours. We assessed the predictive contri-
bution of information from these 3 progressively accrued categories
(demographics, initial VS, 4-hr risk score) by the Area Under Receiver
Operating Curve (AUC) in a 10-fold cross validation experiment setup.
Results: The risk score derived from admission demographics alone
yielded an AUC of 58 ± 0.002 % to forecast future CRI. Adding the ini-
tial VS improved the AUC to 64 ± 0.003 %, and with further adding
the 4-hr risk score the AUC became 67 ± 0.002 %.
Conclusions: A predictive model which incorporates patient data as
it becomes available, including a risk score derived within the first
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 25 of 6074 hours, progressively improves the models ability to forecast future
CRI development. Such forecasting information could enable clinicians
to identify those patients who will become unstable in future very soon
after admission in order to triage patients needing closer surveillance
and potentially apply preemptive interventions.
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Introduction: Physical activity / rehabilitation forms a pivotal aspect
of recovery after critical illness and studies have demonstrated it is
safe, feasible and potentially efficacious at improving patient out-
comes [1,2]. However, international data demonstrate low levels of
mobilisation occur in the ICU[3,4]. A current gap exists between the
perceived need and actual practice of implementing physical activity
across the recovery continuum.
Objectives: To identify, evaluate and synthesise studies examining
the barriers and enablers for patients with critical illness to partici-
pate in physical activity from the perspective of healthcare providers,
patients and caregivers.
Methods: Systematic review of articles using electronic databases:
MEDLINE, CINAHL, EMBASE, Scopus and Cochrane. Quantitative and
qualitative studies which assessed the barriers, or enablers to phys-
ical activity for patients with critical illness were included. Registered
on PROSPERO (number: CRD42016035454).
Results: 79 studies were included. Studies included primarily ICU
survivors (69 %, n = 54 studies), healthcare providers (29 %, n = 23
studies) with only one study specifically examining caregivers and
patients. Barriers and enablers to physical activity were identified (5
major themes and 28 sub-themes). Patient-level barriers included
physical capability (physiological stability, illness severity, sedation,
weakness, delirium), psychological influences (fear/motivation) and per-
ceived relevance. Healthcare provider barriers included lack of time/
knowledge and expertise, communication, and concern for line safety.
Environmental barriers included lack of resources (staffing and
equipment), lower prioritisation, and lack of an established rehabilita-
tion pathway post ICU. Enablers included: presence of mobility teams/
protocols, designated discipline and overall leaders, teamwork and
development of daily care plans.
Conclusions: This systematic review has identified the volume of litera-
ture demonstrating that barriers and enablers to physical activity are
multi-dimensional and span diverse factors. These factors need to beconsidered when developing rehabilitation interventions to facilitate cul-
tural change in rehabilitation practices across the recovery continuum.
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Introduction: Literature depicts differences in perceptions of End-Of-
Life (EOL) decision-making (DM) between nurses and physicians.
Objectives: To examine perceptions of nurses and physicians in re-
gard to EOL DM in the ICU and to test the hypothesis that the worse
the EOL DM climate, the greater the discordance between nurses'
and physicians' rating of EOL DM.
Methods: Perceptions of EOL-DM among health care providers of 68
adult ICUs in 13 European countries and the US were measured in April-
May 2014, using a validated self-assessment questionnaire. The ques-
tionnaire existed of 35 questions and was based on the Appropricus
questionnaire [1], the IPEQS instrument and the LDBQ questionnaire [2].
Results: A total of 2,275 nurses and 717 physicians participated. Re-
sponse rates were 63.1 % and 62.9 %, respectively. Using factor analyses
and cluster analysis, seven meaningful factors (physician leadership,
interdisciplinary reflection, not avoiding EOL decisions, mutual respect
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 26 of 607within the interdisciplinary team, involvement of nurses in EOL, active
DM by physicians, and ethical awareness) yielded 4 climates: good, aver-
age with and average without involvement of nurses at EOL, and fourth
a poor EOL-DM climate.
When looking at overall perceptions, there were for all seven factors
significant differences (p < 0.001) between nurses and physicians,
with physicians consistently perceiving the EOL-DM climate as more
positive as nurses. The largest differences were found in regard to
physician leadership (median factor scores -0.09 for nurses and 0.61
for physicians, respectively), interdisciplinary reflection (medians -0.03
and 0.51) and not avoiding EOL decisions (medians -0.07 and 0.37).
When looking at differences within the 4 types of EOL-DM, the same
general pattern was found, and all differences were statistically signifi-
cant (p < 0.001). The differences were largest in the two lowest types of
EOL-DM: average without nurses and poor EOL-DM climate.
Head nurses generally had a more positive perception of EOL-DM cli-
mate compared to other nurses, and senior physicians had a more
positive perception than junior physicians. When comparing nurses
(without including head nurses) and junior physicians, the physicians
still had a significantly higher perception of EOL-DM, except for “Mu-
tual respect within the interdisciplinary team” (p = 0.26).
Physicians having a more positive perception of EOL-DM compared
to nurses were found within all 13 participating countries and within
the individual ICU's.
Conclusions: The poorer the EOL DM climate, the more physicians
were likely to overestimate the EOL DM climate compared to nurses.
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decision making (DM) between countries and ICUs.
Objectives: To better conceptualize EOL-DM and to develop and val-
idate a tool to assess EOL-DM climates.
Methods: Perceptions of EOL-DM among health care providers
(HCPs) of 68 adult ICUs in 13 European countries and the US were
measured, using a self-assessment questionnaire in April-May 2014.
The EOL-DM climate questionnaire, existing of 35 items, based on
the Appropricus questionnaire (11 items concerning EOL care prac-
tices) and extended with 24 validated items concerning key condi-
tions to provide good EOL care: interdisciplinary collaboration and
communication (Interprofessional Practice and Education Quality
Scales (IPEQS, 11 items) and leadership skills (LBDQ,13 items) (1, 2,3).
Exploratory and confirmatory factor analysis followed by cluster ana-
lysis was used to determine EOL-DM climates.
Results: Of the 3610 nurses and 1137 doctors providing ICU bedside
care, 63,1 % and 62,9 % participated respectively. Seven meaningful
factors were identified (physician leadership, interdisciplinary reflection,
not avoiding EOL decisions, mutual respect, involvement of nurses in
EOL, active DM by physicians, ethical awareness); which yielded 4 EOL-
DM climates: good (17.6 % of the ICUs), average with (+) (17.6 %) and
without involvement of nurses at EOL (-) (32.3 %), and poor (54.3 %)
(factor analysis p < 0.001). According to HCPs working in a good climate
leadership is active and facilitates interdisciplinary reflection and
decision-making overall. Within the 'average + ' climate, HCPs perceive
their leaders as empowering nurses to share interdisciplinary decision-
making at EOL mainly. Stimulating more open ethical awareness overall
and being less hesitant in taking timely EOL decisions could be a main
goal for the leader in this climate. HCPs working in an 'average -' cli-
mate do perceive their leaders as not hesitant to take important deci-
sions (at EOL) however as insufficiently empowering the involvement
of nurses in the DM process. HCPs working in a poor climate perceive a
need for improvement on all previous factors. This climate was further
characterized by poor communication, distrust and low respect.
Conclusions: We identified seven key dimensions, from which 4
meaningful types of ICU EOL-DM climates could be discerned. The
climates differ mainly in 2 key dimensions: the way of nurse involve-
ment in EOL and in physicians active DM. Our research offers oppor-
tunities to develop tailored ICU team interventions.
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Introduction: There is increasing recognition of the need for compre-
hensive expertise in the management of EOLC in the ICU. However
there appear to be many controversies between professionals regard-
ing optimal provision.
Objectives: As a component of a local, on-going quality improvement
process in this area, we performed a survey of nurses' perceptions of
aids and obstacles to the optimal provision of EoLC.
Methods: We modified a previously validated survey tool1 and angli-
cised the language. Nurses were asked to rate both the size and
frequency of 20 possible obstacles and 14 possible aids to providing
EoLC using a 6 point Likert scale (0-5). The survey was distributed to
120 nursing staff on one adult general critical care unit in March 2015.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 27 of 607Confidentiality was assured. For each obstacle and aid, the median and
interquartile ranges were determined for the size and frequency. To de-
termine the effect size of each obstacle and aid, the median of the size
was multiplied by the median of the frequency. These were then
themed
Results: Sixty surveys were returned representing a 50 % return rate.
Conclusions: This study has highlighted the need to proactively identify
a family liaison to cascade information to friends and relatives to allow
nurses to concentrate on care delivery. Despite having a poor unit design
and lack of privacy, nurses feel they can provide a dignified death and
feel that multidisciplinary agreement is an important part of this process.
References
1. Kirchoff and Beckstrand, 2000 Critical care nurses´ perceptions of obstacles
and helpful behaviour's in providing end-of-life care to dying patients. Am J
Crit Care. 2000 Mar;9(2):96-105.
2. Festic E,Wilson ME, Gajic O, Divertie GD, Rabatin JT, 2012 Perspectives of
physicians and nurses regarding end-of-life care in the intensive care unit. J
Intensive Care Med. 2012 Feb;27(1):45-54. doi: 10.1177/0885066610393465.
Epub 2011 Jan 21Table 23 (abstract A43). Effect size and themes obstacles
LARGE OBSTACLES occurring frequently EFFECT SIZE THEME
Family requesting constant updates 16 Workload
Poor unit design restricting privacy 16 Environment
Family unable to accept patient dying 12 Family Coping
Nurse caring for family and patient simultaneously 12 Workload
Not knowing patient's wishes for EOLC 12 Staff Coping
SMALL OBSTACLES occurring infrequently EFFECT SIZE THEME
Lack of chaplaincy services 2 Logistics
Lack of support from colleagues 3.75 Staff coping
Restrictive visiting hours 4 Logisrics
Table 24 (abstract A43). Effect size and themes of aids
LARGE AIDS occurring frequently EFFECT SIZE THEME
Multidisciplinary agreement 15 Communication
Provision of a peaceful and dignified scene 15 Environment
Allowing adequate time after death 15 Logistics
LARGE AIDS that occur infrequently EFFECT SIZE THEME
Having a designated family liaison 10 Workload
Having unit design that allows privacy 10 Environment
SMALL AIDS EFFECT SIZE THEME
Family helping with care 6 Case Specific
Having support outside work 3 Staff copingA44
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Introduction: It has been recognized that healthcare workers in-
volved in “End of life” (EoL) decisions may be influenced by cultural,
geographical, religious and personal characteristics1.Objectives: To investigate possible associations of ICU personnel's
aspects of personality and religiousness with attitude towards EoL.
Methods: A cross-sectional, multicenter study was conducted in a
national level in Greece during June to December 2015. ICU physi-
cians (n = 149) and ICU nurses (n = 320) participated by answering
three questionnaires: the main survey questionnaire investigating
EoL attitudes2, the Eysenck Personality Questionnaire (EPQ)3, and
the Spiritual and Religious Attitudes Questionnaire (SpREUK)4. Different
scores of EPQ-Neuroticism, EPQ-Psychoticism and SpREUK-Trust in a
higher guidance were recorded in each participant.
Results: A high participation rate was recorded (65.7 %). Eighty-four
participants preferred to characterize EoL decisions as “passive euthan-
asia” over “refusal of futile care” (7.6 % of ICU physicians vs.23.3 % of
ICU nurses, p < 0.001), 289 participants declared that removing artificial
ventilation represented a different approach from other EoL decisions
because of the analogy breath = life (51.4 % of physicians vs.75.8 % of
nurses, p < 0.001), and 71 participants acknowledged fear of litigation
as the major reason for not informing the family about EoL decisions
(17.4 % of doctors vs.14.9 % of nurses, p = 0.004). Statistical analysis
with multivariate logistic regression identified that attitude towards
passive euthanasia could independently be predicted by high neuroti-
cism scores (Odds ratio 1.6, 95%CI 1.1-2.7, p = 0.048), attitude towards
withdrawal of artificial ventilation by trust in a higher guidance (Odds
ratio 1.7, 95%CI 1.1-2.5, p = 0.010), and fear of litigation by high psycho-
ticism scores (Odds ratio 2.4, 95%CI 1.3-4.8, p = 0.009).
Conclusions: The results of this study indicate that specific attitudes
towards EoL decisions may be influenced by aspects of personality
and religiousness of ICU personnel.
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Introduction: The decision to limit or withdraw active treatment in
patients admitted to the intensive care unit (ICU) is multi-factorial (1).
Prolonged periods of organ support in elderly, frail patients may not
be beneficial and has resource implications. International guidelines
suggest that goals of treatment should be set within 72 hours of ad-
mission to the ICU (2).
Objectives: We aim to identify the frequency of end-of-life decision-
making and the effectiveness in communicating these decisions to the
ICU team.
Methods: A prospective audit cycle was completed involving un-
planned ICU admissions during a one-week period. Demographic
information, APACHE II score, clinical frailty score (CFS), limitations
of treatment (LOT) and awareness of these decisions were all docu-
mented. A re-audit using the same methodology was conducted
after CFS and communication proformas were introduced for un-
planned admissions.
Results: 61 patients were admitted as unplanned admissions during
the first audit period. Patients were elderly, had a high predicted
mortality and a significant proportion were clinically frail (CFS ≥ 5).
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 28 of 607Mean length of stay (LOS) was prolonged and level of organ support
was high. These results are summarised in Table 25.
LOT was instigated in 9 (11.5 %) patients. Age and APACHE II scores
were similar in patients with LOT and those with none. Frail patients
had a higher LOS and received more organ support compared to
non-frail patients. The proportion of patients with LOT remained low
despite an increasing LOS. Communication between team members
was sub-standard with 33 % of bedside nurses and 44 % of residents
being unaware of these decisions.
The re-audit after intervention demonstrated an increase in patients
receiving LOT, with a higher proportion of frail patients being repre-
sented. These patients also received less organ support and LOT was
instigated earlier in their stay. Awareness regarding these decisions
amongst all staff improved to 100 %. Feedback regarding the com-
munication tools was excellent.
Conclusions: End of life care was performed infrequently in un-
planned admissions to the ICU. When instigated, knowledge of these
plans was substandard. Introducing CFS on admission to ICU identi-
fied patients who were unlikely to benefit from prolonged organ
support, thus increasing LOT decisions. The communication sheets
improved team communication. This has now become standard prac-
tice in two London ICUs.
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shock: 2012. Crit Care Med. 2013 Feb;41(2):580-637Table 25 (abstract A45). Results overview from the audit cycle
No Treatment
Limits (first audit)
Treatment Limits
(first audit)
Treatment
limits after
interventions
Changes observed
after interventions
Mean Age/range
(years)
67.5 (44- 89) 73.33 (47 - 91) 82.5 (62-88) More elderly
population
APACHE II (mean) 22.3 21.8 22.3 No change in
disease severity
CFS < 5, n (%) 29 (58.2%) 2 (22%) 2 (12.5%)
CFS > 5, n (%) 23 (41.8%) 7 (78%) 14 (87.5%) Higher proportion of
frail patients with
LOT
LOS > 72 hours
n/total, (%)
35/39 (90.0%) 4/39 (10.3%) 8/36 (22.2%) Higher proportion at
72 hours with LOT
LOS > 30 days,
n/total (%)
11/14 (78.6%) 3/14 (21.4%) 7/11 (63.6%) Higher proportion at
30 days with LOT
Awareness of
decisions - Nurses,
n (%)
49 (89.1%) 6 (66.7%) 16 (100%) Improved awareness
Awareness of
decisions -
Resident, n (%)
51 (92.7%) 5 (55.6%) 16 (100%) Improved awareness
Fig. 22 (abstract A46). Trends in reported patient safety incidentsPATIENT SAFETY IN THE ICU
A46
Improvements in the safety and quality of care in four UK NHS
hospitals participating in the global tracheostomy collaborative
B.A. McGrath1,2, S.J. Lynch1, B. Bovento1, G. Sharpe1, E. Grainger1, S.
Pieri-Davies1, S. Wallace1
1University Hospital South Manchester, Manchester, United Kingdom,
2Manchester Academic Health Sciences Centre, University of Manchester,
Manchester, United Kingdom
Correspondence: B.A. McGrath – University Hospital South Manchester,
Manchester, United Kingdom
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A46
Introduction: Tracheostomies are used in the management of around
10 % of ICU admissions. Increasingly complex patients require truly
multidisciplinary care to reduce the well described preventable harmthat may occur.[1,2] The Global Tracheostomy (Quality Improvement)
Collaborative (GTC) offers resources for participating hospital sites.
Whilst individual elements of the GTC programme have been shown to
be of benefit in individual sites, implementation of the package of re-
sources and the ability of the GTC database to track and benchmark
healthcare improvements had not been evaluated.
Objectives: The primary aim of the project was to implement the GTC
into four diverse NHS hospitals and to evaluate impact on the safety and
quality of care delivered. We hypothesised that systematic healthcare
improvements would reduce the severity of harm resulting from
tracheostomy-related safety incidents and improve surrogate markers of
the quality of patient-centred outcomes such as time to first vocalisation.
Methods: As part of a Health Foundation funded quality improvement
project, we introduced the GTC into four NHS sites in Manchester,
England between August 2014 and August 2015. Interventions included
multidisciplinary staff educational courses, webinars, standardisation of
protocols and development of multidisciplinary tracheostomy teams.
Local projects were overseen by local staff and patient champions. Data
were collected using the bespoke GTC database and monthly trends in
surrogate and patient safety incidents were analysed. Monthly incident
rates were analysed using Chi Square test for linear trend.
Results: Over the 12 month data collection period 296 tracheostomy pa-
tient admissions were tracked across the four sites with similar demo-
graphics to previously reported national data.[1] A total of 124 adverse
events were identified affecting 29.8 % patients. Analysis of reported in-
cidents over the duration of the project showed a significant reduction
in the severity of harm by month (Chi Square p < 0.01, Fig. 22). There
was also a significant trend towards lower harm categories for incidents
over the duration of the project (Chi Square test for linear trend, r
= -0.21, p < 0.01). Monthly analysis of the dataset for percutaneous
tracheostomies showed non-significant trend toward earlier speaking
valve use and vocalisation (median slope = -0.17, -0.83 to 0.4) associated
with improvements in reported patient satisfaction scores.
Conclusions: Our study has demonstrated that meaningful improve-
ments in the safety and quality of care for patients with tracheostomies
are possible using improvement methodology advocated by the GTC
in diverse NHS Trusts.
References
1. ‘On the right trach?’ NCEPOD 2014. www.ncepod.org
2. McGrath BA,BJA 2015;115(2):155-8.
Grant acknowledgement
This work was supported by the Health Foundation, an independent charity
committed to bringing about better health and health care for people in
the UK.A47
The impact of multidisciplinary tracheostomy safety teams on
hospital length of stay for patients with tracheostomy
B. McGrath1,2, S.J. Lynch1, B. Bovento1, E. Grainger1, S. Pieri-Davies1, G.
Sharpe1, S. Wallace1
1University Hospital South Manchester, Manchester, United Kingdom;
2Manchester Academic Health Sciences Centre, University of Manchester,
Manchester, United Kingdom
Correspondence: B. McGrath – University Hospital South Manchester,
Manchester, United Kingdom
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A47
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 29 of 607Introduction: Around 12-14,000 tracheostomies are performed by
intensivists in critically ill patients in England and Wales annually.
Patients are increasingly complex and high quality care requires the
input of a wide range of multidisciplinary healthcare professionals,
including medical, nursing, speech and language pathology and
specialist physiotherapy staff. National reports have identified dis-
jointed and uncoordinated care that leads to delays in progressing
care.[1,2,3] The Global Tracheotomy (Quality Improvement) Collab-
orative (GTC) brings together resources from international exemplar
centres. Multidisciplinary tracheostomy teams (MDTT) are a key inter-
vention. We introduced GTC MDTT and resources into four diverse
NHS sites and performed a detailed evaluation of their impact.
Objectives: We hypothesised that systematic healthcare improve-
ments that raised the quality and safety of tracheostomy services
would lead to more efficient care, measured by earlier tracheostomy
decannulation times and reduced hospital lengths of stay.
Methods: We introduced MDTT into four diverse NHS sites in
Manchester, England as part of a Health Foundation funded project
between August 2014 and August 2015, measuring outcomes using
the GTC database. Each site set up a MDTT, supported by the resources
of the GTC (via www.globaltrach.org). Webinars offered opportunities
for question and answer sessions around how obstacles to changes in
care delivery had been overcome. MDTTs reviewed tracheostomy
patients weekly and provided a point of contact and education for
bedside ICU and ward staff. The largest site (UHSM) kept detailed MDTT
records over 40 weeks, with all four sites recording individual patient
metrics via the GTC database. Length of stay (LoS) data were plotted
monthly with box-and-whisker plots. All data points were retained for
non-parametric linear regression analysis.
Results: UHSM MDTT undertook 155 reviews, making 184 interven-
tions. There was a significant month-by-month trend towards redu-
cing LoS across all sites for all 296 patients, with median hospital LoS
reduced by 6 days over the 12 month project (95%CI 9.96-3.96). For
the 214 newly inserted tracheostomies, there was a non-significant
trend towards reduced tracheostomy time (median slope -0.05, -0.17
to 0.25). ICU LoS reduced significantly over the duration of the pro-
ject with a median slope of -0.11 (-0.25 to 0), equating to a reduction
of 1.3 days per patient.
Conclusions: Introducing MDTT can coordinate and improve the qual-
ity and safety of care provided to ICU and ward tracheostomy patients.
Improvements are reflected in reductions in ICU and hospital LoS.
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Introduction: Previous studies showed that low nurse staffing levels
were associated with poor outcomes and increased occurrence of ad-
verse events. However, national data are scarce regarding the relation-
ship between the nurse staffing ratio and pediatric patient outcomes.
Objectives: To investigate the association between nurse staffing
levels and the outcome of pediatric patients in Korean intensive care
units (ICUs).
Methods: This retrospective cohort study used data from National
Health Insurance claims. The included patients were under 18 yearsold and admitted to ICUs (but not neonatal ICUs) between August
2009 and September 2014. The ICU nurse staffing was graded into nine
levels according to the total bed to nurse ratio for each hospital
(National Health Insurance policy). The lowest and highest bed-to-nurse
ratios were 0.5:1 and 2:1, respectively. We inspected the differences
between overall patient mortality and the nursing staff grades at
discharge. We also analyzed the mortality of patients who underwent
mechanical ventilator care for more than 3 hours according to the
nursing staff grades.
Results: During the study period, 39,917 medical and surgical pediatric
patients were admitted to the ICUs. Mechanical ventilation was admin-
istered to 45.9 % of these patients. The median (interquartile range)
ICU length of stay was 2 (1-6) days. The overall hospital mortality rate
was 5.5 %, and the mortality rate of mechanically ventilated patients
was 10.8 %. About half of the patients (18,053; 45.2 %) received the
highest grade ICU treatment. The overall mortality rate did not increase
with a higher bed-to-nurse ratio (i.e., lower nurse staffing level). How-
ever, a trend toward increased mortality was observed in mechanically
ventilated patients as the bed-to-nurse ratio increased. The mortality of
mechanically ventilated patients was 7.6 % for a bed-to-nurse ratio
< 0.5:1, 16.7 % for a 0.63-0.77:1 ratio, 25.2 % for a 0.88-1:1 ratio, and
38.1 % for a > 2:1 ratio.
Conclusions: The nursing staff to bed ratio may not be associated
with the overall mortality of pediatric patients at discharge. However,
a low nursing staff level was associated with a higher mortality in
pediatric patients who required mechanical ventilators.
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Introduction: Exposure keratopathy (EK) is a clinical syndrome charac-
terised by incomplete eyelid closure and corneal wetting leading to
corneal damage of variable severity and extent. It has an incidence in
critically ill patients of between 10 and 60 % (1).
Objectives: This study aimed to determine the rate of EK in patients
admitted to critical care (ICU) and identify risk factors for developing
EK. Using the identified risk factors and experience from the first part
of the study, we developed an eye-care protocol. Finally, we studied
the effectiveness of the protocol to prevent EK.
Methods: We undertook a two-phase prospective cohort single-
centre study between November 2014 and August 2015 in a general
adult ICU in the United Kingdom. The first phase of the study was
observational. In the second phase of the study an eye-care protocol
was introduced. Ethical approval was waived by the Trust ethics com-
mittee. Inclusion criteria were all patients admitted to ICU. Exclusion
criteria were age < 16, known eye disease, patient agitation, and re-
fusal to participate. The patient remained in the study until ICU dis-
charge or withdrawal of active therapy. An eye-care protocol was
developed and incorporated into the electronic patient record.All data
were collected by a single investigator. Data were APACHE II score,
daily SOFA, mechanical ventilation, Richmond Agitation-Sedation Scale,
and level of eye care. Ophthalmic assessment was examination of the
external eye, eyelids, and ocular surface using a portable slit lamp pre-
and post-fluorescein dye instillation. Statistical tests were two-tailed (α
= 0.05). Student t-test was used for continuous data and χ2 or Fisher's
exact test for binary data. Logistic regression was used to analyse the
relationship between EK and independent variables. Relative risk (RR)
and Odds ratio (OR) were calculated with 95 % confidence intervals.
Results: We studied 371 patients. The overall rate of EK was 21 %.
Among mechanically ventilated patients the rate was 54.3 % com-
pared to 5.1 % in patients receiving non-invasive or no ventilatory
support: RR = 10.6 (5.5-20.7), p < 0.001. OR for development of EK was
6.8 (3.2-8.0), p = 0.028 with mechanical ventilation and 32.5 (15.3-45.1),
p < 0.001 with lagophthalmos. SOFA was associated with EK with OR
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 30 of 6071.3 (1.1-1.5), p = 0.016. We found no independent effect of age,
sedation or APACHE II score. Following the introduction of the protocol
in the second phase of the study, the rate of EK reduced to 2.6 %
(3 cases): RR = 7.8 (3.5-0.5), p < 0.001. The association with mechan-
ical ventilation and lagophthalmos remained. Compliance with the
protocol was 97 %.
Conclusions: EK is common in critically ill patients, and is associated
with mechanical ventilation and lagophthalmos. A simple protocol
substantially reduced the incidence of EK and was easily achieved in
clinical practice.
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B.i.d. bolus regime Continuous infusion
regime
2 × 1g / day
N = 5
2 × 5g / day
N = 5
2g / day
N = 2
10g / day
N = 2
Age, years: med
(min-max)
64 (37 - 79) 67 (59 - 80) 68 (58 - 78) 74.5 (70 - 79)
Gender male: n (%) 4 (80) 3 (60) 1 (50) 1 (50)
Weight, kg: med
(min-max)
78 (71 - 119) 72 (42 - 90) 87 (73 - 100) 85 (80 - 90)
Recent surgery: n (%) 4 (80) 3 (60) 0 (0) 1 (50)
Admission SOFA score:
med (min-max)
8 (7 - 12) 7 (7 - 7) 8 (7 - 9) 12.5 (11 - 14)
Admission Vitamin C
plasma concentration,
μmol/L: med (min-max)
44 (19 - 86) 31 (9 - 51) 19 (12 - 25) 26 (20 - 32)Poster Corner Sessions: NUTRITION
AND HORMONAL DISTURBANCES
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Introduction: The loss of muscle mass in critical illness is caused
by a mismatch between synthesis and degradation, where syn-
thesis is near-normal, while degradation is enhanced, resulting in
a negative protein balance. A muscle mass loss of 10 % per
week is reported. Studies supporting this mechanism are almost
exclusively from patients during the initial two weeks of critical
illness.
Objectives: To investigate if this mechanism is valid also in a longer
time perspective we studied critical ill patients during days 10-40 of
ICU stay.
Methods: Critically ill patients on mechanical ventilation (n = 20)
were included, multiple times if possible. In total 30 measurements
of muscle protein turnover were performed employing a 3-pool
model technique with a constant infusion of d5-phenylalanine, leg
blood flow measurements, and biopsies to determine tissue
enrichments.
Results: Net protein balance of leg mixed muscle showed a pattern
of becoming less negative over time with regression analyses. This
pattern was totally attributable to an increase in protein synthesis
rate, while protein breakdown rate, although higher than in healthy
subjects, was completely unaltered over time. Net protein balance
during days 10-20 (-21 ± 21 nmol phenylalanine/min/100 g muscle)
was lower (p = 0.002; T-test) than during days 30-40 (1 ± 11 nmol
phenylalanine/min/100 g muscle).
Conclusions: The temporal pattern of protein turnover in leg
muscle showed a pattern of diminished protein losses over time
in surviving patients staying in the ICU. How this pattern relates
to nutrition, mobilization, and pharmacology remains to be
established.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A52Introduction: Critically ill patients exhibit a high degree of vitamin C
deficiency at ICU admission and plasma concentrations decrease
even more during the following days [1, 2]. High intravenous (iv)
doses of vitamin C are required to increase plasma concentrations to
normal and supra-normal ranges [2], but the optimal dosage regime
in this population remains unclear. Prolonged vitamin C administra-
tion may be associated with oxalate kidney stone formation, but the
effect of short-term high-dose supplementation on urinary oxalate
excretion is unknown.
Study design and objectives: We conducted a prospective random-
ized controlled trial to determine the pharmacokinetics of four high
dose regimes of iv Vitamin C in critically ill patients and to measure
oxalate excretion.
Patients:. Adult patients admitted to the ICU with sepsis or SIRS, with
a non-neurological sequential organ failure assessment (SOFA) score
>6 and an expected length of ICU stay >96 hours.
Intervention: Patients were randomized to either 1 g or 5 g vitamin
C twice daily as a 30-min bolus infusion, or to 2 g or 10 g daily as a
continuous infusion. Vitamin C administration was continued for
48 hours, so that all patients received a total dose of either 4 g or
20 g vitamin C.
Measurements: Concentrations of vitamin C were determined in
plasma at t = 0, 1, 2, 4, 8, 12, 24, 36, 48, 72 and 96 hours. Urine vita-
min C and oxalate concentrations were determined during the first
and last 12 hours of vitamin C administration. NONMEM was used for
the pharmacokinetic analysis.
Results: Fourteen patients were included: 5 patients received
1 g vitamin C and 5 patients 5 g vitamin C iv twice daily for
two days. Two patients received 2 g/day vitamin C and 2 pa-
tients received 10 g/day by continuous infusion for two days
(Table 26). Four patients (28 %) were vitamin C deficient on ad-
mission (<20 μmol/L). A two-compartment pharmacokinetic
model best described the data (Fig. 23, model parameters not
shown). The urinary excretion of vitamin C and oxalate is shown
in Table 27.
Conclusion: Normal vitamin C plasma levels are attained with either
1 g iv twice daily or 2 g as continuous infusion. A bolus infusion is
needed for rapid achievement of high-normal plasma concentrations.
Both high-dose regimes produce supra-normal plasma concentrations.
With continuous infusion, urinary vitamin C loss was lower and a higher
proportion remained in the body. The urinary excretion of oxalic acid
increased with higher vitamin C doses.
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Fig. 23 (abstract A52). Predicted Vitamin C plasma concentrations
Table 27 (abstract A52). Excretion of Vitamin C and oxalate
B.i.d. bolus regime Continuous infusion regime
2 x 1g / day
N = 4a
2 x 5g / day
N = 5
2g / day
N = 2
10g / day
N = 2
Vitamin C excretion 36-48h, mg: med (min - max)
T = 0-12
hours
569 (183 - 656) 3760 (1905 - 5367) 13 (11 - 15) 1480 (1176 - 1783)
T = 36-48
hours
918 (791 - 1131) 6573 (3975 - 7235) 339 (120 - 558) 3934 (3569 - 4299)
Oxalate excretion 36-48h, mg: med (min - max)
T = 0-12
hours
30 (13 - 77) 43 (18 - 84) 20 (13 - 27) 36 (26 - 45)
T = 36-48
hours
38 (25 - 82) 76 (27 - 130) 58 (39 - 76) 84 (60 - 108)
Normal oxalate excretion ≤ 20 mg/12h
a Missing urine data from 1 patient because of anuric acute kidney failure
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Introduction: Effects of glucocorticoid therapy for septic shock pa-
tients have been the subject of many studies. Following the study by
Annane et al, which has shown that some patients develop critical ill-
ness related adrenal insufficiency early during the course of sepsis,
changes in adrenal functions during sepsis has gained attention.
There have been recent reports that adrenal functions may decrease
during the course of critical illness, a condition often overlooked.
However prevalence of adrenal exhaustion in critically ill medical pa-
tients and associated factors are unknown.
Objectives: The objective of the study was to determine the preva-
lence of adrenal exhaustion in medical patients with prolonged crit-
ical illness and the factors associated with it.
Methods: This observational study was performed in a medical inten-
sive care unit (ICU) of a university hospital. Admission cortisol levels
were measured in all septic shock patients initially unresponsive to
fluid resuscitation and vasopressors. Consequently, patients with ini-
tial cortisol levels >15 μg/dl were followed and cortisol testing was
repeated in patients with ongoing vasopressor dependency with no
other underlying cause.
Results: A total of 37 septic shock patients were screened on ICU ad-
mission. Of these, 19 patients had cortisol levels >15 μg/dl and under-
went cortisol retesting for ongoing vasopressor need during the same
ICU admission. Eleven (%58) had serum cortisol levels < 15 μg/dl. Mean
(±SD) age was 70 ± 13.5 years. APACHEII and Sequential Organ Failure
Assessment scores on ICU admission were 25.3 ± 6.5 and 10.4 ± 5.2, re-
spectively. Age, gender, APACHEII and SOFA scores, serum albumin,
protein, CRP and procalcitonin levels were similar between the groups.However, at the time of cortisol retesting, patients with lower cortisol
levels had significantly longer length of ICU stay (p = 0.038). Time inter-
val between two cortisol sampling was (median, IQR) 12 (8-30) days.
Time interval between higher and lower cortisol groups did not reach
statistical significance. When glucocorticoid therapy was begun in the
lower cortisol group, vasopressors were weaned within 48 hours; vaso-
pressor weaning was longer and varied in higher cortisol group.
Conclusions: Adrenal response is a dynamic process. During the course
of critical illness, as with other organs, adrenal failure may develop.
With these findings, adrenal exhaustion seems to be a complication of
prolonged critical illness. We suggest prolonged vasopressor depend-
ency should prompt a search for adrenal exhaustion, even if initial corti-
sol testing results are within normal limits. Identifying patients that
could benefit from corticosteroid therapy may be a life-saving measure.
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Introduction: Early and sufficient enteral intake is associated with re-
duced ICU morbidity and mortality. Limited data suggests that use of
nurse-driven feeding protocol with defined targets may facilitate nu-
trition and improve the outcomes.
Objective: To investigate whether implementation of nurse-driven
feeding protocol results in increased enteral caloric intake in critically
ill patients during their first week in the ICU.
Methods: We performed an uncontrolled before-and-after study. Data
of consecutive adult patients, readmissions excluded, treated for at
least 7 days in General ICU of Tartu University Hospital, were extracted
from existing database. In 2013, nurse-driven feeding protocol was in-
stituted in the department [1]. To analyze outcomes of this implemen-
tation, patients treated from 2011 to 2012 were included in Before, and
patients from 2014 to 2015 in After group.
Results: 231 patients were included in Before and 225 in After group,
respectively. The groups are comparable regarding demographics,
case-mix and severity of illness. Instalment of feeding protocol resulted
in significantly higher cumulative amount of enterally provided calories
by day 7 [3165 (1165-5215) kcal in After vs 2360 (450-5075) kcal in
Before group, median (IQR), p = 0.043], while less calories were given
parenterally [2600 (712-4287) vs 3900 (1725-6645) kcal, p < 0.001]. Cu-
mulative proportion of patients who did not receive any enteral feed
was significantly smaller in After group (Fig. 24).
Percentage of enterally received calories from caloric needs was sig-
nificantly higher in After group (Fig. 25).
Prevalence of GI symptoms and intra-abdominal hypertension was not
different between the groups. ICU length of stay was significantly shorter
in After group (11 vs 13 days, respectively, p < 0.001), but no difference
was noted in duration of mechanical ventilation and ICU mortality.
Conclusions: Use of nurse-driven feeding protocol in ICU patients is
associated with improved enteral nutrition without an increase of
GI complications.
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Table 28 (abstract A55). Enteral nutrition practices in mechanically ventil
Routes of nutrition n=374(%)
Enteral nutrition 325(86.8)
Parenteral nutrition 9(2.4)
Enteral + parenteral nutrition 1(0.3)
No nutrition 39(10.5)
Reasons for not feeding n=39(%)
Intestinal obstruction/Post-operative bowel surgery 10(25.6)
Hemodynamic instability 10(25.6)
Poisoning 9(23)
GI bleed 8(20.5)A55
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Introduction: Enteral nutritional is an essential component of critical
care. Adequate nutrition is essential for recovery from critical illness;
malnutrition has been associated with poor patient outcomes in in-
tensive care units.
Objectives: To estimate the adequacy of nutritional in mechanically
ventilated patients and its effect on patient outcomes.
Methods: This was a prospective observational study, done over a
period of one year(Jan.-Dec. 2015}). All adult patients mechanically ven-
tilated for >48 hours were included in the study. Patients were startedon protocol driven continuous enteral nutrition, targeted to achieve 25
Kcal/kg/day of energy and 1 gm/kg/day of protein. Data was collected
on demography, admission severity of illness, hemodynamics, subject-
ive global nutritional assessment (SGA), and lead time to initiation and
achievement of full feeds, adequacy of energy and proteins supplied
reasons for feeds interruptions and complications of enteral nutrition.
All data on nutrition was collected till the patient stayed on ventilator.
Primary outcome was time to achieve full feeds; secondary endpoints
were time to initiate feeds and reason for interrupting feeds.
Results: 374 patients fit into the inclusion criteria. Majority were males
(64 %), mean age of patients was 55.1(±17.8) years and their BMI was
24(±3.5). APACHE II 22.3 (±5.9) and SOFA 7.2(±2.3) scores were high.
35.4 % of patients were malnourished on nutritional screening(SGA). Re-
spiratory failure (59 %) was the most common reason for intubation
followed by neurological deterioration and majority of patients were
medical patients
Two patients(2/374) had nasogastric tube malpositioning on X-ray,
which required re-insertion. 86.8 % received enteral feeds, 2.4 % re-
ceived parenteral nutrition and 10.4 % received no feeds
Time to initiate enteral feeds was 12 hours (median) (IQR)(7.5-24)
hours and it ranged from 1-130 hours
66.86 % of patients received 100 % of target calories in 39.2(±19.4)
hours and 33.1 % of patients didn´t achieve their target calories. 372
interruptions of feeds occurred in 335 patients enterally fed; most
common reasons for interruption was weaning (43.8 %) followed by
airway related procedures (26.6 %) and these patients were restarted
on feeds after 9.8(±5.1) hours following interruption of feeds. Patients
received 70 % (mean-1069 Kcal) of their prescribed calories during
their ventilator days. Mortality rate was 42.2 %, ICU ALOS and ventila-
tor days were 7.7(±5.3) and 5.9(±4.2) days respectively.
Conclusions: Protocol driven enteral nutrition allows early feeding,
with minimum interruptions of feeds in mechanically ventilated pa-
tients and their is still room for improvement.
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Fig. 27 (abstract A55). Lead time to initiate feeding(hours)
Table 29 (abstract A55). Calories achieved over days
No.of patients (n) Calories achieved
mean(±SD) Kcal
Percentage of target
calories achieved (%)
Day 1 309 656(424) 42.3
Day 2 284 1591(512) 88.7
Day 3 221 1517(512) 90
Day 4 176 1400(517) 73.4
42.3% of targeted calories were achieved on day1
Fig. 28 (abstract A55). % of feeds received over days
Table 30 (abstract A55). Reasons for interrupting feeds
Reasons for interrupting feeds n=372(%)
Weaning 163(43.8)
Airway-related procedures 99(26.6)
Free water ( for treatment of hypernatremia) 64(17.2)
Preparation for surgery /procedures 39(10.4)
GRV>500ml 10(2.6)
Diarrhoea 10(2.6)
Vomiting 6(1.6)
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Introduction: The recent randomized controlled DECS-trial demon-
strated that high-dose dexamethasone before cardiac surgery with
cardiopulmonary bypass decreased ICU length of stay [1]. In our
center many patients undergo off-pump cardiac surgery for which no
dexamethasone is administered. Post-operative cortisol levels might be
associated with outcome [2, 3]. In this study we prospectively measured
cortisol levels after cardiothoracic surgery in relation with outcome for
patients who did or did not receive dexamethasone.
Methods: In 2013 and 2014 we prospectively collected post-operative
cortisol levels obtained on the first morning after cardiothoracic sur-
gery. Cortisol was determined in serum with a chemi-luminiscence
assay. The use of dexamethasone (1 mg/kg) was recorded as well ICU
and hospital length of stay and hospital and long-term mortality after
an observation period of at least 1.5 years. Patients were divided into
low or high cortisol according to the median cortisol measured in the
dexamethasone or control patients.
Results: We included 927 patients, 70 % males with a mean ± SD age
of 63 ± 13 years. Cardiopulmonary bypass was used in 488 (53 %) and
high-dose dexamethasone was administered in 439 (47 %) of the oper-
ations. ICU and hospital length of stay were 2.3 ± 5.0 and 13.7 ±
12.5 days respectively. Hospital and long-term mortality were 2.2 %
and 6.5 % respectively. Median (IQR) cortisol on the first day post-
surgery was 600 (195-965) nmol/L (or 22 ug/dL). Median cortisol levels
were lower in the dexa group than the control group (P < 0.0001).
Patients in the dexa group had a median (IQR) cortisol of 205 (75-535)
and were divided into low-cortisol and high cortisol groups (cortisol <
=205 and >205 nmol/L respectively). Likewise control patients had a
median cortisol of 830 (585-1125) and were divided into < =830 and
>830 nmol/L groups. No significant differences in length of stay or mor-
tality were observed between patients with a low or high cortisol level
within the dexa and control groups.
Conclusions: Cortisol levels obtained one day after cardiac surgery
are far lower in dexamethasone treated patients. Both in controls
and dexamethasone-treated patients, lower cortisol levels were not
associated with a worse outcome.
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Introduction: Plasma albumin concentration is low in critically ill pa-
tients despite a higher than normal synthesis rate. It is demonstrated
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 34 of 607that the capillary escape rate of albumin is increased, related to an
enhanced capillary leakage, but the return to plasma through the
lymphatic system is not characterized. Nevertheless it is necessary to
postulate an enhanced degradation rate or increased volume of distri-
bution, to explain this finding.
Objectives: We explored 3 different techniques to assess albumin
turnover and degradation.
Methods: Healthy volunteers (n = 10) were studied over 42 days. The
first day, albumin synthesis rate was measured in the postabsorptive
state by the in vivo incorporation of d5-phenylalanine, and a dose of
125I-albumin was given to assess albumin degradation. Degradation
rate was measured and calculated by the decay in radioactivity in 2
ways; in urine collected over 24 hours at 3 separate days, and in plasma
repeatedly over 42 days.
Results: Basal albumin synthesis rate was 118 ± 16 mg/kg/day, equal
to degradation rate in steady state. Catabolic rate by urine sampling
was 142 ± 31 mg/kg/day (P = 0.022 v. basal), and by plasma 177 ±
29 mg/kg/day (P = 0.001 v. basal).
Conclusions: The differences in calculated turnover rates may corres-
pond to effects of feeding or differences in half-lives between ex-
ogenous and endogenous albumin. The exact explanation needs to
be further investigated.
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Introduction: A low plasma glutamine concentration at ICU admittance
is associated with an unfavorable outcome. A number of studies have
shown beneficial effects of exogenous glutamine supplementation to
unselected critically ill patients. However, recently harm is reported
when pharmacological doses of exogenous glutamine is given to under-
fed unselected ICU patients with ≥ 2 organ failures. The mechanism
behind this finding is not understood and more specifically the reason
for the low levels is not known.
Objectives: The relation between plasma glutamine concentration
and glutamine production rates.
Methods: Critically ill patients (n = 17) with normal or low plasma
glutamine concentration were studied. Glutamine rate of appearance
reflection glutamine production rates was determined employing a
bolus dose technique, and the decay curves were fitted into a single
pool or a 2-pool model.
Results: Glutamine rate of appearance was in the range 5 - 15 umol/
kg/min in ICU patients with plasma concentrations in the range300-
700 umol/L. There was a statistical significant (P < 0.05) relation, but the
coefficient of determination was low R2 = 0.15. Also the correlation
between the 1-pool and 2-pool models was statistically significant (P <
0.01), but the coefficient of determination intermediary R2 = 0.60.
Conclusions: To understand the results of recent glutamine supple-
mentation studies in the critically ill, the relevance of plasma glutamine
levels must be under stood. In healthy volunteers there is a high con-
cordance between 1-pool and 2-pool models to calculate the rate of
appearance. The lower agreement in ICU patients indicates that a more
extensive modeling may be necessary.
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mated at up to 40 % with the majority of critically ill patients
requiring nutritional support. Traditional teaching suggests that
early enteral feeding in mechanically ventilated septic patients is
superior to parenteral feeding due to a lower complication rate but
neither form of support is without risk.
Objectives: In this study, we compared the outcomes in mechanically
ventilated septic ICU patients receiving enteral versus parenteral
nutrition.
Methods: A single centre study of patients admitted to a 25 bed
University Hospital ICU over a period of three years. Demographics,
severity of illness scores (APACHE and SOFA), BMI and MUST were mea-
sured upon admission. Daily nutrition requirements were calculated for
each patient. Patients were randomized to enteral(EN) or parenteral
nutrition(PN) group within 48 hours of intubation and admission to the
unit. Duration of mechanical ventilation, ICU and hospital length of stay
(LOS), and mortality rates were recorded.
Results: A total of 148 patients (76 men) mechanically ventilated septic
patients having a mean(±SD) age of 69.6 ± 19.4 years were studied. All
patients met the consensus criteria for sepsis. Baseline characteristics
were similar in the two groups. APACHE II and SOFA at study entry
were 24 ± 5 and 8 ± 3 respectively. The mean(±SD) BMI was ≈ 21.5 ±
3.4 kg/m2. Seventy seven (52,02 %) patients received EN, and sixty nine
(47,26 %) received PN. There was no difference between the two
groups for age, sex, BMI, and scores. ICU and hospital LOS were similar
for both groups. ICU mortality rate was 29.4 % for PN group vs. 27.2 %
for EN group indicating no significant difference. Hospital mortality was
similar for both groups as well. In the PN fed group however, duration
of mechanical ventilation was longer (p = .018), but the feeding goal
was attained earlier (p = .009).
Conclusions: In mechanically ventilated septic ICU patients the ICU
LOS and the hospital LOS, as well as the ICU and hospital mortality
rates of patients receiving PN are not significantly different than
those in patients receiving EN. Furthermore, feeding goals can be
attained much easier by PN. Duration of mechanical ventilation how-
ever appears to be longer in patients receiving PN.
A60
Association between the route of nutrition and adipokine
hormones levels in critically ill patients: a pilot study
K. Gundogan1, E. Dogan2, R. Coskun1, S. Muhtaroglu3, M. Sungur1, T.
Ziegler4, M. Guven1
1Erciyes University, Intensive Care Unit, Kayseri, Turkey; 2Erciyes
University, Internal Medicine Department, Kayseri, Turkey; 3Erciyes
University, Clinical Biochemistry Department, Kayseri, Turkey; 4Emory
University, Department of Medicine, Division of Endocrinology,
Metabolism and Lipids, Atlanta, United States
Correspondence: K. Gundogan – Erciyes University, Intensive Care Unit,
Kayseri, Turkey
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A60
Introduction: Adipokine hormones play an important role in regula-
tion of insulin metabolism, body fat distribution and regulation of
appetite and satiety. Some adipokine hormones have effects on in-
flammation and insulin resistance but the relation between these
hormones and critical illness and the route of nutrition is not known.
Objectives: The aim of this study to determine association between
nutrition route and adipokine hormones levels in critically ill patients
Methods: This study was performed prospectively in Medical and
Surgical ICU at Erciyes University. Patients expected to stay in ICU at
least 72 hours and received either parenteral or enteral nutrition in-
cluded into the study.
Results: Total of 26 patients were included into the study and 17 of
them were male (65 %). The mean age was 62.8 ± 18.2 years. Total of
14 patients (54 %) were fed via enteral route and 12 patients (46 %)
were received parenteral nutrition. The mean APACHE II score was
22.7 ± 7.1. Resistin levels were lower in enteral nutrition group at
24th (p = 0.015) and 72nd hours (p = 0.014) compared to parenteral
nutrition group. Baseline, 24.th hours and 72.th hours GLP-1 levels
were found to be higher in enteral nutrition group than parenteral
Table 31 (abstract A61).
Sham Survivors Non-survivors
Soleus
Phospho PDH 1.4±0.32 2.85±0.42 5.79±0.42a,b
PDH 0.99±0.11 0.78±0.31 0,24±0.03a,b
Heart
Phospho ACC 0.37±0.01 1.37±0.012a 1.51±0.012a
Phospho AMPK 0.25±0.001 0.32±0.005 0.37±0.004
a p< 0.05 vs control, b p< 0.05 vs survivors
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 35 of 607nutrition group (p = 0.031, p = 0.006 and p = 0.001 respectively). Adi-
ponectin levels were significantly higher in enteral nutrition group
compared to parenteral nutrition group at 72th hour (p = 0.014).
Conclusions: Our study showed that enteral nutrition helped to
reverse abnormal process in critically ill patients with increasing adi-
ponectin and GLP-1 levels and decreasing resistin levels.
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Introduction: A switch from carbohydrate to fat utilization is a hall-
mark of systemic inflammation. While this adaptive response occurs
quickly and allows animals to survive under restricted food supply
conditions, it will markedly affect cell metabolism.
Objectives: To elucidate molecular mechanisms underlying the sub-
strate switch from carbohydrate to fat in different organs, we studied
early alterations in (i) phosphorylation of enzymes involved in energy
metabolism: AMP kinase (AMPK, thr172), acetylCoA carboxylase (ACC
ser179), pyruvate dehydrogenase (PDK ser293), hormone sensitive
lipase (HSL ser563); and (ii) expression of mitochondrial uncoupling
proteins 2 and 3 in soleus and gastrocnemius skeletal muscle, liver,
kidney and heart in sham-operated and septic rats at 6 h in our well-
characterized 72 h fluid-resuscitated rat model of faecal peritonitis
Methods: Awake, instrumented yet fully mobile male Wistar rats
(325 ± 15 g) received an i.p. injection of 4 μl/g faecal slurry. Fluid re-
suscitation (50:50 mix of 5 % glucose/Hartmann´s; 10 ml/kg/h) was
commenced at 2 h. Control animals were treated identically except
for slurry injection. At 6 h, an echo-measured heart rate cut-off of
460 bpm was used to classify animals into predicted survivors SR or
non-survivors NSR.(1) Animals were killed and organs were immedi-
ately collected into liquid nitrogen. Alterations in protein phosphoryl-
ation and expression were studied by Western blot. Normalization
was performed to loading control: actin or PFK. Results were pre-
sented as mean +/- SE, analyzed using Student's t-test and consid-
ered statistically significant when p < 0.05.
Results: At 6 h post-sepsis no differences were seen in renal and
hepatic phosphorylation of AMPK, ACC, PDH and HSL between sham
and septic animals. While cardiac ACC phosphorylation was strongly
increased in septic rats, AMPK phosphorylation did not differ, sug-
gesting that ACC phosphorylation was mediated not by AMPK but
rather via the glucagon-PKA pathway. The biggest changes were ob-
served in skeletal muscle. AMPK phosphorylation was increased in
gastrocnemius and even more so in soleus in septic rats but this was
not accompanied by a corresponding increase in ACC phosphoryl-
ation. In both muscles PDH phosphorylation markedly increased
while PDH fell, suggesting a fall in pyruvate oxidative decarboxyl-
ation and glucose usage as a fuel. HSL phosphorylation was strongly
increased in soleus in non-survivors. UCP2 and UCP3 levels were not
altered in any organ. Table 31.
Conclusions: 1) Each organ has its own program for the switch from
carbohydrate to fat metabolism. 2) The consequences of these changes
on the development of organ dysfunction merit further investigation,
as this may lead to novel directed therapeutics.References
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Introduction: Albeit practical implementation remains a concern,
indirect calorimetry (IC) is the first choice technique for estimating
energy requirements in critically ill patients.
Methods: In our adult mainly surgical intensive care unit (ICU) we retro-
spectively assessed in 25 patients the utility and practical aspects of
estimating the daily energy requirements. We determined energy re-
quirements by IC (Quark, COSMED) and compared the estimates with
those calculated by measuring VCO2 alone using a ventilator (Evita XL;
Draeger) or using formulas based on body mass of body mass index.
Results: Our study population was found to have an average body
mass of 69.7 kg and according to IC and energy requirement of
1987 kcal/day on average. No correlation (R2 = 6E-05) was found
when estimates of IC were compared to estimates based on body
mass alone. However using an adjusted mass (based on hight and an
assumed body mass index of 23) correlation improved (R2 = 0.3358).
VCO2 based estimation of energy requirement only weakly correlated
with IC (R2 = 0.414). Weak correlation is explained by assuming a
fixed respiratory coefficient for ventilator based energy estimates as
well as by imperfect correlation of VCO2 estimates reported by calor-
imeter and ventilator (R2 = 0.6189)
Conclusions: Body parameters such as hight or mass aren't suited to
predict the patient's energy needs. Albeit promising and simple, esti-
mation of energy requirement based on ventilator derived VCO2 also
fails precision. Whether technical improvements on how ventilators
calculate VCO2 can render them more suited in daily praxis will have
to be determined in future studies.
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Introduction: Extracorporeal membrane oxygenation (ECMO) is an
advanced treatment to support the critically ill patients with cardiac
and/or with severe respiratory failure. It is suggested that ECMO
patients are at risk of splanchnic ischemia and thus, enteral feeding
is poorly tolerated needing nasojejunal feeding and is potentially
unsafe. This study aims to investigate the nutritional adequacy of
this patient group.
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during the initial 5 days of feeding.
Methods: A retrospective review of all the patients that received
ECMO between January/2000 and December/2014 was conducted in
a tertiary critical care unit/ECMO referral centre. Patients were all fed
as per unit feeding protocol that recommends early enteral feeding
instead of parenteral or delayed enteral nutrition.
Results: Data were reviewed for 80 patients for the initial 5 feeding
days and is reported as mean and (SD). The average duration of
ECMO was 12.7 (9.9) days. Sixty-five patients received venovenous
ECMO for respiratory failure whilst the remainder received venoarter-
ial ECMO for cardiac failure. Patients age, Body mass index (BMI) and
sofa scores were 44.1 (15.7), 29.1 (8.5) and 15.7 (2.8) respectively. En-
teral feeding started at 14.2 (5.8) hrs and reached 83 % target within
72 hrs. Overall, patients had good tolerance to the feed with a mean
gastric residual volume (GRV) of 176.6 ml/24 hrs (167.75) during the
5 days. Feeding intolerance, defined as GRV >250 ml, were observed
every day with 7, 13, 15, 10 and 8 episodes on days 1, 2, 3, 4 and 5
accordingly. Diarrhoea was observed on 16 % of the patients and
mainly on days 3 (15/80), 4 (16/80) and 5 (17/80). Forty-two patients
needed prokinectics (metoclopramide) and eight of those were also
on erythromycin. Eight patients were on parenteral nutrition to sup-
plement inadequate enteral feeding. Overall patients were receiving
>80 % by day 3 onwards. All patients were on nasogastric feeding
and nasojejunal feeding was not necessary.
Conclusion: Enteral nutrition is well tolerated by patients receiving
ECMO, whether in venovenous or venoarterial mode. No serious
adverse events were attributable to enteral nutrition in these
patients.RESPIRATORY INFECTIONS
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Introduction: Nowadays, hospital acquired infections are the most
widespread phenomena among the critically ill patients. Prophylaxis
of gastric stress ulcer with acid-suppressive therapy increases the risk
of ventilator associated pneumonia (VAP) in critically ill patients(1).
While, two meta- analyses comparing PPI and H2RA in terms of
prophylactic effectiveness for gastric stress ulcer in critical patients
have showed no apparent differences in both groups as regard to
upper gastric ulcer prophylaxis, pneumonia and mortality in patients
admitted to ICU (2,3).
Objectives: Prophylaxis against stress ulcer in mechanically ventilated
patients has been considered as a culprit in the development of ven-
tilator associated pneumonia (VAP) in retrospective studies. To test
this hypothesis in a mixed medical-surgical adult ICU, we designed a
randomized clinical pilot study to determine the necessary sample
size for comparing the effect of intravenous ranitidine and pentopra-
zole on the incidence of VAP.
Methods: Patients with at least 48 hours of expected mechanical venti-
lation were allocated randomly to receive either 50 mg ranitidine (R)
every 8 hours or 40 mg pentoprazole (P) every 12 hours intravenously
from admission till 48 hours after extubation. VAP diagnosis was ac-
cording to Clinical Pneumonia Infection Score and positive culture of
endotracheal tube aspiration.
Results: After recruiting 86 patients during 15 months period and a
preliminary analysis, the study was terminated due to very lowdifference between VAP incidence in R (32.6 %) and P groups
(27.9 %; P value 0.63, Odds ratio; 1.24, confidence interval; 0.49-
3.13). No statistically significant difference was observed in terms of
gastro-intestinal bleeding, ICU and hospital length of stay and mor-
tality between the two groups.
Conclusions: VAP incidence is hardly related to the type of stress
ulcer prophylaxis agent in our ICU setting with high rate of VAP and
low utilization of VAP prophylaxis bundle. To find any such effect a
huge number of patients are needed to be recruited in a large ran-
domized clinical trial
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Rationale: Pneumonia is the leading risk factor of acute respiratory
distress syndrome (ARDS). For the critically ill patients with pneumo-
nia, coinfection had higher mortality and longer length of stay in the
intensive care unit (ICU). Little is known about the impact of coinfec-
tion on the outcomes of pneumonia-induced ARDS patients.
Objectives: To evaluate the role of coinfection from bronchoalveolar
lavage (BAL) examination on the outcomes of pneumonia-induced
ARDS.
Methods: We performed a prospective observational study in adult
ICUs at the Chang Gung Memorial Hospital from October 2012 to
May 2015. Patients were included if they met the Berlin definition
of ARDS. The BAL indication were pneumonia-induced ARDS was
suspected clinically and no definite microbial was indentified from
tracheal aspirate. The BAL specimen was sent for comprehensive
microbiological study including bacteria, fungi and virus. Demo-
graphics and baseline clinical characteristics were collected on
enrollment. The final pathogen identified results and clinical out-
comes were analyzed.
Results: Totally 19936 receiving invasive mechanical ventilation pa-
tients admitted to ICUs with PaO2/FiO2 < 300 mmHg screened, 902
(4.5 %) patients fulfilled the Berlin definition of ARDS. Of these ARDS
patients, 205 (22.7 %) patients who were pneumonia-induced ARDS
with BAL for pathogen survey were included for analysis. One hun-
dred and forty two (55.7 %) patients were identified with microbio-
logical pathogen. According the identified virus pathogen, these 142
patients were divided as only virus identified group (n = 41, 28.9 %),
no virus identified group (n = 60, 42.2 %) and coinfection with other
pathogen group (n = 41, 28.9 %). The distribution of ARDS severity
were no significant difference between these 3 group patients (p =
0.43). The coinfection group had significantly higher hospital mortal-
ity rate than only virus group and no virus group (80.5 % vs 53.7 %
and 63.3 %; p = 0.03).
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 37 of 607Conclusions: The coinfection with virus and other pathogen from
BAL was associated with increased mortality in pneumonia-induced
ARDS patients.
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Introduction: CAP is a potentially life threatening disorder despite
the advent of potent antibiotics & commonly causes acute respira-
tory failure with high mortality1.Assessment of disease severity &
prediction of outcome is essential for appropriate allocation of
health care resources & for optimized treatment decisions2.
Kallistatin, an endogenous tissue kallikrein inhibitor; which protects
against inflammation, fibrosis & oxidative stress may be involved in
CAP pathogenesis through anti-inflammatory effect3.
Objectives: To determine whether kallistatin levels have a prog-
nostic value in severe CAP & to correlate it with other biomarkers
as CRP,APACHE II ,SOFA, CURB-65 scores & Pneumonia severity
index (PSI).
Methods: Plasma samples and clinical data were prospectively col-
lected from 30 patients admitted to the Critical Care Department
with severe CAP according to IDSA/ATS Criteria4. Serum Kallistatin
levels were collected on days 1 and 4 of ICU admission. It was corre-
lated with APACHE II, SOFA, CURB-65 scores & PSI on admission also
with PO2/FiO2 ratio and CRP on days 1 and 4.
Results: Lower kallistatin levels on days 1 & 4 showed a strong
trend toward increased mortality with a p-value of 0.043 & 0.04 re-
spectively. Its level was negatively correlated with APACHE II,SOFA,-
CURB-65 scores & PSI and with a p-value of 0.036,0.001, 0.102 &
0.001 respectively while it showed a positive linear correlation with
Po2/Fio2 ratio on days 1 & 4 with a P-value of 0.001 & 0.005 respect-
ively. It also showed a negative correlation with CRP on days 1 and
4 with a p-value of 0.001. Its level on days 1 & 4 of ICU admission
were significantly decreased in patients who developed septic
shock with a p-value of 0.044 & 0.043 respectively and who had
ARDS requiring mechanical ventilation with a P-value of 0.001 &
0.005 respectively. Kallistatin cut-off value to predict mortality de-
termined by ROC curve was 6.65ug/ ml on day1 with sensitivity
90 % and specificity 80 % & a p-value 0.022 while was 8.6ug/ml on
day 4 with sensitivity 85 % and specificity 77 % & a p-value 0.035.
Conclusions: kallistatin may serve as a promising novel marker for
prognosis of severe CAP & may be involved in its pathogenesis
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Objectives: To assess the clinical and developmental implications of
delayed diagnosis of community-acquired influenza A (H1N1) pdm09
infection in critically ill patients admitted to the ICU.
Methods: Prospective, observational and multicenter study in 148
Spanish ICU. Data were obtained from GETGAG / SEMICYUC (2009-
2015). All patients infected by influenza A (H1N1) confirmed by RT-PCR
in the first week of hospital stay were included (viral community-
acquired pneumonia). Patients were classified according to the moment
of flu diagnosis: early (in the first two days of hospitalization) and late
(between the 3rd and 7th day of admission). Demographic, temporary
variables, comorbidities, severity at ICU admission, treatment and mor-
tality were evaluated intra-ICU. Logistic regression was used to identify
related factors to late diagnosis and Cox regression to determine
whether the late diagnosis was an independently variable associated
with mortality. The results are presented as odds ratios (OR) and 95 %
confidence intervals (CI). We considered p < 0.05 to be significant.
Results: 2059 ICU patients diagnosed in the first 7 days of hospital
stay were evaluated. 1314 (63.8 %) were early diagnosed and 745
(36.2 %) were late diagnosed. Independent variables associated to
late diagnosis were: days of hospital stay until ICU admission (OR
1.254, 95 % CI 1.169 to 1.345; p < 0.001), mechanical ventilation (OR
1.690, 95 % CI 1.259 to 2.268; p < 0.001) and the need of renal re-
placement (OR 1.509, 95 % CI 1.071 to 2.125; p = 0.019). Clinical pres-
entation as viral pneumonia was a protective variable related to the
delay (OR 0.654, 95 % CI 0.495 to 0.881; p = 0.005). Patients with late
diagnosis presented higher ICU [8(4-17) vs 10(5-20), p = 0.000] and
hospital days of stay [14(8-25) vs 18(10-30), p = 0.000] as well as
higher intra-ICU mortality (20.5 % vs 32.6 %, p = 0.000). The diagnosis
delay was an independently variable associated with mortality in the
multivariate analysis (OR 1.364, 95 % CI 1.029 to 1.808).
Conclusions: Influenza A (H1N1)pdm09 diagnosis delay in critically ill
patients admitted to the ICU is associated with delayed ICU admis-
sion, increased respiratory failure or acute renal failure and increased
mortality. Delayed diagnosis is an independently variable associated
with mortality.
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respiratory infection (SARI). To know its clinical features and prognosis
factors are essential for management and outcome.
Objectives: To determine the incidence and mortality of patients
with SARI and influenza A infection admitted to the ICU; and to identify
the most common symptoms and comorbidities among patients
affected by SARI and influenza A infection.
Methods: A prospective observational study was performed includ-
ing patients with SARI admitted in ICU of a tertiary care Hospital from
november 2014 to march 2015. Influenza infection was diagnosed by
RT-PCR. Patients´ demographic, clinical and radiologic features and
outcomes were recorded. Pearsoń s chi-square, Fisher, Mann Whitney
U tests and logistic regression have been used for statistical analysis.
Data are expressed as frequency (percentage) or median (25th-75th
interquartile range).
Results: During study period 425 patients were admitted to ICU.
Seventy-five (17.6 %) were included as SARI (57.3 % male; median
age 57(47-67) years old; APACHE II 21(13-27) and SOFA 8(5-10); ICU
LOS 8(4-23) days; days from symptom onset to hospital admission
4(1-6)). Main co-morbidities were lung diseases in 44(33 %) patients
and cardiovascular diseases in 19(25.3 %) patients. Seventeen
(22.7 %) patients presented Influenza A infection, only one did not
presented viral pneumonia. Cough, shortness of breath and muscle
pain were the most common symptoms in influenza A patients
(87.5 %, 68.8 % and 43.8 % respectively). Influenza-like illness was
more frequent in influenza A patients (52.9 % vs. 32.8 %; p = 0.13),
furthermore most patients with influenza A infection were diagnosed
during influenza epidemic period (88.2 % vs. 37.9 %; p < 0.001); all
patients with influenza A infection were treated with oseltamivir.
High-flow oxygen therapy was required in 53(70.7 %) SARI patients,
11(14.7 %) non-invasive mechanical ventilation, 46(61.3 %) invasive
mechanical ventilation, 30(40 %) inotropic drugs and 11(14.7 %) renal re-
placement therapy. Influenza A patients presented a similar distribution.
Overall SARI mortality was 20 %, only one with influenza A infection
(5.6 % vs. 26.7 %; p = 0.1). APACHE II (25(19-33) vs. 19(11-26); p = 0.03)
and SOFA score (12(8-14) vs. 8(5-10); p = 0.003) showed to be a good
predictor of mortality at ICU admission. Also, delayed admission to ICU
(4(1-16) vs. 1(0-2); p = 0.01) and renal replacement therapy (40 % vs.
6.9 %; p = 0.04) were associated with increased mortality.
Previous renal diseases (OR 10.28 CI 95 % (2.25-46.96); p = 0.003) and
oncology diseases (OR 6.8 CI 95 % (1.59-29.11); p = 0.01) were inde-
pendently associated with mortality.
Conclusions: A nonsignificant decrease in mortality was observed in
patients with influenza A infection. Early ICU admission could im-
prove SARI prognosis.
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Introduction: H1N1 influenza can cause both self-limiting and life-
threatening illnesses. Triaging patients who require hospital admission
and those who can be safely discharged can be difficult in a pandemic
situation. Existing triage tools focus on prediction of hospital admission
in H1N1. We assessed the ability of routine clinical markers to predict
early discharge in patients with confirmed H1N1 influenza.
Objectives: 1) Assess the ability of routine clinical and laboratory var-
iables to predict patients who could safely be discharged home
within 24 hours.
2) Compare the predictive value of clinical variables to triaging tools
(STSS and SOFA) and the qSOFA criteria.
Methods: We reviewed an existing database of patients who presented
to the Royal Liverpool University hospital from 2010 - 2011. Inclusioncriteria were: patients with H1N1 confirmed by reverse transcriptase
polymerase chain reaction who were ≥18 years of age. Exclusion cri-
teria were: unconfirmed cases, patients not seen in the hospital and
with missing case notes. Differences in clinical parameters between
patients discharged within 24 hours of medical assessment and those
admitted to hospital were analysed. A chest X-ray scoring system was
also employed to assess the ability of radiographic findings to predict
likelihood of discharge.
Results: Eighty-six patients were eligible for the study. 17 patients
were discharged early and 69 patients were admitted to hospital. P/F
ratio and CRP predicted discharge with area under receiver operating
characteristic (ROC) curves of 0.788 (CI 0.681-0.894) and 0.763 (CI
0.6377-0.889) respectively, which was higher than triage and bedside
tools. The chest radiograph scoring tool did not predict patient
discharge (p = 0.191-0.999), but demonstrated very good inter-rater
reliability (Cohen's kappa statistic >0.8).
Conclusions: P/F ratio and CRP predicted discharge better other
clinical parameters. Both were superior to H1N1 specific triage tools
described in the literature. P/F ratio is a simple and effective method
to determine oxygen exchange. We recommend this tool in the assess-
ment of patients during influenza pandemic to guide management
decisions and future work would involve validation in prospective
cohorts.
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Introduction: Ventilator-associated pneumonia (VAP) is the most
common ICU-acquired infection. Recently, the incidence of
extended-spectrum beta-lactamase producing Enterobacteriaceae
(ESBLE) has substantially increased in critically ill patients. Identifying
patients at risk for VAP related to ESBLE could be helpful to improve
the rate of appropriate initial antibiotic treatment, and reduce un-
necessary exposure to carbapenems.
Objectives: The primary objective was to identify risk factors for VAP
related to ESBLE. Secondary objective was to determine the impact
of ESBLE on outcome of VAP patients.
Methods: This retrospective study was conducted in a single mixed
ICU, during a 4-year period. All patients with confirmed VAP were in-
cluded. VAP was defined using clinical, radiologic and quantitative
microbiological data. VAP first episodes were prospectively identified
using the continuous surveillance data. Exposure to different risk fac-
tors was taken into account until the diagnosis of ESBLE VAP or until
ICU discharge, in patients with ESBLE VAP and VAP related to other
bacteria, respectively. In all patients, routine screening for ESBL (rec-
tal swab) was performed at ICU admission and once a week.
Patients with ESBLE VAP were compared with those with VAP related
to other bacteria using univariate analysis. All significant factors were
included in the multivariate logistic regression model.
Results: Among the 410 patients with VAP, 43 (10.5 %) had ESBLE
VAP. 76 (18.5 %) patients had polymicrobial VAP, and 189 (46 %) had
VAP related to multidrug resistant bacteria.
The following factors were significantly associated with higher rates of
ESBLE VAP by univariate analysis: female gender, medical admission,
ARDS, shock, or infection at admission, antibiotic treatment during the
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 39 of 60730 days preceding ICU admission, large-spectrum antibiotic treatment
during ICU stay, and digestive tract colonization related to ESBLE. Acute
exacerbation of COPD at ICU admission was significantly associated
with lower rate of ESBLE VAP by univariate analysis.
Multivariate analysis identified prior ESBLE colonization of the digest-
ive tract as the only independent risk factor for ESBLE VAP (OR [95 %
CI] = 23 [10-55], p < 0.001). Whilst the positive predictive value of
ESBL digestive colonization (43.6 %) was low, its negative predictive
value was excellent (97.3 %) in predicting ESBLE VAP.
Duration of mechanical ventilation (median [IQR], 28 [18, 42] vs 23
[15, 42] d, p = 0.4), length of ICU stay 31 [19, 53] vs 29 [18, 46] d, p =
0.6), and mortality rates (55.8 % vs 50 %, p = 0.48) were similar in
ESBLE VAP, compared with VAP related to other bacteria.
Conclusions: Digestive tract colonization related to ESBLE is inde-
pendently associated with ESBLE VAP. Its excellent negative predict-
ive value suggests that patients without ESBLE colonization should
not receive carbapenems as part of their initial empirical antibiotic
treatment to cover ESBLE.
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Introduction: Severe acute respiratory syndrome (SARS) and H1N1
influenza infection (1) have activated an interest in the surveillance
of patients with severe acute respiratory infections (SARI).
Objectives: To investigate the local epidemiology, patterns of infec-
tions, severity and outcome in patients admitted to the intensive care
unit (ICU) as a result of severe acute respiratory infections (SARI).
Methods: This is a prospective observational study. All patients admit-
ted to the ICU, from October 1st, 2015 to march 31st, 2016 were
screened. Were studied, demographic characteristics, underlying condi-
tions, clinical presentation, therapeutic intervention and outcome. SARI
was defined as an acute respiratory illness of recent onset (within
7 days) that includes fever (≥38 °C), cough, and dyspnea requiring over-
night hospitalization (2).
Results: 33 patients were screened over the study period. Median
(IQR) age was 68(18-87) years. 63.6 % were male. Median (IQR) SAPS
II, 26(13-64) and SOFA score, 5(2-9). 24(77.2 %) had underlying
diseases. The symptoms' onset occurred at a median (IQR) of 4(3-7)
days before admission to the ICU. Chest X-ray displayed alveolar con-
solidation in 19(86.4 %).
On admission to the ICU, Gram-positive and Gram-negative bacteria
were found in 5(15 %) and 8(24 %) of SARI patients but rarely atyp-
ical bacteria in 1(3 %). Viruses were present in 6(18 %) of the patients
(influenza A-H1N1, 3; A-H3N2, 3).
22(66.6 %) required invasive mechanical ventilation, 18(54.5 %) vaso-
pressors, 10(45.4 %) corticosteroids, 21(63.6 %) antimicrobial therapy
and none was treated with antiviral agents.
Organ failure occurred in 26 (80 %) patients, (respiratory, 14 (53,9 %)
; hemodynamic, 9(34,6 %) and renal, 3(11,5 %)). Median (IQR) length
of stay was 6(1-30) days and duration of mechanical ventilation was
4(1-20) days. ICU mortality rates in patients with SARI were, overall,
18(54.4 %) ; 7(45 %) in severe and prolonged hypoxemia and 11
(54 %) with refractory shock.
Univariate analysis identified respiratory chronic failure and greater
severity scores at ICU admission to be associated with an increased risk
of ICU death.
Conclusions: Since the pandemic influenza A (H1N1) in 2009, the
proportion of viral infections had decreased. Whatever, admission tothe ICU for SARI remains associated with high morbidity and mortal-
ity rates
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Introduction: The epidemic flu in 2016, predominantly influenza A
(H1N1), is causing chaotic situations to the health care facilities in
Taiwan, including emergency department overcrowding, difficult for
patients to find beds in emergency rooms or in ICUs, and shortage
of respiratory ventilators as well as extracorporeal membrane oxy-
genation (ECMO) machines. Death toll continues to rise and is
record-breaking. The reasons why so many patients suffered from
such a severe influenza that required intensive care is unclear. Some
studies have emphasized the importance of Aspergillus infection dur-
ing severe influenza attack.
Objectives: To show if there is any correlation between the activity
of aspergillosis and influenza infection
Methods: Confirmed influenza case was defined at least one positive
assay for testing influenza included influenza A and B rapid antigens,
real time polymerase chain reaction (PCR), viral isolation and identifica-
tion for specimens of nasopharyngeal swab and/or lower respiratory
tract aspirates. The detection of Aspergillus galactomannan (GM) anti-
gen by Platelia Aspergillus Ag assay in human serum and bronchoalveo-
lar lavage fluid was used as an aid in the assessment of patients with
suspected aspergillosis. A GM index ≥ 0.5 was defined positive for As-
pergillus antigenemia. Decision of testing Aspergillus antigen was made
by attending physicians, mostly for patients with worsening pneumonia
under oseltamivir and/or routine antibiotic therapy.
Results: A total of 1,640 hospitalized medical ICU patients were iden-
tified during the observed 7-month period, including 32 (1.95 %) pa-
tients had a diagnosis of severe influenza and 24 (1.46 %) patients
were positive for Aspergillus GM antigen test. Meanwhile, 12 (37.5 %)
patients of severe influenza with worsening pneumonia had Aspergil-
lus antigenemia. However, only 13 influenza patients were tested for
Aspergillus GM antigen. The physician-dependent patient selection
bias resulted in 92.3 % accuracy. The incidence of patients with influ-
enza and/or positive Aspergillus antigenemia in medical ICU patients
significantly increased in February 2016 in comparison to previous
6 months in the hospital.
Conclusions: Medical imaging and serum galactomannan antigen
currently constitute the basis of the screening approach for invasive
pulmonary aspergillosis. The presence of Aspergillus antigenemia
might not represent true invasive Aspergillus infection, but a prompt
diagnostic workup should be encouraged as most of these patients
suffering life-threatening ARDS. The clinical impact of invasive asper-
gillosis on severe influenza may be more important than previous
thought. In conclusion, our study revealed a possible link between
invasive aspergillosis and severe influenza patients. Recognition of
this potential might help physicians to initiate a prompt diagnostic
workup incorporated into strategies of preparedness for the epidemic
crisis.
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Objectives: To assess the prognostic implications of hospital acquisi-
tion of influenza A (H1N1) pdm09 virus in a population of critically ill
patients admitted to the ICU.
Methods: prospective, observational and multi-center study in 148
Spanish ICU. Data were obtained from the GETGAG / SEMICYUC (2009-
2015) registry. All patients infected by influenza A (H1N1) confirmed by
RT-PCR were included. Patients were classified into two groups depend-
ing on the day of diagnosis of flu: community-acquired (in the first 48 h
of hospital admission) and nosocomial infection (after the 7th day of
admission and without treatment with oseltamivir). Demographic and
temporary variables, comorbidities, severity on admission, treatment
and mortality were evaluated. Differences between groups were
assessed using chi-square for categorical variables and Student's t-test
or Mann-Whitney test for continuous variables. Significant variables in
the univariate analysis were included in a multivariate model (logistic
regression). We considered p < 0.05 to be significant.
Results: 2421 patients with influenza A (H1N1) were included of
which 2035 (84 %) were evaluables. 1103 (54.2 %) were classified as
influenza A community-acquired infection and 224 (11.0 %) as noso-
comial infection. 708 (34.8 %) could'nt be classified in either groups
of patients. Patients with nosocomial pneumonia presented: older
age (53.47 ± 15.15 vs 48.86 ± 15.33; p < 0.000), higher rates of severity
on admission (APACHE II 17 (7) vs 15 (7); p = 0.005 and SOFA 7 (3) vs
5 (3); p = 0.004), more immunosuppression and hematological dis-
eases (20.5 % vs 9.1 %, p = 0.000; 12.5 % vs 5.5 % p = 0.000), more re-
quirements of invasive mechanical ventilatilation (82.7 % vs 66.1 %,
p < 0.001) and more days of mechanical ventilation (12 [5-20] vs 8 [3-
15], p = 0.000). ICU stay (8 (4-17) vs 12 (5-22), p = 0.001), hospital stay
(14 (8-25) vs 20 (12-30), p = 0.000) and mortality (18.8 % vs 39.2 %, p
= 0.000) also increased significantly in the group of nosocomial infec-
tion. Furthermore, the hospital acquisition of influenza A H1N1 (OR =
1.63, 95%IC 1.33-1.99, p = 0.000), the APACHEII (OR = 1.08, 95%IC
1.06-1.11, p = 0.000), the hematological diseases (OR = 3.19, 95%IC
1.77-5.73, p = 0.000) and the need of renal replacement (OR = 4.20,
95%IC 2.60-6.77, p = 0.000) and mechanical ventilation (OR = 4.34,
95%IC 2.62-7.20, p = 0.000) were independently variables associated
with mortality in the multivariate analysis.
Conclusions: Patients with nosocomial influenza A (H1N1) pdm09 admit-
ted in the ICU are more seriously ill requiring more resources consumption.
The hospital acquisition of influenza A (H1N1) pdm09 in critically ill patients
who need to be admitted in the ICU is associated with increased mortality.
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tury caused by influenza virus A (H1N1). This virus did not affect only
patients in extreme ages of life and significant comorbidity, it also
affected young and immunocompetent patients. The antigenic varia-
tions these viruses suffer, cause seasonal outbreaks of different
extension.
Objectives: Describe the characteristics of patients diagnosed by
influenza who required admission to an intensive care unit
(ICU).
METHODOLOGY: Descriptive analysis including all patients diagnosed
with influenza admitted from October 2010 to April 2016 in the ICU
of a referral hospital for a population of 450,000 inhabitants. The
diagnosis was obtained by PCR on nasal or pharyngeal swabs, spu-
tum or tracheal aspirate. Epidemiological variables, risk factors, sever-
ity on admission, administered treatments, life support therapies and
mortality were collected.
Results: During this period, 52 patients with influenza were admit-
ted with an average of 8.67 per year (0-22). The mean age was
55.38 years (16-86) and 65.38 % were men. Mean APACHE II was
17.56 and mean SOFA was 6.15. Only 16 patients (30.76 %) had
been vaccinated. Influenza A was identified in 94.23 % cases
(78.85 % influenza A H1N1). Comorbidities presented by the
patients were: COPD 14 (26.92 %), hematologic diseases 10
(19.23 %), diabetes mellitus 10 (19.23 %), obesity 9 (17.3 %) and
pregnancy 4 (7.69 %). Radiological affectation was observed in 40
patients (76.92 %) at admission. 32 patients required vasoactive
drugs, 7 required renal replacement and 4 patients were moved
into the prone position (applied in our center since 2013).
94.23 % patients received oseltamivir for an average of 7.7 days
(5.98 days on average between onset of symptoms and first
dose). 94.23 % received empirical antibiotic therapy. There was
respiratory coinfection in 18 cases (44.44 % S. pneumoniae).
Ventilator-associated pneumonia was not observed in any patient.
In 48 patients (92.3 %) was required mechanical ventilation (MV).
Initially, 37 patients received non-invasive mechanical ventilation
(NIMV) and 11 invasive mechanical ventilation (IMV). NIMV failure
occurred in 21 patients (59.96 %) and 20 of them were con-
nected to IMV. Only 4 patients did not require ventilatory sup-
port. The mean ICU stay was 12 days. A total of 11 patients
(22.92 %) died during their hospital stay, all of them in the ICU.
In this group, the mean APACHE II was 18.1 and mean SOFA 7.5,
and the days between onset of symptoms and the administration
of the first dose of oseltamivir were, on average, 8.72
Conclusions: Influenza A H1N1 was identified in most of the patients.
The non-survivor subgroup presented a higher rate of immunosup-
pression, an increased severity at admission and a longer period of
time between onset of symptoms and the administration of the first
dose of oseltamivir.
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Introduction: Mortality in patients with community-acquired pneu-
monia (CAP) remains high despite improvements in treatment.
OBJECTIVE. To determine immunoglobulin levels in patients with
CAP and impact on disease severity and mortality
Methods: Observational study. Hospitalized patients with CAP were
followed up 30-days. Levels of immunoglobulin G (IgG) and sub-
classes, immunoglobulin A (IgA) and immunoglobulin M (IgM) were
measured in serum on the first 24 hours of CAP diagnosis.
Fig. 29 (abstract A76) Potential risk factors for VAP
Fig. 30 (abstract A76). Outcome
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treated — were enrolled. ICU-treated patients had significantly lower
values of IgG1, IgG2, IgG3 subclasses and IgA than ward-treated
patients. 38 patients died before 30 days. Levels of IgG2 were signifi-
cantly lower in non-survivors than survivors (p = .004) and a level of
IgG2 < 301 mg/dL was associated with poorer survival according
to both the bivariate (HR 4.47; p < .001) and multivariate (HR 3.48;
p = .003) analyses.
Conclusions: Patients with CAP with IgG2 levels < 301 mg/dL had a
poorer prognosis and a higher risk of death. Our study suggests the
utility of IgG2 to predict the evolution of CAP and increase support
measures or additional treatment.
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Introduction: Ventilator-Associated Pneumonia (VAP) is one of the
most frequent nosocomial infections in ICU and results in in-
creased mortality, prolonged hospital stay and greater healthcare
costs.
Objectives: To analyze the frequency, risk factors and the anti-
microbial resistance pattern of microbiological agents respon-
sible for VAP in patients admitted in the ICU at Clínica Sagrada
Esperança, in 2015.
Methods: A retrospective cohort of 99 patients mechanically
ventilated for ≥48 h. Data was collected from ICU admission to
28 days or death. The VAP diagnosis was defined according to
CDC but required microbiological confirmation. We analyzed
the association between risk factors and the occurrence of
VAP.
Results: The mechanical ventilation utilization ratio was 0.67. The in-
cidence of VAP was 14.9 episodes per 1,000 days of mechanical ven-
tilation. 69 % of cases of VAP were late onset VAP. The reintubation
OR ( 95 % CI) 10,714 ( 2.320 to 49.490 ) was identified as independ-
ent risk factor for VAP.
VAP was not associated with attributable mortality in the ICU or
28 days mortality (8%vs.49 %; p = 0.013 )vs.(15%vs.51 %; p = 0.011),
but was related to a threefold increase in duration of mechanical
ventilation (29.8 ± 13.7vs.10.7 ± 6.5; p = 0.000) and increase in hospital
stay (20.6 ± 13.7vs.7.0 ± 4.2; p = 0.000).
Gram-negative bacteria were the most common agents in our ICU.
Conclusions: To know and close monitoring of the incidence of VAP,
microbiological agents associated and its antimicrobial resistance
pattern is the key to the adoption of more specific standards ICU
rules.
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Introduction: Ventilator Associated Pneumonia (VAP) is the most
common hospital acquired infection in those requiring mechanical
ventilation. It is associated with prolonged length of stay on the ICU,
poorer outcomes and increased cost1.There is currently no 'gold
standard' definition but a high clinical suspicion is often enough to
begin treatment. Diagnosis can be complicated as the signs that are
seen with VAP are not uncommon in those who are critically ill in
ITU, potentially delaying treatment1,2.
Objectives: The aim of this project was to establish if there are sig-
nificant differences between the Triggers which predicted VAPs (VAP
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 42 of 607triggers) as opposed to triggers which did not predict a VAP (Non
VAP triggers) where both groups had triggered an alert.
Methods: All data from the Intensive Care Unit electronic recording
system (ICIP Phillips) was queried to extract all VAP alerts triggered
between June 2009 and March 2012. During this time period there
were 28 VAP triggers and 130 non-VAP cases.
We looked at acknowledgment time, differences in values and order
of the index parameters between VAP triggers and Non VAP triggers
to look for differences suggesting early predictors for positive micro-
biology and radiology.
Microsoft Excel ® was used to manipulate data for analysis and SPSS
Statistics 17.0 ® was used to calculate summary statistics, generate
tables, perform the student's t-test analysis and produce graphs.
Student's t-test was used to analyse statistical significance between
groups.
Results: Of the quantitative variables measured, there was no statisti-
cally significant difference between the confirmed VAP cases and the
non-VAP cases apart from in temperature with non-VAP cases having
a higher average temperature, 38.2 °C, compared with 37.89 °C in
confirmed VAP.
This notwithstanding we noted a lower mean C-rective protein (CRP),
a higher oxygen requirement and a lower White Cell Count (WCC) in
confirmed VAP cases.
As would be expected those in the VAP group had secretions most
commonly described as creamy with moderate to copious amount.
In terms of trigger order in the confirmed VAP cases, secretion
amount was the most common first and second trigger in the VAP
alert followed by nonspecific inflammatory markers such as WBC,
CRP and temperature.
In the non VAP group, temperature, oxygen requirement (PaO2/FiO2)
and WBC were the most common first trigger factors.
Conclusions: In conclusion early Secretion quantity and description
predict positive microbiology and radiology compared with other
parameters such as temperature, WBC, CRP which do not.
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Introduction: The survival predictors and optimal mechanical ventila-
tor (MV) settings in patients with severe acute respiratory distress
syndrome (ARDS) undergoing extracorporeal membrane oxygenation
(ECMO) are uncertain.
Objectives: To evaluate the influence of clinical variables and MV set-
tings on intensive care unit (ICU) mortality for severe ARDS patients
treated with ECMO.
Methods: We retrospectively reviewed severe ARDS patients who re-
ceived ECMO due to refractory hypoxemia between May 2006 and
October 2015. Serial MV settings during ECMO and factors associated
with ICU mortality were analyzed.Results: A total of 158 severe ARDS patients received ECMO were an-
alyzed. Overall ICU mortality was 55.1 %. After ECMO initiation, non-
survivors had significantly higher peak inspiratory pressure and
driving pressure than survivors on day 2, day 3, and day 7 (32.8 ± 6.4
vs 30.6 ± 5.2; 32.9 ± 6.8 vs 30.4 ± 6.0; 33.1 ± 7.1 vs 29.9 ± 5.8 cm H2O,
p < 0.05; 20.9 ± 6.8 vs 18.3 ± 5.9; 21.3 ± 7.2 vs 17.9 ± 6.8; 21.4 ± 7.5 vs
17.7 ± 6.8 cm H2O, p < 0.05). After multivariate analysis, mean driving
pressure above 21 cm H2O during first 3 days on ECMO were inde-
pendently associated with higher death (odds ratio, 2.968; 95 % con-
fidence interval, 1.312-6.712; p = 0.009). Other factors independently
associated with ICU mortality included ARDS duration before ECMO
(odds ratio, 1.005; 95 % confidence interval, 1.001-1.010; p = 0.009),
and Acute Physiology and Chronic Health Evaluation II score before
ECMO initiation (odds ratio, 1.092; 95 % confidence interval, 1.032-
1.156; p = 0.002).
Conclusions: Driving pressure during first 3 days of ECMO support in
severe ARDS was independently associated with ICU mortality and
level above 21 cm H2O was related to higher death. Further large
multicenter, prospective, randomized, controlled trials are warranted
to confirm our findings.
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Introduction: Acute Respiratory Distress Syndrome (ARDS) is a se-
vere acute inflammatory lung injury with still high mortality, des-
pite current lung protective ventilatory strategy and rescue
therapies, such as veno-venous extracorporeal membrane oxygen-
ation (VV-ECMO)1. During ARDS, immune system and inflamma-
tory pathways are strongly activated, resulting in a systemic
disease2. Microparticles (MPs), tiny cell-derived vescicles released
from a variety of activated or apoptotic cells, play a role in sev-
eral disease processes3. However, MPs role during vv-ECMO has
not been described yet.
Objectives: To assess the presence, the origin of circulating micropar-
ticles in patients with severe ARDS treated with VV-ECMO, and their
relation with the clinical course.
Methods: 15 consecutive patients admitted to our ICU for severe
ARDS that required VV-ECMO were enrolled. Immediately before (T0),
in the 2nd day after placement (T1) and removal (T2) of VV-ECMO, ar-
terial platelet free plasma was collected and analysed by Flow Cy-
tometry to evaluate endothelial (EMPs), platelet-derived (PMPs),
leucocyte-derived (LMPs), and tissue factor-bearing (TF-MPs) micro-
particles levels. Comparisons were drawn between different time
points and survivors (n = 8) and non survivors (n = 7) with analysis by
two-way ANOVA. P values < 0.05 were considered significantly
different.
Results: We found a progressive and significant reduction in both cir-
culating EMPs (median 207, IQR 95-404 è median 64, IQR 45-90 MPs/
mL, p = 0.013) and LMPs (median 432, IQR 93-479 èmedian 39, IQR
35-282 MPs/mL, p = 0.044) between the start of ECMO support (T0)
and soon after the decannulation (T2), as shown in Fig. 31. Survivors
showed higer levels of LMPs (p = 0.034) compared to non survivors
and almost significantly higher levels of EMPs (p = 0.062). Standard
laboratory tests (i.e. CRP, PCT, and WBC) did not show any significant
difference between the same time points, and between different out-
comes. There was no correlation between level of any kind of MPs
and heparin dose, bleeding episodes, and mortality.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 43 of 607Conclusions: In patients with severe ARDS treated with VV-ECMO,
plasma levels of both EMPs and LMPs were significantly elevated
just before ECMO support, then gradually reduced during treat-
ment and after decannulation. Moreover, blood passage through
the ECMO circuit did not seem to generate more procoagulant,
endothelial, leucocyte-derived or platelet-derived MPs, compared
to baseline.
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Microparticles (MPs) at T0: just before ECMO, T1: two days after ECMO
start, and T2: two days after decannulationA80
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Introduction: The use of extracorporeal membrane oxygenation
(ECMO) for acute respiratory distress syndrome (ARDS) that is unre-
sponsive to conventional ventilatory management has been increas-
ing rapidly. Therefore, in April 2015, we established a new ECMO
program under the Japanese health care system without
regionalization.
Objectives: This study aimed to determine whether the outcome of
our ECMO program is associated with the inter-hospital transfer of
patients.
Methods: The clinical data of patients treated with ECMO, from April
2015 to March 2016, were collected and analyzed retrospectively.
The clinical data of patients who were transferred from other hospi-
tals (transferred group) and those who were not (non-transferred
group) were compared before and after the venovenous (VV) ECMO
treatment
Results: During the study period, 20 patients were treated with
VV-ECMO. The median age of the patients was 60 years. The me-
dian duration of mechanical ventilation prior to introducing
ECMO was 2 days. The median duration of VV-ECMO was 7.2 days,
and the total duration of intensive care unit stay was 23 days.
Twelve (60 %) patients were successfully weaned from ECMO,
and 10 (50 %) patients survived to discharge. However, the me-
dian respiratory ECMO survival prediction (RESP) score was -2.5,
indicating that the estimated survival rate was low (35 %). More-
over, 70 % of patients were transferred from other hospitals. The
results showed that the survival rate was higher for the trans-
ferred group than for the non-transferred group (57.1 % vs.
33.3 %, P = 0.6). The proportion of immunocompromised patients
in the transferred group was lower than that in the non-
transferred group (14.2 % vs. 50.0 %, P = 0.13). Before VV-ECMO
treatment, the duration of mechanical ventilation in the trans-
ferred group was shorter than that in the non-transferred group
(2 vs. 5.5 d, P = 0.047). Moreover, the RESP score for thetransferred group was lower than that for the non-transferred
group (-1 vs. -4, P = 0.0076). During the treatment with VV-ECMO,
the duration of ECMO support in the transferred group was
longer than that in the non-transferred group (8.6 vs. 7.0 d, P =
0.030)
Conclusions: The clinical outcomes of our program were inferior to
those of advanced ECMO centers in Europe and North America. To
improve the outcomes of ECMO for ARDS in Japan, our results sug-
gest that regionalization should be employed such that ARDS
patients with better RESP scores are transferred to an ECMO center.
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Introduction: Influenza A (H1N1)pdm09 pandemic was a determinant
event for development of modern extracorporeal life support tech-
niques. It still represents a frequent cause of conventional respiratory
support failure, usually presenting with rapidly evolving critical hyp-
oxemia demanding extracorporeal oxygenation (ECMO) rescue
treatment.
Objectives: Identify characteristics of patients with the most severe
forms of H1N1-associated ARDS in order to promote early identifica-
tion of patients with putative need for ECMO treatment. Comparison
of the ECMO H1N1-infected population with the ECMO treated popu-
lation with ARDS from other causes in terms of physiological, func-
tional and biomechanical ventilation parameters to rule prognosis
prediction.
Methods: Retrospective review of prospectively collected data from a
protocol-driven ECMO referral centre, with inter-hospital patient res-
cue capability and ELSO registered activity.
Results: Between 2011 and 2015, sixty one patients were treated
with ECMO support for severe acute respiratory distress syndrome
(Quadrox HLS or PLS Oxygenator System, Maquet). There were 25 pa-
tients with H1N1-associated ARDS and 34 patients with ARDS from
other causes (two patients excluded because of insufficient data).
H1N1-patients, when compared with non H1N1-patients, had similar
age (50.0 ± 12.1 vs 46.0 ± 11.3; p > 0.05), SAPS II (41.8 ± 14.4 vs 39.3 ±
14.5; p > 0.05), pre-ECMO mechanical ventilation duration (4.2 ± 2.0 vs
6.4 ± 5.0 days; p > 0.05), hypoxemia degree (65.1 ± 17.9 vs 63.1 ±
9.0 mmHg; p > 0.05), static lung compliance at day 1 (22.3 ± 8.3 vs
23.6 ± 9.8 ml/cmH2O; p > 0.05) and average ECMO run duration (14.8
± 9.7 vs 12.8 ± 9.4 days; p > 0.05). Patients with H1N1-ARDS had higher
body mass index (32.2 ± 7.3 vs 29.6 ± 4.5; p < 0.05), higher Murray
scores from more diffuse lung involvement (3.56 ± 0.30 vs 3.28 ±
0.34; p < 0.05), lower levels of PaCO2 (56.6 ± 18.3 vs 67.0 ± 20.2 mmHg;
p < 0.05) and higher levels of pH (7.33 ± 0.8 vs 7.26 ± 0,11; p < 0.05)
translating less severe alveolar ventilation compromise. Global sur-
vival was 73 % with no difference between the groups, and progno-
sis prediction scores were also similar (ECMOnet: 4.0 ± 1.6 vs 4.7 ± 2.1;
p > 0,05; LIPS: 7.5 ± 1.8 vs 6.3 ± 2.4; p > 0,05).
Conclusions: Patients with H1N1-associated severe ARDS presented
with predominantly hypoxemic respiratory failure, with more diffuse
bilateral lung disease, higher Murray scores and less effective ventila-
tion compromise, but those characteristics did not result in worse
outcomes when compared with patients with severe ARDS from
other causes.
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Objective: In patients with moderate to severe ARDS and respiratory
acidosis we can introduce ECCO2r to enable protective ventilation or
ultra-protective ventilation. We don't know the results we can obtain
after the introduction of ECCO2R in a population of ARDS with re-
spiratory acidosis.The objective of this study is to describe if we can
at the same time improved the blood pH and allow ultra-protective
ventilation.
Methods: We retrospectively included patients who received
ECCO2r for ARDS with respiratory acidosis between august 2014
and march 2016 in our ICU. The ECCO2R was performed with
ILAACTIVE® device (Novalung®) with a Minilung® or ILA® mem-
brane. The sweep gas was oxygen at 10 l/min. The vascular ac-
cess was a 24 F dual light catheter in femoral position. The
blood flow in the membrane was around 1.5 l/min. The ECCO2R
was introduced in patients with PaO2/fiO2 ratio between 80 and
150 and acidosis. All the patients was ventilated in controled
ventilation with 6 ml/kg (PBW) of tidal volume (Vt) and a respira-
tory rate (RR) above 25/min. All the patient was sedated with
midazolam and Sufentanyl and if necessary we used neuromuscu-
lar blocking agent. If is necessary the clinician in charge of the
patient performed prone position session during 16H.We collect
pH, PaCO2, the PaO2/FiO2ratio, Vt, RR, PEEPtotal and driving pres-
sure, before ECCO2r and at 4 h the initiation of ECCO2r then at
J1, J2, J3. We compared the parameters with repeated measures
ANOVA test.
Results: We included 16 patients, 9 males and 7 females. The
average for the age was 67 years (36-84), for the BMI was 32.2
(22-60). The cause of the ARDS was a pneumonia for 14
patients, a cellulitis for 1 patient and a septicemia for the last
patient. On eleven patients, we performed at least one prone
position session, during 16 hours, with ECCO2R. The average
duration of treatment by ECCO2R was 11 days (2-28).The mortal-
ity was 50 %, none patient died by a complication of the
ECCO2R. We didn't have any hemorrhage complication on the
catheter for ECCO2R.
The evolution of parameters was in the Table 32.
Conclusion: The ECCO2r for ARDS patients with respiratory acidosis
helps to normalize the pH and decreased Vt and RR to make ultra-
protective ventilation and decrease the driving pressure. In this type
of ARDS with severe hypercapnia, others studies are necessary to
know if this kind of procedure can improve the mortality of this
patients.Table 32 (abstract A82). Evolution of the parameters
before ECCO2R H4 J1 J2 J3
pH 7.20 (7.14-7.25) 7.33±(7.29-7.37) 7,33± (7.28-7.38) 7.37± (7.32-7.41) 7.35± (7.32-7.38)
PaCO2 (mmHg) 67 (59-75) 44± (39-49) 47± (39-54) 46± (40-52) 51± (43-59)
PaO2/fiO2 111 (91-132) 126 (103-149) 161 (136-186) 134 (110-157) 151 (123-179)
Vt (ml/kg
(PBW))
6.1 (5.5-6.7) 4.4± (3.5-5.2) 4.4± (3.6-5.2) 4.2± (3.1-5.2) 4.3± (3.5-5.1)
RR (/min) 30.6 (28.3-32.8) 25.5 (21.1-29.9) 24.9± (21.4-28.5) 23.9± (20.3-27.5) 23.4± (19.7-27.2)
PEEP total
(cmH2O)
14.8 (12.8-16.7) 15.4 (13.0-17.7) 15.2 (13.1-17.4) 13.9 (11-16.1) 14.9 (12,4-17,3)
Driving
pressure(cmH2O)
11.9 (9.4-14.3) 8.6± (6.2-11.1) 8.6± (6.3-10.9) 9.6± (7.7-11.6) 8.8± (6.8-10.8)
(± mean that p< 0.05 compared to before ECCO2R)A83
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Introduction: In critically ill patients evidence suggests a conservative
transfusion strategy. Some paper questioned the standard use of Hb
7 mg/dl trigger considering comorbidities and clinical picture. [1]
Thresholds for transfusion of PRBC in ECMO are still a matter of debate,
because PRBC given to increase DO2 act on a critical point of patients
with ARDS and consumption coagulopathy and bleeding are frequent
in ECMO. ELSO guidelines suggest to keep Hb at a normal value (12-
14 g/dl) and frequently 2-3 PRBC units are transfused daily, but also in
this setting have been reported lower Hb trigger for transfusion. [2]
OBJECTIVE. Describe transfusion practice in VV-ECMO for severe
ARDS (Berlin definition) at ISMETT (2011-2015)
Methods: Our blood management strategy is based on:
1. Hb level 8-10 according to SvO2, metabolic and perfusion data
2. transfusion using antileukocyte filters
3. low dose anticoagulation by heparin (aPTT range 40-50)
4. anticoagulation stop in case of bleeding
5. autotransfusion of the blood in the circuit at decannulation if
possible.
Retrospective observation analysis from electronic medical charts.
Data management performed by STATA 13.1
Results: Results are reported as mean value +/- standard deviation or
total number and percentage. In case of high variability median and
interquartile range are reported and marked as *. During the selected
period we run 59 ECMO for severe ARDS due to: H1N1 (28), Bacterial
Pneumonia 15), Politrauma (8), Post-pneumonectomy (2), Pneumo-
cystis Pneumonia (2), Lung graft failure and pneumonia (2), Compli-
cated pleural empyema (1), Chemical pneumonia (1).
Main results are 78 % of ECMO weaning and 71.2 % of ICU discharge.
Conclusion: Transfusion practice at or institution has not a definite
trigger, and since several years we abandoned the suggested Hb
value tacking more into account functional data. This is possible
thanks to high blood flow reached and high efficiency of oxygena-
tors. Decision is left to the care team considering actual DO2, SvO2,
hemodynamic parameters, lactates, comorbidities, sepsis, circuit func-
tion. We reach a 78 % weaning from ECMO (2016 ELSO registry
66 %) with main result of 5 patients without transfusion and a me-
dian rate of PRBC transfusion of 125 ml/day of ECMO support that is
higher than reports that use lower Hb trigger, but probably are quite
restrictive considering the severity of patients supported.
Related to the transfusion strategy we report a 18 % of bleeding
needing a treatment (stop anticoagulation or surgical/endoscopic)
and 8.5 % of patients needing FFP and 23 % needing PLT.
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N. Male N (%) Age years BMI SAPS II Sofa LOS preECMO Mech. Vent.
preECMO
PaO2/
FiO2
Murray
score
59 49 (83) 43±12 29±5 42±12 9±3 5 (6)* 4 (7)* 63±17 3.5±0.25
Table 34 (abstract A83). Transfusion parameters
Mean HTC ECMO
Days
PRBC total
ml/pt
PRBC Day
ml/pt/day
No PRBC
N. (%)
FFP N. (%) PLT N. (%) Bleeding
N. (%)
30±3 13 (14)* 1500(3100)* 125(141)* 5 (8.5) 5 (8.5) 14(23) 11(18)
Table 35 (abstract A83). Predictive score and outcomes
Preserve
score
ECMOnet
score
RESPSCORE ECMO
survivors
N. (%)
ICU discharge
N. (%)
CRRT
N. (%)
Mech.Vent.
post ECMO
LOS ICU
post
ECMO
LOS TOT
Hospital
4±2 5.8±1.5 1(6)* 46(78) 42 (71.2) 32 (54) 10 (12)* 14.5 (12)* 30 (24)*
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Introduction: Indications for extracorporeal membrane oxygen-
ation (ECMO) use in lung transplantation (LT) are: bridge to trans-
plantation, intraoperative extracorporeal respiratory and/or
circulatory support and treatment of primary graft dysfunction
(PGD) in postoperative period. Several mortality risk factors pre-
ECMO initiation has been investigated. Prealbumin and body
mass index (BMI) are predictors of mortality in critically ill
patients.
Objectives: To estimate if nutritional state at the beginning of ECMO
is associated with mortality.
Methods: Retrospective observational study between January 2009 -
March 2016, in 12 beds intensive care unit (ICU) of a tertiary hospital
center. Inclusion criteria for ECMO entry: patients listed for LT as a
bridge to transplant, intraoperative extracorporeal respiratory and/or
circulatory support and PGD. ECMO systems: centrifugal pump and
polymethylpentene membrane oxygenation with Bioline® coated cir-
cuits and cannulas.
Demographic data (included BMI), level of prealbumin and time
of mechanical ventilation (MV) were collected at the time of
ECMO initiation. ECMO indications, type of ECMO support and
ICU mortality were also recorded. Prealbumin level and BMI were
compared between survivors and non-survivors. Continuous vari-
ables, reported as mean ± standard deviation (SD) or median with
range were compared using the Student t-test. Categorical vari-
ables were compared using the X2 test. Analysis was performed
using SPSS ver. 22.0 and value of p ≤ 0.005 was considered to be
statistically significant.
Results: 33 patients (p), 22 male and 11 females were included with
a median age of 49.63 years (SD ± 13.37, interval 16-66. Median sim-
plified Acute Physiology Score (SAPS II) was 38.63 ± 12.97. Pulmonary
fibrosis was the most frequent diagnosis (13 p). In 16 p (50 %) MV
was started before ECMO support, with a median of 24.27 hours
(interval 0-146). Intraoperative support was used in 17 p (2 p respira-
tory, 10 p cardiac and 5 p both support); bridge to LT in 8 p (4 p re-
spiratory, 3 p cardiac and 1 p both support); PGD was the indication
in 8 p. In 4 p ECMO was placed after cardiopulmonary bypass. Type
of ECMO support was peripheral venous-arterial in 19 p, centralvenous- arterial in 2 p and venous-venous in 12 p. ICU mortality was
42.42 %. Median BMI in survivors was 24.85 ± 5.19 and 24.99 ± 4.16 in
nonsurvivors. Median prealbumin level in survivors was 14.09 ± 4.69
and 14.28 ± 10.66 in nonsurvivors. No statistical significance was ob-
served in BMI or prealbumin level between survivors and
nonsurvivors.
Conclusions: In this review with ECMO patients and LT, there are
not statistically significant differences in prealbumin level and
BMI between survivors and nonsurvivors at the time ECMO
initiation.
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Introduction: Venovenous ECMO (VV-ECMO) is a rescue therapy in re-
fractory ARDS. Despite technological progress and enhanced biocompati-
bility, anticoagulation with unfractionated heparin remains the most
often used as recommended. Bleeding complications remains a main
cause of increasing morbidity and mortality in patients under VV-ECMO.
Objectives: We aimed to study the effectiveness of the dosage of
unfractionated heparin (CAW and heparinization, anti-Xa) in patients
on VV-ECMO for ARDS.
Methods: We performed a retrospective observational study from
2008 to the first quarter 2015. Patients' baseline characteristics, the
dose of UFH anticoagulation and biological data of anticoagulation
(APTT, anti-Xa, HEMOCHRON ACT, ATIII, fibrinogen) were collected
and we studied the incidence of haemorragic or thromboembolic
events under UFH anticoagulation.
Results: 48 patients with ARDS requiring VV-ECMO were inclu-
ded,with a majority of men (35 (63.6 %) vs 20 (36.4 %) (p < 0.5)
The mean age was. 47 years (+/- 15 years). In 35.4 % of cases, a
double-lumen cannula (Avalon®) was used (mean diameter of
27GB), while the others had a femorà-jugular cannulation with
an average diameter of femoral vein to 25GB. UFH anticoagulant
was used in most patients. 33 % of patients did not have UFH
during installation of VV-ECMO. The average value of APTT was
35 +/- 8 secondes, the anti-Xa to 0.14 +/- 0.06. The average of
the Hemochron was 171 +/- 23 sec. The values of UFH adminis-
tered averaged 778 +/- 601 IU / h IVSE. Bleeding complications
were noted in 56.25 % of cases. None of our patients had ECMO
thrombosis cannulas or oxygenator. 39 % of patients had
positive anti-PF4 and only 11 patients had a change in
anticoagulation.
Conclusions: Anticoagulation used in our study appears lower than
recommendations without increasing thromboembolic complications,
with persistence of a high rate of bleeding complications with or
without a direct connection with ECMO. Does these results reinforce
the idea of lowering the anticoagulation ratio on patients under VV-
ECMO?
Fig. 32 (abstract A86).
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 46 of 607Note: This abstract has been previously published and is available at
[2]. It is included here as a complete record of the abstracts from the
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Introduction: Low flow extracorporeal veno-venous CO2 removal
therapy (ECCO2RT) in addition to mechanical ventilation is used to
remove CO2 while allowing protective ventilation (PV) during ARDS.
However, this technique requires anticoagulation that may induce se-
vere bleeding in critically ill patients (1). An alternative method con-
sists in using citrate anticoagulation.
Objectives: The aim of this study was to assess the effect of citrate
anticoagulation on CO2 extraction during ECCO2RT.
Methods: This study was conducted on an experimental model of
severe hypercapnic acidosis performed in 2 groups of 3 pigs. In
the first group (heparin group), pigs were anticoagulated with a
standard protocol of unfractionated heparin while citrate was
used for ECCO2RT device anticoagulation in the second group
(citrate group). After sedation, analgesia and endotracheal intub-
ation via a cervical tracheostomy, pigs were connected to a
volume-cycled ventilator (tidal volume 10 mL/Kg, respiratory rate
20/min, FiO2 1.0, PEEP 5 cmH2O). Severe hypercapnic acidosis
was obtained by reducing tidal volume by half. ECCO2RT was
started in both groups when arterial pH was lower than 7.2.
Pump Assisted Lung Protection (PALP, Maquet, Germany) system
was used with two small cannulas to remove CO2. Blood flow in
the PALP was successively set at 200, 400, 600 and 0 mL/min,
each setting lasting 60 minutes. Sweep gas flow was set at 10 L/
min. CO2 extraction, arterial pH, PaCO2 as well as systemic and
pulmonary pressures were continuously followed.
Results: CO2 extraction is depicted in graph 1. Mean arterial pH was
normalized to 7.37 ± 1.4 at an extracorporeal blood flow of 400 mL/
min, coming from 7.11 ± 1.3. Arterial pH did not significantly changed
in the citrate group as compared to the heparin group.
Conclusions: Using citrate anticoagulation during ECCO2RT is feas-
ible. A trend toward better CO2 extraction was observed in the cit-
rate group but not statistically significant as compared to the
heparin group.
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Introduction: Extracorporeal Membrane Oxygenation (ECMO) is one
of the rescue therapies in severe acute respiratory distress syndrome
(ARDS)1. The need for anticoagulation and the activation of clotting
cascade caused by ECMO circuit put patients at risk of bleeding and
thrombosis. Conventional coagulation tests fail to fully describe such
a complicated process, but the use of point of care (POC) methods
like thromboelastometry and platelet aggregometry may provide
additional information on clot development, lysis and platelet activ-
ity. However, the role of POC tests during veno-venous (VV) ECMO
for ARDS still remains unclear2.
Objectives: To assess the association between POC tests and epi-
sodes of hemorrhage during ECMO.
Methods: Blood samples for rotational thromboelastometry (ROTEM®)
and aggregometry (Multiplate®) were collected immediately before
starting ECMO, every 2 days for the first 10 days and 48 hours after the
removal of the circuit. Prothrombin time (PT), activated partial
thromboplastin time (aPTT), platelet count (PLT), anti-Xa activity, plasma
fibrinogen levels and activated clotting time (ACT) were recorded.
Bleeding episodes were defined as severe when associated with the
administration of at least 2 units of packed red blood cells (RBC).
Results: We enrolled 15 severe ARDS patients requiring VV-ECMO.
ECMO median duration was 9 (interquartile range 8-14.5) days. Mor-
tality was 53.3 %. We found a strong correlation between maximum
clot firmness (MCF) and amplitude of the curve at 10 minutes (A10)
in all ROTEM tests (Rho > 0.96, p < 0.001). 67 % of patients had at
least one episode of bleeding. 30.5 % of the hemorrhages were
severe. PLT was lower in bleeding compared to non-bleeding group
(p = 0.02). Among the ROTEM tests, heparinase modified thromboe-
lastometry clotting time and clot formation time (HEPTEM CT and
CFT) were significantly higher in bleeding group (p < 0.05) (Fig. 33).
The POC tests evaluating the intrinsic and extrinsic coagulation path-
ways, as well as the thrombin receptor activating peptide-6 test
(TRAP-AUC) assessing platelet aggregometry, were different between
groups, even though not statistically significant (Fig. 34). There was
no difference in PT, aPTT, anti-Xa activity, fibrinogen and ACT be-
tween groups.
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ing a fast coagulation assessment during ECMO. Bleeding episodes
are not predictable using conventional laboratory coagulation tests,
except for PLT. We found an association only between HEPTEM CT
and CFT and hemorrhage. Increasing the sample size might identify
other POC tests useful to predict and monitor hemorrhagic and
thrombotic complications.
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Introduction: Noninvasive ventilation (NIV) is routinely used in hyper-
capnic patients with an acute exacerbation of COPD. Extracorporeal
CO2 removal (ECCO2R) techniques are being evaluated in patients
who have NIV failure but the feasibility of these techniques in late
NIV failure (after 24 hours) is unknown (1,2).
Objectives: We tried to assess the feasibility of a single site ECCO2R
system in hypercapnic patients with an acute exacerbation of COPD
who had late NIV failure.
Methods: Five hypercapnic COPD patients who were admitted to
the ICU with an acute exacerbation whose respiratory acidosis
did not improve despite 24 hours of NIV were enrolled in this
single center, prospective, feasibility trial. A low flow single site
ECCO2R system (ALung Technologies, Pittsburgh, Pa) was used.
The primary endpoint was the time to normalization of arterial
blood gas pH levels (above 7.35). Data are expressed as median
(25th-75th percentiles).
Results: The pH and PaCO2 levels at ICU admission were 7.24 (7.17-
7.27) and 92 (75-125) mmHg respectively. pH and PaCO2 levels just
before the initiation of ECCO2R were 7.29 (7.27-7.33) and 93 (70-104)
mmHg respectively. ECCO2R was started after 72 (36-170) hours of
NIV treatment. Arterial blood gas pH levels came to normal ranges
after 22 (12-43) hours of ECCO2R treatment. In one patient ECCO2R
was stopped due to clotting in the circuit. No other complications
were observed regarding the use of ECCO2R system.
Conclusions: ECCO2R systems can be an alternative in COPD patients
who are having late NIV failure. The system seems to be safe due to
its low flow characteristics but clotting complication must be kept in
mind. Further studies are needed to emphasize these results and also
test the impact of this procedure on other outcomes like ventilator
free days, duration of ICU stay, cost and mortality.
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Introduction: Severe acute respiratory distress syndrome (ARDS) is
associated with a mortality of 46.1 %[1]. Currently only low tidal
volume ventilation has been proven to reduce mortality in all pa-
tients with ARDS[2]. This is frequently difficult to achieve in the
presence of hypercapnia. Decreases in ventilatory driving pressure
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 48 of 607have been strongly associated with ICU survival[3]. It has been
hypothesised that ventilation combining reduced tidal volumes
with extracorporeal carbon dioxide removal (ECCOR) may result
in further improvements in mortality[4], and prospective rando-
mised trials are planned [5].
Objectives: To assess in patients with severe ARDS and acidosis
secondary to hypercapnia if by using veno-veno ECCOR there can be
a normalisation of pH and reduction of peak airway pressures.
Secondary outcomes - survival to hospital discharge and complica-
tions of therapy.
Methods: Data on ventilatory and arterial blood gas parameters be-
fore and during therapy was prospectively collected and entered into
the Extracorporeal Life Support Organisation (ELSO) registry in line
with national guidance[6]. The Hemolung RAS (A Lung technologies)
was used to provide ECCOR.
Results: 4 patients received ECCOR using the Hemolung. All pa-
tients had an improvement in the degree of acidosis with mean
hydrogen ion concentration falling from 72.65 nM (pH 7.14) to
46.59 nM (pH 7.33) over the first 24 hours, with a mean PaCO2
fall from 13.5 kPa to 8.7 kPa. Peak airway pressures dropped from
31.5 cmH2O to 29.1 cmH2O over the same time period. There
were no direct complications of therapy. 3 patients survived to
hospital discharge.
Discussion: Using ECCOR locally in patients with severe ARDS it is
possible to lower the hydrogen ion concentration improving the
degree of acidosis. This corresponds to a trend in lower peak air-
way pressures, which in this small case series does not reach
statistical significance. There were no complications of the ther-
apy and mortality was shown to be lower then quoted in other
ARDS trials [1].
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Introduction: We would like to present our experience with use of
arterio-venous extracorporeal membrane carbon dioxide removal
(ECCO2R) device- Novalung iLA in the District General Hospital
setting.
Objectives: We analysed our data to review our practice in use of
ECCO2R in respiratory failure.
Methods: Over the period of 5 years we used arterio-venous ECCO2R
device Novalung iLA in 10 patients, with overall 50 % mortality. We
analysed retrospectively only 8 patients due to lack of complete
documentation in 2 patients (survivors).Results: From a reviewed sample of 8 patients three patients (37 %)
survived. Most common diagnosis in our population was pneumonia
(6), others were ARDS post cardiac arrest (1) and refractory asthma
(1). We compared our patients in groups of survivors and non-
survivors.
Mean age of survivors was 29 (18-39) vs 70.8 (59-80) of non-
survivors. Mean APACHE score was 13.6 vs 21. Two of three survivors
had single organ failure, one required CRRT for AKI. All patients in
non-surviving group had multi-organ failure. Mean time to initiation
of ECCO2R support post ITU admission was 39 vs 80 hours (11-75 vs
6.5-174 hours).
In all patients mean paCO2 before initiation of ECCO2R was 10.89
kPa, after the first hour 7.59 kPa and after 24 hours 5.9 kPa. No
ECCO2R device associated complications in survivors dgroup, one
limb ischaemia in non-survivors group.
Conclusion: Our analysis showed that the use of ECCO2R device
significantly improved CO2 elimination in all our patients,
allowed us to use lung protective ventilation strategy. Survival
of 37 % in our small group is clearly influenced by selection of
our patients.
We tried to identify a group of patients who would most likely bene-
fit from this invasive intervention. In our small group of patients were
early initiation, lower APACHE score, single organ failure and young
age factors predicting good outcome.
We continue to audit use of ECCO2R device on our unit and
currently using veno-venous ECCOR2 device which eliminates
the risk of significant complication of A-V ECCOR2 - limb
ischaemia.
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Introduction: Meta-analyses suggest that levosimendan is super-
ior to traditional inotropes, with decreased postoperative
morbidity, improved hemodynamic function and decreased myo-
cardial injury but at no time has been compared to the balloon
counterpulsation.
Methods: Observational prospective admitted patients in ARIAM
registry from February2010 to September 2012 in 13 public and pri-
vate hospitals with CCV. We retrospectively compared the patients
who underwent CABG who were treated with IABP before surgery
and those who received levosimendan during surgery or immedi-
ately after surgery. We analysed clinical and epidemiological data of
both groups as well as complications, hospital stays and mortality.
We used the Mann Whitney U test and Fischer´s exact test with an
alpha maximum of 5 % for the comparison of variables according to
necessity.
Results: 949 patients were involved CABG in the time period
studied. Of these, 17 patients were treated with BCIAO before
surgery and 96 received levosimendan. No differences in age or
comorbidities between the two groups analysed or extracorporeal
circulation time (p > 0.05). However, functional status at the time
of surgery was worse in the group BCIAo (NYHA III or IV 43.8 %
from 22.2 %) p = 0.011, and the risk score used (EuroSCORE p = 0,
0001), 30 % of patients had no postoperative complications, simi-
lar in both groups. There were no differences in hospital stay or
mortality in both groups. The group of patients treated with levo-
simendan developed lower rate of heart failure, renal failure
(Creat > 2 mg / dl) and prolonged mechanical ventilation than
the group that received BCIAO (p < 0.05). However, the
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 49 of 607levosimendan group required in 4.2 % of patients while it was
not necessary in the other group.
Conclusions: levosimendan in heart coronary artery bypass sur-
gery decreases postoperative morbidity (heart failure, renal fail-
ure or prolonged mechanical ventilation)with an increase in the
need for CRRT. No differences were found in mortality or hos-
pital stay.
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Patients with FO
(n=108)
Patients without FO
(n=1018)
p
Days in ICU, mean (SD) 19.6 (15.7) 12.8 (14.9) <0.0001
SOFA score on day of RRT,
mean (SD)
11.4 (3.7) 9.9 (3.5) <0.0001FLUID BALANCE, THERAPIES AND
OUTCOMES IN AKI
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Introduction: Fluid overload is associated with worse outcomes in
critically ill patients.
Objectives: The aim of this study was to investigate the impact of
fluid overload (FO) at initiation of renal replacement therapy (RRT) in
critically ill patients with acute kidney injury (AKI).
Methods: We performed a retrospective analysis of all patients
who were treated with RRT for AKI in the multi-disciplinary Inten-
sive Care Unit (ICU) at a university hospital in London (UK) be-
tween 2012 - 2015.Total cumulative fluid balance on day of
initiation of RRT was used to describe fluid accumulation and es-
timated in % of baseline body weight (BW). FO was defined as
fluid accumulation greater than 10 % of BW. We collected data
related to patient demographics, anthropometrics and SOFA
score. Outcomes were hospital mortality and length of stay in
ICU.
Results: 1129 patients received RRT for AKI of whom 42 % died in
hospital. There was a significant difference in cumulative fluid bal-
ance at initiation of RRT between hospital survivors and non-
survivors. (Fig. 35)
108 patients (9.6 %) had FO >10 %. They had a significantly higher
hospital mortality (X2 = 5,89; p = 0,015) and longer stay in ICU
(19.6 days versus 12.8; p < 0,001) but also higher SOFA score com-
pared to patients with FO ≤10 %. (Table 36)
Conclusions: In critically ill patients with AKI, fluid overload at initi-
ation of RRT was associated with a significantly higher mortality and
longer stay in ICU.
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Introduction: AKI complicating acute illness has significant implica-
tions with volume resuscitation seen as integral to the management
of AKI1,2. There has been much recent debate regarding overall vol-
ume balance with important treatment implications3.
Objectives: We decided to examine the relationship between fluid
prescription and patient outcomes in patients with AKI
Methods: From the Premier database we identified a study population
of 62,695 from 493 hospitals. Patients were admitted to the ICU with AKI
on the first day of the hospitalisation, received at least 1 L of Day 1 fluids
and survived to Day 2. A multivariate model was built to predict mortality
with a case-mix adjustment model applied to the data set in order to ad-
just for severity of illness together with premorbid assessment.
Results: Mean age was 65 years, 55 % male, 75 % emergencies, 43 %
diabetic and 36 % had CKD. Mean LOS: 8.7 days with 4.6 days in the ICU.
Average Day 1 fluids were 3.7 L (median 3.1 L), lowest in those without
pressors (3.2 L) and highest in those with MV and septic shock (5.4 L).
Hospital mortality was 16.5 % for Day 1 survivors, varying from 7.8 % in
those with no MV nor pressors (NMNP), to 53 % among those with MV
and pressors (MVAP). Significant associations between volume of Day 1
fluids and hospital survival was seen. Overall mortality was ca.15 %,19.4 %
and 29.3 % for those receiving 1-5 L of fluid, 6 L fluid and (9 + L)
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 50 of 607respectively.For NMNP cases (57 %) both actual and expected mortality
rates decreased with increased fluid volume (8.3 % at 1 L, 6.6 % at 9 + L).
Patients receiving pressors and MV (17 %) exhibited minimal variation in
expected mortality but presented with a decrease in mortality from low to
middle ranges (23.2 % at 1 L to 15.7 % at 5 L) and an increase in mortality
from middle to high ranges (15.7 % at 5 L to 25.4 % at 8 L). The highest
severity group exhibited no change in actual or expected mortality with
fluid administration. Septic shock requiring MV (13 % of cases) had no
variation in mortality across the lower groups of day 1 fluid use (1 L to
5 L). However, higher ranges of 6 + L (38 % of the group) had increased
actual mortality rates (40 % at 6 L to 45 % at 9 + L), higher than predicted.
Conclusions: A potential for both under resuscitation and over resus-
citation is observed in patients with AKI who received treatment with
vasopressors in those requiring pressor and MV support a clear asso-
ciation existed between volume excess and outcomes emphasizing
the need for a better understanding of individual fluid needs in this
important population.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A94Introduction: Laparoscopic abdominal surgery has been widely used
to reduce length of stay and complications from open abdominal
surgery. During the operation, pneumoperitoneum needs to be cre-
ated for better visualization of operating fields. This is followed by
decreased urine output and resulted in acute kidney injury. However,
we do not know the effect of pneumoperitoneum and factors indu-
cing acute kidney injury (AKI).
Objectives: We aimed to 1) show the incidence of AKI in patients
undergone laparoscopic abdominal surgery and 2) propose a set of
risk factors associated with the development of AKI following laparo-
scopic abdominal surgery
Methods: All patients underwent laparoscopic abdominal surgery
at King Chulalongkorn Memorial hospital, Bangkok, Thailand
were prospectively enrolled between 2012 and 2013 (n = 64).
Two were excluded due to preexisting chronic kidney disease
and NSAIDs use in previous 1 week. Baseline characteristics, la-
boratory results, and introperative data were prospectively re-
corded in case record forms. Urine neutrophil gelatinase-
associated lipokalin (NGAL) was measured as the surrogate
marker. AKI was identified by KDIGO criteria. Characteristics
were analyzed by student´s t-test and nonparametric test. Fac-
tors associated with AKI were identified using the logistic
regression and the area under the receiver operating character-
istics curve (AUC).
Results: Of the 62 patients receiving laparoscopic abdominal
surgery, 12(19 %) developed postoperative AKI. The mean age,
initial blood pressure, and initial glomerular filtration rate were
not different between AKI and non-AKI groups. The peak serum
creatinine was seen at 24 hours postoperatively. AKI patients
had significantly increased urine NGAL level at 24 hours post-
operatively compared to non-AKI (p = 0.01). Mean operative
time, inflation time, and exposure index, defined by the prod-
uct of inflation time and intra-abdominal pressure were signifi-
cantly higher in AKI compared with non-AKI patients (p < 0.05
for all). Duration of intraoperative hypotension, amount of
blood loss and intravenous fluid were not different between
groups. By multivariate analysis, exposure index was signifi-
cantly associated with postoperative AKI, with adjusted odds
ratio (95 % CI) of 1.59 (1.02-2.38). AUCs of inflation time, oper-
ation time, and exposure index were 0.68, 0.67, and 0.67, re-
spectively (p < 0.05).
Conclusions: Postoperative AKI can occur in patients undergone lap-
aroscopic abdominal surgery. A larger cohort is required to confirm
these findings.
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Introduction: The incidence of acute kidney injury (AKI) in critically ill
patients approximates 50 % with an odds ratio for death as high as
Fig. 37 (abstract A95). Study flowchart
Fig. 38 (abstract A95). FB = fluid balance, MV = mechanical
ventilation, RRT = renal replacement therapy
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water[2]. On the other hand, intravenous fluids are part of the man-
agement of AKI, which increases the risk of fluid overload in these
patients.
Objective: We examined the association between fluid overload and
outcome in ICU patients with AKI.
Method: Retrospective cohort study of adult ICU-patients from
two university hospitals in Denmark admitted between Jan 1st
2012 and Dec 31st 2013. All cases of AKI were identified accord-
ing to the creatinine criteria of the KDIGO definition. Fluid data
was missing in 13 patients (1.5 %), and these were excluded from
the analysis.
The association between cumulative fluid balance and the risk
of death/renal recovery at day 28 was estimated with joint
modeling techniques [3]. The cumulative fluid balance was di-
chotomized with cutoffs at 5 % and 10 % of admission body
weight at any day during the first five days of admission. The
longitudinal submodel was fitted using mixed effects logistic re-
gression, and the survival submodel was a Cox model adjusted
for age, gender, severity of disease (SAPS II, KDIGO grade) and
use of life support (norepinephrine, mechanical ventilation and
dialysis).
The study was approved by the national board of health, who
waived the need for consent.
Results: We screened 4087 patients and identified 864 with AKI
(Fig. 37) of whom 461 and 255 developed fluid overload above re-
spectively 5 % and 10 % of bodywieght (BW) during their first 5 days
in ICU (Fig. 38). At day 28, 514 of the AKI patients had renal recovery
and 282 had died (Table 37).
Fluid overload >10 % BW at any day during the first 5 days in ICU
was associated with a hazard ratio (HR) for death of 1.08 (p < 0.001);
for > 5 % BW fluid overload the HR for death was 1.07 (p < 0.001). In
contrast, there was no association between fluid accumulation and
renal recovery.
Conclusion: In our cohort of 864 patients with AKI, 255 developed
fluid overload (10 % BW) during the first 5 days in ICU. Fluid over-
load, even at 5 % BW, was associated with increased mortality after
adjusting for risk factors, but fluid overload was not associated with
renal recovery.
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All patients
(N = 864)
Fluid Balance > 5%
BW (N = 461)
Fluid Balance < 5%
BW (N = 367)
Age, median (IQR), years 68 (59-76) 68 (59-76) 68 (58-77)
Male gender, N(%) 528 (61 %) 267 (58 %) 237 (65 %)
SAPSS II, median (IQR) 50 (39-63) 54 (43-66) 46 (36-59)
KDIGO score ≥ 2, N(%) 405 (47%) 237 (51 %) 155 (42 %)
Mechanical ventilation, N(%) 728 (84 %) 401 (87 %) 300 (82 %)
Renal replacement
therapy, N(%)
277 (32 %) 171 (37 %) 97 (26 %)
Vasopressor use, N(%) 593 (69 %) 347 (75 %) 232 (63 %)
Renal recovery, N (%) 514 (60 %) 247 (54 %) 246 (67 %)
Mortality, N(%) 282 (33 %) 192 (42 %) 85 (23 %)A96
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Introduction: Subtle worsening of renal function is associated
with adverse outcomes in pediatric patients (pts) with heart fail-
ure. Cardiorenal syndrome (CRS) is a recently coined term under-
scoring the co-existence of cardiac and renal dysfunction and
stresses the bidirectional nature of the heart-kidney interactions.
While well defined in adult populations, available pediatric data
is scarce. Acute kidney injury (AKI) consensus definitions could
Fig. 39 (abstract A97).
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stratify patients.
Objectives: To apply three consensus definitions of AKI previously
validated in heterogeneous pediatric populations (pediatric Risk,
Injury, Failure (pRIFLE), Acute Kidney Injury Network (AKIN), and
Kidney Disease Improving Global Outcomes (KDIGO) to assess CRS
burden and association with outcomes
Methods: Retrospective study of all pts admitted with acute decom-
pensated heart failure (ADHF).Failure of medical therapy was defined
as mechanical support, transplantation or death. CRS was defined as
admission with ADHF and concomitant AKI according to KDIGO, AKIN
or pRIFLE creatinine criteria.
Results: 75 pts (47 % male, 5.5 years (IQR 0.8-15.4)) were included.
Hospital LOS was 48.9 ± 59.1 days, 33 pts (44 %) had a prior diagno-
sis of heart failure, 39 (52 %) did not have a baseline creatinine. FMT
happened in 25 pts(33 %), mortality was 13 % (10/75). AKIN and
KDIGO were identical in diagnosing and staging CRS so only KDIGO
data are presented. CRS on admission was present in 63 %(47/75) by
pRIFLE vs 27 % (20/75) by KDIGO (p < 0.001). pRIFLE identified 27
additional pts with CRS on admission compared to KDIGO (21 R, 5 I,
1 F). CRS on admission either by pRIFLE or KDIGO did not have good
prediction for FMT (AUC 0.58 vs 0.64, respectively), similar to any
stage of CRS reached during admission by either definition (AUC 0.58
any pRIFLE stage vs 0.61 any KDIGO stage), whereas peak CRS stage
reached during admission had good predictive ability for FMT for
both (AUC 0.79 for both). 35 and 24 pts still fulfilled CRS criteria by
pRIFLE and KDIGO, respectively, at discharge, Of the 47 pRIFLE and
20 KDIGO admission CRS pts, 25 (53 %) and 15 (75 %) had persistent
CRS at discharge. KDIGO stage of CRS on discharge was associated
with readmission (p < 0.001) but pRIFLE stage was not (p = 0.25)(AUC
0.63 for KDIGO vs 0.5 for pRIFLE for readmission).
Conclusions: CRS was very common in pediatric pts with ADH, per-
sisted at discharge, and renal function at discharge predicted re-
admission. Peak KDIGO stage predicted composite outcome of
death, transplant, or mechanical support; discharge KDIGO stage pre-
dicted readmission. KDIGO staging outperformed pRIFLE staging for
outcome prediction in pediatric CRS. This finding needs to be vali-
dated in a prospective multicenter study.
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Introduction: Microcirculatory dysfunction is an important triggering
event of organ dysfunction in sepsis, and the fluid therapy is essen-
tial for improvement of the hemodynamic, but the ideal fluid strat-
egy in sepsis has not been developed yet. Aggressive-fluid therapy is
controversial and the consequences for the kidney dysfunction are
little known. This study investigated the effect of an early phase
aggressive-fluid therapy at the kidney microcirculation and tubular
structures.
Methods: Adult Wistar rats (200 g) were submitted to sepsis {iv. 2 mL
E. coli 108 CFU/mL (S8), DL60 in 26 hours}, or sepsis and Ringer Lac-
tate infusion (30 mL/kg/20 min), 30 minutes after the sepsis chal-
lenge. Under general anesthesia, the microcirculation of the renal
cortical area was monitored by Sidestream Dark Field Imaging (SDF)
video-microscopy, at 6 hours (T6h - n = 3/group) and 30 days (T30d -
n = 3/group) after sepsis. The tissue samples were evaluated by hist-
ology (T6h,T30d) by HE and PAS staining.
Results and conclusions: SDF at T6h showed broadly distributed
microcirculation and tissue dysfunction at both groups (Fig. 39). The
outlining of tubules became blurred by their enlargement, withcompression of tubular lumen and of the peritubular microvessels,
suggesting an obstructive phenomenon by cellular edema. Histology.
After 6 hours of sepsis, animals treated with aggressive fluid infusion-
showed less peritubular congestion, preserved mesangial space and
lower areas with hyaline degenerations and better preservation of
the tubular lumen compared to sepsis without aggressive overhy-
drating. PAS staining showed a very slight hyaline degeneration,
better preservation of tissue architecture, lower occurrence of cellular
death, suggesting that the aggressive fluid therapy in the early stage
of sepsis minimizes the severity of vascular and tissue injury in the
kidney. The live animals treated with the aggressive fluid showed
less peritubularmicrovesselscongestion compared to S8, better
preservation of the mesangial space, minor hyaline degeneration,
and less cell death in deeper regions of the cortexafter a month
of recovery. However, the general appearance showing a kidney
limitation for venous blood drainage. Clearly, the aggressive-fluid
therapy attenuates renal damage compared to S8. The results
suggest that animals treated with aggressive fluid therapy, at the
early stage of sepsis, have better conditions to respond against
new harmful challenges to the kidney. Besides, the recover
process after sepsis seems to be partial, justifying the occurrence
of the post-sepsis syndrome.
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Introduction: Electrical Cardiometry allows measurement of fluid sta-
tus using thoracic fluid content(TFC),cardiac output,cardiac index,sys-
temic vascular resistance index which could be ideal noninvasive
hemodynamic monitoring for patients undergoing hemodialysis(HD.
Objectives: Investigating relation between changes in TFC and
amount of fluid removal during HD session and to monitor
Fig. 40 (abstract A99).
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promise during HD session.
Methods: Thirty critically ill patients on HD were enrolled.Clinical as-
sessment of volume overload and hemodynamics(BP,MAP,CVP),moni-
tored by Electrical Cardiometry ICON® before HD and all through
sessions.
Results: Out of studied patients males represented 46.7%n = 14with
mean age 48 ± 16 years.There was positive correlation between UFvo-
lume and TFC (r = 0.410, P = 0.025). Out of the 30pts studied
18pts60%were hemodynamically stable vs 12pts40% had hypotension
represented non responders group and had lower TFC compared to
hemodunamically stable group (26.45kohm-1 vs 37.8kohm-1) P value
0.004 indicating that they were hypovolemic. Out of the 30pts studied
18pts60%weren´t congested vs 12pts40%were remained persistently
congested after accomplishing HD session with significantly higher TFC
when compared to those get red off congestion (43.14± 9.9kohm-1 vs
25.44± 5.5kohm-1) P value 0.0001 indicating that they were still hypervole-
mic. Using analysis of ROC curve TFC at 25.34kohm-1 was significantly pre-
dictor of hypotension with P value0.002, AUC83.4 %, sensitivity67%,
specificity100%. Also TFC cutoff value predicting persistent congestion was
37.02kohm-1 with P value0.0001, AUC95.8 %, sensitivity83%, specificity100%.
Conclusions: Electrical Cardiometry is evolving noninvasive tool for
adjusting fluid status of critically ill patient on RRT using thoracic
fluid content as indicator of fluid status that could be used to avoid
hemodynamic instability and persistent volume overload and con-
gestion during and after HD session.
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Introduction: Acute Kidney Injury (AKI) is believed to carry a good
prognosis but recent reports have raised concern about long-term
outcome. Assessment of renal functional reserve after AKI can be of
aid for ascertaining recovery of kidney function.
Objective: To develop a method for the estimation of renal reserve
in the critical care setting.
Methods: Exploratory study. We selected 8 patients (4 men/women)
between 20 to 50 years, without known previous renal disease who
did not develop AKI during ICU stay. Patients were not receiving
drugs that could interfere with renal function, were stable and
already recovered from their initial problem, but still with a bladder
catheter, a IV line and a nasogastric tube for enteral feeding. Afteradministration of a load of 20 gr of proteins by enteral route, a cre-
atinine clearance (CrCl) was calculated for each of the next 6 hours,
with a timely collection of urine and a sample of serum creatinine at
the end of every period. For the analysis we performed u-Mann-
Whitney and Kruskal-Wallis non-parametric test. Data as mean (mean
error standard) or median (percentiles 25-75).
Results: Age 41.13 (3.2) years, 50 % men and base CrCl 163 (19.51)
mL/min. Median percentage of change between base and maximum CrCl
was 123.5 % (78.2-143.2) and because a pick was detected between 3
and four hours after protein load we analysed these two hours together,
finding a median change of 80.7 % (69.95-144). Changes between the
first and third hours were significant either for absolute values (p 0.023)
or % (p 0.031). Hourly changes in CrCl are presented in Fig. 40
Conclusions: A protein load by enteral route is followed by an early
rise in creatinine clearance. The profile of this response lets us
propose a creatinine clearance 3-4 hours after a load of 20 gr of pro-
teins as a quick and easy way to estimate renal reserve. Our next
goal should be to define the profile of response for different kind of
patients and degrees of renal dysfunction.A100
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Introduction: Evidence has established that there is strong link with
Acute Kidney Injury (AKI) and progression to chronic kidney disease
(CKD) and end stage renal failure (ESRF) [1]. After AKI, 9 % have per-
menant loss of kidney function and 9-13 % are dialysis dependent
post hospital discharge[2]. Renal followup is recommended for pa-
tients who have had AKI whilst critically ill [3].
Objectives: To assess whether patients that received renal replace-
ment therapy (RRT) in ICU had a nephrology follow up, and deter-
mine if there was a need for the service.To assess if there were any
difference in mortality between the groups.
Methods: We performed a retrospective longitudinal cohort study
analysis of all patients that received RRT after an AKI in the Greater
Glasgow and Clyde Hospitals over one year. Renal function at 3-6
months pre-admission and post discharge were examined by com-
paring urea, creatinine and eGFR values. Nephrology follow up status
was also investigated. We excluded patients that had renal baselines out
with the 3-6 month period.Paired t-test analysis was used to analyze pre-
admission vs post discharge renal baselines in normal eGFR patients
Table 38 (abstract A102).
RRT (n=1471) No RRT (n=9078) p value
Age (years) 59.3 ± 0.8 56.1 ± 0.4 <0.001
Previous chronic RRT (%) 10 1.3 <0.001
APACHE II 24.7 ± 0.5 15.7 ± 0.2 <0.001
Mortality on discharge (%) 52.6 28.2 <0.001
Urine output 1st 24hrs (mls) 625 ± 43.4 1646 ± 25.7 <0.001
Highest K+ in 1st 24hrs (mmol/l) 5.0 ± 0.1 4.3 ± 0.1 <0.001
Highest Urea in 1st 24hrs (mmol/l) 19.7 ± 0.7 9.0 ± 0.2 <0.001
Highest creatinine 1st 24hrs (mmol/l) 337 ± 12 118 ± 2 <0.001
Unit stay (days) 8.6 ± 0.5 3.8 ± 0.1 <0.001
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 54 of 607Results: We sampled 130 admissions with 68 patients surviving
discharge from ICU. 28 patients (41 %) had a nephrology follow-up.
The remaining 49 patients (59 %) were not followed up. 39 patients
(57 %) had an abnormal eGFR at 3-6 months, and of these 24 (61 %)
were followed up. 4 patients (6 %) died in each group .
Conclusions: Renal follow up rate after RRT in critical care is low despite
37 % having an abnormal eGFR. An efficient followup service is required.
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Introduction The risk of chronic kidney disease increases with the
time of evolution of type 2 diabetes and chronic metabolic control. In
people over 40 years occur a progressive loss of glomerular filtration rate
corresponding to 1 mL per year. This is associated with progressive deteri-
oration of renal tissue replacement by fibrous tissue, which involves pro-
gressive glomeruroesclerosis, tubulointerstitial fibrosis and nephrosclerosis.
Objectives To determine the evolution time of diabetes and
prevalence for stages on chronic kidney disease. Material and
method: A cross-sectional and descriptive study was done on 150
patients diabetic type 2. There were included all of them that have
more than 5 years of evolution on the diabetes type 2, the sample was
calculated with the averages formula for finite population and the se-
lection was simple random. Sociodemographic variables and health
variables were studied, the stage of chronic kidney disease were esti-
mated by the Cockcroft-Gault equation. The statistic analysis included
averages, percentages and confidence intervals.
Methods A cross- sectional, descriptive, observational, retrospective
study was conducted which included adult patients that were
50 years and older, and had 10 year diabetes mellitus type 2 diagno-
sis, without complications mentioned in the Nephrology Unit in Hos-
pital General de Mexico, Mexico City.
Results Regarding the study population, 57 % are female, the aver-
age age was 62.12 years and mean glucose was 165.23 mg / dL. The time
evolution of diabetes 2 patients in stage 5 was 20.05 years and in patients
with stage 1 was 11.05 years. The average creatinine clearance in stage 2
was 75.10 mL / min and in stage 5 10.33 mL / min. 13 % of the population
was in stage 4 and a similar percentage (15 %) in stage 5. The time evolu-
tion of stage 1 to stage 5 was 10.10 years and stage 3 to 4, 1.5 years.
Conclusions Chronic kidney disease is a public health problem
that affects health systems around the world. Today his studio is pref-
erably focused on the population undergoing dialysis treatment in its
various forms which lies in stage 5; However, a comprehensive ap-
proach to chronic kidney disease in all its stages is necessary to have
information about the condition; hence the importance of this study, in
which the time evolution of diabetes and population analyzed by stage
of chronic kidney disease. The diabetic patient with chronic kidney dis-
ease is not flattering; it is distinguished by short evolution times be-
tween the stages and high population percentage on stages 4 and 5.
Reference(s)
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for the year 2000 and projections for 2030. Diabetes care 2004;27:1047-1053.
Eknoyan G, LAmeire N, EckardKU, Kasiske BL, et al. KDIGO 2012, clinical
practice guideline for the evaluation and Management of Chronic Kidney
Disease. 2013;3.Fluid balance, therapies and outcomes
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Introduction Approximately 4 % of patients in Intensive Care Units
(ICU´s) require renal replacement therapy (RRT) during their admis-
sion, though this figure ranges from 1-25 % depending on the par-
ticular hospital (1). Previous studies suggest that patients requiring
RRT in ICU have a 60 % in-hospital mortality rate, compared with an
overall mortality rate of 19 % for patients admitted to ICU.
(1.2).
Objectives The aim of the study was to compare demographic and
physiological characteristics of patients requiring RRT in ICU with those
who did not require it, and to investigate the impact of receiving RRT
on length of unit stay and mortality on ultimate hospital discharge.
Methods The study is a multi-centre retrospective observational cohort
study. It uses data from January 1st 2005 to December 31st 2014 from
three teaching hospital intensive care units with 18 combined beds
and an associated tertiary referral renal service in Glasgow. The data
used was collected prospectively from the Wardwatcher service. Demo-
graphic details, severity scores, physiological parameters and informa-
tion on length of unit stay and in-hospital mortality was gathered.
Standardised Mortality Ratios (SMRs) were calculated using the APACHE
II predicted mortality scores as the denominator.
Results Data for a total of 10549 patients was collected, of whom
13.9% (1471) received RRT during their admission. The mean duration
of RRT was 5.0 +/- 0.2days. Standardised mortality ratios between the
two groups is comparable at 1.04 for the RRT group, and 10.6 for the
non RRT group. The results for the two groups are shown below.
Conclusions Patients receiving RRT had a mortality rate on ultimate
hospital discharge of 52.6 %, roughly in line with previous studies, and
nearly twice the rate in those not requiring RRT. (1). These patient also
stayed in ICU for over twice as many days as those not requiring RRT. It
is interesting to note, however that the SMR is actually marginally lower
for those receiving RRT than not. Patients who require RRT at some
point during their ICU stay also have significantly more deranged physi-
ology during their first 24hours of admission, as evidenced by the urine
output, potassium, urea and creatinine values for the two groups.
Reference(s)
1. Uchino S, Kellum JA. Acute renal failure in critically ill patients: a
multinational, multicenter study. JAMA:2005:294(7): 813-8.
2. Scottish Intensive Care Society Audit group. Audit of Critical Care in
Scotland 2014: reporting on 2013. Edinburgh, Uk: NHS National Services
Scotland; 2014.
Table 40 (abstract A103). Outcomes
Received RRT Did not receive RRT P-value
Unit stay (days) 8.6±0.5 3.8±0.1 <0.001
Mortality on ultimate hospital
discharge (%)
52.6 28.2 <0.001
SMR 1.04 1.08
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 55 of 607A103
Outcomes of patients requiring renal replacement therapy in
intensive care: a 10 year retrospective study
M.R. Ralston, L. Gemmell, R. Appleton, C. Wright, R.I. Docking, E. Black, A. Mackay
Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, United Kingdom
Correspondence: M.R. Ralston – Queen Elizabeth University Hospital,
Intensive Care Unit, Glasgow, United Kingdom
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A103
Introduction Approximately 4 % of patients in intensive care units
(ICUs) require renal replacement therapy (RRT) during their admis-
sion, though this figure ranges from 1-25 % depending on the
particular hospital (1). Studies have suggested that patients
requiring RRT in ICU have roughly a 60 % in-hospital mortality
rate, compared with an overall mortality rate of 19 % for patients
admitted to ICU (1,2).
Objectives The aim of the study was to compare demographic and
physiological characteristics of patients requiring RRT in ICU with
those who did not require it, and to investigate the impact of receiv-
ing RRT on length of unit stay and mortality on ultimate hospital
discharge.
Methods The study is a multi-centre retrospective observational
cohort study. It uses data from January 1, 2005 to December 31, 2014
for three intensive care units (ICUs) based in teaching hospitals, with 18
beds combined, and an associated tertiary renal service. The data used
was collected prospectively for the Wardwatcher™ service. Demo-
graphic details, severity scores, physiological parameters and informa-
tion on length of unit stay and in-hospital mortality were gathered.
Standardised Mortality Ratios (SMRs) were calculated using the APACHE
II predicted mortality scores as the denominator.
Results Data for a total of 10549 patients was collected, of whom
13.9 % (1471) received RRT during their admission. The mean dur-
ation of RRT was 5.0 ± 0.2 days. The results for the two groups are
shown below:
Conclusions Patients receiving RRT had a mortality rate on ultimate
hospital discharge of 52.6 %, roughly in line with previous studies,
and nearly twice the rate in those not requiring RRT (1). These pa-
tients also stayed in ICU for over twice as many days as those not re-
quiring RRT. It is interesting to note, however, that the SMR is
actually lower for those receiving RRT than not. Patients who require
RRT at some point during their ICU stay also have significantly more
deranged physiology during their first 24 hours of admission, as evi-
denced by the urine output, potassium, urea and creatinine values
for the two groups.
References
1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al.
Acute renal failure in critically ill patients: a multinational, multicenter
study. JAMA. 2005 Aug 17;294(7):813-8.
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Scotland; 2014.Table 39 (abstract A103). Demographics and physiology
Received RRT Did not
receive RRT
P-value
Male gender 60.8% 58.4% 0.002
Age (years) 59.3±0.8 56.1±0.4 <0.001
Previous chronic RRT (%) 10 1.3 <0.001
APACHE II score 24.7±0.5 15.7±0.2 <0.001
APACHE II predicted mortality (%) 50.6±1.3 26.0±0.5 <0.001
Urine output in 1st 24h (ml) 625±43.4 1646±25.7 <0.001
Highest potassium in 1st 24h (mmol/l) 5.0±0.1 4.3±0.1 <0.001
Highest urea 1st in 24h (mmol/l) 19.7±0.7 9.0±0.2 <0.001
Highest creatinine in 1st 24h 337±12 118±2 <0.001A104
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Introduction Acute Kidney Injury (AKI) is a severe complication of
shock. Pathophysiological pathways include renal vasoconstriction
and endothelial damage to microvessels, thereby impairing micro-
and macrovascular flow. Microvascular flow can be measured by
sublingual Sidestream Dark Field imaging. Renal macrocirculation
can be assessed with Renal Resistive Index (RRI), (peak systolic
flow velocity - end diastolic flow velocity)/ peak systolic velocity,
using Doppler ultrasound, obtained from the intrarenal arcuate or
interlobar arteries. High RRI is a predictor of persistent AKI (1).
Whether RRI reflects the systemic circulation or renal microcircula-
tion is not well known.
Objectives To determine whether RRI is elevated in patients with
shock and to relate RRI to concomitant markers of the systemic circula-
tion, the sublingual microcirculation, hydration state and renal function.
Methods We performed a prospective observational cohort study in
critically ill patients admitted to the ICU between August 2015 and
February 2016. Patients with shock and patients without shock were
included < 24-h after ICU admission. Shock was defined as persistent
hypotension or low cardiac index (<2 L/min) despite adequate fluid
resuscitation and the need of vasopressors. Deferred consent was ob-
tained. At inclusion, three study measurements were performed: RRI,
SDF and Bioelectral Impedance Analysis (BIA) to assess fluid status
(resistance) and membrane integrity (reactance). Uni- and multivari-
ate analyses were computed to determine the relation between po-
tential determinants and the RRI.
Results Forty patients with shock and 52 without shock were in-
cluded. Patients with eGFR < 30 mL/min were excluded. Mean age
was 69 (60-76) vs. 67 (59-76) yrs. and APACHE III score was 81 (63-
107) vs. 57 (45-70) (p < 0.001). Shock patients had a higher RRI than
patients without shock (median, 0.751 (0.692-0.788) vs. 0.654 (0.610-
0.686); p < 0.001), (Fig. 41). On univariate analysis, high age, APACHE
III score, vasopressor support, pulse pressure index (PPI: (systolic-dia-
stolic)/systolic blood pressure), central venous pressure and positive
fluid balance, and low mean arterial pressure (MAP), reactance/m
and creatinine clearance were the markers most significantly associ-
ated with high RRI (p < 0.01). Markers of the microcirculation were
not. On multivariate analysis, vasopressor support, higher PPI, lower
MAP and lower Xc/m remained as independent determinants of RRI
(n = 89, Adj. R2 = 0.472).
Conclusions Critically ill patients with shock have a higher RRI
than patients without shock. High RRI was associated with renal dys-
function on the one hand and a disturbed systemic circulation (vaso-
pressor support, high PPI and low MAP) and poor cellular membrane
resistance on the other, but not with markers of microcirculation. These
findings support the concept that shock-induced AKI is associated with
renal vasoconstriction and cellular damage.
Reference
1. Darmon, ICM. 2011;37:68.
Fig. 41 (abstract A104). Boxplot of the distribution of the RRI
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Introduction Severe sepsis state constitute a worlwide public health
problem. (1,2).Thus SSC has edicted recommendations to improve
the management of this pathology.(3)But some authors have
expressed reserves on the implementation of these recommenda-
tions in low income countries. (4)
Objectives To evaluate the faisability and the impact of the recom-
mendations of SSC on adults in septic shock in University Hospital of
Kinshasa.
Methods We conducted a quasi-experimental prospective study of
twelve months from 1st February 2014 to 28 february 2015 .This study was
divided into 2 phases of 6 months each, before the protocol or the pre-
protocol phase and after the protocol or the post-protocol phase. Adults
(over 16 years old) with septic shock within this period were included. Pre-
protocol group were treated as usual. After establishing a local protocol
based on the SSC recommendations, post-protocol group received during
the earlier 6 hours intravenous fluids,vasopressors, blood transfusion and
large broad spectrum antibiotics. The next 24 hours, was devoted to or-
gans´ failure management. Our 2 endpoints were the compliance accord-
ing to the SSC recommendations and the mortality between both groups.
Results 72 patients were included. 33 during the first phase and 39
in the second phase. Patients' characteristics were similar in both
group. The infection site responsible of septic shock was mainly pul-
monary (24 %) , cutaneous (21 %), urinary (19 %) and abdominal
(13 %). Post-protocol group received more intravenously fluids
(+1229 ml); catecholamines (+20 %) as well as blood transfusion (X3)
than those of the pre-protocol group. They were also more likely to
achieve the target mean arterial pressure (36.6 versus 82.1 %) and to
receive appropriate antibiotics (0 versus 12.8 %). The compliance to
SSC bundles was significantly improved, passing from 0 % before
protocol to 50 % after protocol. We also observed a significant
decrease of the mortality, of 17 % in 6 months.
Conclusions SSC recommendations can be apply in a country of sub-
saharan Africa with a significant reduction of mortality.References
1. Alberti C, Brun-Buisson C, Burchardi H, and al (2002)Epidemiology of
sepsis and infection in ICU patients from an international multicentre
cohort study. Intensive Care Med 28:108-121
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, and al: Epidemiology
of severe sepsis in the United States: analysis of incidence, outcome, and
associated costs of care. Crit Care Med 2001, 29:1303-1310.
3. Dellinger RP, Levy MM, Rhodes A,and al. Surviving sepsis campaign:
international guidelines for management of severe sepsis and septic
shock: 2012. Crit Care Med. 2013 Feb; 41(2):580-637.
4. Baelani L,Jochberger S,Laimer T and al: Availibilityof critical care resources to treat
patients with severe sepsis and septic shock in Africa:a self-reported,continent
wide survey of anaesthesia providers.Crit Care.2011,15(1):R10
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Introduction Venovenous (VV) extracorporeal membrane oxygen-
ation (ECMO) has become a widely accepted treatment option for
life-threatening acute respiratory failure. To date, nosocomial infec-
tions or bloodstream infections occurring during ECMO support have
been reported but few studies are related to infections directly attrib-
utable to ECMO devices.
Objectives To evaluate infection and colonization rates related to
ECMO devices in VV-ECMO adult patients.
Methods We prospectively included all consecutive adult patients
treated with VV-ECMO for at least 48 hours in a referral regional
ECMO center. At the time of ECMO removal, we systematically per-
formed blood cultures, swabs cultures on insertion cannula site (fem-
oral and jugular) and intravascular cannula extremities cultures. Then,
we classified each ECMO support according to the infectious status
in three groups;
1) Uninfected/Uncolonized ECMO device,
2) ECMO device colonization,
3) ECMO device infection. Impact on outcome was assessed.
Results Ninety-nine patients underwent one hundred and three
VV-ECMO, representing 1472 ECMO-days. The ECMO device infec-
tion rate was 6.8 per 1000 ECMO-days (10 events, 9.7 % of ECMO
support) including 7 ECMO device-related bloodstream infections
(4.7 per 1000 ECMO-days). The ECMO device colonization rate
was 22.4 per 1000 ECMO-days (33 events, 32 % of ECMO sup-
port). Coagulase negative staphylococcus was the most frequently
organism responsible for ECMO device infections (8/10, 80 %)
and ECMO device colonization (20/33, 60.6 %). No difference was
observed between the three groups, regarding days of mechan-
ical ventilation, both ICU length of stay and mortality, and in hos-
pital mortality. We observed a longer ECMO duration in the
ECMO-device colonization group as compared with the Unin-
fected/Uncolonized ECMO-device group [12 days (9-20 days) ver-
sus 5 days (5-16 days); respectively, p < 0.05].
Conclusions At the time of ECMO device removal, we reported a low
incidence of infection related to the devices. Further studies are needed
to evaluate the benefits of systematic strategies using chlorhexidine-
impregnated dressing to reduce the rate of colonization.
References
1) Brodie D, Bacchetta M (2011) Extracorporeal membrane oxygenation for
ARDS in adults. N Engl J Med 365:1905-1914.
2) Schmidt M, Bréchot N, Hariri S, et al. (2012) Nosocomial infections in adult
cardiogenic shock patients supported by venoarterial extracorporeal membrane
oxygenation. Clin Infect Dis Off Publ Infect Dis Soc Am 55:1633-1641.
3) Bizzarro MJ, Conrad SA, Kaufman DA, et al. (2011) Infections acquired
during extracorporeal membrane oxygenation in neonates, children, and
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Introduction Severe necrotizing soft tissue infection (NSTI) is a life
threatening bacterial disease that spreads quickly to cutis, sub-cutis
and fasciae with an estimated mortality of 24 %1. Incidence in
Denmark is 50-100 cases per year and in Sweden 150-200 (1-2 in
100.000). The fulminant course of NSTI progresses in the matter of
hours requiring immediate diagnosis and treatment to save lives and
limbs. Little is known of the human cost of the disease for patient
and family in the short and long term2.
Objectives The objective was to explore the lived experience of the
family during the acute stage of NSTI using diaries written by close
family members.
Methods The study had a multicenter, binational, qualitative explora-
tive design using diaries written by close family members (n = 17)
during the acute stage of the trajectory starting in the intensive care
unit (ICU) at the hospitals where NSTI is centralized in Denmark and
Sweden. Family was defined in its broadest terms as spouse, partner,
blood-relation, neighbor or friend. Qualitative content analysis and
investigator triangulation were used. The study was part of the P-
INFECT-study investigating the patient and family experience of NSTI
from different perspectives. Patient and family involvement was
applied in constructing the study.
Results The mean age of the patients was 62 years with a range of
34-92. The mean length of stay in ICU was 5.5 days with a range of
1-12 days. Main themes identified: I Trajectory, II Treatment, III
Patient & Family. The first theme led to the description of the typical
course, The NSTI trajectory model. The second theme focused on in-
formational needs of the family, and the third theme identified issues
of importance to the close family: Being close to the patient, Being
worst for the family, Fearing relapse, Network and travel, and reflec-
tions on Life and death.
Conclusions NSTI is generally unknown to patient and family and
comes as a shock. Patients in our sample received rapid treatment in
the ICU and the worst consequences were avoided. Nevertheless,
close family, including spouses were faced with the sudden risk of
disfigurement or death in the patient as they coped with ambiva-
lence of being several places at once, lack of sleep and lack of cer-
tainty. We recommend the provision of systematic information
during the acute stage, including knowledge on what to expect.
References
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Introduction Giving their serious underlying conditions followed by
the need of invasive procedures, ICU-patients are highly at risk to de-
velop ICU-acquired infections representing an additional mortality
factor.
Objective To estimate incidence of ICU-acquired infections in a Tu-
nisian medical intensive care unit.
Methods A prospective study was conducted from September 2015 over
the span of a year. All consecutive ICU patients, in whom ICU length of
stay was over 48 h, were included for surveillance till discharge or death.
The data collected were, patients characteristics, initial diagnosis,
SAPS II, ventilation modality, conditions of invasive catheters inser-
tion (peripheral venous catheter, central venous catheter, urinary cath-
eter). When an infection declares, the diagnosis is retained according
to the Centers for Disease Control and Prevention National Health-
care Safety Network (CDC/NHSN) definition for each type of
infection.
Results One hundred patients were included over a 7-month period. They
were 55± 19 years mean aged. History included, diabetes mellitus, 26 % ;
COPD, 25 % ; immunocompromised, 12 %. 69 % had antibiotics at admis-
sion. Mean SAPS II, 31 ± 19. 64 % were mechanically ventilated. Central
venous catheters were inserted in 70 % of cases. Mean length of stay, 11
± 10 days. Mean duration of invasive mechanical ventilation, 12 ± 9 days.
25(25 %) patients developed ICU-acquired infections. Overall ICU-
acquired infections density incidence was 22.7events/1000patient days.
13 % developed ICU-acquired pneumonia. ICU-acquired pneumonia
density incidence was 16,6/1000ventilator days. 9(9 %) patients were di-
agnosed with central line related infection with a density incidence of
13/1000central line days. 3(3 %) patients developed peripheral catheter
related infections.
Acinetobacter baumannii was isolated in tracheal aspirates in all ICU-
acquired pneumonia cases.
Overall mortality in patients who developed ICU-acquired infections
was 72 %.
Conclusion/commentary Compared to the International Nosocomial
Infection Control Consortium (INICC) report 2007-2012 (1), the
present study showed similar rates for ICU-acquired pneumonia
(16.6 vs 16.8/1000ventilator days), however, central line-associated
infections rate was higher (13 vs 4.9/1000central line days).
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Objectives This study was designed to investigate the clinical and
microbiological characteristics of infections in a surgical intensive
care unit (SICU) of a university hospital in Iran.
Fig. 42 (abstract A110). Validity of different ICD abstraction
stategies
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an infection in our ICU during a 5 year period from January 2011 up
to December 2015 .
Results A total of 1963 consecutive patients were admitted in
our ICU during this period. Among them, 569 (28.9 %) developed 1024
infections. The mean age of patients was 42.5 ± 4.8 years. 324 (56.9 %)
of patients were women. Infections were: ventilator-associated pneu-
monia (25.9 %), bloodstream (16.7 %), surgical site (12.8 %), central ven-
ous catheter (11.1 %) and urinary tract infection (10.2 %). The
microorganisms found, in order of frequency were: Acinetobacter bau-
mannii (27.9 %), enterobacteriaceae (16.1 %), Klebsiella pneumoniae
(13.3 %), Candida albicans (8.9 %), Pseudomonas aeruginosa (5.4 %)
and Staphylococcus aureus (3.8 %). Microorganisms were highly resist-
ant to antibiotics in 18.0 % of cases. The complication and mortality
rates were 67.2 % and 48.1 %.
Conclusions Infections are one of the leading causes of morbidity
and mortality in SICUs due to high incidence, drug resistance and
rate of associated complications. Ventilator-associated pneumonia
was the leading cause of ICU infections in our study and Acinetobac-
ter baumannii was the most frequently found organism in our
patients.
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Introduction Various ICD code abstraction strategies are used to
identify severe sepsis cases in administrative data, but reliable data
on their validity is scarce.
Objectives To assess the accuracy of severe sepsis coding by valid-
ation trough clinical chart review and to identify reasons for wrong-
or non-coding.
Methods A random sample of 1120 patients stratified by hospital
length of stay and ICU admission status admitted to an academic
medical center in Germany between 2007 and 2013 was selected.
Severe sepsis patients were identified by the following ICD-10
abstraction strategies applied to patients' primary and secondary dis-
charge diagnoses:
(1) clinical sepsis codes (R codes),
(2) explicit approach (microbiological + clinical sepsis codes [R
codes]), and
(3) implicit approach (infection + organ dysfunction codes).
Gold standard was the diagnosis of sepsis according to ACCP/
SCCM consensus criteria based on the review of full patient
charts by four independent physicians. Predictive accuracies of
abstraction strategies were compared correcting for stratified
sampling by using sampling weights. Following the analysis, false
negatives and false positives were reviewed to determine reasons
for misclassification.
Results From 937 charts from adult patients that were accessible
in full, 81 patients with severe sepsis/septic shock. Sensitivity,
specificity, positive and negative predictive values are shown in
Tab. 1. Overall, explicit coding strategies are limited in their
sensitivity, but have a better positive prediction than implicit
coding strategies. Identification strategies based on clinical and/
or microbiological sepsis codes risk underestimating true sepsis
incidences by 1.4-2.2-fold, whereas indirect coding strategies
carry the risk of overestimation. In explicitly identified cases
which were coded false positive (n = 13), 23 % organdysfunction was not caused by infection (23 %), infection or
organ dysfunction were not documented in the chart (54 %) or
patients did not meet two or more SIRS criteria (23 %). For the
implicit approach, false-positives (n = 90) resulted from concur-
rence of infection and organ dysfunction without causality
(51 %) or that infection or organ dysfunctions were not identifi-
able retrospectively by chart review (40 %). 9 % did not meet
the SIRS criteria. In implicitly false-negatives (n = 21), organ dys-
function, infection or both were not coded in 67 %, 14 % and
17 % of cases, respectively.
Conclusions Existing ICD coding strategies differ in their
accuracy in identifying septic patients in hospital discharge
databases and thus may over- or underestimate true sepsis
incidences. Standardized and valid coding strategies for se-
vere sepsis are needed to ensure comparability between epi-
demiological and intervention studies based on administrative
data.
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Introduction The level of healthcare workers knowledge on Hospital
Acquired Infection (HAI) international recommendations strongly in-
fluences its increase.
Objectives To describe the level of knowledge of ICU doctors, nurses
and physiotherapists at Sagrada Esperança Clinic on HAI international
recommendations.
Methods It was applied to ICU doctors, nurses and physiotherapists
the questionnaire used in the EVIDENCE study, which includes 50
comprehensive questions concerning bloodstream infection,
catheter-associated infection, ventilator-associated pneumonia, urin-
ary catheter-associated infection, surgical site infection, hands wash-
ing and general knowledge on HAI. We validated the number of
correct answers and rated the staff as GOOD (50-40); MEDIUM (39 to
30); ENOUGH (29-25) and POOR (<25).
Results Out of 50 healthcare workers invited to participate, we re-
ceived and analyzed a total of 28 completed questionnaires, with a
Table 41 (abstract A112). Demographic Data
Survived
(n=90)
Death prior to ITU
Discharge (n=146)
P value
Age (yrs) (SD +/- SEM) 59.5 ± 1.246 64.01 ± 1.411 0.0208
Apache II (SD +/- SEM) 19.25 ± 0.541 22.8 ± 0.7393 0.0002
Time to antibiotics (minutes)
(SD +/- SEM)
128.9 ± 15.05 165.4 ± 24.5 0.1971
Male: Female (n=136:100) 81:65 55:35
Admitted from Emergency
Dept. (n=80)
46 34
Admitted from Acute Medical
Unit (n=45)
29 16
Admitted from other medical
ward (n=49)
25 24
Admitted from Surgical ward
(n=48)
33 15
Admitted from theatre (n=14) 13 1
Fig. 43 (abstract A112). Source of Infection and Survival
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 59 of 607response rate of 50 % - 8 doctors (28.5 %), 16 nurses (57.1 %), 4
physiotherapists (14.3 %). Overall, mean age ± standard deviation
was 41 ± 6.98 - doctors: 44.2 ± 6.2; Nurses: 41.0 ± 7.0; physiothera-
pists: 34.5 ± 6.9. Most participants were females (57.4 %). The
mean number of years working in the ICU was 10.4 ± 7.6 - doc-
tors: 12.4 ± 6.4; nurses: 12.5 ± 7.6; physiotherapists: 2.0 ± 7.1. Four-
teen (50 %) healthcare workers received training in HAI in the
past three years, ten (35.7 %) did not attend to any training and
four (14.3 %) omitted. Mean of correct answers: 13.1 ± 7.0 and
wrong answers: 14.9 ± 7.0; (P = 0,22). No healthcare worker was
rated as GOOD; three were rated as MEDIUM (all doctors); eight
as ENOUGH (three doctors and five nurses); seventeen as POOR
(two doctors, ten nurses and four physiotherapists). Comparing
the results, we found a significant difference between doctors
and nurses (P = 0.022) and between doctors and physiotherapists
(P = 0.005). There was no difference between nurses and physio-
therapists (P = 0.071).
Conclusions Healthcare workers did not show, in this study, good
knowledge on Hospital Acquired Infection international
recommendations.
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Introduction Sepsis is one of the leading causes of mortality
amongst ICU patients [1]. However there is a paucity of informa-
tion on the variables that could advise the physician to predict
mortality.
Objectives To identify risk factors associated with poor prognosis in
patients with sepsis on the critical care unit.
Methods A retrospective, observational study performed in a tertiary
referral University Hospital over 12 months (September 2014 to
September 2015). Inclusion: All patients admitted to the ICU with a
diagnosis of sepsis and coded by the audit team. Exclusion: Age less
than18 years and patients admitted with end of life care plan. Data
collection: Case notes were reviewed and the following details were
recorded in a predesigned data collection sheet: demographic pro-
file, admission diagnosis, APACHE II score, antibiotics, co-morbidities,
survival and length of stay. Ethical approval was not sought as study
considered a service evaluation.
Results We included 236 patients (n = 236). The mortality rate was
38.1 %. The demographic details of the patients can be seen in the
table.
It was noted that age and APACHE II score at admission signifi-
cantly are associated with high mortality. Mortality increased pro-
portionately with time to administration of antibiotics although
not significantly. It was noted that the most common source of
infection was the respiratory system (64 %) as demonstrated in
the graph below.
The most common antibiotic used was piperacillin-tazobactam. Mor-
tality was higher in patients with a respiratory or soft tissue/bone
source of infection, the lowest mortality was seen in infections of the
nervous system.
Conclusions Our study demonstrates that increased age, high
APACHE II score and delay in administration of antibiotics are as-
sociated with higher mortality in sepsis related admissions to ICU.
We aim to develop a scoring system identifying different vari-
ables which will contribute to informed decision making in sepsis
related admissions.Reference [1] Vincent JL, Akr Y, Sprung CL, et al. Sepsis in European
intensive care units: results of the SOAP study. Crit Care Med 2006 Feb;
34(2): 344-53A113
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Introduction Sepsis is the leading cause of ICU admissions, associ-
ated with high mortality. Very few Indian data is available to
identify the incidence of severe sepsis/ septic shock and their
outcomes.
Objectives To identify the incidence, risk factors and outcomes of
patients with severe sepsis/septic shock
Methods Prospective observational study, done in a multidisciplin-
ary ICU over a period of 18 months. We included all adult pa-
tients admitted to ICU with features of severe sepsis/septic shock
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 60 of 607as per SCCM/ACCP guidelines. Data collection was done on dem-
ography, co-existing illness, parameters to assess Acute Physi-
ology and Chronic Health Evaluation (APACHE) II and Sequential
Organ Failure Assessment (SOFA) scores and other relevant lab
data including vital parameters. Data concerning the source of in-
fection was obtained. Organ failures and other supportive mea-
sures taken were captured. Primary outcome data on mortality
was collected and secondary outcome data on ventilator days,
ICU length of stay (ALOS) and ventilator free days were captured.
Results 1162 patients were screened and 356 patients had severe
sepsis; incidence of severe sepsis was 30.6 %, mortality rate was
51.6 %. Admission APACHE II (23.37 ± 9.47) and SOFA (7.58 ± 4.05)
scores were high. Most common source of infection was from re-
spiratory tract (37.2 %) followed by urinary tract (10.3 %) and intra-
abdominal (9.5 %) infections. 62.9 % of patients required ventilator
support, 25.5 % of patients required vasopressor support despite ad-
equate fluid resuscitation, more than one third of patients required
renal replacement therapies (35.7 %). Hematocrit, total leucocyte
count, serum bilirubin and SOFA scores were significantly higher
among non-survivors.
Conclusions Incidence of severe sepsis was high and was associated
with poor patient outcomes.
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Introduction Inadequate ICU bed concurrent cleaning is associ-
ated with increased risk of nosocomial infections in critically ill
patients. Healthcare provider training and continuous education
have been associated with better outcomes in several settings.
Objectives To evaluate the microbiological impact of training a
critical care staff in concurrent cleaning of ICU beds.
Methods design Before-and-after study. Intervention: Training
program in concurrent cleaning for critical care healthcare pro-
viders. Period and setting: From January 2014 to October 2014
in a mixed private ICU. A pretest questionnaire was applied to
all participating nurses to assess initial knowledge of concurrent
cleaning. After training a new test was applied and the partici-
pating nurse was deemed approved if answers correctly at least
80 % of the questions. Microbiological burden was evaluated
before training and 30 days by a quantitative ATP essay. TheICU bed was considered clean if quantitative assay resulted was
less or equal to 150 URL. If quantitative essay result was higher
than 150 URL the ICU bed was considered contaminated and a
new cleaning process initiated. Each microbiological burden
evaluation included three different moments, as follows: (1) be-
fore patient admission, (2) six hours after admission, and (3)
24 hours after admission.
Results A total of 60 ICU beds were included, being 30 before
training and 30 after training. We included in training 269 critical
care healthcare providers. The pre and post-test was answered by
all participating providers, which answered correctly to 73 % and
93 % of the questions, respectively. The microbiological quantita-
tive results before training were 259 (±101) URL, 209 (±103) URL
and 261(±101) URL for before admission, six hours after admis-
sion and 24 hours after admission, respectively. Thirty days after
training, the results were 169 (±110) URL, 61 (±21) URL and 52
(±20) URL for before admission, six hours after admission and
24 hours after admission, respectively. The microbiological burden
significantly reduced after training before admission (p = 0.001),
six hours after admission (p < 0.001) and 24 hours after admission
(p < 0.001).
Conclusions A training program in concurrent cleaning for critical
care healthcare providers was effective in reducing the burden of
microbiological specimens in ICU beds.
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Introduction Prevention of hospital acquired infections is among the
most intricate problems in critical care setting.
Objectives This study sought to assess the effect of a multidimen-
sional approach developed by our team on the reduction of catheter
related hospital acquired infection (CR-HAI) rates in the patients hos-
pitalized in an adult intensive care unit (AICU) in an INICC member
hospital in Shiraz, Iran.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 61 of 607Methods The study was divided into two periods: During the base-
line period, we conducted active prospective surveillance of VAP,
VAE, CLABSI and CAUTI using the CDC and NHSN definition and
INICC methods. During the intervention period, we implemented a
multidimensional approach for VAP, VAE, CLABSI and CAUTI in
addition to performing active surveillance. This multidimensional ap-
proach included a bundle of infection control interventions including
hand hygiene, active screening, contact precaution and environmental
cleaning. The baseline rates of CR-HAI were compared to the rates ob-
tained after intervention, and we analyzed the impact of our interven-
tions by Z score.
Results The two years of study period were divided to 4 epochs
with six-month duration. 621 patients were admitted in the ICU
with 6190 bed days. Central line utilization ratio was 65 per-
cent.The rate of CLABSI was reduced from 21 to 7 per thousand
catheter days (p < 0.007). The incidence of VAP plus VAE de-
creased from 26 to 11 per thousand mechanical ventilation days
(p < 0.0128) while ventilator utilization ratio was 51 percent. The
rate of CAUTI also decreased from 23 to 9 per thousand catheter
days (p < 0.0126).
Conclusions The implementation of this multidimensional ap-
proach for CR-HAI was associated with a significant reduction in
the CLABSI, VAP plus VAE and CAUTI rates in the participating
AICU.Fig. 44 (abstract A115).
Fig. 45 (abstract A115).
Fig. 46 (abstract A115). VAE + VAPA116
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Introduction At Salford Royal Foundation Trust(SRFT), all HCAIs involving
infection with methicillin resistant staph aureus (MRSA) and Clostridium
difficile (C. diff.) are fully investigated using the process recommended by
the National Patient Safety Agency, which includes the use of 'Root Cause
Analysis (RCA)', where the events surrounding such infections are fully de-
scribed and compared with acceptable practice.
The sharing of outcomes of such investigations is an essential part of
the process; unless the results are disseminated lessons cannot be
learnt by staff involved. The NHS national patient safety agency de-
scribes a seven stage process to patient safety, which outlines this
process clearly.1
Objectives To how assess how effectively the results of investigations
into infection with MRSA and C.diff are disseminated to staff working
in the CCU at SRFT.
Methods On 22.11.2015, all CCU staff on duty were asked to complete
a questionnaire, and to do so without reference to additional sources
of information (eg noticeboards, colleagues and websites).
The survey asked participants the following questions:
· How long ago was the last C.diff/MRSA infection on CCU?
· Do you know what the RCA into this infection showed?
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 62 of 607Participants were then asked for additional comments, including how
they had heard about the results of the investigations, and for ideas for
on how such information could be more effectively shared.
Results 33 members of staff participated in our study and all groups
from the MDT were represented.
Most of the staff were not aware of the time since the most recent
infections, as can be seen in Table 42.
Perhaps even more worryingly, fewer than one third of the participants
were aware what the investigation into either of these HCAIs had shown.
Conclusions On the day of the survey, the most recent cases of
MRSA and C.diff had been fully investigated and the results of the RCAs
into the events had been published. Despite the completion of these
investigations, our survey shows the learning points raised had only
been shared with a small percentage of the critical care team, limiting
the impact of the investigative work.
As a result of this work, we intend to involve more members of the
MDT in RCAs, and change the way results of such investigations are
communicated with the critical care team to ensure any lessons can
be learnt by a wider group of individuals.
References
1. Seven steps to patient safety. An overview guide for NHS staff. London:
The National Patient Safety Agency 2nd Edition, April 2004Table 42 (abstract A116). Number of staff indicating time since most
recent C.diff and MRSA acquisitions
<1 month 2-3
months
3-6
months
6-12
months
12-18
months
>18
months
C. difficile 9 9 4a 7 4 0
MRSA 2 13b 3 7 6 2
a Most recent C.diff acquisition occurred on 25.06.15 (5 months before the survey)
b Most recent MRSA acquisition occurred on 26.09.16 (2 months before the survey)A117
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Introduction ICU infections increases the ICU mortality and length of
hospital stay is extended. Micro-organsims that cause infections in
intensive care varies according to country and type of intensive care.
Objectives The aims of this study were to determine the the inten-
sive care infections (ICI) prevalence in Derince Kocaeli Educational
Hospital, to ascertaine risk factors, to describe the pathogens associ-
ated with intensive care infections
Methods In our study, we aimed to identify the infectious agent retro-
spectively. Point-prevalence survey in march 2012 concerning all patients
who had been in the intensive care unit for at least 48 hours. A retrospect-
ive analysis of 1780 patients who underwent ICU therapy between 2012
and March 2016 was performed. The primary outcomes of our study, we
aimed to identify the infectious agent retrospectively. The secondary out-
comes of our study, was to identify areas of infections in intensive care.
Results 1780 patients undergoing enfection were screened. Infec-
tious agents are as respectively Pseudomonas aeroginosa, Acineto-
bacter baumania and Klebsiella pneumonia . The area of infection,
respectively: lower respiratory tracts, urinary tract and blood circula-
tion. There were 1780 cases admitted to the ICU. ICU infectious
agents per cent respectively; Pseudomonas auroginosa (%28.7), Aci-
netobacter baumania ( %14.29), Klebsiella pneumonia (%28,57).
Conclusions We think that is appropriate to the profile of the factors
of intensive care infections in intensive care in Turkey. At the end of
the study, there was no resistance in Acinetobacter colistin. Riskfactors associated with infection were longer of hospital stay, pre-
cence comorbidity and mulitrauma. Still in Turkey, the first in the in-
tensive care unit is located Gram negative factors.
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Introduction Plasmapheresis (therapeutic plasma exchange - TPE) is
an established treatment option in the therapy of Guillain-Barré syn-
drome (GBS). 3 randomized controlled trials established its efficiency
between 1985 and 1995. So far the recommended number of TPE
sessions is four, but the optimum TPE protocol (number of ex-
changes and volumes exchanged) remains to be established (1). Also
the role of TPE in patients with GBS who fail to respond to therapy
and who relapse after therapy remains to be determined (1). TPE is ex-
pected to be a logical therapeutic option in diseases in which pathogen-
esis is linked with a biological substance with a relatively high molecular
weight, a slow rate of formation and a distribution in the vascular space.
TPE is used in the treatment of diseases in which the pathogenesis is as-
sociated with abnormal circulating pathogenic autoantibodies (2). The
role of antibodies against gangliosides in GBS is established only in
Miller Fisher variant, in other types of GBS the role of antibodies still re-
mains to be determined. But as the optimum TPE protocol (especially in
patients who fail to respond to therapy and in patiens who relapse after
standard TPE protocol) has not been determined, it is a question,
whether in these patients the role of antibodies should not be consid-
ered and the number of TPE sessions should not be individualized and
adapted to these results.
Objectives We wanted to determine the relationship of antibodies to
gangliosides in patients with GBS and TPE and its influence on TPE
protocol.
Methods We prospectively screened patients with GBS treated by TPE for
antibodies to gangliosides before, during and after TPE series and adapted
the number of TPE to the neurological status and results of antibodies.
Results In 2014 we had and unexpected number of GBS patients at
our ICU. 4 patients were admitted to our ICU during the period of
3 months.In all 4 patients we chose TPE as an initial therapy. We tested
the patients for antibodies against gangliosides before, during and after
the TPE protocol and adapted the number of TPE to the clinical course
of the disease and to the results of antibodies against gangliosides. In
patients with positive antibodies and a remaining neurological deffi-
ciency or a relapse we repeated a series of TPE.
Conclusions The studies on TPE protocols and GBS are 20 years old.
The optimal TPE protocol remains to be established. The question is
whether the efficacy of TPE should not at least in patients with se-
vere neurological symptoms and in patients who fail to respond to
standard TPE protocol be individualised according to the results of
antibodies to gangliosides.
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Patients Type of
GBS
No. of
TPE
Dates
of TPE
Results of
antibodies
Results of
antibodies
Results of
antibodies
Results of
antibodies
Outcome
Male, 28
years
AMAN 15 6 June-1
July
16 June -
positive
16 July-
positive
recovered
Female,
29 years
AIDP 9 TPE, 5
TPE
(relaps)
5 - 19
June 29
July-11
Aug
6 June -
positive
29 July
borderline
7 August
borderline
11 August
negative
relapse,
recovered
Male, 58
years
AMSAN 13 29 June-
22 July
9 July
borderline
25 July
negative
recovered
Male, 59
years
AIDP 9 9 July-
24 July
9 July-
positive
16 July-
positive
25 July
borderline
recovered
Table 44 (abstract A120).
Patient characteristics Number (%) / Mean ± SD
Age 41 ± 15
Male 26 (72%)
Female 10 (27%)
Weight 76 ± 13 kg
Duration of infusion 80 ± 55 hours
Insulin during infusion 17 (47%)
Fig. 47 (abstract A120).
Table 45 (abstract A120). Hypokalaemia during infusion
Hypokalaemia No hypokalaemia
Insulin 13 5
No Insulin 12 6 chi-square
p=0.88
Duration (hours-
mean) ± SD
85.68 ± 52 66.27 ± 56 t-test p=0.32
Initial potassium 3.8 3.8
Weight ± SD 78.2 ± 12.7 73 ± 15 t-test p=0.29
Table 46 (abstract A120). Hyperkalaemia following infusion]
Hyperkalaemia No hyperkalaemia
Insulin 6 11
No insulin 5 13 chi-square
p=0.63
Duration (hours- mean) ± SD 67.7 ± 27 86.8 ± 63 t-test p=0.34
Weight ± SD 81.2 ± 16 74.9 ± 11 t-test p=0.19
K+ replacement (mmol) ± SD 272 ± 202.8 216 ± 139.3 t-test p=0.34
Hypokalaemia during infusion 9 16
No hypokalaemia 2 8 chi-square
p=0.36A120
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Introduction Traumatic brain injury (TBI) is a common cause of mor-
bidity in Europe. Managing raised intracranial pressure (ICP) with bar-
biturate coma is a final option in medical management1. Interactions
between thiopentone and potassium have been reported2 and have
been attributed to mortality in our ICU.
Objectives To review the frequency, complications and contributing
factors in the loss of potassium homeostasis during and after a thio-
pentone infusion.
Methods Patients who were prescribed thiopentone by infusion from
March 2011-May 2015 were selected. Serum potassium was recorded
at baseline and 6 hourly until 72 hours or infusion stopped.
Following cessation, potassium levels were recorded 6 hourly for
60 hours unless death occurred. Potassium replacement during the
72 hours and the use of insulin were noted. Complications following
infusion were reviewed.
Results In total 50 patients were prescribed thiopentone. Eight re-
ceived a bolus and three had other indications. A further 3 patients
had a duration under 6 hours and were excluded. Thirty-six patients
were reviewed with 1 patient dying during infusion. Patient charac-
teristics are shown in Table 44.
Hypokalaemia (potassium < 3.5) developed in 25 patients (69.4 %)
during infusion with the mean lowest at 12 hours (Fig. 49). Subse-
quently 11 (31.4 %) patients developed hyperkalaemia (potassium >
5.5), mean peak 12 hours after.
Three patients died due to cardiac arrest with hyperkalaemia fol-
lowing infusion and 2 patients required filtration to control
potassium.
Insulin use, duration of infusion, weight, potassium replacement or
presence of hypokalaemia had no statistical significance relating to
loss of regulation (Tables 45 and 46).
Conclusions After fatalities attributed to hyperkalaemia post bar-
biturate coma, we aimed to assess the occurrence and any con-
tributing factor. A case series2 highlighted the potassium
replacement as a significant variable. This was not shown here,
possibly due to restrictive replacement in patients during infu-
sion. We did find an earlier fall in potassium following the start
of infusion and an earlier peak after cessation. That no variable
showed significance suggests a lack of understanding of the
cause of dysregulation.This study was limited by sample size, likely due to limiting barbitur-
ate coma to a final attempt at ICP control. Further large trials may be
required to identify variables predicting hyperkalaemia.
Overall, with little to indicate which patients will develop hyperkalae-
mia, ICU staff should beware this potentially fatal complication.
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Fig. 48 (abstract A122). Predictive Factors for Infections
Table 47 (abstract A122). Clinical Infections and Bacteriological Profile
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Introduction Inflammation is a key player in brain damage and in-
creased production of pro-inflammatory and lower levels of the anti-
inflammatory cytokines in periphery blood and cerebrospinal fluid
(CSF) are associated with poorer clinical outcome after primary intra-
ventricular hemorrhage (IVH).
Objectives The aim of this study was to investigate changes in concen-
tration of interleukin (IL)-1β and Transforming Growth Factor β (TGF β) in
CSS of patients with IVH and external ventricular drainage treated with
catheter-based clot lysis with low-dose tissue plasminogen activator (tPA).
Methods Thirty adult patients with IVH were enrolled in the pro-
spective study. The patients were divided in two groups: group A
was treated with 3x1 mg/12 h tPA (15 pts; age 69 (60-74); male 7)
and control group B with placebo (15 pts; age 62 (59-68); male 8). In-
tracerebral hemorrhage score on admission was equal in both
groups (ICH = 3 (2-3)). Concentration of IL-1 β and TGF β in CSF were
determined 24 hours (day 1), 3 and 7 days after the start of clot lysis.
Results In the patients from group A the concentrations of IL- 1β were
significantly lower on day 3 (19,5 (11,5-28,5) vs. 39,7 (16,8-50,5); p =
0,022) and on day 7 (9 (0,2-13,3) vs. 50 (22,6-65); p < 0,001) and not sig-
nificantly lower on day 1 (26 (12,3-38,2) vs. 37,8 (15,4-59,3); p = 0,15),
while the concentrations of TGF β were significantly higher on day 1
(2781 (1987,7-3611 vs. 1982,7 (1777,4-1985); p = 0,009) and day 3 (2179
(1889-2249,3) vs. 1679 (1652,8-1777,4); p = 0,002) and not significantly
higher on day 7 (2321 (1787,7-2057,3) vs. 2057,3 (1756,8-1862); p = 0,51).
Conclusion Intraventricular clot lysis with low-dose tPA probably
amplifies the initial anti-inflammatory response and diminishes in-
flammatory response at a later stage.
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Introduction Bone marrow suppression, leucopenia and infectious
complications have been reported during the use of barbiturate coma
therapy (BCT) for refractory intracranial hypertension. However, these
studies have mainly involved small sample sizes. Thus, although effect-
ive in lowering intracranial pressure, barbiturate-mediated infections
may severely limit the potential life saving utility of BCT.
Objectives /Methods We conducted a retrospective cohort study of
all patients (n = 72) receiving thiopentone BCT for the control of re-
fractory intracranial hypertension in a neurosurgical intensive care
unit over 4 years. We collected data including changes in cell count,
procalcitonin levels and incidence of clinically diagnosed infections.
The microbiological profile of the organisms isolated and antibiotics
prescribed were also analysed.
Results The mean pre-induction WBC count was 15.1 ± 12.2 x 109 L;
91.7 % of patients experienced a decrease in WBC count after induction
with a mean maximal decrease in white cell count of 9.15 x 109 L. Theincidence of leucopenia and neutropenia were 34.7 % and 2.8 %, re-
spectively. Procalcitonin levels were generally raised as early as first day
of BCT. The incidence of clinical infections was 46.2 %. Pneumonia (n =
15) and blood stream infections (n = 9) accounted for majority of the in-
fections. The main causative organisms causing pneumonia were Kleb-
siella pneumonia (n = 4), Staphyloccus aureus (n = 2) and Pseudomonas
aeruginosa (n = 2). The main cultured organisms from blood stream in-
fections were Pseudomonas aeruginosia (n = 3), Klebsiella pneumonia
(n = 1), Enterococcus cloacae (n = 1) and Acinetobacter baumannii with
Staphyloccus aureus (n = 1). Out of 40 positive cultures, Klebsiella pneu-
monia (n = 14, 1 was multiresistant) and Staphyloccus Aureus (n = 9, 4
were methicillin-resistant) constituted the commonest bacteria isolated.
Conclusions Leucopenia and infections (predominantly pneumonia)
are common complications in patients on BCT for refractory intracra-
nial hypertension.
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Table 48 (abstract A124). The results of treatment (M ± m)
Indicators Group 1 Group 2 P
Starting MV, day 2.8±0.6 2.8±0.8 >0.05
Ventilator days 34.4±4.3 19.1±3.3 <0.05
Staying in ICU, day 46.2±4.9 35.1±4.9 >0.05
Pneumonia,abs (%) Diagnosis
(day of hospitalization)
10 (31.2) 8±1.5 8 (34.8) 8±3.4 >0.05 >0.05
Vasopressor, abs(%) Duration
of treat., day
6 (18.8) 66.6±13.4 9 (39.1) 47.6±5.8 >0.05 >0.05
Daeths, abs (%) 12 (37.5) 18 (78.3) <0.01
COS, ball 3.5±0.3 3.4±0.4 >0.05
28-th day: - Died, abs (%) 0 5 (21.7) <0.01
- Alive, he is in the ICU ,
abs (%)
17 (53.1) 7 (30.5) >0.05
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Introduction Stroke is a disease with high morbidity and mortality, it
constitutes a main medical cause of permanent disability in adult-
hood, and in Spain it is one of the leading causes of death. The intra-
venous thrombolysis is an approved treatment in selected patients
that with the new recomendations this group could be bigger.
Advances in imaging studies for acute ischemic stroke are largely
due to the development of new efficacious treatments carried out in
the acute phase. The computed tomography (CT) perfusion studies
and CT angiography facilitates the selections of patients who are
likely to benefit from appropriate early treatment.
Objectives To analyze the impact of new recomendations for acute
ischemic stroke treatment in the selection of patients for treatment
and the outcomes in patients atended in a polyvalent ICU during the
last year (2015) and the first trimester of this year.
Methods Consecutive registry of patients seen in the last year (2015)
and the first trimester of this year whom were suffering acute stroke
in the ICU of a university hospital. Descriptive analyze of the registry
during this period.
Results During 2015 were approached as suffering an acute stroke
28 patients, 13 women (46 %) and 15 men (54 %) with a medium
age of 62.3 y.o.; in whom were treated with thrombolysis 9 (32 %)
patients being this treatment considerate as efective in 1 (11 %) pa-
tient, reporting up to 3 cases (33 %) of bleeding in CT control. In 19
patients thrombolysis was not applied and the causes were: thromb-
olysis contraindicated (4 cases), with out indication of thrombolysis
(4 cases) and improvement of disability (11 cases).
During the first trimester of this year we had 18 patients, 6
women (33 %) and 12 men (67 %) with a medium age of 63.6
y.o.; thrombolysis was appplied in 10 patients (55 %), being efec-
tive the treatment in 3 (30 %) cases with no one case of bleed-
ing in CT control. And in the 8 patients in whom thrombolysis
was not applied the causes were: thrombolysis contraindicated
and with out indication of thrombolysis with 4 cases for every
group. Improvement of disability is not considerated as cause of
no thrombolysis.
Conclusions The new recomendations in acute ischemic stroke and
the advances in neuroradiology allow a better approach of patients,
is increasing the patients whom benefits of this treatment, and the
effectiveness seems to increase, in the same way the adverse results
seem to remain in low cases.
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Introduction Acute ischemic stroke is a leader in terms of mortality
and disability. Early rehabilitation significantly improves the outcome
of treatment. One of the most effective methods of early rehabilita-
tion is passive verticalization, aimed at prevention and elimination ofcomplications associated with long-stay patient in the supine
position.
One of the relative contraindications for verticalization is to carry out
mechanical ventilation (AV).
Objectives To assess the effectiveness of early passive verticalization
conducted against the background of mechanical ventilation in
patients with ischemic stroke.
Methods The analysis of 55 and medical history of patients with a
diagnosis - ischemic stroke. It formed two groups - the addition of
verticalization (Group 1 - 32 persons) and without a verticalization
(Group 2 - 23 people). All patients were treated according to the Rec-
ommendations AHA / ASA 2013. All patients underwent mechanical
ventilation respirators "Hamilton C2 " (Switzerland). In verticalization
carried out by verticalization table «Beka Hospital» (Germany). All
patients conducted severity rating scales for SOFA, NIHHS, CGS at
admission and on the first, 3rd, 5th, 7th, 10th. At these stages were
assessed respiratory status.
Results In both groups assessed results are presented in Table 48.
Starting ventilator patients in both groups were required at different
times substantially on average, and the eighth day in both groups
were diagnosed with pneumonia.The frequency of hemodynamic dis-
turbances and duration of inotropic support were comparable in
both groups. The mortality rate in group 1 was significantly lower
than in group 2, which explains the increase in the period of mech-
anical ventilation and stay of patients in the ICU and in the hospital.
Analysis on GOS the surviving patients showed no significant
differences.
Conclusions
1. The use of early passive verticalization in patients with ischemic
stroke on the background of mechanical ventilation does not lead to
a deterioration in the neurological and somatic status.
2. Applying early verticalization in patients with ischemic stroke sig-
nificantly reduces mortality and increases the time of mechanical
ventilation, the patient´s stay in the intensive care ward and in the
hospital.A125
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Introduction Post-craniotomy pain has been reported to be moder-
ate to severe. Management of post-craniotomy pain is inadequate in
many cases, yet is limited by the side effects of opioids. Codeine has
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 66 of 607been the mainstay of treatment of post-craniotomy pain in our insti-
tution, due to its safer side effect profile when compared to more
potent opioids. However, its effectiveness may be limited due to the
need to be de-methylated before it has any analgesic effect and this
process is subject to inter-individual variability.
Objectives Our primary objective was to determine if there is a dif-
ference in the mean pain VAS scores in the oxycodone and codeine
groups at 24 hours. Secondary objectives were to compare pain VAS
scores at 48 and 72 hours and to compare the incidence of excessive
sedation, depression of respiratory rate and GCS.
Methods A randomized, double blinded controlled trial was used to
evaluate the efficacy of oral oxycodone versus oral codeine. 40
patients were randomized to the control group of codeine (n = 20) or
the experimental group receiving oxycodone (n = 20), in addition to
regular oral paracetamol for both groups of patients. Analgesia was
to be administered according to a strict protocol. Patients were
reviewed by blinded assessors closely in the 1st day and then subse-
quently once a day at the 48th and 72nd hour post-operatively.
Results A total of 36 patients were analysed (4 patients dropped out
due to post-surgical complications). The mean pain score at 24 hours
was 1.85 ± 1.60 and 2.78 ± 1.92 (p = 0.110) in the codeine and oxy-
codone group respectively. There were also no statistically significant
difference in the sedation scores, respiratory rate and GCS scores.
Conclusions Oral oxycodone is as effective as oral codeine in the
management of post-craniotomy pain.
Our local population also seemingly has very mild pain after a crani-
otomy (mean pain VAS scores 1-3), as compared to what was re-
ported in the literature. One deduction is that compared to the
Western population, our population probably has minimal genetic
variability in the ability to metabolise codeine. Our population may
all be efficient metabolisers, thus allowing codeine to be as effective
as oxycodone. Also, as our patients generally had mild pain, codeine
may be adequate analgesia for them.
As there is no difference in adverse effects, oxycodone may also be
as safe as codeine, in bioequivalent doses.
Hence, oxycodone can be considered as an effective alternative to
codeine.
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Introduction Ischemic Stroke still constitutes the major cause of
death in Portugal. With the widespread investment in information to
the population and creation of a net of reference hospitals with
established protocols of Intravenous Fibrinolysis and endovascular
treatment, mortality and morbidity have declined.
Objectives The objective of this study is characterize the population
undergoing Intravenous Fibrinolysis with alteplase at the Intensive
Care Unit of the researchers' hospital, verify the early (48 hours) and
60-days mortality after admission,and identify the causes of death.
Methods Observational retrospective study based on information ac-
quired from the clinical records of patients admitted in the Intensive
Care Unit for Intravenous Thrombolysis between the 1st of January
2010 and 31st December 2015, and its statistical analysis.
Results Among the total of patients included (n = 102), 63 % were male
with an average of 70 years old.The average admission National Insti-
tutes of Health Stroke Scale (NIHSS) score was 14 and the average
Symptoms-to-Needle time was 156 minutes. There was a total of 4
deaths in the first 48 h after admission and 19 deaths between 48 hours
and 60 days post admission. Of the early deaths, 2 were due to intrace-
rebral hemorrhage and the other 2 accounted for progression of ische-
mic disease, unresponsive to thrombolysis. The highest cause of deathat 60 days was Aspiration Pneumonia (10), followed by progression of
ischemic disease (5), Intracerebral Hemorrhage (2), Septic Shock (1) and
1 prehospital death, with no reference to cause of death on clinical re-
cords. The average NIHSS score at twelve hours of patients who died
between 48 hours and 60 days was 20.
Conclusions With the application of adequate guidelines and
evaluation of the patients proposed to Fibrinolysis, early deaths
accounted for 17 % of total deaths and were attributed to non
effectiveness of fibrinolytic therapy or its hemorrhagic complica-
tions. Deaths occurring at 60 days post admission occurred in
patients with higher NIHSS scores, revealing important neuro-
logical dysfunction. The most frequent cause of death was Aspir-
ation Pneumonia. Being so, it is important to apply prevention
measures to patients during ICU and hospital stay, in order to
reduce
Aspiration Pneumonia's incidence and allow the patient to start
physiotherapy as soon as possible to regain lost functionality.
Patients suffering stroke should be evaluated by a multidiscip-
linary team involving Neurology, Internal Medicine and Physio-
therapy at regular periods to adequately assist them to resume
their lives.
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Introduction Propofol and midazolam are known to be excellent
drugs for sedation for intensive care units.
Objectives This study aimed to compare the sedative and analgesic
effects and the recovery profiles of propofol and midazolam in a rat
model by conducting motor coordination tests (rotarod-accelerod
test) and by evaluating the analgesic response times by conducting
hot plate and tail flick tests.
Methods Rats were randomly divided into the following 4
groups on the basis of the treatment received. The first group
received 600 μg/kg/min propofol, the second, 83 μg/kg/min
midazolam; and the third, 83 μg/kg/min morphine; the fourth
was a control group. The rats were placed on a rotating rod
and tested first at the slowest speed (5 rpm), followed by a
speed of 10 rpm, and then with 10-rpm speed increments at
speeds up to 40 rpm. The speed was set to increase from 1 to
79 rpm within 4 and 10 min in the accelerod test. Pain reflexes
in response to a thermal stimulus were measured at 0, 10, 20,
and 60 min after the drug injection by using the hot plate and
tail flick tests. The neurobehavioral status, including sensory and
motor function, was assessed every 30 min until normal func-
tioning resumed by an investigator who was blinded to the
groups.
Results At all the tested speeds, the midazolam-injected rats
remained on the rotarod longer than did the propofol-injected
rats. Furthermore, in the 10 min accelerod test, the midazolam-
injected rats remained for a longer duration than did the
propofol-injected rats. The latency time for the hot plate test
was significantly higher at 10 min in the propofol group than in
the midazolam group. At 10 and 20 min, the latency time was
greater in the propofol group than in the midazolam group.
Further, the latency time at 10 min for the tail flick test was
greater in the propofol group than in the midazolam group.
Propofol enhanced sensory blockade to a greater extent at 90
and 120 min than midazolam did at the corresponding time
points. Further, the duration of complete motor blockade was
significantly greater in the propofol group than in the midazo-
lam group.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 67 of 607Conclusions For achieving a long-term analgesic benefit, propofol
treatment may be more effective than midazolam treatment. Pro-
pofol may be preferable sedation applications in intensive care
units as it affords faster onset of recovery of motor coordination
performance.
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Introduction Ranolazine (Rn), a drug used for the treatment of
chronic angina pectoris (1), has been proposed for the manage-
ment of epileptic disorders for its ability to decrease neuronal ex-
citability by blocking late inward sodium current (late INa) in the
central nervous system (2, 3). We recently demonstrated in pri-
mary cultures that Rn could act as a neuroprotective drug by
promoting astrocyte viability, preventing necrosis and apoptosis,
inhibiting inflammatory phenomena and inducing anti-
inflammatory and antioxidant agents (4). Amyloid-β peptide 1-42
(Aβ1-42), a protein involved in the pathogenesis of Alzheimer´s
disease, produce glial activation, inflammatory response and oxi-
dative stress that can lead to neuronal death (5).
Objectives Under the hypothesis that ranolazine acts as a neuropro-
tective drug, the present study focuses on the effects ranolazine on
astrocytes exposed to Aβ1-42 toxic peptide.
Methods We incubated rat astrocytes in primary cultures for 24 hours
with Rn (10−7, 10−6 and 10−5 M), Aβ1-42 (15 μM) or Rn (10
−6 M) + Aβ1-
42 (15 μM). Cell viability and proliferation were measured using MTT
conversion assay and LDH release assay. Apoptosis was determined
by Caspase 3 activity assay.
Results In cultured astrocytes, Rn significantly increased cell viabil-
ity and proliferation at any concentration tested, and decreased
LDH leakage and Caspase 3 activity indicating less cell death.
Aβ1-42 significantly decreased cell viability compared to control
astrocytes. Incubation with Rn (10−6 M) prevented the decrease
in cell viability induced by Aβ1-42. Rn decreased LDH release to
the medium (15 % with Rn 10-6M and 20 % with Rn 10-5). Toxic
peptide increased LDH release in about 75 % and incubation
with Rn (10-6) lowered by 60 % LDH levels, indicating a protect-
ive effect against Aβ1-42.
Conclusions Ranolazine increases cell viability and prevents necrosis
and apoptosis induced by Aβ1-42, suggesting that Rn could act as a
neuroprotective drug in situations associated with oxidative stress or
inflammation.
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Introduction Delayed cerebral ischaemia (DCI) (1) is the first cause of
morbidity after subarachnoid haemorrhage (SAH). F2isoprostanes
and eicosanoids were found in the cerebrospinal fluid (CSF) of pa-
tients with DCI. These potent vasoconstrictors induce platelet aggre-
gation and mediate inflammation by a thromboxaneprostaglandine
(TP) receptor binding (2).
Objectives The aim of our study was first to estimate the occurrence
of DCI in a proinflammatory state using an high omega 6 polyunsat-
urated fatty acid (w6) diet and secondly to evaluate the efficiency of
terutroban (TER) a TP receptor inhibitor.
Methods Ninety wistar rats (400 g) were randomly assigned to
one of 5 groups: a double 250 μL intracisternal injection of au-
tologous arterial blood (SAH groups) (3) or artificial CSF (CSF
group) was performed. To induce a proinflammatory state ani-
mals were fat with w6 during 6 weeks before SAH procedure
(SAH_w6/SAH_w6 + TER). TER was administered (30 mg/kg/day)
during 5 days following SAH (SAH + TER/SAH_w6 + TER groups).
Evaluation of uptakes of 3 [99mTc]radiolabeled agents was
achieved using microSPECT/CT imaging: HMPAO at D5 for cere-
bral perfusion quantification; DTPA at D3 for blood brain barrier
(BBB) integrity study; and AnnexinV at D4 for apoptotic activity
study. ANOVA followed by Student́s t test.
Results HMPAO uptake analysis showed a significant decrease in
the SAH group (figure). DTPA and AnnexinV uptake were also
significantly increased in the SAH group compare to the CSF
group. Proinflammatory state before SAH dramatically decreased
HMPAO uptake (figure); increased DTPA (0.37 ± 0.04 vs. 0.43 ±
0.01 Mbeq/mm3; P < 0.05) and AnnexinV (0.39 ± 0.03 vs. 0.48 ±
0.03 Mbeq/mm3; P < 0.05). TER significantly counteracted the
decrease in HMPAO uptake (figure) and the increase in DTPA
uptake (P < 0.05) and in AnnexinV uptake (P < 0.001) induced by
SAH.
Conclusions For the first time, a proinflammatory SAH rat
model of DCI has been described. microSPECT study shows
that a proinflammatory diet dramatically increases apoptosis
and DCI. TER improved hypoperfusion, BBB disruption and
apoptosis. TP receptor antagonists could be promising treat-
ments after SAH.
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Table 49 (abstract A130).
Baseline (4 hours
prior to tracheostomy)
Tracheostomy
(Worse measurement
during tracheostomy)
After (8 hours after
tracheostomy)
ICP (mmHg) 8 (5 - 11)* 12 (7 - 17) 9 (6 - 11)*
MAP (mmHg) 83 (72 - 94) 84 (71 - 100) 80 (68,5 - 90)*
CPP (mmHg) 77 (65 - 87) 75,5 (60 - 91) 73 (62 - 81)
PaO2/FiO2
(mmHg)
345 (299,5 - 392) - 351 (294 - 400)°
pH 7,43 (7,41 - 7,45) - 7,43 (7,41 - 7,45)
PaCO2
(mmHg)
42,5 (39,5 - 46) - 41,5 (38 - 45)°
ICP intracranial pressure, MAP mean arterial pressure, CPP cerebral perfusion
pressure, PaO2 arterial PO2, FiO2 inspired fraction of oxygen, PaCO2 arterial
PCO2
*) p < 0.001 vs. Tracheostomy, °) p < 0.05 vs. Baseline.
Fig. 49 (abstract A129). 99mTc-HMPAO uptake at D5 expressed in
% of D0
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Introduction Brain injured critically ill patients have often impaired
airways reflexes and require long-term mechanical ventilation and
tracheostomy, which is a standard of care. Many issues still remain
unclear, for example the optimal timing (early versus late), the better
technique and the effect on ICP in brain injured patients.
Objectives To describe the approach and the systemic/intracranial
effects of tracheostomy in severe brain injured patients in a neurocri-
tical intensive care unit (San Gerardo Hospital, Monza, Italy).
Methods All consecutive adult patients undergone tracheostomies
from 2010 to 2015 were included. A retrospective analysis of
prospectively-collected data retrieved from a digital PDM system was
performed (demographics, procedures characteristics, and blood gas
analyses, intracranial pressure (ICP), mean arterial pressure (MAP), cere-
bral perfusion pressure (CPP)). Data are reported as median (interquar-
tile range) prior to/during/after tracheostomy. A repeated measures
analysis of variance was utilized to assess the effects of tracheostomy.
Results Preliminary data are based on 170 patients (58 % male and
42 % female, 67 (56-73) years old, GCS at admission 7 (6-9)) admitted
for intracranial hemorrhage (29 %), subarachnoid hemorrhage (22 %),
trauma (21 %), stroke (12 %). Tracheostomy was performed at 10 (7-
13) days from admission for compromised neurological status (89 %,
GCS at tracheostomy 7 (6-8)). Direct laryngoscopy Fantoni´s translar-
yngeal technique (TLT), Percutwist, surgical, standard TLT and Dol-
phin were used in 63 %, 18 %, 11 %, 6 % and 2 % of the cases. ENT
specialists and intenstivists performed 46 % and 54 % of the trache-
ostomy, respectively. No deleterious effect on recorded parameters
was detected (see Table 48). Four lesions of the tracheal rings were
documented.
Conclusions In a large cohort of brain-injured patients tracheostomy
performed one week after the initial insult is safe.A131
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Introduction The paradigm for the treatment of ischemic stroke hy-
peracute changed in recent years with the Introduction of thrombo-
lytic - Alteplase (rt-PA), the efficacy directly related to the time
interval between the onset of symptoms and drug administration.
Hospital Moyses Deutsch, in the southern city of São Paulo, is indi-
cated for the use of rtPA intravenously in patients with ischemic
stroke frame according to the protocol established by the service
since 2011. It is necessary to ask neurological evaluation the distance
trough of the Hospital Israelita Albert Einstein Telemedicine.
Objectives Demonstrate experience the use of intravenous alteplase
clinical practice with Neurologist Telemedecine support, checking the
efficiencies and procedure safety.
Methods Retrospective study, in all cases of ischemic stroke who
received intravenous alteplase, from December 2011 to February
2016. The protocol indicates the use of alteplase for patients with
inclusion criteria, the period between the onset of symptoms and
hospital admission up to 4.5 hours and no contraindication to
the use of thrombolytics, NIHSS (National Institutes of Health
Scale course) calculated on admission and 24 hours after thromb-
olysis. Computed tomography (CT) on admission and after
24 hours. Solicitation evaluation required by neurological Tele-
medicine Hospital Israelita Albert Einstein shortly after the conclu-
sion of the TC Cranio. The rt-PA dose of 0.9 mg / kg, 10 % of
the remaining bolus dose continuous infusion over 1 hour to a
maximum dose of 90 mg.
Results Alteplase was used in 64 patients with diagnosis of stroke
ischemic. Evaluation Neurology Telemedicine trough has been
triggered in 51 cases. Time between onset of symptoms and
drug administration, 19 patients less than 90 minutes between 37
90 and 180 minutes, 8 patients between 180-360 minutes .The
average NIHSS at admission was 18, with 42 patients showed a
reduction of 5 or more the points NIHSS score within the first
24 hours. 8 patient non-symptomatic intracranial hemorrhage and
6 symptomatic intracranial hemorrhage and 9 deaths during the
period.
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time interval and underwent CT Cranio control. Some cases were not
triggered by the evaluation of Neurology Telemedicine. There was
improvement in NIHSS score similar percentage observed in refer-
ence studies. The protocol implementation has been adequate excel-
lent support of Telemdicina Neurology team. Good profitability of
time and therapeutic efficacy. The mortality that correlated with the
severity of patients and the NIHSS admission. This data ratifies the
safety of intravenous Alteplase use in the treatment of Ischaemic
Stroke.
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No conflicts of concernFig. 50 (abstract A132). Plasma levels of inflammatory mediators
and adhesion molecules during endotoxemia. (A) Interleukin-6, (B)
Interleukin-8, (C) Monocyte Chemotactic Protein-1, (D) Vascular Cell
Adhesion Molecule-1. Data are represented as means with SEM of
n = 7 in the EA-230 180 mg/kg group and n = 12 in the placebo
group. Gray box indicates the period in which the active group
received EA-230. P-values between groups were calculated using
repeated measures two-way analysis of variance (ANOVA, interaction
term)
Fig. 51 (abstract A132). Body temperature (A) and symptom score
(B) during endotoxemia. Data are represented as means with SEM of
n = 7 in the EA-230 180 mg/kg group and n = 12 in the placebo
group. Gray box indicates the period in which the active group re-
ceived EA-230. P-values between groups were calculated using re-
peated measures two-way analysis of variance (ANOVA, interaction
term)Sepsis, host response
A132
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Introduction The systemic inflammatory response syndrome (SIRS)
can lead to pronounced tissue damage and is a frequent cause of
multi-organ failure and mortality in Intensive Care units1. SIRS can be
elicited by a variety of insults, such as sepsis, trauma, and major sur-
gery, and no specific therapy is currently in routine use. EA-230 is a
newly developed synthetic linear tetrapeptide derived from the β-
human chorionic gonadotropin hormone (β-hCG), which has shown
promising anti-inflammatory and tissue-protective effects in animal
studies2,3.
Objectives To investigate the tolerability, safety and immunomodula-
tory effects of EA-230 in humans.
Methods We conducted a double blind, placebo controlled, dose-
escalating randomized clinical trial in 60 healthy volunteers. The
study was carried out in two phases. In the first phase (n = 24), safety
and tolerability was established for escalating doses of EA-230 (30,
90, and 180 mg/kg). In the second phase (n = 36), the same doses
were used to assess the effects of EA-230 on systemic inflammation
during experimental human endotoxemia. At t = 0 hours, 2 ng/kg E.
Coli endotoxin was administered i.v. followed by a 2-hour continuous
i.v. infusion of EA-230 or placebo. Levels of circulating cytokines and
adhesion molecules as well as body temperature and flu-like symp-
toms were assessed. Furthermore, effects on renal function were in-
vestigated using plasma clearance of iohexol.
Results EA-230 was well tolerated and showed an excellent safety
profile. Treatment with the highest dose of EA-230, but not with
lower doses, resulted in a significant attenuation of the endotoxin-
induced increase in plasma levels of IL-6, IL-8, IL-1RA, MCP-1, MIP-1α,
and MIP-1β (IL-6, IL-8, and MCP-1 shown in Fig. 50a, b, and c), and
the adhesion molecule VCAM-1 (Fig. 50d). Furthermore, the highest
dose of EA-230 reduced fever and flu-like symptoms (Fig. 51). Endo-
toxemia resulted in a marked increase in GFR, but no differences be-
tween groups were observed.
Conclusion Administration of EA-230 is safe and results in attenu-
ation of the systemic inflammatory response in humans. These
promising results pave the way for a phase IIb clinical trial to as-
sess the anti-inflammatory and tissue-protective effects of EA-230
in patients.References
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Introduction Mortality from sepsis and septic shock remains high.
Results of trials on intravenous immunoglobulins (IVIG) as adjunctive
therapy for sepsis have showed controversies.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 70 of 607Objectives The aim of this study was to identify factors for pre-
dicting prognosis in patients with severe sepsis (SS) or septic
shock (SSh) according to quartiles of immunoglobulin G (IgG)
concentrations
Methods It is a cohort study of 133 critically ill adults admitted in a
polivalent Intensive Care Unit of a University Hospital. Demographic
data, clinical parameters and IgG levels were determinated within
24 hours from SS or SSh onset, defined according to Surviving Sepsis
Campaign (SSC) criteria.
The patients were divided into four groups (quartiles) based on
the 25th, 50th and 75th percentiles of their initial level of IgG.
We tested for differences in baseline characteristics by IgG inter-
val using a Kruskal-Wallis test for continuous data or a Chi
Square test for categorical data and reported the median and
interquartile ranges. A logistic regression model was adjusted for
potential confounders as age, APACHE II score, SOFA score, num-
ber of organ failure (NOF) and presence of shock on admission.
Statistical analysis was performed using SPSS 15.0 for Windows
(SPSS Inc. Chicago, IL, USA)
Results We analyzed 133 consecutive episodes of SS (16.5 %) or ShS
(83.5 %) admitted in the ICU. The median age of the study sample
was 62 (inter-quartile range: 48.5-70.5) years old; male: 62.4 %. The
main sources of infection were: respiratory tract 36.8 % and intra-
abdomen 28.6 % and 69.9 % had medical pathology. 28-day mortal-
ity was 21.8 %.
Quartiles of serum IgG concentration were: quartile 1 (Q1:
607 mg/dL or less), quartile 2 (Q2: 607-792 mg/dL), quartile 3
(Q3: 792.1-976 mg/dL) and quartile 4 (Q4: 976.1 mg/dL or
greater). The median IgG concentrations of each quartile were
525 mg/dL in Q1, 695 mg/dL in Q2, 881 mg/dL in Q3 and
1340 mg/dL in Q4, (p < 0.001). The differences between these
quartiles shown no significant difference in APACHE II, SOFA
score, number of organ failure (NOF) neither 28 day-mortality.
Surprisingly the patients in Q4 had the higher 28-day mortality
(30.3 %) compared with the other quartiles (OR 0.998, CI 0.996 to
1, P = 0.072), following by patients in Q1 (21.1 %).
Conclusions Our studied did not show prognostic value with low
levels of serum IgG within 24 hours from SS or SSh onset. High levels
of IgG within 24 hours from SS or SSh may be a risk factor for in-
crease 28 day-mortality in septic patients; should be further investi-
gated in this field.
Reference(s) Alejandria MM, Lansang MAD, Dans LF, Mantaring
III JB. Intravenous immunoglobulin for treating sepsis, severe
sepsis and septic shock (Review). The Cochrane Library 2013,
Issue 9: 1-107Table 50 (abstract A133). Characteristics Sever Sepsis/Septic Shock
patients
IGG <607
N=33
IGG= 607-792
N=33
IGG=792.1-976
N=34
IGG >976
N=33
p
Age (years) 61 [48-72.5] 60 [42-70] 65.5 [52.5-72.5] 65 [51-72] ns
APACHE II 25 [19-30] 25 [20-28] 24 [21-30.25] 27 [21-31] ns
Sepsis Related
Organ Failure
Assessment
(SOFA)
9 [7-11] 9 [8-11.5] 9 [7.75-11] 10 [7-12] ns
Number
organs
failure (NOF)
3 [3-5] 4 [3-4.5] 4 [3-4.25] 4 [2.5-4.5] ns
IgG (mg/dL) 525 [457.5-571] 695 [655-731,5] 881 [833.5-926.5] 1340 [1125-1620] <0.001
IgA (mg/dL) 145 [110-195] 190 [148-236] 222.5 [149.75-294.5] 385 [289.5-550] <0.001
IgM (mg/dL) 51.1 [34-126.5] 47.5 [35-78.7] 97.3 [66.3-128] 111 [65.7-148.5] 0.006
28-day
mortality (%)
21.2 18.2 17.6 30.3 ns
Septic Shock (%) 90.9 78.8 85.3 78.8 nsA134
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Introduction T lymphocytes play fundamental roles in the immuno-
logical response to sepsis. γδ T cells are a new subset of T lympho-
cytes that represent a small population of immune cells, exhibit
features of both innate and adaptive immunity, and play an indis-
pensable role in host defense, immune surveillance and homeostasis.
Recent studies found massive loss of gamma delta T (γδT) cells in pa-
tients with sepsis. However, little did we know about their function
changes and role in such a pathological status.
Objectives This study was designed to evaluate the phenotype and
function of peripheral γδ T cells in patients with severe sepsis and
septic shock, and its association with prognosis.
Methods This prospective observational study was conducted in three
ICUs of a university hospital. A total of 107 patients, consecutively admit-
ted and diagnosed with severe sepsis or septic shock (excluding previous
immunosuppression) and 30 healthy controls, were enrolled. Surface
markers (CD69, NKG2D, PD-1) and intracellular cytokines (IFN-γ, IL-17, IL-
10, TGF-β) of γδT cells isolated from peripheral blood were analyzed by
flow cytometry. Results were also correlated with clinical outcome.
Results Septic patients displayed decreased percentage of γδT cells and
NKG2D expression, and increased CD69, pro- (IFN-γ, IL-17) and anti-
inflammatory (IL-10, TGF-β) intracellular cytokines as compared to healthy
controls. After stimulation of γδ T cells in vitro by pamidronate (PAM) or
phorbol-myristate acetate (PMA) plus ionomycin, both CD69 expression
and IFN-γ secretion significantly reduced in septic patients as compared to
healthy controls, 19.041 ± 11.74 % vs. 52.47 ± 19.84 % and 23.66 ± 17.37 %
vs. 70.47 ± 16.41 %, respectively, p < 0.001. Importantly, these decreased
expressions were more pronounced in nonsurvivors as compared to survi-
vors. Using multi-regression logistic method to adjust factors that impacted
patient outcome, IFN-γ secretion after stimulation and SOFA score were in-
dependent risk factors associated with patient death, OR: 0.937 (95 % CI:
0.893-0.982) and 1.248 (95 % CI: 1.056-1.474), respectively, p < 0.05.
Conclusions Our results showed pronounced changes in γδT cell
phenotype and function in septic patients. This finding provides
novel insights into the role of γδT cells in sepsis.
Reference(s)
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 71 of 607Introduction Hallmarks for sepsis severity include loss of vascular
and immunological homeostasis. NO is an important vasodilatator
and loss of NO may contribute to impaired microcirculation. More-
over, NO is involved in protein modification, regulation of transcrip-
tion factors and production of superoxide anions. L-Arginine (L-Arg)
is substrate of NO producing synthase (NOS) and its homolog, L-
homoarginine (h-Arg), is the competitive substrate. Asymmetric
dimethylarginine (ADMA) is an endogenous NOS inhibitor (see
reference).
Objectives Therefore we sought to investigate whether L-Arg, h-Arg
or ADMA are altered in septic patients. In addition we analyzed
mRNA expression levels of dimethlyarginin-dimethylamino-hydrolase
2 (DDAH2), the ADMA degrading enzyme in peripheral blood mono-
cytes (PBMC) of sepsis patients.
Methods Blood from 129 sepsis patients and 25 healthy controls was
drawn and analyzed. L-Arg, h-Arg and ADMA concentrations were
measured by mass spectrometry. In peripheral blood monocytes
DDAH2 mRNA expression was measured by quantitative PCR (qPCR).
All parameters were correlated with Sequential Organ Failure Assess-
ment Score (SOFA) score for sepsis severity.
Results We did not observe any difference of NOS substrate L-
arg between controls and patients. In contrast the concentration
of h-Arg in blood was significant decreased in patients (P <
0.01), whereas ADMA concentration was increased in patients
(P < 0.01). Both h-Arg and ADMA concentrations were associated
with diseases severity. Spearman-rank analysis revealed a posi-
tive association between SOFA score and blood levels of ADMA
with rho of 0.25 (P < 0.01). A negative association of h-Arg with
the SOFA score was determined, however this was not signifi-
cant. In ROC analysis ADMA emerged as the most powerful indi-
cator of organ dysfunction, followed by the SOFA score,
whereby both parameters yielded almost identical AUCs. Fur-
thermore, in PBMCs DDAH2 expression was decreased in pa-
tients and significant lower in patients with sepsis related organ
dysfunction (P < 0.05).
Conclusions In blood of septic patients we found increased concen-
trations of the endogenous NOS inhibitor ADMA together with de-
creased mRNA expression for DDAH2 in PBMCs. These
measurements may influence systemic and intracellular NO levels in
patients with sepsis and may contribute to the septic phenotype of
microcirculatory and immunological collapse during sepsis. De-
creased concentration of h-Arg the competitive substrate of NOS
may be a reaction to restore NO equilibrium during sepsis. Further
prospective studies are needed to confirm the results in a larger co-
hort of non-septic patients and controls.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A136Introduction Antimicrobial resistance threatens to undermine treat-
ment for severe infection; new therapeutic strategies are urgently
needed. Augmented passive immunotherapy with P4 peptide is a
novel therapeutic strategy that increases phagocytic activity in vitro
and rescues moribund septic mice.
Objectives Our aim was to determine ex vivo P4 activity in a tar-
get population of patients admitted to critical care with severe
infection.
Methods We prospectively recruited UK critical care unit patients
with severe sepsis and observed clinical course (≥3 months post
discharge). Blood samples were taken in early (≤48 hrs post-
diagnosis, n = 54), latent (seven days post-diagnosis, n = 39) and
convalescent (3-6 months post-diagnosis, n = 18) phases of dis-
ease. The primary outcome measure was killing of opsonised
S.pneumoniae by neutrophils with and without P4 peptide stimu-
lation. We also used a flow cytometric whole blood phagocytosis
assay to determine phagocyte association and oxidation of intra-
phagosomal reporter beads.
Results P4 peptide increased neutrophil killing of opsonised
pneumococci by 8.6 % (C.I. 6.35 - 10.76, p < 0.001) in all phases of
sepsis, independent of infection source and microbiological status.
This represented a 54.9 % increase in bacterial killing compared to
unstimulated neutrophils (15.6 %) in early phase samples. Similarly,
P4 peptide treatment significantly increased neutrophil and mono-
cyte intraphagosomal reporter bead association and oxidation, inde-
pendent of infection source.
Conclusions We have extended in vitro and mice models work
to demonstrate P4 peptide significantly increases phagocytosis
and bacterial killing in samples from a target patient population
with severe sepsis. This study supports the rationale for aug-
mented passive immunotherapy as a therapeutic strategy in se-
vere sepsis.
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Introduction It is well-known that bacterial sepsis induces an im-
munosuppressed state, impairing the host's ability to clear the
primary infection and increasing vulnerability for secondary bac-
terial or fungal infections[1]. However, whether bacterial sepsis
affects the subsequent response to influenza infection is
unknown, as is the safety of administration of live attenuated
influenza vaccines (LAIVs) in immunosuppressed patients. Experi-
mental human endotoxemia induces systemic inflammation that
mimics bacterial sepsis and subsequent development of im-
mune suppresion[2].
Objectives To investigate the effects of human endotoxemia on the
immune response elicited by a subsequent challenge with the LAIV
Fluenz (surrogate for influenza infection[3]).
Methods In a randomized, placebo-controlled study 30 healthy
male subjects received intravenous placebo (NaCl, n = 15) or
endotoxin (E. coli LPS 2 ng/kg, n = 15), followed by administration
of quadrivalent Fluenz on day 7 in all subjects. Nasal wash sam-
ples were obtained to measure viral shedding and inflammatory
mediators. Symptoms were recorded daily using an online symp-
tom diary.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 72 of 607Results LPS administration resulted in a typical increase in plasma
levels of cytokines, which was absent in the placebo group (Fig. 52).
Following Fluenz challenge, viral shedding for at least one of the four
influenza strains present in the vaccine was 12/15 (80 %) in the LPS-
Fluenz group compared with 13/15 (87 %) in the placebo-Fluenz
group. The increase in viral shedding of the influenza A and B strains
was similar between groups (Fig. 53, upper panels). Likewise, the
Fluenz-induced increase in levels of the chemokine IP-10 in nasal
wash, as well as local symptoms, were not different between the
LPS-Fluenz and placebo-Fluenz group (Fig. 53, lower panels).
Conclusions While human endotoxemia attenuates the inflammatory re-
sponse of a second challenge with endotoxin with approximately 70 %[2],
it does not influence the Fluenz-induced local immune response and viral
shedding. These data suggest that the immune response to a bacterial
compound does not alter the response to a subsequent viral infection.
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(2011-013287).Fig. 52 (abstract A137). Plasma levels of the cytokines TNF-α, IL-6
and IL-10 over time in subjects that received an intravenous
administration of endotoxin or placebo at T = 0. Data are represented
as mean with SEM
Fig. 53 (abstract A137). Viral shedding in nasal wash of the
influenza A and B strain (upper panels), levels of IP-10 in nasal wash
(lower left panel) and local symptoms (lower right panel) following
intranasal administration of Fluenz in subjects that were administered
LPS or placebo one week before. Data are presented as Geometric
means with 95 % CI. P-values are calculated on area under curves using
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Introduction Sepsis is a severe infection with a hyperinflamma-
tory response mediated by cytokines that can induce acute lung
injury and multi-organ dysfunction. It is the most common cause
of death in intensive care units and currently, there is no spe-
cific drug treatment for this disease. That is why new thera-
peutic alternatives are essential to be found1. Methotrexate
(MTX) is an immunosuppressant currently used in autoimmune
disease; it acts by decreasing lymphocyte proliferation and cyto-
kines production2.
Objectives The aim of this study is to evaluate the effect of MTX in
inflammation caused by sepsis, focusing on systemic and lung injury.
Our main hypothesis is that treatment with MTX reduces damage
and control the inflammatory response in both the lung and sys-
temic level.
Methods Sepsis was induced by a cecal ligation and puncture (CLP)
in Sprague-Dawley rats (300-325 g). 6 hours later we did a surgical
source control and administered antibiotics, fluids and analgesics. In
addition, we administered to one group MTX i.p. (2.5 mg/kg). 48 h
later the animals were sacrificed and samples of lung tissue, bron-
choalveolar lavage and blood were collected.
Groups:
– Sham
– Sham +MTX
– CLP
– CLP +MTX
Survival, Body weight and lung weight were mesured. Neutrophils,
macrophages, lymphocytes and protein concentration in bronchoal-
veolar lavage were quantified. Different T cells subsets in blood were
analysed. Molecular markers related with inflammation, infiltration
and damage were evaluated by qRT-PCR in lung tissue.
Results Results show a decrease in circulating lymphocytes, Treg
lymphocytes and lung weight in groups treated with MTX compared
to the septic group (Fig. 54a-c). The cellular content in alveolus in
the CLP MTX group shows a decrease in cell infiltration of polimorfo-
nuclear cells and lymphocytes compared to CLP group, while the
number of alveolar macrophages is not altered in the different
groups (Fig. 54d-f).
Expression of the inflammatory cells recruitment, matrix remodelling
and proinflmatory markers show an increase in septic rats, while with
MTX treatment exhibit a reduction. Finally, MTX cause an increase of
the expression of the anti-inflammatory cytokine IL4 (Fig. 55).
Conclusions MTX administration in an animal model of sepsis re-
duces systemic and lung injury causes by sepsis. This drug inhibits
cytokine cascade and recruitment of pro-inflammatory cells in the
lung.
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Fig. 54 (abstract A138). (A) Lung relative weight (B) Lymphocytes
per ml of blood (C) Percentrage of Treg Lymphocytes (characterized
by the expression of CD4, CD25, FoxP3 markers). (D)(E)(F) Total
number of PMNs, Lymphocytes and Macrophages present in
broncoalveolar lavage (BAL). All values are represented as mean
±SEM. *p<0.05 vs Sham and #p<0.05 vs CLP. **/## p<0.01, ***/###
p<0.001 (Sham and Tham MTX n=13, CLP and CLP MTX n=17)
Fig. 55 (abstract A138). Relative expression of molecular markers in
lung tissue homogenate corrected with GADPH as a control
gen;calculated with RT-qPCR. All values are represented as mean
±SEM. *p<0.05 vs Sham and #p<0.05 vs CLP. **/## p<0.01, ***/###
p<0.001 (Sham and Tham MTX n=13, CLP and CLP MTX n=17)
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Introduction Neutrophils are key effectors in the host´s immune re-
sponse to sepsis. Excessive stimulation or dysregulated functions of
neutrophils are considered responsible for the pathogenesis of sepsis.
Objectives We report that neutrophil autophagy primes neutrophils
for increased neutrophil extracellular trap (NET) formation, which is
responsible for host survival during sepsis.Method We studied patients with community-acquired pneumonia
who have been admitted to the intensive care unit. To investigate
this hypothesis, we isolated neutrophils from community-acquired
pneumonia patients on day 1 (PD1) and day 3 (PD3). Then we deter-
mined the ROS generation, NETs Formation, surface expression of
granule markers (CD63, CD66b, CD35.
Results Neutrophils isolated from septic patients expressed high
levels of the autophagy-specific protein LC3 and primed neutrophils
for NET formation in response to subsequent phorbol 12-myristate
13-acetate (PMA) stimulation. These neutrophils showed decreased
mean lobe counts and distinct changes in surface marker expression
(CD62Ldim/CD64brt). In contrast, neutrophils isolated from non-
surviving septic patients showed dysregulated autophagy and de-
creased responses to PMA stimulation. In a mouse model of sepsis,
autophagy augmentation improved survival via a NET-dependent
mechanism. Our study provides important insights into the role of
autophagy in neutrophils during sepsis.
Conclusion Neutrophil autophagy could be an attractive therapeutic
target for the treatment of sepsis.
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Introduction Septic shock with Acute kidney injury are common in
critically ill patients. The apelinergic system improves cardiac func-
tions, decreases vascular tones and exhibits diuretic properties. These
effects are held by two distinct endogenous peptides: Apelin-13
(APL-13) a dominant bioactive fragment of the apelin family mainly
expressed in the cardiovascular system, and ELABELA (ELA) a recently
discovered ligand of APJ-R described to regulate cardiovascular de-
velopment and mainly expressed in kidney tissues.
Objectives ELABELA vs. APL-13 during sepsis-induced cardio-renal
syndrome.
Methods Sepsis induced by cecal ligature and puncture (CLP) in
adult rats. Myocardial impact of ELA vs. APL-13 on healthy and
septic isolated-heart assessed by Langendorff apparatus ex vivo.
Peptides and fluid resuscitation intra-venous infusions through os-
motic and/or syringe pumps in healthy vs. CLP rats in vivo. Moni-
toring of myocardial functions by echocardiography, and in vivo
left ventricular (LV) hemodynamics through pressure-volume
probing 24 h after CLP induction. Water intake and urine output
recording, heart; kidney and blood collection for subsequent bio-
logical assays.
Results ELA as well as APL-13 stimulated left ventricular ino- and lusi-
tropy of healthy and septic hearts ex vivo (sepsis, dP/dtmax from
baseline 10pM; APL-13: 92 %; ELA: 83 %). Both APL-13 and ELA also
Fig. 56 (abstract A141).
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CLP: 0 %, CLP + APL13: 33 %,
p < 0.05 vs. CLP; CLP + ELA: 50 % p < 0.05 vs. CLP). CLP-induced myo-
cardial dysfunction in vivo was counteracted by APL-13 and ELA infu-
sion as shown by a higher cardiac index (CI: Sham 20.1 mL/min/
100 g; CLP 8.4 p < 0.01 vs Sham; CLP + APL-13 17.9 p < 0.05 vs. CLP;
CLP + ELA 20.5 p < 0.05 vs. CLP) and an improved left ventricular
pressure-volume relationship. Nonetheless, ELA-treated CLP rats were
the only ones
i) displaying a significant improvement of LV filling as shown
by the increased E-wave velocity (Sham: 101; CLP: 68; CLP +
APL-13: 82, CLP + ELA: 97 cm.s-1 p < 0.05 vs. CLP) and LV
end-diastolic volume (Sham: 378; CLP: 264; CLP + APL-13: 333,
CLP + ELA: 448 μL p < 0.05 vs. CLP),
ii) exhibiting a higher plasma volume (Sham: 40.2 ml.kg-1; CLP:
36.9; CLP + APL-13: 38.2; CLP + ELA: 41.4 p < 0.05 vs. CLP) and
iii) limiting CLP-induced drop of urine output with limitation of
free water clearance. Moreover, ELA improved creatinine
clearance and reduced KIM-1 & micro-albuminuria in CLP rats.
Conclusions Modulation of the apelinergic system by exogenous
APL-13 or ELA infusion improves survival and cardiovascular dysfunc-
tion after sepsis induction. The recently discovered ELA displays an
added-value by improving hemodynamics and limiting kidney dys-
function and injury. ELABELA is a potential new therapeutic drug to
support cardio-renal dysfunction during sepsis.
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Introduction The major sources of body heat production are muscu-
lar activity, oxidation of food, and uncoupled mitochondrial respir-
ation due to proton leak. The cause of fever in sepsis is unknown,
particularly in sedated, ventilated patients who neither perform
much voluntary skeletal muscle activity nor shiver, and are often not
fed in the acute early phase. Furthermore, the usual vasodilated state
implies increased heat loss, so this must be exceeded by heat gener-
ation to generate a pyrexia.
Objectives To determine the association between fever and
uncoupled mitochondrial respiration, by comparing the effects of ex-
ogenous uncoupling with dinitrophenol in sham and septic rats.
Methods Awake, male Wistar rats (approx. 300 g body weight), previ-
ously instrumented with tunnelled carotid and jugular lines, were
placed in metabolic cages to continuously monitor whole body oxy-
gen consumption (VO2). Core temperature was measured intermit-
tently with a rectal probe. Sepsis was induced by i.p. injection of
faecal slurry. Sham animals received i.p. saline. Intravenous fluid re-
suscitation (10 ml/kg/h crystalloid) was started at 2 h. At 6 and 24 h,
animals received the mitochondrial uncoupler, dinitrophenol (DNP)
(30 mg/kg), given over 1 h. Statistical differences comparing pre- and
post-DNP were assessed using a paired T-test. P values < 0.05 were
considered statistically significant.
Results Sham animals were euthermic at 6 and 24 h, and their VO2
was similar to baseline values. DNP produced significant rises in VO2
(20 % and 22 %, respectively) and temperature (>1 °C) at bothtimepoints (p < 0.05). By contrast, septic animals were febrile pre-
DNP at 6 h (p < 0.05) but not 24 h, and DNP only induced small, non-
significant rises in temperature. No change in VO2 was seen at either
timepoint.
Conclusions Whereas sham animals generated an appropriate rise in
temperature and VO2 in response to mitochondrial uncoupling with
DNP, septic rats could only generate a small rise in temperature and
a minimal VO2 response. This implies that mitochondrial uncoupling
was already increased in septic rats (thus explaining the pyrexia) and
could not be increased further by exogenous uncoupling. It is also
possible that upstream inhibition of the electron transport chain may
have prevented the response to DNP seen in septic animals. This
possibility is under further investigation.
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Introduction Critical illness acquired myopathy in rats is character-
ized by homogeneous muscle atrophy (1). Conversely, histological
abnormalities are heterogeneous among muscle types: oxidative
muscles show patchy alterations (myofascitis, necrosis), while glyco-
lytic types demonstrate normal patterns. Activation of the ubiquitin-
proteasome system (UPS) is responsible for 80-100 % of myofibrillar
protein breakdown in skeletal muscle. Whether UPS activation is
dependent on the oxidative and glycolytic muscle type during critical
illness is unknown.
Objectives To characterize UPS activation by skeletal muscle type in
a long-term peritonitis model
Methods Male Wistar rats were followed for up to 2 weeks after in-
traperitoneal injection of the yeast cell wall constituent, zymosan or
n-saline. Soleus (oxidative, slow twitch muscle), and gastrocnemius
(mixed glycolytic-oxidative, fast twitch muscle) were harvested from
both the zymosan and control group 2, 7 and 14 days after the in-
sult. Caspase-, trypsin-, and chemotrypsin-like activities of the 26S
proteasome were measured by enzymatic assay. Protein expression
of activated caspase-3, muscle-specific ubiquitin ligases (MuRF1 and
MAFbx), and polyubiquitinated proteins were assessed by Western
blots at all time points. Protein expression of caspase-3 specific frag-
ments of myofibrillar actin was assessed at day 7.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 75 of 607Results Weight loss was not statistically different for soleus versus
gastrocnemius in the zymosan group (-26 ± 11 % versus -16 ±
9 %, p = 0.17) at day 2. Catalytic activity of the 26S proteasome
was increased at day 2 in soleus, and days 2 and 7 in gastrocne-
mius. Soleus displayed upregulation of MuRF1 at days 2 and 14.
Gastrocnemius displayed both activation of MuRF1 and MAFbx at
day 2 and 7. Activated caspase-3 and polyubiquitinated proteins
were increased at days 2, 7 and 14 in soleus but not in gastro-
cnemius. Caspase-3 specific fragments of myofibrillar actin were
increased in soleus, but not in gastrocnemius. Results are summa-
rized in the Table.
Conclusions In a rodent model of long-term peritonitis, oxidative
and glycolytic muscles show some similarities (e.g. up-regulation of
ubiquitin ligases, early proteasome activation) but also marked differ-
ences in caspase activation, polyubiquitination and duration of prote-
asome activation.
Reference(s) Hill NE et al. Detailed characterization of a long-term
rodent model of critical illness and recovery. Crit Care
Med. 2015;43:e84-96.Table 51 (abstract A142). Caspase-3 and ubiquitin-proteasome system
Soleus Gastrocnemius
Day 2 7 14 2 7 14
Activated caspase-3 + + + <-> <-> <->
Actin fragments + <->
MuRF-1 + <-> + + + <->
MAFbx <-> <-> <-> + + <->
Polyubiquitinated proteins + + + <-> <-> <->
26S proteasome + <-> <-> + + <->
Fig. 57 (abstract A143). In Vivo Imaging (IVIS) of GFP, DF-MSCs
Fig. 58 (abstract A143). Flowcytometric analysis of Treg cells
Fig. 59 (abstract A142). Histopathologi analysis of ilear tissueA143
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Introduction Mesenchymal Stem Cells (MSCs) application is a candidate
for preventing organ dysfunctions in sepsis treatment algorithm (1, 2).
Objectives In our study, we aimed to investigate the effects of intra-
venous application of Dental Follicule Derived Mesenchymal Stem
Cells (DF-MSCs) on cytokine balance, T regulator levels and ileal tis-
sue histopathology.
Methods 38- Sprague Dawley male rats were seperated into five
groups. I.Group was control; II. Group was healty + DF-MSC adminis-
trated, III. Group was cecal ligation-perforation(CLP), IV. Group was
CLP + administration of DF-MSC at zero hour and V. Group was CLP
+ administration of DF-MSC at fourth hour. At the 24th hour CD4 +
CD25 + FoxP3 + (Treg) levels, lymphocyte proliferation and cytokine
levels were analyzed from the spleen of sacrificed rats. Histopatho-
logic evaluation of ileal tissue was done by using Chiu score.
Results Migration of Green Fluorescent Protein marked MSC(GFP, DF-
MSC) to damaged ileocecal epithelium was shown by in Vivo
Imaging system(iVIS) studies.
Lympocyte proliferation was greater and CD8 + T lymphocyte levels
were lower (18.1 ± 0.5 vs 14.3 ± 0.8) (P < 0.05) in group III, IV and V
compared to control one (34.8 ± 7.8 vs 69.1 ± 5.7). Lymphocyte prolif-
eration, cytokine and lymphocyte levels were not different between
group III and IV. Treg levels were higher (2.7 ± 0.4 vs 4.4 ± 0.2) and IL-10levels were lower (1410 ± 120 vs 806 ± 64) (p < 0.05) in group V com-
pared to group III. In addition, TNFalfa levels were tendency to decrease
in group V . Ileal damage in group V was lesser than the group III
according to Chiu score.
I.group (control): Normal ileal mucosae (Chiu 0)
II.group (CLP + PBS): Naked lamina propria due to denudation of sur-
face epithelium (Chiu 4)
III.group (CLP + 0.h MSC): Disintegration of surface epithelium (Chiu 3)
IV.group (CLP + 4.h MCS): Subepiethelial space formation in apex of
villi (Chiu 1)
Conclusions There is no known data in the literature about the hu-
man derived DF-MSC on treatment of sepsis in experimental models.
Our results suggest that intravenous application of DF-MSC results in
migration of stem cells to damaged ileoceceal tissue where they can
function and protect the integrity of ileal tissue. Our findings showed
that immunomodulation is ensured with the supression of proinfla-
matory(TNF alpha) and anti-inflammatory(IL-10) cytokines together
with the increase of Treg ratio and this might be a new therapeutic
approach to treat sepsis related organ dysfunctions.
Reference(s)
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Fig. 60 (abstract A144). General overview of the relationship
between the in vivo and ex vivo models of sepsis described in the
text. Rats are instrumented and following surgical recovery are
administered with an intraperitoneal injection of either faecal slurry
or normal saline. At 24 hours the animals are culled and blood
removed. The blood is processed into serum and used for further
experiments using slices of kidney tissue from a naïve rate. Serum
and kidney slices incubated together may be examined for dynamic
changes in mitochondrial function using fluorescent probes under a
two-photon laser microscope
Fig. 61 (abstract A144). a) Mitochondrial membrane potential.
Mean tetremethylrhodamine methyl ester RFI at 90 min (relative to
baseline) for kidney slices exposed to PSS, sham serum or septic
serum. b) Reactive oxygen species generation. Mean
dihydroethidium RFI at 90 min (relative to baseline) for kidney slices
exposed to PSS, sham serum or septic serum. c) Redox state. Mean
NADH RFI at 90 min (relative to baseline) for kidney slices exposed
to PSS, sham serum or septic serum. * = p < 0.05, n = 9, RFI = relative
fluorescence intensity, PSS = physiological saline solution
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Introduction Increasing evidence is being presented which sug-
gests that modulation of mitochondrial bioenergetics may play a
key role in the apparent paradox between the clinical and bio-
chemical presentation of acute kidney injury (AKI) observed in
sepsis, and the lack of cell death, maintenance of tissue oxygen-
ation, and eventual recovery.1 Furthermore, evidence from
in vitro studies have indicated that humoral mediators carried in
the circulation may play a role in the mitochondrial dysfunction
observed in sepsis that result in organ dysfunction unrelated to
haemodynamic changes.2
Objectives Determine if exposure to septic serum modulates
mitochondrial function in a live naïve kidney slice. The mito-
chondrial functions probed were: mitochondrial membrane po-
tential (MMP), redox state, and reactive oxygen species (ROS)
generation.
Methods Live naïve kidney slices (200 μm thick) were exposed
to serum from 24 hour sham operated or septic rats for 90 mi-
nutes and imaged with a confocal microscope using fluorescent
dyes to detect dynamic changes in mitochondrial function
(Fig. 60).
Tetramethylrhodamine methyl ester (TMRM) is an indicator of MMP
whose signal decreases with MMP depolarisation. Dihydroethidium
(HEt) is an indicator of ROS whose signal increases with increasing
ROS. NADH is constitutively fluorescent and can be used as a marker
of the redox state.
Results Septic serum caused a decrease in MMP, an increase in ROS,
but no change in NADH at 90 minutes exposure compared to base-
line (Fig. 61). Sham serum did not cause any change from baseline
and was comparable to slices exposed only to a physiological saline
solution.
Conclusions The decrease in MMP seen during exposure to sep-
tic serum could be indicative of either increased uncoupling or
decreased electron transport chain activity. In the first case
one would expect a parallel decrease in NADH signal while in
the second one would expect an increase in NADH. In this
study, NADH did not change in the septic exposed slices and
so it is not clear which of the two proposed scenarios is more
likely.
Mitochondria are an established source of cellular ROS and in this
ex-vivo model, ROS increased significantly following exposure to sep-
tic serum. ROS may be a both a mediator and a consequence of
mitochondrial dysfunction and the relationship between the two
should be explored further.
This study has suggested that humoral factors within septic serum
are capable of causing mitochondrial dysfunction in an ex-vivo kid-
ney slice model.
Reference(s)
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Introduction The incidence of ICU-acquired infection following
major trauma is greater than 60 % (1). A hyperacute increase in
IL-10 (2) as well as a reduction in monocyte HLA-DR (mHLA-DR)
expression (3) has been documented following injury and these
are associated with the development of late nosocomial
infection.
Objectives To evaluate the role of IL-10 mediated pathways in post-
traumatic immune suppression and to assess the reversibility of this
phenomenon.
Methods Serum was collected from consecutive patients suffering
severe blunt polytrauma at admission and again at 24 hours
(24HR). Age and sex matched healthy volunteers served as
controls.
Pooled peripheral blood mononuclear cells (PMBCs) from healthy
volunteers were incubated for 20 hrs with media containing
30 % serum from either trauma patients or healthy volunteers.
These were cultured in the presence or absence of granulocyte-
macrophage Colony-stimulating factor (GM-CSF, 200 ng/mL), Inter-
feron Gamma (IFN-γ, 250 International Units) or an IL-10 neutralis-
ing antibody (10 ng/mL). Monocyte HLA-DR (mHLA-DR)
membrane density (geometric mean florescent intensity (gMFI))
was characterised on a BD FACS ARIA IIIu flow cytometer. Data
are displayed as median and interquartile range (IQR) and ana-
lysed with non-parametric statistics.
Results Ten polytrauma patients with a median Injury Severity
Score (ISS) of 38 (IQR 29-50) were recruited. This cohort was
80 % male with a median age of 27 (IQR 23-50). There was a
decrease in antigen density of mHLA-DR on healthy donor
PBMCs when incubated with admission (P < 0.01) or 24HR (P <
0.05) polytrauma serum, compared to incubation with serum
from age and sex matched controls (Fig. 62a). Culturing in the
presence of IFN-γ (P < 0.01) or GM-CSF (P < 0.05) prevented this
decrease in antigen density (Fig. 62b). Pre-incubation with an
IL-10 neutralising antibody partially reversed the detrimental ef-
fects of the incubation with polytrauma trauma serum (P <
0.001; Fig. 62c).
Conclusions Serum obtained from polytrauma patients induces an
immunosuppressive response through an IL-10 dependent pathway,
which is reversible with IFN-γ or GM-CSF treatment.
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Introduction Prolonged use of intravenous (IV) drugs for intensive
care unit (ICU) sedation is associated with accumulation and diffi-
culty of control. After a new volatile anesthetic conserving device
(ACD) was introduced, the use of volatile anesthetic agents for
sedation in ICU has emerged. Though many trials have shown
the effectiveness of sedation using volatile agents in several as-
pects, these studies have been too small to identify significant
effects.
Objectives To access the overall efficacy for volatile sedation com-
pared with IV sedation in the ICU patients.
Fig. 64 (abstract A146). Forest plot of extubation time
Fig. 65 (abstract A146). Forest plot of ICU length of stay
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 78 of 607Methods We reviewed for all publications from PubMed,
Embase, and the Cochrane database on ICU sedation comparing
volatile anesthetics (sevoflurane or isoflurane) using ACD with IV
agents (propofol or midazolam ± remifentanil). And we per-
formed meta-analysis on eligible studies. Two reviewers inde-
pendently assessed studies for inclusion and extracted data. The
Cochrane Collaboration methodology was used. Standardized
mean differences (SMD) with 95 % confidence intervals (CIs)
were estimated.
Results Sixteen trials and 942 patients were included in our meta-
analysis. Extubation time from termination of sedation comparing
volatile with intravenous sedatives was significantly shorter in the
volatile sedation group than IV sedation group (SMD -1.062, 95 %
CIs -1.311 - -0.813; p < 0.001). In addition, the ICU length of stay
(LOS) was significantly shorter in the volatile sedation group than
IV sedation group (SMD -0.183, 95 % CIs -0.350 - -0.016, p =
0.032).
Conclusions We found evidence that ICU sedation with volatile ACD
provides the shorter extubation time from termination of sedation
and the ICU LOS
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Introduction The clinical practice guideline for the management of
agitation of the American College of Critical Care Medicine suggests
that either propofol or dexmedetomidine may be preferred over sed-
ation with benzodiazepine to improve clinical outcomes in critically
ill intubated patients.
(1) Recent study have revealed that dexmedetomidine
reduces incidence and shortens duration of postoperative
delirium.
(2) It remains unknown that whether the side effects of
bradycardia and hypotension of dexmedetomidine may
affect cardiac output or stroke volume in critically ill
patients.
Objectives The aim of this study is to compare the hemodynamic
effects between dexmedetomidine and propofol for postoperative
sedation in patients with abdominal surgery.
Table 53 (abstract A147). Hemodynamic Parameters and Patient
Outcomes
Propofol (n = 29) Dexmedetomidine
(n = 31)
P value
Heart rate_2h (bpm) 87(13) 77(11) 0.003
Heart rate_6h (bpm) 88(17) 75(12) 0.001
Mean arterial pressure_
2h (mm Hg)
94(11) 83(14) 0.001
Mean arterial pressure_
6h (mm Hg)
89(13) 76(10) <0.001
Blood sugar level_
6h (mg/dL)
201(60) 183(43) 0.228
Equivalent morphine
consumption_24h (mg)
35.1(22.5) 39.8(29.5) 0.488
Urine output_24h (mL) 1769(684) 1629(711) 0.440
Length of ICU stay (h) 47.8(28.0) 60.0(44.1) 0.209
Length of hospital stay (day) 26.6(12.6) 20.3(10.1) 0.037
Table 54 (abstract A147). Hemodynamic Parameters and Patient
Outcomes
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 79 of 607Methods This is a randomized controlled clinical trial (Clinical-
Trials.gov ID: NCT02393066). 60 patients undergoing abdominal
tumor surgery were enrolled in the study and randomly allo-
cated to Propofol group or Dexmedetomidine group. Cardiac
index and stroke volume index were measured by a continuous
non-invasive cardiac output monitoring using bioreactance-
based technique. Opioid requirement, urine output, length of
ICU stay and hospital stay were compared between the two
groups.
Results The baseline heart rate and mean arterial pressure were not
significantly different between the two groups.
During the treatment period, heart rate and mean arterial pressure
were significantly lower in the Dexmedetomidine group than in the
Propofol group.
No severe bradycardia no hypotension was noted in both groups.
The cardiac index and stroke volume index were not significantly dif-
ferent between the two groups.
The mean length of hospital stay was shorter in the Dexmedetomi-
dine group than in the Propofol group (20.3(10.1) vs 20.6(12.6) days,
p = 0.037).
Conclusions Our results support that the cardiac output and stoke
volume were not significantly different between sedation with dex-
medetomidine or propofol. We found that postoperative sedation
with dexmedetomidine shortens the length of hospital stay in pa-
tients with abdominal surgery.Propofol (n = 29) Dexmedetomidine
(n = 31)
P value
Heart rate_2h (bpm) 87(13) 77(11) 0.003
Heart rate_6h (bpm) 88(17) 75(12) 0.001
Mean arterial pressure_
2h (mm Hg)
94(11) 83(14) 0.001
Mean arterial pressure_
6h (mm Hg)
89(13) 76(10) <0.001
Blood sugar level_
6h (mg/dL)
201(60) 183(43) 0.228
Equivalent morphine
consumption_24h (mg)
35.1(22.5) 39.8(29.5) 0.488
Urine output_24h (mL) 1769(684) 1629(711) 0.440Reference(s)
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Taiwan University Hospital.Table 52 (abstract A147). Patient Characteristics
Propofol Dexmedetomidine P value
Patient number 29 31
Age (y/O) 70(10) 71(12) 0.64
Gender(male/female) 16 / 13 19 / 12 0.79
Height (cm) 159 (9) 161 (10) 0.55
Weight (kg) 59.8 (8.5) 61.1 (16.9) 0.70
Baseline heart rate (bpm) 75 (9) 76 (10) 0.74
Baseline NIBP MAP(mm Hg) 93 (8) 93 (11) 0.85
APACHE II score 13 (3) 13 (4) 0.46
Infusion dose 0.42 (0.08) mg/kg/h 0.17 (0.06) mcg/kg/h
Length of ICU stay (h) 47.8(28.0) 60.0(44.1) 0.209
Length of hospital
stay (day)
26.6(12.6) 20.3(10.1) 0.037
Fig. 66 (abstract A147). Cardiac index and Stroke Volume Index
Table 55 (abstract A148). Association delirium - hospital mortality
(1) Hospital
mortality
(2) Hospital mortality
Delirium during ICU admission1 1.95*** 8.61***
(1.62 - 2.34) (4.46 - 16.63)
APACHE II score 1.19***
(1.17 - 1.21)
Delirium during ICU * APACHE II
(interaction term)
0.91***
(0.89 - 0.94)
Number of patients (n) 4033 4017*
1 Any delirium diagnosis in before- and after-period (with or without screen-
ing) Coefficients are odds ratios (ORs) and their 95% confidence intervals (95%
CI). (1)=crude analysis, (2) =adjusted analyses with the following covariates
next to those shown in table: age, hospital (n=6), admission type
*** p<0.001, ** p<0.01, *numbers differ due to small numbers of patients with
missing covariable values (not imputed)
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Introduction Delirium is common in the critically ill and is an im-
portant independent predictor of mortality. To be able to accur-
ately manage delirium, screening for its presence with the
Confusion Assessment Method for the Intensive Care Unit (CAM-
ICU) or the Intensive Care Delirium Screening Checklist (ICDSC) is
essential.
Objective To assess the impact of delirium screening with a val-
idated screening tool and the tool used (CAM-ICU versus
ICDSC) on the prognostic value of delirium for hospital
mortality.
Methods A prospective multicenter before-after implementation
intervention study was conducted in six ICUs between March
2012 and April 2015 in the Netherlands. The intervention con-
sisted of a multifaceted implementation of the Pain, Agitation
and Delirium guidelines. For this sub-analysis, all consecutive
adult patients who were admitted to ICU, excluding those with
primary neurological diagnoses, were included during three 4-
month periods. We discerned a before-period (no routine daily
delirium screening with CAM-ICU or ICDSC; delirium was consid-
ered present when noted in medical or nursing charts or when
antipsychotics were given) and after-period (after multifaceted
implementation of daily delirium screening; three hospital using
CAM-ICU and three ICDSC). The primary outcome was the asso-
ciation of delirium, assessed with or without screening and with
ICDSC or CAM-ICU, with hospital mortality. Multivariable logistic
regression analysis was used with adjustment for covariables
age, APACHE II, admission type (medical, or elective/emergency
surgery) and hospital (only for before- vs. after-period analysis).
Interactions between covariables were tested. We further
assessed the primary outcome in the before- vs. after-period
(screening -/+), and in the after-period (screening+) when
assessed with CAM-ICU versus ICDSC, by entering these as co-
variates in the regression model.
Results 4033 patients were included (before- and after-period:
1385 and 2632 patients, 15 patients had missing data on covari-
ables). Delirium was independently associated with hospital
mortality in crude analysis (OR 1.95, p < 0.001, Table 55). There
was significant interaction between APACHE II and delirium (p <
0.001). After adjustment the OR for delirium was 8.61, but the
effect was much stronger in the patients with a higher APACHE
II score above the median value (≤15; OR 1.68, p = 0.07 versus
>15; OR 19.0, p < 0.001). Mortality risk of delirium in the after-
period compared with the before-period and with CAM-ICU ver-
sus ICDSC (after-period) did not differ (before versus after-
period, OR 0.82, p = 0.079 and ICDSC versus CAM-ICU, OR 1.03,
p = 0.831).Conclusions In this large multicentre prospective study, we con-
firmed the independent association of ICU delirium with hospital
mortality but found significant interaction with APACHE II. The
screening instrument used (CAM-ICU versus ICDSC) did not influence
the delirium-associated risk of in-hospital death.A149
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Introduction Levels of analgesia under sedation are traditionally eval-
uated by clinical signs such as an increase in heart rate (HR), blood
pressure, lacrimation and defensive movements. However, the pa-
tients' analgesic level under sedation is hard to determine in the in-
tensive care setting, as these clinical signs are not specific. Recently,
the assessment of the anti-/ nociception balance by different moni-
toring devices was described. The Analgesia Nociception Index (ANI)
(MetroDoloris, Lille, France) is derived from HR variability and pro-
vides an index between 0 (nociception) and 100 (analgesia). The Sur-
gical Pleth Index (SPI) (GE Healthcare, Helsinki, Finland) derived from
HR and pulse wave amplitude measured with photoplethysmography
displays the parasympathetic tone as index between 0 and 100.
Pupillary reflex dilatation (PRD) following a noxious event is mea-
sured with video recording (AlgiScan, IDMed, Marseille, France).
Objectives This prospective observational clinical study was designed
to evaluate the diagnostic accuracy of the analgesic indices in asses-
sing the level of analgesia under sedation compared to clinical signs.
Methods After obtaining ethics approval and informed consent, 37
surgical patients were anaesthetized pre-operative with propofol to a
bispectral index (BIS) 30-60. A laryngeal mask was inserted and remi-
fentanil was increased step-wise to a dose of 0.05, 0.10, 0.15 and
0.2 μg/kg/min. After ensuring a steady-state period, two different
standardized painful stimuli were applied. Tetanic stimulation
(80 mA, 30 sec., 50Hz), the most common used noxious event in clin-
ical studies, was compared to Bromm's pain model, a direct intracu-
taneous stimulation (80 mA, 30 sec., 2Hz) of Aδ- and C-fibres [1]. All
stimulations were accompanied by recordings of SPI, ANI, PRD, HR,
mean arterial pressure (MAP) and BIS. Sensitivity and specificity in
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 81 of 607detecting the painful stimulus were compared by calculating the
area under the curve (AUC) of the Receiver Operating Characteristic
curves.
Results Under propofol sedation, sensitivity and specificity of ANI
(AUC = 0.97 and 0.99), SPI (AUC = 0.86 and 0.90) and PRD (AUC = 1.00
and 0.96) for detecting both painful stimuli were high compared to
HR, MAP and BIS (AUC = 0.75 and 0.74, 0.74 and 0.76 and 0.53 and
0.58, resp., Fig. 67a + b). Likewise, with propofol sedation and remi-
fentanil 0.2 mcg/kg/min, sensitivity and specificity of ANI (AUC = 0.82
and 0.80.), SPI (AUC = 0.73 and 0.84) and PRD (AUC = 0.63 and 0.68)
for detecting both painful stimuli were higher compared to HR, MAP
and BIS (AUC = 0.52 and 0.51, 0.48 and 0.48 and 0.52 and 0.60, resp.,
Fig. 67c-f).
Conclusions All three analgesic indices are superior in detecting both
painful stimuli under sedation compared to clinical signs. BIS, as a
marker of sedation, is confirmed to be no marker of the analgesic
level.
Reference(s)
[1] Bromm et al. Neurophysiological evaluation of pain. Electroencephalogr
Clin Neurophysiol. 1998;107:227-53.
Grant acknowledgement
None.Fig. 67 (abstract A149).A150
Sevoflurane pharmacokinetics during a procedural sedation in
critically ill burn patients: a comparative study
S. Perbet1, C. Biboulet1, A. Lenoire2, D. Bourdeaux3, B. Pereira4, B. Plaud2,
J.-E. Bazin1, V. Sautou3, A. Mebazaa2, J.-M. Constantin1, M. Legrand2
1University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France;
2Saint-Louis Hospital, APHP, Burn ICU, Paris, France; 3University Hospital
Clermont-Ferrand, Pharmacy, Clermont-Ferrand, France; 4University
Hospital Clermont-Ferrand, Biostatistics, Clermont-Ferrand, France
Correspondence: S. Perbet – University Hospital Clermont-Ferrand, ICU,
Clermont-Ferrand, France
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A150Introduction The use of sevoflurane in ICU is possible with the Ana-
conda® system. Its properties could be interesting during a proced-
ural sedation for repetitive dressings of burn patients in ICU.
Objectives To evaluate the pharmacokinetics of sevoflurane adminis-
tration during a procedural sedation in a population of burn patients
compared to a standard population of critically ill patients
Methods Burn patients (body surface area burned (BSAB) with 3rd
degree between 20 and 50 %) requiring procedural sedation and
control patients were enrolled. Sevoflurane was administered with an
expired fraction target of 2 %. Plasma concentrations of sevoflurane,
the hexafluoroisopropanolol (HFIP) and free fluoride ions were re-
corded at different times. The Kinetic Pro (Wgroupe, France) was
used for pharmacokinetic analysis.
Results Twelve burn patients (BSAB 36 ± 11 %) and 12 controls
(mean age of 49 ± 17 years, respectively, vs 55 ± 17 years (p = 0.43)
and mean body mass index 26 ± 3 vs 25 ± 2 kg / m2, p = 0.21) were
included. The average plasma concentration of sevoflurane was 70.4
± 37.5 mg / l in burn patients and 57.2 ± 28.1 mg / l in controls at
the end of sedation (p = 0.58) with a slower decrease in burn (p =
0.02 after discontinuation of sedation). The volume of distribution
was higher (47 against 22 l l) and the half-life was longer (1.2 hours
against 0.7 h) in burn patients. The HFIP free rates were higher in
burn patients (2.6 mg / L vs 1.6 mg / mL 30 minutes after discontinu-
ation of sedation, p = 0.02) but remained below 6 mg / ml . The aver-
age plasma fluoride was not different at day 1 (21.6 ± 12.1 mmol / L
vs 38.1 ± 34.6 mmol / L, p = 0.16) and J2 (10.3 ± 7.1 mmol / L vs 15.6
± 18.8 mmol / L, p = 0.41). The values of urea and plasma creatinine
remained stable.
Conclusions The study of the pharmacokinetics of the administration
of sevoflurane with Anaconda® system in burns highlights an in-
creased volume of distribution and a slower elimination. The times of
wash-in and wash-out were very correct with a conserved
maneuverability.
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Introduction Sleep and wakefulness are strong interconnected
stages regulated by complex mechanism in the basal brain. Dis-
turbed sleep impairs function of nervous and immune systems and
metabolism. There has been much focus on sleep in ICU during the
recent years: disturbed sleep causes prolonged stay in ICU, increased
morbidity, including delirium, and mortality. Several studies reveal
pathological sleep patterns in critically ill patients. Critically ill pa-
tients in the busy environment of an ICU are exposed to a range of
different disturbances such as the high level of noise and light, pro-
cedures, mechanical ventilation, medication, and the critical illness
itself.Polysomnography (PSG) has never been used in studies on crit-
ically ill patients in an ICU to test whether environmental changes
improve sleep in this patient group.
Objectives We hypothesised that improvement of the intensive care
environment would lead to better sleep quality in critically ill mech-
anically ventilated patients.
Methods This study was conducted in a general 8-bed ICU, Vejle
Hospital, Denmark. The night-intervention ´Quiet routine' protocol
was planned as a bundle of procedures, directed towards improve-
ment of ICU environment between 10 pm and 6 am. Noise levels
during control and intervention nights were recorded to control for
the intervention. Adult patients with relevant contact on mechanical
ventilation were randomized after informed consent to the
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 82 of 607intervention either during the first or the second night of the study.
We monitored sleep by PSG. The standard, American Academy of
Sleep Medicine's (AASM's), sleep scoring criteria were insufficient for
the assessment of polysomnograms (PSGs). Accordingly, AASM's clas-
sification was extended by supplemental criteria for sleep scoring in
critically ill patients, suggested by Watson et al. The PSGs were
assessed by an expert in sleep medicine blinded to the intervention.
Results 19 patients were included in the study. Two patients were
excluded due to deterioration.Sound level analysis showed insignifi-
cant effect of the intervention on noise reduction (p = 0.3).The ana-
lysis of PSGs in accordance with Watson's classification, revealed,
only 42 % of the patients exhibited characteristics of normal sleep,
while 58 % of the patients had only pathologic patterns.
Conclusions Unpredictable factors related to critically ill patients' sta-
tus hindered implementing the environmental intervention and re-
sulted in insignificant noise reduction. We only found 42 % of the
patients having characteristics of normal sleep. The presence of nor-
mal sleep characteristics was not associated with the environmental
intervention.
Reference(s)
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Introduction Pressure ulcers increase the patients risk of serious in-
fection, and are associated with a higher mortality [1,2]. Critically ill
patients are often sedated, leading to sustained periods of immobil-
ity. Clinical experience suggests that non-sedated patients are easier
to mobilize and change position in bed more often. We therefore
hypothesize that non-sedation might prevent pressure ulcers.
Objective To assess whether non-sedation is associated with fewer
pressure ulcers.
Methods Retrospective data on patients included in the multicenter
NONSEDA trial, at the Kolding trial site (DK) per March 15, 2016 (145patients). Participants were randomised to either standard care of
sedation with a daily wake up or to non-sedation during mechanical
ventilation.
It is not possible to blind whether a patient is sedated or not. How-
ever, the ICU-nurses who performed the clinical assessments and
registrations were unaware that we were investigating the incidence
of pressure ulcers. All clinical data were extracted and interpreted by
the principal investigator before the patient's randomization status
was revealed.
If we encountered difficulties ascertaining whether an ulcer was ac-
quired in the ICU or already present at admission, we assumed that
the ulcer was ICU-acquired to avoid risk of underestimation.
Primary outcome: total number of pressure ulcers acquired in the
ICU, described by grade (I-IV) and localization.
Results 65 ICU-acquired or assumed ICU-acquired pressure ulcers
were identified. There were no significant differences between
groups regarding sex, age, BMI, APACHE II or SAPS II. There were
34 grade 1 pressure ulcers (sedated: 18, non-sedated: 16), 29
grade 2 ulcers (sedated: 17, non-sedated: 12) and 2 grade 3 ul-
cers (sedated: 1, non-sedated: 1), with no significant difference
between groups. Concerning localization, results were grouped
into three: sacrum, heels and caused by equipment (for example
at nostril from oxygen catheter or at wrist from arterial line). The
localization of the ulcers were significantly different (p = 0.04):
sacrum (sedated: 36 %, non-sedated: 21 %), heels (sedated: 33 %,
non-sedated: 17 %), from equipment (sedated: 31 %, non-
sedated: 62 %).
Conclusions There were no significant difference in the incidence
of pressure ulcers in the two groups. An interesting difference in
the localization of the pressure ulcers was found. The sedated pa-
tients mainly had ulcers in the classical localizations, namely
sacrum and heels, whereas the non-sedated mainly had ulcers re-
lated to equipment, in diverse localizations such as the face,
limbs and genitalia. Considering the long-term prognosis, ulcers
deriving from equipment are easier to relieve and must be ex-
pected to heel faster.
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Introduction Delirium is an acute confusional state that is common
in the intensive care unit (ICU). Many critically ill patients treated in
the ICU experience sleep disruption. Disrupted sleep in the ICU has
been proposed as a potential risk factor for delirium, but the evi-
dence is sparse.
Objectives This study was undertaken to identify the sleep status for
the development of delirium in non-sedated critically ill patients.
Methods This prospective study was conducted in medical ICU of a
tertiary referral hospital. Polysomnography recording was performed
over 24 hour to assess the quantity and quality of sleep. Delirium
was measured daily using the Confusion Assessment Method for the
ICU.
Results Total 20 patients were enrolled. Their median APAPCHE II
score was 19 (IQR : 16 - 27). Median total sleep time was 03:43
(hh:mm, IQR: 00:49 - 06:10). The majority of sleep was stage 1
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 83 of 607(median 03:02 [00:47 - 04:34]) with scant stage 2 (median 00:00
[00:00 - 00:46]), REM (median 00:00 [00:00 - 00:15]) and absent
stage 3. Delirium was developed in 4 patients (20 %). In multivar-
iable analysis, the duration of ICU stay more than 5 days was in-
dependently associated with delirium incidence (P = 0.042). We
also found that patients who stayed more than 5 days in ICU
showed significant reduction in night sleep time compared to
patients who stayed less than 5 days (00:42 ± 0:46 vs 2:04 ± 1:25,
P = 0.012), despite of similar total sleep time.
Conclusions The quantity and quality of sleep in critically ill patients
were poor. The long duration of ICU stay disrupted circadian rhythm
which might contribute to the development of delirium in critically ill
patients.
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Introduction Mechanically ventilated patients frequently receive an-
algesia and sedation to manage pain and agitation in the intensive
care unit (ICU). Current clinical practice guidelines advocate the
maintenance of light target levels of sedation along with the use of
structured sedation protocols and daily sedation interruption. A sed-
ation protocol was therefore developed and implemented in a med-
ical intensive care unit (MICU) at a tertiary hospital to standardize the
management of analgesia and sedation in mechanically ventilated
patients.
Objectives To evaluate the impact of a sedation protocol on patient
outcomes in mechanically ventilated patients.
Methods This observational before-after study was conducted in the
MICU at the National University Hospital (NUH), Singapore between
September 2014 and March 2015. The sedation protocol incorpo-
rated daily sedation interruption and routine objective assessments
of pain, agitation and delirium by nurses and advocated titration of
analgesia and sedation to maintain a target Richmond Agitation Sed-
ation Scale (RASS) range of -2 to 0.
Data were collected retrospectively from electronic patient records.
The primary outcome was the duration of mechanical ventilation,
and the main secondary outcomes included the number of
ventilator-free days at day 28, ICU length of stay, ICU mortality and
28-day mortality.
Results The study included 53 and 41 patients before and after
protocol implementation respectively. There was significant im-
provement in the percentage of ICU days with daily sedation
interruption in the post-implementation period (23.6 % vs 35.9 %,
p = 0.0087). There was a trend for decreased duration of mechan-
ical ventilation after implementation (4.45 ± 4.2 days vs 2.55 ±
2.7 days respectively; adjusted effect estimate 0.70, [95 % CI 0.47-
1.43], p = 0.067) and a trend for increased ventilator-free days at
day 28 post implementation (18.35 ± 11.1 days vs 24.01 ± 7.1 days,
adjusted effect estimate 1.64, [95 % CI 0.99-2.70], p = 0.053). The
mean ICU length of stay was similar in both groups (6.07 ±
6.3 days vs 4.84 ± 4.4 days, adjusted effect estimate 0.90, [95 %
CI 0.64-1.26], p = 0.527), and the ICU and 28-day mortality did not
demonstrate any significant differences between groups (13.2 %
vs 4.9 %, p = 0.290 and 9 % vs 7.3 %, p =0.219 respectively). The
rate of protocol adherence was low, with 68.3 % of patients (n =
28) in the protocol group who had deviations from the sedation
protocol.
Conclusions For mechanically ventilated patients, the use of a stan-
dardized sedation protocol may reduce the duration of mechanical
ventilation. Barriers to protocol use should be identified to improve
protocol adherence.Reference(s)
Barr, J., et al., Clinical practice guidelines for the management of pain, agitation,
and delirium in adult patients in the intensive care unit. Crit Care Med,
2013. 41(1): p. 263-306.
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Introduction Mechanically ventilated intensive care patients are trad-
itionally sedated to assure analgesia, anxiolysis and comfort. This
might have negative effects such as prolonged mechanical ventila-
tion (MV) and longer length of stay (LOS). Dexmedetomidine has
been shown to shorten time to extubation, but its role in the wean-
ing process is not fully elucidated.
Objectives To determine whether sedation regimes affect the wean-
ing process.
Methods This was a non-interventional, multicenter, retrospective
study. Lightly to moderately sedated intubated adult patients mech-
anically ventilated for ≥ 24 h were included. SAPS III scores were
measured at admission. After admission to the intensive care unit
(ICU) and until fit for weaning all patients were sedated with stand-
ard of care according to their respective clinics protocol. During
weaning period patients sedated with only dexmedetomidine (DEX)
were compared to those sedated with midazolam and/or propofol-
standard of care (SOC) or SOC + dexmedetomidine (SOCDEX) con-
cerning weaning time. Weaning time, was defined as time from “fit
for weaning” to extubation. Total time on MV and LOS in the ICU
were measured. Amount of sedatives and analgesics used as well as
anxiety and ICU delirium were recorded using NuDESC/CAM-ICU.
Measurements of 15D and PTSS were obtained for evaluation of
quality of life and incidence of Post-Traumatic Stress Disorder (PTSD)
at 2-4 months after ICU discharge.
Results A total of 152 patient records were reviewed and in-
cluded in the study: DEX (31), SOC (67) and SOCDEX (54). The
DEX group could be more rapidly weaned as compared to the
SOC (p = 0.040) group and SOCDEX (p < 0.001) group, despite lon-
ger time in MV prior to weaning 77.2/37.0/50.0 hours of DEX/
SOC/SOCDEX respectively. The ICU LOS was shortest for patients
in the SOC group 4.9 days (d) compared to SOCDEX: 6.9 d and
DEX: 7.0 d. The SAPS III scores were similar in all three groups
61.4/60.6/59.8 of DEX/SOC/SOCDEX patients respectively. Anxiety
during weaning and after extubation was present in 0/5/12 and
9/10/15 of DEX/SOC/SOCDEX patients respectively. Delirium was
present in 1/1/2 (50 assessed) and 0/1/3 (65 assessed) of DEX/
SOC/SOCDEX patients during weaning and at ICU discharge re-
spectively. Quality of life at follow-up as measured by 15D
showed better scores in the DEX group as compared to SOCDEX
(p = 0.040 ) but not better than SOC (p = 0.175 ). At this point
SOCDEX patients showed a tendency for more symptoms related
to severe pain, breathing troubles, nightmares and severe anxiety
as compared to DEX and SOC. Very few patients fulfilled the
PTSD criteria with no differences among groups.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 84 of 607Conclusions Dexmedetomidine, when used as single sedation, con-
tributes to a shorter weaning period. These patients tend to describe
better quality of life at 2-4 months after ICU discharge.
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Introduction Sleep disturbances are common in critically ill patients
treated in the intensive care unit (ICU) with the potential for serious
consequences and long-term effects on health outcomes and patient
morbidity.
Objectives Our aim was to describe sleep management and sedation
practices of adult ICUs in ten countries and to evaluate roles and re-
sponsibilities of the ICU staff in relation to key sleep and sedation
decisions.
Methods A multicenter, self-administered survey sent to nurse man-
agers of adult ICUs across 10 countries. The questionnaire comprised
four domains: sleep characteristics of the critically ill; sleep and sed-
ation practices; non-pharmacological and pharmacological interven-
tions used to improve sleep; and the autonomy and influence of
nurses on sleeping practices in the ICU.
Results Overall response rate was 66 % (range 32 % UK to 100 %
Cyprus), providing data from 522 ICUs. In all countries, the most
frequent patient characteristic perceived to identify sleep was
lying quietly with closed eyes (N = 409, 78 %) (range 92 %
Denmark to 36 % Italy). The most commonly used sedation scale
was the Richmond Agitation-Sedation Score (RASS) (N = 220,
42 %) (range 81 % UK to 0 % Denmark, Cyprus where most ICUs
used the Ramsay score). In most ICUs, selection of sleep medica-
tion (N = 265, 51 %) and assessment of effect (N = 309, 59 %) was
performed by physicians and nurses based on collaborative dis-
cussion. In a minority of ICUs (N = 161, 31 %), decisions and as-
sessments were made by physicians alone. The most commonly
used (in all countries) non-pharmacological intervention to pro-
mote sleep was reducing ICU staff noise (N = 473, 91 %) (range
100 % Denmark, Norway to 78 % Canada). Only 95 ICUs (18 %)
used earplugs on a frequent basis (range 0 % Greece, Cyprus,
Denmark to 57 % Sweden). Propofol was the drug used most
commonly for sedation (N = 359, 69 %) (range 96 % Sweden to
29 % Canada). Chloral hydrate was used by only 63 (12 %) ICUs
(range 0 % Greece, Cyprus, Denmark, Italy to 56 % Germany).
Sedation scales were used on a routine basis by 77 % of the 522
ICUs. Participants scored nursing autonomy for sleep and sed-
ation management as moderate; median score of 5 (scale of 0 to
10), range 7 (Canada, Greece, Sweden) to 4 (Norway, Poland).
Nursing influence on sleep and sedation decisions was perceived
considerable; median score 8, range 9 (Denmark) to 5 (Poland).
Conclusions We found considerable across country variation in sleep
promotion and sedation management practices though most have
adopted a sedation scale as recommended in professional society
guidelines. Most ICUs in all countries used a range of pharmaco-
logical and non-pharmacological interventions to promote sleep.Most units reported inter-professional decision-making with nurses
perceived to have substantial influence on sleep/sedation decisions.
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Introduction Opioid drug dependency is not uncommon worldwide
and withdrawal syndrome is a major clinical concern when these pa-
tients are admitted in intensive care unit (ICU) with low levels of
consciousness.
Objectives We hypothesized if a software could be designed to esti-
mate daily need of these patients to opioids and if a protocol could
be designed and implemented to concomitantly control pain, agita-
tion and delirium (PAD) and prevent withdrawal signs in this popula-
tion during ICU admission.
Methods A multidisciplinary team designed the software and
protocol. Methadone was used to prevent withdrawal syndrome
and pain was assessed hourly, by Behavioral Pain Scale and con-
trolled by morphine or fentanyl. Level of sedation was also
assessed hourly, by Richmond Agitation-Sedation Scale and con-
trolled by midazolam or propofol, according to the protocol. De-
lirium was checked by Confusion Assessment Method for ICU,
once in every working shift.
Results Thirty patients with history of opium dependency were re-
cruited during an 8-month period in 2 mixed medical-surgical ICU's.
The protocol was effective to completely prevent the withdrawal syn-
drome in 24 patients (80 %). The average need to methadone was
14.5 ± 22.2 mg in the patients.The pain, sedation and delirium were
evaluated and documented by the staff in 97, 98 % and 56 % of situ-
ations, respectively. Pain and sedation scores were within acceptable
limits in 93 and 98 % of occasions, respectively. Delirium occurred in
2 patients during the ICU stay.
Conclusions Implementation of a PAD protocol and using a software,
especially designed for the opium dependent patients is feasible.
Management of PAD could be effectively done with a multidisciplin-
ary approach, along with prevention of withdrawal syndrome.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 85 of 607Introduction The numeric rating scale (NRS) and skin conductance
responses per second (NSCR) are both used as methods to assess
pain in the perioperative setting (1). An experimental study was con-
ducted to investigate the relationship between NRS and NSCR, and
how these measures are related to anxiety and degree of pain
stimulation.
Methods Eighteen volunteers were exposed to conditions simulat-
ing ICU circumstances using pictorial emotional stimuli (neutral,
positive, negative), authentic ICU sound (noise, no noise) and
electrocutaneous stimulation (pain, no pain). The electrical stimu-
lation was individually titrated prior to the experiment to induce
moderate pain (40 mm > VAS < 60 mm) and NSCR was measured
throughout the experiment. All possible combinations of condi-
tions resulted in twelve 60 second sessions, each followed up by
NRS for pain, and ratings of arousal and valence as indicators of
experienced anxiety.
Results Both NRS and NSCR increased in the pain conditions (NRS: M
= 3.95, [SD = 1.78]; NSCR: 0.22 [0.09]), compared to no pain (NRS:0.00
[0.00]; NSCR: 0.09 [0.08]), t(18) = 9.45, p < .001 and t(18) = 8.72, p
< .001, respectively. There was no change over time in NRS nor NSCR.
Significant positive correlations were found between NSCR and the
magnitude of the electrical stimulation, r(18) = .48, p = .046, and also
between NRS and the anxiety index (mean of arousal and valence
ratings), r(18) = .60, p = .009. In the pain condition, 3 (emotion) x 2
(noise) ANOVAs of NSCR, NRS, and anxiety showed that both NRS
and anxiety were sensitive to the experimental manipulations, shown
by main effects of both emotion, F(2,34) = 7.54, p = .002 and F(2,34) =
16.89, p < .001 (for NRS and anxiety respectively), and main effects of
noise, F(1,17) = 8.67, p = .009 and F(1,17) = 9.78, p = .006 (for NRS and
anxiety respectively), with elevated ratings of both pain and anxiety
in negative conditions compared to ratings in both positive and neu-
tral conditions. NSCR was not influenced by emotion or noise in the
pain condition. However, Helmert's contrasts of emotion state only,
showed significantly larger NSCR in emotional conditions compared
to the neutral, F(1,17) = 5.21, p = .036.
Conclusions Both NRS and NSCR are reliable indicators of pain, and
the correspondence between NSCR and actual pain stimulation
moreover validates the use of NSCR as a measure of pain in patients.
However, NRS is also sensitive to the contextual setting and anxiety,
which NSCR is not. A discussion, whether to administer analgesic or
ataractic drugs during the perioperative stage when NRS is moderate
or higher, is warranted.
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Introduction According to the recent guideline (2013), non-
benzodiazepine drugs, like propofol, are preferred to benzodiaze-
pines in sedation of ICU patients undergoing mechanical ventilation
due to decreased duration of mechanical ventilation, shortened ICU
stay, lower risk of patients death and decreased costs of treatment.
Propofol is a relatively well known drug, nevertheless the influence
of various factors connected with patients, like demographics, healthstatus or co-administered drugs on the propofol pharmacokinetics
has not been fully understood.
Objectives The aim of our study was to examine the pharmacokinet-
ics of propofol in a heterogeneous group of patients sedated in an
ICU. The specific objective was to investigate the influence of differ-
ent variables monitored and patients' health status descriptors, like
SOFA or presence of sepsis, on the PK of propofol.
Methods The propofol concentration-time profiles were obtained
from 29 patients. All the subjects were evaluated according to APA-
CHE II score and SOFA score, whereas the level of sedation was ap-
plied according to modified Ramsay Sedation score to achieve a
sedation score of 3-4. Non-linear mixed-effects modelling in NON-
MEM (Version 7.3.0, Icon Development Solutions, Ellicott City, MD,
USA) was used to analyse the observed data. Blood samples for pro-
pofol assay were collected from the patients' arteries on every day of
the infusion, at the selected time points after its termination. The
propofol concentration in the plasma was measured within eight
weeks by HPLC method with a fluorescence detector. Non-
parametric bootstrap and visual predictive check were conducted to
evaluate the adequacy of the induced model to describe the
observations.
Results Propofol pharmacokinetics was best described with a three-
compartment disposition model. A typical value of propofol clear-
ance (1.46 L/min) approximated liver blood flow. The volume of
distribution at steady state was high 955.1 L, but consistent with
other studies on ICU patients. We were unable to identify any statisti-
cally significant covariate relationships between PK parameters and
opioid type, SOFA score at admission, APACHE II, predicted death
rate, reason for admission to the ICU (sepsis, trauma or surgery), gen-
der, body weight, age, infusion duration and C-reactive protein.
Conclusions The population PK model was successfully developed to
describe the time course of propofol concentration in ICU patients
undergoing prolonged sedation. Despite a very heterogeneous group
of patients, consistent PK profiles were observed.
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Introduction Fluid challenge (FC) is commonly used to increase car-
diac index and oxygen delivery. A Tidal volume (Vt) > 8 ml/kg, which
is required to guarantee the efficacy of dynamic index of fluid re-
sponsiveness in predicting fluid responsiveness, is nowadays not rec-
ommended in operating room (1).
The identification of early variation of hemodynamic variables may
act as a clinical target or a safety limit to stop infusion. This approach
has been successfully used to assess fluid responsiveness in critically
ill patients ventilated with low tidal volume (2).
We evaluated the early variations after a FC in operating room of car-
diac cycle efficacy (CCE) and dicrotic pressure (Pdic) to improve
Fig. 70 (abstract A160).
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responsiveness.
Methods 40 consecutive adult patients scheduled for elective ab-
dominal surgery and ventilated with Vt
<8 ml/kg. FC was performed according to anesthetist indication and
consisted of 500 ml of crystalloids infused over 10 minutes
(responders = increase in cardiac index ≥ 15 %).
Bivariate analysis was performed using Student t test, Wilcoxon rank
sum test, and Pearson's test as appropriate for continuous and cat-
egorical variables. Significance was set at p < 0.05. Within-group
changes from baseline were analyzed by ANOVA with Bonferroni
post hoc tests adjusting for multiple comparisons.
Results Overall, 42.5 % of patients were fluid responders. Baseline
AUCs for PPV, CCE and Pdic were 0.76, 0.63 and 0.60, respectively.
The bivariate analysis identified a model able to predict fluid respon-
siveness in 91 % of patients (AUC 0.92; Y = 24.9 + PPV*1.243 +
Pdic*0.911 + CCEnor*0.004). In responders, the reduction of PPV dur-
ing fluid challenge was statistically significant between baseline and
minute 3 (p < 0.01), baseline and minute 4, 5 and 10 (p < 0.001). The
increase of CCE during fluid challenge was statistically significant be-
tween baseline and minute 4 (p < 0.05). The increase of dicrotic pres-
sure during fluid challenge was statistically significant between
baseline minute 4 and 10 (p < 0.01), baseline and minute 5 (p <
0.001).
In non responders, PPV and dicrotic pressure did not change signifi-
cantly during the FC while CCE was significantly reduced from base-
line to minute 10 (p < 0.05) (Figs. 69, 70, 71).
Discussion In this pilot study the baseline values of CCE and Pdic sig-
nificantly increased reliability of PPV. During the FC nor the PPV, nei-
ther Pdic significantly changed in non responders, while the CCE was
reduced at the end of the FC. In responders, the reduction of PPV
and the increase of CCE and Pdic were significant and the first time
point of significance was minute 3 for PPV and Pdic and minute 4 for
CCE, potentially acting as an early safety-limit for the FC.
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Introduction A positive fluid balance is associated with worse
outcomes in the critically ill [1,2], and it has been suggested
that conservative fluid administration or deresuscitation (ac-
tive removal of fluid using diuretics or renal replacement
therapy (RRT)) may be beneficial following haemodynamic
stabilisation [3].
Objectives We performed a systematic review and meta-analysis to
evaluate the efficacy and safety of conservative or deresuscitative
fluid strategies in adults and children with acute respiratory distress
syndrome (ARDS), sepsis, or systemic inflammatory response syn-
drome (SIRS) following initial resuscitation [4].
Methods We searched Medline, Embase, and the Cochrane central
register of controlled trials without restrictions, and manually
searched conference proceedings for the last 5 years. Two re-
viewers independently assessed publications. We included rando-
mised controlled trials comparing two or more fluid regimens in
which fluid balance differed, and observational studies investigat-
ing the relationship between fluid volume administered or fluid
balance achieved and patient outcomes. We excluded studies
published before 1980, studies of neonatal, post-cardiac surgical,
or heart failure patients, and observational studies with fewer
than 50 participants.
Results In a meta-analysis of the 7 included randomised trials (n
= 1390), we found a non-significant reduction in mortality with a
conservative or deresuscitative fluid strategy (pooled odds ratio
0.86, 95 % confidence interval (CI) 0.68-1.09) compared to a lib-
eral strategy or usual care (Fig. 72). We found a non-significant
reduction in RRT use with a conservative or deresuscitative fluid
strategy (2 studies, pooled odds ratio 0.73, 95 % CI 0.51-1.05).
Four trials reported shorter length of ICU stay or increased num-
ber of ICU-free days, and 2 studies reported shorter duration of
mechanical ventilation or increased ventilator-free days with a
conservative or deresuscitative fluid strategy compared to a lib-
eral strategy or usual care. Marked clinical heterogeneity was
present.
Conclusions A conservative or deresuscitative approach to fluid man-
agement may improve patient outcomes, and does not appear to in-
crease the incidence of acute kidney injury or RRT use. Large
randomised trials comparing alternative fluid regimens are needed
to determine the optimal approach to fluid management in critically
ill patients.
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Introduction Volume expansion is the first-line treatment in the ma-
jority of cases of acute circulatory failure, but only 50 % of patients
in shock respond to fluid challenge (FC) in a conventional manner,
the use of dynamic measurements can increase the prediction of this
patients
Objectives The goal of this study was to determine the correlation of
the distensibility index of inferior vena cava (dIVC) and pulse pres-
sure variation (PPV) in patients with shock which received FC.
Methods This prospective, observational correlational study was con-
ducted at the Intensive Care Unit, Centro Médico Nacional del Bajío
UMAE 1, in León Guanajuato, between December 2014 to December
2015. Patients were admitted over 18 years, shock, mechanical venti-
lation and hypoperfusion (lactate, mean arterial pressure, urine out-
put, and ΔPCO2). PPV and dIVC was measured in the admission, after
the FC we analyzed hemodynamic variables. We excluded patients
with arrhythmias, tidal volume >8 ml/kg, unconventional modes of
mechanical ventilation. Statistical analysis was performed using SPSS
program version 19.
Results We included 66 patients, mean age of 47.19 years, female
gender 53 % male 47 %; the mean APACHE II and SOFA were 14 and
8 points respectively; more frequent admission diagnosis was sepsis
(31.8 %); the most frequent hypoperfusion criteria was lactate
>2 mmol/L (33.3 %); We found a positive correlation between dIVC
and PPV with r = 0.642(p = < 0.05). After FC there was an increase of
cardiac index 0.6196 ± 0.53 l/min/m2, a decrease of lactate 0.68 ±
0.49 mmol/L, an increase urine output of 0.26 ± 0.23 ml/kg/hour, and
decrease ΔPCO2 3.37 ± 1.7 mmHg with T 5.214(p = < 0.05), U 4.834(p
= 0.009), U 3.057(p = 0.07) and U -5.863(p = < 0.05) respectively.
Conclusions There is a positive correlation between dIVC and PPV, in
patients with shock which received FC in a conventional manner.
Reference(s)
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therapy. Marik et al. Annals of Intensive Care 2011, 1:1 2. Monnet X,
Teboul JL. Assessment of volume responsiveness during mechanical
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Introduction In contrast to static parameters, e.g. central venous
pressure (CVP), dynamic variables representing cardiorespiratory in-
teractions, e.g. stroke volume variation, allow excellent prediction of
fluid responsiveness (FR). A recently published study suggested that
positive end-expiratory pressure (PEEP) induced changes of CVP or
mean arterial pressure (MAP) might represent a promising tool to
evaluate FR in ventilated patients with sepsis.
Objectives We evaluated the ability of hemodynamic changes pro-
duced by an increase in PEEP to predict FR in ventilated adult
patients after cardiac surgery.
Methods 50 consecutive hemodynamically stable patients undergo-
ing cardiac surgery with use of cardiopulmonary bypass were en-
rolled in this study. Hemodynamic monitoring included pulmonary
artery catheter (PAC) and transesophageal echocardiography (TEE).
Hemodynamic variables were assessed at 4 different time points: 1.
Baseline (PEEP 6.0 ± 1.2 cm H2O), 2. PEEP challenge (PEEP + 10 cm
H2O for 5 minutes), 3. Baseline 2 (with reduction of PEEP to initial
value), 4. After a crystalloid fluid challenge of 6 ml/kgBW. Fluid re-
sponsiveness was defined as increase of stroke volume (SV) >15 %
after fluid challenge measured by PAC.
Results 58 % of patients (n = 29) were fluid responders. The PEEP in-
duced changes in CVP, MAP, pulse pressure (PP) and pulmonary ca-
pillary wedge pressure (PWP) were comparable between non-
responders (Δ CVP 2.5 ± 5.2 mmHg, ΔMAP 4.1 ± 10.3 mmHg, ΔPP:
11.4 ± 15.2 mmHg, Δ PCWP 1.9 ± 3.4 mmHg ) and responders (Δ CVP
3.3 ± 4.5 mmHg, Δ MAP 7.6 ± 8.6 mmHg, ΔPP: 7.5 ± 17.1, ΔPCWP 3.7
± 4.,1 mmHg) (p = n.s.). Accordingly, there was no correlation be-
tween PEEP-induced changes in CVP, MAP, PP and PCWP and
changes in SV after a fluid challenge and the area under the curve
(AUC) for predicting fluid responsiveness was low (CVP:0.584,MAP:0.653, PP: 0.557, PCWP:0.644). In contrast, increase in SV after
PEEP challenge was significantly higher in fluid-responders than non-
responders (8.6 ± 7.7 vs. 1.3 ± 12.1 ml, p = 0.023) predicting FR with
an AUC of 0.750 (p < 0.001).
Conclusion Our data suggest that PEEP-induced changes of CVP,
MAP, PP and PCWP in mechanically ventilated patients after cardiac
surgery cannot predict fluid responsiveness whereas an increase of
SV under PEEP elevation appears to be a good parameter to predict
fluid responsiveness.
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Introduction Fluid administration is one of the principal therapy
adopted in order to achieve early haemodynamic stabilization in sep-
tic patients. Despite international guidelines promote rapid volume
expansion in the early stages of shock [1], several studies have re-
cently shown that excessive fluid balance in septic patients is corre-
lated with increased mortality [1]
Objectives This study aims to investigate the impact of fluid balance
on mortality in septic patients along with any associated electrolytes
(strong ion difference-SID) and pH imbalance
Methods This pilot retrospective study enrolled approximately 10 %
of the adult patients admitted to the intensive care unit (ICU) of the
Gemelli University Hospital with a diagnosis of severe sepsis/septic
shock. We excluded pregnant women and those who survived less
than 48 hours. We collected all the data concerning daily fluid bal-
ance, arterial blood gases (ABG), the hemodynamics and daily SOFA,
until day 28 of ICU stay or discharge. Fluid balance at 24 hours was
divided into quartiles for subsequent analysis. Mortality was assessed
at 90 days.
Results 61 patients were included in this pilot analysis from the
1st January 2008 to 30 June 2015, age 66 ± 14 years , SAPS II 51
[IQR 38.75-64]. The 36 patients who died had higher blood lac-
tate (4.3 ± 3.7 vs. 2.1 ± 1.7 mmol/L, p = 0.007), developed more fre-
quently acute kidney injury (AKI) (44.4 % vs. 16 %, p = 0.027) and
presented a more positive fluid balance at 48, 72 and 96 hours
(2228 ± 539 vs. 784 ± 465 ml, p = 0.048; 2225 ± 824 vs. -181 ±
479 ml, p = 0.016; 2189 ± 922 vs. -475 ± 154.7 ml, p < 0.01, respect-
ively). A non significant trend toward increased mortality in the
3rd (dead 40 % vs. alive 60 %) and 4th quartile (dead 73.3 % vs
alive 26.7 %) of fluid balance at 24 hours, was also found. No sig-
nificant differences in terms of pH and electrolytic alterations
have emerged, though a trend towards higher SID in the 2nd
quartile was evident (28 ± 6 vs. 31 ± 5 vs. 28 ± 5 vs. 27 ± 6 vs. 29
± 6, respectively p = 0.13). Multivariate analysis, including SAPS II
on, Charlson's comorbidity score AKI and blood lactate on admis-
sion confirmed the association between positive fluid balance
and 90-day survival even after adjustment for several confound-
ing factors (OR 0.54 96 % CI 0.30-0.96, p = 0.035).
Conclusions In our population positive fluid balance was independ-
ently associated with increased mortality at 90 days, but without any
significant differences in terms of SID and pH.
Reference(s)
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Introduction The gold standard to evaluate fluid responsiveness and
guide fluid administration, in both critically ill and surgical patients, is
the fluid challenge technique (FC). Recent evidence has highlighted
an important variability in the current practice of this technique. Dif-
ferent techniques may lead to different results and different clinical
decisions.
Objectives The aim of this study is to describe the fluid challenge
techniques reported in fluid responsiveness studies and clinical trials
and to assess whether there is a difference in the proportion of “re-
sponders” depending on the type of fluid, volume and duration of
infusion.
Methods We conducted a systematic review using Medline and
EMBASE.
The inclusion criteria for the studies were: the use of the FC as
a test of cardiac preload; the inclusion of a description of the
FC ( reporting volume, type of fluid and duration of infusion); a
reported definition of fluid responsiveness; a reported propor-
tion of responders and non-responders;clinical setting(ICU or
operative theatre).Included studies were examined in full and
subjected to quantifiable analysis.The predictors were catego-
rized as follows: volume (<500 ml, 500 ml and >500 ml); fluid
type (colloids or crystalloids); infusion rate (<15 min, between
15 and 30 min, ≥30 min). The proportion of responders was
compared.
Results 76 studies were included in the analysis. 7 stud-
ies(12 %)used less than 500 mL, 46 studies(79,3 %)used
500 mL and 5 studies(8,6 %) used more than 500 mL. The pro-
portion of responders in the group of < 500 mL is .48(me-
dian:.49 IQR: .39-.57), in the group of 500 mL is .57(median
= .56, IQR = .44-.68) and in the group of > 500 mL is .57 (me-
dian = .50, IQR = .38-.79). There is no evidence to suggest that
the proportion of responders changes with the volume used
(H = 1,79 p = .40).
23 (31,5 %)studies reported the use of crystalloids, whilst 50
(68,5 %) studies used colloids. In 3 studies the type of fluid was
not clearly reported. There is no evidence to suggest that the
proportion of responders changes between colloids and crystal-
loids (M = .53, SD = .15 vs M = .56, SD = .15, F(1,71) = .85, p = .35).
The duration of infusion was <15 min in 19 studies(27,9 %), be-
tween 15 and 30 min in 23 studies(33,8 %) and ≥30 min in 26
studies (39,2 %).The proportion of responders changes across
the different infusion times (F(2,65) =4,16 p = .02).Planned con-
trast revealed that the proportion of responders in the group
of < 15 min(M = .60)and the group of 15 to 30 min(M = .57) were
similar, but both were significantly different from the proportion
of responders in the group with an infusion time ≥30 min (M
= .49, F(2,65) = 4.17, p = 0.02).
Conclusions Most studies assessing fluid responsiveness use
500 mL of colloids infused over 30 minutes or more. A long infu-
sion rate decrease the proportion of fluid responders.
Reference
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Intensive care medicine 41.9 (2015):1529-1537.
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Introduction In patients under mechanical ventilation, end-expiratory
and end-inspiratory occlusions induce changes in cardiac preload
that may be used to test preload dependence.
Objectives To test whether volume responsiveness can be predicted
by the effects of respiratory occlusions on the stroke volume (SV) es-
timated by transthoracic echocardiography or measured by
oesophageal Doppler.
Methods In 35 mechanically ventilated patients, we measured the
pulse contour analysis-derived cardiac index (PiCCO2). SV was esti-
mated by the measure of the velocity-time integral of the left ven-
tricular outflow tract by transthoracic echocardiography (n = 29) or
measured by oesophageal Doppler (n = 6) during the 5 last seconds
of 15-second end-inspiratory and end-expiratory occlusions, sepa-
rated by 1 minute, and after the subsequent infusion of 500-mL sa-
line. Patients where volume expansion induced an increase in cardiac
index ≥15 % were defined as “volume-responders”.
Results Volume expansion increased cardiac index by more than 15 %
(2.71 ± 0.78 to 3.27 ± 0.86 L/min/m2, p < 0.05) in 16 patients. During the
end-expiratory occlusion, SV increased more in responders than in non-
responders (increase by 10 ± 5 % vs. 2 ± 1 %, respectively, p < 0.0001).
Similarly, during the end-inspiratory occlusion, SV decreased more in re-
sponders than in non-responders (decrease by 11 ± 5 % vs. 5 ± 3 %, re-
spectively, p < 0.0001). Volume responsiveness was predicted by an
end-expiratory-induced increase in SV > 4 % (sensitivity = 94 % [95 %
confidence interval, CI: 70-100 %]; specificity = 100 % [95%CI: 82-
100 %]). If the absolute values of SV changes recorded during end-
expiratory plus end-inspiratory occlusions were added, volume respon-
siveness was predicted by an increase in SV >12 % (sensitivity = 94 %
[95%CI: 70-100 %]; specificity = 95 % [95%CI: 74-100 %]). This predictive
accuracy for volume responsiveness was not better than for the SV
changes recorded during the only end-expiratory occlusion (area under
the ROC curve: 0.98 (95%CI: 0.86-1.00) vs. 0.94 (95%CI: 0.81-0.99), re-
spectively, p = 0.46).
Conclusions The sum of the absolute values of changes in SV re-
corded during consecutive end-expiratory and end-inspiratory occlu-
sions reliably predict volume responsiveness. This prediction is not
better than for the changes in SV during the only end-expiratory oc-
clusion. Nevertheless, combining end-expiratory and end-inspiratory
occlusions induces larger SV changes and increases the value of the
threshold, what is more compatible with the precision of echocardi-
ography and oesophageal Doppler.
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Fig. 74 (abstract A168). AUROC for Co2 Gap and ScVo2 to predict
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immediate and adequate interventions. Adequate fluid resuscitation
is the cornerstone of maintaining and correcting oxygen delivery (1).
According to Starling's “3-compartment model”, 4-times more crystal-
loids should have the same volume effect as colloids. However, this
volume-replacement ratio remains a controversial issue as this may
be affected by the degradation of the endothelial glycocalyx layer
often found in the critically ill.
Objectives Our aim was to compare colloid and crystalloid based
fluid resuscitation during an experimental stroke volume index (SVI)
guided hemorrhage and resuscitation model in Vietnamese mini-
pigs.
Methods In this experiment 15 anesthetized and mechanically venti-
lated pigs were randomized to receive colloid (Voluven®,HES, n = 7)
or crystalloid (Ringerfundin®,RF, n = 8) infusion. Animals were bled till
baseline SVI (Tbsl) dropped by 50 % (T0), followed by resuscitation
until initial SVI was reached (T4) in four steps. Statistics were per-
formed by using SPSS® 23.0 and statistical analysis were tested by
General Linear Model, Independent samples T-test and Mann-
Whitney U test, as appropriate.
Results Hemodynamic changes during the experiment did not show
clinically relevant differences between the groups. At Tbsl the SVI
values were similar (HES: 34 ± 8 ml/m2, RF: 33 ± 4 ml/m2), after bleed-
ing, the SVI decreased by the planned 50 % to T0 (HES: 17 ± 4, RF:
15 ± 2 ml/m2) and returned to its initial value by T4 (HES: 34 ± 7, RF:
32 ± 3 ml/m2). Cardiac index(CI) also decreased (Tbsl, HES: 3.25 ± 0.23,
RF: 3.14 ± 0.19 l/min/m2; T0, HES: 1.58 ± 0.27, RF: 1.84 ± 0.40 l/min/m2)
and reached a higher value by T4 (HES: 3.99 ± 0.54, RF: 3.39 ± 0.36 l/
min/m2, p = 0,006). There was a significant increase in heart rate over
time (Tbsl, HES: 95 ± 19; RF: 97 ± 18 beats/min; T4, HES: 117 ± 17, RF:
102 ± 14 beats/min, p‹0.05). Similar amount of blood was shed in
both groups (HES: 553 ± 206 ml, RF: 506 ± 107 ml) but the animals re-
ceived significantly less resuscitation fluid (623 ± 208, 1754 ± 602 ml,
p = 0.002, respectively) and total fluid in the HES-group (1029 ± 252,
2010 ± 600 ml, p = 0.006, respectively). The volume replacement ratio
was significantly different between the HES median and RF-groups:
median = 0.87 [IQR: 0.78-1.83], 3.06 [2.93-4.57], p = 0,002,
respectively).
Conclusions Our results showed that in healthy pigs the volume-
replacement ratio follows the Starling's principle. This indicates that
in acute bleeding events, like in trauma and during surgery when
the glycocalix is most likely to be still intact, colloids may be benefi-
cial as hemodynamic stability can be achieved faster than with
crystalloids.
Reference(s)
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Introduction Passive leg raising (PLR) test has been a popular
method used for detection of fluid responsiveness (FR) in patients
with acute circulatory failure. The most important limitation with PLR
test is the need to a real-time cardiac output (CO) monitor to trace
the patient hemodynamic response to PLR. Increased end-tidal Co2with PLR has been reported as a surrogate of increased CO in predic-
tion of FR (1), however, the use of end-tidal Co2 is limited to mechan-
ically ventilated patients. Increased mixed venous oxygen saturation
was another surrogate of increased CO in prediction of FR with PLR
(2), however, this parameter needs insertion of pulmonary artery
catheter. Although central venous oxygen saturation (Scvo2) has
been a surrogate of mixed venous oxygen saturation, however Scvo2
was not investigated in prediction of FR. Venous-Arterial Co2 gap
(VA-Co2 gap) is defined as the difference between central venous
and arterial Co2 partial pressure. VA-Co2 gap increases in cases of tis-
sue hypoperfusion (3) and decreases after CO improvement.
Objectives We investigated the role of the change in VA-Co2 gap
and the change in Scvo2 after PLR in prediction of FR
Methods We included 42 patients with acute circulatory failure with
elevated serum lactate. PLR test was performed to detect FR. Fluid
responders were defined as patients with increased stroke volume
by 10 % (measured by ICON cardiometry device) after PLR test. In
addition to demographic and hemodynamic data, arterial and central
venous blood gases were obtained before and after PLR. The predict-
ive ability of the change in VA-Co2 gap and the change in Scvo2 with
PLR to predict FR was obtained using area under receiver operating
characteristic (AUROC) curve.
Results Fluid responders were 11 patients (26 %). AUROC for the
change in VA-Co2 gap in prediction of FR was 0.786(95 % CI: 0.625-
0.895). Sensitivity was 73 % and specificity was 65 % at cutoff value
of 0.5 mmHg increase in VA-Co2 gap. AUROC for the change in Scvo2
in prediction of FR was 0.608(95 % CI: 0.443-0.756). Sensitivity was
64 % and specificity was 63 % at cutoff value of 2 % decrease in
Scvo2.
Conclusions The change in VA-Co2 gap with PLR is superior to the
change in Scvo2 in prediction of FR in patients with acute circulatory
failure. VA-Co2 gap can be considered in settings where CO monitor-
ing is not feasible.
References
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Introduction Fluid management is one of the most difficult tasks
in critical care medicine. A recent study shows that in current
practice, fluid administration is not evidence based despite a lot
of tools available for physician (1). However many of them are in-
vasive or not always applicable depending on clinical context. Ca-
rotid doppler, a non invasive and easy-to-use method, has shown
excellent predictive values to monitor fluid responsiveness after
passive leg raising (2). Otherwise, mini fluid challenge is de-
scribed as a reliable alternative to classical fluid challenge to pre-
vent fluid overload.
Objectives To assess if variation of carotid doppler flow can predict
fluid responsiveness after a mini fluid challenge.
Methods This prospective observational study was performed
from September to December 2015. Patients requiring volume
expansion were eligible for enrollment. Patients less than
18 years old, with carotid stenosis or poor insonation were ex-
cluded. We recorded the variation of carotid doppler flow after
100 cc of cristalloids (ΔDc100) over 1 min and the variation of
velocity time integral (VTI) after an additional infusion of 400 cc
over 14 min assessed by transthoracic echocardiography. The
cardiac output (CO) was calculated as CO = VTI x Heart Rate x
Aortic Surface . A patient whose CO increased by 15 % follow-
ing 500 cc (ΔCO500) was consider as a fluid responder. If mech-
anical ventilation was required, a lung protective strategy was
applied.
Statistics: Spearman's correlation test was used. The receiver operat-
ing curve (ROC) and grey zone were defined for ΔDc100.
Results In total, 30 patients were included. Diagnosis admission
were severe sepsis/septic shock (22), brain injury (4) and post op-
erative (4). Sixty five percent of patients were ventilated and
45 % required vasopressor support. There was no difference be-
tween responders and non responders. Fourteen patients (45 %)
were volume responders. Dc100 increased by 32 % +/- 24 % in
the responders compared with 10 % +/- 8 % in the non re-
sponders (p < 0.001). ΔDc100 was strongly correlated with
ΔCO500 (r 0,78 ; p < 0,001). The best threshold of ΔDc100 was
14 % with a sensitivity and specificity of 93 % and 82 %
respectively.
The areas under the ROC curve of ΔDc100 was 0,91 +/- 0,01.
After bootstrapping (1000 resamples) a grey zone ranging
between 11 and 20 % was observed in up to 29 % of
patients.
Conclusion Our study shows that variation of carotid doppler after a
mini fluid challenge can predict fluid responsiveness in heteroge-
neous critical care population.
Reference(s)
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Background Sepsis-related acute circulatory dysfunction is a life
threatening condition. Peripheral perfusion as a marker of hypoperfu-
sion could be used to trigger initial fluid resuscitation (FR). The re-
sponse of peripheral perfusion to FR in patients with abnormal
perfusion could potentially identify high-risk patients.
Objective Our aim was to study the effects of the first protocolized
FR on capillary refill time (CRT) and other perfusion parameters, and
the relationship of the response with outcome.
Methods Prospective observational study including patients with
sepsis and acute circulatory dysfunction just admitted to the Emer-
gency department (ED) and in whom an initial FR was indicated
according to standard care.
Peripheral perfusion and laboratory assessments were performed be-
fore and after protocolized FR. Follow-up of patients until hospital
discharge. CRT responders were defined as patients who were
able to maintain normal CRT or to normalize abnormal CRT
values after FR.
Results One hundred consecutive patients were included. Of 30 pa-
tients with an abnormal CRT at admission, 23 (77 %) normalized CRT
after initial FR. CRT responders showed a significant decrease in heart
rate and lactate, presented less organ dysfunction and requirement
of mechanical ventilation. Hospital mortality was significantly lower
in CRT responders when compared to non-responders (9.6 % vs.
55.6 %; p < 0.001). In logistic regression analysis only CRT was signifi-
cantly related to hospital mortality. This association was maintained
after adjusting for baseline severity.
Conclusions Patients with sepsis-related acute circulatory dysfunction
that exhibit normal CRT after early FR have low mortality rates. In
contrast, failure to improve peripheral perfusion in response to initial
FR is a strong predictor of mortality. This finding could be very im-
portant for the ED or limited-resource settings since it could help to
decide on additional diagnostic and treatment options.
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Introduction Appropriate fluid support is crucial in critical care. To
guide fluid resuscitation filling pressures such as central venous pres-
sure CVP, volumetric parameters (e.g. global end-diastolic volume
index GEDVI) and dynamic parameters of fluid responsiveness (FR)
like stroke volume variation SVV are used. Prediction of FR is
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 92 of 607particular difficult in patients with spontaneous breathing, since the
use of SVV is usually restricted to patients under controlled ventila-
tion. Under these circumstances passive leg raising PLR and “mini
volume challenges” can be used for intermittent assessment of FR.
Recently “fluid responsiveness index” FRI has been introduced as ex-
perimental marker of FR. FRI is derived from a proprietary algorithm
based on the continuous analysis of arterial and central-venous pres-
sures by a special software provided for scientific use with the
PiCCO-2 device (Pulsion Medical Systems SE, Feldkirchen, Germany).
Objectives It was the aim of our study to compare the prediction of
FR (defined as an increase in stroke volume index ≥10 %) by FRI,
GEDVI, CVP and SVV after a volume challenge (VC) with 7 mL/kg crys-
talloid within ≤30 minutes in 27 patients under assisted mechanical
ventilation and equipped with TPTD-monitoring irrespective of the
study.
Methods All haemodynamic parameters were measured immediately
before and after the VC with a modified PiCCO-2-device providing
continuous FRI. The study was approved by the local Ethics Commit-
tee. Statistics: SPSS 23.
Results 20 male, 7 female patients; APACHE-II 25 ± 6. FRI (ROC-AUC
0.881; p = 0.005) and GEDVI (AUC 0.778; p = 0.041) significantly pre-
dicted an increase in stroke volume index ≥10 %, whereas neither
CVP (AUC 0.675; p = 0.199) nor SVV were predictive (AUC 0.702; p =
0.137). FRI was significantly higher in fluid-responders than in non-
responders (0.60 ± 0.20 vs 0.20 ± 024; p = 0.003), while GEDVI was sig-
nificantly lower in responders (657 ± 109 vs. 797 ± 170 mL/m2; p =
0.042). CVP and SVV were not different between responders and
non-responders. A cut-off of 0.42 for FRI-provided a sensitivity of
83 % and a specificity of 81 % regarding an increase in stroke vol-
ume index ≥10 %. GEDVI values below 800 mL/m2 predicted FR with
a sensitivity of 83 % and a specificity of 62 %. In binary regression
analysis only FRI (p = 0.015) was independently associated to the pri-
mary endpoint.
Similarly, FRI (AUC 0.827; p = 0.025) and GEDVI (AUC 0.809; p = 0.034)
predicted an increase in CI ≥10 % after VC, whereas CVP and SVV
were not predictive. Finally, only FRI predicted an increase in cardiac
power index CPI ≥10 % (AUC 0.812; p = 0.008).
Conclusions FRI significantly and independently predicts FR in pa-
tients with spontaneous assisted ventilation. Furthermore, GEDVI is
significantly associated to FR in these patients, while CVP and SVV
were not predictive. With regard to the limited number of patients
included, confirmatory validation studies are required.
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Introduction Fluid expansion (FE) is a major issue in the manage-
ment of critically ill patients. Accurate and practical tools to pre-
dict fluid responsiveness are still lacking. Venous return gradient
(dVR) is a major component of venous return and therefore of
right heart preload and cardiac output. dVR is the difference be-
tween mean systemic filling pressure (Pmsf) and central venous
pressure (CVP) or right atrial pressure (RAP). Pmsf can be esti-
mated by measuring the static filling pressure of the arm (Parm).
This later has shown to be a useful predictor of fluid responsive-
ness in cardiac surgery patients [1].
Objective The aim of the study was to evaluate if dVR is a reliable
variable to predict fluid responsiveness.
Methods Twenty-nine critically ill patients requiring FE were included
in this prospective observational study. In each patient, Parm was
measured three times before FE from the arterial pressure curve ob-
tained from a radial artery catheter 30 sec after occluding the arterial
flow by a cuff inflated up to 50 mmHg above systolic blood pressure.
The average value of triplicate measurements was calculated. Strokevolume was estimated either by Swan-Ganz catheter or transthoracic
echocardiography. A positive response to the fluid expansion was de-
fined as a SV increased by at least 10 %. The optimal cut offs were
chosen using a receiver operating characteristic curve (ROC) analysis
and identifying the maximal Youden's index. Sensitivity, specificity,
and their approximate 95 % confidence intervals were computed.
Results In the group of patients who responded to the fluid expan-
sion (n = 19), the mean CVP/RAP was 8 mmHg ±3, the mean Parm
was 21 mmHg ±7 and the mean dVR was 13 mmHg ±7. In non-
responders patients (n = 10), the mean CVP/RAP was 8 mmHg ±3,
the mean Parm was 26 mmHg ±6 and the mean dVR was 18 mmHg
±6. The best parameter in order to predict fluid responsiveness was
dVR, with an area under the curve of 0,77 (95 % confidence interval
0,57-0,97); a dVR cut-off of < 15 mmHg predicting a successful FE
with a sensitivity of 74 % and a specificity of 90 %. In comparison,
for Parm, the area under the curve was 0,73 (95 % confidence inter-
val 0,54-0,92); a Parm cut-off of < 24 mmHg predicting a successful
FE with a sensitivity of 74 % and a specificity of 70 %.
Conclusion Venous return gradient estimated by arm occlusion pres-
sure is at least as good as Parm for the prediction of fluid responsive-
ness in critically ill patients.
Reference(s)
[1] Geerts, B.F., et al., Arm occlusion pressure is a useful predictor of an
increase in cardiac output after fluid loading following cardiac surgery.
Eur J Anaesthesiol, 2011.
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Introduction The ability of echocardiography and analysis of mitral
profile to predict fluid responsiveness in a septic shock with left sys-
tolic heart failure is difficult to manage.
Objective The objective of the study was to evaluate the ability of
mitral profile and its evolution with a test of passive leg raising to
discriminate fluid responsiveness in septic shock with left systolic
heart failure.
Methods 60 patients in septic shock and left systolic failure, moni-
tored by transthoracic echocardiography (TTE) and continuous meas-
urement of cardiac output (CO) (catheter pulmonary artery catheter
(PAC) or transpulmonary thermodilution (TPTD)) were included. Mitral
profile (E, A, E/A, E´ lateral, E´ septal, E´ average, E/E´), CO, pulmonary
artery occlusion pressure (PAOP) and extravascular lung water
(EVLW)) were collected before volume expansion (VE), after passive
leg raising (PLR) and after VE with 500 ml of crystalloid solution. Vari-
ation of each hemodynamic values after VE (Δ(VE)) and after PLR
(Δ(PLR)) was performed. The left systolic heart failure was defined
with left ventricle ejection fraction (LVEF) ≤ 40 %. Patients were classi-
fied into two groups according to their response after VE measured
by thermodilution: responders (R) defined by an increase ≥ 15 % of
CO, and non-responders (NR).
Results Of the 60 patients monitored by TTE, 28 (46 %) with also
TPTD and 32 (54 %) with PAC. 25 (42 %) were R and 35 (58 %) NR.
All were under norepinephrine (1.1 gamma/kg/min +/- 0.4). There
was no significant difference between R and NR with E, A, E/A (1.67
+/- 0.85 vs 1.40 +/- 0.97), E´ average (7.5 +/- 2.5 vs 7.1 +/- 2.8 ), E/E´
average (12.5 +/- 6.1 vs 13.5 + / 7.5). It was not found correlation be-
tween the E/E ´and PAOP (p = 0.48) nor with the EVLW (p = 0.78).
Table 56 (abstract A174). Correlation between CFB, TFC, Ee' (Day 3)
Cumulative Fluid balance
r-value p-value
TFC 0.25 0.18
LUS -0.107 0.57
Ee´ -0.002 0.99
Table 57 (abstract A174). Correlation between TFC, Ee' & LUS (Day 1 &
Day 3)
Day 1 Day 3
r-value p-value r-value p-value
TFC & LUS 0.610 <0.01 0.358 0.052
TFC and Ee´ 0.287 0.124 0.393 0.032
LUS and Ee´ 0.242 0.198 0.426 0.019
Table 58 (abstract A174). Correlation between TFC, LUS, Ee' (Day 3)
Positive- balanced patients
(n=10)
Negative balanced patients
(n=20)
r-value p-value r-value p-value
TFC & LUS 0.186 0.6 0.566 0.009
TFC & Ee´ratio 0.628 0.052 0.283 0.227
LUS & Ee´ratio 0.256 0.47 0.516 0.02
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 93 of 60733 % (10/30) of NR had an E/E´ lat < 8 and 28 % (9/25) of R had an E/
E´ lat > 15. ΔCO(VE) (p < 0.05) and ΔE ´ average(VE) (p < 0.05) were
higher in the R while ΔE/E´ lat (VE) (p < 0.05) and ΔE/E ´ average (VE)
(p < 0.05) were higher in NR. ΔE´(VE) was correlated with the ΔCO(VE)
independently with LVEF (r = 0.39 p < 0.05). He was found a positive
correlation between ΔCO(EV) and ΔCO(PLR) (r = 0.58 p < 0.05). The
ΔCO(PLR) AUC with an optimal threshold at 12 % to predicted fluid
responsiveness was 0.890 p < 0.05) with 92 % sensitivity and 85 %
specificity. ΔE/E ´average(PLR) was correlated with ΔE/E´ average(VE)
(r = 0.29 p < 0.05).
Conclusions In decompensated patients with septic shock and left
systolic heart failure, analysis of mitral profile alone not be reliable in
predicting left filling pressure nor in predicting fluid responsiveness.
The PLR and the variation of the mitral profile (ΔE/E´ average and
ΔE´ lat) would secure VE in this population.
Cardiovascular monitoring 2
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Introduction Fluid balance is one of the most frequently manipu-
lated clinical care variables in the ICU. The risks associated with inva-
sive monitoring and its relationship to heightened mortality make
the evaluation and utilization of other modalities for tracking volume
status in critically ill patients vitally important.1
Objectives To correlate the three day cumulative fluid balance (CFB)
with extravascular lung water assessed by LUS & electrical cardiome-
try by the end of the 3rd day & to assess the diagnostic accuracy of
electrical cardiometry in assessment of thoracic fluid content (TFC) in
comparison to lung ultrasound.
Methods Three day CFB was measured in the 1st three days of ICU
stay. Lung ultrasound score was obtained by scanning 12-rib inter-
spaces. & the sum of B-lines yielded a score (0-36) 2. Electrical cardio-
metry was used to assess TFC (considered abnormal if exceeding a
predetermined value). E/e´ ratio was done to assess fluid load; for
further correlation with CFB, lung score, & thoracic fluid content
(TFC). All measurements were done on day 1 & day 3. Other variables
collected were age, gender, cardiac output, APACHE II score, medical
or surgical patient, mechanical ventilation, length of ICU stay & ICU
mortality.
Results 30 patients were enrolled. The median (IQR) cumulative 3-
day fluid balance was -600 (-2225, 437). Ten patients (33.3 %) had
positive fluid balance & 20 patients (67.7 %) had negative fluid bal-
ance. The median (IQR) of TFC at day 1 was 52 (35.5, 58) and at day
3 was 46 (37, 52.75).
There was no significant correlation between 3-day cumulative fluid
balance with either LUS, Ee´ ratio, or TFC (Table 56).
There was a significant correlation between TFC & LUS on day 1 &
day 3 (r = 0.610, p < 0.01), (r = 0.4, p = 0.05) respectively. There was no
relationship between Ee´ ratio & both TFC & LUS on day 1, it became
significant on day 3 (Table 57).
TFC correlated significantly with LUS in patients with negative fluid
balance but not in those with positive fluid balance. By the same
token, LUS was correlated significantly with Ee´ in patients with
negative balance only. However, no correlation was found between
TFC & Ee´ in patients with either negative or positive fluid balance
(Table 58).
Conclusions There is a good relationship between TFC & LUS for as-
sessment of extra-vascular lung water. However the relationship be-
tween CFB & extra-vascular lung water is poor. Future larger studies
are warranted to develop predictive equation for assessment of the
amount of extravascular lung water from TFC.Reference(s)
1. Martin GS, Ely EW, Carroll FE, Bernard GR. Findings on the Portable Chest
Radiograph Correlate With Fluid Balance in Critically Ill Patients. 2007;
2087-95.
2. Volpicelli G, Mussa A, Garofalo G, Cardinale L, Casoli G, Perotto F, et al.
Bedside lung ultrasound in the assessment of alveolar-interstitial syn-
drome. Am J Emerg Med. 2006 Oct;24(6):689-96.A175
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Introduction Obtaining the maximum oxygen consumption (VO2max)
in a direct way, requires equipment and trained personnel, which is
not available in most intensive care units. We modify the formula
from Uths Niels et al: VO2max = 15 x (maximum heart rate during ex-
ercise / heart rate at rest), replacing the maximum rate during exer-
cise to maximum heart rate for age and frequency at rest for heart
rate 24 hours from admission to intensive care unit. VO2max modi-
fied = 15 x maximum heart rate for age / heart rate at 24 hours.
Objective To evaluate the usefulness of maximum oxygen uptake
determination in patients with sepsis and septic shock as a prognos-
tic marker.
Methods Cohort, prospective, longitudinal, analytical study. Patients
over 18 years old, admitted to ICU of ABC Medical Center with diag-
nosis of sepsis. The maximum oxygen consumption at admission of
patients with sepsis was calculated, and compared according groups
based on VO2max modified. A bivariate analysis was performed,
using Chi2, ROC curve and relative risk.
Fig. 75 (abstract A176). % change values (mean ± standard
deviation) from 15 to 0 minutes prior to event (used in classification
of groups); 15 to 10 min; and 10 to 5 min
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 94 of 607Results 78 patients were analyzed, 42 men (54 %), aged 68+ 16 years
old, with 57 % primary site of infection from the lungs, followed by
urinary ( 19 % ), with MODS 6 ± 3 points, 39 % and 61 % with sepsis
and septic shock respectively, 21 patients died (27 %). ROC curve
was obtained for VO2max at 24 hours modified, with an AUC 0.70, CI
from 0.64 to 0.89; p = 0.03, with a cutoff of 25 ml/kg/min, sensitivity
and specificity of 70 % to 70 % respectively. Patients with VO2max
higher than 25 ml/kg/min have a RR of 0.4 (CI 0.2-0.7) for mortality at
30 days.
Conclusions Modified VO2max could be a useful tool to identify sep-
tic patients with adequate reanimation. This trial suggests that a
VO2max value calculated at 24 hours from ICU admission, greater
than 25 ml/kg/min is a reflection of good reanimation, however; fu-
ture researches are needed to corroborate the prognostic utility and
to set a goal of reanimation.
Bibliography:
1. Uth, N., Sorensen, H., et al. (2004). Estimation of VO2max from the
ratio between HRmax and HRrest - the Heart Rate Ratio Method. Eur
J Appl Physiol. 91, 111-115.
2. Harms, F., Bodmer, S., et al. (2015). Cutaneous mitochondrial respi-
rometry: non-invasive monitoring of mitochondrial function. J Clin
Monit Comput. 29, 509-519.
3. Koutlianos, N., Dimitros, E., et al. (2013). Indirect estimation of
VO2max in athletes by ACSM´s equation: valid or not?. Hippokratia.
17 (2), 136-140.
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Background Patients in critical care settings are often at risk of de-
veloping hypotension, which can lead to poor outcomes. To address
this need for early detection of hypotensive events, we have devel-
oped a hypotension probability indicator (HPI™). A hypotensive event
was defined by any time period where MAP < 65 mmHg. After train-
ing the HPI™ model on 3,000 ICU and surgical patients, we tested it
on an independent data set and demonstrated sensitivity and speci-
ficity > 80 % for detection of an event respectively at 5, 10, and 15 mi-
nutes prior to its start. To give further clinical value to the HPI™ as a
decision support index, there is a need for understanding the under-
lying reasons for a patient trending towards hypotension. In this
study, we evaluate the use of stroke volume (SV), cardiac output
(CO), stroke volume variation (SVV), dynamic elastance (Ea dyn), sys-
temic vascular resistances (SVR), and dp/dt to classify patients into 4
prescriptive hypotensive groups: 1) Decreased preload, 2) Decreased
afterload, 3) Decreased contractility, and 4) Uncertain.
Methods Data used in this study came from the MIMIC II MIT data-
base (n = 326). Arterial pressure waveforms from these patients were
processed through FloTrac (Edwards Lifesciences) for calculation of
mean arterial pressure (MAP), CO, SV, SVV, Ea dyn, dp/dt, and SVR. All
data was annotated for events as defined previously. Events were
then classified into 4 groups based on % change from 15 to 0 mi-
nutes prior to event: 1) Decreased preload (decrease in SV, CO, and
increase in SVV); 2) Decreased afterload (decrease in Ea and SVR); 3)
Decreased contractility (decrease in dP/dt); and 4) Uncertain (did not
meet any criteria). Any events that met more than 1 group cri-
teria were not used in the analysis to avoid any overlap. After
classification of events, % changes of SV, CO, SVV, Ea dyn, SVR,
and dP/dt from 15 to 10 minutes prior to event and 15 to 5
were evaluated to assess if an event's underlying cause could be
identified early on. A t-test was used to assess significant differ-
ence (p < 0.05) in mean % changes by group.Results / conclusions There were 25,419 total hypotensive events.
Group 1 contained 1,200 events, 2 had 2,066, 3 had 7,290, and 4 had
5,283. 9,560 events were not used in analysis due to data outliers or
meeting more than 1 group criteria. Overall, each group's 5 minute %
change profile was different at 5 and 10 minutes (Fig. 75). % change
in CO, SVV, and SV were significantly different when comparing
Group 1 to 2, 3, and 4 at 10 minutes. % change in Ea dyn and SVR
were significantly different when comparing Group 2 to 1, 3, and 4
at 10 minutes prior to event. % change in dP/dt were all significantly
different when comparing Group 3 to 1, 2, and 4 at 10 and 5 minutes
prior to event. In conclusion, the underlying cause of a hypotensive
event can potentially be classified into 1 of 4 prescriptive groups up
to 10 minutes prior to the start of an event.A177
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Introduction The dynamic arterial elastance (EaDyn) is used to pre-
dict the rising of mean arterial pressure (MAP) from fluid challenge in
fluid responders. However, according to ventricular-arterial coupling,
arterial resistance (Rart), not arterial elastance should be a predictor
for MAP responsiveness
Objectives Our study aimed to understand the relationship between
arterial resistance variables and arterial elastance variables, and ana-
lyzed their performances to predict MAP responders in septic shock
patients received fluid challenge (FC).
Methods The Rart was MAP divided by cardiac output. The EaStat
was pulse pressure (PP) divided by stroke volume (SV) and the EaDyn
was pulse pressure variation (PPV) divided by stroke volume variation
(SVV). We obtained these parameters at baseline and at the end of
fluid challenge (FC). We performed FC with 1,000 ml of normal saline
solution infused in 30 minutes. The relationship among variables was
determined by correlation coefficient. The performance was deter-
mined by the area under the ROC curve.
Results A total of 28 septic shock subjects were included consecu-
tively. The mean APACHE II, SOFA and lactate were 30.93 ± 7.34,
10.93 ± 4.10 and 6.71 ± 5.07 respectively. All subjects received fluid
therapy prior to enrollment. The mean MAP at baseline was 61.36 ±
8.27 mmHg. The mean Rart at baseline was 14.48 ± 6.21 mmHg.min/
L. The mean DBP, EaStat and EaDyn at baseline were 46.9 ±
38.31 mmHg, 1.03 ± 0.52 mmHg/L and 1.22 ± 0.78 respectively. The
mean Rart at baseline was similar to the mean Rart at the end of FC
Fig. 76 (abstract A179). Bland-Altman plot of the differences
between Echocardiography & TIPD SV against their averages
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 95 of 607(14.48 ± 6.21 mmHg.min/L vs. 13.96 ± 6.34 mmHg.min/L; p = 0.259). At
baseline, the diastolic blood pressure (DBP) and EaStat correlated to
the Rart (r = 0.428;p = 0.023 vs. r = 0.551;p = 0.002). At end of FC, the
DBP and EaStat correlated to the Rart (r = 0.55;p = 0.002 vs. r = 0.69;p <
0.0001). No correlation was observed between the EaDyn and Rart.
Only DBP at baseline showed significant difference between MAP re-
sponders and non-responders (41.00 ± 6.43 mmHg vs. 50.76 ±
7.13 mmHg; p = 0.001). The area under the ROC curve of DBP at base-
line to predict MAP responsiveness were 0.845 (95%CI 0.699-0.991). The
value of DBP at baseline < 42 mmHg predicted MAP responders with
63.6 % sensitivity and 94.1 % specificity. Fluid responders had the mean
DBP at baseline significantly lower than the non-responders (43.60 ±
7.35 mmHg vs. 50.77 ± 7.91 mmHg; p = 0.02), whereas the Rart, EaStat
and EaDyn were similar in both groups.
Conclusions The Rart remained stable throughout period of FC. Even
though we found the correlation between DBP, EaStat and Rart, but
the meaning of DBP, arterial elastance and arterial resistance are not
identical. In a group of septic shock with very low DBP, the DBP, not
arterial resistance and elastance variables, correlated to increasing of
MAP and CO after FC. Thus we may use it as a predictor of MAP
responders instead of the EaDyn.
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Introduction In high-risk surgical patients arterial catheterization is
needed to monitoring blood pressure and perform blood gas ana-
lysis, both in the operating room and ICU. The Seldinger technique is
considered the gold standard, but many catheters are recently pro-
posed to be as effective and safe.
Objectives Evaluate effectiveness and safety of BBraun Introcan
Safety 3 for arterial catheterization in adult high-risk surgical patients
scheduled to postoperative ICU stay, compared to Seldinger devices.
Methods BBraun Introcan Safety 3, Vygon Leader-Cath and Arrow Ar-
terial Catheterization Set were analysed for arterial cannulation in adult
high-risk surgical patients scheduled to postoperative ICU stay, for the
follow parameters: adequate size, easy recognition of the vascular
space, easy Introduction, traumaticity, cannula fixation, efficacy in blood
pressure monitoring and taking blood samples for the first 96 hours,
safety. The catheter was placed in the operating room before induction
of general anesthesia and maintained during ICU stay. A questionnaire
was administrated to the physician after arterial cannulation and each
parameter was score as poor (2 points), middling (4 points), sufficient (6
points), good (8 points) or excellent (10 points); the maximum score
was 70/70 points. Failures and complications were recorded. Appropri-
ate statistical analysis was performed to compare effectiveness and
safety of the three devices and p < 0.05 was considered to be signifi-
cant. The non-inferiority margin was defined as 5 %.
Results 100 arterial cannulations for each device were performed by
10 medical doctors with a mean experience in arterial catheterization
of 8 years. Seldinger kits obtained the best score (56/70 points), but
Introcan Safety 3 resulted to be non-inferior (54/70 points), with a
4 % of failure rate. No statistical differences were founded for ad-
equate size, easy recognition of the vascular space, easy Introduction,
traumaticity, cannula fixation, efficacy in blood pressure monitoring
and taking blood samples during the first 96 hours. Introcan Safety 3
emerged to be the safer device, due to its anti-reflux and anti-
puncture systems (p < 0.05). No severe complications were reported
during and after procedures.
Conclusions BBraun Introcan Safety 3 resulted a safe and effective
device to perform arterial catheterization in adult high-risk surgical
patients scheduled to postoperative ICU stay.References
1. Gershengorn HB, et al: Variation of arterial and central venous
catheter use in United States intensive care units. Anesthesiology
2014, 120:650-64.
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Introduction The transpulmonary thermodilution (TPTD) technique
of cardiac output monitoring which applies the Stewart Hamilton
principle is well established in terms of cardiac output accuracy.(1)
However, it is an invasive procedure that involves various risks.(2).
Researchers are continuously exploring potential less invasive alter-
natives. Transthoracic echocardiographic left ventricular outflow tract
(LVOT) measurements is a recognized tool for assessing the cardiac
output noninvasively. However, there is paucity of definitive data
concerning its accuracy.
Objectives We aimed to validate the noninvasive transthoracic echo-
cardiographic estimates of the stroke volume against the stroke vol-
ume measurements obtained invasively by the TPTD technique.
Methods Twenty successive critically ill patients in whom a PiCCO™
cardiac output monitor (9 female; 11 male; mean (SD) age 66 (12.9)
years) were the subject of this study. We compared 20 pairs of stroke
volume (SV) readings obtained simultaneously from the TPTD com-
ponent of the PiCCO™ cardiac output monitor and from transthoracic
echocardiography (LVOT diameter and velocity time integral).
Results The averaged values of SV measurements from Echocardiog-
raphy compared to the TPTD were 61 (20) vs. 67 (28) ml. The SV
measurements from Echocardiography and TPTD showed a signifi-
cant correlation (p = 0.015), the mean bias was 6.1 ml and the 95 %
limits of agreement (mean difference ± 1.96 SD) were 47.04 to
-34.79 ml.
Conclusions Monitoring of the cardiac output noninvasively using
transthoracic echocardiography is a reproducible feasible option.
References
1. Reuter DA, Huang C, Edrich T, Shernan SK, Eltzschig HK. Cardiac output
monitoring using indicator-dilution techniques: basics, limits, and per-
spectives. Anesthesia and analgesia. 2010;110(3):799-811.
2. Kornbau C, Lee KC, Hughes GD, Firstenberg MS. Central line
complications. International journal of critical illness and injury science.
2015;5(3):170-8.
Fig. 77 (abstract A179). Linear regression of pollsed data for
Echocardiography SV against TPTD SV
Fig. 78 (abstract A180).
Fig. 79 (abstract A180).
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Background Traumatic Hemorrhagic Shock (THS) is a leading cause
of preventable death following severe traumatic injury. The microcir-
culation is the ultimate structure concerned with tissue perfusion,
and is therefore of primary importance during THS. The microcircula-
tion was examined in a large animal model of THS, in order to inves-
tigate the effects of microcirculatory dysfunction during resuscitation.
Methods Baseline standard microcirculatory parameters were ob-
tained for 22 large white pigs using sublingual Incident Dark Field
(IDF) video-microscopy. All animals were subjected to a standardized
hind-limb injury followed by a controlled haemorrhage of ap-
proximately 35 % of blood volume (shock phase). This was
followed by 60 min of fluid resuscitation with either 0.9 % saline
or component blood products and a target SBP of 80 mmHg
(early resuscitation phase). All animals were then given blood
products to a target SBP of 110 mmHg for 120 min (mid resusci-
tation phase), and a further 100 min (late resuscitation phase).
IDF readings were obtained at the mid point of each of these
phases. Cardiac output was measured using a pulmonary artery
catheter. Animals were divided into above average (A) and below
average (B) perfused vessel density (PVD) groups based on the
lowest recorded PVD measurement taken during the shock and
early resuscitation phases.
Results During shock and early resuscitation Group A (n = 10) had a
mean PVD of 10.5 (SD ± 2.5) mm/mm2, and Group B (n = 12) 5.5 (SD
± 4.1) mm/mm2. During the later resuscitation phases, Group A main-
tained a significantly higher PVD than Group B. Group A initially had
a higher cardiac output but the difference between the groups nar-
rowed as resuscitation progressed. At the end of resuscitation group
A had significantly lower plasma lactate, higher lactate clearance,
lower standard base deficit, and smaller mixed venous - arterial CO2
gradient. There was no significant difference in blood pressure be-
tween the two groups at any stage. There was a wide spread of PVD
for a given blood pressure, especially during the shock and early
(hypotensive) resuscitation phases (Fig. 78). The choice of initial re-
suscitation fluid appeared not to produce differing effects in terms of
microcirculatory perfusion (Figs. 79 and 80).Note: This abstract has been previously published and is available at
[1]. It is included here as a complete record of the abstracts from the
conference.
References
1. Hutchings SD, Naumaan DN, Watts S, Wilson C, Burton C, Wendon J,
Kirkman E (2016) Microcirculatory perfusion shows wide inter-
individual variation and is important in determining shock reversal
during resuscitation in a porcine experimental model of complex
traumatic hemorrhagic shock. Intensive Care Medicine Experimental
4:17.
Conclusions Early changes in microvascular perfusion are key
determinants in subsequent tissue perfusion following fluid
resuscitation, and appear unrelated to pressure based parameters.
Choice of initial resuscitation fluid appears to have little impact
on microcirculatory perfusion during resuscitation from traumatic
haemorrhagic shock. Microcirculatory parameters may be
more reliable markers of physiological insult than global
haemodynamic parameters, and are potential targets for
goal-directed resuscitation.
Fig. 80 (abstract A180).
Table 59 (abstract A181).
Age, years, mean (SD) 62 (15)
Weight, kg, mean (SD) 81 (24)
Height, cm, mean (SD) 170 (11)
Gender 478 (170 F, 308 M)
Duration of ICU time, hours, mean (10th, 90th percentile) 108 (26, 219)
Fig. 81 (abstract A181).
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Introduction Patients in critical care settings are often at risk of de-
veloping hypotension, which can increase the risk of complications.
Early hypotension typically manifests as subtle changes of physio-
logical signals that can go unnoticed at first. We used machine learn-
ing (ML) techniques to develop a predictive algorithm for
hypotensive episodes, by exploiting arterial pressure waveform
characteristics.
Objectives To test the accuracy of the hypotension probability algo-
rithm on ICU patients.
Methods ML techniques based on multivariate logistic regres-
sion analysis were used to construct a mathematical model for
predicting hypotension expressed as a hypotension probability
indicator (HPI™). A hypotensive episode was defined as MAP <
65 mmHg for at least 1 minute. Multiple hemodynamic features
were extracted from the arterial pressure waveform and used
as predictor variables in the model. The model was trained
and cross-validated with data from a 3,000 patient clinical
database.
478 ICU patients from multiple clinical sites that were not used
in the calibration set were used as a test set for the final valid-
ation of HPI™. Patients included septic shock (189), post cardiac
surgery (208), cardiogenic shock (32), post liver transplantation
(19), and others (30, respiratory failure, post non cardiac surgery,
etc.). The patient demographics are listed in Table 58. Radial ar-
terial pressure waveforms were recorded with a FloTrac™ sensor
(Edwards Lifesciences, Irvine, CA). The waveforms were passed to
the algorithm to calculate the hypotension probability. The re-
ceiver operating characteristic (ROC) analysis was used to assess
algorithm performance.
Results 16,078 hypotensive events were registered, on average 34
events per patient with a duration of 11 (±89) minutes per event.
The algorithm was able to predict hypotension with a sensitivity and
specificity of 90 %, 87 % and 86 %, for 5, 10, and 15 minutes prior to
the event, respectively. The area under the curve (AUC) is 0.96, 0.94,
and 0.93, for 5, 10, and 15 minutes prior to the event, respectively
(Fig. 81).
Conclusions These data suggest that HPI™ is capable of predicting
hypotensive events with high sensitivity and specificity in ICU pa-
tients, up to 15 minutes prior to event.A182
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Introduction Machine learning is an emerging technique that en-
ables computers to learn from data without been explicitly pro-
grammed [1], in the medical field has been used for classification
and prediction analysis in both supervised and supervised fashion
[2]. Cardiomechanics determinants end-systolic and arterial elas-
tances and ventricular arterial coupling (VAC) in the critical care pa-
tient treated for hemodynamic derangement has been recently
investigated [3].
Objectives In this study we aimed to identify the possibility of a ma-
chine learning approach to classify hemodynamic data in the inten-
sive care unit.
Methods We used three non linear supervised machine learning ap-
proaches (multilayer perceptron neural network, decision tree and
gaussian support vector machine) to classify responders vs non re-
sponders from a dataset of 115 patients using Matlab R2015b soft-
ware. The classification models were run three times with respect to
independent variables: mean arterial pressure (MAP), arterial elas-
tance (Ea), VAC.
Results Best performance of the classification models was carried out
by decision trees, in all runs.
With accuracy of 86.7 % with respect to MAP increase, 96.8 % with
respect to VAC decrease and 80 % with respect to Ea increase.
Conclusions In this analysis we demonstrated the feasibility of a
machine learning approach to hemodynamic data analysis in the
intensive care patient. Decision tree was found to be the most
effective technique in analysing hemodynamic data. The models
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 98 of 607built allowed prediction for responders vs non responders with
respect to independent variable VAC decrement with an accuracy
above 96 %.
Reference(s)
1. Simon P: Too Big to Ignore: The Business Case for Big Data: Wiley; 2013.
2. Chen L, Dubrawski A, Wang D, Fiterau M, Guillame-Bert M, Bose E, Kaynar
AM, Wallace DJ, Guttendorf J, Clermont G et al: Using Supervised Ma-
chine Learning to Classify Real Alerts and Artifact in Online Multisignal
Vital Sign Monitoring Data. Critical care medicine 2016.
3. Guarracino F, Ferro B, Morelli A, Bertini P, Baldassarri R, Pinsky MR:
Ventriculoarterial decoupling in human septic shock. Critical care 2014,
18(2):R80.
A183
A novel approach for evaluation of preload independent left
ventricular contractile cardiac function by means of thermodilution
and pulse contour analysis in an experimental animal model
C. Trepte1, P. Richter2, S.A. Haas1, V. Eichhorn3, J.C. Kubitz1, D.A. Reuter1
1University Medical Center Hamburg-Eppendorf, Hamburg, Germany;
2Klinikum Harlaching, München, Germany; 3Dalhousie University, Halifax,
Canada
Correspondence: C. Trepte – University Medical Center Hamburg-
Eppendorf, Hamburg, Germany
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A183
Introduction Evaluating and monitoring contractile cardiac function
is a key element in hemodynamic management of critically ill pa-
tients. However, evaluation of intrinsic contractile cardiac function is
difficult in a clinical setting.
Objectives Aim of the study was to evaluate a novel approach of
assessing load-independent left-ventricular contractility based on
pulse contour analysis (rate of aortic maximum pressure rise (dP/
dtAo)) and estimation of end-diastolic volume (VED) by transcardio-
pulmonary thermodilution (TCPTD) in an experimental animal model
in pigs.
Methods 16 domestic pigs were studied. dP/dtAo as evaluated by
pulse contour analysis was related to VED by TCPTD. Direct meas-
urement of rate of maximum pressure rise in left ventricle (dP/
dtLV) related to VED (cdP/dtLV) served as experimental reference
of preload independent contractility. [1] Measurements were car-
ried out in normal cardiac function and experimentally impaired
cardiac function (continuous infusion of verapamil) during a wide
modification of cardiac preload (withdrawal of blood 20 ml kg -1
bodyweight).
Results While impairment of contractile cardiac function by continu-
ous infusion of verapamil resulted in significant changes of cdP/dtAo
and cdP/dtLV (p < 0.05), neither in normal as well as in impaired car-
diac function did cdP/dtAo and cdP/dtLV present significant changes
during preload modifications (p > 0.05).
Conclusions Estimation of cdP/dtAo by means of pulse contour
analysis and thermodilution provides reliable assessment of preload-
independent left ventricular contractility and its changes in an ex-
perimental animal model.
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Background Aortic corrected flow time (FTc) is easily measured by
Doppler techniques. Recent data using transoesophageal Doppler
suggest that it may predict fluid responsiveness in critical care. This
use of FTc has not previously been evaluated in septic shock, only
one preliminary study have incorporated transcutaneously measured
FTc. Denoting its importance in prediction of fluid responsiveness in
septic patient Furthermore, no comparison has been made between
transesopahgeal FTc and central venous pressure(CVP).
Objective The aim of our study was to compare the impact of using
FTc versus CVP as a guide for fluid resuscitation in septic shock on
stroke volume denoting cardiac responsiveness for fluid administration.
Methods This was a prospective study of 46 consecutive adult septic
shock patients (in sinus rhythm) 44 patients were mechanically venti-
lated, treated with intravenous fluid challenge (500 ml over 15 -
minutes) guided with CVP in control group and guided by FTC in
Doppler group assessment incorporating transesophageal aortic Dop-
pler (CardioQ®) measurements in a surgical tertiary intensive care
unit. Stroke volume (SV), mechanical ventilation days, length of stay
and mortality of both groups were recorded
Results Percent change in stroke volume strongly correlated with
baseline FTc (r = -0.6831, P = 0.000) but not central venous pressure
(r = -0.0864, P = 0.56). Baseline FTc < 332 ms discriminated responders
from non-responders [AUC = 0.989, 95 % confidence interval = 0.954
to 1.023; P = 0.01)]. Regarding survival, there were no statistically sig-
nificant differences between both CVP& FTC groups.
Conclusion Transesophageal aortic Doppler is a simple, non-invasive
tool of guiding fluid therapy in patients with severe sepsis and septic
shock. FTC change was a better predictor of fluid responsiveness
than CVP in septic shock.Reference(s)
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Introduction Vascular occlusion tests (VOT) have been utilized along-
side near infrared spectroscopy as a means of dynamically investigat-
ing microcirculatory function (1), with correlation demonstrated
between derangement in muscle tissue oxygenation and mortality
(2). Human skin has an exquisite microcirculatory blood supply which
can be visualized by means of infrared thermography. Thermography
may therefore be a potentially useful non-contact, real-time monitor
of microcirculatory function.
Objectives To investigate the thermal infrared profile of the palm
during a VOT in healthy volunteers.
Methods Participants were recruited from faculty and students at the
University of Leicester. Room temperature was confirmed between
19-21oC throughout data acquisition and participants were allowed a
period of acclimatization prior to measurement. Baseline blood pres-
sure was measured in the left forearm. The right forearm was then
placed on a bench with a blood pressure cuff placed around it. A
FLIR T650sc thermal imaging camera was placed at a distance of 1
meter from the participant. Thermal video recording was com-
menced and the blood pressure cuff was inflated to 50 mmHg above
the previously measured systolic pressure for a total of 3 minutes.
Recording continued for 5 minutes following deflation of the cuff.
Average palm temperatures were measured using a 100 x 100 pixel
sample. Data were extracted using FLIR Tools + software and ana-
lyzed using Microsoft Excel and R-Studio.
Results Data were collected from 34 healthy volunteers (19 male),
mean age 23 years [range 20-49] on 4 non-consecutive days. Two
distinct stages of cooling and reheating were seen, with a rapid post-
occlusion/reheating slope demonstrated at the end of the VOT in all
volunteers [Fig. 82]. The mean rate of reheating in the palm was
0.015 °C.s-1 [SD 0.009 °C.s-1]. This is comparable to the mean gradient
found when determining a linear model for the same stage, return-
ing a result of 0.0148 °C.s-1 [SD 0.008 °C.s-1].
Conclusion From these results it can be concluded that the rate of
reheating per second measured using infrared thermography follow-
ing a vascular occlusion test in healthy volunteers is 0.015 +/- 0.009 °
C.s-1. It is our hypothesis that this gradient will be prolonged in pa-
tients with sepsis. If demonstrated to be true, this technique could
be used as a non-invasive diagnostic technique in sepsis.
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Introduction Focused Intensive Care Echo (FICE) is becoming an in-
creasingly important tool in the intensivists' arsenal of haemo-
dynamic assessment. It has the ability to diagnose structural and
dynamic problems, is non-invasive, and inter-user variability is lim-
ited. Rigorous training and CPD is essential in order to prevent mis-
management based on incorrect findings. In the UK the Intensive
Care Society administers FICE accreditation with this becoming com-
pulsory for critical care trainees in future.
Methods Every patient who undergoes diagnostic FICE has the result
documented in their notes and in an audit folder. This follows a stan-
dardised “sticker”. All results documented in this folder, ranging be-
tween December 2014 and January 2015, were collated and analysed
in a spreadsheet. The aim was to assess how FICE impacts on care at
a district general critical care unit.
Results 57 patients underwent documented FICE
37 % of these scans occurred during the weekend
Indications for scan: Haemodynamic Instability (5/57), Haemodynamic
Instability - Post Operative (9/57), PE (1/57), Post Cardiac Arrest (8),
Pulmonary Oedema (1), Respiratory Failure (11), Sepsis/SIRS (10), Not
documented/Unclear (12)
Documented Views Obtained:
Parasternal Long Axis 42
Parasternal Short Axis 34
Apical 4 Chamber View 34
Subcostal View 31
FICE Questions
LV Significantly or Moderately Impaired 18
LV Dilated 5
RV Impaired/Dilated 8
Hypovolaemia 17
Pericardial Effusion (trace or above) 6
Evidence of Pleural Effusion 13
Additional Findings
Valve Problem 11 patients
Regional Wall Abnormality (4)
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 100 of 607Fluid Status Improvement (1)
Other Finding (8) - including dilated bowel loops!
Significant Conclusions
14 patients had a problem of cardiac origin
3 patients were fluid overloaded/required restriction
2 found to have pericardial effusion (not drainable)
1 Respiratory Problem
20 patients had no significant abnormality/not documented
Changed management in 44 patients, Ventilation (1), Fluid Adminis-
tration 17, Inotrope Addition/Change 5, Vasopressor Addition/Change
6, Fluid Restriction 1,Fluid Removal, (Diuretic/RRT) 2
Other Investigations 4
Contributed to decision about escalation/limitation of critical care 4
Formal ECHO documented as requested following FICE: 20/53
Consultant 31/57, Registrar 11, 2 FICE trainee (1 documented as
reviewed by FICE approved Consultant)
Conclusion It is clear that FICE echo has had a significant impact
on the management strategies of a significant number of pa-
tients, however the impact of this on morbidity/mortality is im-
possible to assess. It is also interesting to see that a
disproportionate number of scans were performed during the
weekend, when formal cardiac investigations aren't always as
available as during the week. Documentation was generally good
but some gaps in documentation were found and require im-
provement. We suggest that this data, although limited in num-
ber, supports funding of expanded FICE training and availability
at district general critical care units.
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Introduction Right atrial pressure is considered a surrogate for right
ventricular filling pressure or cardiac preload. Evaluation of the infer-
ior vena cava is the most common technique for the estimation of
RAP.(1)
Another alternative approach has been proposed using tissue Dop-
pler imaging of the tricuspid valve.(2)
Objectives investigate the reliability of using the Tricuspid E/Ea ratio,
IVC collapsibility index by bedside echocardiography and Stroke vol-
ume variation (SVV) by electrical cardiometry for the assessment of
right atrial pressure in critically ill septic patients as an alternative to
invasive CVP.
Methods Thirty patients with severe sepsis and hypotension (Mean
arterial pressure i.e. MAP < 65 mmHg), were enrolled in our study.
Fluid resuscitation (30 ml/kg) was administered. Fluid response was
defined as MAP ≥ 65 mmHg. Preload assessment was done through
CVP, IVC collapsibility and tricuspid E/Ea by tissue Doppler imaging
(TDI). Stroke volume variation (SVV) measured by ICON® was used to
assess fluid response.
Results The study included 13 males (43.3 %) with age 47.8 ± 19.7.
Paired comparison showed significant change in MAP readings (P
value < 0.001). Right ventricular filling pressures (CVP) were correlated
to tricuspid E/Ea (R 0.608, P value < 0.001), and to IVC collapsibility
index (R -0.495, P value 0.005). ROC curve showed cutoff 11.5 % for
SVV to predict fluid responsiveness with Area under Curve (AUC)
0.927, sensitivity 100.0 %, and specificity 70.0 %.Conclusions Tricuspid excursion using TDI offers non-invasive evalu-
ation of right sided heart pressures and SVV could be used to predict
fluid response in critically ill septic patients.
Keywords: right atrial pressure, tricuspid excursion, stroke volume
variation, fluid response
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Introduction Sepsis is a clinical syndrome characterized by a sys-
temic inflammatory response to an infectious process. Patient with
acute myocardial infarction (AMI) may be predisposed to develop to
sepsis during admission.
Objectives The aim of this study was to evaluate the rates of sepsis
during admission in patients with acute myocardial infarction (AMI)
and their associated factors, and the long-term mortality in patients
with AMI in associated with or without sepsis.
Methods The data from the National Healthcare Insurance Research
Database (NHIRD) in Taiwan between January of 2000 and December
of 2012 was used in this study. All patients who were first admitted
to AMI were enrolled. Among the 186,112 identified cases hospital-
ized for AMI, 13,065 cases with an alternative diagnosis of sepsis
(ICD: 038) were identified. Of the remaining 173,047 cases, patients
with any diagnosis of infectious disease were excluded, leaving
146,737 AMI cases for comparison. For analysis, survival was defined
as the end date of National Healthcare Insurance coverage.
Results The overall rate of sepsis during admission in patients with
AMI was 8.18 %. The rates of sepsis in patients with AMI were
11.70 % in female and 6.63 % in male (P < 0.001). The rates of sepsis
in patients with AMI were 3.19 % in percutaneous coronary interven-
tion (PCI) group and 14.06 % in non-PCI group (P < 0.001). The rates
of sepsis in patients with AMI were 3.79 % in below-65-year-old
group and 11.32 % in equal-to-or-more-than-65-year-old group (P <
0.001). About the comorbidities, patients with AMI and sepsis have
significant higher rates of hypertension, dyslipidemia, diabetes, per-
ipheral vascular disease, congestive heart failure, end-stage renal dis-
ease, cerebral vascular accident and chronic obstructive pulmonary
disease (all P < 0.05).
After 13 years of follow up, the survival rate of AMI was significant
higher in patients without sepsis during admission (1.97 % vs.
0.19 %, adjusted HR 1.97; 95 % CI 1.93 to 2.01). Subgroup analysis
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 101 of 607revealed that both male and female patients with AMI have signifi-
cant higher survival rates in non-sepsis groups (2.20 % vs. 0.26 % in
male, P < 0.001; 1.40 % vs. 0.11 % in female, P < 0.001). Both patients
with age below 65 and equal to or more than 65 years with AMI
have significant higher survival rates in non-sepsis groups (3.23 % vs.
0.63 % in below 65 years, P < 0.001; 0.99 % vs. 0.09 % in equal to or
more than 65 years, P < 0.001). Both PCI or non-PCI patients with AMI
have significant higher survival rates in non-sepsis groups (2.17 % vs.
0.47 % in PCI group, P < 0.001; 1.70 % vs. 0.12 % in non-PCI
group, P < 0.001).
Conclusions This study demonstrated that female gender, no PCI,
and older age groups were associated with higher rates of sepsis
during admission in patients with AMI. The long-term survival rates
of AMI were significant higher in patients without sepsis during ad-
mission, including subgroup analysis of genders, ages, and PCI.Table 60 (abstract A188). Characteristics in patients with/without
sepsis-1
Variable Sepsis P-value
No Yes
n (%) n (%)
Gender
Female 43063(29.35%) 5706(43.67%) <.0001
Male 103674(70.65%) 7359(56.33%)
Age (years)
<65 64198(43.75%) 2532(19.38%) <.0001
≧65 82539(56.25%) 10533(80.62%)
Table 61 (abstract A188). Characteristics in patients with/without
sepsis-2
Variable Sepsis P-value
Comorbidities
Hypertension 86523(58.96%) 7889(60.38%) 0.0016
Dyslipidemia 70758(48.22%) 3732(28.56%) <.0001
Diabete Mellitus 56215(38.31%) 6070(46.46%) <.0001
Peripheral vascular disease 5014(3.42%) 871(6.67%) <.0001
Congestive heart failure 34000(23.17%) 4090(31.31%) <.0001
End-stage renal disease 5854(3.99%) 974(7.46%) <.0001
Cerebral vascular accident 30714(20.93%) 4899(37.5%) <.0001
Chroinc obstructive pulmonary disease 15394(10.49%) 2651(20.29%) <.0001
Table 62 (abstract A188). Characteristics in patients with/without
sepsis-3
Variable Sepsis P-value
PCI
Non-PCI 63040(42.96%) 10311(78.92%) <.0001
PCI 83697(57.04%) 2754(21.08%)
Fig. 83 (abstract A188). Kaplan-Meier survival curve after AMIA189
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Introduction Cardiogenic Shock (CS) is a severe complication of the
Acute Myocardial Infarction (AMI). At the ESICM Congress 2004, we
presented a study on the mortality of CS by gender in Spain, based
on ARIAM Registry.
Objectives Evaluate the gender differences regarding the diagnosis,
management and prognosis of patients with CS. A secondary object-
ive was to compare these differences ten years later.
Methods Observational, descriptive and retrospective study. Pa-
tients included in the study are from ARIAM - SEMICYUC Registry
(2012- 2015) and the ARIAM Registry (2000- 2004). All patients stud-
ied were diagnosed with CS. Variables: gender, age, pulmonary
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 102 of 607catheter and supportive measures (inotropics, mechanical ventila-
tion, thrombolysis and Percutaneous Coronary Interventions(PCI) ).
Statistical analysis: Chi- square.
Results In 2012-2015, there were 15,750 AMI patients with 847 (5.3 %)
CS. 583 (68.83 %) men and 264 (31.17 %) women. PCI 628 (74.14 %).
372 (43.9 %) patients died in the ICU, of these 232 (39.79 %) were men
and 140 (53.03 %) women. In 2000- 2004, there were 20,181 AMI pa-
tients and 555 (2.75 %) CS. PCI 126( 22.7 %). 249 (44.86 %) patients died
in ICU, 160 (43.24 %) men and 89 (48 %) women.
Conclusions There are differences by gender in the management
and outcome of the patients with CS. Supportive measures and PCI
are used less frequently in women than in men. Mortality is higher in
women. These latest results are very similar to those of ten years
ago, even with the increase in the use of PCI.
Grant acknowledgement
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Table 63 (abstract A189). General Data
2012-2015 Male
Mortality*
232
Female
Mortality*
140
p* Male Total
583
Female
Total 264
Mortality/
Total
AP Catheter 25(53.2%) 6(50%) 0.0033 47(5.6%) 12(1.4%) 31/59
(52.5%)
Inotropics 208(42%) 104(50.5%) 0.001 495(58.4%) 206(24.3%) 312/701
(44.4%)
Mechanical
Ventilation
142(45.9%) 64(59.3%) 0.004 309(36.5%) 108(12.8%) 206/417
(49.5%)
Thrombolysis 38(41.8%) 23(56.1%) 0.038 91(10.7%) 41(4.8%) 61/132
(46.2%)
PCI 145(32.3%) 76(42.5%) 0.001 449(53%) 179(21.1%) 221/628
(35.2%)A190
Is there a long term prognosis impact for different
revascularization strategies in acute coronary syndromes
complicated with acute heart failure at admission?
L. Sayagues Moreira1, R. Vidal-Perez2, U. Anido Herranz1, J.M. Garcia
Acuna2, C. Pena Gil2, J.L. Garcia Allut1, P. Rascado Sedes1, C. Martin
Lopez1, E. Saborido Paz1, C. Galban Rodriguez1, J.R. Gonzalez-Juanatey2
1Complexo Hospitalario Universitario de Santiago de Compostela,
Intensive Care, Santiago de Compostela, Spain; 2Complexo Hospitalario
Universitario de Santiago de Compostela, Cardiology, Santiago de
Compostela, Spain
Correspondence: L. Sayagues Moreira – Complexo Hospitalario
Universitario de Santiago de Compostela, Intensive Care, Santiago de
Compostela, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A190
Introduction Acute heart failure (AHF) has a strong negative prog-
nostic impact in patients with non-ST-elevation acute coronary syn-
dromes (ACS) and ST elevation ACS.
Objectives To establish the effect of coronary revascularization on
the prognosis of ACS complicated with AHF at admission
Methods We retrospectively studied 5070 non selected patients ad-
mitted in a third level hospital from 2004 to 2009 followed up a
mean of 5.4 ± 2.4 years. The effect of coronary revascularization on
the outcome of patients with and without AHF was assessed using a
multivariable regression model.
Results Acute heart failure was present in 765 patients (14.5 %) at hos-
pital admission. During the index hospitalization 471 (61.5 %) patients
received coronary revascularization by percutaneous coronary interven-
tion (PCI) in 424 cases (55.4 %), and by coronary artery bypass grafting
(CABG) in 47 patients (6.1 %). In a 5-year follow-up the mortality was
255 patients PCI group (49.7 %) , 27 (41.1 % ) in CABG group, and 289
(69.63 %) in the non revascularized group. AHF was an independent
predictor of 5-year mortality (adjusted HR 4.3; 95 % CI 3.16-4.97; p <
0.001). Revascularization with PCI was protective in AHF population and
non AHF population. Revascularization significantly influenced the
prognosis of patients presenting AHF by CABG (adjusted HR 0.55; 95 %CI 0.28-1.09), but not of those without AHF (adjusted HR 0.51; 95 % CI
0.33-0.774; p = 0.001), data shown in figure.
Conclusions In patients with ACS, clinical manifestations of AHF at
admission constitute a strong predictor of adverse outcome in the
follow up that may be significantly modified by the coronary revas-
cularization strategyA191
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Introduction Early coronary reperfusion improves clinical course,
prognosis and reduces mortality in patients with ST-segment eleva-
tion acute coronary syndrome
Objectives To analyze over a period of 10 years the evolution of reperfu-
sion strategy and mortality in patients with ST-segment elevation
myocardial infarction (STEMI), admitted in a 18 beds medical-surgical Inten-
sive Care Unit (ICU), compared to other hospitals in the region (Andalusia).
Methods It is a prospective cohort study of patients with a diagnosis of
STEMI admitted to a second level Universitary Hospital Virgen de la
Victoria (UHVV) ICU, n = 2313 or, in other ICUs of Andalusia, n = 23167.
The data were extracted from the Spanish record of Acute Myocardial
Infarction Delay (ARIAM) between 01/01/2005 to 31/12/2014. The de-
gree of coronary reperfusion, systemic fibrinolysis, primary and rescue
percutaneous coronary intervention (PCI) and mortality were compared
in three periods: 2005-2007, 2008-2010 and 2011-14. Descriptive and
comparative statistical analysis was performed using the statistical soft-
ware packages SPSS version 18.0 (SPSS Inc., Chicago, IL, USA)
Results We studied 2313 patients in UHVV group with a mean age of
61.8 ± 12.2 years old (61.3 ± 12.3 vs. 61.9 ± 12.5 vs. 62.2 ± 11.69, p= > 0.05)
and 23 % were female (23 % vs. 22 % vs. 22 %; p= > 0.05). In Andalusia
group (n = 23167) mean age was 62.3 ± 11.7 years old (62.5 ± 11.7 vs.
62.1 ± 11.8 vs. 61.9 ± 11.9; p= > 0.05) and 23 % were female (24 % vs.
23 % vs. 22 %; p= > 0.05). No significant differences between three pe-
riods in both groups The results we can see in the Table 64.
Conclusions During the studied period we found a higher percent-
age in the degree of coronary reperfusion in UHVV vs. Andalusia
(84 % vs. 76 %), mainly by primary and rescue PCI (66 % vs. 48 %)
and, greater decline in mortality in the first group than the regional
benchmark (1.8 vs. 1.2).
Reference(s)
El Khoury C, et al. Five-year evolution of reperfusion strategies and early
mortality in patients with ST-segment elevation myocardial infarction in
France. Eur Heart J Acute Cardiovasc Care. 2015 Dec 17, 2015: 1-10
Grant acknowledgement
ARIAM spanish record.
Table 64 (abstract A191). Ten-year evolution of reperfusion strategies
Variables UVVH:
2005-
07
N=592
UVVH:
2008-
10
N=718
UVVH:
2011-
14
N=1003
UVVH*:
2005-
14
N=2313
Andalusia:
2005-07
N=6322
Andalusia:
2008-14
N=6727
Andalusia:
2011-14
N=10118
Andalusia**:
2005-14
N=23167
Reperfusion 75% 79% 93% 84% 67% 74% 83% 76%
No
reperfusion
25% 21% 7% 16% 33% 26% 17% 24%
Fibrinolysis 57% 44% 27% 40% 61% 56% 40% 50%
Primary
Percutaneous
Coronary
Intervention
18% 34% 66% 44% 6% 18% 43% 26%
Rescue
Percutaneous
Coronary
Intervention
11% 20% 38% 22% 7% 21% 33% 22%
Intensive
Care Unit
Mortality
6.8% 5.7% 5% 5.7% 5.9% 5.9% 4.7% 5.4%
ICU intensive care unit, UVVH University Virgen de la Victoria Hospital
(*)Chi Square p= 0,000
(**)Chi Square p=0,000
Table 65 (abstract A192). Outcome measures
< Day 2
Commenced
> Day 2
Commenced
P value
Total no. 38 24
RRT days m (range) 5 (1 -41) 9.7 (0-50) 0.06
Vent days, m (range) 6.08 (0-32) 10.7 (1-23) 0.013*
ICU LOS, m (range) 8.44 (1 -41) 18.6 (3-60) 0.0009*
30-day mort, n (%) 24 (63.2%) 13(54.2%)
Survival to discharge, n (%) 14 (36.8%) 10 (41.7%)
Hosp LOS in survivors, m
(range)
35.6 (14 - 121) 45.7 (7 -114) 0.45
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Introduction Levosimendan improves haemodynamic performance and
may have cardio-protective effects. Small trials have demonstrated effi-
cacy in well-defined populations (1). There is no consistent evidence of
mortality reduction, however a recent meta-analysis (2) demonstrated
that levosimendan reduced mortality in the overall population and sub-
populations of cardiac surgery and cardiology.
Objectives Given the uncertain benefits, an analysis of the utilisation
of levosimendan for low cardiac output states was undertaken.
Methods The retrospective analysis was performed at a single center.
Data from 62 admissions due to low cardiac output state, treated with
levosimendan, was retrospectively abstracted; demographics, illness se-
verity, co-morbidity, haemodynamic, metabolic, biochemical, resource
utilisation, organ support and hospital outcomes where analysed.
Results The population group had a mean age of 59.2 years (range
19-84) and a mean APACHE II score of 23.7 (range 7 - 61). Causes of
low CO state included myocardial infarction (n = 14, 22.5 %), after
cardiac arrest (n = 6, 9.7 %), after cardiac surgery (n = 7, 11.3 %), sep-
tic cardiac dysfunction (n = 5, 8.1 %), acute cardiomyopathies (n = 7,
11.3 %) amongst other causes (n = 23, 37 %).
Levosimendan was received at a variable point during their ICU treat-
ment (mean day 3.7, range 0 -14 days) and was usually the 3rd ino-
trope (range 0-5) commenced.
Treatment with levosimendan resulted in significant improvements
in CI (p = 0.013) and acidosis (p < 0.0001) . There was a trend towards
improved lactate clearance and oxygenation.
Overall length of stay (LOS) in ICU was 12.7 days (range 1 - 60), 30-
day mortality was 59.7 % and survival to discharge was 38.7 %.
Commencing levosimendan within 48 hours after admission resulted
in decreased duration of ventilation
(p 0.013) and ICU LOS (p 0.0009), with a trend towards a reduction in
length of renal replacement therapy (p 0.06) (Table 64). Similar benefits
were not demonstrated if levosimendan was introduced as a first or
second vasoactive agent compared to a third or fourth agent. However
survival to discharge was improved (41.5 % vs 33.3 % respectively).
Conclusions When levosimendan was used early in the disease
process ICU LOS and duration of ventilation were reduced. When
used as a first or second inotrope, rather than a third or fourth, sur-
vival to discharge was higher. More research is required to determine
the optimum timing of therapy.Reference(s)
1. S Mathieu, G Craig; Levosimendan in the treatment of acute heart failure,
cardiogenic and septic shock: a critical review. JICS 2011;12, 15-24
2. G Landoni et al; Effects of levosimendan on mortality and hospitilisation.
A meta-analysis of RCT; CCM 2012;40.2A193
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Introduction Cardiogenic shock (CS) is a syndrome characterized by
tissue congestion and hypo-perfusion consequently to cardiac pump
failure. While many studies have evaluated the outcome of post-
ischemic CS there is a paucity of data on non-ischemic CS etiology.
Objectives The aim of this study is to identify independent predic-
tors of death for CS caused by different etiologies.
Methods We performed a retrospective observational study on patients
with CS admitted in our ICU from Jan 2010 to Dec 2014. Patients with
postcardiotomy and/or post-transplant CS were excluded. Demographic,
clinical and biochemical variables were collected. Continuous variables
are presented as median (IQR). Data were analyzed using comparative
statistics and multivariate analysis was performed with Cox regression.
Results We recruited 80 patients. Etiologies of CS were: 33 acute de-
compensation of chronic cardiomyopathies, 16 acute myocarditis, 16
acute myocardial infarctions and 15 other causes. Baseline variables
are reported in Table 66 (*p < 0,05).
In the first six hours after presentation all patients received inotropes,
79 % needed invasive mechanical ventilation, 75 % intra aortic ballon
pump and 29 % VA ECMO for refractory CS. 27 patients died during
their ICU stay while 53 survived. 39 patients were bridged to recovery,
11 patients to heart transplant and 6 patients to left ventricle assist de-
vice (LVAD). No differences for etiology at ninety days mortality were
observed (Kaplan-Meyer; log-rank p = 0,41). Non-survivors were charac-
terized by a higher need for inotropes dose and VA ECMO assistance
rate in the first 6 hours (inotropic score: 14 (8-20) vs. 24 (14-30), p =
0.01; VA ECMO: 11/53 vs 12/27, p = 0,037). Multivariate analysis revealed
Lactate at ICU admission as an independent risk factor for hospital mor-
tality at ninety days: HR 1,18 (per mmol/l) IC95% 1,09-1,27 p = 0,001.
Conclusions Hyperlactatemia at presentation is an independent pre-
dictor of death in CS caused by different etiologies. It is likely that this
is due to a more severe state of global hypoperfusion or a prolonged
state of shock.
Table 66 (abstract A193).
Survivors (n=53) Non-survivors (n=27)
Age (years)* 44 (25-62) 51 (44-64)
Lactate (mmol/l)* 2,5 (1,0-5,2) 5,1 (2,8-12)
Base Excess (mmol/l)* -2(-6-0,6) -6(-8 - -2)
Mean Arterial Pressure (mmHg) 67 (58-73) 68 (59-73)
Heart Rate (bpm) 94 (82-120) 97 (88-120)
SOFA score* 9 (7-12) 12 (11-14)
Bilirubine (mg/dl) 0,9 (0,5-1,4) 1,3 (0,7-2,3)
Creatinine (mg/dl) 1,1 (0,7-2) 1,7 (1,3-2,3)
Platlets (10^9/l)* 251 (151-343) 170(111-274)
Table 67 (abstract A194). Thrombolysis and Mortality in STEMI
Period
Studies, n
P1,
n=354
P1,
n=354
P2,
n=323
P2,
n=323
P3,
n=269
P3,
n=269
Pt,
2005-
2014,
n=946
Pt,
2005-
2014,
n=946
Place and
Time
Fx, n/
%
M, n/
%
Fx, n/
%
M, n/
%
Fx, n/
%
M, n/
%
M, n/% Total
Fx, n
Prehospital*,
n/%
48/16 6/12.5 118/
40
3/2.5 132/
44
6/4.5 15/5 298
Emergency*,
n/%
265/
45
14/5.3 193/
32
13/6.7 137/
23
0/0 27/4.5 595
ICU, n/% 24/75 3/12.5 7/22 1/14.3 1/3 0/0 4/12.5 32
<60 minutes
n/%
22/23 0/0 36/37 1/2.8 39/40 1/2.6 2/2.1 97
<120
minutes n/%
136/
33
8/5.9 145/
35
4/2.8 134/
32
4/3 16/3.9 415
<180
minutes n/%
234/
36
14/6 221/
34
9/4.1 204/
30
4/2 27/4 659
P1 2005-2007, P2 2008-2010, P3 2011-2014, Pt 2005-2014, n number, %
percentage, Fx Fibrinolysis, M mortality
(*)Chi Square, p=<0.05
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Introduction Early reperfusion may prevent damage to the myocar-
dium, improves left ventricular function and prognosis of patients
suffering a ST elevation in acute myocardial infarction (STEMI).
Objectives To analyze the mortality in the groups of patients with
STEMI and fibrinolytic therapy in relation with the thrombolysis place
and hours of symptom onset
Methods It is a prospective cohort study of patients diagnosed of
STEMI admitted to a coronary Intensive Care Unit (ICU) at a second
level hospital, University Hospital Virgen de la Victoria (UHVV) during
three periods, 2005 to 2007 (n = 354), 2208-2010 (n = 323) and 2011-
2014 (n = 269). The data belong to ARIAM (Delay Analysis Acute Myo-
cardial Infarction) record. The variables studied are ICU mortality,
thrombolysis place (prehospital, emergency or ICU) and time in mi-
nutes after symptom onset (>60,> 120 and > 180). All patients receive
rescue or facilitated percutaneous coronary intervention (PCI). Descrip-
tive and comparative statistical analysis was performed using the statis-
tical software packages SPSS version 18.0 (SPSS Inc., Chicago, IL, USA).
Results We studied 946 patients with a mean age of 61.8 ± 12.2 years
(61.3 ± 12.3 vs. 61.9 ± 12.5 vs. 62.2 ± 11.69, p= > 0.05) and 22.7 % were
female (22 % vs. 23 % vs. 23 %; p= > 0.05), no significant differences be-
tween three periods. The results we can see in the Table 66.
Conclusions In three periods study there was significant differences
between mortality and thrombolysis place in STEMI. Early thromboly-
sis in prehospital and emergency hospital areas showed decreased in
mortality ICU.
Reference(s)
McCaul M, Lourens A, Kredo T. Pre-hospital versus in-hospital thrombolysis
for ST-elevation myocardial infarction. Cochrane Database Syst Rev. 2014
Sep 10;9:CD010191
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Introduction The Killip class classification for heart failure it is used
to predict short-term mortality in patients with acute coronary syn-
drome (ACS)
Objectives To determine the contemporary long-term prognosis of ACS
with acute heart failure graded according to the Killip classification.
Methods Cohort study of consecutive hospitalized patients with
ACS diagnosis from 2004 to 2009. Follow-up was done by clinical
review or telephone contact and death or cardiovascular events
were recorded, as well as the cause of death
Results 5070 patients were included with a complete follow up after
a mean of 5.8 ± 2.6 years. The clinical characteristics were analyzed in
relation with Killip class at admission (shown in Table). A stepwise
gradient in the adjusted hazard ratio (HR) for mortality was observed
with increasing Killip class: class > I HR 4.35 (95 % CI 3.81 to 4.97) un-
expectedly, in a landmark analysis excluding deaths < 30 days after
admission, patients in Killip class IV had a lower adjusted long-term
mortality than those in class III (shown in Figure).
Conclusions The heterogeneity in early versus late risk in patients
with Killip class IV heart failure it is present in our contemporary co-
hort highlighting the importance of an appropriate early treatment
in cardiogenic shock patients.
Table 68 (abstract A195). Characteristics by Killip Class
KILLIP I
N:4305
(84.9%)
KILLIP II
N:554
(10.9%)
KILLIP III
N:146
(2.8%)
KILLIP IV
N:65 (1.4%)
P-Value
Mean Age
(years)
64,5 (SD 13) 72 (SD 13) 77 (SD 7.9) 66.8 (SD
12.9)
0.000
Sex (% male) 3085
(71.7%)
358 (64.6%) 93 (63.7%) 48 (73.8%) 0.001
Hypertension
(%)
2373
(55.1%)
345 (62.3%) 102 (69.9%) 26 (40%) 26
(40%)
0.000
Diabetes (%) 1049
(24.4%)
218 (39.4%) 69(47.3%) 17 (26.2%) 0.170
Hyperlipidemia
(%)
2054
(47.7%)
237(42.8%) 53 (36.3%) 16 (24.6%) 0.170
ACS with ST
elevation(%)
1237
(28.4%)
190 (33.3%) 51 (32%) 51 (69%) 0.000
Prior PCI (%) 370 (8.6%) 40 (7.2%) 9 (6.2%) 2 (3.1%) 0.209
Prior Heart
Failure (%)
115 (2.7%) 76 (13.7%) 20 (13.7%) 5 (7.7%) 0.000
Mortality at end
follow up (%)
610 (14.1%) 284 (51.3%) 103 (70.5%) 45 (69.5%) 0.000
Fig. 85 (abstract A195). Mortality in follow up by Killip Class
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Introduction Myocardial infarction (MI) has known several sub-
classifications through the time. A consensus statement classified MI
by clinical scenario into various subtypes. Type 2 MI is now definedas myocardial injury with necrosis where a condition other than CAD
contributes to an imbalance between myocardial oxygen supply
and/or demand (1). Several mechanisms were identified to lead to
this type of MI. These conditions are under-recognized in the
critically-ill.
Objectives To appreciate the incidence of type 2 MI in medical ICU
patients.
To identify risk factors associated with type 2 MI.
Methods A retrospective chart review of consecutive patients dis-
charged from a medical ICU with the final diagnosis of type 2 MI.
Two chart reviewers (senior intensivists) studied all the medical re-
cords using an explicit protocol. Were analyzed, demographics,
underlying conditions, clinical characteristics, therapeutic interven-
tions and outcome.
Results From January 2010 to December 2015, a total of 1809 pa-
tients were hospitalized in a 7-bed medical ICU. 62(3.4 %) patients
met the definition criteria of type 2 MI. Median (IQR) age was 50[15-
85] years. 36(58 %) were male and 5(8 %) were obese, with diabetes
mellitus in 8(13 %); arterial hypertension, 18(29 %); CHF, 8(13 %) ;
chronic respiratory failure, 25(41 %). On ICU admission, 40(65 %) had
acute respiratory failure; 26(42 %), shock, 7(15 %), near drowning and
3(5 %) had carbon monoxide poisoning. Median (IQR) SAPS II was
42[6-78]; PaO2/FIO2 ratio, 204[32-367]; lactate level, 4.8[0.7-8.9]
mmol/l; pH, 7.15[6.80-7.51] and bicarbonates at 25[6-37] mmol/l.
55(89 %) patients underwent TTE, 30(55 %) had kinesis abnormalities.
Median (IQR) cTn I level was 9[0-18] ng/ml. 13(21 %) had a coronary
angiography, 100 % with no luminal irregularities. 49(78 %) had inva-
sive mechanical ventilation and received vasopressors. 20(31 %) pa-
tients received anti-ischemic, anti-thrombotic and/or anticoagulant
therapy. 3(4 %) received fibrinolytic therapy. 34(55 %) demonstrated
complete regression of all abnormalities after the correction of re-
spiratory and/or hemodynamic distresses. 30(48.4 %) died.
Conclusions Type 2 MI reveals rather common and frequently mis-
diagnosed in ICU patients. This lead to management delay and er-
rors. Patients are rather young, without underlying cardiovascular risk
factors. They exhibit a myriad of clinical conditions in which the com-
mon factor is oxygen supply-demand mismatch. They have less cTn I
levels but relatively high mortality related to the associated illness
severity.
References 1 Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maar-
ten L. Simoons, Bernard R. Chaitman and Harvey D. White: the Writ-
ing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for
the Universal Definition of Myocardial Infarction. Third Universal Def-
inition of Myocardial Infarction.2012. Journal of the American College
of Cardiology 2012; 16:1581-98.
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Background HAS- BLED scoring in assessment of bleeding risk
among patients with atrial fibrillation has been proven effective in
risk stratification. This helps in anticoagulation management as well
as in assessing morbidity and mortality of patients with atrial fibrilla-
tion who are on anti coagulants.
Objective This study aims to show if HASBLED scoring is also useful
in bleeding risk assessment among patients without atrial fibrillation
admitted in the medical intensive care unit.
Study design This is a single centered retrospective cross sectional
Study.
Methods Descriptive statistics will be reported as mean ± SD, median
(IQR) or proportion (%) as applicable and presented in tables or
graphs. Cox regression analysis was used to determine association of
Fig. 86 (abstract A198). Cell viability following I/R injury. # p < 0.05
vs CTR (no I/R) and *p < 0.05 vs 0 mM (I/R, untreated)
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ity. Hazard-ratios and predictive values were also estimated.
Participants Included in this study were Filipino patients ages 19 and
above, admitted to the Medical ICU from the Emergency Room with
outcome seen during the same admission and those patients who
satisfied all criteria for the HAS BLED scoring. Excluded are patients
who are known case of Atrial Fibrillation, those admitted for any epi-
sode of active bleeding. and patient admitted for major surgery.
Results A total of 281 patient charts of which only 231 were included
in the study. The study was able to risk stratify patients who are high
risk for bleeding both patients with or without atrial fibrillation.
Twenty percent of the patients had atrial fibrillation. The majority of
the patients were classified as high risk for bleeding (HAS-BLED) and
for venous thromboembolic risk (Caprini). The most common out-
come of patients was Acute Coronary Syndrome. Those with a
HASBLED score of 3 or more, where in 107 (46 %) out of 231 had an
acute coronary event through the course of admission. Among the
231 respondents, 69 of them had any episode of bleeding, both
minor and major. AF and Non-AF on HAS-BLED score are not signifi-
cant with p-value of 0.1048. However the odds ratio presents
10.8391 (0.6086 to 193.0421) which means that the AF respondents
as compared to Non-AF are 10.839 times likely (more likely) to have
a HAS-BLED score greater than or equal to 3 than HAS-BLED < 3.
It also showed that those with high HASBLED score are at high risk
for bleeding, even among patitnes without atrial fibrillation. How-
ever, on statistical analysis, it did not show clinical significance. HAS-
BLED and Caprini scores were found to be directly and moderately
correlated, with Spearman's rho = 0.386 (p-value < 0.005).
Conclusion Patients admitted in the critical care unit, regardless if
with or without history of atrial fibrillation, both HASBLED and
Caprini scoring should be done to risk stratify patients for bleeding,
and longer period of observation is warranted.
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Introduction As myocardial infarction can result in permanent is-
chaemic damage, early revascularization is vital to spare myocardium.
However, the downside of this treatment is reperfusion injury, and
this in itself will contribute to long-term ventricular dysfunction.
Strategies attenuating reperfusion injury have, to date, proved unsuc-
cessful. As reactive oxygen species (ROS) derived from the mitochon-
drial electron transport chain (ETC) are the main cause of reperfusion
injury, modulation of oxidative phosphorylation (peri-revasculariza-
tion) may confer benefit. Sulphide donors reversibly inhibit complex
IV of the ETC so this approach offers putative benefit.
Objectives To test the slow-release sulphide donor, MGC-0109, in a
cell (cardiomyocyte) model of ischaemia/reperfusion injury.
Methods H9C2 cells were subjected to 24 h hypoxia followed by 2 h
reoxygenation (in room air). Cells received MGC-0109 (0.005-5.5 mM) or
vehicle (cell medium) at the beginning of the reoxygenation period. In
separate experiments, normoxic cells were treated with the ROS, hydro-
gen peroxide (H2O2) 500 microM for 4 h with MGC-0109 (5.5.mM)
added to half the wells after 1 h. Cell viability was assessed by flow cy-
tometry using an Annexin V/PI assay. One-way ANOVA and Tukey post-
hoc testing (SPSS v20) was used to test for statistical significance.
Results Ischaemia/reperfusion reduced cell viability from 94 % to
79 % (Fig. 86). MGC-0109 adminstered at the onset of reperfusion in-
creased cell survival in a dose-dependent manner. At the highest
concentration survival was similar to cells that did not undergo I/R.
Protective effects were also seen with addition of MGC-0109 to
H2O2-treated normoxic cells (data not shown).Conclusions MGC-0109 reversed cell death related to reperfusion in-
jury. Further studies are ongoing to confirm if its mechanism of ac-
tion is via mitochondrial ETC inhibition.A199
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Introduction Rapid revascularisation is the treatment of choice to
minimize ischaemic injury in acute myocardial infarction. However,
this procedure can itself induce reperfusion injury that may further
damage the myocardium [1]. Experimental models of myocardial
infarction and reperfusion involve temporary ligation of the left an-
terior descending coronary artery (LAD). This model, though repre-
sentative of the clinical scenario, is associated with infarcts of
variable size, and, consequently, insult severity [2]. However, peri-
procedural haemodynamics are not well described.
Objectives To assess the impact of insult severity on cardiac, haemo-
dynamic and perfusion markers.
Methods Eight instrumented, mechanically ventilated, thoracoto-
mized, male Wistar rats (250-300 g) were subjected to 20 minutes of
myocardial ischaemia by temporary occlusion of the LAD. Animals
were monitored for up to 240 min post-reperfusion. At baseline, end-
ischaemia and at hourly intervals post-reperfusion, mean arterial
pressure (MAP), echocardiographic and arterial blood gas measure-
ments were performed. Aortic peak systolic blood flow velocity
(Vmax) was used as a marker of myocardial contractility. At experi-
ment end the infarct area/left ventricle ratio (IA/LV) was assessed by
histology to determine insult severity. Comparisons were drawn
between mild (<19 % IA/LV, n = 4) and severe (>19 % IA/LV, n = 4)
insults, with analysis by two-way ANOVA. P values < 0.05 were con-
sidered significantly different. Normality was tested by the Shapiro-
Wilk test.
Results Insult severity (IA/LV ratio) was normally distributed with a
mean ± SEM of 19 ± 10 %. The severe group (IA/LV > 19 %) had signifi-
cantly lower MAP and higher lactate values than the mild severity
group (Fig. 87, top panel). Temporal changes in cardiac contractility
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 107 of 607and output did not however relate to insult severity (Fig. 87, bottom
panel).
Conclusions
In an experimental rat myocardial ischaemia/reperfusion injury
model, blood pressure and metabolic impairments related to insult
severity. By contrast, cardiac contractility and cardiac output showed
no significant temporal change.
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and perfusion markers in mild (IA/LV < 19 %, green dots) and severe
(IA/LV > 19 %, blue dots) animals. Ischaemia time shown as red area
Table 69 (abstract A200). Group 1 using telephone; group 2 using
smartphone
Group 1 (n=40) (95 % CI) Group2 (n=44) (95 % CI) P value
Sex, Male 34 40 0.40
Age, years 60.0±1.8 (56.2~63.7) 64.4±2.1 (60.2~68.5) 0.11
Time to ECG Time to
ECG done, minutes
9.8±3.3 (3.1~16.5) 7.8±2.3 (3.6~11.5) 0.57
Time to ECG
interpretation by EP,
minutes
11.8±3.5 (4.6~19.0) 8.6±2.0 (4.6~12.7) 0.44
Activate CCL time, minutes 54.5±12.7 (28.8~8.02) 34.7±9.0 (16.5~52.8) 0.10
EP read ECG to CCL
activation time, minutes
28.3±4.1 (19.9~36.7) 17.6±2.3 (13.1~22.1) 0.01
EP read ECG to balloon
inflation time, minutes
93.1±9.5 (73.9~112.4) 73.4±3.9 (65.6~81.2) 0.025
D2B, minutes 119.3±16.3 (86.4~152.2) 90.4±9.8 (70.7~110.1) 0.13
Mortality rate Mortality rate 12.5%
(Expire 5; Survive 35)
Mortality rate 2.2%
(Expire 1; Survive 43)
0.07A200
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Introduction How to reduce the time of percutaneous intervention
in patients diagnosed with ST elevation myocardial infarction (STEMI)
is a critical issue for care process. Many interventions such as prehos-
pital ECG, cardiac catheterization laboratory (CCL) activated by emer-
gency physician (EP) have been proved to improve the result(1).
However discordance in diagnosis between the EP and the interven-
tional cardiologist may result in unnecessary activation of the CCL.
Communication between EP and interventional cardiologist is often
verbal report via telephone. After Development of the smartphones,
EPs can use application to transmit ECG images to interventional car-
diologists when STEMIs were diagnosed.
Objectives This study aims to evaluate the use of smartphone appli-
cation to facilitate communication between the EP and the interven-
tional cardiologist in order to minimize the time to activate CCL and
time of percutaneous intervention.
Methods We retrospectively collected time-point of every step in man-
agement and outcome of patients diagnosed with STEMI in the ED.
Total 84 patients were enrolled. In group 1, patient's ECG was described
by traditional verbal communication via telephone. In group 2, we use
smartphone application for transmitting ECG to interventional cardiolo-
gist. Time-points of intervention were recorded for analysis.Results Time of ECG done was not significantly different between the
groups, 9.8 ± 3.3 and 7.8 ± 2.3 minutesThe D2B time was 119.3 ±
16.3 minutes in group 1 compared with 90.4 ± 9.8 minutes in group 2
(p = 0.13). The reduction in the D2B time was driven by a reduction
in time from ECG interpretation to activate CCL (28.3 ± 4.1 in the
group 1 and 17.6 ± 2.3 minutes in the group 2) (p = .001) shown in
Table 69. Mortality rate in group 1 is 12.5 % compare to 2.2 % in
group 2 (p = .07), shown in Table 69.
Conclusions Usage smartphone to transmit ECG in the ED to inter-
ventional cardiologists can facilitate communication and reduce the
time of CCL activation and balloon inflation.
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Introduction
The prehospital electrocardiogram (ECG) was identified as an critical
part of treatment for patients with STEMI. However, it remained a
challenging issue to set up prehospital ECG in Asia.
Objectives
This study is to investigate the application of innovative design of an
electrocardiogram exam accessory device to improve ambulance pre-
hospital ambulance electrocardiogram implantation rate via in a city
based multicenter trail.
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This study started since Sep, 2011 via a multidisciplinary team among
Kaohsiung veterans General hospital, fire bureau and department of
health, Kaohsiung city government. The unique accessory device for
12 lead electrocardiography apparatus has 10 holes, which are ar-
ranged according to a standard electrode placement for the 12 lead
ECG measurements. The design of inter-nipple line and mid-sternum
line on the device can assist the staffs to perform ECG shortly. This
breakthrough innovation designed to address the core issue of the
efficiency of the ambulance pre-hospital ECG system. Therefore, the
invention successfully promoted Kaohsiung city council to set up
Asian first ambulance prehospital telemetry electrocardiogram
system. The innovative design of a ECG exam accessory device was
patented in Taiwan and won golden award in Geneva and Korean
international invention. The consecutative chest pain patients re-
ceived ambulance ECG exam were enrolled from Jan. 2011 to
September. 2015 in 18 different fire brigades at Kaohsiung city. The
ECG implementation rate is defined as chest pain patients received
ambulance ECG exam divided by all patients with chest pain.
Results
The ECG implementation rate increased from 0 % in pre-
interventional to 62.2 % in post-interventional group (p < 0.001).
Total 66 patients with STEMI was detected in 1205 chest pain pa-
tients received ambulance ECG exam. In these STEMI patients, aver-
age door to balloon time was 51 minutes, average ischemia to
balloon time was 125 minutes and in-hospital mortality was 0 %.
Conclusions
This study demonstrates that application of innovative design of an
electrocardiogram exam accessory device can solve the main prob-
lem of system and assist to set up first ambulance prehospital telem-
etry electrocardiogram system in Asia and further improve
ambulance prehospital electrocardiogram implantation rate in Kao-
hsiung city.
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Introduction
The demand for critical care services is increasing steadily both na-
tionally and internationally. It is important that with increasing de-
mand the quality of care delivered is maintained. A well-recognised
quality marker for intensive care units(ICU) are readmissions within
48 hours of discharge[1]. ICU readmission is associated with signifi-
cantly increased morbidity, mortality, prolonged hospital admissions
and increased cost[2,3]. The reported average of unplanned readmis-
sions is 1.4 % in the UK[4]. Globally this varies between 1.3-13.7 %[2].
There have been no specific causal factors found[2].
Objectives
Identify the 48 hour readmission rate over two consecutive years and
its impact on patient care.
Method
This was a retrospective study in a 16 bedded adult general medico-
surgical ICU in a large acute hospital in England. The sample was col-
lated from the ICU discharges in 2014 and 2015, identifying those pa-
tients who were readmitted within 48 hours of discharge. Specific
times of discharge and readmission, underlying cause, length of re-
admission stay and final outcome data was collected. The results of
2014 and 2015 were compared.
Results
In 2014, 672 patients were discharged from ICU, with 21 readmis-
sions and only 2 within 48 hours (0.3 %). The time of re-admissionranged from 14 to 48 hours. Following readmission, the length of
stay ranged from 10 days to 17 days.
In 2015, there were 702 discharges with 30 readmissions. 14 of these
were within 48 hours (2.0 %). The time of readmission varied from 9
to 48 hours (median = 25 hours). Cardio-respiratory failure was the
most common cause for readmission. The length of the readmission
stay on ICU ranged from 1 day to 68 days (median = 8 days).
Over the two year period the ICU mortality rate remained unchanged
at 16 % however patients readmitted within 48 hours showed
considerably higher hospital mortality rates of 50 % in 2014 and
42 % in 2015.
Conclusions
Over the two year period, there was an increase in admissions and
discharges from ICU. This was associated with an increase in the mid-
night bed occupancy rate from 79.5 % in 2014 to 84.3 % in 2015.
However, this was linked with a 7 fold rise in readmissions within
48 hours and an associated hospital mortality rate higher than both
the previous year and national average.
An increasing demand for ICU services can have an adverse effect on
the quality of care delivered. Further research is needed to inform cli-
nicians and commissioners how quality can be maintained with in-
creasing demand.
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Introduction
There is growing evidence that a protective lung ventilation strategy
offers benefits to all patients undergoing mechanical ventilation[1].
In addition, the deleterious effects of excess oxygen in critically ill pa-
tients are becoming increasingly well recognised[2].
We present the results of a 10-month-long quality improvement pro-
ject that has improved adherence to a lung protective ventilation
strategy on our unit. The project has also yielded a culture shift in
the way that oxygen is prescribed and titrated for all our patients.
Objectives
1. Record the height of all critical care patients and calculate their
ideal body weight (IBW).
2. Adopt a lung protective (6-8 ml/kg IBW) ventilation strategy for
all patients receiving controlled ventilation.
3. Titrate oxygen delivery according to prescribed saturation
targets (90 % or 95 %).
Method
Our project consisted of a series of tools to raise awareness, educa-
tional interventions, daily prompts and practical measures to pro-
mote adherence. In addition we adopted a pressure-control, volume-
guarantee mode of ventilation as the initial standard for all patients
ventilated on our unit. Our critical care technologists offered on-
going practice education for members of the clinical team whilst a
run-chart of week-by-week performance offered immediate feedback
on the status of the project.
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We have reviewed over 4200 patient-days of data in a rolling audit
of the effectiveness of our project. Fig. 88 demonstrates the percent-
age of patients for whom an IBW was recorded and for whom a tar-
get oxygen saturation was prescribed each month.
Our latest results (April 2016) showed that 88 % (75/85) of patients on
our unit had their IBW recorded and 100 % (14/14) of those receiving
controlled ventilation had an appropriate tidal volume prescribed. Ven-
tilation matched the prescription in 71 % (10/14) of cases. Routinely
knowing the IBW of every patient on the unit has also been useful for
the safe prescribing of haemofiltration and critical care drugs.
76 % (65/85) of patients had target oxygen saturations prescribed al-
though only 38 % (25/65) were 'on target' at the time of data collec-
tion. Most importantly, prescribing an oxygen saturation target has
empowered our nursing staff to wean inspired oxygen concentra-
tions without waiting for an arterial blood gas.
Conclusions
Our project has demonstrated that a series of simple interventions can
help to optimise mechanical ventilation and oxygen titration within
critical care. There have been associated benefits in terms of safe pre-
scribing and a reduction in our reliance on arterial blood gas analysis.
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Introduction
VAP is an ICU-specific nosocomial infection, causing important add-
itional costs in healthcare, extending ICU and hospital length of stay,
with its own attributable mortality.
A sudden rise in VAP-rate in 2007 urged the ICU of the az Sint-
Blasius to improve quality of care.
Objectives
To reduce VAP-rate by systematical Introduction of evidence based
measures supported by PDCA-cycle Methodology.
Method
Process improvements included:
2008: tracheal suction protocol, prevention of colonization of ventila-
tor tubing, HME change, oral care with hexetidin, cuff pressurecontrol, 30° head elevation, ETT fixation, gastric residue control, ETT
with polyurethane cuff, closed airway suctioning
2009: stop closed airway suctioning, ETT with PVC tapered shaped
cuff and subglottic suctioning, digital continuous cuff pressure con-
troller, automated subglottic suctioning pump
2011: oral care with chlorhexidine 0,2 % and oral care system permit-
ting social control
2012: Belgian VAP-bundle, with continuous compliance measurement
2014: RASS to adjust the depth of sedation
Results
2008 measures were ineffective. Nurses identified ineffective tracheal
suctioning by closed airway suctioning as a major problem. In 2009,
stopping closed airway suctioning and the Introduction of 3 new
technologies, reduced VAP-rate by half. In 2011, oral care with chlor-
hexidine 0,2 % and an oral care system permitting social control did
not improve results. Although almost all VAP-bundle elements
already were used in our ICU, the formal implementation of the Bel-
gian VAP-bundle in 2012 caused an important additional decline in
VAP-rate, emphasizing the importance of sedation control and com-
pliance measurement.
In 2014, adjusting depth of sedation by RASS resulted in the lowest
VAP-rate in 10 years.
Conclusions
This continuous quality improvement program shows that the sys-
tematic use of evidence based and PDCA-cycle driven process im-
provements may contribute to reduce VAP-rate.
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Introduction
Morbidity and mortality conferences (MMCs) are a traditional tool of
improving local care management, and clinical management educa-
tion especially in high risk specialty, but they lack a precise format
for practice in intensive care units (ICU).
Fig. 91 (abstract A205). [ICU1 mortality]
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To explore the impact of goal directed MMCs on mortality rate and
adverse events.
Method
3 year prospective study in 2 ICUs (15 bed each) for evaluating a sys-
tematized MMCs with a clear goal of improving local care (how to
avoid this) through case discussion, analysis, brainstorming and clear
recommendations in a multidisciplinary meeting involving all related
caregivers in a blame free environment. The present study included
4 phases; pre-intervention (Jan-12-April-13), intervention (May-July
2013), post-intervention (Aug-13-Oct-14), washout period (Nov-14-
Dec-15). A period prevalence of ICU acquired adverse events were
audited in March and December 2013.
Results
4589 patients were included in the study, from which 1456 died
(31.7 %). During the intervention and post-intervention phases, 18
MMCs were held which discussed 36 died cases (28 from ICU3 and 8
from ICU1), reviewed other causes of death and unit performance in-
dicators and made 96 recommendations (80 % accomplished in ICU3
versus 60 % in ICU1). The mortality rate decreased in post-
intervention phase from 44.2 % to 25.1 % in ICU3 (p < 0.001) and
from 21 % to 20.5 % in ICU1 (p = 0.748) then increased in washout
period to 28.3 % in ICU3 (p = 0.189) and to 25.2 % in ICU1 (p =
0.041). Conversely, the mortality rate in washout period (in relation
to pre-intervention phase) decreased in ICU3 (p < 0.001) but in-
creased in ICU1(p = 0.036). Subanalysis in ICU1 mortality revealed sig-
nificant decrease in early post-intervention (17.3 % with p = 0.031)
and significant increase in late post-intervention (24.4 % with p =
0.028). Adverse events decreased insignificantly in December 2013
(as compared to April 2013); unplanned extubation from 71 to 48/
1000 ventilator days ( 24 % to 15.5 %) in ICU3, unexpected cardiac
arrest from 17.7 to 12.7/1000 patient days (8.6 % to 6.2 %) in ICU1,
stress ulcer bleeding from 17 to 4.5/ 1000 patient days (12.6 % to
4.4 %) in ICU3 and 25 to 18/1000 patient days (12 % to 8.7 %) in
ICU1, Deep vein thrombosis from 5.7 to 0/1000 patient days (4 % to
0 %) in ICU3 and from 12.6 to 5/1000 patient days (6 % to 2.5 %) in
ICU1, iatrogenic pneumothorax from 5.7 to 0/1000 patient days (4 to
0 %) in ICU3 and from 5 to 7.6/1000 patient days (from 2.5 to 3.8 %) in
ICU1. However, unexpected cardiac arrest (from 26.7 to 6.8/1000 pa-
tient days, p = 0.019) and VAP rate (from 10 to 2.5/1000 ventilator days,
p = 0.002) in ICU3 and unplanned extubation (from 105 to 33/1000 ven-
tilator days, p = 0.003) in ICU1 decreased significantly in Dec-13.
Conclusions
Although confounding factors were not controlled, goal oriented
MMC reduced some adverse event and probably mortality rate espe-
cially with continuous monitoring and improvement.Fig. 90 (abstract A205). [ICU3 mortality]A206
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Introduction
Intensive care is one of the most resource-intensive forms of medical
care due to severely ill patients. During recent years the quality of in-
tensive care has been in focus however there is still lacking result
from nursing point of view.
Objectives
To describe nurse/patient ratio in relation to Care burdened meas-
urement (VTS) and optimal medical and nursing-related result usually
used indicators as mortality and complications during intensive care.
Method
This is a retrospective registry study includes a survey of critical care
of registry data (all patients > 15 years) receiving care in two general
Level I critical care units with similar rate of admissions during 2010-
2014. Data of nurse/patient ratio is collected from each unit. The data
is analyzed by descriptive and comparative statistical Method
Results
The result showed differences in specialized nurse/patient ratio of
0,5:1 to 1:1 ratio and Care burdened measurement (VTS) despite simi-
larities in admission rate. Differences in cause of admission (surgi-
calv.s medical) and in the amount of unexpected surgery patients
were found. Differences were also found in mean time on non-
invasive ventilation and mean time on ventilator. Complications dur-
ing critical care was measured by readmission and unplanned reintu-
bation and showed that unplanned reintubation varied between 2.4-
1.6 percent. ICU mortality showed differences with the lowest ICU
mortality in the hospital with lower nurse/patient ratio. However,
30 days mortality was lower in the hospital with higher nurse/patient
ratio. Further analysis is needed.
Conclusions
Preliminary results show differences in nurse/patient ratios and Care
burdened measurement (VTS) with differences in and quality mea-
surements in general critical care units.
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Introduction
The use of quality indicators (QIs) for improvement of care in the in-
tensive care unit (ICU) is increasing. Incidence of adverse events like
ventilator associated pneumonia (VAP) and pressure ulcers are not
routinely measured in norwegian ICUs.
Objectives
The aim of this pilot study was to evaluate the frequency of these
two adverse events measured by specific QIs in two ICUs at the Oslo
University Hospital Ullevål (OUHU).
Method
ICU-patients at two different ICUs at OUHU were included in the
study in a predefined time period during Autumn 2015. Data for
determining VAP and pressure ulcers were retrieved from the
daily electronic patient record, journal and/ or bedside on a spe-
cific study sheet. Pneumonia (PN) was identified using the Euro-
pean Centre for Disease Prevention and Control (ECDC) protocol;
-a combination of imaging, clinical and laboratory criteria. VAP
was defined as a PN where the patient had been on mechanical
ventilation for more than 48 hours and ventilator in place on the
day of event or the day before. Pressure ulcers were identified
using the European Pressure Ulcer Advisory Panel (EPUAP) classifi-
cation system. To determine the severity of the pressure ulcer,
four categories were used. Descriptive statistics are presented
using SPSS version 21. Results are presented as mean ± standard
deviation (SD).
Results
We included 58 adult ICU patients, all mechanically ventilated for a
minimum of 48 hours, of whom 93 % were surgical patients. Among
those, 69 % were trauma patients and 12 % acute surgery patients.
Mean SAPSII score was 32,3 ± 14,1 and mean time on mechanical venti-
lation was 11,2 days ± 9,6. PN was present in 28 patients (48 %), and 19
(33 %) had per definition VAP. Per ECDC classification 19 of the 28 PNs
were classified as PN1 with microbiology confirmation from Broncho-
Alveolar Lavage (BAL), five PN2 with microbiology confirmation from
endotracheal aspirates, and four PN5 without microbiology confirm-
ation (clinical pneumonia). The incidence of VAP was 29/1000 ventilator
days. Pressure ulcers were present in 18 (31 %) of the patients, and the
majority of patients had more than one ulcer. The ulcers were classified
as EPUAP category one (57 %), two (34 %), three (4 %) and four (1 %).
The incidence of pressure ulcers was 70/ 1000 ICU days.
Conclusions
At OUHU there is a potential for reducing the incidence of VAP and
pressure ulcers if we are to reach the current standard of care. Identifi-
cation of specific QIs is important for future improving quality of care.
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Introduction
Care that takes the needs of families into account is very important,
but in order to offer family-centered care, it is necessary to under-
stand families experiences.
Objectives
To develop a valid and reliable tool to measure the perceived
quality of care, the quality of the process of death and the satis-
faction generated from the perspective of relatives of deceased
patients in an ICU.
Method
Elaboration of an ad hoc questionnaire after literature review and
validated by a multidisciplinary panel of experts. The construct of
quality of service (QS) was measured by using three different
constructs: quality of the communication (QS1), with two dimen-
sions (“kindness and respect” and “sincerity and empathy”); qual-
ity of the information (QS2), with four dimensions (“welcome”,
“information about disease”, “shared decission making” and “em-
pathy with family needs”); technical and infraestructural quality
(QS3), with six dimensions (“human aproach, “professionalism”,
“waiting room”, “facilities”, “visiting hours” and “meals”). The con-
struct about the process of death was measured by using three
dimensions (“technical quality”, “human quality” and “quality of
the information given”. Finally, the construct about overall satis-
faction with the service was measured with three dimensions
about satisfaction with “form and content of the information”,
“technical and structural quality”, and “process of death”.
95 relatives of deceased patients participated with a post mail
questionnaire (response rate: 38,9 %). After a month since the
death, recruitment by telephone was carried out. Analysis of psy-
chometric properties: convergent validity with correlation coeffi-
cient of Pearson, predictive validity with multiple regression
models in order to predict the dimensions of satisfaction from
the scales of quality, and reliability with α Cronbach and test of
two halves.
Results
Nearly all of the correlation coefficients between the items of each
construct were > 0,5, which meant, therefore, that all constructs had
convergent validity. The three regression models performed to evalu-
ate the predictive validity showed high determination coefficients
(78,2 %. 94,9 % and 75,4 %). The evaluation of the items of all dimen-
sions were high, with mean values around 6, except dimensions “em-
pathy with family needs” and “waiting room”, with scores < 5.
Conclusions
The ad hoc tool developed was easy to use and showed ad-
equate psychometric properties of validity and reliability which
could be improved by removing some items that showed low
correlations.
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Objectives
The purpose of this study was to evaluate the profile of antibiotic re-
sistance and the effect of the Introduction of an antibiotic protocol
in the ICU length of stay and mortality, costs and consumption of
antibiotics.
Method
We conducted a retrospective study from a total of 476 patients ad-
mitted with in the ICU between January 2015 and December 2015.
For the purpose of this study, and to obtain a profile of the microor-
ganisms in our ICU, resistant microorganisms (RM) were defined as
those with non-susceptibility to one (RM1) or more than one class of
antibiotics (RM2).We also compared our results whit previous studies
conducted in the ICU.
Results
Most prevalent microorganisms were: Staphylococcus aureus,
Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumo-
nia, 33 % of all microorganisms identified were resistant to
more than one class of antibiotics (RM2) and 17 % of the
patients had a RM1.Resistance was statistically significantly
(p < 0,05) associated with:Previous stay in wards - in particular
patients coming from surgical wards or Emergency;Number of
days from admission in hospital to ICU admission - patients
with RM2 had a mean hospital stay before ICU admission of
12 days;Number of previous surgeries in the same hospital
event - RM2 were identified in patients with an average of two
previous surgeries;Admission type - mainly patients coming
from urgent surgery and medical causes;Number of days in ICU
- patients with RM2 stay in average at least 5 days more in ICU
than patients with microorganisms with no resistance;Antibiotic
treatment previous to ICU admission (for at least 5 days before
ICU admission), more than 30 % of patients with RM2 were sub-
mitted to antibiotic treatment before ICU admission.After the
implementation of the antibiotic protocols we verified that the
ICU length of stay was reduced in almost 3 days; the number
of agents isolated increased 33 %; microbiological analyses in-
creased 53 % which allowed us the practice of de-escalation
consumption of antibiotics, by category, decreased by 82 % for
the carbapenems, 33 % for antifungals and 35 % for antipseu-
domonal beta-lactams.There was a significant decrease in mor-
tality, from 31,8 % to 26,8 %;There was a 22 % reduction in
antibiotics consumption, with a total saving of 65,862€ in one
year.
Conclusions
Resistance was associated with previous stay in wards, previous surgery
and antibiotic treatment previous to surgery. The implementation of
antibiotic protocols has had a positive impact as it was significantly as-
sociated with reduction on the length of ICU stay and ICU mortality, as
well as consumption and costs associated with antibiotic therapy
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Introduction
Advances in cardiac surgery techniques and postoperative care had
led to decrease in major postoperative morbidity and mortality. Since
operative risk declines, improvement of quality of life became an im-
portant patient centred outcome. It depends not only on physical
but also on mental status and individual perception of health and
rehabilitation.
Objectives
The primary aim of our study was to define the impact of preopera-
tive patient characteristics and quality of preoperative life on Health
Related Quality Of Life (HRQOL) dynamics one year after cardiac sur-
gery. Secondary aim was to identify factors influencing long-term
HRQOL postoperatively.
Method
A prospective cohort study in a tertiary referral university hos-
pital. Study protocol was approved by institutional bioethics
committee. The 36-item Short Form Health Survey (SF-36) was
used to assess HRQOL amongst the study participants. An in-
patient SF-36 questionnaire was completed a day before the
elective surgery and repeated one year after surgery via tele-
phonic interview. SF-36 is composed of 8 domains covering
physical and mental aspects of health. Answers are converted
to scale from 0 to 100 where higher values represent better
health status. Effect Size Method was used to establish clinically
significant change, therefore improvement was defined as posi-
tive change exceeding 1 Standard Deviation between baseline
and follow up score in particular domain. Summary scores of
Physical Component (PCS) and Mental Component (MCS) were
used to identify patients with overall improvement in HRQOL.
Based on these results study group was divided into improvers
and non-improvers. Clinical data was collected from medical re-
cords. Independent samples and paired samples T-tests were
used to compare baseline and follow-up data and differences
between two groups.
Results
210 patients were enrolled in the study and underwent surgery
in 2013-2014. After one year we were able to contact 53.8 %
patients, hence final analysis included 105 patients. Overall posi-
tive significant change was identified in half of the domains,
with significant improvement in PCS and MCS. Mean PCS at
baseline was 42.5 (13.13-91.25) and 58.75 (23.13-92.5) at follow-
up; MCS 52.75 (24.38-91) at baseline and 62 (24.5-99) at follow-
up, p < 0,001 for both. There were 51 patients in non-improvers
group and 54 patients in improvers group. No significant
differences were identified between groups in demographic and
peri-operative variables. Non-improvers had significantly higher
preoperative scores in all domains including MCS (60.59 ± 14.28
vs 44.09 ± 12.09, p < 0,001) and PCS (54.36 ± 14.94 vs 37.93 ±
11.83 p < 0,001).
Conclusions
Our findings suggest that patients with worse HRQOL at baseline are
more likely to experience long-term improvement following cardiac
surgery. We did not identify any other factors influencing long-term
HRQOL outcomes.
Table 70 (abstract A212). Spirometry Results
Spirometric
variables
Normal (n=79) Restrictive
(n=10)
Obstructive
(n=35)
p
FEV1 2.98 + 0.81 2.21 + 0.67 2.24 + 1.01 0.00002
PEF 375.84 +
128.92
321.79 + 130.04 282.37 + 139.70 0.001
FVC 3.60 + 1.01 2.48 + 0.69 3.48 + 1.36 0.001
Table 71 (abstract A212). Results of SF-36
SF-36 Normal
(n=79)
Restrictive
(n=10)
Obstructive
(n=35)
p
Functional
Capacity
65.57 ±
110.34
47.86 ± 27.99 33.50 ± 30.32 0.09
Physical Limitations 23.73 ± 35.33 25.00 ± 34.26 22.50 ± 36.88 0.91
Pain 34.53 ± 38.81 24,17 ± 49.93 42.20 ± 33.10 0.23
General Health 68.51 ± 24.07 62.57 ± 25.76 62.40 ± 25.84 0.20
Vitality 68.10 ± 25.87 58.00 ± 27.11 57.50 ± 26.46 0.04*
Social Aspects 72.66 ± 34.12 64.40 ± 33.92 46.40 ± 35.21 0.04*
Emotional Aspects 35.43 ± 40.81 38.11 ± 47.14 33.30 ± 45.14 0.96
Mental Health 67.44 ± 26.75 65.14 ± 26.94 65.20 ± 30.49 0.80
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Introduction
Patients who have been treated at an ICU often have affected mental
and physical health with complications such as depression, anxiety, post-
traumatic stress disorder (PTSD) and, sleep disturbances[1-4]. Decreased
health-related quality of life (HRQoL) after ICU stay have been shown in
mixed ICU-populations but there is a lack of knowledge of HRQoL after
surgical intensive care.
Objectives
The aim of this study was to describe HRQoL 3, 6 and 12 months after
discharge from a general surgical ICU and to analyze factors associated
with impaired HRQoL.
Method
Prospective cohort study in a general surgical ICU in Sweden. Included
are patients with an ICU length of stay≥ 96 hrs, < 18 years old, 2004-
2012. HRQoL was measured with SF-36 at 3, 6 and 12 months after dis-
charge from the ICU. Age, gender, APACHE II, LoS, mechanical ventilation,
admission diagnosis, preexisting disease and marital status were recorded.
Wilcoxon Signed Ranks Test was used for comparing HRQoL and changes
over time. A general linear regression analysis was performed to analyze
impact of background and ICU-related factors on HRQoL at 12-months,
standardized to a general population in the same age in Sweden.
Results
A total of 276 (62 %) patients 18 - 89 yrs were included. HRQoL sig-
nificantly improved between 3-12 months after ICU in six domains;
PF (p = 0.00), RP (p = 0.00), GH (p = 0.03), VT (p = 0.00), SF (p = 0.00)
and RE (p = 0.01), but were still lower in all eight domains compared
to standard population. Age < 75 years was a risk factor.
Conclusions
Surgical intensive care patients have lower HRQoL compared to standard
population one year after stay in the ICU. Age < 75 yrs is a risk factor for
worse HRQoL. This study also contributes to the knowledge of risk factors
for impaired HRQoL which can be important when considering selection
of patients to the ICU follow-up clinics.
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Critical illness survivors have physical impairment, reduced functional
capacity and change in quality of life after discharge from the Inten-
sive Care Unit (ICU).
Objectives
To evaluate pulmonary function and quality of life of critically ill pa-
tients three months after discharge from the ICU.
Method
Cohort study conducted in the Post-ICU Follow-Up Outpatient Clinic of
an University Hospital, Southern Brazil, from April 2012 to June 2013. It
was performed spirometry test and the patients answered SF-36 after
three months of discharge from ICU. The patients were divided into 3
groups: normal spirometry (G1), restrictive (G2) and obstructive (G3).
The variables that were in accordance with the assumptions of normal-
ity and homoscedasticity were evaluated by analysis of variance
(ANOVA single-factor) and those that were not in accordance with the
assumptions were evaluated by Kruskal-Wallis test.
Results
609 patients were admitted, 440 were discharged alive from the hos-
pital. In the Outpatient Clinic, 126 patients were evaluated, 61 %
male, age 44 ± 18.19 years, 48 % were smokers and 8 % COPD. The
main causes of admission were postoperative elective surgery (26 %)
and trauma with head injury (20 %), mean APACHE II 19.08, ICU
length of time 7.23 days, hospital length of time 17.75 days, MV >
24 hours 47.62 %, and mean MV time 86.45 hours. The groups
showed significant differences in spirometric data, shown in Table 70.
In the SF-36 only the areas vitality and social aspects showed statis-
tical difference (Table 71).
Conclusions
Most of the patients had normal spirometry. The main pulmonary im-
pairment was obstructive feature. Some areas of quality of life after
ICU discharge present relationship with worsening of lung function.A213
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Fig. 92 (abstract A214). Family satisfaction with decision making
Fig. 93 (abstract A214). Support during the decision making
process
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The evolution of care to critically ill patients has provided a considerable
number of survivors after admission to the ICU, but several patients have
impaired quality of life owing to changes in physical, functional, social
and emotional disorders that often culminate in a prolonged recovery. In
low-income countries this picture is poorly described.
Objective
To evaluate health-related quality of life in patients that survived to
ICU stay three months after ICU discharge.
Method
Prospective cohort study conducted in the period 2012-2014, at the
Post-ICU Multiprofessional Follow-up outpatient Clinic of a teaching
hospital, in Southern Brazil. Included patients > 24 hours in the ICU, ≥
18 years old and who attended the outpatient evaluation. To evalu-
ate the quality of life it was applied the questionnaire SF-36.
Results
In the 2-year period, 275 patients were evaluated: 63.6 % male, mean
age 44.0 years. Trauma was the leading cause of hospitalization
(37.1 %). 45.5 % had comorbidities: hypertension (43.7 %), diabetes
(32.4 %) and alcohol / tobacco (18.7 %). Mean ICU length of stay was
9.9 days; 74.9 % remained more than 48 hours with mechanical ventila-
tion; 63.6 % were sedated and 25.8 % tracheostomy. Mean APACHE II
20.2.There was significant impairment in relation to the limitations of
physical and emotional aspects. The main factors associated with
change in QOL were: Physical Component: Mechanical Ventilation,
Sedation and the presence of post-ICU sequelae; Mental Component:
Admission by neuro-trauma and the presence of post-ICU sequelae.
Conclusion
There was impairment in quality of life related to the limitations of
physical, social and emotional aspects, justifying the need for moni-
toring and rehabilitation after discharge, mainly the patients victim
of neurological trauma and underwent sedation and prolonged MV.
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Introduction
Patient experience is a key marker of healthcare quality and is a
focus of the Department of Health. 1 in 5 critically ill patients die,
those that survive often have little memory of their intensive care
stay. Family members are a valuable proxy for patient experience in
ICU. The Family Satisfaction in the Intensive Care Unit FS(ICU) 24
questionnaire was developed in Canada and is widely validated. It
has 2 domains: Satisfaction with Care and Satisfaction with Decision
Making[1]. The UK FREE study adapted the questionnaire and found
it to have high internal consistency and criterion validity, but that
the free text responses demonstrated scope for improvement [2].
Objectives
To assess levels of satisfaction in family members of ICU patients to
guide improvement in quality of care.
Method
213 patients were admitted between 01/10/15 and 01/01/16. 210
FS(ICU)-24 questionnaires were sent to their next of kin in the month
after death or ICU discharge. 19 questions were analysed using the
5-point Likert scale.
Results
96 questionnaires were returned (45.7 %). 62.5 % of responders were
female; the mean age was 60.4 (±15.7) yrs. 25 % of relatives had pre-
vious ICU experience and 71.6 % lived with the patient prior to their
illness. 66 % were the patient's partner.
Overall satisfaction was 86.1. Satisfaction with Care score was 87.6 The
highest score was in Concern and Caring (95.3) and the lowest in Wait-
ing Room Atmosphere (67.4). Satisfaction with Decision Making scored82.8. The highest score was in Honesty of Information (85.7); the lowest
score of 76.9 was in Frequency of Communication with Doctors.
11 % of relatives felt they could have used more time when making
decisions. 77 % felt they had been supported through the decision-
making process; 6 % felt overwhelmed. 8 % felt out of control over
the care of the patient, although this was not always negative - 'leav-
ing it to the experts'. The free text responses were insightful and a
valuable contribution to the data.
Conclusions
The low response rate and the potential for response bias due to the
most dissatisfied relatives declining to respond limit this study. Its
strengths are that it provides individualised feedback which can be
used to enhance quality of care locally. Future quality improvement
projects will target improving communication and include dissemin-
ating a study summary to staff members to highlight the importance
of communication, more information in the waiting room on expec-
tations in the intensive care unit and the use of family ward rounds.
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Introduction
Critical illness of different etiology triggers an inflammatory cascade
associated with organ dysfunction. However it is not known if the in-
flammatory pattern is disease specific or related to the severity of in-
jury. We hypothesized that in critical ill patients of different etiology
a specific pattern of cytokines measured in the early phase after ICU
admission may predict mortality.
Objectives
Aim of this study was to investigate the early inflammatory profile in
critical ill patients and its association with ICU mortality.
Method
Local Ethic Committee approved the study protocol. Critical ill pa-
tients admitted to ICU for sepsis-associated acute respiratory distress
syndrome (ARDS), severe traumatic brain injury (TBI) and subarach-
noid hemorrhage (SAH) were studied. Demographic data, severity in-
dexes at admission and physiological variables were recorded. Blood
samples for cytokines analysis were collected at days 1, 2 and 4 after
admission. The cytokine analysis was performed with Bioplex tech-
nology and 27 cytokines were analysed. Statistical analysis: Multivari-
ate projection technique was applied to analyse variation and
collinearity within the cytokines dataset without a priori selecting po-
tential relevant molecules. Principal component analysis (PCA) was
used to identify principal components (PC) which account for the
majority of the variation within the dataset.
Results
Eighty-six critical ill patients admitted for sepsis-associated ARDS (n = 36),
severe TBI (n = 29), SAH (n = 21) were studied. Mean age was 52.8 ± 18,
APACHE II 17.6 ± 2.9, SAPS II 44.9 ± 11.7, mean SOFA in the first week 8.3
± 2.9; median ICU-length of stay was 19 days (range 14-31), median
Hospital-LOS was 34 days (range 17-50), ICU mortality 31.7 %. Using PCA,
the first five PCs generated by the model explained 65 % of the variation
within the dataset. The first component is strongly correlated with the fol-
lowing cytokines - IL4, IL12, IL10, IL-1ra, FGF basic, IL13, GCSF, IL-1β, IL7,
TNFα, IL5, MIP-1α, INFγ, IL8, IL2, IL17, IL6. Moreover the second compo-
nent is strongly correlated with VEGF, IP-10, IL9. After correcting for age,
ApacheII, SAPS and SOFA, the two principal components PC1 and PC2were evaluated as predictor of ICU mortality with OR 1.0737 (C.I. 0.8897;
1.2956) and OR = 1.5204 (C.I. 1.0962; 2.1086), respectively.
Conclusions
In critical ill patients of different etiology the multivariate projection
Method represents a valuable technique to identify inflammatory
patterns as predictor of outcome.
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Introduction
High quality clinical databases facilitate repeated evaluation of clin-
ical practice and comparative audit. [1] However, inaccurate data
entry can lead to inaccurate conclusions.
Objectives
We sought to determine whether patients in our intensive care unit (ICU)
were appropriately coded as having chronic severe respiratory disease.
Method
We conducted a retrospective case note review of patients admitted to
a general adult ICU between January 2009 and December 2014 and la-
belled with chronic severe respiratory disease. Severe respiratory dis-
ease was defined as “chronic restrictive, obstructive or vascular disease
resulting in severe exercise restriction or documented chronic hypoxia,
hypercapnia, secondary polycythaemia, severe pulmonary hypertension
or respirator dependence”. Patients were identified from the Ward-
Watcher™ database, electronic records interrogated and statistical sig-
nificance assessed using the Paired T-test and the Chi Squared test.
Results
There were 112 ICU patients (48 men, 43 %) labelled with chronic se-
vere respiratory disease over this six year period. These patients had
a median age of 62 years (IQR 54-70 years) and median APACHE II
score of 20 (IQR 16-28). Electronic records were insufficient to con-
firm or refute the label of chronic severe respiratory disease in 13
cases and these patients were excluded from analyses. Forty-two of
the remaining 99 patients (42 %) did not have chronic severe respira-
tory disease by the standardised definition. There was no significant
difference in APACHE-II, ICU mortality, ICU length of stay, hospital
mortality or hospital stay. The standardised mortality ratio was 0.752
(95 % CI 0.748-0.756) for appropriately coded patients and 0.855
(95 % CI 0.848-0.862) for inappropriately coded patients.
Conclusions
Almost half of patients are wrongly coded as having chronic severe re-
spiratory disease. Moreover, this clearly impacts the SMR for this group
of patients. Such errors in data entry compromise conclusions drawn
from this cohort and comparisons made with prior cohorts and other
ICUs. In order to improve this resource, stringent documentation by cli-
nicians and education of those inputting the data is required.
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Fig. 95 (abstract A217).
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Introduction
Primary graft dysfunction is a significant cause of lung transplant mor-
bidity and mortality, but its underlying mechanisms are not completely
understood.
Objectives
Aims of the study: 1) to confirm that right ventricular function is a risk fac-
tor for severe primary graft dysfunction; 2) to propose a clinical model for
predicting the development of severe primary graft dysfunction.
Method
A prospective cohort study was performed over 14 months. The pri-
mary outcome was development of primary graft dysfunction grade
3. An echocardiogram was performed immediately before transplant-
ation, measuring conventional and speckle-tracking parameters. Pul-
monary artery catheter data were also measured. A classification and
a regression tree were made to identify prognostic models for the
development of severe graft dysfunction.
Results
Seventy lung transplant recipients were included. Patients who devel-
oped severe primary graft dysfunction had better right ventricular func-
tion, as estimated by cardiac index (3.5 ± 0.8 vs. 2.6 ± 0.7 l/min*m2; p <
0.01) and basal longitudinal strain (-25.7 ± 7.3 vs. -19.5 ± 6.6 %; p < 0.01).
Regression tree analysis provided an algorithm based on the combined
use of three variables (Basal longitudinal strain, pulmonary fibrosis dis-
ease and ischemia time), allowing accurate preoperative discrimination of
three distinct subgroups with low (11 to 20 %), intermediate (54 %) and
high (75 %) risk of severe primary graft dysfunction (AUROC 0.81).
Conclusions
Better right ventricular function is a risk factor for the development
of severe primary graft dysfunction. Preoperative estimation of right
ventricular function could allow early identification of recipients at in-
creased risk, who would benefit the most from careful perioperative
management in order to limit pulmonary overflow.
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Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized
by a perturbation in surfactant homeostasis, resulting in its accumu-
lation within alveolar spaces, with a consequent development of se-
vere hypoxemia.
Whole lung lavage (WLL) is a complex procedure, dedicated to those
patients affected by a severe condition not responsive to medical
treatment[1].
Objective
To analyze the evolution of gas exchanges during WLL, evaluating
PaO2 variations during the different phases of the procedure.
Patients and method
We enrolled 27 patients with PAP (16 males, age 15-64 years),
who underwent WLL in our ICU between 2010 and 2015.
WLL was conducted in general anesthesia, using selective endo-
tracheal tubes. It consisted of different phases, for each lung: 1)
bipulmonary mechanical ventilation in supine position at FiO2 1
and ZEEP; 2) bipulmonary ventilation in supine position with
PEEP; 3) monopulmonary ventilation in supine position, in order
to achieve complete atelectasis of the contralateral lung; 4)
monopulmonary ventilation in lateral position, with the ventilated
lung downward; 5) lavage of the whole atelectatic lung with li-
quid tidal ventilation at different levels of hydrostatic lavage
pressure.
We collected data regarding patient gas exchanges by performing
several blood gas analysis during the different steps of WLL. We
expressed data as mean ± standard deviation (SD).
Results
Figure 95 shows the mean values of PaO2 during the different
phases of WLL. During bipulmonary ventilation gas exchanges im-
proved in response to FiO2 1 and PEEP. Monopulmonary ventila-
tion, instead, induced a clear reduction of PaO2, which increased
in lateral position and during liquid tidal ventilation, with a sub-
stantial effect of elevated hydrostatic lavage pressures. The wide
SD indicates an uneven response of gas exchanges in the studied
population.
Conclusions
The pathophysiology of PAP is characterized by altered alveolo-
capillary diffusion and intrapulmonary shunt, thus significantly
responsive to FiO2 and PEEP, respectively. During monopulmon-
ary ventilation, shunt is reduced by the lateral position, which
provides a better perfusion of the ventilated lung, and the ele-
vated hydrostatic lavage pressures, which are able to limit per-
fusion in the contralateral lung under WLL.
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Introduction WHO reported that influenza A(H1N1) pandemic in
2009 caused 4100 deaths globally[1]. New Delhi reported 2241 cases
in 2015 with 8 confirmed deaths till March 2015 [2]. The mortality in
severe refractory ARDS related to H1N1 influenza A pneumonia is
high [3]. During 2015 swine flu epidemic our hospital admitted 162
adult patients who were either suspected or confirmed cases.
Objectives To study the epidemiological and clinical profile of pa-
tients admitted to BLK Superspeciality Hospital, New Delhi during
2015 H1N1 influenza epidemic.
Method Data was collected retrospectively from hospital records
after IRB approval, for patients admitted either as a suspected or
proven case (outside) of Influenza A (H1N1) pneumonia. Demograph-
ical details, category of presentation, hospital and ICU course and
ventilation strategies applied were collected.18 patients were ex-
cluded as significant data was missing from records.
Results We analysed 144 patients out of which, 66 % (n = 96) were
from an urban background and 33 % (n = 48) were from a rural
background. 56.9 % (n = 82) patients were H1N1 positive by RT-PCR
technique. 24.4 % (n = 20) had a positive history of contact with
established H1N1 cases, whereas history of travel to affected areas
was present in 54.6 % (n = 45) patients. Maximum admissions were
reported in the month of February (n = 47) and March( n = 28).
21.8 % patients ( n = 21 ) were belonging to age group 30 - 35 years
and > 60 years age group.15.85 % (n = 13) of all the positive patients
were of Category C, who were admitted to ICU directly.
71.6 % (n = 58) were managed with non invasive ventilatory support
only, and 14.6 % (n = 12) were intubated and mechanically venti-
lated. 10 out of 12 patients requiring intubation and mechanical ven-
tilation belonged to Category C. 75 % (n = 9) of intubated patients
had refractory hypoxemia (mean PaO2/FIO2 ratio 61.33 ± 4.05), and 6
patients required early prone ventilation. 8.5 % (n = 7) patients died
and all of them were mechanically ventilated. 89 % (n = 73) were
successfully discharged from the hospital. Mean ICU and hospital
LOS was 3.83 ± 4.06 days and 7.53 ± 4.2 days respectively. Higher
mortality rates was also seen in those patients who had more
than 3 days of time lag for initiation of oseltamivir after the
symptom onset (n = 5).
Conclusions Influenza A H1N1 pneumonia is a significant burden
during epidemics associated with a high morbidity. The mortality
among severe refractory ARDS patients who were invasively venti-
lated is very high.
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Severe community-acquired pneumonia patients bear the highest
morbidity, in-hospital mortality, and cost of all patients with commu-
nity acquired pneumonia[1]. The appropriate management of these
patients has received close attention in the current era of rising
health care costs. Nevertheless, the outcome of these patients re-
mains poor[2] and it is unknown which patient characteristics or
treatment modalities are associated with a better outcome.
By combining a national registry with a specifically designed question-
naire we were able to examine the factors related to organizational
characteristics and treatment policies that might explain the variation
in mortality outcomes in sCAP patients in the ICU.
Method
This study used a dataset from a national registry containing data on
patient and ICU level combined with a web-based survey on treat-
ment policies. The relationship between in-hospital mortality and
determinants was analyzed using multivariable logistic regression
analysis.
Results
From January 1st , 2008 to January 1st 2013, 79 Dutch ICUs provided
data to the registry, from which 62 (78.5 %) returned the question-
naire. The responding ICUs admitted 11,245 patients with severe
community-acquired pneumonia. These patients had a higher sever-
ity of illness than the general medical ICU population and their mor-
tality was also higher (ICU mortality 17.8 %; hospital mortality 25.1 %
versus ICU mortality 15.8 %; hospital mortality 22.5 %, respectively).
Severe community-acquired pneumonia patients had more co-
morbidities and stayed longer at the ICU. Rare use of tracheostomies
for the weaning process (OR:0.784(0.662-0.928)) was associated with
better outcomes in these patients. The need for mechanical ventila-
tion (OR:1.385(1.194-1.607)) was associated with poor outcomes as
was the case for the mean number of ICU admissions per year (OR:
1.006 ( 1.001-1.010).
Conclusions
CAP is a disease with a high in-hospital mortality. We have shown
that, after correction for confounding factors some treatment and
organizational factors are related with outcome in patients with
sCAP. The need for mechanical ventilation remained an independent
risk factor for mortality, and liberal use of tracheostomies for the
weaning process was also associated with higher mortality. The
mean number of ICU admissions with sCAP per year was inversely
correlated with hospital mortality. Many other parameters that are
often claimed to be associated with better or worse outcome (like
differences in antibiotic therapy) did not correlate with outcome.
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Background and objectives
Severe asthmatic patient who requires the use of invasive mechan-
ical ventilation in an intensive care unit is, despite its low incidence,
a potentially very serious case, which requires early and very specific
respiratory care. This care will largely determine the average ICU stay,
occurrence of secondary injuries or even death. Our objective is to
describe the characteristics of severe asthmatic patient admitted to
ICU and to analyze the initial treatment.
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Descriptive study of patients admitted to the ICU of the Clinical Hos-
pital Virgin of Arrixaca in the period between January 2011 and
September 2015. We analyzed different variables, age, sex, APACHE
II, SAPS II, parameters of mechanical ventilation, ICU stay and labora-
tory parameters.
Results
18 patients (6 women) admitted to the ICU with a diagnosis of se-
vere asthma. The average age was 35.06. The average stay in the ICU
was 14.39 ± 25.55 days, with 16.89 ± 6.67 APACHE II and SAPS II
33.72 ± 13.45 points. Eight patients needed non invasive mechanical
ventilation (44.4 %) with a failure rate of 50 % (4 patients). The use
of invasive mechanical ventilation was required in 10 patients, 3 of
them needed tracheostomy for prolonged mechanical ventilation
and sevoflurane Anaconda® device was used in 2 of them. Data res-
pirator parameters were collected during the first 48 hours, highlight-
ing VT (ml / kg) 6.46 ± 1.23, 2.25 ± 2.26 initial PEEP, Ppeak 37.0 ±
13.32 and 12.57 ± 4.68 AutoPEEP cm H2O. The average pH at admis-
sion was 7.21 ± 0.14 with a range of [6.99 to 7.40], PCO2 of 64.5 ±
24.22 mm Hg and a lactate concentration of 2.91 ± 2.11 mMol/L. All
patients were administered inhaled beta-agonists (two patients sal-
butamol endovenous) and corticosteroids. 5 patients required mag-
nesium sulfate, 11 patients required sedation; 6 of these patients
required relaxation with atracurium or cisatracurium. One patient
presented barotrauma while using noninvasive mechanical ventila-
tion prior to endotracheal intubation.
Conclusions
The clinical profile of patients admitted to the ICU with severe/status
asthmaticus is a young male, with requirements of invasive mechan-
ical ventilation after the failure in using medical gases such as helium
and noninvasive mechanical ventilation. The strategy of ventilation is
protective with permissive hypercapnia.Table 72 (abstract A220). Characteristics (n = 18)
Average age 35,06
Woman 6 (33,3%)
Average stay (days) 14,39±25,55
APACHE II 16,89±6,67
INVASIVE MECHANICAL VENTILATION 10 patients
Tidal Volume (ml/kg) 6,46±1,23
AutoPEEP (cm H2O) 12,57±4,68)
pH at admission 7,21±0,14. Range [6,99-7,40]
pCO2 (mm Hg) 64,5±24,22
Ion lactate at admission 2,91±2,11A221
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Introduction
Viral influenza, especially influenza A (H1N1) pandemic influenza, is
associated with a significant increase in morbidity and Intensive Care
Unit (ICU) admissions.
Objectives
The aim of this study is to characterise the burden of illness and sec-
ondary infection among critically unwell patients admitted to our ICU
this year.Method
A retrospective, observational, cohort study of critically ill adult pa-
tients with influenza admitted to a Level 3 ICU Dublin, between
Decemeber 2015 and March 2016. IntelliVue Clinical Information
Portfolio (ICIP) was used to obtain data.
Results
Critical illness occurred in twenty patients with confirmed influenza;
12 A(H1N1) (60 %), 1 A(H3N2) (5 %), 4 A(non-subtyped) (20 %) and 3
B (15 %). The median age was 50 years (42.5-66.5); 14 patients (70 %)
were under 65; 11 (55 %) were male. Thirteen (65 %) had comorbidi-
ties, including respiratory disease 5 (25 %), morbid obesity 3 (15 %)
and malignancy or immunosuppression 3 (15 %). One was pregnant
(5 %) and 8 (40 %) had a smoking history. Nine (45 %) were retrieved
from outside the Ireland East Hospital Group. The mean APACHE
(Acute Physiology and Chronic Health Evaluation) II Score and the
mean SOFA (Sequential Organ Failure Assessment) score, on day
one, were 17.85 ± 5.78 and 9.85 ± 3.33 respectively. Twenty (100 %)
were mechanically ventilated, for a median of 17.5 days (9.5-32).
Eighteen (90 %) satisfied the criteria for Acute Respiratory Distress
Syndrome, with a mean PaO2/FIO2 ratio on day one of 13.35 ± 6.46.
Fifteen (83.3 %) required rescue therapies for severe hypoxaemia, in-
cluding extracorporeal life support (ECLS) in five (25 %), prone venti-
lation and inhaled nitric oxide. Sixteen (80 %) received vasopressors,
and 12 (60 %) required renal replacement therapy. The median ICU
length of stay was 18.5 days (11-42) and as of 31st March 2016, three
(15 %) had died. Four (20 %) had documented early secondary infec-
tion, at less than 48 hours; streptococcus pneumoniae was the sole
isolate (100 %). Seven (35 %) were treated for presumed late (greater
than 48 hours) secondary infection; aspergillus fumigatus (28.6 %)
and pansensitive staphylococcus aureus (42.9 %) were the most
prevalent. All patients received a neuraminidase inhibitor: oseltamivir
was prescribed in 19 (95 %), for a median of 7 days (7-9.75), with 3
(20 %) patients receiving the higher, 150 mg twice daily, dosing
regime.
Conclusion
Seasonal influenza is a major public health concern. It is associated
with severe morbidity, resulting in significant economic conse-
quences, as well as a substantial burden on tertiary ICUs. In keeping
with national trends, the predominant circulating virus was influenza
A(H1N1) and secondary coinfection was common. Although trad-
itional teaching emphasises S.aureus as a common coinfection in viral
illness, our results highlight the importance of considering a broad
spectrum of bacterial, viral and fungal microorganisms when pre-
scribing empirically in the critically ill patient.
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Introduction
About 10-16 % patients are reintubated after planned endotracheal
intubation for 48-72 hours. Reintubation will increase the risk of
pneumonia, ventilator and ICU days, and resulting in 25-50 % mortal-
ity. Many studies had explored the risk factors of failed extubation,
but the integrated indexes for successfully planned endotracheal
extubation are inadequate.
Objectives
To establish useful predictors for successfully-planned extubation
which can be followed by medical personnel.
Method
The patients admitted to the adult ICUs of a tertiary hospital in
southern Taiwan, who met the criteria of intubated over 48 hours
and prepared for extubation were collected retrospectively between
January 2005 to December 2015. Patient's characteristics, disease se-
verity, rapid shallow breath index (RSBI), maximal inspiratory pressure
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 119 of 607(MIP), maximal expiratory pressure (MEP), cuff leak test (CLT) before
extubation, ICU days and outcomes were recorded retrospectively.
CLT was classified as 2+ with audible flow without stethoscope, 1+
with audible flow by stethoscope and negative (N) with no audible
flow even by stethoscope. Failure of extubation was defined as rein-
tubated within 48 hours.
Results
Totally 7460 patients were enrolled with 436 (5.8 %) patients failure for
extubation. The extubation failure rate of female was higher than male
(7.1 % vs 5.1 %, P < 0.001). Failure group patients were noted to have
older age (66.6 ± 14.5 vs 64.4 ± 16.4, P = 0.002), higher APACHE II score
(17.0 ± 7.5 vs 16.2 ± 7.9, P = 0.044), lower coma scale (10.1 ± 3.8 vs 10.6 ±
3.8, P = 0.019), higher RSBI (69.2 ± 38.0 vs 58.6 ± 30.2, P < 0.001), lower
MIP and MEP (-35.5 ± 15.1 vs -38.0 ± 14.7, P = 0.0001; 49.5 ± 28.2 vs 58.9 ±
30.5,P < 0.001 respectively), and higher mortality rate (24.6 % vs 10.7 %,
P < 0.001) as compared with successful group. After multivariate logistic
regression, cuff leak test 2 + (OR 1.85, P = 0.002), MEP≧55 cmH2O(OR 1.48,
P = 0.001), RSBI < 68 (OR 1.47, P < 0.001) and MIP < -40cmH2O(OR
1.26, P = 0.048) were found as predictors for successful extubation.
Conclusions
Cuff leak test, RSBI < 58, MEP≧60 cmH2O and MIP < -40cmH2O are iden-
tified as effective predictors for successfully planned endotracheal
extubation.
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Background
Respiratory system impairment may be caused by an increase of the
intra-abdominal pressure.
Aim of work: To assess the role of measuring intra-abdominal pres-
sure in predicting successful weaning from mechanical ventilation.
Method
124 patients with ARF fulfilling the criteria for weaning were in-
cluded. Each underwent a 1-hour SBT. All clinical, respiratory parame-
ters and mechanics were recorded. IAP was measured using Kron`s
technique at the beginning and every 15 minutes till the end of SBT.
The mean of IAP during SBT was calculated.
Results
Of 124 patients included in the study, 94 patients achieved success-
ful SBT and extubation, while 31 patients needed re-intubation
within 48 hours. Mean IAP was lower in patients achieved successful
SBT compared to patients who didn`t, 7.25 ± 2.28 vs 9.96 ± 2.6, p
value < 0.001. Moreover, patients who needed re-intubation within
48 hours had higher mean IAP compared to patients who didn`t,9.96 ± 1.4 vs 5.92 ± 1.17, P value < 0.001. Using Spearman´s rank cor-
relation coefficient, it was found that mean IAP was positively corre-
lated with auto PEEP that measured at the beginning and at the end
of SBT, and admission APACHE II score, with correlation coefficient
measuring 0.515, 0.595, and 0.4 respectively.
Conclusion
High IAP predicts failure of SBT and need for re-intubation within
48 hours.
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Introduction
The use of life support in intensive care units (ICUs) is common
and associated with a high risk of poor outcome. However, the
prognostic importance of the duration of life support is less
studied.
Objectives
We aimed to assess the use of life support and the association be-
tween its duration and 90-day mortality in adult ICU patients.
Method
We performed a post-hoc analysis of the SUP-ICU 7-day inception
cohort study (1) conducted from Dec 2013 till April 2014 in 97
ICUs in 11 countries. From this cohort (n = 1034), we included
adult general ICU patients with an ICU stay of ≥3 days. We
assessed the use of life support day 1-3 in the ICU and the crude
and adjusted association between its duration and 90-day mortal-
ity using logistic regression analysis.
Results
We included 690 patients with a 90-day mortality rate of 23 %. During
the first 3 days in ICU, 65 % of the patients received respiratory support,
57 % circulatory support and 13 % renal replacement therapy (RRT). Pa-
tients receiving 3 days of RRT had the worst outcome (OR 6.5 [95 % CI
1.3 - 32.8]) as compared to patients receiving 1 day. For respiratory-
and circulatory support the odds ratios were 2.2 [0.9 - 5.3] and 1.2 [0.5 -
2.6], respectively (Fig. 96).
Conclusions
The outcome of adult ICU patients was associated with both type
and duration of life support. RRT seemed to be associated with worst
outcome, potentially because kidney failure often occurs concomi-
tantly to respiratory and circulatory failure.
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Introduction
Effective lung volume (ELV) can be calculated continuously using a
capnodynamic equation, and correlates well with functional residual
capacity (FRC) in healthy lungs in a porcine model [1]. Hypercapnia is
common in the ICU during lung protective mechanical ventilation,
and may affect the capnodynamic method.
Objectives
The aim of this study was to evaluate ELV during induced hypercapnia
in pigs, and to confirm its stability during hemodynamic challenges.
Method
A cyclic sequence altering breaths with expiratory holds with normal
breaths induces periodic changes in alveolar concentration of carbon
dioxide. By integrating these variations into the capnodynamic equa-
tion ELV can be calculated. Hypercapnia was induced by increasing
instrumental dead space in eight anaesthetized, relaxed and mech-
anically ventilated pigs. FRC was measured with a Sulfur-hexa-
fluoride wash out technique. Cardiac output (CO) was measured
using an ultrasonic flow probe placed around the pulmonary artery
trunk. Hemodynamic measurements and blood gas analysis were ob-
tained during normocapnia and during hypercapnia at baseline, pre-
load reduction (cava balloon inflation) and dobutamine stimulation.
Results
Carbon dioxide levels raised from (mean (SD)) 5.6 kPa (0.40) to 9.2
kPa (0.47) during hypercapnia. The bias (limits of agreement, LoA) for
ELV at normocapnia was 303 (131 to 476) ml, and percentage error
(PE) was 31 %. During hypercapnia, bias (LoA) decreased to -75 (-188
to 39) ml, and PE to 20 %. The hemodynamic interventions resulted
in significant changes in CO, i.e. a decrease by 41 % (caval occlusion)
followed by a 59 % increase (dobutamine inf.). ELV and FRC
remained stable throughout these changes (Fig. 97).
Conclusions
ELV showed good performance during hypercapnia. The Method
shows good stability during severe changes in cardiac output. This
indicates that it would be interesting to further evaluate if the
Method could be suitable for monitoring lung function in the ICU for
instance during protective lung ventilation with permissive hypercap-
nia or in septic patient with hyper dynamic hemodynamics.References
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Introduction
In ARDS, independent of severity, lung protective strategy implies a
high-PEEP ventilation setting to prevent end-expiratory collapse and
to prevent cyclic alveolar opening and closing. [1] [2]
Objectives
Measure the intratidal collapse and decollapse at similar tidal vol-
umes at positive end-expiratory pressure (PEEP) of 5 and 15 cmH2O.
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ARDS patients [3] underwent expiratory and inspiratory CT scans at
5-15 cmH2O PEEP during inspiratory and expiratory pause keeping
constant the tidal volume (6-8 ml/kg IBW). In each of the CT slices,
lung profiles were manually delineated, excluding hilar structures.
Thereafter, quantitative analysis of CT scan images was performed
with a dedicated software package (Soft-E-Film, www.elekton.it).
Lung tissue was classified, according to its gas/tissue content, as not
inflated when CT number between +100 and -100. [4] Lung collapse-
decollapse was estimated as:
1. Collapse-decollapse PEEP 5 cmH2O = not inflated 5 insp (g) -
not inflated 5 esp (g) Collapse-decollapse PEEP 15 cmH2O = not
inflated 15 insp (g) - not inflated 15 esp (g)
Results
Thirty-three ARDS patients were enrolled (5 mild, 10 moderate and
18 severe). As shown in Fig. 98, within a given class of severity, the
grams of tissue undergoing the intratidal collapse did not change
significantly between PEEP 5 or 15 cmH2O (63 ± 26 vs 39 ± 32, 92 ±
53 vs 78 ± 142 and 123 ± 94 vs 96 ± 84 in mild, moderate and severe
ARDS respectively). We observed a clear tendency to decrease from
PEEP 5 to 15 cmH2O, though it was not statistically significant
(p = 0.23, 0.76 and 0.27 respectively in mild, moderate and se-
vere ARDS - paired t-test).
Conclusions
A consistent intratidal collapse and decollapse is still present at 15
cmH2O PEEP. We observed a clear tendency to decrease at 15
cmH2O PEEP, though it was not significant.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a common prevent-
able and treatable disease. Low level laser (LLL) therapy appears to
be a promising noninvasive modality in COPD management.
Objectives
Study the short-term effects of LLL therapy on clinical and cardiac
status in stable COPD patients.Method
After exclusion of patients with Impaired left ventricular systolic func-
tion, atrial fibrillation, pulmonary hypertension due to causes other
than COPD, and those who had any contraindication to exercise test,
thirty stable COPD patients were divided into laser and control
groups (15 pts each). Medical treatment was optimized in each
group with the addition of LLL in the laser group.
In addition to history and physical examination, MMRC scale, 6 MWT,
echocardiography with measurements of RV dimensions, TAPSE, and
lateral tricuspid annulus tissue Doppler velocities were assessed in
each patient before and after LLL. The LLL was done using the fol-
lowing parameters: Wave length: 905 nm, Output 5-20 mw & Fre-
quency 500 HZ. Laser probe was placed on intercostal space
corresponding to the site of lesion both anteriorly and posteriorly on
chest wall and arm with standardized laser acupuncture points of ap-
plication with a frequency of 5 sessions/week for 2 successive weeks.
Results
No significant differences in both groups regarding demographic
data. The laser group had higher PASP, lower E´, and higher A´ vel-
ocities versus control with p 0.009, 0.03, and < 0.0001 respectively.
The laser group showed more improvement in MMRC scale and 6
MWT versus control. 100 % of laser patients showed improvement in
MMRC scale by at least one grade versus 46 % in the control. In laser
group, 6 MWT was 24.4 ± 10.4 before the study versus 52.9 ± 14.7
meters at the end of the study, p 0.001. In control, 6 MWT was 32.4 ±
14.9 versus 40.1 ± 19.2, p 0.003. No significant changes between any
of the echocardiographic criteria before and after the study.
Conclusions
The use of LLL was associated with more clinical improvement. No
echocardiographic changes were noticed after LLL.
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Introduction
Timing of extubation is of clinical importance as extended periods of
intubation and premature extubation resulting in reintubation are
both associated with negative patient outcomes[1]. Adult intensive
care unit (AICU) extubation failure rates of 10-20 % have been
reported[2].
Within a large, UK teaching hospital it was identified that extubation
assessment was a multidisciplinary decision but different clinicians
applied varying criteria and assessment was not standardised. Fol-
lowing a review of extubation failure rates, a quality improvement
initiative was instigated including the development of local ventilator
weaning guidelines and physiotherapy (PT) led assessment of extu-
bation suitability.
Objectives
The aims of this evaluation were to describe the PT assessment of
extubation suitability in the AICU and to report extubation failure
rates.
Method
All patients under consideration for extubation by the AICU physi-
cians, who underwent a PT assessment of extubation were included.
This assessment was documented within the patient's electronic
casenotes.
Data was collected by retrospective casenote review during a 3 week
period in August 2015. The project was registered as a service evalu-
ation and therefore ethics requirements were waived. Demographics,
details of the PT assessment ,and outcomes following extubation
were collected (Table 72). Extubation failure was defined as reintuba-
tion up to one week following extubation.
Fig. 100 (abstract A228). Parameters in relation to PT advice given
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Data was collected from 45 PT assessments. These assessments most fre-
quently included neurological status, Rapid Shallow Breathing index
(RSBi), occlusion pressure during initial 100 ms of inspiration (P0.1), Nega-
tive Inspiratory Force (NIF), peak cough flow (PCF) and secretion load.
Range of values for the assessed parameters are shown below.
When providing opinion regarding suitability for extubation, PTs
gave more weight to neurological status, PCF and secretion load
than other weaning parameters (see image below). They were more
likely to recommend against extubation in the presence of low PCF,
inappropriate neurology and large secretion load.
Conclusions
Physiotherapists frequently include neurological status, work of
breathing, PCF, secretion load and NIF in their assessment for extuba-
tion. They predominantly use neurological status, cough strength
and secretion load to inform recommendations regarding extubation.
The extubation failure rate of 15 % is in keeping with current litera-
ture although the studied sample size was small.
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Demographic
Age (median) 56.5
% male 68
Number of patients 33
Number of assessments 45
Days ET ventilated (median) 3
Extubationn events 33
Failure rate 15%
Table 74 (abstract A228). Parameters assessed
Parameter Frequency of assessment (%, n=45)
Neurology 88
RSBi 90
P01 95
NIF 90
PCF 100
Secretion load 90
Fig. 99 (abstract A228). Ranges of parameters assessedCLINICAL STUDIES ON ARDS AND
MECHANICAL VENTILATION
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Introduction
Reclassification after 24 hours using PaO2/FiO2 and PEEP thresholds im-
proves the prognostication of patients with moderate/severe ARDS [1,2]
but it is uncertain if this also holds true for patients with mild ARDS.
Objectives
The aim of this investigation was to determine if reclassification after
24 hours using PaO2/FiO2 and PEEP thresholds improves prognosti-
cation of mortality in a cohort of prospectively identified patients
with mild ARDS in two intensive care units in the Netherlands.
Method
Patients with mild ARDS, according to the Berlin definition [3], were
categorized into 4 groups based on measurements obtained at pres-
entation of ARDS or 24 hours after: PaO2/FiO2 ≥ 250 mm Hg and
PEEP = 5 cm H2O (group I); PaO2/FiO2 ≥ 250 mm Hg and PEEP >
5 cm H2O (group II); PaO2/FiO2 < 250 mm Hg and PEEP = 5 cm H2O
(group III); PaO2/FiO2 < 250 mm Hg and PEEP > 5 cm H2O (group IV).
Patients no longer receiving mechanical ventilation after 24 hours
were classified as 'extubated' (group 0). No patients died within
24 hours. The primary outcome was all-cause in hospital mortality.
Secondary outcomes were , ICU- and 90-day mortality and the num-
ber of ventilator-free days and alive at day 28.
Results
Of 7,784 patients, 693 patients had ARDS of which 164 patients with mild
ARDS and on invasive ventilation were included in the analysis. Table 75
shows outcomes per group at the moment mild ARDS was diagnosed,
and after 24 hours. Reclassification after 24 hours showed an improved
prognostication with regard to hospital mortality, ICU- and 90-day mortal-
ity and the number of ventilator-free days and alive at day 28.
Conclusions
Reclassification after 24 hours using two simple cutoffs improves
prognostication in mild ARDS patients.
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Table 75 (abstract A229). Distribution of outcome in patients with
mild ARDS
at
onset
Group 0
(n=0)
Group I
(n=28)
Group II
(n=29)
Group III
(n=38)
Group IV
(n=69)
P-value
ICU
mortality
- 7% 17% 18% 26% 0.03
All-cause
hospital
mortality
- 39% 38% 29% 36% 0.73
90-day
mortality
- 39% 38% 42% 40.5% 0.83
VFD-28 - 22 [15-
25]
23 [7-25] 22 [8-25] 17 [0-24] 0.09
after 24
hours
Group 0
(n=20)
Group I
(n=27)
Group II
(n=15)
Group III
(n=42)
Group IV
(n=60)
P-value
ICU
mortality
0% 7% 20% 12% 37% <0.0001
All-cause
hospital
mortality
10% 33% 27% 38% 45% 0.0073
90-day
mortality
20% 30% 33% 45% 50% 0.0057
VFD-28 27 [27-
27]
21 [11-
25]
20 [2-24] 21 [13-24] 11 [0-21] <0.0001
Data are medians [IQR] or percentages. P-value is p-for trend or p for linear
regression
Abbreviations: ARDS acute respiratory distress syndrome, VFD-28 ventilator free
days and alive at day 28
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Introduction ARDS still carries a high mortality. Therefore, extracor-
poreal lung membrane oxygenation (ECMO) should be considered in
these patients. However, indication and timing of ECMO are still con-
troversial. Several recent ECMO registries suggest that early initiation
of ECMO might be more beneficial than its use as a rescue therapy.
However, there is no consensus, according to which criteria ECMO
should be initiated. Most of the recent multi-centric studies such as
CESAR, EOLIA and EXODUS (NCT02550600) include(d) patients based
on ARDS definitions and on scores like the Murray-score. However,
the predictive capabilities of these scores depending on the time
after intubation are poorly investigated.
Objectives
To compare the predictive capabilities of pO2/FiO2, oxygenation-index
OI (mean airway pressure*FiO2/pO2), AECC- and Berlin-definition of
ARDS, single components of the Murray-score and its total score with-
out radiological points (Murray-WRP) regarding ICU-, 28d- and hospital
mortality in 43 patients screened for the EXODUS-study.
Method
28 male, 15 female patients with ARDS according to Berlin-definition.
PiCCO-monitoring (Pulsion, Germany) in 25 patients. Statistics: SPSS 23.
Results
Primary ARDS in 17 of 43 cases (39 %), secondary ARDS in 26/43
(61 %). ALI in 22 (51 %) and ARDS according to AECC in 21 (49 %)
out of 43 cases. Mild, moderate and severe ARDS according to theBerlin definition in 20 (46.5 %), 20 (46.5 %) and 3 (7 %) of the pa-
tients. Due to prolonged hospitalization the final outcome was avail-
able in only 40 of 43 patients. 28-day-, ICU- and hospital-mortality
rates were 13/40 (33 %), 19/40 (48 %) and 20/40 (50 %). On the day
of intubation, 28-day mortality (primary endpoint) was best predicted
by OI (ROC-AUC 0.725; p = 0.026), pO2/FiO2 (ROC-AUC 0.725; p =
0.026) and Murray-WRP (AUC 0.702; p = 0.046). By contrast, AECC
(AUC 0.648), Berlin (AUC 0.667) and APACHE-II (AUC 0.639) were not
predictive. While Murray-WRP was predictive on day-1, it was not
predictive on day-2 (AUC 0.688; p = 0.057), day-3 (AUC 0.604; p =
0.338) and day-4 (AUC 0.598; p = 0.390).
Pulmonary vascular permeability index PVPI on day-2 (AUC 0.825; p =
0.013; largest of all AUCs), on day-3 ( AUC 0.810; p = 0.018) and on day-
4 (AUC 0.800; p = 0.048) as well as extravascular lung water index EVLWI
on day-2 (AUC 0.782; p = 0.032) significantly predicted mortality. PVPI >
2 on day-2 predicted 28d-mortality with a specificity of 94 %, a sensitiv-
ity of 57 % and an accuracy of 80 %.
Conclusions
OI, pO2/FiO2 and Murray-WRP predict mortality of patients with
ARDS on the day of intubation. By contrast, AECC- and Berlin-
definition were not predictive. Since Murray-WRP on the 2nd, 3rd and
4th day after intubation were less predictive than on the day of in-
tubation, earlier consideration of ECMO might be preferable. High
values of PVPI and EVLWI on day-2 were the best predictors of 28-d
mortality in the subgroup with PiCCO.
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Introduction In the Lung Injury Prevention Study with Budesonide
and formoterol (LIPS-B), we studied feasibility of nebulized budeso-
nide and formoterol to prevent or alleviate lung injury in patients at
risk for ARDS. All available blood samples obtained prior to study
drug and on hospital day 2 were analyzed for biomarkers associated
with progression or severity of ARDS.
Objectives
To determine if early administration of inhaled budesonide and for-
moterol modulates ARDS-associated plasma biomarkers.
Method
Serum samples were analyzed in duplicates with Luminex Plate in a
1:2 dilution and per manufacturer´s directions. Analytes were IL-6,
vWF-A2, IL-8, IL-10, RAGE, ICAM-1, and SP-D. We analyzed biomarker
concentrations in specimens from the treatment versus placebo arms
at baseline (before the study drug delivery) and day 2 (after at least
one dose of the study drug). The observed concentrations that were
above or below calibrated expected range were replaced with high-
est and lowest observed within the range concentration values, re-
spectively. Subsequently, the values were log-transformed and
differences between treatment arms were compared by type 3
folded F test.
Results
Of 59 enrolled patients, 39 had samples available for baseline and
day 2. The log-transformed values of IL-6, vWF-A2, IL-8, RAGE, and
ICAM-1 decreased on day 2 with the observed decreases being
greater in the treatment arm. However, the differences were not sta-
tistically significant: IL-6 p = 0.16, vWF-A2 p = 0.9, IL-8 p = 0.68, RAGE
p = 0.27, ICAM-1 p = 0.1. Interestingly, IL-10 also decreased in the
treatment arm while slightly increasing in the placebo arm, although
differences were not significant (p = 0.28). The concentration of SP-D
increased on day 2 in both arms with a non-significant greater in-
crease in the placebo arm (p = 0.5).
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Early treatment with nebulized budesonide and formoterol in pa-
tients at risk for ARDS in LIPS-B trial did not significantly alter serum
levels of biomarkers associated with acute lung injury on day 2 of
hospital admission. However, IL-6 and ICAM-1 showed trends toward
greater reduction in treated patients and our small sample size likely
lacked power to detect smaller differences between two arms.
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Introduction
In the past 20 years, management of the acute respiratory distress syn-
drome (ARDS) has been revolutionised by the application of lower tidal
volume, lung protective ventilation strategies. Whilst our understanding
of ARDS management has improved, the worldwide incidence and out-
comes are unclear, with several studies reporting highly variable re-
gional incidence rates, and no studies characterising ARDS
epidemiology in Asia.
Objectives
The goal of this observation study was to determine the incidence,
mortality and management practices of ARDS in a developed South
East Asian country.
Method
We conducted a prospective, population based observational study in
6 public hospitals. During a one month period from May to June 2015,
we identified all patients admitted to any Singapore public hospital in-
tensive care unit (ICU) who met ARDS criteria. Demographic informa-
tion, clinical management data and ICU outcomes data were collected.
Concurrently, a survey was conducted to determine ARDS manage-
ment preferences of physicians at the study centres involved.
Results
A total of 904 adult patients were admitted to the ICUs during the study
period and 16 patients met ARDS criteria, using the Berlin definition.
Based on this, the unadjusted incidence of ARDS in Singapore is 5.49
cases per 100,000 population and 1.76 % of all ICU patients. Most pa-
tients belonged to Medical ICUs (56 %), were male (75 %), Chinese (62 %)
and had pneumonia (73 %). Management strategies varied across all
ICUs. Our survey results showed that the majority of physicians thought
that it was useful to study ARDS prevalence but that they believed overall
mortality and prevalence was decreasing. Our 28 day in hospital mortality
was 15 % and median length of stay was 7 ± 3 days.
Conclusions
The incidence of ARDS in a developed S.E Asia country is comparable
to European reported rates. The proportion of ventilated patients de-
veloping ARDS is lower than international studies published in differ-
ent regions. However, management strategies varied considerably.
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Introduction
A restrictive, post resuscitation, fluid balance strategy for patients
with Acute Respiratory Distress Syndrome (ARDS) has been sug-
gested by the fluid and catheter treatment trial (FACTT) study in
2006. This showed increased ventilator free days and trends towards
reduced mortality with no change in other organ dysfunction with
restrictive fluid balance compared to a liberal fluid balance.
Objectives
Quantify fluid balance, severity of illness and mortality of ARDS patients.
Aim to reduce post resuscitation fluid balance in our population.
Method
Retrospective review of all patients coded as ARDS for Intensive Care
National Audit and Research Centre (ICNARC) from 1/1/12 to 31/12/
15. A review of the electronic record and comparison of APACHE II
score, ventilator free days, mortality and fluid balance. Data was com-
pared to the FACTT study.
Results
86 patients were included for analysis, mean age was 53 with a pre-
dominance of females (54 %). 74 (86 %) were ventilated, with a mean
ventilator free days of 9.7. Mean post resuscitation fluid balance was
4950mls. 51 % of patients had an underlying diagnosis of pneumo-
nia. Mean APACHE II score was 17.5 and unit stay was 10.9 days.
Overall mortality was 46 % compared to 25.5-28.4 % in the FACTT
trial group. The mean fluid balance was 3 litres less in the survivors
compared with those who died, however, APACHE II score was 14.8
in the survivors and 20.4 in the group that died (p value 0.03).
Mortality was 37.0 % in patients who received a cumulative post re-
suscitation fluid balance of less than
1 litre and 49.1 % in patients with fluid balance greater than 1 litre
(p value 0.35).
Conclusions
A trend towards improved mortality with less fluid was observed but
not statistically significant. Higher than expected mortality could be ex-
plained by the exclusion criteria for the FACTT population in particular
chronic lung disease. Further education of junior medical and nursing
staff, a daily review of fluid balance has been emphasised and re-audit
in 18 months to keep awareness high were recommended.
Reference
1. The National Heart, Lung, and Blood Institute Acute Respiratory
Distress Syndrome (ARDS) Clinical Trials Network. Comparison of Two
Fluid-Management Strategies in Acute Lung Injury. N Engl J Med 2006;
354:2564-2575.
A234
Relationship between age and mortality of acute respiratory
distress syndrome (ARDS)
C.-H. Wang1, H.-C. Hu2, I.-J. Li3, W.-R. Tang1, K.-C. Kao4
1Chang Gung University, School of Nursing, College of Medicine,
Taoyuan, Taiwan, Province of China; 2Chang Gung Memorial Hospital,
Division of Thoracic Medicine, Taoyuan, Taiwan, Province of China;
3Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation,
Department of Nursing, New Taipei City, Taiwan, Province of China;
4Chang Gung Memorial Hospital, Department of Respiratory Therapy,
Taoyuan, Taiwan, Province of China
Correspondence: H.-C. Hu – Chang Gung Memorial Hospital, Division
of Thoracic Medicine, Taoyuan, Taiwan, Province of China
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A234
Introduction
Old patients have become an increasingly prevalent proportion of the
critically ill population. The outcomes of patients with acute respiratory
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 125 of 607distress syndrome (ARDS) were improving in recent years. However,
limited information existed on the studies for elderly of ARDS patients.
Objectives
To evaluate the factors associated with mortality of ARDS patients and
investigate the relationship between age and mortality in ARDS patients.
Method
We performed a prospective observational study in adult ICUs at the
Chang Gung Memorial Hospital from October 2012 to May 2015. Pa-
tients were included if they met the Berlin definition of ARDS. Data
collected included patients' demographic, severity of illness, manage-
ment and clinical outcomes. All the studied patients were followed
until discharged from the hospital.
Results
During the study period, 22470 receiving invasive mechanical ventila-
tion patients admitted to adult ICUs with PaO2/FiO2 < 300 mmHg
were screened. Totally, 945 ARDS patients were included for analysis.
The mean age and hospital mortality were 63.2 ± 16.1 years and
56.9 %. Of these 945 ARDS patients, 463 (49 %) patients were older
than 65 years. By multivariate logistic regression analysis, factor asso-
ciated with hospital mortality included body mass index (odds ratio
1.07, 95 % confidence interval 1.04-1.11; p < 0.001), Sequential Organ
Failure Assessment score (odds ratio 0.88, 95 % confidence interval
0.81-0.95; p = 0.002), Lung Injury Score (odds ratio 0.68, 95 % confi-
dence interval 0.46-1.00; p = 0.05) and PaO2/FiO2 (odds ration 0.995,
95 % confidence interval 0.991-1.00; p = 0.04). The hospital mortality
in ARDS patients younger than 65 years was significantly lower than
ARDS patients older than 65 years patients (50.2 % vs. 63.9 %, p <
0.001). For ARDS patients older than 65 years, we classified the pa-
tients as the young-old (65 ~ 74 years, n = 194, 41.9 %), middle-old
(75 ~ 84 years, n = 189, 40.8 %) and old-old (≥85 years, n = 80,
17.3 %). The hospital mortality were not significantly different be-
tween these three group (63.9 % vs. 65.6 % vs.60 %, p = 0.682).
Conclusions
For ARDS patients, younger patients had lower mortality than older
patients. For ARDS patients older than 65 years, the age did not influ-
ence the hospital mortality.
Keywords
Elderly, Outcomes, Berlin definition, Mechanical ventilation
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Introduction
ARDS is a life-threatening condition characterized by increased lung
weight and loss of lung aeration. Recently, prone position as adjunct to
lung protective ventilation demonstrated significant mortality reduction
in ARDS patients[1]. Lung Ultrasound (LUS) has emerged as a powerful
diagnostic tool that could help in diagnosis and guide management at
the bedside. Performance of serial CT scans, the gold standard for lung
recruitment assessment, can be challenging and not feasible outside re-
search protocols.
Objectives
We hypothesized that, in ARDS patients, LUS could detect changes in
regional inflation during prone position compared to supine position
and over time. We also hypothesized that such changes correlate
with commonly monitored parameters of aeration, oxygenation and
ventilation, as measured by arterial blood gas analysis and respiratory
mechanics. Finally, we hypothesized that specific LUS aeration pat-
terns, identified immediately before and after prone position initi-
ation, are predictive of clinical response to this adjunctive treatment.
Method
In this observational prospective study on ARDS patients, we performed
LUS on the first day of prone position treatment at different timepoints: before (supine - S0), immediately after (P0) and 1 hour after (P1)
initiation of prone position, immediately before (Pfin) and after return-
ing the patient supine (Sfin). For the LUS protocol, we used a 2-4 MHz
curvilinear transducer and we divided each hemithorax in 2 anterior, 2
lateral and 3 posterior zones. The worst LUS pattern detected in each
zone was considered as characterizing the examined region. Off-line
image review by two independent physicians, unaware of timing, pos-
ition and patient's characteristics, was used to calculate a modified LUS
aeration score, as previously described[2]. Spearman's rank correlation
coefficient was used to correlate changes in LUS score (V-LUSS) with
changes in compliance and PaO2/FiO2 (P/F).
Results
We enrolled 13 ARDS patients, admitted to the Padova University
Hospital ICU [median age 58 years (IQR 53-61); median SAPSII 45.5 (IQR
33-52)]. V-LUSS between P0 and P1 correlated with changes in compli-
ance (r = 0.690; p < 0.05) and P/F (r = 0.70; p < 0.02) between S0 and
Sfin. V-LUSS P0-Pfin also correlated with changes in P/F (r = 0.61; p <
0.05) and compliance (r = 0.60; p < 0.05) between S0 and SFin.
Conclusions
LUS is feasible in ARDS patients in prone position and V-LUSS corre-
lates with changes in compliance and P/F. Moreover, the V-LUSS at
1 hour after initiation of prone position may predict the change in
compliance and P/F at the end of a pronation cycle, after returning
the patient in supine position.
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Introduction
Influenza A (H1N1) pneumonia could cause severe hypoxemia and
need mechanical ventilation support. The incidence of development
to ARDS and the related mortality rate in H1N1 pneumonia with re-
spiratory failure were not clear.
Objectives
Our purpose is to analyze the outcome of patients with ARDS caused
by influenza A (H1N1) in intensive care unit (ICU) requiring mechan-
ical ventilation.
Method
This was a retrospective study including adult patients with ARDS due
to confirmed influenza A(H1N1) pneumonia needed mechanical venti-
lation in a medical center between July 2009 and May 2014 in Chang
Gung Memorial Hospital in Taiwan. We investigated the patients' char-
acteristics, clinical presentation, severity of illness and outcomes.
Results
There were 199 influenza-infected patients hospitalized in ICU during
the study period. Seventy-three patients were confirmed influenza A
(H1N1), and 54 (82 %) patients developed to ARDS, including 36
(67 %) with severe ARDS and 14 (26 %) with moderate ARDS by
Berlin definition. Compared with non-ARDS influenza A (H1N1) pa-
tients, age was younger (50 ± 14 vs. 62 ± 16 years, p = 0.016) and
body mass index (BMI) was higher (26.7 ± 4.7 vs. 23.7 ± 4.0 kg/m2, p =
0.045) in ARDS patients. The duration of oseltamivir therapy in ARDS
patients was longer (7.2 ± 2.6 vs. 4.9 ± 0.7 days, p = 0.010) than no ARDS
patients. Despite significantly prolonged mechanical ventilation support
(20.7 ± 18.5 vs. 9.6 ± 9.8 days, p = 0.013) and intensive care unit stay
(21.7 ± 16.0 vs. 8.7 ± 8.2 days, p = 0.003) in ARDS patients, there were
Table 76 (abstract A237). Demographics and clinical data
Age 53.9 ± 16.3
Male 22 (73.3%)
Ever smoke 21 (67.7%)
Days of machanical ventilation 20 ± 18.9
Days in ICU 24 ± 19.3
Days in hospital 60.38 ± 44.04
Follow-up period (months) 65.8 ± 21.1
APACHE II 20,38 ± 7,42
SOFA 10 ± 3,44
LIS at admission 3,06 ± 0,63
Table 77 (abstract A237). HRQL by SGRQ
Total 24.1 ± 19.6
Symptoms 29.1 ± 26.5
Activity 32 ± 25.3
Impacts on Daily Life 17.6 ± 17.4
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p = 0.256) and hospital (37 % vs. 33.3 %, p = 0.809) between ARDS and
non-ARDS patients.
Conclusions
For patients with influenza A (H1N1) pneumonia complicated respira-
tory failure, high incidence developed to severe ARDS but not corres-
pond to high mortality rate.
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Introduction
In the last years, there has been an enormous research effort into the
knowledge of physiopathology of acute respiratory distress syndrome
(ARDS) which, together with the advances in critical care, has led to a
reduction in mortality. With declining fatality rates, the interest of re-
searchers has shifted from mortality statistics to other outcome param-
eters such as health-related quality of life (HRQL) after ARDS.
Objective
The aim of our study was to investigate HRQL in long-term survivors
(longer than 2 years) after ARDS, all of them ventilated with the low-
tidal volume protocol.
Method
A total of 54 patients more than 2-year survival after an ADRS episode
were identified between June 2008 and May 2009. 8 patients were ex-
cluded because of pulmonary o cardiovascular previous disease. 15 pa-
tients refused to participate. Finally, 31 previously healthy patients
participated in this study. The medical records were searched for demo-
graphic data, smoke status, ventilator data, length of ICU and hospital
stays and measures of severity of illness such APACHEII, LIS and SOFA.
HRQL was evaluated using the St George's Respiratory Questionnaire
(SGRQ).
SGRQ is a self-administered questionnaire that measures perceived
quality of life and impairments in health due to respiratory disease. It
contains 76 items in three domains (symptoms, activity, and impacts
on daily life) and a summary or total score. Scores range from 0
(good health) to 100 (poor health). The questionnaire has been vali-
dated in a Spanish population.
Results
The results of the demographic and clinical variables are shown in
Table 76.
Regarding the evaluation of HRQL by SGRQ, the mean scores were
slightly higher in all domains with regard to the reference values from
Spanish population by age and sex, indicating subjective respiratory
problems with an impact on daily life. Only 7 of our 31 patients
(22.6 %) had scores normal in all domains and in the total scores. 18
patients (58.1 %) had higher scores in all domains. The other 6 patients
(19.3 %) had a higher score in some of the domains. Table 77Conclusions
· ARDS has a negative impact on the quality of life of survivors de-
tectable even beyond two years after the acute episode.
· Domains of activity and symptoms are the most affected in patients
who survive ADRS.
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Introduction
Appropriated level of positive end expiratory pressure (PEEP) can im-
prove oxygenation and avoid ventilator induced lung injury. Many
Method for setting PEEP have been proposed, but they are long-
standing and difficult to perform in clinical practice, or based in oxy-
genation table, ignoring individual mechanical characteristics. We
propose a Method to titrate PEEP at bedside, that considers regional
respiratory mechanical differences, in a fast and practical way.
Objectives
Compare agreement between a PEEP titration Method performed
fast (about 7 minutes) and slow (about 45 minutes).
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Eleven mechanically ventilated patients after elective cardiac surgery
with moderated ARDS according to the Berlin criteria, but using a P/F ≤
250 mmHg, received descending PEEP titration in steps of 2cmH2O from
23 to 5cmH2O performed in two randomly ways. One of them was per-
formed with steps of 40 seconds (total time less than 7 minutes), and
the other, in steps of 4 minutes (total time of 45 minutes). Each PEEP tri-
als were preceded by standard (or maximal) alveolar recruitment man-
ouver. PEEP trials were performed with PEEP titration tool available in
Electrical Impedance Tomography (EIT) device (ENLIGHT 1800, TIMPEL).
This tool [1] provides a report with a functional map ventilation, demon-
strating the amount of collapsed and hyperdistension tissue for each
step of PEEP. The minor PEEP with less than 5 % of collapse was chosen
as the optimal PEEP. This is part of a translational research, in the experi-
mental setting, 3 pigs with establish lung injury received a descendent
PEEP titration using EIT monitoring and dynamic Computed Tomog-
raphy (CT). The CT was performed to evaluate the correlation of col-
lapsed tissue amount in each step of PEEP between CT and EIT.
Results
There were no differences in optimal PEEP titrated with fast and slow ti-
tration Method (13,20 ± 3,58cmH2O versus 13,40 ± 3,37cmH2O, p =0,727).
The mean difference between two Method was 0,20 ± 1,75cmH2O with
limits of agreement of -3,23 to 3,63cmH2O. Analysing the amount of
collapse during entire titration, there was no significant differences be-
tween the fast and the slow titration (p = 0,401), however there
were differences between each PEEP steps (p < 0,001) and there
was no interaction between the fast and the slow titration groups
and PEEP steps (p = 0,997). There was a good correlation between
collapsed tissue provided by the EIT and CT (R2 = 0,97).
Conclusions
There is agreement between the fast and the slow titration Method
and the PEEP titration can be performed easily in less than 7 minutes
with EIT monitoring, at bedside.
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Introduction
Ventilation Induced Lung Injury (VILI) is associated with an increased
mortality in ARDS [1]. Through mechanical stress and strain of the lung,
VILI triggers an inflammatory response, which may be spatially charac-
terized by imaging techniques such as Positron Emission Tomography
combined with computed tomography (PET/CT). 11C-PK11195 is a PET
radiotracer with short half-life and potential to repeatedly quantify
macrophage inflammation.
Objectives
To evaluate 11C-PK11195 lung uptake and its association with mech-
anical strain assessed with CT, as well as its relation with both macro-
phage lung recruitment and histologic injury.
Method
VILI was performed in 5 anesthetized pigs by increasing the tidal vol-
ume (VT) to obtain a transpulmonary pressure (TPP) between 35 and40 cmH2O under zero end-expiratory pressure. CT and PET acquisi-
tions, were performed before (T1) and after 4 hours of high volume
ventilation (T2), and measurements were performed globally on the
whole lungs, and regionally by partitioning the lung in 4 regions
defined by the cephalo-caudal and the antero-posterior planes. 11C-
PK11195 uptake was quantified using the Standardized Uptake Value
(SUV), corrected for the fraction of tissue in each lung region (as
assessed in CT). Regional strains (dynamic and static) were estimated
by CT analysis. After euthanasia, a semi-quantitative lung injury score
and macrophages recruitment were quantified in lung samples.
Results
Between T1 and T2, VT and TPP increased from 6.0 ± 0.1 to 49.4 ±
2.9 ml/kg and from 9 ± 2 to 38 ± 4 cmH2O, respectively. Between T1
and T2, global 11C-PK11195 SUV and global dynamic strain in-
creased significantly from 1.83 ± 0.58 to 2.97 ± 0.53, and from 0.36
± 0.03 to 2.06 ± 0.23, respectively, whereas static strain did not
change significantly. Regional 11C-PK11195 SUV significantly in-
creased between T1 and T2, without significant inter-regional differ-
ences, while regional dynamic strain increased after VILI, with
significant inter-regional differences between antero-caudal and
postero-caudal regions. Regional static strain differed neither be-
tween T1 and T2, nor between regions. In multivariate analysis, re-
gional dynamic strain was independently associated with regional
SUV (p = 0.04). Histologic analysis showed greater alveolar damage
in the caudal regions (p < 0.01). SUV was positively correlated with
macrophages recruitment (p = 0.03).
Conclusions
11C-PK11195 is a macrophage-specific PET radiotracer whose lung
uptake is independently associated with dynamic strain and macro-
phage lung recruitment in a high-volume VILI model.
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Introduction
Experimental evidence suggest that ventilator induced lung injury (VILI)
depends on the energy load applied to the respiratory system, which in
healthy lungs encompasses tidal volume, respiratory rate and flow. [1]
Objectives
To investigate if putative mechanisms of VILI (lung strain [2], lung in-
homogeneities [3], collapse and decollapse [4]) are associated with
an increased energy load per breath.
Method
Patients underwent a CT scan at PEEP 5 cmH2O end-expiration and a
second CT scan at end-inspiration. Airway and esophageal pressure
were recorded during tidal ventilation. Energy load per breath (Joule)
was defined as the area between the inspiratory limb of the delta-
transpulmonary pressure (x-axis)-volume curve and the volume axis
(y). Tidal strain was defined as tidal volume (ml)/gas volume at PEEP
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described [2]. Intratidal collapse and decollapse was defined as the
difference in not inflated tissue between end-inspiration and end-
expiration expressed as fraction of total lung weight.
Results
Twenty-seven ARDS patients were studied at PEEP 5 cmH2O. Age 58
[44-72] years (median [IQ range]), BMI 25 [22-29] kg/m2, PaO2/FiO2 105
[83-168], PaCO2 44 [40-51] mmHg, tidal volume 7 [5-8] ml/Kg IBW. En-
ergy delivered per breath (J) was significantly related to lung strain
(Fig. 101, upper panel) and inhomogeneity (Fig. 101, lower panel); the
relationship between delivered energy and intratidal collapse-
decollapse did not reach statististical significance (r2 = 0.10, p = 0.11).
Conclusions
Greater lung strain and lung inhomogeneities increase the energy
delivered to the respiratory system by the tidal volume.
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Invasive mechanical ventilation (IMV) is frequently applied in critically ill
elderly patients. Age, comprehensive geriatric assessment (CGA) param-
eters and recently frailty were reported as general prognostic factors in
these patients [1, 2]. However, there aren't enough studies about the
prognostic factors specifically in patients with IMV.
Objectives
To investigate the clinical characteristics of elderly patients receiving
IMV and to show the impact of age, CGA parameters and particularly
frailty on weaning success and outcomes of these patients.
Method
The patients, >50 years old, admitted to the medical and pulmonary in-
tensive care units (ICU) in Gazi University Hospital were prospectively
included. Patients without consent and stayed < 24 hours in the ICU
were excluded. Frieds, Clinical and Edmonton frailty scores (FS) were
calculated and CGA parameters were assessed by the geriatrician. The
length and the result of weaning were recorded. The weaning was clas-
sified as simple, difficult and prolonged weaning.
Results
IMV was applied in %49 of 180 patients. While the age had no impact on
the need of IMV(p = 0.407), frailty defined by Edmonton FS was an inde-
pendent factor for IMV; increasing the need approximately 3 times (p =
0.023). The presence and the degree of frailty according to all FSs and
CGA parameters had no impact on weaning and mortality in patients
with IMV(p > 0.05). In the whole study group, when the patients with and
without fraility according to the Edmonton FS were compared, disease
severity scores (APACHE and SOFA scores), duration of weaning were
similar in both groups (p > 0.05), but the comorbidities in the ICU such as
development of infection and septic shock, frequency of renal replace-
ment therapy and and mortality were higher in the frail patients (p =
0.03, p = 0.04, p = 0.02 and p =< 0.01, respectively).
Conclusions
The presence of frailty in critically ill elderly patients increased the
need for IMV. After initiation of IMV, frailty had no impact on wean-
ing and mortality in these patients. On the other hand, as the need
for IMV, comorbidities in the ICU and therefore overall mortality are
found to be incresead with fraility.
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Introduction
Refractory hypoxemia is the leading cause of early mortality following
lung transplantation (LT). Rescue therapies, such as extracorporeal mem-
brane oxygenation, have been shown to be useful for supporting LT re-
cipients with refractory hypoxemia. Prone position (PP) is a low cost
measure that has been shown to improve gas interchange in patients
with severe acute respiratory distress syndrome. Major thoracic surgery
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 129 of 607has been considered a contraindication for its implementation. Thus, to
date there is no published evidence of the beneficial effects of PP as a
bridge to recovery for patients with refractory hypoxemia after LT.
Objectives
The primary objective was to assess the gas interchange improvement
with PP. The secondary objective was to compare the outcomes of these
patients with those of the general population of our LT recipients.
Method
Prospectively collected data from 131 consecutive adult patients under-
going LT between January 2013 and December 2014 were evaluated. In-
dications, associated complications, time to initiation and duration of the
maneuver were analyzed and the effects of PP on gas interchange were
evaluated. Finally, outcomes in this cohort were compared against the
rest of LT recipients. Continuous data are reported as median and inter-
quartile range(IQR) and categorical data as numbers and percentages. Dif-
ferences between categorical variables were assessed with the Chi-square
test and continuous variables with the Mann-Whitney test. The Student
“t” test was used to evaluate the effects of PP on gas interchange.
Results
Twenty-two patients received PP. The maneuver was more frequently
implemented within the first 72 hours (68.2 %) and its main indication
was primary graft dysfunction. The maneuver was maintained during a
median of 21 hours. After PP, the PaO2/FIO2 ratio significantly increased
from 81.0 mmHg (IQR 71.5-104.0) to 220.0 (IQR 160.0-288.0) (P < 0.001).
No complications related with the technique were reported. Patients
who underwent the maneuver had longer hospital stay (50.0 days [IQR
36.0-67.0] vs 30.0 [IQR 23.0-56.0],P = 0.006) than the rest of the popula-
tion. No differences were found comparing either one-year mortality
(9.1 % vs 15.6 %; P = 0.740) or one-year graft function (FEV1 of 70.0 [IQR
53.0-83.0] vs 68.0 [IQR 53.5-80.5], P = 0.469).
Conclusions
PP was found to be a safe and successful therapy for refractory hyp-
oxemia after LT and should be considered as an option in treating
these patients.
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Iron is an essential element for both proper immune function and for
the growth of most human pathogens. Alterations in iron status may
affect the immune system and the risk of infections. No population-
based studies have investigated the association between markers of
iron status and the risk of bloodstream infection (BSI).
Objectives
We assessed the associations of serum iron concentration (SI), total
iron binding capacity (TIBC) and transferrin saturation percent (TS)
with the risk of BSI and fatal BSI (death within 30 days after detection
of a BSI).
Method
We studied 64033 participants with baseline measurements of SI,
TIBC and TS in the second survey of the population-based HUNT
Study in Nord-Trøndelag County, Norway (HUNT2, 1995-97). SI, TIBC
and TS were categorized as low (<2.5-percentile), high (>97.5 per-
centile) and quintiles of values between the 2.5 and 97.5 percentiles.
Incident BSIs through 2011 were identified though linkage to pro-
spectively recorded information at the local and regional hospitals.
For each measure of iron status, we assessed the risk of a first-time
BSI and fatal BSI using Cox proportional hazards regression, with the
middle quintile as the reference. The primary analyses were adjusted
for age and sex. Additionally, we adjusted for self-reported comorbid
conditions; lung disease, cardiovascular disease, cancer, kidney fail-
ure, diabetes and body mass index at baseline.
Results
During a median follow-up of 15 years, 1840 persons had at least
one episode of BSI, and 396 experienced a fatal BSI. In age- and sex-
adjusted analyses, BSI risk was increased among participants with in-
dices of iron deficiency, either low SI (HR 1.77, 95 % CI 1.39-2.26), low
TS (HR 1.62, CI 1.24-2.11) or high TIBC (HR 1.42, CI 1.03-1.95). After
adjustment for comorbidities, the associations remained similar for
low SI (HR 1.79, CI 1.38-2.31) and low TS (HR 1.59, CI 1.19-2.12), but
attenuated for high TIBC (HR 1.22, CI 0.85-1.75). The corresponding
HRs of fatal BSI were 1.60 (CI 0.90-2.83) for low SI, 1.43 (CI 0.65-3.11)
for low TS and 2.21 (CI 1.15 - 4.25) for high TIBC. We found no in-
crease in BSI risk related to indices of high iron status.
Conclusions
In this large population-based cohort study, indices of low iron status
were associated with increased risk of BSI. Iron is a crucial element in
our immune response and these findings suggest that alterations in
this fine tuned system could influence the risk of BSI.
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Bloodstream infection (BSI) causes considerable morbidity and mortal-
ity. As emerging antibiotic resistance seriously threatens global public
health, primary prevention of bacterial infections should be a priority.
Lifestyle factors are of particular interest since they are modifiable, and
optimization could reduce the population-level burden of BSI.
Objectives
To assess the associations of smoking, obesity, alcohol intake and
physical inactivity with the risk of incident and fatal BSI.
Method
In a prospective population-based cohort study, 65236 participants
of the HUNT2 Survey (1995-97) in Norway were followed up through
2011 by linkage to prospectively recorded information on BSI at the
local and regional hospitals. Using Cox regression, we estimated age-
and sex- adjusted hazard ratios (HR) of a first-time BSI and fatal BSI
(death within 30 days after BSI) by baseline body mass index (BMI)
measurements and self-reported smoking habits, leisure time phys-
ical activity and alcohol intake. In additional analysis we also adjusted
for education and lifestyle factors.
Results
During 14.8 years of follow-up, 1844 (2.9 %) participants experienced
at least one episode of BSI, and 396 (0.62 %) experienced a fatal BSI.
Obesity was dose-dependently associated with increased risk of BSI
and fatal BSI. Compared with normal weight participants (BMI 18.5-
24.9 kg/m2), the age- and sex-adjusted risk of a first-time BSI was
28 % (95 % confidence interval (CI) 11-47 %) higher at BMI 30.0-
34.9 kg/m2, 83 % (95 % CI 46-129 %) higher at BMI 35.0-39.9 kg/m2
and 200 % (95 % CI 111-328 %) higher at BMI ≥ 40.0 kg/m2. Corres-
pondingly, the risk of fatal BSI was 34 % (95 % CI -1-81 %) higher at
BMI 30.0-34.9 kg/m2, 144 % (95 % CI 55-286 %) higher at BMI 35.0-
39.9 kg/m2, and 300 % (95 % CI 94-727 %) higher at BMI ≥ 40.0 kg/
m2, compared with normal weight participants. Current smokers had
a 55 % (95 % CI 37-75 %) higher risk of BSI and a 77 % (95 % CI 36-
130 %) higher risk of fatal BSI compared with never-smokers. Inactive
participants had a 65 % (95 % CI 37-101 %) higher risk of BSI and a
105 % (95 % CI 35-212 %) higher risk of fatal BSI compared with the
most physically active participants. The findings were essentially un-
changed after adjustment for education and lifestyle factors.
Conclusions
This study underscores that maintaining a healthy lifestyle with nor-
mal weight, non-smoking and physical activity may contribute to the
prevention of invasive bacterial infections.
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Objective
Recent observational studies showed that obese critically-ill pa-
tients have an unexpectedly reduced risk of death, having low
mortality rate in the course of septic shock, as well. This situation
is described as “obesity paradox”. Leptin, a hormone made by
white adipose cells regulating energy balance by inhibiting hunger
and which rises proportionally to body weight has also been
shown to have a role in immune modulation. Therefore, leptin
could play the pivot role in case of obesity paradox. The aim of
this study was to investigate the relationship between mortality
and body mass index (BMI) in patients with septic shock. In addition,
we tested association of leptin levels with BMI and mortality.
Method
Between September 2014 and January 2016, 52 patients with septic
shock were included in the study. As a control group, 27 healthy peoplewith BMI (kg/m2) similar to patients' BMI values were included. Patients
who had uncontrolled diabetes mellitus, malignancy and who received
corticosteroids chronically prior to ICU admission were excluded.
Patients were categorized into five groups according to BMI (group 1
(n = 6) ≤18; group 2 (n = 14) 18.1-24.9; group 3 (n = 19) 25-29.9; group 4
(n = 10) 30-39.9; grup 5 (n = 3) ≥40 kg/m2). We measured leptin levels
at 9:00 a.m. after patient has been diagnosed with septic shock.
Results
The median (min-max) age of 52 patients was 68 (19-88). 25 of
these patients were male. The median APACHE II score was 28.5
(11-45). Median leptin level was 0.2 (0.1-54.5) ng/ml. Control pa-
tients' median age, BMI and leptin levels were [62 (24-82); 26.8
(18.8-44.8) and 4 (0.1-22.8)], respectively. 27 of the 52 septic shock
patients died within 28 days. The APACHE II scores were similar be-
tween the survivor and non-survivor groups (28 (11-40), 29 (11-45),
p = 0.37). The surviving patients had lower but statistically insignifi-
cant BMI values compared to non-survivors (24.9 (17.8-35.1), 27.2
(16.5-49.0), p = 0.12). 28th day mortality rate in 5 groups stratified
according to BMI was similar (p = 0.50). Leptin levels were similar in
surviving and non-surviving patients (0.13 (0.1-11.0), 0.25 (0.1-54.5),
p = 0.23). However, there was a difference among 5 BMI groups in
terms of leptin levels (median leptin: group 1 0.28, group 2 0.16,
group 3 0.22, group 4 0.37, group 5 4.80; p = 0.046), such that
group 5 (BMI ≥ 40) had the highest leptin level compared to other 4
groups (p = 0.047). Control patients have higher leptin levels than
patients with septic shock (p < 0.001). There was a statistically sig-
nificant correlation between BMI and leptin level in all patients (n =
79, r = 0.49, p < 0.001).
Conclusion
Our study showed that increased BMI was not related to increased
survival. Leptin levels were lower in patients with septic shock com-
pared to control patients. Although leptin levels correlated with BMI,
there was no difference in leptin levels between surviving and non-
surviving patients.
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Introduction
ICU-acquired weakness is related to loss of muscle mass and function,
especially in long-stayers. Both factors can be assessed at the bedside
using independent techniques, but the correlation between mass and
function is unknown
Objectives
To evaluate any correlation between muscle mass and force in long-
stay ICU patients.
Method
Muscle mass and force were assessed on admission and at the
end of the ICU stay in patients with an expected length of stay
(LOS) of at least 5 days. Mass was measured from anthropometric
variables (skinfolds of calf and arm) using the Lee formula (1)
and bioelectric impedance (phase angle (PhA)) at 50 Hz. Force
was measured using the Medical Research Council (MRC) score
(2) and dynamometry (handgrip test). Effect of time over the ICU
stay was assessed using a Student's t test. Correlations between
mass and force, and between these variables and the APACHE II
score, the duration of ICU stay and of mechanical ventilation
were investigated.
Results
Eighteen patients (age 56 ± 16 years, 12 male, APACHE II 20 ± 5)
were included. During the ICU stay (17 ± 12 days), muscle mass
assessed by skin folds and by PhA at 50 Hz decreased from 26.8 ±
5.4 kg to 25.6 ± 5.4 kg (p < 0.003) and from 4.0 ± 1.6 to 3.4 ± 1.4
(NS), respectively. Likewise, force evaluated with MRC score de-
creased from 52 ± 2 to 42 ± 5 (NS). There was a correlation between
the percentage change in mass and in force (r =0.57, p < 0.01),
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(r = - 0.79; p < 0.0001) and between the durations of mechanical
ventilation and ICU stay (r = 0.89; p < 0.0001). The APACHE II score
was negatively correlated with force measured using the handgrip
test (r = -0.67; p = 0.002), with the MRC score (r = -0.765; p < 0.0001) and
with muscle mass evaluated by PhA (r = -0.665; p = 0.004).
Conclusions
Muscle mass and function decrease during a long ICU stay, and these
changes are correlated. Use of these bedside Method to guide thera-
peutic management needs to be assessed.
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Introduction
The mortality of severe acute respiratory distress syndrome(ARDS)
caused by pulmonary infection after renal transplantation is high.
Prone position ventilation can effectively improve the prognosis of
patients with ARDS. Post- pylorus feeding can significantly improve
the nutritional intake and reduce the risk of aspiration.
Objectives
To evaluate the value of prone position combined with post- pylorus
feeding on severe ARDS caused by severe pneumonia after renal
transplantation.
Method
Prospective observational study in a surgical intensive care unit (10
beds) of a university hospital. Patients met the berlin criteria of se-
vere ARDS after renal transplantation and needed invasive mechanic-
ally ventilation were included.12 consective hours of prone position
ventilation and post-pylorus feeding tube placement were applied to
all included patients
Results
In total, 8 patients were included, average 38 ± 10 years, 6 (75 %)
were men. The 28-day mortality was 12.5 %(1/8). The ratio of the par-
tial pressure of arterial oxygen(Pao2) to the fraction of inspired oxy-
gen (Fio2)on 1 h,6 h and 12 h after prone positon were improved
significantly than before(P < 0.05). The time to reach target feeds was
73 ± 15 hours through Post-pyloric feeding, the rate of aspiration is 0,
Nutritional status of all patiens was gradually improved.
Conclusions
Prone position combined with post- pylorus feeding can improve the
prognosis of severe ARDS cuased by pulmonary infection after renal
transplantation.
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Introduction
Nutritional support is an essential part of intensive care unit manage-
ment However, the appropriate caloric intake for critically ill patients
still remains unclear. Permissive underfeeding is based on the fact
that provision of 100 % of estimated nutrient requirements may be
metabolically and functionally detrimental to some patient popula-
tions. It has also been shown that meeting a patient's estimated
needs may result in inflammation, cytokine release, and oxidant pro-
duction while short term restriction of nutrient intake may limit the
pathologic processes that occur in critical illness and reduce organ
dysfunction.
Objectives
To evaluate the effect of permissive underfeeding, as compared with
standard protocol enteral feeding, on 28-day mortality among septic
mechanically ventilated critically ill patients
Method
A single centre study of patients admitted to a 25 bed University
Hospital ICU over a period of one year. Demographics, severity of ill-
ness scores (APACHE and SOFA), BMI and “Malnutrition Universal
Screening Tool” (MUST) were measured upon admission. Daily nutri-
tion requirements were calculated for each patient. Patients were
randomly assigned to permissive underfeeding group with caloric
goal: 50-70 % of the calculated requirement or standard protocol
feeding groups with caloric goal: 80-100 % of calculated require-
ment. Each patient was monitored for 14 days. The protein intake
(1.5 g/kg/day) was maintained the same in both groups. The primary
outcome was 28-day mortality. Results are expressed as mean ± SD.
P < 0.05 was considered significant.
Results
A total of 74 patients (38 men) mechanically ventilated septic pa-
tients having a mean(±SD) age of 68.4 ± 18.4 years were studied. All
patients met the consensus criteria for sepsis. Baseline characteristics
were similar in the two groups. APACHE II and SOFA at study entry
were 22 ± 4 and 8 ± 4respectively.The mean height of the patients
was 164.0 cm. The mean(±SD) BMI was ≈ 21.5 ± 3.4 kg/m2. Obese
patients were excluded from the study. During the study period, the
permissive-underfeeding group received fewer calories than did the
standard-protocol feeding group (962 ± 314 kcal per day vs. 1308 ±
513 kcal per day) achieving caloric requirements of 51 ± 14 % vs. 82 ±
11 %, respectively (P < 0.001). Protein intake was similar in both groups
(57 ± 24 g per day and 59 ± 25 g per day, respectively). The 28-day mor-
tality was lower in the permissive-underfeeding group (18.4 %) than in
the standard-feeding group (28.9 %). There were no significant differ-
ences among the groups with respect to feeding intolerance, diarrhoea
or serious adverse events.
Conclusions
In critically ill patients, permissive underfeeding may be associated
with lower mortality rates than standard-protocol feeding. It is evi-
dent that permissive underfeeding is a strategy that should be con-
sidered in the ICU septic patient. Employing such an approach may
offer clinical benefit.
Table 78 (abstract A249). Correlation analysis with APACHE IV score
r P-value
Initial TC -0.231 <0.001
Second week TC -0.361 <0.001
Third week TC -0.327 <0.001
C-reactive protein 0.277 <0.001
Pro-BNP 0.139 0.037
Fig. 102 (abstract A249). The second week TC and APACHE4 score
Table 79 (abstract A249). Risk factors for hospital mortality
P-value Hazard ratio 95% Confidential Interval
Second week TC <0.001 0.98 0.97-0.99
C-reactive protein 0.02 1.05 1.01-1.09
ARDS 8.24 8.24 2.49-27.29
CRRT 0.34 0.53 0.15-1.94
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Introduction
The serum total cholesterol (TC) level is known to be associated with
survival of critical illness, especially in sepsis and surgical patients.
However, there are only a few studies evaluating TC as a prognostic
factor in medical patients.
Objectives
The aim of this study was to determine the relationship between
TC level and survival in medical patients admitted in intensive
care unit (ICU).
Method
From September 2013 to February 2014, the data was acquired at
the nine intensive care units in the four provincial academic medical
centers retrospectively. Statistical analysis was conducted to confirm
risk factors with using correlation analysis and logistic regression.
Results
In this study, a total of 503 patients were enrolled. The hospital mor-
tality which is based on 28 days after admission was 28.2 %. TC levels
derived at specific point of time showed negative correlation with
APACHE IV score (initial TC, r = -0.231, p < 0.001; second week TC,
r = -0.361, p < 0.001; third week TC, r = -0.327, p < 0.001)
TC level of the second week, C-reactive protein level and status of
ARDS were the independent risk factor for mortality in multivariate
analysis (hazard ratio (HR) =0.98, p < 0.001; HR = 1.05, p = 0.02, HR =
8.24, p = 0.001, respectively)
Conclusions
Lower TC level is a prognostic indicator of hospital mortality in med-
ical patients admitted in ICU. Following up TC level regularly has the
advantage of managing critically ill patients.
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Introduction
Acute pancreatitis accompanied by organ dysfunction is termed
severe acute pancreatitis (SAP) and if local complications (such
as infected pancreatic pseudocysts) develop it may be described
as complex SAP. As these patients often require care by special-
ist hepatopancreaticobiliary (HPB) surgeons and interventional
radiologists, they may be transferred to specialist HPB centres.
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is greatest in those with multiple organ systems requiring support. It
is associated with prolonged need for mechanical ventilation and
ICU stay, increased risk of death following hospital discharge, and
long-term complications including impaired physical function [1,2].
One Method of quantifying muscle wasting is the measurement of
the cross sectional area (CSA) of para-spinal muscles at the level of
the third lumbar vertebra from CT imaging [3].
The ICU at RSCH receives patients transferred from other ICUs for
specialist care relating to their complex SAP. For clinical reasons
these patients often have repeated CT imaging of their abdomens.
Objectives
To characterise patients requiring critical care who have been trans-
ferred for specialist care of their complex pancreatitis between 2008
and 2014; and to measure their L3 para-spinal muscle CSA (L3MCSA)
from each CT scan to ascertain their rate of muscle wasting.
Method
Patients were identified from our ICU patient database (Ward-
Watcher) and additional clinical details acquired from electronic data-
bases. CT Images were exported as DICOM files from our PACS
system. The cross-sectional area of the paraspinal muscles were mea-
sured using ImageJ software in duplicate by two independent users
and the average values were used. Analysis used Excel (MS) and
GraphPad (PRISM).
Results
45 patients met inclusion criteria and of these, 21 patients had ≥ 2 CT
scans in ICU, enabling serial estimation of L3 paraspinal muscle CSA
(L3MCSA). The average age was 53 (16.6) years. The median APACHE
II score was 17. Patients underwent a median of 2 interventional/sur-
gical procedures. The mean ICU LOS was 48 (26.9) days and ICU mor-
tality was 19.1 %.
95 % of patients had a decrease in their L3MCSA during their ICU
stay. See Table 80.
The median % L3MCSA change / day was -0.56 %. Higher pancreatitis
severity score (Glasgow score at admission to our ICU) was associated
with greater loss of muscle (p = 0.03). Increased systemic inflammation
(% of time with CRP > 200 mg/l) was associated with increased rate of
loss of muscle (r = -0.45 and p = 0.03). L3MCSA was not demonstrated
to relate to duration of ventilation or ICU mortality.
Conclusions
This cohort of ICU patients with complex SAP showed profound
muscle wasting, greatest in those with persistent severe inflam-
mation. Identification of preventative strategies is a research
priority.
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ICU admission ICU discharge
L3MCSA/cm2 Median (IQR) 82.4 (65.9 - 90) 69.0 (62.6 - 75.3) p<0.001
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Oxidative stress is known to adversely affect a variety of cellular func-
tions, promote inflammation and take part in development of multi-
organ dysfunction. Oxidant status can be evaluated by thiol/disulphide
homeostasis. Previous studies have indicated that certain lipid formula-
tions may contribute to decrease the oxidative stress. Potentiation of
PON1 activity is one of the suggested mechanisms [1].
Objectives
Our aim was to evaluate basal paraoxonase1 activity(PON1), salt stim-
ulated paraoxonase(stPON1), arylesterase(ARE), plasma native thiol,
total thiol and disulphide levels in critically ill patients on parenteral
nutrition(PN) containing different lipid formulations.
Method
Critically ill patients for whom PN was planned, and who did not
have a contraindication to PN were included in the study. Patients
already on PN or who did not give consent were excluded. Three dif-
ferent PN solutions were used: a soya oil containing solution [long
chain fatty acids(LCT)], an olive oil containing solution, and a solution
containing middle and long chain fatty acids(MCT/LCT). Nutritional
support was planned to provide 25-30 kcal/kg/day. Age, sex, admis-
sion diagnosis, smoking status, APACHEII and SOFA scores, invasive
procedures performed, FiO2 levels, administered drugs, transfusion
were recorded for 3 days(0, 24 and 48th hour). Lipid profiles(HDL,
LDL, total cholesterol, triglyceride), liver enzyme levels(AST, ALT, GGT,
ALP, total/direct bilirubin), CRP, prealbumin values were recorded. As
well, nosocomial infections that developed during admission, ICU
and hospital length of stays and outcomes were recorded. Serum
samples were collected before start of PN, at 24th and 48th hours of
PN for PON-1, stPON1, ARE and total thiol levels and stored at -20 °C.
Biochemical studies were conducted after collection of all samples.
PON1, stPON1 and ARE were measured spectrophotometrically.
Plasma native thiol, total thiol and disulphide levels were measured
as previously defined.
Results
A total of 36 patients, 12 in each group, were included in the study.
Age, sex, day of admission to hospital, APACHEII scores, smoking sta-
tus were similar across the groups. Lipid profiles, liver enzyme levels,
CRP levels were also similar. Although initial (prenutrition) plasma na-
tive thiol, total thiol and disulfite levels were different across groups;
on follow-up no difference was observed between the groups on the
basis of PON1, stPON1, ARE, plasma thiol, total thiol and disulphide
levels.
Conclusions
Based on the results of this study, different PN solutions with differ-
ent lipid compositions do not seem to alter the oxidant status as
evaluated by the thiol/disulphide homeostasis. Although olive oil is
expected to promote PON1 activity, this could not be demonstrated
in this study. Prospective, randomized, dose dependent studies may
be planned for further evaluation.
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Introduction
Autophagy is a survival process involved in the removal of protein ag-
gregates and organelles that cannot be processed by the proteasome.
Recently an impairment of this system has been hypothesized in the
development of organ failure of the ICU patients.
Objectives
Autophagy is a highly dynamic process that cannot be studied in
human in vivo. The aim of this study was to develop an experimental
model to study the autophagy flux in ICU patients and to investigate
Fig. 103 (abstract A253). Results distribution for gastric aspirate
(pH)
Table 81 (abstract A253). Gastric pH with acid suppressing therapy,
mean (n)
Medication No acid suppressing
therapy
Histamine 2
blocking agent
Proton pump
inhibitor
pH 3 (12) 5.2 (41) 6.2 (37)
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an in vitro screening Method to measure autophagic flux in human pri-
mary myotubes incubated with serum from ICU patients.
Method
Human primary myotubes were incubated with serum from consecu-
tive ICU patients taken in the first 24 h of admission (n = 95) and
healthy volunteers (n = 10) with a similar age range (40 - 60 years
old). Myotubes were cultured in 96-well plates, at 7 days of differenti-
ation they were incubated with 10 % of human serum for 24 hours
in the presence or absence of chloroquine (50 μM, 6 hr), an inhibitor
of autophagy. p62 expression, a marker of autophagic vacuole accumu-
lation, was measured by in-cell western, with an Odyssey scanner. The
autophagic flux was calculated as followed: autophagic flux = p62
expression (+CQ) - p62 expression (-CQ). The results were normalized
against cells number and expressed as a % of the autophagic flux in
control condition. The screening on all serum samples have been re-
peated in 5 independent experiments. Results were analyzed by
ANOVA with a Fisher post-hoc test.
Results
We observe a larger variation in the expression of p62 induced by
the patients' serum compared to the variation induce by the
serum from healthy volunteers. p62 expression in myotubes incu-
bated with the serum from 66 patients (ICU group) was similar to
the healthy group (131 ± 4 vs. 122 ± 9 % of control; ICU vs.
healthy). Interestingly, the serum from 29 ICU patients (ICU+ and
ICU- groups) induced an expression of p62 superior of 2 SD in
comparison with the values observed in myotubes incubated with
the serum from healthy volunteers. Within this 29 samples, 14
were inducing an increase in the autophagic flux (p < 0.05, ICU+
vs. Healthy) and 15 were inducing a block of the autophagic flux
(p < 0.05, ICU- vs. Healthy). Interestingly, the length of hospital stay
was significantly greater in the ICU- (8.7 days, 95 % CI [6.0, 11.4])
compared to the ICU (4.0 days, 95 % CI [2.8, 5.3]) and the ICU+
(4.3 days, 95 % CI [1.7, 7.0]).
Conclusion
Serum from ICU patients was able to activate or block the flux of au-
tophagy in human primary myotubes. Interestingly, even if the serum
was collected during the first 24 h of admission we observed differ-
ences in the length of stay between our groups. The group inducing
a block in autophagy corresponded to the long stayers patients.
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Introduction
Nasal or oro-gastric nutrition tube placement is verified radiologically.
Daily placement verification is typically by air insufflation into the
tube and auscultation, which has been shown to be unreliable. Tubes
may move with patient movement, patient pulling, or coughing; ne-
cessitating ongoing placement verification. Other verification Method
are testing gastric aspirate pH or pepsin, tube CO2 output,
visualization of gastric aspirate, and record of tube insertion length.
Our intensive care unit (ICU) at Mount Sinai Hospital initiated a qual-
ity improvement (QI) project to change from auscultation to the gas-
tric pH, with record of tube insertion length and visualization of
gastric aspirate.
Objective
To adopt an evidenced based practice change and complete plan,
do, see, act (PDSA) cycles, then make further changes based on our
results.
Method
Gastric aspirate samples were sent to the laboratory for testing
by pH meter. Nursing education was done to introduce the test
and procedure. A pH ≤ 5.5 was considered confirmation of gastricplacement. Data collected included aspirate pH, use of acid inhi-
biting drugs, calories from EN and ordered and delivered, time
EN held before pH testing, tube insertion marking length, and as-
pirate appearance. Ongoing education and changes to nursing
and nutrition practice were made as results were evaluated as
part of our PDSA cycle. Statistical analysis included mean pH,
stratified by acid inhibitor, mean calorie deficit from holding EN
for the test, and the 90th percentile laboratory turnaround time.
Results
Ninety pH tests were done and 21 tests missed, for 12 patients. The
overall mean pH was 5.2 and median pH 5.7. Stratification by drug
therapy results can be found in Table 81. A cumulative percentile
chart of pH with acid inhibitor Method is reported in Fig. 103. All pa-
tients received EN. The mean calorie deficit observed was 1513 calo-
ries, for all reasons, not the gastric pH test alone. EN was held for 1 h
before the test. The lab reported results usually in 30 minutes.
Length of the feeding tube to insertion point was recorded for 1
patient.
Conclusion
Nurses were accepting of this process as evidenced by the few
missed tests. Tests weren't done due to confusion over tube
types requiring the test, inability to aspirate fluid from the tube,
and forgetting. This created an opportunity for staff education to
improve our process. Our data suggest that gastric aspirate pH ≤
5.5 alone is not a reliable marker of gastric feeding tube place-
ment when patients receive acid inhibiting drugs. There is oppor-
tunity to develop a confirmation bundle including a description
of the aspirate, recording of length of the tube at insertion, and
use of acid suppressing therapy. The possibility of underfeeding
is an opportunity to implement a volume based EN protocol to
allow the nurse to adjust the hourly volume of EN to compensate
for time EN is held. This ICU QI project implemented a best prac-
tice following a PDSA cycle.
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Introduction
Following insertion of a naso/oro gastric enteral tube and periodically
afterwards in the United Kingdom it is essential to ensure that the
distal portion of the tube is in the lower protion of the GI tract (the
stomach). This is achieved principally through measuring the pH of
gastric aspirate (1st line test) =/- x-ray (2nd line test) (NPSA, 2011).
This small pilot study illuminates the accuracy (and potential for
errors) with using pH indicator strips to confirm gastric placment.
Objectives
To establish the accuracy of Nurses and Doctors interpretation of a
range of known pH solutions using CE marked pH indicator strips
with visual interpretation of pH results
Method
50 nursing and medical staff were asked to identify the pH of clear/
colourless solutions with pH values ranging between 1 and 7. They were
blinded to the pH value of the soultion until after they had completed
the test. The pH indicator strips used had a possible range of 0-6.0.
Results
All staff agreed to participate in this small study with the assurance of
anonymity. Staff were observed to perform the test correctly if they
a) waited 10-60 seconds prior to reading the strip;
b) did not wipe the strip after immersion in the test solution.
100 % acheived accurate testing procedures.
The majority of staff (approximately 80 %) correctly interpreted the
pH of solutions between 1 and 4 but demonstrated slightly less
accuracy with pH of 5.8 (75 % accurate), erring on the lower value on
the pH indicator strip of 5.5
When challenged with a pH solution which was know to be 7, only 1
out of ten staff they could not identify the pH value since the colour
change was out of range of the pH indicator strip. The remaing staff
(9-90 %) incorrectly interpreted the solution as having a pH of 6).
Conclusions
Although this was a small study, there is clearly a danger in relying
on visual interpretation of colour change of CE marked pH indicator
strips to confirm correct placement of naso/orogastric feeding tubes.
Future/further studies intend to compare alternative Method of pH
quantification, incuding electronic pH testing devices.
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Introduction
Measurements of cardiac output (CO) are frequentlydone in surgical
and critically ill patients as part of optimizationstrategies Transthoracicechocardiography (TTE) Method of CO measurement is more popular
in critically ill patients.
Objectives
Whether TTE Method of CO measurement is accurate as transpul-
monary thermodilution (TPTD).
Method
We compared near-simultaneously performed CO measurements in
severe sepsis patients using TPTD with the PiCCO (Pulse index
Continuous Cardiac Output) system or TTE. Outcomes were com-
pared using t-tests, linear regression
Results
Forty severe sepsis patients were studied. An analysis of 120 data
pairs revealed that PiCCO yielded similar CO measurements to TTE
(p > 0.05). PiCCO- derived CO measurements highly related to and
TTE- derived CO measurements (R = 0.75, p < 0.05).
Conclusions
TTE can used for objective cardiovascular monitoring and to guide
goal-directed fluid resuscitation in severe sepsis patients instead of
PiCCO, and is noninvasive and convenient.
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Introduction
Norepinephrine (NE) is the most common vasoconstrictor drug used in
the treatment of septic shock. High doses of NE are associated to bad
prognosis, but the limits of refractory septic shock have not been well
established.
Objective
To analyze the prognostic value of the maximum dose of norepineph-
rine on the mortality of patients admitted to ICU with septic shock.
Method
A two-years retrospective study in a single ICU on patients admitted
with septic shock treated with NE. The NE maximum dose was ana-
lyzed, the time to reach this dose, the days of treatment, the origin and
focus of sepsis, the use of other amines, the APACHE II and SOFA score
and ICU and hospital mortality. Prognostic value of maximum dose of
NE was analyzed using multivariate logistic regression and a ROC curve
analysis was carried out to assess its discriminating ability.
Results
We analyzed 128 consecutive patients, with an average age of 64 years
(SD 15,6), a mean APACHE II 20 (SD 8) and a mean SOFA score of 8,3 (SD
3,4). The average value of the maximum dose of NE was 0,94 μg/Kg/min
(SD 0,84) and the median time to achieve it was 1 day (range 0-22). ICU
mortality was 30 % and hospital mortality was 34 %. In the multivariate
analysis, the maximum dose of NE was independently associated with
ICU mortality (14,6 95 % CI: 6,1-34, 8; p < 0,001) and hospital mortality
(9,2 95 % CI: 4,0-19,3; p < 0,001). ROC curve of the maximum dose of NE
showed a high discriminative ability for ICU mortality with a r = 0, 93
(95 % CI 0,88-0,97; p < 0,001) and for hospital mortality with r = 0,87
(95 % CI 0,81-0,94, p < 0,001), with a cut-off point of maximum sensitivity
(0,82) and specificity (0,83) on 1 μg/Kg/min. In-hospital mortality of
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 136 of 607patients with dose maximum of NE > 1 μg/Kg/min was 72 % versus
10,3 % in patients with lower doses and it was 100 % in the patients with
septic shock with doses greater than 2 μg/Kg/min (20 cases).Table 82 (abstract A257). Mean differences in delta cytokine
concentrations from baseline to day 2 in patients with severe sepsis
resuscitated with either HES or Ringer's acetate
Cytokine Estimate, HES vs. Ringer 95% CI P-value
TNF-alfa (pg/mL) -23.9 -58.7 to 10.8 0.18
IL-6 (pg/mL) 17.3 -69.0 to 103.6 0.69
IL-10 (pg/mL) -66.7 -164.9 to 31.5 0.18
The imputed dataset from all the 202 day 2 survivors were analysed and
adjusted for SAPS II and the stratification variables: university hospital,
hematologic malignancy and shock at randomizationConclusions
The maximum dose of norepinephrine had an independent prognos-
tic value in septic shock. Doses higher than 1 μg/Kg/min are associ-
ated with a clear worse prognosis, so it could be considered the limit
of refractory septic shock.
References
1. Kastrup M, Braun J, Kaffarnik M, von Dossow-Hanfstingl V, Ahlborn R, Wer-
necke KD, et al. Catecholamine dosing and survival in adult intensive care
unit patients. World J Surg. 2013 Apr;37(4):766-73
2. Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. Survival after
shock requiring high-dose vasopressor therapy. Chest 2013 Mar; 143(3):664-71.
3. Martin C, Medam S, Antonini F, Alingrin J, Haddam M, Hammad E, et al.
Norepinephrine: not too much, not too long. Shock 2015 Oct; 44(4):305-9
A257
The effects of hydroxyethyl starch 130/0.42 vs. Ringer’s acetate on
cytokine levels in patients with severe sepsis
C.T. Anthon1, R.B. Müller1, N. Haase1, K. Møller2, P.B. Hjortrup1, J.
Wetterslev3, A. Perner1
1Copenhagen University Hospital - Rigshospitalet, Department of
Intensive Care, Copenhagen, Denmark; 2Copenhagen University Hospital
- Rigshospitalet, Center of Inflammation and Metabolism, Copenhagen,
Denmark; 3Copenhagen University Hospital - Rigshospitalet, Centre for
Clinical Intervention Research - Copenhagen Trial Unit, Copenhagen,
Denmark
Correspondence: C.T. Anthon – Copenhagen University Hospital -
Rigshospitalet, Department of Intensive Care, Copenhagen, Denmark
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A257
Introduction
The 6S trial showed increased 90-day mortality with hydroxyethyl
starch (HES) 130/0.42 vs. Ringer's acetate in patients with severe sep-
sis [1], but the pathophysiology driving this has not been fully
elucidated.
Objectives
To compare changes in cytokine plasma concentrations in the days
after randomisation into the 6S trial.
Method
In a subgroup of 226 patients from the 6S trial we analysed differ-
ences between the HES- and Ringer's groups in delta plasma concen-
trations of TNF-α, IL-6 and IL-10 from baseline to day 2 after
randomisation using multiple linear regression analysis. Additionally,
associations between the changes in cytokines and 90-day mortality
were investigated using multiple logistic regression analysis. We
imputed values missing due to discharge or errors using multiple
imputation.
Results
Baseline characteristics were similar in the HES- and the Ringer's
groups. By day 2, 13 (11 %) patients in the HES group had died vs.
11 (10 %) in the Ringer's group (P = 0.91). Plasma concentrations of
TNF-α, IL-6 and IL-10 decreased from baseline to day 2 in the HES-
and the Ringer's groups, but mean delta cytokine concentrations did
not differ between the groups (Table 82). Also, no associations were
observed between changes in the cytokine plasma concentrations
and 90-day mortality (TNF-α: odds ratio for 1-unit increase, 1.000
(95 % Confidence Interval, 0.998 - 1.003), P = 0.87; IL-6: 1.001 (0.999 -
1.002), P = 0.32; IL-10: 1.000 (0.999 - 1.001), P = 0.89).
Conclusions
Resuscitation with HES 130/0.42 vs Ringer's acetate did not affect
TNF-α, IL-6 and IL-10 plasma concentrations and changes in these
cytokines were not associated with 90-day mortality in patients with
severe sepsis. Consequently, our results suggest that the increased
mortality seen with HES in the 6S trial was not mediated by early
changes in systemic inflammation.References
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Introduction
Fluid overload is associated with poor outcomes in septic patients. B-
type natriuretic peptide (BNP) concentrations are useful tools to
guide the therapy of patients with heart failure. However, BNP con-
centrations in the patients after septic shock resucitation are poorly
studied. If BNP concentrations can predict the day of the peak fluid
balance, BNP guided therapy enables us to restrict the fluid volume
and start the diuresis appropriately.
Objectives
We investigated daily BNP concentrations and fluid balance in
septic patients. We hypothesized that the day of the peak BNP
concentration predict the day of maximum fluid balance. The
patient age, sources of infection are included in the analysis as
confounders.
Method
Our inclusion criteria was as follows; 1) septic patients of any sources of
infection (urinary tract infection, pneumonia, soft tissue infections, upper
and lower GI tract perforation, and bacteremia), 2) those admitted to our
ICU, and 3) the daily BNP concentrations were measured during the ICU
stay. We excluded patients who had been already on hemodialysis. We
first described the time lag between the day of the peak BNP concentra-
tion and that of maximum daily fluid balance. We conducted multivariate
regression analysis on this time lag with patient age, sources of infection,
and maximum daily fluid balance as covariates.
Results
We included 48 patients, aged 75 in average. The peak BNP concen-
tration followed the maximum daily fluid balance by 0.57 day (SD,
2.36). In multivariate regression analysis, the delay of maximum BNP
concentration after the maximum daily fluid balance was associated
with older age (β 0.08, p = 0.03), but was not associated with net
daily fluid balance or sites of infections.
Conclusions
Our study suggested that the timing of maximum BNP concentra-
tions and the maximum daily fluid balance might parallel in septic
patients. However, the peak BNP concentrations tended to follow the
maximum daily fluid balance as the patients get older. Thus, BNP
cannot be used to estimate the refilling phase.
Grant acknowledgement
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Introduction
Microcirculatory alterations in sepsis plays a vital role in development
of multi organ system failure, and this is clear from the observation
that despite correction of systemic hemodynamic parameters still
usually the course of multi organ system failure continue[1]. Effective
fluid resuscitation is a corner stone in the effective management of
patients with septic shock with the goal to improve tissue perfusion
at the micro circulatory level[2].
Objectives
The aim of this work is to compare and evaluate the influence of gel-
atin and saline on sublingual microcirculation in patients with severe
sepsis and septic shock. Another objective is to assess its effects on
the incidence of renal dysfunction and acid base disturbance.
Method
Prospective, randomized, controlled study was conducted on 42 pa-
tients with severe sepsis and septic shock, Patients meeting inclusion
criteria was randomly assigned to receive either gelatin 4 % (21 pts)
or saline 0.9 % (21 pts). Patients received 500 ml of either solution
every 30 minutes till reaching the goals of initial resuscitation, using
a Sidestream Dark Field device mean flow index was determined
before and 6 hours after resuscitation. Arterial blood pressure, heart
rate, and vasopressor therapy was recorded every 30 min during the
first 6 h. Arterial blood samples were collected at three specific times:
on randomization before fluid administration, 6 and 24 hours after
initial resuscitation. Urea, creatinine, urine output and SOFA score
was measured daily for the first 5 days after resuscitation.
Results
Among forty two patients enrolled in the study, demographic data
and patients´ characteristics were comparable among both groups.
After 6 hours from resuscitation, no difference arose in the Sublin-
gual microcirculation parameters between both groups, mean flow
index after resuscitation in gelatin group (1.65 ± 0.65) which was not
superior to saline group (1.74 ± 0.65). No difference was noticed in
acute kidney injury nor acid base disturbance, but there was signifi-
cantly greater net cumulative fluid balance in saline group 2726
(1429) ml compared to gelatin group 930 (2450) ml (P = 0.006) which
indicates more fluid need for the first 24 hours in the saline group.
Conclusions
The main finding in this prospective randomized study was that the use
of gelatin in resuscitation of patients with septic shock does not confer
any advantage over saline in recruitment of sublingual microcirculation.
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Central venous oxygen saturation (ScvO2) is an indirect indicator of
the adequacy of oxygen delivery and cardiac output. A reduction in
the level of ScvO2 below normal levels indicates an increase in oxy-
gen extraction by the tissues in response to a decrease in the arterial
oxygen content or cardiac output[1]. The ScvO2 has been widely uti-
lized for hemodynamic optimization in severe sepsis/septic shock[2].
A time lag usually occurs between admission of a septic patient to
the emergency department and the insertion of a central venous
catheter (CVC). Thus, the need for a surrogate to the ScvO2 which is
easily and rapidly obtainable.
To date peripheral venous oxygen saturation (SpvO2), which involves
an antecubital blood sample has not been validated to replace the
ScvO2 for the purpose of hemodynamic optimization in severe sepsis/
septic shock.
Objectives
The objective of this study was to assess the feasibility of replacing
the ScvO2 with the antecubital SpvO2 for the management of severe
sepsis/septic shock.
Method
Thirty five successive patients with severe sepsis/septic shock in whom
a CVC was inserted were the subject of this study. Simultaneous central
venous and antecubital peripheral venous samples were withdrawn
and tested for oxygen saturations. We compared 35 pairs of simultan-
eous ScvO2 and SpvO2 samples.
Results
Mean age was 65.3 ± 16 years. Sex-ratio (M/F) was 1.7. Eleven
patients (31.4 %) had severe sepsis and 24 patients (68.6 %) had
septic shock.
Spearman's correlation coefficient between ScvO2 and SpvO2 was
0.497 (p = 0.002). Subgroup analysis of patients with severe sepsis
and patients with septic shock showed a Spearman's rho coefficient
of 0.727 (p = 0.011) and 0.422 (p = 0.065) respectively.
Conclusions
SpvO2 showed good correlation with ScvO2 in patients with severe
sepsis. Therefore, it may be a useful tool for early implication of
hemodynamic optimization in patients with severe sepsis.
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Introduction
For several decades, RDW has been typically used in combination with
the MCV to differentiate the cause of underlying anaemia in clinical
practice. Recently, high RDW has been associated with increased
mortality in patients with severe sepsis and Septic Shock [2]. The patho-
physiologic mechanisms underlying the association between RDW and
mortality are unclear; however, it is possible that its relationship with
inflammation and oxidative states plays role in this[3]. RDW has been
linked with inflammation in critically ill patients and with oxidative
stress in animal models.
Objectives
To assess the prognostic value of red cell distribution in patients with
sepsis and its relation with hemodynamic parameters assessed non-
invasively.
Fig. 104 (abstract A262). Sublingual and Jejunal Microcirculation in
Sepsis
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Prospective observational study that included thirty patients admitted
to the MICU sepsis. RDW, shock Index & Hemodynamic Parameters by
Cardiac Bio impedance measurement were assessed during hospital
stay in all Patients[4,5].
Results
RDW was higher in Non-survivors than survivors (22.46 % ±3.2 Vs
15.97 % ± 1.32 ), (P value < 0.001) with cutoff value of mortality
18.5 % with sensitivity 96 %, specificity 100 % and AUC 0.99 . Higher
Shock Index in Non-survivors than survivors (1.26 ± 0.39 Vs 0.78 ±
0.13), (P value < 0.001) with cutoff value of Mortality 0.87 with sensi-
tivity 85 %, specificity 89 % and AUC 0.86. There was a Significant
correlation between RDW & lactate and between RDW & shock index
with P < 0.001 in Both respectively . -Cardiac output & cardiac Index
were higher in Non-survivors than survivors (8.59 ± 2.4 vs 6.6 ± 1.25)
& (4.76 ± 1.47 vs 3.46 ± 0.72) , (P value = 0.031 & 0.003) respectively
but without significant correlation with RDW.
Conclusions
High RDW is associated with higher mortality in sepsis patients and
is higher in patients who developed respiratory failure during ICU
stay. RDW showed significant correlations with shock index and lactate
levels.
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The installation of progressive microcirculatory dysfunction has been
identified as a crucial factor in the development of MODS in sepsis,
which is why the identification, prevention or recovery of microcircu-
latory damage has been a major focus of research. In clinical practice,
the sublingual region has been the site of choice for evaluation of
dysfunction in sepsis, mainly for ease of access. However, there are
doubts as to its validity in relation to microcirculation of other organs
commonly committed in sepsis. This study aimed to compare the
sublingual microcirculation with intestinal, during the initial phase of
sepsis in order to assess whether the sites with the same embryo-
logical origin have similarities in microcirculatory dynamics.
Method
Wistar rats were subjected to sepsis (iv. E. coli 2x109 CFU/mL, DL80 in
26 hours, n = 10) and microcirculation of sublingual regions and je-
junum were captured by Sidestream Darkfield images (SDF). The total
vessel density (TVD) was analyzed by software AVA-3.0 at 0, 1, 2, 3, 4,
5 and 6 consecutive hours post sepsis. The sham group was injected
with saline only. (n = 5). In all periods of the study the animals were
kept under general anesthesia with mechanical ventilation, receiving
hydration (7 ml saline/kg/hr, iv).
Result
In sublingual, there was a significant reduction in vascular density of
animals with sepsis only after 3 hours of sepsis compared to the
sham group. (Fig. 104). This suggests that reducing the density insepsis is only noticeable during periods of increased severity of sep-
sis. The comparison between the periods of sepsis showed that only
the first two hours had a higher density compared to other periods
of sepsis. These results have shown that in sepsis, the density of the
microcirculation decreases with the severity of sepsis, however, AVA-
3.0 Method was able to show differences only between extreme
stages (almost normal with the stages of extreme severity), indicating
a low sensitivity of the Method to differentiate small changes in
density. In the gut, no changes were detected between groups and
between periods, showing that the jejunum density is not variable in
sepsis. These data showed that the dynamic microcirculatory is
organ-specific and independent of embryological origin. In short, the
evaluation of microcirculatory dysfunction is site-dependent and ap-
pears to require assessment Method also organ-specific to the kinetic
measurement of microcirculatory dysfunction in sepsis.
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Introduction
Derangements on microvascular blood flow distribution have been
implied on impairment of oxygen extraction by peripheral tissues.
Objectives
To evaluate the effects of dobutamine on the heterogeneity of
microvascular blood flow at intestinal and sublingual territories and
its relationship with mesenteric and systemic oxygen extraction in a
severe hypodynamic septic shock model.
Method
Fifteen landrace pigs were anesthetized and mechanically ventilated.
Catheters were inserted into carotid artery, pulmonary artery and portal
vein for blood sampling, and for invasive pressures and cardiac output
monitoring. A gas-tonometer was placed into jejunum for mucosal-CO2
determination while a jejunostomy was prepared to visualize gut-
mucosal microcirculation. At each measurement time-point, arterial,
mesenteric-venous and mixed-venous blood samples were obtained to
blood gases analysis. Images of intestinal microcirculation were acquired
using the Side-stream dark Field technique. These video-sequences were
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 139 of 607stored under a random number for ulterior blinded analysis. After
baseline measurements (BL), fecal peritonitis was induced. When
hypotension was not responsive to fluid resuscitation, norepinephrine
was started and shock was declared (TS). Then, pigs were randomized to
a fixed-dose of dobutamine at 5 μg/kg/min (n = 6) or placebo (n = 6).
New measurements were performed 2 (T2H) and 6 hours (T6H) after.
Three sham animals subjected to identical monitoring served as time-
matched controls
Results
We observed a significant decrease in the proportion of intestinal-
villi perfused (%villi-PPV) at TS in both dobutamine and placebo
groups. Cardiac output and systemic DO2 evolved similarly in both
experimental groups. After starting resuscitation, %villi-PPV signifi-
cantly increased in dobutamine group (Friedman repeated-measures
analysis of variance, p < 0.05 for time and time/group interactions).
Variations of %villi-PPV between baseline measurements and each
measurement time-point (BL-to-TS; BL-to-T2H; BL-to-T6H) exhibited a
good agreement with variations in mesenteric VO2 and oxygen ex-
traction ratio (R2 = 0.57 and 0.71 respectively, p < 0.001). Variations of
small-vessels perfused (PPV) at sublingual mucosa (SL-PPV) tracked
%villi-PPV throughout the experiment and were well correlated with
mesenteric VO2 (R
2 = 0.70)
Conclusions
Dobutamine improved heterogeneity of gut microvascular blood
flow during severe hypodynamic septic shock. Decreasing heterogen-
eity of flow was associated with an improvement in regional oxygen
extraction, suggesting the crucial role of microvascular blood flow
distribution on oxygen consumption in sepsis
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Table 83 (abstract A264). Global hemodynamic variables
T1 T2 T3 T4 T5
MAP (mmHg) 106(97-110) 86(79-93)* 64(61-83)* 51(45-54)* 44(37-49)*
Cardiac index
(L/min/m2)
4.9(4.0-5.2) 4.0(3.6-5.1)* 4.3(3.7-4.8)* 3.2(2.9-3.9)* 2.7(2.3-3.3)*
Art LACT
(mmol/L)
1.2(0.9-1.5) 1.2(0.8-1.3) 1.3(1.1-1.7) 2.2(1.7-3.0)* 5.7(4.8-10.7)*
SvO2 (%) 74(70-79) 72(68-80) 70(61-79)* 61(57-69)* 44(39-54)*
CO2 gap
(mmHg)
6(4-7) 6(4-7) 6(5-8) 9(6-10)* 14(12-23)*
Table 84 (abstract A264). Peripheral perfusion variables
T1 T2 T3 T4 T5
Femoral blood
flow (mL/min) †
50(30-100) 32(29-40) * 14(10-31)* 6(4-10)* 5(3-12)*
LP ratio 35(25-49) 29(15-47) 35(21-200) 77(42-357)* 84(28-658)*
fLACT gap
(mmol/L)
0.18(0.03-
0.23)
0.34(0.15-
0.53)*
0.65(0.56-
1.04)*
1.68(1.06-
2.08)*
1.80(1.20-
2.31)*
fLACT/O2
index
0.05(0.01-
0.10)
0.09(0.06-
0.12)
0.14(0.09-
0.17)*
0.22(0.13-
0.30)*
0.25(0.20-
0.27)*
fCO2 gap
(mmHg)
4(4-8) 8(6-9)* 11(8-13)* 18(15-19)* 23(18-33)*
fCO2/O2
index
1.89(1.68-
2.14)
1.64(1.53-
1.90)
1.70(1.58-
2.15)
2.23(1.86-
3.00)
3.15(2.97-
3.70)*
m fCO2/O2
index
28(26-33) 27(25-34) 29(25-40) 41(32-51) 59(52-66)*A264
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Introduction
Septic shock is characterized by altered perfusion, potentially leading
to tissue hypoxia. The central-peripheral difference of some metabolites(lactate, oxygen and CO2) and their ratios may be good markers of per-
ipheral hypoperfusion.
Objectives
To characterize the evolution of some peripheral indexes of perfusion
and metabolism in a model of sepsis due to peritonitis.
Method
We studied 18 anesthetized, mechanical ventilated and invasively
monitored sheep, in which autologous feces were injected into
the abdomen. Fluid administration was titrated to maintain initial
pulmonary artery occlusion pressure. Vasopressors were not used.
Arterial, mixed venous (v), and right femoral venous (fv) blood
samples were collected at baseline and every 4 hours to perform
blood gas analysis and lactate (LACT) measurements. A microdial-
ysis catheter was placed in the posterior leg muscle to measure
the lactate/pyruvate (LP) ratio every hour. We calculated the fCO2
gap as PfvCO2-PaCO2, fLACT gap as fvLACT - art LACT, fO2con-
tent gap as [(SaO2 × 1.34 × Hb) + (0.031 × PaO2)]-[(SfvO2 × 1.34 ×
Hb) + (0.031 × PfvO2)], fO2Sat gap as SaO2-SfvO2, fLACT/O2 index
as fLACTgap/fO2content gap, fCO2/O2 index as fCO2gap/fO2con-
tent gap and the modified (m) fCO2/O2 index as fCO2gap/fO2Sat
gap. These variables were investigated at baseline (T1), before
hypotension (MAP < 60 mmHg) (T3), before death (T5) and at
midpoints between these times (T2 and T4). Results are pre-
sented as median (p25-75) values. Statistical analyses were per-
formed using SPSS 23.0.
Results
All animals died during the 30-hour observation period. Results at
each time point are presented in Tables 83 and 84, and all data be-
fore and after the development of hypotension are presented in
Table 85. († = only 12 animals; * = p < 0.05 vs T1).
Conclusions
All peripheral indexes were influenced by the decreased blood
flow, but the fCO2 gap and the fLACT gap were altered earlier;
these indexes could potentially be useful to detect tissue hypo-
perfusion during sepsis.
Table 85 (abstract A264). Median values before and after hypotension
MAP>60mmHg MAP<60mmHg p
MAP (mmHg) 84 (72-93) 48 (40-54) <0.01
Art LACT (mmol/L) 1.1 (0.8-1.4) 3.6 (2.0-6.4) <0.01
Femoral blood flow (mL/min) 32 (18-48) 6 (4-11) <0.01
L/P ratio 31 (19-47) 66 (30-408) <0.01
fLACT gap (mmol/L) 0.33 (0.15-0.60) 1.75 (1.12-2.08) <0.01
fLACT/O2 index 0.09 (0.04-0.13) 0.22 (0.16-0.29) <0.01
fCO2 gap (mmHg) 8 (6-10) 17 (14-23) <0.01
fCO2/O2 index 1.68 (1.48-1.92) 2.93 (2.00-3.53) <0.01
m fCO2/O2 index 27 (25-33) 51 (37-61) <0.01
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Introduction
Shock is best defined as a life-threatening, generalized form of acute
circulatory failure associated with inadequate oxygen utilization by
the cell. Importantly, peripheral vasodilation (relative hypovolemia
and low systemic vascular resistance) coexist with cardiac dysfunc-
tion (left ventricular (LV) diastolic and systolic dysfunction secondary
to primary myocardial injury or right ventricular dysfunction due to
pulmonary hypertension) resulting in ventriculoarterial decoupling.
Ventriculoarterial coupling is defined by the ratio of arterial elastance
(Ea) to left ventricular end-systolic elastance (Ees).
Objectives
In this study, we analyzed the variability of ventriculoarterial coupling
in ICU patients with septic shock and the effect of therapeutic in-
terventions such as vasopressor and inotropic agent to improve
perfusion.
Method
In this prospective study, we measured routine hemodynamics using
indwelling arterial catheters and transthoracic echocardiograms in
septic patients upon ICU admission. Hemodynamic variables included
cardiac index (CI), heart rate (HR), mean arterial pressure (MAP). Ees was
measured by echocardiography using a single-beat (EesSB) Method Ea
was calculated as 0.9 systolic arterial pressure/stroke volume, and
then the Ea/EesSB ratio was calculated (normal value < 1.36).The
measure were repeated every day for a maximum of seven days.
Results
We analyzed a series of measured parameters in six patients. At the
time of diagnosis of septic shock patients presented in a hyperdynamic
state (median CI = 2.96 ± 1.10 L/min/m2 and HR = 84 ± 24 beats/min,
hypotensive (MAP 56.8 ± 17,6 ) and higher Ea/EesSB ratio (1.41 ± 0.08).
After starting treatment with norepinephrine and levosimendan and as
it improved the state of septic patients , there was a parallel
normalization of haemodynamic parameters and especially of ventricu-
loarterial coupling, the Ea/EesSB ratio was respectively 1.21 ± 0.1, 1.01
± 0.10, 0.93 ± 0.11 on day 2, 3 and 4.
Conclusions
In septic shock patients, there is a higher percentage of ventriculoar-
terial decoupling.. Because ventriculoarterial decoupling is an index
of cardiovascular inefficiency and a determinant of cardiac energet-
ics, we speculate that such “uncoupled” patients may benefit from
therapies aimed at normalizing the Ea/Ees ratio
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Objectives
To evaluate the characteristics of fluid therapy during the first week
of septic shock and its possible impact in 28-day mortality.
Method
Prospective, observational study, conducted in a polyvalent ICU
(intensive care unit). 35 patients with diagnosis of septic shock were in-
cluded over a period of 5 months. Demographic data, comorbidities,
APACHE II, SOFA, clinical and hemodynamics parameters, as well as
fluid therapy characteristics were analysed during the first week of
hospitalization. The impact in 28-day mortality was evaluated. We de-
fined “hidden volume” as the volume delivered beyond the resuscita-
tion fluid therapy.
Results
During the first 72 hours of treatment in ICU, the patients received
an average total volume of 12.8 ± 4.0 litters. The amount of resuscita-
tion fluids decreased progressively from 48 % (mean 1313.1 ±
664.7 ml) to 4 % (mean 520 ± 382.4 ml) within the first 72 hours. The
opposite was found regarding maintenance and drug-associated vol-
ume, with an increase from 27 % (mean 383.5 ± 189.2 ml) to 42 %
(mean 1493.6 ± 649.7 ml) and from 30 % (mean 421.7 ± 297.3 ml) to
37 % (mean 1304.1 ± 906.8 ml) respectively, within the first 72 hours.
A tendency towards hemodynamic stabilization was observed within
the first 72 hours, with a mean arterial pressure of 70 ± 13 mmHg to
86 ± 14 mmHg, diuresis of 1188 ± 1119 ml to 1782 ± 1404 ml and lac-
tate of 3.68 ± 2.38 mmol/l to 2.19 ± 1.58 mmol/L. It was found that
28-day mortality was significantly lower when patients received more
resuscitation fluids during the first 6 hours of hospitalisation
(1087.6 ± 1102.8 ml vs. 492.4 ± 416 ml, p = 0.024). In contrast,
those patients with a higher 7-day cumulative hydric balance
(321 ± 7702.4 ml vs 2346.6 ± 2444.2 ml, p = 0,018) showed a
higher mortality. Clinical and hemodynamic characteristics in ad-
mission to the ICU were compared between 28-day survivors and
non-survivors without significant differences, except for more left
ventricular systolic dysfunction within the non-survivors (33,3 %
vs. 18,7 %; p > 0,05).
Conclusions
During the first week of ICU admission, the excess of fluids seems to
be caused by hidden fluids (maintenance and drug-related fluids).
Furthermore, these appear to be related with a higher mortality, as
does an insufficient resuscitation within the first 6 hours of ICU
admission.
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Fig. 106 (abstract A268). Intravascular Optimization Algorithim
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Heart rate variability (HRV), has shown promise in predicting pediatric
patients at high risk for sepsis and death [1]. However, its use in clin-
ical practice has been precluded by the absence of real-time data.
Objective
This study was conducted to evaluate the utility of electrical cardiome-
try for real-time determination of HRV and using these data in predict-
ing the outcome in pediatric patients presented with septic shock.
Method
Prospective enrolment of pediatric patients who met the criteria of
septic shock. Electric cardiometry (ICON) was used to measure
time-domain HRV continuously in real time for 2 hours after admis-
sion to intensive care unit. Electric impedance cardiography was
used to determine cardiac output. Hemodynamic parameters which
discriminate survivors from non-survivors were evaluated.
Results
We enrolled 15 pediatric patients with septic shock of whom 5 (33 %)
patients were discharged and 10 (66 %) died. Heart rate was similar be-
tween survivor and non-survivor. The median (interquartile range [IQR])
of HRV of enrolled patients was significantly lower among the non- sur-
vivors (4.3 {3.8-7.3}) than survivors (19.5 {13.5-34.7}) (P = 0.005).The cut-
off of the HRV value for predicting mortality was ≤ 12.5. This cut-off value
had a sensitivity of 100 % and a specificity of 80 %; the area under the
curve was 0.96 (95 % confidence interval 0.7-1.0, P < 0.0001.
Conclusion
We concluded that decreased HRV is good predictor of mortality in
pediatric patient with septic shock. Real-time HRV may be a useful
adjunct to standard vital signs monitoring in this population.
References
1. Griffin MP, Lake DE, Bissonette EA, et al. Heart rate characteristics:
novel physiomarkers to predict neonatal infection and death. Pediatrics
2005;116:1070-4.
A268
Effectiveness of fluid thoracic content measurement by
bioimpedance guiding intravascular volume optimization in
patients with septic shock
M.F. Aguilar Arzapalo
SSA UADY, Mérida, Mexico
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A268
Introduction
Appropriate resuscitation and intravascular volume optimization are
treatment cornerstone in septic shock. Optimization requires invasive
monitoring and static measurements, due to it, is necessary a non in-
vasive, fast and dynamic Method Thoracic fluid content (TFC) by
thoracic bioimpedance surge as a monitoring system that fulfills the
requirements: non invasive, easy placement and dynamic
Objectives
Evaluate the effectiveness of fluid thoracic content measurement by
bioimpedance guiding intravascular volume optimization in patients
with septic shock
Method
Sixty patients were enrolled, divided in two groups with 30 subjects
each, admitted at ICU with septic shock diagnosis. F Group was formed
by patients in whom TFC was measured by thoracic bioimpedance, in
order to guide intravascular volume optimization; C Group patients
were optimized following “Surviving Sepsis Campaign Guidelines”, re-
cording mortality at ICU discharge and at 28 days, mechanical ventila-
tion length and ICU length of stay
Results
Based on TFC F Group obtained a faster and higher Mean Arterial Pres-
sure (MAP) increasing up to 42.5 % at 6 hours, compared to C Group
where MAP arise only 19.5 % at 6 hours (p:< 0.05). Due to lactate clear-
ance F Group, obtained a total clearance of 54.4 % and 66.6 % at 6 and
12 hours, on C Group clearance just came up to 25.3 % and 35.8 % at 6
and 12 hours (p: 0.001). A higher mortality at ICU discharge was reach
on C Group with 33.4 % vs 26.7 % (p: 0.001) from F Group, 28 day mor-
tality was 36.5 % and 27.8 % (p:0.003) on C and F Group respectively.Note: This abstract has been previously published and is available at [1].
It is included here as a complete record of the abstracts from the
conference.
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Conclusions
Measurement of thoracic fluid content by thoracic bioimpedance is
effective while optimizing intravascular volume in septic shock
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Introduction
Posttraumatic stress symptoms (PTSS) following intensive care
treatment are frequent. In accident victims strong sense of coher-
ence (SOC) has previously been associated with less PTSS. To our
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 142 of 607knowledge no study has investigated the association between PTSS
and SOC in a mixed intensive care unit (ICU) population.
Objectives
To examine the prevalence of PTSS after ICU stay, and the relation-
ship between PTSS, SOC and demographic and clinical characteristics
in ICU patients.
Method
In a cross sectional study patients 318 years treated in two ICUs at
Oslo University Hospital Ullevål for 3 24 hours were consecutively in-
cluded during one year (2014-2015). Demographic and clinical data
were collected. PTS symptoms and SOC were measured with Post
Traumatic Stress Scale 10 Intensive care screen (PTSS10-I) and Sense
of Coherence Scale 12 (SOC-12) at the ward after ICU discharge.
PTSS-I0-I scores 335 was used as cut off value indicating clinical
significant PTSS. Descriptive and multivariate logistic regressions ana-
lysis was performed with IBM SPSS statistics 21.
Results
We included 133 patients with mean age 54 ( ±17 SD) and 56 % being
male, of whom 37 % were trauma patients and 54 % receiving ventila-
tor treatment. Prevalence rate of defined PTSS was 25 %. Demographic
and clinical variables were investigated for association with PTSS and
variables with a p value < 0,1 were included in the multivariate logistic
regression analysis. Adjusting for gender and age, only SOC (OR 0.91,
[95%CI: 0.87-0.95]) and ventilator treatment (OR 4.98, [95%CI: 1.67-
14.83]) were significantly associated with PTSS symptoms.
Conclusions
In our study population low SOC and ventilator treatment was as-
sociated with clinical significant PTSS in patients after discharge
from the ICU.
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Introduction
Intensive Care Units (ICU) are characterized not only for caring the
sickest patients but also due to its high levels of anxiety and stress in
health workers, which takes its maximum expression in the burnout
syndrome. The cause of this burden is frequently related to specific ICU
work factors such as physical and emotional workload. There are sev-
eral theoretical approaches to these problems, for example the imbal-
ance effort - reward (ERI) model, which has been poorly tested in the
ICUs. In chilean ICUs, the multidisciplinary team is mostly composed by
registered nurses and nurse aides whom must work hand in hand to
ensure the quality and safety of care. The aim of this study was to in-
vestigate the prevalence of effort-reward imbalance and burnout
among ICU registered nurses and nurse aides in a teaching hospital.
Methodology
Comparative, cross-sectional study. A convenience sample of ICU reg-
istered nurses (RN) and nurse aides (NA) from a teaching hospital in
Santiago, Chile was obtained. Three questionnaires were used for
data collection:
i.) A sociodemographic questionnaire,
ii.) Spanish short version of Effort-Reward Imbalance questionnaire
by Siegrist, an ERI > 1 indicated an imbalance between efforts
and rewards , and
iii.)Maslach Burnout Inventory, including their 3 subscales:
emotional exhaustion (EE), personal accomplishment (PA)
and depersonalization (DP). A p-value < 0.1 was considered.
Results
The response rate was 87.2 % (n = 82). A 56.1 % of the sample was NA
and 43.9 % was RN. An 89.1 % of NA reported an ERI > 1, whileregistered nurses reached 75 % (p < 0.1). Compared to RN, NA had
higher ERI (1.58 v/s 1.23, p < 0.05) and lower rewards (13.9 v/s 17.5,
p < 0.01). Only one case of burnout was observed among NA, but
no cases were observed among RN. A higher proportion of RN was
observed with medium levels of DP (47.2 % v/s 32.6 %, p < 0.1) and
PA (44.4 % v/s 30.4 %, p < 0.1) compared to NA, however NA had a
higher proportion of low levels of PA compared to RN (56.5 % v/s
30.6 % p < 0.05).
Conclusions
Most of the ICU nursing team has an effort-reward imbalance,
which is higher in nurse aides due to a lower perception of
rewards. Burnout seems not to be a problem, but low degree of
personal accomplishment suggests that is necessary to perform
early interventions based on the recognition and opportunities for
personal development, specifically on nurse aides, this interven-
tions could help to maintain low levels of burnout and improve ef-
fort reward imbalance.
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Introduction
Climate safety is a design factor guiding the judgment and behavior
of health care professionals, and highlights the issue of patient safety
at the top of their priorities. At safety climate, employees are directed
to act in accordance with company-wide commitment to safety, so
that each state maintain personal safety norms and those of col-
leagues. This formed a consensus on the relative importance of safe
behavior in situations that present conflicting requirements in safety
competitors such as meeting deadlines.
Objectives
Checking the safety climate concept among intensive care nurses
while making a comparison between ICU nurses and CCU nurses.
And check whether the theoretical model fails to predict a safe cul-
ture among intensive care nurses?
Method
The study population consisted of 81 nurses who work in intensive
care units in hospitals at tel aviv district. The subjects were asked to
complete a structured questionnaire containing 69 items. Which ex-
amined the perception of nurses´ patient safety climate in workplace,
communication between employees, frequency of reported incidents,
organizational and departmental policies and procedures and prac-
tices. Data were collected in April-May 2015.
Results
This study increased moderately positive correlation exists between
the perception of workers ICU patient safety, and the total score of
the atmosphere of safety (r = 0.623, p < 0.000). There is a positive
medium correlation between the perception of icu workers of cor-
porate policies and departmental and between process and Method-
ology (r = 0.568, p < 0.01), while in the ICU General (r = 0.626, p <
0.01), compared to intensive care Cardiology (r = 0.508, P < 0.01).
Conclusions
The findings support the theory of ZOHAR (2000, 2003) about the
safety climate that is meaningful for intensive care nurses. Which re-
fers to a common perception among members in all aspects of the
organizational environment, that dictates the behavior at work and
the extent to which certain aspects are rewarded and supported in
the organization. There are differences between the general intensive
care and cardiac intensive care in evaluating patient safety and an at-
mosphere of safety, particularly in assessing and evaluating the work
area corporate policy.
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Introduction
Ventilator-associated respiratory infections (VARI) are an important
source of morbidity in ICU patients. Continuous endotracheal Pcuff-
control is a way to minimize micro-aspiration of subglottic secretions,
which is considered to be a major pathogenic mechanism of VARI.
Objectives
To perform a systematic review and meta-analysis to assess the effi-
cacy of continuous Pcuff-control in the prevention of VARI.
Method
MEDLINE, EMBASE, CENTRAL/CCTR, Clinicaltrials.gov and ICTRP were
systematically searched. Eligible trials were randomized controlled
clinical trials (RCTs) and quasi-RCTs comparing continuous Pcuff-con-
trol with manual, intermittent Pcuff-control in intubated patients. All
studies reporting VARI incidence were included. VARI includes
ventilator-associated pneumonia and ventilator-associated tracheo-
bronchitis. Inclusion of trials was irrespective of publication status,
date of publication or language.
Results
Two RCTs [1,2] and one quasi-RCT [3] meeting the inclusion criteria
were identified (one using a pneumatic device [1] and two using an
electronic device for continuous Pcuff-control [2,3]). All studies were
single-center; none of the trials was blinded for the intervention. 465
patients were allocated to the intervention arm and 455 to the con-
trol arm. 50 VARI episodes occurred in the intervention group and 91
in the control group. The pooled Odds Ratio for the incidence of
VARI was 0.45 (random effects model, 95 % confidence interval, 0.30-
0.69; z = 3.68 p < 0.001).
Conclusions
This meta-analysis shows that continuous Pcuff-control appears to re-
duce the incidence of VARI. However, the number of included studies
is small, and there is an inherent risk of bias due to the unblinded
designs.
References
1. Valencia M, et al. Crit Care Med 2007
2. Nseir S, et al. Am J Respir Crit Care Med 2011
3. Lorente L, et al. Am J Infect Control 2014
Grant acknowledgment
We received no grants for this study.Fig. 107 (abstract A272). Meta-analysis Forest plot; incidence of
VARIA273
Acute kidney injury in adult patients undergoing heart
transplantation: incidence and outcomes according KDIGO criteria
E. Santana-Santos1, E.R. dos Santos2, R.E.D.L. Ferretti-Rebustini3,
R.D.C.C.D.O. dos Santos1, R.G.S. Verardino1, L.A. Bortolotto4
1Heart Institute (InCor) do Hospital das Clínicas da Faculdades de
Medicina da Universidade de São Paulo, Nursing Coordination, São
Paulo, Brazil; 2Instituto Israelita de Ensino e Pesquisa Albert Einstein,
School of Nursing, São Paulo, Brazil; 3Nursing School of University of São
Paulo, São Paulo, Brazil; 4Heart Institute (InCor) do Hospital das Clínicas
da Faculdades de Medicina da Universidade de São Paulo, Hypertension
Department, São Paulo, Brazil
Correspondence: E. Santana-Santos – Heart Institute (InCor) do
Hospital das Clínicas da Faculdades de Medicina da Universidade de São
Paulo, Nursing Coordination, São Paulo, Brazil
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A273
Introduction acute kidney injury (AKI) is a commom complication
after heart transplantation and it is associated with high morbidity
and mortality.
Objective
To evaluate the incidence of acute kidney injury (AKI) and outcomes
in adult patients undergoing heart transplantation according KDIGO
criteria.
Method
We performed a retrospective cohort study in a tertiary hospital spe-
cialized in cardiac surgery and reference in Latin America. Patients
older than 18 years old who had undergone heart transplantation
between January 2011 and January 2015 were included. Patients
with congenital heart disease were excluded.
Results
Patients were divided into two groups (those who did not develop
AKI and those who did develop AKI). The incidence of acute kidney
injury was 86 %. We did not observe diference between the groups
in relation to males (70.0 % vs. 66.7 %, p = 0.834), age (43 ± 13 years
vs. 46 ± 12 years, p = 0.493) and EuroSCORE (8.2 ± 1.6 vs. 7.4 ± 2.2, p =
0.289), respectively in no AKI and AKI group. When we compared
clinical characteristics before the transplantation, we found signifi-
cant differences in relation to in inotropic dosis (18.6 ± 5.1 mcg/kg/
min vs. 14.2 ± 5.9 mcg/kg/min, p = 0.037) and the use of intra-aortic
balloon pump (88.9 vs. 46.7, p = 0.012), respectively in no AKI and
AKI group. The outcomes length of stay and mortality were greater
in the postoperative period in the group of patients who did develop
AKI when compared with the group who did not develop AKI.
Conclusion
The incidence of acute kidney injury in patients undergoing heart
transplantation was 86 %. The mortality was higher with the pres-
ence of AKI.
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Team leadership & staff engagement are key influences on per-
formance, clinical outcomes & patient satisfaction[1,2]. There is
increasing recognition of stress experienced by critical care
nurses[3,4,5]. These factors, alongside a shortage of critical care
nurses, indicate that recruitment, retention & professional sup-
port for nurses are key issues in the delivery of safe & effective
healthcare.
Objective
The study aimed to positively engage nurses, as key stakeholders in
critical care, to identify the gold standard framework for a high
performance team, from a nursing perspective. The study uses
qualitative Methodology, which is recognised to be under-utilised
as a research tool in critical care[6].
Method
Critical care nurses (n = 102) participated in focus group discussions
addressing four key themes: 1. Identification of the gold standard high
performance team in critical care; 2. Identification of current team per-
formance; 3. Identification of current team strengths; 4. Identification of
key priorities for quality improvement.
Results
Results were analysed using inductive content analysis & re-
vealed the outline of a gold standard high performance critical
care team from a nursing perspective. Key factors included: high
morale, positive team climate, effective/open communication,
role clarity, good clinical outcomes, patient satisfaction, profes-
sional development opportunities, job satisfaction, strong leader-
ship & supportive management. The results also indicated the
nursing team's perception of current team strengths & key prior-
ity for change.
Conclusion
This is the first study outlining the gold standard high performance
team in critical care from a nursing perspective using qualitative re-
search Methodology. The work forms part of a wider quality im-
provement strategy engaging multi-disciplinary staff in critical care
team performance work with the aim of improving the quality and
safety of patient healthcare.
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Nurse Staffing guidelines in Critical Care generally suggest a nurse/
patient ratio of 1:2 for High Dependency Unit (HDU) patients and 1:1
for Intensive Care Units (ICU) (FICM, 2015). Current recommendations
depend mainly on organ failure as the evidence available on which
to judge adequate levels of staffing is relatively limited and based on
the opinions of expert group.
Objective
The United Kingdom Critical Care Nursing Alliance (UKCCNA), an alli-
ance of all the leading critical care nursing organisations in the
United Kingdom, have developed a proposal, commissioned and di-
rected a literature review of critical care nursing activity tools that
currently exists and utilised around the world.
Method
A rapid review Methodology was employed by a team of critical care
experts, an information specialist and two nursing academics. The
scope of the search included research studies, guidelines and surveys
within and outside United Kingdom in the last 20 years. The search
encompassed subject specific electronic databases. The SPICE stan-
dardised framework was used (Booth 2004).
Results
117 abstracts were considered, 81 abstracts excluded and a total of
36 further considered. Studies were drawn from around the globe,
with considerable work undertaken in UK (9 studies) and Brazil (10
studies). The empirical studies ranged from retrospective analyses,
staff diaries and surveys, observational studies, prospective studies of
the use of specific tools and staffing models and instrument develop-
ment. The tools examined fell into two main groups: those related to
the condition and needs of the patient, and those related to nursing
activities and interventions.
Conclusions
Understanding nursing workload and activity is complex and there
are numerous tools available to measure this. Nursing Activities Score
(NAS) was the most extensively examined tool, with generally reliable
results focusing on the whole of the ICU nurse's workload so most
suitable for evaluating overall staffing levels. The risk based model
provides a means of determining nurse allocation around risk as op-
posed to Workload or patient dependency. However, we concluded
that there is a scope to develop a new tool using the elements from
the tools examined in this review which then needs to be tested in
clinical practice.References
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Introduction
There is a direct link between Intensive Care Unit (ICU) staff num-
bers and clinical outcomes; an increase in the ICU staff capacity
translates to improved clinical outcomes, which results in a de-
crease in ICU mortality rates. This effect is more pronounced when
the staff are dedicated and specifically trained to care for critically
ill patients. Furthermore, an increase in ICU staff numbers has a cost
saving benefit to both the patient and the healthcare institution.
Increased staff numbers result in a decline in patients' lengths of
stay hence there is a drop in the risk of hospital related complica-
tions including hospital-acquired infections and also the cost of
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is against this background that the Paediatric Critical Care Nursing
program (PCCN) was launched in Nairobi, Kenya.
Objectives
The program aims to train 30 nurses per year (two intakes per year
of 15 nurses each) as per the Nursing Council of Kenya guidelines so
as to build the capacity of critical care nurses in East Africa.
Method
The PCCN training program is tailored for state registered nurses or
Bachelor of Science in Nursing graduates who wish to specialize in
critical care environments; critical care of neonates, infants, children
and adolescents along the critical care continuum across a variety of
health services, from resuscitation, critical stabilization, transfer and
vigilant and responsive care through the often turbulent and dy-
namic period of critical illness in the Paediatric Intensive Care Unit
(PICU), Neonatal Intensive Care Unit (NICU) and High Dependency
Unit (HDU). Training is over a 52-week period and includes theory
(16 weeks) and critical nursing experience (36 weeks). Additional
courses include EPLS (European Advanced Pediatric Life Support),
ETAT+ (Emergency Treatment and Triage) and PEWS chart (Pediatric
early warning score).
Results
A total of 45 nurses from 22 healthcare institutions across East Africa
have benefitted from the training since the launch of the program in
2013 to-date; four (4) nurses from Rwanda, one (1) from Uganda and
forty (40) from Kenya. Of the nurses trained nine (9) were male and
thirty six (36), female with a mean age of thirty seven (37) years. The
graduates have taken up leadership positions and are now using the
skills acquired to improve paediatric critical care through evidence
based clinical practices, besides the management of critical care units
and translation of strategic health care policies to tactical and oper-
ational plans for effective implementation for positive outcomes in
national healthcare systems.
Conclusions
These efforts are in line with the United Nations Convention on the
Rights of a Child, which is in place to ensure quality healthcare for all
children globally.
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Introduction
It is well acknowledged that the intensive care unit (ICU) environ-
ment can create a stressful work atmosphere for clinicians. Promot-
ing a healthy work environment for ICU settings has been
identified as a way to reduce work-related stress in the ICU. As part
of an overall initiative to enhance the work environment in the ICU
at a 620 bed university affiliated medical center, an employee ap-
preciation day was designated and 10 minute massages were pro-
vided to clinical staff.
Objective
The objective of this study was to assess the impact of a massage
intervention on self-reported stress ratings.
Method
The Numeric Stress Scale, an established Likert scale ranging from
“0” or “No Stress” to “10” or “Unbearable Stress” was used to collect
self-assessed perceptions of stress ratings. A 10 minute massage was
provided by certified massage therapists using portable massage
chairs set up in a conference room.
Results
A total of 182 nurses and other clinicians completed a pre-post assess-
ment of self- reported levels of stress. Before the massage, clinicians
rated their own level of stress as being, on average, 6 out of ten (mod-
erate). After the 10 minute massage, stress ratings were found todecrease, with over one third of respondents reporting low levels of
stress [0 or 1], and 30 % of respondents reporting “no stress”. The num-
ber of clinicians reporting high levels of stress [9 or 10] decreased
from 11 to 3 after the massage intervention. An independent sam-
ples T-test was used to compare the pre (mean = 6.15, standard de-
viation 2.02) and post (mean = 2.25, standard deviation 2.14) stress
ratings. The change in self-reported levels of stress was found to be
a statistically significant decrease (t-statistic = 12.5, df 181, p < .000).
Conclusion
A 10 minute massage intervention was found to result in de-
creased levels of self-reported stress levels in ICU clinicians in this
single center study. Exploring the impact of stress reducing inter-
ventions for ICU clinicians requires further investigation as part of
an overall focus in promoting a healthy work environment in the
ICU.
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Introduction
Diabetic ketoacidosis (DKA) is a major complication of diabetes melli-
tus. It is more and more frequent in Tunisia with an incidence ran-
ging from 4 to 8 per 1000 diabetic patients. There are many insulin
administration protocols and many unresolved questions : the place
of alkalinization and the signification of hyperchloremic acidosis.
Objectives
The aim of this work was to evaluate the management of DKA in a
Tunisian medical intensive care unit and to determine the prognosis
factors in our diabetic patients.
Method
We conducted a retrospective analysis over two years (January 2013
- December 2015), of records of patients who were admitted to our
intensive care unit (ICU). Diabetic ketoacidosis was diagnosed by the
biochemical triad: ketonaemia, hyperglycemia and acidaemia. We
picked up all the clinical and laboratory data, fluid replacement,
complications and disease progression.
Results
52 patients were enrolled. The prevalence of ketoacidosis was 3 %
and nearly 0.02 % of all patients who attended our emergency de-
partment. The mean age was 36 ± 21 years with a sex ratio of 0.4.
70 % of our patients had type 1 juvenile diabetes and 15 % had
type 2 diabetes. The other 15 % had inaugural ketoacidosis. The
mean SAPS II score was 24 ± 15. Asthenia was the most frequent
clinical sign (71 %). 61 % of patients expressed digestive symptoms.
Nine patients had altered vital signs with mainly a shock and nine
other patients had altered mental status. 40 patients had hyper
leukocytosis. All patients had both venous and capillary glycaemia.
The mean capillary glycaemia was 5, 16 ± 1, 40 g/l. Twenty two pa-
tients (40 %) had pseud hyponatremia. Seven patients (13 %) pre-
sented hyperkaliemia at admission. The mean c-reactive protein
level was 15,28 ± 23,81 mg/l. The mean level of bicarbonate value
was 10,68 ± 5 mEq/l at admission. The mean overall osmolarity was
318 ± 16 mEq/l. 28 patients were infected (54 %). All patients had a
close bedside monitoring of blood glucose, blood gas and blood
electrolyte measurement according to our local protocol management
which will be detailed in this work. The fluid replacement therapy was
based on crystalloids. Three patients received alkalinization. Four pa-
tients presented a coronary syndrome. Five patients developed hyper-
chloremic acidosis. The overall mortality rate was 13.5 % (7 patients).
The mean hospital stay in our ICU was 37,8 ± 22,7 hours. Factors associ-
ated with mortality were type 1 of diabetes (p = 0.004), SAPS 2 (p < 10-6),
shock ((p < 10-6), and acute renal failure (ARF)(p < 10-6) in univariate
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poor outcome in multivariate analysis.
Conclusions
The clinical assessment and aims of treatment in the management of
DKA are similar to literature. But, many controversial points about the
optimum treatment regimen, the fluid to use, alkalinization and the
management of hyperchloremic acidosis are discussed in this work.
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Introduction
Both NT- proBNP and Doppler echocardiography have been ap-
proved in the diagnosis of heart failure. In our Study, we compared
the contribution of the NT-proBNP levels with the Doppler echocardi-
ography findings in the diagnosis of decompensated congestive left-
heart failure (CHF) in patients with acute dyspnea.
Objectives
To compare NT-proBNP levels and echocardiography finding in the
determination of the etiology of difficult-to-diagnose severe dyspnea
in the emergency department.
Method
It was a prospective, observational study at the teaching depart-
ment of emergency and intensive care in the regional hospital of
Zaghouan, including patients with severe dyspnea over six months.
All patients underwent physical examination, 12-lead ECG, RX
Thorax, NT-ProBNP essay and echocardiography by an attending
cardiologist on admission. The accuracy of the two Method for etio-
logic diagnosis was compared on the basis of the final diagnoses
established by the medical staff.
Results
65 patients were enrolled, including 45 (69 %) with CHF. Diagnosis
of CHF was due to coronary artery disease, hypertension, valve dis-
ease, arrhythmia and dilated cardiomyopathy. Non-CHF was due to
decompensated chronic obstructive pulmonary disease, pneumo-
nia, and severe asthma. Fifteen patients (23 %) were misdiagnosed
at admission. The mean NT-proBNP concentration was 8989 [769 to
18945] pg/ml in the CHF subgroup and 462 [22 to 1589] pg/ml in
the other patients (p < 0.01). Systolic LV dysfunction (LVEF < 0.45)
was found in 31 patients with CHF (60 %) and in 7 patients with
other causes of dyspnea (15 %) (p < 0.01). The E/A ratio and the de-
celeration time of E-wave (DT) were respectively 1,85 ± 0,77 and
12o ± 23 in the group CHF; 0,81 ± 0,44 and 208 ± 47 in the group
Non-CHF (p < 0.01). Impaired relaxation and Restrictive mitral pat-
tern were observed respectively in 28 % and 30 % of the patients
with CHF and in only two patients and th + ree patients in the other
group.
Conclusions
Both NT-proBNP assay and echocardiography can be used for the
diagnosis of CHF inacutely dyspneic patients. However, the echocar-
diography is more accurate in patients with intermediate BNP levels.
Note: This abstract has been previously published and is available at
[1]. It is included here as a complete record of the abstracts from the
conference.References
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Introduction
Despite decades of research, predictors of weaning and extuba-
tion failure remain unclear, although ineffective cough and secre-
tion retention likely play a role. Cough augmentation techniques
(lung volume recruitment [LVR], manually assisted cough [MAC],
and mechanical insufflation-exsufflation [MI-E]) are used to pre-
vent and manage respiratory complications of chronic disease
and may improve short- and long-term outcomes for patients
experiencing acute respiratory failure. The role of cough augmen-
tation to enable extubation and prevent post-extubation respira-
tory failure for critically ill patients with acute respiratory failure
is unclear.
Objectives
To determine extubation success, duration of ventilation, ICU stay,
mortality, and harm using cough augmentation techniques com-
pared to no cough augmentation for critically ill adult and paediatric
patients with acute respiratory failure.
Method
Systematic review of trials evaluating LVR, MAC, or MI-E compared to
a control group without this intervention. We considered non-
randomized studies [NRS] for harm evaluation only. Two authors in-
dependently screened electronic databases to April 2016 and ab-
stracted data on a standardized form with accuracy verified by a 3rd
author.
Results
We screened 2686 references, identified 23 for full text review
and excluded 15. Included studies comprised 2 RCTs (112 partici-
pants); 1 evaluated MI-E + MAC, the other LVR + MAC. NRS in-
cluded 1 case-control study and 5 large case series. One trial
reported greater extubation success (no need for reintubation
for 48 hours) in the MI-E + MAC group (82.9 % vs 52.5 %, rela-
tive risk [RR] 1.58, 95 % CI 1.13 to 2.20). One trial reported a
statistically significant reduction in mechanical ventilation favour-
ing MI-E + MAC (mean difference -6.1 days, 95 % CI -8.4 to -3.8).
Two trials reporting on ICU stay and mortality demonstrated no
difference. Harm reported in the 2 RCTs comprised 2 interven-
tion patients experiencing hemodynamic compromise compared
to no control arm patient (RR 3.2, 95 % CI 0.35 to 29.2). In the
trial of MI-E + MAC, 9 (23 %) control group patients compared to
2 (6 %) MI-E + MAC patients experienced secretion retention and
severe hypoxemia warranting reintubation (RR 0.25, 95 % CI 0.06
to 1.10). No patient in either trial experienced new onset
arrhythmia or pneumothorax. Of the 5 case series, 2 studies (33
patients) evaluating MAC during invasive ventilation reported no
complications (hemodynamic compromise, pneumothorax, hyp-
oxemia, mucus plugging). In the 3 case series that evaluated MI-
Table 86 (abstract A281). Prehabilitation outcomes
Initial Assessment Post Prehab Difference
ISWT (m) 401 515 114 (28%)
Anxiety 5.1 4.2 -0.9
Depression 4.2 2.5 -1.7
EQ5D 70 82 +12%
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 147 of 607E + MAC (292 patients considered non-weanable), no complica-
tions were reported; however, 14/37 (38 %), 8/157 (5 %) and 8/
98 (8 %) required reintubation due to plug related desaturation
after extubation (harm not reported in case control study).
Conclusions
Data on the efficacy of LVR, MAC, and MI-E to promote extubation
success are limited though complications appear to be uncommon.
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Introduction
Major oesophagogastric surgery is associated with significant post-
operative morbidity, reduced functional capacity and quality of
life[1]. Evidence from colorectal surgery populations demonstrates
significant benefits of prehabilitation[2]. There is no evidence to
support this approach for patients undergoing oesophagectomy
and TG.
Objective
To assess the impact of implementing prehabilitation and enhanced
post-operative physiotherapy in patients undergoing oesophagect-
omy and TG.
Method
Consecutive patients from November 2014 to March 2015 were en-
tered into a standardised ERAS programme incorporating twice
daily physiotherapy for five days postoperatively with pre-specified
mobility milestones. Of these, 17 were eligible and offered prehabi-
litation, incorporating twice-weekly cardiovascular and strengthen-
ing classes for 4 weeks, of which 13 attended. Outcomes measured
were functional capacity by incremental shuttle walk test (ISWT),
anxiety and depression by HADS score, and perceived health status
by EQ5D. We also compared data for those who attended prehabili-
tation to those who received ERAS only post operatively. Post-
operative outcomes were time to mobilise 30 m, mobility level at
critical care discharge by MMS and total hospital length of stay
(LOS).
Results
Thirteen patients attended prehabilitation, with improvements seen
for all outcomes on completion (see Table 86).
Post operatively, patients who attended prehabilitation were more
mobile at ICU discharge (MMS 7 vs 6) and quicker to mobilise 30 m
(3.2 vs 4.7 days). A reduction in LOS was also seen for prehabilitation
patients in comparison to those receiving ERAS alone (14.7 days vs
17.5 days).
Conclusion
Implementation of a programme of prehabilitation is feasible in
patients undergoing major oesophagogastric surgery and was as-
sociated with improved outcomes preoperatively. These improve-
ments were associated with a higher level of mobility at the point
of critical care discharge and shorter hospital length of stay.
Future appropriately powered research is needed to confirm these
findings.References
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Introduction
Infusion pumps are often associated with poor usability and an
increased likelihood of medication errors [1]. Critically ill patients
in the intensive care unit (ICU) usually receive multiple infusions
simultaneously, which increases the likelihood of pump-related er-
rors. Furthermore, the ICU is frequently a hectic environment,
compounding the likelihood of human error. Improving the usabil-
ity of infusion pumps could help prevent injury or death in this
vulnerable population. Where previous usability studies focused
on individual pumps, this study focuses on the pump system as a
whole, a situation more representative of the ICU.
Objectives
The aim of this study is to develop and test a pump display that facil-
itates centralized monitoring and control of multiple infusion pumps
to improve the safety and efficiency in the interaction with infusion
technology.
Method
A central pump display was developed according to the latest guide-
lines in user-centered design [2]. The usability of this display was
compared to that of a conventional pump setup in a simulation
study where 18 ICU nurses performed common pump-related tasks
with either the central or conventional interface. Participants had a
mean of 12 (±12) years of ICU work experience. Task execution times
and key presses were recorded and logs were scanned for errors
after the experiment. A usability questionnaire with a 5-point Likert
scale was administered at the end of each experimental run to assess
end-user satisfaction.
Results
Overall there was no difference in total task execution time between
the central (M = 421 ± 107 seconds) and conventional system (M =
405 ± 119), p = 0.78. Fewer clicks were needed to execute the tasks
with the centralized system compared to the conventional system
(40 ± 3 and 73 ± 20 clicks respectively), p = 0.001. Fewer errors were
made with the centralized system compared to the conventional sys-
tem (0.9 ± 1 and 2.9 ± 2 errors respectively), p = 0.031. Questionnaire
results indicated an overall preference towards the centralized sys-
tem (4.6 ± 0.3 vs. 4.1 ± 0.5), p = 0.033.
Conclusions
Expert users with significant experience using the conventional
pump interface demonstrated a more efficient and safer performance
using the central control display. The central control display had a
better overall usability than the conventional pump control interface,
despite participants never having used it before. The results of this
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 148 of 607study underline the importance of usability testing in the improve-
ment of high-risk medical systems.
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Introduction
Renal failure in a patient, whether it develops during hospitalization
or admission, is an independent predictor of mortality so efforts to
detect it earlier in an ICU setting should be performed in all pa-
tients in order to set up preventive and therapeutic maneuvers.
Despite well established diagnostic criteria for acute kidney injury
(AKI), the detection is often delayed in the clinical practice. When
making the analogy with cardiac angina, even though several bio-
markers have been developed for an early detection of AKI none of
them have the sensitivity and specificity of troponin levels in a car-
diac setting. Therefore, the concept of renal angina was developed
considering risk factors and clinical signs of renal failure, scoring
patients in 4 groups according to the need of Continuous Renal Re-
placement Therapy (CRRT): very high, high, moderate and low risk.
In pediatric ICU populations this concept has been widespread, not
as well in adult ICU patients.
Objectives
To present a pilot study where we describe 8 patients who required
CRRT in the last month and determine the risk for the presence of
renal angina at admission.
Method
Descriptive pilot study. We retrospectively analyzed all adults pa-
tients who required CRRT during March 2016 in which all data
needed to evaluate the risk for renal angina was completed. We ob-
tained and interpreted their demographics and laboratory results as
well as their pre-medical history.
Results
All patients were male, with a mean age of 74 ± 12 (55-89). 3 patients
died. The most common diagnosis was community acquired pneu-
monia (50 %), and second was acute on chronic cardiac failure
(25 %). At admission they were all classified in the very high risk
group. Also, the 8 patients had one or more mayor chronic criteria.
The most frequent risk factors were hypertension history or
hypotension at admission (75 % respectively), age and sepsis (62.5 %
respectively). All patients had early elevation of serum creatinine
(sCr) of at least 0.1 mg/dl. Average days between admission to the
ICU and beginning of CRRT was 3.Conclusion
Determining renal angina score in patients admitted to the ICU might
be a cornerstone for treatment and prevention of renal failure, espe-
cially in patients within the very high and high risk groups. This will
allow clinicians to be very suspicious of the slightest sCr elevation (as
low as 0.1 mg/dl), as it can predict the need for CRRT, and thus estab-
lish preventive maneuvers or initiate replacement therapy early.
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Introduction
Acute kidney after cardiac surgery is well described [1]. AKI is asso-
ciated with an increase in morbidity and mortality both in the short
and long term [2]. The severity of AKI is directly proportional to
outcome [3] and is independently associated with mortality, specif-
ically if sustained injury occurs [4]. In 2012 we implemented a
protocol post cardiac surgery to ensure adequate fluid resuscitation
as a strategy to reduce complications, namely AKI. The incidence of
AKI was reduced from 19.9 % to 6.5 %.
Objectives
To ensure our efforts to reduce the incidence of AKI were still effective.
Method
Pre-operative baseline and peak creatinine data is prospectively re-
corded by our audit team to monitor the incidence of AKI. Baseline
characteristics were collected along with the discharge creatinine, in-
cidence of CVVH, length of ICU and hospital stay, ICU readmissions
and mortality.
Results
Over 6 month period, 431 cardiac surgical admissions occurred in
CTICU of those 9.28 % (n = 40) sustained AKI using the KDIGO classifi-
cation. Of those 4.87 % (n = 20) sustained stage I, 1.62 % (n = 7)
sustained stage II, and 2.78 % (n = 12) sustained stage III. 12.5 % (n =
5) died. 10 % (n = 4) were re-admitted to ICU and 44 % (n = 15) of
those surviving, the AKI had resolved prior to hospital discharge.Conclusions
The incidence of AKI remained below the baseline from 2012. Though
resolution of AKI did not occur in most.
Further follow up is required by GP's to ensure further injury doesn't
occur and to highlight caution. There was no evidence of AKI within
the surgical discharge summary. Our recommendation is to write ICU
discharge letters including such events. Although the incidence of
AKI has remained lower, AKI still occurs. Identifying patients at risk
for AKI during pre-op assessment is recommended. Modifiable risk
factors should be optimized and high risk patients should be identi-
fied prior to cardiac surgery as recommended in the literature to
reduce this complication further.
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Background
Pressure ulcers (PU) are a frequent adverse event in intensive care
unit (ICU). The main risk factor for their development is patient's im-
mobility. This analysis is part of a study named CAPCRI which had
the objective to determine the factors related to the head-of-bed ele-
vation (HOBE) in patients with mechanical ventilation.
Objective
To investigate the risk factors for the development of the PU related to
the patient positioning in critically ill patients with mechanical ventila-
tion and the effect of the presence of a pressure ulcer in HOBE.
Method
Descriptive, longitudinal and multicentre study in 6 Spanish ICUs from
March to December 2013. Inclusion criteria were: patients >18 years
old, mechanical ventilation >48 h and being able to measure HOBE
during the first 24 hours of mechanical ventilation. Patients with contra-
indications for HOBE 30-45° were excluded. Sample size calculation re-
sulted in 50 patients/center. PUs were diagnosed according to NPUAP/
EPUAP guidelines. Descriptive, bivariate and multivariate analyses were
performed. Significance level was set at p < 0.05.
Fig. 110 (abstract A286).
Fig. 111 (abstract A286).
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25 patients (9 %) out of the 276 included developed PU representing
34 PU. The most frequent diagnose was surgical (52 %). Patients
were admitted to the ICU for a median of 22 (11-35) days and 16 (9-
26) days under mechanical ventilation. 68 % of the patients devel-
oped only 1 PU. The mean admission time until PU diagnosis was
10.6 (10.3) days. The majority of PU were Stage I and Stage II (35.3 %
and 44.1 % respectively) and diagnosed in sacrum and heel (52.9 %
and 41.2 %).
In multivariate logistic regression analysis the independent risk fac-
tors for PU were the sedation time [OR 1.018 (CI95% 1.009-1.027)],
vasoactive drugs duration [OR 1.023 (CI95% 1.015-1.031)] and time
with a mean arterial pressure < 70 mmHg [OR 1.016 (CI95% 1.005-
1.026)]. On the contrary, the factors preventing PU were a higher
APACHE II Score [OR 0.876 (CI95% 0.833-0.920)] and higher values of
albumin and pre-albumin [OR 0.617 (CI95% 0.388-0.982); OR 0.873
(CI95% 0.822-0.927)] respectively. The degree of HOBE was not statis-
tically significant [OR 0.96 (CI95%0.90-1.02)].
When analyzing the impact of the presence of a PU, it did not affect
HOBE as it remained similar to previous (before diagnosis mean 29.6
(4.6)° vs after diagnosis mean 29.9 (4.0)°; p = 0.677).
Conclusions
9 % of the patients analysed developed PU related with body posi-
tioning. The degree of HOBE was not evidenced as a risk factor for
PU. The hypotension, the duration of the sedation and the vasoactive
drugs are important risk factors for the development of PU. Besides
other preventive measures, maintaining adequate values of albumin
and pre-albumin is important to prevent PU. The presence of PU did
not affect the attitude of the nurses towards the degree of HOBE.
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Objectives
To assess NGAL as a predictor of acute kidney injury in patients
undergoing cardiac surgery.
Method
Prospective, longitudinal study involving ICU patients undergoing
cardiac surgery without renal disease. Creatinine and plasma and
urinary NGAL level determinations were performed at 0, 2, 6 and
12 hours post ICU admission. NGAL cut-off was considered to pre-
dict acute renal failure when above 137 ng/mL and 131.7 ng/mL in
plasma and urine, respectively. Statistical analysis: Patients were
classified according to presence or absence of renal failure. Cat-
egorical variables were summarized in frequencies and percentages
and numerical in means and standard deviations (SD) or medians
and interquartile ranges (IQR). The percentages were compared, as
appropriate, with the X2 test or Fisher´s exact test, mean the t-test
and medians with the Wilcoxon test for independent groups. In
order to evaluate the diagnostic potential of NGAL (in urine andplasma) for renal failure ROC (Receiver Operating Characteristics)
analysis for each of the markers was performed. The predictive abil-
ity of the markers was assessed through areas under the corre-
sponding ROC curves, which were estimated by 95 % confidence
intervals. Optimal cutoff for each of the markers was considered
those ones that corresponded to the sensitivity and specificity
values that minimized the following expression: . For these cut-off
sensitivity, specificity, positive predictive value, negative predictive
value, positive likelihood ratio and negative likelihood ratio were
obtained. These parameters were estimated by 95 % confidence. A
hypothesis test was considered statistically significant when the
corresponding p-value was less than .05 and the obtained area
under the two ROC curves were also compared.
Results
Figure 110 shows the variables of the study in the groups defined as
presence or absence of renal failure. The behavior of the variables
analyzed is similar in both study groups.
Conclusion
NGAL is a good marker of early acute renal injury in patients after
cardiac surgery and it did not show statistically significant differences
when comparing urine vs. plasma levels.
Fig. 112 (abstract A286). ROC`s comparative
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Introduction
Immediate diagnosis of sepsis in critical conditions of cancer patients
can be complicated due to the similarity between the manifestations
of drug toxicity and systemic infectious complications. Generally this
category of patients have overdiagnosis of sepsis in case of the SIRS
criteria use [1]. New clinical criteria for the sepsis diagnosis were de-
veloped (S-3) [2], but the rationale of their use in patients receiving
anticancer therapy is not yet determined.
Objectives
To determine the sensitivity and specificity of the new sepsis clinical
criteria in patients who received anti-cancer therapy
Method
A total of 48 records of patients having 2 or more SIRS criteria (S-2)
that admitted to therapeutic ICU in 2014-2015 were subjected to a
retrospective analysis. All patients had anticancer drug-related ad-
verse events of various grade. The diagnosis of sepsis (criteria SIRS +
defined infectious lesion ± defined infectious agent) was determined
in 35 (72.9 %) of cases. Retrospectively, all patients met the S-3 cri-
teria. The sensitivity, specificity and accuracy of S-3 criteria were cal-
culated. The calculation of 95 % confidence interval (CI) was carried
out by means of the Wilson Method
Results
At the time of the ICU admission 34 patients met the S-3 criteria.
Sepsis was further confirmed in 29 (85.3 %) patients. S-3 sensitivity
was 0.83 (95%CI 0.67-0.92), S-3 specificity was 0.62 (95%CI 0.36-0.82)
and S-3 accuracy - 0.77 (95%CI 0.53-0.97). S-2 sensitivity was 0.73
(95%CI 0.59-0.83).
Conclusions
New clinical criteria of sepsis have sufficient specificity and high sen-
sitivity in patients receiving anticancer therapy.
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Introduction
Traumatic brain injury (TBI) doesn't seem to be a single insult with a
monophasic resolution. Recently, degenerative mechanisms have
been suggested to occur in the chronic phase and could constituted
“tertiary” lesions [1]. These degenerative phenomena can potentially
have a worsening impact on the long-term functional prognosis.
Objectives
The objective of this prospective study was to longitudinally evaluate
(1) white and grey matter structures volumes measured from T1
three-dimensional (3D) and (2) white matter integrity assessed from
diffusion tensor imaging (DTI) in severe TBI.
Method
20 severe TBI (37 ± 16 yrs) and 12 healthy volunteers (HV; 42 ± 6 yrs)
underwent multimodal magnetic resonance imaging in the sub-
acute phase (within 21 ± 8 days after injury). A longitudinal follow-up
was obtained for all of them at the chronic phase of injury (median
64 ± 16 months after injury) together with neuropsychological assess-
ments. Longitudinal imaging changes were assessed using cortical
volumetric reconstruction and segmentation of white and deep grey
matter structures with Freesurfer [2]; cortical sulci were automatically
reconstructed and identified with Brainvisa software, and a voxel-
based DTI analysis was performed with Comasoft. The Extended GOS
(GOSE) was used to classify at 5 years the TBI subjects into " good"
(GOSE 6-7; n = 11) and “intermediate” (GOSE 3-5; n = 9) recovery.
Cortical morphometry and fractional anisotropy (FA) derived from
DTI were used with linear mixed effects models to link changes to
behaviour status.
Results
At baseline, there were no volumetric differences between the 3
groups (GOSE 3-5; GOSE 6-7; HV). At 5 years, patients with TBI dem-
onstrated a significant volumetric reduction of the whole white mat-
ter (-10 ± 4 %; P < 0.01), and of the deep grey matter structures (-13
± 10 %; P < 0.03). In contrast, HV did not present any significant
change over the same period. Specifically, direct comparisons be-
tween patient groups revealed that over time GOSE 3-5 showed
greater atrophy than GOSE 6-7 in the parietal lobe (-5 ± 2 vs. -3 ± 5 %
respectively; P < 0.001), brain stem (-12 ± 6 vs. -6 ± 7 %; P < 0.006),
corpus callosum (-19 ± 19 vs. -10 ± 15 %; P < 0.01), and cingulate
(-7 ± 5 vs. -2 ± 6 %; P < 0.023). This was associated with higher
depth mean on sulci data. Furthermore, FA was lower at the first
MRI in GOSE 3-5 group in the same regions.Finally, neuropsycho-
logical score (Z-score) correlated significantly with the volume
loss in these anatomical regions.
Conclusions
We observed a strong correlation between neuropsychological scores
and morphometric changes over time suggesting (1) occurrence of
tertiary lesions and (2) that lesions location influence functional out-
come. These data provide further insight into early and late patho-
physiology of cognitive dysfunctions after TBI.
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Introduction
Different degree of maturation of various systems and organs in chil-
dren and neonates might disturb desired therapeutic effects. Therefore,
the identification of inter-individual differences affecting pharmacokin-
etics (PK) of drugs, is important for the dose individualization, especially
in children in severe conditions. It especially applies to new drugs such
as dexmedetomidine (DEX), for which there is a relatively small number
of studies performed. Pediatric Intensive Care Units (PICU).
Objectives
The goal of this study was to assess the pharmacokinetics of dexme-
detomidine in the PICU settings during the prolonged infusion to as-
sess the influence of routinely collected covariates on underlying PK
parameters.
Method
Thirty eight patients were enrolled into the study. Continuous intra-
venous infusion of DEX was initiated at the rate of 0.8 μg/kg/h fol-
lowing by gradual increase or decrease to keep the level of sedation
between 7 and 14 points in the Cook Scale. Blood samples for PK as-
sessment (2.0 mL) were collected from the arterial catheter. The ana-
lysis was made for the concentrations obtained at two occasions:
first from 0 to 24 hr after infusion initiation and second from 0 to
8 hr after infusion end. Data analysis was conducted using WINBUGS
software With informative literature priors.
Results
The incorporation of time-depended (different between two occa-
sions) PK parameters improved the model. The typical value of the
volume of the central compartment (V1) scaled to 70 kg was 52 L,
whereas the volume of the peripheral compartment was slightly
higher (V2 = 70 L). The typical systemic clearance (CL) of DEX and the
distribution clearance (Q) were 41.6 L/h and 56.8 L/h for a patient
with a weight of 70 kg. The IIV estimated for the CL, Q, and V1 and
V2, were 56 %, 83 %, 152 %, 68 % with a strong correlation (0.7) be-
tween Q and V1. Those values are consistent with literature parame-
ters in children and adults and are very close to the priors used. It
was observed that volume of distribution and clearance is 1.5-fold
and 1.3-fold, respectively higher during the second occasion.
Conclusions
Population PK model was successfully developed to describe the
time course and variability of dexmedetomidine in PICU patients
using allometric principles and clearance maturation model. More
data is needed to fully confirm clinical significance of the
phenomenon of an increase in the volume of distribution and clear-
ance after infusion cessation. The disease status described by PRISM
score, the duration of infusion, gender, body weight and age were
not found to be independent significant covariates in this study.References
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Introduction
CRRT are being used increasingly in the intensive care unit, not only for
renal indications but also other organ-supportive strategies. Although
early initiation of RRT is not clearly associated with benefit, avoiding or
delaying RRT is associated with higher mortality and increased hos-
pital/ICU lengths of stay
Objectives
To describe the use of CRRT for the treatment of non-renal metabolic
acidosis in a cardiothoracic intensive care unit.
Method
We performed a retrospective observational study including all pa-
tients admitted to level 3 areas requiring CRRT for refractory meta-
bolic acidosis at Harefield Hospital during 2015, i.e. pH less than 7.15
and base deficit less than or equal to -8 mmol/L. This population in-
cluded patients admitted after cardiac and thoracic surgery, heart or
lung transplantation, mechanical circulatory devices, out of hospital
cardiac arrests (OOHCA) and medical admissions from the cardiology
or cardio-thoracic surgical wards. Demographic variables were col-
lected, along with the timing and duration of CRRT.
Results
Of the 1829 patients admitted to level 3 areas at Harefield Hospital
during 2015, 229 (12.5 %), required CRRT during their admission. 134
(58.5 %) of those patients were initiated on CRRT due to refractory
metabolic acidosis. The median age of this group was 61 years:
70.1 % were male, 47.8 % hypertensive and 19.4 % diabetic. Most
patients (113 patients, 84.3 %) were haemodynamically unstable,
defined as the need for one inotropic drug at a high dose or the
combination of two or more vasoactive drugs. The reason for admis-
sion also differed from the general CRRT group, with a higher fre-
quency of heart transplantations and OOHCA, as shown in Table 87
and Fig. 113. Time from admission to ITU to initiation of CRRT was
shorter at 1 day in the refractory metabolic acidosis CRRT group vs.
4 days in the general CRRT group. The ITU mortality in the study
group was 42.5 % vs. 36.2 % in the general CRRT group.
Conclusions
CRRT for refractory metabolic acidosis in the context of cardiac in-
stability is used in the critically ill patient as an adjunct strategy and
is applied earlier than CRRT initiated for other indications.
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CRRT group (n= 239) Metabolic acidosis group
(n=134)
Median age in
years
58.32 60.63
Haemodynamic
instability
160 ( 69.95%) 113 (84.8%)
Reason for
admission
Cardiac surgery 36.2%
Cardiology ward 10%
Transplant ward 10% VA-ECMO
10% Lung transplantation 9.2%
Heart transplantation 7.9%
OOHCA 7.4% LVAD implant-
ation 3.4% Thoracic surgery
1.7% VV-ECMO 1.7% Cardio-
thoracic ward 1.3%
Cardiac surgery 39.6% Heart
transplantation 11.2% OOHCA
9.7% Lung transplantation
8.2% Transplant ward 8.2% VA
ECMO 7.5% Cardiology ward
6.7% LVAD implantation 5.2%
VV-ECMO 1.7% Cardiothoracic
ward 0.7%
Mortality in ITU 83(36.2%) 57 ( 42.5%)
Mean ITU LOS
in days
18 17.6
Time to CRRt in
days
1 4
Fig. 113 (abstract A290). Reason for admission to ITUA291
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Introduction
Respective proportions of final etiologies are disparate in cohorts of
cardiac arrest patients, depending on examined population and diag-
nostic algorithms. In particular, incidence and characteristics ofsudden unexplained death (SUD) are debated. We aimed at describ-
ing etiologies in a large cohort of out-of-hospital cardiac arrest
(OHCA) patients, in order to characterize victims without identified
diagnosis.
Patients and method
We analyzed data from our prospective registry of OHCA patients
admitted between January 2000 and December 2014. Initial diag-
nostic strategy included coronary angiography, brain and chest CT
scan. This was completed by an extensive diagnostic strategy,
encompassing biological and toxicological tests, repeated electro-
cardiograms and echocardiography, MRI, Holter monitoring and
endocavitary explorations. Two independent investigators reviewed
each final diagnosis. Baseline characteristics were compared be-
tween subgroups of patients with chi-square test and Mann-
Whitney test, as appropriate. One-year mortality was compared be-
tween subgroups using univariate Kaplan-Meier curves.
Results
Over the study period, 1,857 patients were admitted in our unit
after a resuscitated OHCA. The event was related to a non-cardiac
and a cardiac cause in 526 (30.7 %) and 1,057 (61.8 %) patients, re-
spectively. The main cause of cardiac related OHCA was ischemic
heart disease (78,4 %) while non-structural cardiomyopathies
accounted for only 2,2 %. No diagnosis was evidenced in 127
(7.4 %) patients. In these SUD patients, baseline characteristics and
one-year survival of patients under 35y were similar to those with
identified non-structural cardiomyopathy.
Conclusion
We observed that ischemic heart disease was by far the most com-
mon cause of cardiac arrest, while non-structural cardiomyopathies
accounted for a very low part of diagnosis. Young patients victims of
a sudden unexplained death shared similar baseline characteristics
and outcome with patients with non-structural cardiomyopathies. Fo-
cusing on this subgroup of patients for further investigations and
follow-up may help in managing themselves and their relatives.
Note: This abstract has been previously published and is available at
[1]. It is included here as a complete record of the abstracts from the
conference.
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Introduction
Patients after cardiac surgery are prone to develop postoperative pul-
monary complication (PPCs), which are currently diagnosed by chest X-
ray (CXR). LUS may provide accurate diagnostic information in patients
with acute respiratory distress [1]. The role of LUS in detecting PPCs in
patients after cardiac surgery has yet to be determined.
Objectives
To compare the rates of PPCs detected by LUS - and CXR in patients
after cardiac surgery admitted to ICU. Additionally, we assessed the
inter-observer agreement for LUS and compared the time it takes to
perform LUS and CXR.
Method
This is a prospective observational single centre study. The study was
approved by the institutional review board. On admission to the ICU,
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and by CXR were compared. In addition, accuracy of LUS and CXR for
detecting clinical relevant (cr-PPCs), PPCs for which the attending
physician, blinded for the LUS data, initiated therapy was evaluated.
Cr-PPCs were considered the composite reference standard. 70 blue
points were assessed to determine inter-observer agreement. In 15
patients time to perform both techniques was compared.
Results
70 % Of the 134 enrolled patients was male with a mean age of
68 ± 9,5. LUS identified 62 PPCs (46 %), compared to 29 (22 %)
by CXR (P = 0,011). PPCs identified were: positive Postero-Lateral
Alveolar and/or Pleural Syndrome (PLAPS) 40 % vs 13 %, pulmon-
ary edema (5 % vs 9 %) and pneumothorax (1 % vs 0 %). Inci-
dence of cr-PPCs was 16 (12 %). Table 88 summarizes the
diagnostic accuracy of LUS and CXR for the cr-PPCs identified.
LUS can be performed within 15 ± 5 minutes compared to 42 ±
16 minutes for CXR,(p < 0.01). Overall inter-observer agreement for
LUS showed a near to perfect agreement (k = 0.907, p ≤ 0.000).
Conclusions
LUS detects more PPCs than CXR in patients after cardiac surgery
and with good inter-observer agreement. In addition, time to per-
form LUS is significantly shorter. However, most PPCs detected by
LUS come with little clinical consequence. Therefore, we suggest in
further studies to quantify the extent of the PPC detected by LUS to
improve its value in clinical decision making.
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clinical relevant PPC's for which attending physician initiated therapy
Findings (N=134) LUS/CXR SN% SP% NPV% PPV%
PLAPS positive LUS 53(40%)
CXR 17(13%)
100% vs
73%
65% vs
91%
100% vs
97%
19% vs
47%
Pulmonary
edema
LUS 7 (5%)
CXR 12(9%)
100% vs
75%
97% vs
93%
100% vs
99%
43% vs
25%
Total PPCs
detected
LUS 62(64%)
CXR 29(22%)
100% vs
81%
62% vs
86%
100% vs
66%
26% vs
45%
Table 89 (abstract A293).
Smoking 39(62,9%)
Hypertension 33(50,0%)
Previous isquemic heart disease 13(12,0%)
Microbiologic isolation 24(38,7%)
Empirical Amoxicilin-Clavulanate 34(54,8%)
Empirical Piperacilin-Tazobactam 4(6,5%)
Empirical Quinolones 3(4,8%)
Other empirical antibiotic therapy 1(1,5%)
No antibiotic 20(32,3%)
Inappropriate empirical antibiotic therapy 8(38,1%)A293
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Introduction
Respiratory infection is a common complication in ICU patients admit-
ted after a cardiac arrest. Amoxicillin-clavulanate is used as empirical
antibiotic therapy in these patients to prevent aspiration pneumonia.
However, recent studies have shown a resistance rate up to 15 %.Objectives
To describe the resistance pattern of microorganisms isolated from
bronchial sample of patients admitted to the ICU after a resuscitated
cardiac arrest. To assess the appropriate empiric antibiotic therapy.
Method
Prospective, observational study from 2013 to 2015. We included all
patients admitted in the ICU after a recovered out-of-hospital cardiac
arrest and all patients with an in-of-hospital cardiac arrest admitted
in the hospital less than 48 hours and without previous administra-
tion of antibiotics.
We took samples of tracheobronchial secretions through the endo-
tracheal tube in all patients within the first three days of admission.
Demographic information, comorbidities, performing of therapeutic
hypothermia, empirical antibiotic therapy administered and the result
of bronchial aspirates culture were collected. Empiric antibiotic ther-
apy was considered adequate when at least one effective antibiotic
was administered within the first 24 hours of ICU admission.
Results
60 patients were included. The average age was 59 and 83,9 %
were male. 87,1 % were out-of-hospital cardiac arrests. 50 % of
them received therapeutic hypothermia. The most used antibiotic
was amoxicillin-clavulanate (54.8 %), followed by piperacillin-
tazobactam (6.5 %) and levofloxacin (4.8 %). In 32,3 % of cases no
antibiotics were prescribed. Positive microbiological results were
obtained in 38.7 % of bronchial aspirates. The most common micro-
organisms isolated were S. aureus (22,2 %), E. coli (14,8 %), E. clo-
acae (14,8 %), K. pneumoniae (11.1 %), S. marcescens (11.1 %) and
H. Influenzae (7,4 %).
48.1 % of the isolates microorganisms were resistant to amoxicillin-
clavulanate, 18.5 % to piperacillin-tazobactam and 14.8 % to third-
generation cephalosporin. No organism was resistant to quinolones
nor carbapenems.
According to this pattern of sensitivity, 38.1 % of patients with micro-
biological isolation in the bronchial sample received inappropriate
empirical antibiotic therapy.
Conclusions
Our results suggest that there is a high resistance rate to amoxicillin-
clavulanate of germs isolated in respiratory samples of patients after
a resuscitated cardiac arrest.
The most common microorganisms isolated in these samples were S.
Aureus, E. coli and E. cloacae, resulting in a high rate of inappropriate
empirical antibiotic therapy.
References
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Table 90 (abstract A293). Isolations and resistances
S. aureus 6 (22,2%)
E. coli 4 (14,8%)
E. cloacae 4 (14,8%)
K. pneumoniae 3 (11,1%)
S .marscescens 3 (11,1%)
H. influenzae 2 (7,4%)
P. aeruginosa 1 (3,7%)
Amoxicilin-Clavulanate resistance 13 (48,1%)
Piperacilin-Tazobactam resistance 5 (18,5%)
3rd generation cephalosporin resistance 4 (14,8%)
Table 91 (abstract A294). Noradrenaline reduction at 96 h septic shock
onset
Group 1 (35ml/Kg/h)
n=52
Group 5 (55ml/Kg/h)
n=50
Total n=102
Hemodynamic
Disfunction
Media/DS/IC95% Media/DS/IC95% Media/DS/
IC95%
T-0h: NA mc/Kg/min* 1.42/0.84/1-18-1.65 1.80/0.95/1.53-2.07 1.6/0.91/
1.41-1.7
T-96h: NA mcg/kgr/
min
0.66/1.10/0.36-0.97 0.72/0.87/0.47-0.96 0.69/0.99/
0.49-0.8
%NA Reduction: T-96h
and T-0h*
54%/65/36-72 61%/39/50-72 57%/54/42-
68
p ns, NA Noradrenaline
(*) T Student
Table 92 (abstract A294). Hospital Mortality
Hospital
Mortality
Group 1 (35ml/kg/h)
n=52
Group 1 (55 ml/kg/h)
n=50
Total n=102
Número / % Group Número / % Group Número / %
Group
No 36 / 69% 37 / 74% 73 / 72%
Si 16 / 31% 13 / 26% 29 / 28%
Total 52 / 100% 50 / 100% 102 / 100%
(*) Chi Square, p=ns
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Introduction
Refractory septic shock mortality is about 50 %. In the early phase of
septic shock, hemofiltration can attenuate the inflammatory cascade,
thus alleviating cell and tissue damage and reducing the mortality
due to multiple-organ failure syndrome.
Objectives
In patients with refractory septic shock Hemofiltration Veno-Venous
Continuous High Volume (HFVVCHV, 35 ml / kgr / h) or Hemofiltra-
tion Veno-Venous Continuous Very High Volume (HFVVCVHV, 55 ml /
kgr / h) decreases vasoactive support and mortality
Method
102 refractory septic shock patients, with or without renal dysfunc-
tion and consecutively admitted to the ICU, were treated with early
resuscitation and support bundles, according Surviving Sepsis Cam-
paign (SSC) 2012, and 36 hours septic shock onset randomly
assigned to group 1 (35 ml / kg / h) or group 2 (55 ml / kg / h). The
variables studied were hemodynamic parameters (arterial pressure,
heart rate, cardiac output, systemic vascular resistance, and central
venous pressure), vasoactive drug parameters (dose and time of nor-
epinephrine and hourly fluid intake), pulmonary (paO2/FiO2), and
renal function.
Results
In both groups the percentage of the initial dose of norepinephrine
was reduced 96 hours septic shock onset, higher in group 2 (61 %)
than group 1 (54 %).
ICU mortality in the series of patients globally was 19 %, higher per-
centage in group 1 (23 %) than in group 2 (16 %). Hospital mortality
showed an increase of 8 points in group 1 and 10 points in group 2;
the global hospital mortality was 29 %.
Conclusions
In refractory septic shock patients, after the SSC measures correctly
applied in time, an early horizontal treatment with HFVVCHV and
HFVVCVHV could improve the prognosis.
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Introduction
Neutrophil gelatinase-associated lipocalin (NGAL) is used as a bio-
marker of acute kidney injury (AKI), measured in serum and urine. Re-
cently, serum NGAL has been reported as biomarker of mortality and
organ dysfunction in sepsis and post cardiac arrest patients, which is
related to systemic inflammation. Therefore, we measured serum
NGAL in emergency department patients, and tried to assess which
type of pathophysiology was related to increased serum NGAL.
Objectives
To assess serum NGAL could be a biomarker of systemic inflamma-
tion in emergency department.
Method
Forty-four cases admitted emergency department were retrospect-
ively analyzed. Serum NGAL, C-reactive protein (CRP), and white
blood cell count (WBC) were compared between 2 groups (estimated
glomerular filtration rate (eGFR) >40 mL/min/1.73 m2 or not). Correl-
ation analysis was also performed between serum NGAL and others.
Results
Median age was 64 y.o., 61 % of patients were male. Median value of
serum NGAL was 83 ng/mL. The value of serum NGAL was significant
difference between the groups of eGFR > 40 ng/mL and eGFR < 40 ng/
mL (80 ng/mL v.s. 163 ng/mL, P = 0.045). Serum NGAL and CRP were
significantly correlated in the group of eGFR > 40 ng/mL (R = 0.650,
P < 0.001).
Conclusions
Serum NGAL might reflects systemic inflammation with patient in
emergency department.
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Introduction
In comatose cardiac arrest survivors, the extent of myocardial damage
and cardiovascular instability have an important role in the course of
developing post cardiac arrest syndrome and predicting long-term out-
come. Recent clinical studies have revealed that inhaled xenon pro-
vides beneficial cardiovascular effect and mitigate ischemic brain injury
in out-of-hospital cardiac arrest (OHCA) patients [1,2].
Objectives
The purpose of this study was to assess the effect of xenon inhal-
ation on myocardial ischemic damage and left ventricular function
after OHCA.
Method
A total of 110 comatose patients who had experienced OHCA were
randomized to receive either inhaled xenon combined with
hypothermia (33 °C) for 24 hours (n = 55 in the xenon group) or
hypothermia treatment alone (n = 55 in the control group). When-
ever indicated, coronary angiography and percutaneous interven-
tions were performed before intensive care unit admission or later
during hospital stay. Xenon was administered with at least 40 %
end-tidal concentration and completed at start of rewarming.
Troponin-T (TnT) was measured at hospital admission, and at 24 h,
48 h and 72 h post cardiac arrest. Left ventricular function was
assessed with echocardiography by cardiologist at intensive care
arrival and at 24 hours after completing rewarming.
Results
Among the 110 patients comprehensive TnT measurements were
available from 51 xenon patients (median age 63) and 53 control
patients (median age 60). Complete echocardiographic data was
available on 18 xenon and 20 control patients. The number of ST-
elevation myocardial infarction and primary coronary intervention,
time for return of spontaneous circulation, cardiovascular medica-
tion among other baseline characteristics did not differ signifi-
cantly between the groups. A median (interquartile range, IQR)
post-arrival incremental change in TnT at 72 hours was 0.05 μg/l
(-0.03 μg/l -0.61 μg/l) in the xenon group and 0.28 μg/l (0.04 μg/l
-1.48 μg/l) in the control group (P = 0.014 for the difference be-
tween the groups). A mean (95 % confidence interval) absolute
post-arrival incremental change in left ventricular ejection fraction
at 24 hours after rewarming was 10.4 % (5.6 %-15.3 %) in thexenon group and 4.3 % (1.4 %-7.2 %) in the control group (P =
0.028 for the difference between the groups).
Conclusions
Inhaled xenon in combination with mild therapeutic hypothermia
may protect against ischemic myocardial injury as demonstrated by
significantly attenuated short-term TnT release and better left ven-
tricular function when compared with hypothermia treatment alone.
These observations suggest that inhaled xenon may provide cardio-
protective effect in OHCA patients.
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Introduction
Both NT- proBNP and Doppler echocardiography have been ap-
proved in the diagnosis of heart failure. In our Study, we compared
the contribution of the NT-proBNP levels with the Doppler echocardi-
ography findings in the diagnosis of decompensated congestive left-
heart failure (CHF) in patients with acute dyspnea.
Patients and method
It was a prospective, observation al study at the teaching department
of emergency and intensive care in the regional hospital of Zaghouan,
including patients with severe dyspnea over six months. All patients
underwent physical examination, 12-lead ECG, RX Thorax, NT-ProBNP
essay and echocardiography by an attending cardiologist on admission.
The accuracy of the two Method for etiologic diagnosis was compared
on the basis of the final diagnoses established by the medical staff.
Results
65 patients were enrolled, including 45 (69 %) with CHF. Diagnosis of
CHF was due to coronary artery disease, hypertension, valve disease,
arrhythmia and dilated cardiomyopathy. Non-CHF was due to de-
compensated chronic obstructive pulmonary disease, pneumonia,
and severe asthma. Fifteen patients (23 %) were misdiagnosed at ad-
mission. The mean NT-proBNP concentration was 8989 [769 to
18945] pg/ml in the CHF subgroup and 462 [22 to 1589] pg/ml in
the other patients (p < 0.01). Systolic LV dysfunction (LVEF < 0.45)
was found in 31 patients with CHF (60 %) and in 7 patients with
other causes of dyspnea (15 %) (p < 0.01). The E/A ratio and the de-
celeration time of E-wave (DT) were respectively 1,85 ± 0,77 and 12o
± 23 in the group CHF; 0,81 ± 0,44 and 208 ± 47 in the group Non-
CHF (p < 0.01). Impaired relaxation and Restrictive mitral pattern were
observed respectively in 28 % and 30 % of the patients with CHF
and in only two patients and tree patients in the other group.
Conclusion
Both NT-proBNP assay and echocardiography can be used for the
diagnosis of CHF in acutely dyspneic patients. However, the echocar-
diography is more accurate in patients with intermediate BNP levels.
Note: This abstract has been previously published and is available at
[1]. It is included here as a complete record of the abstracts from the
conference.
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Table 93 (abstract A299). Patient demographic data
Group A Group B p-value
Patients 10 8
Gender (male/female) 2/8 5/3 0.145
Age (years old) 21.2±2.6 20.7±3.7 0.756
TBSA (%) 55.4±9.4 57.1±20.6 0.832
Inhalation injury 6 5 1.000
Intubation 7 5 1.000
Body Weight (kg) 52.9±7.3 60.1±10.7 0.109
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Introduction
The predictive mortality of major trauma patients in the South Korea
is 35-40 %. High mortality late of major trauma in the South Korea is
due to underdevelopment of prehospital management and transport
system, hospital care system, and insufficient supporting system of
government policy. Establishment and operation of level I trauma
center and management of major trauma patients in the South Korea
is at an early stage. In house trauma surgeon´s role in the initial re-
suscitation of patient with major trauma is very important.
Objectives
This study will evaluate the effect of in house trauma surgeon
(IHTS) on time for decision making about major procedure (TD),
time for hospitalization (TH) and time to operation (TO) in patients
with major trauma.
Method
This is a retrospective cohort study using trauma database in Uijeonbu
St. Mary´s hospital. According to the hospital system, IHTS takes on
trauma patients at emergency room for three days on a week. On the
other four days, trauma patients were managed by on-call surgeon.
Between January, 2013 and December, 2013, 372 of major trauma
patients were consecutively enrolled in the study. TD, TH, TO, trauma
team activation (TTA). Data were analyzed with presence of IHTS.
Results
In patients who were admitted to the department of trauma surgery
of general surgery, TD and TH with IHTS took significantly less than
those without IHTS (TD: 137 minutes vs. 283 minutes, p = 0.002;
TH:302 minutes vs. 635 minutes, p < 0.001). Also TO with IHTS took
shorter than that without IHTS (200 minutes vs. 256 minutes), al-
though it shows no statistical significance (p = 0.202). In patients who
were admitted to the department of orthopedic surgery, neurosur-
gery, thoracic surgery or plastic surgery, TD and TH with IHTS took
173,331 minutes. They were lower than those without IHTS
(289,642 minutes) and showed statistical significance (p = 0.001,
0.001), Likewise TO with IHTS took shorter than that without IHTS
(238 minutes vs. 283 minutes) and showed no statistical difference
(p = 0.497). In patients with TTA, TD and TH took statistically less time
than those without TTA (TD: 168 minutes vs. 320 minutes, p < 0.001;
TH: 329 minutes vs. 773 minutes, P < 0.001). However, TO showed no
statistical difference patient with an without TTA (2016 minutes vs.
271 minutes, p = 0.200)
Conclusions
IHTS proved it important role by deducing TD and TH in initial
trauma resuscitation.
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Fluid resuscitation is a crucial component of initial resuscitation in major
burn patients to avoid early mortality. Large amount of intravenous
fluids are given during this period of time no matter Parkland formula
or other formulae are used as the fluid resuscitation guidelines. Further-
more, it is a trend to administrate even larger amount of intravenous
fluids in these years, which is known as “fluid creep” phenomenon [1].
However, excessive intravenous fluids would produce generalized and
lung edema, which may preclude wound healing and prolong intub-
ation. Besides, no guideline tells us how to adjust intravenous fluids
after the first 48 hours.
Objectives
We investigate the impact of total intravenous fluids given in the first
week to prognosis.
Method
This is a retrospective cohort study. Patients who injured in Taiwan
Formosa Fun Coast explosion event and admitted to the intensive
care units (ICUs) in our hospital in 7 days were included. Group A
were patients who admitted to the ICU where a more restrictive fluid
management Method was conducted; Group B were patients who
admitted to other ICUs where more liberal fluid management ap-
proach was applied. We compare the outcome such as sepsis insults,
organ dysfunctions, intubation days, ICU days, and hospital days
between these 2 groups of patient of different fluid management
strategies in major burn patients.
Results
18 patients were included. The mean age and total body surface area
of burn (TBSA burn) were 21.0 ± 3.0 years old and 56.2 ± 15.0 %, re-
spectively [Table 93].
The total intravenous fluids in the first week in Group A patients
(57,363.1 ml) were much less than in Group B patients (68,437.9 ml),
and the daily fluids of Group A patients were significantly less at day
4 and day 5 [Table 94] comparing to Group B patients.
Group A patients also had less body weight gain than Group B pa-
tients [Fig. 114].
As the results, Group A patients had significantly less days of mech-
anical ventilation than Group B patients, while length of ICU stay,
length of hospitalization, sepsis insults, and organ dysfunctions were
all similar in 2 groups [Table 95].
Conclusions
We concluded that a more restrictive fluid resuscitation strategy
might shorten the period of mechanical ventilation in major burn pa-
tients. The aggressive resuscitation fluids should be tapered down
quickly after 72 hours.
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Table 94 (abstract A299). Daily intravenous fluids in the 1st week
Day Group A Group B p-value
1 12501±4509 15069±5647 0.369
2 13183±3446 13437±2904 0.890
3 10074±2338 10720±4340 0.702
4 5870±1518 8702±2288 0.010*
5 5465±1017 9013±2765 0.023*
6 5049±834 6260±2235 0.214
7 5521±863 5237±1328 0.975
Fig. 114 (abstract A299). The trend of body weight
Table 95 (abstract A299). Patient Outcomes
Group A Group B p-value
Days with mechanical ventilation
(all patients)
8.7±9.0 18.4±16.2 0.127
Days with mechanical ventilation
(patients with mechanical ventilation)
12.4±8.2 29.4±7.5 0.004*
Length of ICU stay 42.7±12.5 42.9±15.9 0.979
Length of hospitalization 82.7±36.5 82.4±28.8 0.984
ARDS 3/10 4/8 0.630
Sepsis 7/10 6/8 1.000
Acute kidney injury 1/10 1/8 1.000
Mortality 0/10 0/8
Fig. 115 (abstract A300). Times vs CT strategy
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A300Introduction
Time is critical in trauma patient care. In other critical diseases (sepsis or
IM), decreasing time to definitive treatment have improved patient out-
come. Computed Tomography (CT) help us to detect life-threatening le-
sions. The time until definitive treatment is highly related with CT
acquisition times. Due to variations in current literature, there is no
consistent arrival to CT times established.
Objectives
To describe the time related with Computer Tomography for trauma
patients as well as determining associated factors.
Method
The design was a prospective and unicentric with a previous
protocol. The inclusion criteria were trauma patients accepted in
ICU from February to December 2015. Exclusion criteria were
previous admission in other hospital. We collected information
about demographic characteristics, severity trauma scores and
treatment in the Trauma Room (TR). A form was used to collect
the time-points (in minutes). Five time-period were defined: T1
from admission (TR) until the start of transferring to CT; T2 from
the start of transferring until first image; T3 between the first
and the last CT image; T4 from admission (TR) until first oral
report by radiologist, T5 from admission (TR) until definitive des-
tination ( ICU, operating room or interventional radiology). Con-
tinuous data are presented as medians (interquartile range; IQR)
and categorical data in percents. Analyses were performed with
Wilcoxon or Fisher´s test depending on data. We perform a
multivariate logistic analysis to asses the factors implicated in
the times. Using STATA 12, we calculated 2 tailed P-values set-
ting significance at 0.05.
Results
113 patients were admitted during study period with a median age
of 39 years; 82.2 % were men. The injury severity score (ISS) was > 16
in 53.9 % of patients and urgent surgery was required in 38 % of
them. The most frequent mechanism of injury was precipitation
(23.3 %). For the described time periods in minutes (T1-T5) me-
dian were T1: 30 (25-41), T2: 8 (6-11), T3: 15 (9-20), T4: 50 (30-65),
T5: 65 (52-87). Total body strategy was achieved in 78.9 %. In this
subgroup, times were longer at T3 (15 vs 9 ) and at T5 (65 vs 50 )
; p < 0.05.
In the multivariate analysis the factors included were: sex, age, GCS
and the related with the resuscitation. At T1 the factors associated
with an increased time to definitive treatment were shock and thor-
acic drainage in the TR (p < 0.05). For T5 the factors were shock ,
thoracic drainage and whole body strategy (p < 0.05).
Conclusions
The CT acquisition times in our center were similar to other cen-
ters. Prolonged times were associated with shock patients who
needed more aggressive therapies. Awareness about time-wasting
activities in trauma patients could help us to detect correctable
delays.
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Introduction Tracheal intubation is associated with significant compli-
cations including death and neurological injury. Patients who require
rapid sequence induction (RSI) for emergency tracheal intubation are
often critically ill or injured with little physiological reserve. Desatur-
ation is a common problem and studies have demonstrated severe
hypoxaemia (arterial oxygen saturation, SaO2 < 80 %), in up to 26 % of
patients during emergency RSI performed on Intensive Care Units (ICU).
Episodes of hypoxaemia during RSI are associated with worse morbidity
and increased mortality.
Preoxygenation is intended to reduce desaturation and hypoxaemia
in the drug-induced apnoeic phase of RSI. Application of 100 % oxy-
gen via nasal prongs promotes movement of oxygen-enriched air
into the alveoli during apnoea, which can help sustain SaO2. The ma-
jority of studies, though of variable methodology suggest a benefit
with apnoeic oxygenation with improvement in SaO2 during the
apnoeic phase or difficult laryngoscopy. One RCT comparing apnoeic
oxygenation to standard facemask oxygen prior to laryngoscopy
failed to show any benefit of apnoeic oxygenation.
Objectives This is a clinical effectiveness study of apnoeic oxygen-
ation as a preoxygenation strategy to reduce episodes of hypox-
aemia for patients undergoing emergency RSI. The primary endpoint
was the number of patients who desaturate to less than 90 % in the
peri-RSI period.
Methods Patients undergoing emergency RSI in the Emergency
Department (ED) and ICU at Southmead Hospital, Bristol were in-
cluded in the study. Southmead Hospital is the regional major
trauma, neuroscience and vascular centre and has an additional
large unselected medical and surgical take. Data collected included
patient demographics, observations before, during and after RSI, and
indication for RSI. Data from current standard practice (preoxygenation
via a face-mask) was collected over a 3-month period to establish
current rates of hypoxaemia. The same data were collected for a subse-
quent 3 months using apneic oxygenation.
Results In total, 71 patients underwent emergency RSI in the study
period. Common reasons for intubation were clinical course (39 %), fail-
ure to oxygenate (34 %) and failure to ventilate (14 %). Twenty-one
complications were experienced during RSI in 20 patients; hypoxia was
the most common complication, occurring in 23 % of patients. In the
study period, 24 patients received apnoeic oxygenation. Nine of 47 pa-
tients who did not receive apnoeic oxygenation experienced hypoxia
(19 %), compared with 7 of 24 patients (24 %) did, p = 0.377.
Summary: The incidence of hypoxia associated with emergency RSI
in unselected patients is high. The use of apnoeic oxygenation to re-
duce hypoxia during the drug-induced apnoeic phase of RSI remains
a much debated intervention. Having established feasibility, we now
intend to investigate the utility of apnoeic oxygenation with larger
patient numbers.A302
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A302Introduction Given the increase in intra- and inter-hospital transport
of critically ill patients it is of vital importance that transport ventila-
tors perform at the same level as ICU ventilators, despite their com-
pact design and challenging conditions during transport 1.
Objectives To determine accuracy of tidal volume (VT), plateau pres-
sure (Pplat) and positive expiratory pressure (PEEP) delivery by gas-
driven and turbine equipped transports ventilators under different
simulated pulmonary conditions, ventilator settings and oxygen
supply modes.
Methods Six transport ventilators (gas-driven Hamilton Raphael, Oxy-
log 3000, Medumat Transport and turbine-equipped Hamilton C1, C2,
Elisée 350) and two ICU ventilators (Servo-I , Hamilton G5) were
tested under pulmonary conditions simulating healthy lungs, Acute
Respiratory Distress Syndrome (ARDS) and Chronic Obstructive Pul-
monary Disease (COPD). Accuracy of VT, Pplat and PEEP were mea-
sured by a calibrated pneumotachograph. A percentage difference
between actual and displayed values of more than ±10 % was de-
fined as inaccurate.
Results Inaccuracy in VT delivery was demonstrated in gas-driven
transport ventilators Medumat Transport 66010 (in 8 of 10 experi-
ments), Oxylog 3000 (in 7 of 10 experiments), Hamilton Raphael 350
(in 4 of 10 experiments) as well in the turbine-equipped ventilator
Elisée 350 (in 6 of 10 experiments). Inaccuracy in PEEP was present
mainly in Medumat Transport 66010 (in 5 of 10 experiments) and
turbine-equipped Hamilton C2 (in 4 of 10 experiments). No Pplat
inaccuracies were detected in any ventilator. Pulmonary conditions
as ARDS or COPD or ventilation settings with high PEEP and respira-
tory rate did not consistently influence inaccuracy in VT. The influ-
ence of delivery of oxygen from a cylinder on VT inaccuracy was
present only in gas-driven ventilators Oxylog 3000 and Medumat
Transport 66010 under ARDS-conditions.
Conclusions Transport ventilators differ in accuracy of delivering
tidal volume demonstrating better performance in turbine
equipped models. Oxygen supply by cylinder was of limited influ-
ence in two gas-driven ventilators only. Two of three turbine
equipped transport ventilators (Hamilton C1 & C2) tested showed
accuracy comparable to ICU ventilators and therefore are suitable
for critical care transport. The use of many gas-driven ventilators
in critical care transport should be questioned considering their in-
accurate performance.
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Introduction Early detection of clinical response is determinants of
clinical outcome in people with acute illness. IHCA (intrahospital car-
diac arrest) often is preceded by a clinical deterioration that could be
identified and treated by trained personnel. The NEWS (National Early
Warning Score) from NHS (National Health System)1, is based on a
simple scoring system in which a score is allocated to six simple vital
signs parameters (respiratory rate, oxygen saturations, temperature,
systolic blood pressure, pulse rate, level of consciousness. Figure 116
Objectives To describe the patient clinical state prior to IHCA and
the relationship with prognosis, in a University Hospital.
Methods A retrospective, single-center and descriptive study was
conducted during 2014 and 2015. We analyzed all patients admitted
on hospital ward that were assisted by the IHCA team. Patients ad-
mitted less than 24 hours on Ward and patients not eligible for
Table 96 (abstract A303). Characteristics of the study population
Characteristics of the study population All patients (n=85)
Age. Years mean (SD) 75.1 (SD 11.7).
Male % 65.9
Pre-cardiac arrest situation at IHCA team´s arrival % 37.8
ROSC % 41.5
Hospital mortality % 63.5
IHCA witnessed % 60
IHCA in holiday schedule % 61.5
Recording frequency of vital signs at least every 8 hours % 85
Medical patient % 71.8
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 160 of 607resuscitation were excluded. Demographic data (age and gender)
were collected. We described the type of patient (medical or surgi-
cal), features of IHCA attention. The NEWS has 3 levels of scoring,
low (1-4), medium (5 and 6) and high (>6) that are related to clinical
risk. It was performed by evaluating the data from the vital signs reg-
istered on the Ward in the 24 hours prior IHCA.
Statistics.Qualitative variables are expressed as percentages and com-
pared using the X2-test; quantitative ones are expressed as means
and standard deviations (± S.D), and analyzed using Student´s t-test.
The level of significance was placed at p < 0.05. The statistical ana-
lysis was performed using specific software (IBM SPSS Statistics for
Windows, Version 19.0. Armonk, NY: IBM Corp).
Results 85 patients were included. In Table 96 we described the
characteristics of the study population. The beginning of cardiopul-
monary resuscitation (CPR) maneuvers were immediate on ward, ac-
cording to IHCA protocol. The arrival of IHCA team was less than
5 minutes in all cases. Figure 117 shows the distribution of NEWS in
the IHCA analyzed.
In 43.5 % of cases there are not enough information to make a
NEWS. In the remaining patients it was able to perform the
NEWS although we could only obtain all data in 6.5 % of pa-
tients, in the remaining 50 % of IHCA in which was calculated
the NEWS some data (vital sings) was missing. Respiratory rate
and oxygen saturations were the most frequent missed data. It
could be probably underestimating the NEWS performed. Fig-
ure 118 shows the relationship between a greater hospital mor-
tality and a higher NEWS.
Conclusions Abnormal vital signs are common within 24 hours be-
fore IHCA events on hospital wards. A suitable recording vital signs
could be useful to alert patients at risk and anticipate in the detec-
tion of IHCA.
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Introduction We conducted a retrospective review of all our ICU ad-
missions post cardiac arrest to identify OOHVF survivors and com-
pare our own care in the post TTM era with ILCOR standards of care
and unit guidelines.
Objectives To analyse the electronic record of all OOHVF patients ad-
mitted to our unit between October 2014 and July 2015 and identify
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 161 of 607our performance in achieving key components of current standard
post-resuscitation care having adopted 36C as our target for 30H
post ROSC. Unit LOS and outcomes were also collected.
Methods We identified all admissions to our unit post cardiac arrest
using the ICNARC database. Our electronic record was then analysed
to identify all those patients admitted post OOHVF.
Electronic records were used to identify age, sex, unit LOS(d), esti-
mated ROSC duration, cooling method, time to achieve TTM target
36C, max temp recorded 30H post ROSC, presence of rebound hyper-
thermia >38C within 48H post TTM, incidence of seizures, use of
anticonvulsants and NMB drugs, SSEP N20 and EEG, GCS on unit dis-
charge and unit outcome.
Results 66 OOHVF survivors were admitted to our ICU in the audit
period. Median age was 62.7 (17-85) M 54, F 12. Median unit LOS
was 5.7 days. 56 % of admissions were discharged alive from ICU.
25.7 % patients had seizures on EEG and SSEP was used to prognos-
ticate in 19.7 %. 38 % patients required atracurium to prevent shiver-
ing during the TTM period. TTM target 36C was achieved within 4 h
post ROSC in 87 %. 78 % patients received cooling via the Icycath
and the remainder via surface methods. 37 % of patients had re-
bound hyperthermia over 38C within 48 h post TTM.
One patient was discharged with GCS9. All other survivors had a GCS
of 14 or 15 at unit discharge.
Conclusions Our unit adopted controlled temperature management
to 36C for 30 h post ROSC after publication of the TTM trial. Our ad-
mission numbers and demographics have remained unchanged and
our adherence to our guideline is good, though only 78 % received
IV cooling catheters as stipulated. Our unit survival of 56 % is identi-
cal to audits previously performed and is in line with published out-
comes. Despite using cooling catheters to control temperature after
the TTM period, 37 % of patients suffered rebound hyperthermia in
that 48H window. This does not seem to have adversely affected
mortality. Use of EEG and SSEP to assist prognostication common on
our unit in prolonged coma. The incidence of seizures is common in
the post TTM phase.
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Introduction Sudden cardiac death represents a major health problem.
In adults, the prevalence of out of hospital cardiac arrests (OHCA)
attended by the emergency medical services is 75 per 100,000. Mortal-
ity remains high, and exceeds 90 %. It is well documented that patients
with a shockable rhythm have a consistently higher survival than those
whose initial cardiac rhythm is non-shockable (1).
Objectives The aim of this study was to look at outcome from car-
diac arrests admitted to a tertiary referral service and assess whether
the presentation of a shockable rhythm was associated with a better
prognosis.
Methods A retrospective case note review over a one year period of all
patients admitted to the Golden Jubilee National hospital with an
OHCA with initial rhythm being ventricular tachycardia (VT) or ventricu-
lar fibrillation (VF) were included. We looked at cause of cardiac arrest,
ICU survival and dependance upon survival, age and length of stay.Results Sixty three patients were identified, and a full data set ob-
tained for 59. Median age of admission was 59 years, with age range
from 26 years to 83 years. All presenting rhythms were either VF or
VT. 58 % of this cohort of patients survived post cardiac arrest. Me-
dian length of stay was 5 days (IQ range 1-14days). Of the 34patients
that survived, 32 of these patients went on to live an independant
life. Of the 25patients that died, all of these patients died during
their admission to Intensive Care and did not die post ICU discharge.
Interestingly, patients whose cause of cardiac arrest was purely ar-
rhythmogenic all survived to hospital discharge, although these num-
bers are small (n = 11).
Conclusions Mortality from cardiac arrest is high and places a huge
burden on ICU services. The median length of stay for OHCA pa-
tients is 5 days, and with patient numbers in this study is attribut-
able to one ICU bed per day. Their length of stay is thought to
quantify the difficulties in prognostication of survival in this cohort
of patients, particularly when it comes to the secondary brain in-
jury. Although our sample size is small, it is demonstrated that sur-
vival after OHCA where a shockable rhythm is the presenting
rhythm, is higher than quoted in literature. Interestingly, patients
that survive OHCA are likely to lead an independant life post dis-
charge. If the cardiac arrest cause is arrhythmogenic, although the
numbers are small, the survival for this cohort is 100 %.
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The occurrence of septic shock and sepsis in critically ill patients,
hospitalized in ICU, continues to be among the most serious compli-
cations, despite the new methods of diagnosis and treatment. The
aim of the study is to investigate the effect of fever onset on endo-
toxin markers.
Materials & methods Eighteen polytrauma patients admitted in ICU
and 18 healthy volunteers enrolled in the study. 10 ml of blood col-
lected from i) each patient within 24 h of admission (A) and the on-
set of fever >38° (F) and ii) from healthy individuals (H). Clinical and
demographic data recorded on admission. Serum/plasma samples
were isolated with centrifugation and stored at -70 ° C. Lipopolysa-
charide binding protein (LBP), measured with ELISA and circulating
endotoxin (LAL) with chromatometric assay.
Results On admission, the levels of LBP and endotoxin had no signifi-
cant differences between patients (A) and healthy (H), P > 0.05. The
onset of fever (F) was accompanied by abundant significant LBP re-
lease (PFA >0.001 and PFH >0.001) parallel reduction of circulating
endotoxin (PFA >0.001 and PFH >0.001)
Conclusions Increased LBP release at the onset of fever could ac-
count for marker of circulating endotoxin and the following inflam-
matory implications, in trauma patients hospitalized in ICU.
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Introduction In Intensive Care Unit (ICU) per cutaneous tracheotomy
plays a vital role in airway management of patients with Cervical Spinal
Cord Injury (CSCI). This retrospective study evaluated the favorable
effect of early tracheotomy in patients CSCI.
OBJETICVES. To evaluate the timing of tracheotomy in patients with
cervical injury and its effect on ICU stay
Methods Retrospective data analysis of 72 patients with CSCI who
underwent tracheotomy. The primary objective was to evaluate the
impact of early tracheotomy(performed within 1 week of CSCI) on
better outcome, in terms of days on mechanical ventilation and ICU
stay in patients with high (C1, C2) and low (C3 to C7) CSCI. Outcome
measures were also compared between the high and low CSCI pa-
tients when early tracheotomy was performed in both. In addition
the impact of early tracheotomy in terms of survival benefit, ventila-
tor dependence, requirement of inotropic medications, and whether
surgical intervention resulted in better outcome in terms of days in
mechanical ventilation and ICU stay were also analysed.
Results Patients with high CSCI patients with early tracheotomy had
significantly less days on mechanical ventilation and inotropic sup-
port compared to those with late tracheostomy (9.3+/-7.2 and 13.7
+/-3.2; p = 0.04 and 0.3+/-1.8 and 4.7+/-11.4; p = 0.035 respectively).
Low CSCI patients with early tracheotomy also had significantly less
days on mechanical ventilation compared to those with late trache-
otomy (12.1+/-10.4 and 25.2+/-17.7; p = 0.034). Early tracheotomy re-
sulted in significantly less days of inotropic support in high CSCI
patients compared to low CSCI (0.3+/-1.8 and 2.7+/-5.6; p = 0.022). A
trend was observed towards lesser ICU stay and days on mechanical
ventilation in patients of high CSCI with early tracheotomy. There
was no difference in terms of survival benefits, ventilator depend-
ence, and impact of surgery on outcome measures
Conclusions Our retrospective analysis supports the hypothesis that
early tracheotomy is beneficial in reducing the period on mechanical
ventilation and inotropic support in patients with CSCI, irrespective
of the anatomical level of injury
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Introduction Severe abdominal sepsis is one of the more important
risk factor for ICU and Hospital Mortality in the abdominal post-
operative period.
Objectives The objective was to analyze ICU, and Hospital mortality,
Days of Mechanical ventilation, kidney failure, pneumonia, adult respira-
tory distress syndrome, and vasoactive drugs used. Also we study thedifferences between temporary abdominal closure and negative pres-
sure therapy (ABThera,kCI).
Methods We analyze all patients admitted in our ICU from emer-
gency abdominal Trauma and surgery areas, between January 2009
to January 2015 . It was a retrospective study. We compered different
variables as age, sex, manheim peritonitis index, CHARLSON INDEX,
APACHE II, and SOFA on first day admission ,ICU, Hospital Mortality,
pneumonia, days of mechanical ventilation in two groups of patients;
patients with primary temporary abdominal closure, and patients
with previous negative pressure assistance. Significant statically re-
sults when P level was < 0.05.
Results. 93 patients were admitted in our ICU between 2009-2015,
Mean APACHE II 22.3,Mean SOFA 3,8.
Group 1: patients with primary abdominal closure: Hospital mortality
was lower in patients after prymary abdominal closure 32 % vs 37 %
( ns P > 0.05) in patients with previous negative abdominal pressure
assistance, longer stay 22.6 days vs 15.6 days in patients without
primary abdominal closure ( P ns), less days of mechanical ventilation
8 days vs 11 days in patients without abdominal closure, P > 0.05,
pneumonia 12.9 % vs 18 %, ns, nosocomial infections, 36 % vs 58 %,
p ns, kidney failure by RIFLE score 11 % vs 21 %, ns.
Conclusions In our study the primary abdominal closure showed less
ICU and Hospital mortality also less ICU complications as pneumonia
or Kidney failure although the differences were not significant static-
ally. Probably we will need it a bigger sample to observe significant
differences.
CARDIOVASCULAR MONITORING 1
A309
The influence of peep and positioning on central venous pressure
and venous hepatic hemodynamics in patients undergoing liver
resection
A. Ukere1, S. Meisner2, G. Greiwe1, B. Opitz1, D. Benten2, B. Nashan3, L.
Fischer3, C.J.C. Trepte1, D.A. Reuter1, S.A. Haas1, C.R. Behem1
1University Medical Center Hamburg-Eppendorf, Anesthesiology,
Hamburg, Germany; 2University Medical Center Hamburg-Eppendorf,
Internal Medicine, Hamburg, Germany; 3University Medical Center
Hamburg-Eppendorf, Hepatobiliary Surgery and Visceral Transplantation,
Hamburg, Germany
Correspondence: C.R. Behem – University Medical Center Hamburg-
Eppendorf, Anesthesiology, Hamburg, Germany
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A309
Introduction Quantity of blood loss during liver resection is known
to be a predictor for poor clinical outcome (1). One generally used
approach for minimization of blood loss is to decrease central ven-
ous pressure (CVP) (2). The rationale for this concept is that low CVP
is supposed to reduce hepatic blood congestion.
Objectives In order to assess blood congestion of the liver we aimed
to evaluate the influence of a positive-end-expiratory-pressure (PEEP)
and positioning of the patient on CVP and venous hepatic blood
flow in patients undergoing liver resection. Further, we analyzed cor-
relation between CVP and venous hepatic blood flow parameters.
Methods We analyzed 20 patients scheduled for elective liver resec-
tion in this study. We measured CVP and quantified venous hepatic
hemodynamics by ultrasound assessment of flow velocity and
diameter of the right hepatic vein and the portal vein during the
following maneuvers: M1: 0° supine position, PEEP 0cmH2O; M2: 0°
supine position, PEEP 10cmH2O; M3: 20° reverse-trendelenburg pos-
ition; PEEP 10cmH2O; M4: 20° reverse-trendelenburg position, PEEP
0cmH2O.
Results Changing from supine to reverse-trendelenburg position
was accompanied by a significant decrease in CVP (M3 5.95 ±
2.06 mmHg vs. M1 7.35 ± 2.18 mmHg, p = 0.031 and M2 8.55 ±
1.79 mmHg, p < 0.01 respectively). The reduction of PEEP in reverse-
trendelenburg position further decreased CVP (M4 2.9 ± 2.17 mmHg vs.
M1 7.35 ± 2.18 mmHg, p < 0.01, M2 8.55 ± 1.79 mmHg, p < 0.01 and M3
5.95 ± 2.06 mmHg, p < 0.01 respectively). PEEP and positioning induced
no significant changes in the diameters of the right hepatic or portal
vein. The combination of PEEP 10cmH2O and reverse-trendelenburg
Table 98 (abstract A310). t-IVT correlation with echo&hemodynamic
indice
Whole population Respiratory Cardiac post-surgery Cardiac primary
SV 0.006 [0.75-0.94] <0.0001 [0.85-0.95] <0.0001 [0.8 - 0.96] <0.0001 [0.87-0.96]
CO 0.0001 [0.43-0.65] <0.0001 [0.04-0.38] <0.0001 [0.04 - 0.62] <0.0001[0.18- 0.58]
MAPSE lateral <0.0001 [0.68-0.89] <0.0001[0.65-0.91] 0.008 [0.03-0-58] <0.0001[0.25-0.53]
MAPSE septal <0.0001 [0.45-0.72] <0.0001[0.68-0.89] 0.01 [0.05-0.56] <0.0001[0.42-0.82]
E/A 0.13 [0.05-1.47] 0.48 [0.13-2.22] 0.54 [0.12-1.89] 0.015 [-7.5—0.85]
E/E´ 0.23 [0.04-1.34] 0.32 [0.12-1.76] 0.57[0.1-1.5] 0.08[-6.5-0.67]
Table 99 (abstract A310). Outcome predictor
Coeff Std Err t P CI 95%
MAPSE -23.29 5.44 -4.28 <0.0001 -34.08 - -12.52
SV 0.16 0.41 4.06 <0.0001 0.08 -0.25
CO -1.39 0.4 -3.47 0.001 -2.2 - -0.59
SAPSII 0.16 0.02 5.65 <0.001 0.1 - 0.21
Fig. 119 (abstract A310). t-IVT outcome
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flow velocities of the right hepatic vein (VsHV M3 19.96 ± 6.47 cm s
-1 vs.
M1 27.81 ± 11.03 cm s-1, p < 0,01; VdHV M3 14.94 ± 6.22 cm s
-1 vs. M1
20.15 ± 10.34 cm s-1, p = 0,01 and M2 20.19 ± 13.19 cm s-1, p = 0,021 re-
spectively) whereas no significant changes of flow velocity of the portal
vein occurred in any of the maneuvers. No correlations between CVP and
diameters or flow velocities of the right hepatic and the portal vein were
found.
Conclusions Changes of central venous pressure due to changes of
PEEP and positioning were not correlated with changes of venous
liver blood flow. Therefore, those strategies aiming for low central
venous pressure maneuvers in liver resection are not supported by
these results.
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Introduction There are few data reporting which hemodynamic vari-
ables are associated with outcome1 Despite the widespread of echocar-
diography, indices to assess the cardiac function in ICU are the same
used in the cardiology ward although they have not been validated.
Systolic longitudinal function (MAPSE) and total isovolumic time (t-IVT),
although under recognized, are sensitive and early marker of myocar-
dial perfusion mismatch and, the latter, of cardiac output(CO) and VO2
changes in patients with coronary artery disease and chronic heart
failure1.
Objectives We sought to determine the correlation between echo-
cardiographic systo-diastolic indices, including t-IVT and MAPSE, and
hemodynamic parameters and their outcome value on 30-days mor-
tality in the cardiothoracic ICU.
Methods The local ethical committee approved the study. We retro-
spectively analyzed data for patients (n = 131; age 59 ± 18.3; 61.3 %
male) admitted to ICU requiring an echocardiography from January to
August 2012.
Patients were divided in 3 groups: 55 patients had severe respiratory
failure; 40 patients after cardiac surgery and 36 had primary cardio-
circulatory failure.
In addition to demographic and hemodynamic parameters, echo-
cardiographic indices included: MAPSE (M-mode on the four portion
of the mitral annulus), ejection fraction(EF), fractional shortening(FS), E/
A, E/E', Doppler assessment ejection time (ET-aortic forward flow)& fill-
ing time(FT-mitral inflow), t-IVT (calculated as [60-(total ET + total FT)])
and SV&CO derived from aortic VTI.
Continuous variables were compared using the Wilcoxon rank-sum test,
categorical variables were compared using the Pearson χ2 test. Thesignificance of differences in mortality between groups was assessed
using the log-rank test.
Results In univariate analysis a strong inverse correlation was found
between t-IVT and MAPSE and SV&CO.
In the univariate logistic analysis, SV&CO, MAPSE and t-IVT were all
good predictors of the 30 days outcome. In the multivariate model,
along with SAPS II (HR 1.07, IC 95 %1.05-1.098), t-IVT (HR 5.1, IC 95 %
2.2-11,8) and MAPSE (HR 0.17, IC95%0.02 -0.97)showed to be inde-
pendent predictors of mortality.
EF and FS do not correlate with other echocardiographic and
hemodynamic parameters and no relation with outcome was found.
Conclusions This is the first study investigating the role of those
echocardiographic indices in the ICU cohort. EF, a validated index to
stratify patients according to the systolic function, failed to correlate
with hemodynamic parameters and outcome. t-IVT, index of systo-
diastolic interaction correlating with the consequences, in term of car-
diac output, of those variations, and MAPSE resulted the most sensitive
parameters reflecting cardiac efficiency and outcome.
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Introduction To improve accessibility, central vein catheterization in
upper body region classically done in trendelenburg position but it
may impose potential disadvantages to respiratory system and disturb
physiologic status of many other organs. Passive leg raising (PLR), a
simple maneuver , widely used to improve cardiac preload and to pre-
dict patients' volume responsiveness could be an alternative.
Objectives In this study, we evaluated the effect of PLR maneuver on
right internal jugular vein (RIJV) diameter in intensive care unit pa-
tients under mechanical ventilation.
Methods As a prospective study , twenty patients under synchronized
intermittent mandatory ventilation (SIMV) without valvular heart prob-
lem or heart failure and acute respiratory distress syndrome were
studied. RIJV diameter was measured with bedside color Doppler son-
ography of neck , first in supine position and then for second and third
measurement, after 30° PLR for 1 and 10 minutes. Measurements were
at the end of inspiratory cycle with positive end expiratory pressure of
5. We chose 30° PLR to keep bedridden patients away from possible
damage that may be induced with higher upward slope.
Results RIJV diameter increased with 30° PLR maneuver , more promin-
ent after 1 minute in comparison to 10th minute time point . Mean RIJV
diameter was 11.66 mm in supine, 13.37 mm (P = 0.001) and 12.95 mm
(P = 0.005), 1 and 10 minutes after 30° PLR maneuver respectively . Incre-
ments in diameter were slightly lower than that associated with trende-
lenburg position reported in other studies . No complication was noted.
Conclusions PLR maneuver can be safely considered as an alterna-
tive to trendelenberg position to increase internal jugular vein diam-
eter in mechanically ventilated patients.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A312Introduction The assessment of Central Venous Pressure (CVP) is
fundamental in critical patients particularly in shock.
The inferior vena cava (IVC) ultrasound exam has been suggested to
predict the CVP but there are few and divergent conclusions on the
its effectiveness in spontaneously breathing patients.
Objectives To check the level of reliability, validity and correlation
with CVP of the IVC ultrasound measures and the quality of reporting
of literature on this topic.
Methods This review was based on the PRISMA guideline. The sys-
tematic search of the literature published from 1941 through 30
June 2015 explored the PubMed, Cochrane Library, Web of Know-
ledge and Scopus databases. Inclusion criteria were studies who
investigated the reliability, the validity in predicting CVP and the
correlation with CVP of the IVC ultrasound measures in adult
(>18 yrs) spontaneously breathing patients. Two researchers se-
lected studies using inclusion criteria and then assessed their qual-
ity using the STARD and QUADAS guidelines. The key words for
literature search were: inferior vena cava, ultrasonography, volume
status, central venous pressure.
Results We collected 593 studies: 148 excluded with reasons, 433
because duplicates. 12 studies were included for the final analysis
with 7 reports which included spontaneously breathing patients
and 5 a mixed population (spontaneous and ventilated): 3 on reli-
ability, 10 on correlation with CVP, 5 on validity. The IVC ultrasound
measures (IVC ratio, IVC MAX diameter, IVC MIN diameter , Caval
index [IVC-CI]) showed an inter-rater agreement range from moder-
ate to very good. The IVC MAX diameter had a significant high
correlation with CVP; there were divergent conclusions on IVC-CI
and poorly correlation for IVC ratio. The IVC-MAX and IVC-CI
showed a good validity in predicting low CVP; the IVC Max and IVC-
CI showed good validity in prediction high CVP in one study. Eight
studies respected more than 60 % of the STARD items and five
more than 80 % of QUADAS items.
Conclusions Because few reports have been published on the reliabil-
ity and validity of IVC ultrasound measures the conclusions of this
review should be confirmed. Anyway the quality of reporting and
methodology of the studies collected were good. The IVC max and min
diameter seem to correlate with CVP. All IVC measures show a good
accuracy in predicting low or high CVP.
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Introduction Transesophageal Echocardiography (TEE) is a stand-
ard procedure in Intensive Care. In patients with respiratory insuffi-
ciency, TEE with often necessary sedation may lead to further
deterioration. We performed TEE in pts. already under NIV via a full
face mask.
Methods Consecutive pts. already under NIV because of respiratory
failure (15 pts, 8 m/7f , age 72 ± 11,2 years, SAPS II score 44 ± 12,
PaO2/ FiO2 ≤ 250) with a clinically given indication for immediate
TEE were equipped with a full face mask (“endoscopy mask“, VBM
Medizintechnik GmbH, Sulz a.N.,Germany).
Ventilation was uniformely set (BiPAP f = 20/ min, 30-10 cmH2O, I:E
1:1, FiO2 1,0). For sedation, disoprivan was given as needed.
Heart rate, arterial blood pressures and transcutaneous SaO2 were
monitored continuously. Blood gases were taken 15 min before, on
start and then every five min troughout TEE and 15 and 60 min
thereafter. Indications for TEE included endocarditis/ sepsis- focus,
n = 8; intracavitary thrombus in tachyarrhythmia, n = 5; or quantifi-
cation of vituim cordis, n = 2.
Results TEE was completed in all pts. Mean duration of the procedure
was 11,6 ± 2,9 min, mean ejectionfraction was 45 ± 15 %. Percutaneous
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 165 of 607SaO2 never fell below 92 %. No pt. had to be intubated within 24 h.
Mean HR (99,5 ± 13,7 / min), MAP (74,3 ± 3,2 mmHg), pH (7,41 ± 0,01),
PaO2/ FiO2 - ratio (212 ± 21) und pCO2 (42,9 ± 1,8 mmHg) did not
change significantly (p < 0,5, ANOVA).
In 11 pts. TEE lead to definite diagnosis. In 5 pts. immediate therapy
(i.e. electrical cardioversion) was be performed
Conclusions Performed by experienced physicians, TEE at the bed-
side during NIV in sedated pts. was feasible and save.Fig. 120 (abstract A314). Example of peak in conductivity caused
by the hypertonic saline bolus within the pixel representing the
aorta; the dark blue line shows the filtered conductivity signal, while
the light blue line marks the bolus event
Fig. 121 (abstract A314). Examplary EIT image with superimposed
CT-derived outer contours of thorax and lungs. The red circle marks
the location of the aorta according to CT. The red asterisk indicates
the location of aorta as detected by EIT using a bolus of hypertonic
saline as contrast agentA314
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Introduction Electrical impedance tomography (EIT) is a noninvasive
and radiation free bedside monitoring technology, primarily used to
detect ventilation disorders. First experimental data in animals
suggests that measurement of central hemodynamics within the de-
scending aorta might become possible with EIT.1 To achieve this
goal, it is first necessary to determine within the EIT images the exact
location of an individual´s aorta.
Objectives The aim of this study was to improve and validate an al-
gorithm to automatically detect the aorta by EIT using a hypertonic
saline bolus.2
Methods Ten domestic pigs were anesthetized and mechanically
ventilated. A bolus of hypertonic saline (10 mL, 20 %), with a higher
conductivity than blood was administered into the ascending aorta
while EIT data were recorded. The resulting EIT images were analyzed
pixel by pixel to identify the aortic pixel (pA), in which the bolus
caused the highest transient impedance peak in time (Fig. 120). After
completion of the EIT measurements a thoracic computed tomog-
raphy scan (CT) was performed for each pig. The CT-images were
segmented individually for the relevant anatomical structures. EIT
images were reconstructed using the GREIT model, based on the
individual´s thoracic contours derived from the segmented CT-
images.3The resulting spatial resolution of EIT images was 3 mm /
pixel.
Results The location of the aorta could be detected by EIT in all ani-
mals, showing a mean offset of 15 ± 7.5 mm when compared to the
center of the true anatomical location identified by CT (Fig. 121).
Conclusions It is possible to detect the aorta by EIT using an
intraaortic bolus of hypertonic saline. There is a misalignment be-
tween the location of the aorta identified by EIT and CT. The
significance of this offset for an accurate measurement of fluid re-
sponsiveness needs to be determined in further studies.
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calculate non shunted pulmonary blood flow (COEPBF) during severe
hemodynamic changes ADDIN EN.CITE ADDIN EN.CITE.DATA (1). Hy-
percapnia is a common clinical state both in the perioperative period
and the ICU. Theoretically, elevated carbon dioxide levels could affect
the performance of the capnodynamic method.
Objectives The aim of the current study was to evaluate the per-
formance of COEPBF during elevated PvCO2 in a porcine model.
Methods The required alterations of alveolar concentration of carbon
dioxide were created by a ventilatory pattern containing cyclic re-
occurring expiratory holds during controlled ventilation. The math-
ematical model used to calculate COEPBF assumes a steady state in
PvCO2 levels.
Hypercapnia was induced by three means; decreasing minute ven-
tilation by either lowering respiratory rate or tidal volume, and fi-
nally, increasing dead space with preserved minute ventilation.
COEPBF was compared to a reference method for CO, an ultrasonic
flow probe around the pulmonary trunk. Hemodynamic measure-
ments and blood gas analysis were obtained at baseline before
hypercapnia and during the three different types of hypercapnia.
Preload reduction (inflated cava balloon) and dobutamine stimula-
tion was performed during low respiratory rate and increased
dead space.
Results During hypercapnia the PaCO2 and PvCO2 levels were
raised on average 58 % and 40 % (+/- 17 and 16 %) from within
normal limits, respectively. Bias (LoA) att baseline before induc-
tion of hypercapnia was 0.5 L/min (-0.5 to 1.5) and percentage
error (PE) 28 %. During hypercapnia, bias (LoA) was 1.4 L/min
(0.2 to 2.7), PE 26 % following lower respiratory rate, 0.7 L/min
(-0.7 to 2.2), PE 30 % when tidal volumes were decreased, and
0.5 L/min (-0.4 to 1.4), PE 19 % when dead space was increased.
During hemodynamic changes the PE was slightly increased (see
Table 100 for all values) and the concordance rate was 100 %
(see Fig. 122).
Conclusions COEPBF performed well during hypercapnia, both dur-
ing different types of low minute ventilation and increased dead
space. The performance was maintained during major changes in
cardiac output and trending was excellent. These results indicate
that the capnodynamic method should be tested during lung
protective ventilation with permissive hypercapnia and even in
laparoscopic surgery.
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Intervention COEPBF
(L/min)
COTS
(L/min)
Shunt
(%)
Dead
space
(%)
PaCO2
(kPa)
PvCO2
(kPa)
Bias
(L/
min)
LoA
(L/min)
PE
(%)
Normocapnia 3.8 (0.5) 3.3 (0.5) 8 (3) 55 (3) 5.56
(0.42)
7.41
(0.69)
0.5 -0.5 to
1.5
28
Hypercapnia
low RR
5.5 (0.9) 4.1 (0.8) 13 (4) 47 (9) 8.52
(0.79)
9.83
(1.22)
1.4 0.2 to
2.7
26
>Caval
occlusion
3.1 (0.5) 2.3 (0.4) 7 (2) 53 (4) 8.05
(0.84)
10.46
(1.00)
0.8 0.1 to
1.4
24
>Dobutamine 7.0 (0.7) 5.5 (0.7) 19 (5) 45 (10) 9.40
(0.74)
10.65
(1.02)
1.6 -0.1 to
3.2
27
Hypercapnia
low TV
5.6 (1.0) 4.9 (0.6) 13 (4) 66 (4) 9.23
(0.32)
10.94
(0.46)
0.7 -0.8 to
2.2
30
Hypercapnia
dead space
5.0 (0.7) 4.5 (0.5) 13 (4) 78 (2) 9.06
(0.49)
10.50
(0.91)
0.5 -0.4 to
1.4
19
>Caval
occlusion
3.1 (0.5) 2.7 (0.2) 7 (3) 80 (2) 8.34
(0.42)
10.33
(0.95)
0.4 -0.5 to
1.3
31
>Dobutamine 5.0 (0.7) 4.4 (0.5) 14 (4) 78 (3) 9.91
(0.43)
10.46
(1.32)
-0.04 -2.3 to
2.2
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Introduction Echocardiography in the setting of the critically ill pa-
tient might be hindered due to poor transthoracic acoustic window.
The modified subcostal window, which is obtained from an extra-
thoracic region, gives us a short-axis parasternal-like view, at the level
of the great vessels.
Objectives To address the consistency of cardiac output values, mea-
sured from the modified subcostal view as compared with those ob-
tained from a transthoracic approach.
Methods In 54 consecutive critically-ill patients undergoing trans-
thoracic ecocardiography (Philips Sparq) for both initial diagnosis
of shock or subsequent hemodynamic monitoring, velocity time
integral of pulsed wave Doppler of the left ventricular outflow
tract (VTILVOT) and the pulmonary flow (VTIPu-Ps and VTIPu-Ms) were
measured from the apical four-chamber view, the short-axis para-
esternal and modified subcostal views respectively. Results were
analyzed with predictive performance test and the consistency
analysis. Interobserver reproducibility analysis was assessed in 20
patients with repeated measurements by two experienced physi-
cians using the intraclass correlation coefficient (ICC).
Results Baseline characteristics included: mean heart rate 79 beats
per minute (15.7), age 59.2 years (15.6), male 29 (53.7 %), previus
cardiac disease 9 (16.7 %), medical diagnosis at admission in 40 pa-
tients (74.1 %, with primary cardiac diagnosis in 8 [14.8 %]); 19
mechanically ventilated patients (35.2 %, mean PEEP 6.8 [2.8]), with
vasoactive drugs in 13 patients (24.1 %, mean norepinephrine dose
.38 [.29] mcg/Kg/min). Median VTILVOT was 24.3 cm (interquartile
range [IQR] 8-36), VTIPu-Ps 24.5 cm (IQR: 6-57) and VTIPu-Ms 18.9 cm
(IQR: 7-43). The comparison between VTILVOT and VTIPu-Ms revealed
a consistency of .52 (95%CI .29 to .69, p < .001), see Fig. 123; and
between VTILVOT and VTIPu-Ps .44 (95%CI .13 to .67, p = .004), see
Fig. 124. The ICC observed was .93.
Conclusions The consistencies between VTILVOT and VTIPu-Ms and
VTILVOT and VTIPu-Ps were moderate but VTILVOT and VTIPu-Ms
consistency improved after excluding patients with VTILVOT >29 cm.
VTIPu-Ms underestimate VTILVOT a mean 4.45 cm. Further research is
required in order to assess it.
Fig. 123 (abstract A316).
Fig. 124 (abstract A316).
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Introduction The assessment of the left ventricle function is of para-
mount importance for the management of patients with acute circu-
latory failure. In this regard, the measurement of the left ventricle
ejection fraction (LVEF) by echocardiography is considered to be the
gold standard. Only few studies investigated the correlation between
the LVEF and the Cardiac Function Index (CFI) calculated through
transpulmonary thermodilution [1, 2].
Objective To assess the usefulness of cardiac function index (CFI) as
a surrogate of left ventricle ejection fraction (LVEF) in patients with
acute circulatory failure.
Methods We conducted a prospective study in a 12-bed medical surgi-
cal intensive care unit. All patients admitted with acute circulatory fail-
ure and monitored with a transpulmonary thermodilution device were
included in our study. We excluded the patients with acute core
pulmonale and those with poor echogenicity. A bedside trans-thoracicechocardiography was performed simultaneously with transpulmonary
thermodilution. Cardiac function index and left ventricle ejection frac-
tion were recorded simultaneously.
Results Twenty-one patients were included in our study. Median
[quartile] age was 66 [57-81] years. Sex-ratio (M/F) was 12/9. Fourteen
patients (66.7 %) were admitted with septic shock whereas 7 patients
(33.3 %) had cardiogenic shock. Mechanical ventilation was required
for 13 patients (61.9 %). Median [quartile] CFI was 4.5 [2.75 - 6] min-1.
Median [quartile] LVEF was 60 [45.75 - 66] %. Spearman coefficient was
0.844 (p < 0.001). Moreover, a CFI > 4.5 min-1 predicted a LVEF > 60 %
with a sensitivity of 100 % and a specificity of 82 %.
Conclusion CFI can be used as a reliable tool to predict LVEF in pa-
tients with acute circulatory failure.
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Objectives Hypotension is a common problem in critically ill patients.
Arterial blood pressure (ABP) is influenced by changes in intravascu-
lar volume, cardiac output and vascular tone. In particular, systemic
vascular resistance (SVR) is a main determinant of arterial elastance
(Ea); SVR is also influenced by peripheral endothelial function (e.g.
microcirculatory flow). However, few data are available on the correl-
ation of these parameters in this setting.
Methods Prospective study conducted in a 35-bed medico-surgical
ICU since January 2016. Patients with an invasive ABP monitoring
and requiring a cardiac output (CO) monitoring during a fluid chal-
lenge (FC) were simultaneously assessed with a pulse wave analysis
(PWA) system (MostCare, Vygon, France) to estimate Ea and with an
Incident Dark Field (IDF) handheld device (Braedius Medical BV, The
Netherlands) to evaluate sublingual microcirculation. Microvascular
perfusion was assessed using the proportion of small-perfused ves-
sels (PPV). SVR was calculated according to standard formulas. Rela-
tive changes in each variable were calculated before and after FC;
fluid responders had a CO increase of at least 10 % from baseline.
Results We included 13 patients (age 64 [54-73] years; 7 male) requir-
ing a fluid challenge (n = 6 for hypotension; n = 5 for oliguria; n = 2 for
hypovolemia). At baseline, mean arterial pressure was 72 [66-84]
mmHg, heart rate (HR) 83 [80-106] bpm and CO 4.2 [3.5-4.4] L/min;
after fluid challenge, MAP was 73 [71-74] mmHg, HR 85 [77-103] bpm
and CO 4.8 [3.9-5.4] L/min. Seven patients were fluid responders. There
was no correlation between PPV and SVR (ρ = 0.12; p = 0.23) or Ea (ρ =
0.03; p = 0.56). Likewise changes in SVR and Ea during fluid challenge
were not correlated with changes of PPV (-ρ = 0.01; p = 0.91).
Conclusions No correlation was found between either SVR or elastance
and indexes of microvascular perfusion in the sublingual region. The
impact of microcirculatory perfusion on the arterial load should be
further defined.
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Introduction Monitoring of a systemic hemodynamic at victims with
the severe combined injury allows to outline the volume and structure
of an infusion therapy. At this moment invasive methods are typically
used for monitoring of a systemic hemodynamic. However, invasive
monitoring is impossible or extremely limited in some patients because
of a mode of failure (for example, pelvic fracture) and a consumable
cost. In such cases non-invasive monitoring of a systemic hemodynamic
can be used as an optional method.
Objective to compare cardiac output measurements between trans-
thoracic Doppler sonography and echocardiography (EchoKG).
Material and methods Twenty four patients at the age of 41 ± 14 en-
rolled in the study (women/men - 3/19, traumatic brain injury - 3, a
spinal trauma - 2, a concomitant injury- 19). We determined a stroke
volume (SV) and a cardiac output (CO) with the use of the transtho-
racic Doppler sonography ("USCOM", Australia) and the transthoracic
EchoKG (GE Vivid Q, USA).
Transthoracic doppler sonography was provided by doctors of the in-
tensive care unit, EchoKG was performed by doctors of the functional
diagnostics.
Results We didn't find differences between the average values SV
and CO evaluated by DS and EchoKG: 67,2 ± 21,4 ml vs 64,2 ± 18 ml,
and 6,5 ± 2,4 l/min vs 6,4 ± 2 l/min.
Conclusion Usage of transthoracic doppler sonography for determin-
ing systemic hemodynamic values at victims with a severe injury allows
to receive the measured data of the systolic discharge and cardiac out-
put comparable to data of transthoracic EchoKG.
TDS provided a comparable results of SV and CO measurements with
EchoKG and could be used in trauma care practice.
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Introduction Transcranial cerebral oximetry is a non-invasive method
to monitor the changes in the cerebral oxygen metabolism. It is a
near-infrared spectroscopy method that uses multi-wavelength radi-
ation between 690-1100 nm spectrum. This photons can pass skin,
bone, brain and cerebrospinal fluid.
Objectives The aim of the study is to analyze the association of mon-
itoring transcranial cerebral oximertry with morbidity and mortality
in patients with postresuscitation syndrome.
Methods In this study we retrospectively analyzed the data of 23
patients with postresuscitation syndrome. The data included age, sex,arrest time, location of arrest, light reflex, Glascow coma scale and
cerebral oximetry values compared with mean arterial pressures, SpO2
values and survival.
Results Glascow coma scale and survival are well correlated with
higher values of cerebral oximetry (p < 0.05).
Conclusions This study suggests that, high cerebral oxygen saturation
values in patients with postresuscitation syndrome are associated with
lower morbidity and mortality.
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Introduction Classically, central venous pressure (CVP) and pulmon-
ary artery occlusion pressures (PAOPs) have been used as surrogates
for volume measurements.However dynamic preload variables like as
pulse pressure variations (PPV) and stroke volumen variations (SVV)
could be very useful in hepatic postresection phase to optimize the
volumen needed for the patients.
Objectives The aim of this study is to assess if is better to reduce post-
operative complications, optimizing hemodynamic situation after hep-
atic resection guided by dynamic variables preload (PPV and SVV) versus
using liberal fluid management.
Methods Experimental clinical trial, controlled, randomized, single
blind, in patients undergoing hepatic resection. In both groups peri-
operative fluid restriction was done (5 ml/kg/hour of Ringer Lactate)
until removal of the surgical specimen was performed. Affer that, two
randomized groups were established. In the control group fluids
(colloids) were administered until hemodiámica stability was achiveved
and standard pressures were got (MAP > 65 mmHg CVP 8-14, urine out-
put > 0.5 ml / kg / h). In the other group volume was administered until
a SVV < 12 and a PPV < 14 and MAP > 65 mmHg were achieved.
In both groups the volume administered to achieve quantified objec-
tives and postoperative complications (nausea and vomiting, respira-
tory and infectious complications) was registred.
Results 9 patients were enrolled in the GDT group and 10 patients in
the control group. There were no statistically significant differences in
preoperative variables. A statistically significant difference in the volume
administered after resection in both groups (1290 +/- 375 vs 128 +/-
485.55, p < 0.01) was found. In the surgical time we found no correlation
between VPP and CVP (r = 0,172, p = 0.656) and between the VSS and
CVP (r = 0,243, p =0.492). We found very good ability to predict the
Table 101 (abstract A322). Cumulative nephrotoxin exposure and AKI
Exp No AKI Risk Injury Failure
No exposure 2171, (84%) 201, (7.8%) 90, (3.5%) 122, (4.7%)
3 meds 59, (49.2%) 22, (18.3%) 12, (10%) 27, (22.5%)
4 meds 28, (38.4%) 11, (15.1%) 11, (15.1%) 23, (31.5%)
5 meds 12, (40%) 6, (20%) 2, (6.7%) 10, (33.3%)
6 meds 5, (35.7%) 1, (7.1%) 2, (14.3%) 6, (42.9%)
7 meds 0, (0%) 1, (11.1%) 2, (22.2%) 6, (66.7%)
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 169 of 607response to volume with both the VPP (ROC curve: 0.96) as the VSS
(ROC curve: 0.92), defined as the 20 % improvement in cardiac output.
We found a decrease in complications but no statistically significant dif-
ferences in respiratory complications (4 vs 2, p = 0.62), infectious compli-
cations (5 vs 2, p = 0.35) and nausea and vomiting (6 vs 1, p = 0.057).
Conclusions Guided therapy goals (GTD) is able to decrease the vol-
ume of liquid provided after hepatic resection. This fact optimize
hemodynamics values in these patients (cardiac output, mean arterial
pressure) and therefore, reduce postoperative complications due to
excessive intake volumen.
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Introduction Critically ill children are exposed to multiple nephro-
toxic medications due to the nature of the underlying disease
process as well as comorbid conditions. Acute kidney injury (AKI) is
prevalent in the pediatric critically ill. Nephrotoxin exposure is a po-
tentially modifiable risk factor for AKI in non-critically ill children, with
exposure to three or more discrete nephrotoxic agents significantly
increasing odds of AKI. Despite higher inherent risk, data on AKI and
nephrotoxin use in the pediatric intensive care unit (PICU) setting is
scarce. Fluid Overload Kidney Injury Score (FOKIS) is a decision sup-
port tool piloted in our PICU as a daily score incorporating subscores
for AKI (pRIFLE creatinine and urine output), fluid overload (total fluid
(in- out)/ICU admission weight), and exposure to nephrotoxic medi-
cations (a priori determined list of medications).
Objectives We aimed to investigate AKI prevalence and frequency of
nephrotoxin exposure using FOKIS subscores.
Methods Retrospective analysis of daily FOKIS subscores in PICU pa-
tients (pts) over 18 months. AKI was defined and staged using pRIFLE
creatinine criteria. Nephrotoxin exposure (Exp) was defined as expos-
ure to three or more nephrotoxic agents in 24 hours. Each additional
medication exposure was also recorded.
Results 2830 pts (median age 5.5 years (IQR 1.3-12.9 years), 55 %
male) were included over 18 months. 246 pts (8.7 %) had Exp
during PICU stay (120 (49 %) to 3, 73 (30 %) to 4, 30 (12 %) to 5, 14
(5.7 %) to 6, 9 (3.7 %) to 7 different nephrotoxins). Fifty eight
percent (142/246) of pts with Exp had AKI (41 (16.7 %) R, 29
(11.8 %) I, 72 (29.3 %) F) compared to 16 % (413/2584) without
(201 (7.8 %) R, 90 (3.5 %) I, 122 (4.7 %) F) (p < 0.001).
Conclusions A majority of PICU pts with AKI had exposure to
nephrotoxins. Patients who had exposure to three or more nephro-
toxins had increased AKI compared to patients who did not. This
association needs to be further studied prospectively to determinecausality, specifically exploring timing of AKI onset in relation to
nephrotoxin exposure in critically ill pediatric patients. Cumulative
nephrotoxin exposure is a possible modifiable AKI risk factor in crit-
ically ill children.A323
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Introduction Until two thirds of critically ill patients develop Acute Kid-
ney Injury (AKI) and it is associated with an increased risk of death.
Renal Angina Index is a score that evaluates the risk of presenting AKI.
Objectives This study was used to determine the effectiveness of the
Renal Angina Index as a developing predictor of AKI in 3 days.
Methods The study was based on a prospective cohort of critically ill
patients in whom Renal Angina Index score was completed with a
72 hour follow up of serum creatinine levels, water balance and urinary
output, establishing after patients that develop AKI. Afterwards a rela-
tionship was established between Renal Angina Index score and its pre-
dictive capacity of developing AKI, determining sensibility, specificity,
positive predictive value and negative predictive value for the score.
Results A final sample of 206 patients was obtained at the end of
the study. The incidence of AKI in the studied population was 27.2 %
(n = 56), and the average scores of Renal Angina Index were 20.52 in
those who develop AKI and 4.35 in those who didn't develop AKI.
This score offers a 90.7 % sensibility, 95.4 % specificity with an area
under de curve of 0.963 (0.934-0.991). A positive predictive value of
0.88 was obtained and a negative predictive value 0.97
Conclusions Renal Angina Index score is effective predicting AKI in
critically ill adult patients.
Note: This abstract has been previously published and is available at
[4]. It is included here as a complete record of the abstracts from the
conference.
References
1. Chawla L, Goldstein S, Kellum J, Ronco C. Renal Agina: concept and
development pretest probability assessment in acute kidney injury. Critical
Care. 2015; 19: 93.
2. Basu R, Zappitelli M, Brunner L, Wang Y, Wong H et al. Kidney International.
2013; 85, 659-667.
3. Basu R, Wang Y, Wong H, Chawla L, Wheeler D, Goldstein S, Incorporation
of biomarkers with the renal angina index for prediction of severe AKI in
critically ill children. Clin J Am Soc Nephrol. 2014; 9: 654-662.
4. Aguilar Arzapalo M, Barradas L, Lopez V, Escalante A, Jimmy G, Cetina M
(2016) Effectiveness of renal angina index score predicting acute kidney
injury on critically ill patients. Critical Care 20(Suppl 2): 94.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 170 of 607Grant acknowledgement
To Hospital O´Horán.Fig. 125 (abstract A323). ROC Curve ''Angina Renal Index Score''
Table 102 (abstract A324). Risk factors selected for the predictive
model
Significance (p) Odds Ratio Confidence Interval 95%
APACHE II <0.01 1.04 1.069-1.014
Hemoglobin <0.01 0.86 0.942-0.793
Diuretics <0.01 2.31 3.515-1.513
Vasoactive drugs <0.01 1.87 2.960-1.174
Fig. 126 (abstract A324). ROC curve of the modelA324
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Introduction Incidence of acute kidney injury in critically ill patients
increases with chronic diseases, nephrotoxic drugs, and the use of
contrast in diagnostic/therapeutic techniques. Contrast-associated
acute kidney injury (CA-AKI) is strongly predictive of adverse
outcomes.
Objectives To build a statistical predictive model to evaluate the
probability of developing contrast-associated acute kidney injury in
critical patients.
Methods This study has been endorsed by the Spanish Society of In-
tensive Critical and Emergency Care Medicine (SEMICYUC). Data were
obtained in a prospective multicenter study in 33 Spanish Intensive
Care Units, with a total of 1009 patients. The criteria used to define
CA-AKI was the AKIN criteria: a rise of serum creatinine of ≥0.5 mg/dl
or a 50 % relative rise in creatinine at 48-72 hours after contrast ex-
posure. The predictive model has been developed employing a bin-
ary logistic regression using the software R. The ROC curve was
obtained (Fig. 126) and the model was calibrated using this graph.
From the model, we have generated a graphical nomogram (Fig. 127)
to facilitate its use in a clinical environment. The nomogram includes
the 4 variables shown to have prognostic value.Results 12 % of the patients developed CA-AKI. Predicting factors
were elevated APACHE II test score, hemoglobin and baseline
serum creatinine, shock or acute myocardium infarct at admission,
vasoactive drugs and diuretics at the moment of the contrast ad-
ministration, and the following comorbidities: chronic heart failure
and chronic kidney failure. Significant risk factors in the univariate
analysis were selected for the predictive model (Table 102). A boot-
strap method was used to select the best subset of risk factors to
avoid overfitting the data. The corresponding ROC curve of the
model (Fig. 126) has an area under the curve of AUC = 0.75 (range
0.71-0-79).
Conclusions A predictive model of CA-AKI has been developed. Pre-
dicting variables with prognostic value are the hemoglobin content,
the APACHE II test score on admission and the use of vasoactive
drugs and of diuretics. The corresponding nomogram allows for
easy evaluation of the probability of developing CA-AKI in critical
patients.
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Introduction It is postulated that the effects of continuous renal re-
placement therapy (CRRT) delivered as hemofiltration (CVVH-ST150)
might benefit critically ill patients with sepsis-associated acute kidney
injury (AKI), by better clearing large toxic inflammatory cytokines.
Objectives To compare CRRT delivered as hemodialysis associated
with an adsorptive membrane (CVVHD-ST150), with CRRT delivered
as CVVH-ST150 in 81 septic patients with AKI.
Methods In this randomized non-blinded control trial, patients were
recruited from 2 ICUs in Barcelona (Spain), and were assigned to one
of two arms of intervention: CVVH-ST150 or CVVHD-ST150. The primary
outcome was 90-day mortality. Secondary outcomes were inflamma-
tory cytokine clearance, consumption of extracorporeal circuits, ICU
and hospital length-of-stay (LOS), and presence of CRRT associated
complications (dialytrauma).
Results The median duration of follow up was 130 days. Mean age was
63.5 ± 13.3 years and distribution of baseline characteristics were similar
between groups. Overall 90-day mortality was 56.1 % in the CVVH-
ST150 group and 50 % in the CVVHD-ST 150 group (p = 0.94). Number
of extracorporeal circuits employed after 72 hours of CRRT initiation
were 4.08 ± 1.8 in the CVVH-ST150 group and 3.31 ± 1.28 in the
CVVHD-ST150 group (p = 0.038). Median extracorporeal circuit lifespanwas 18,91 ± 6 and 20,63 ± 4.3 hours in the CVVH-ST150 group and the
CVVHD-ST150 group (p = 0.019), respectively. Heparin was employed in
26.8 % in the CVVH-ST150 group and 15 % in the CVVHD-ST150 group
(p = 0.27). Mean ICU stay was 17.3 ± 14.3 days and 12.4 ± 11.9 days in
CVVH-ST150 group and CVVHD-ST150 group (P = 0.098), respectively.
Hospital length-of stay (LOS) was 33.5 ± 25.7 in the CVVH-ST150 group,
as compared with 21.2 ± 18.5 in CVVHD-ST150 group (P = 0.016). Serum
levels of inflammatory cytokines were similar between groups.
Conclusions There were no differences on survival, dialytrauma and
inflammatory cytokine clearance between CVVH-ST150 and CVVHD-
ST150 groups. However, the use of CVVHD-ST150 was associated
with a lower hospital LOS and less consumption of extracorporeal
circuits during the first 72 hours of CRRT.
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Introduction Critically ill patients with acute kidney injury (AKI) who
receive renal replacement therapy (RRT) have very high mortality
rate. During RRT, there are markedly changes in the metabolism of
macro- and micronutrients which may cause malnutrition and result
in impaired renal recovery and patient survival.
Objectives We aimed to examine the predictive role of macro- and
micronutrients on survival and renal outcomes in critically ill patients
undergoing continuous RRT (CRRT).
Methods This prospective observational study enrolled critically ill
patients requiring CRRT at Intensive Care Unit of King Chulalongkorn
Memorial Hospital from November 2012 until November 2013. The
serum, urine, and effluent fluid were serially collected on the first three
days to calculate protein metabolism including dietary protein intake
(DPI), nitrogen balance, and normalized protein catabolic rate (nPCR).
Serum zinc, selenium, and copper were measured for micronutrients
analysis on the first three days of CRRT. Survivor was defined as being
alive on day 28 after initiation of CRRT. Dialysis status on day 28 was
also determined.
Results Of the 70 critically ill patients requiring CRRT, 27 patients
(37.5 %) survived on day 28. The DPI and serum albumin of survi-
vors were significantly higher than non-survivors (0.8 ± 0.2 vs 0.5 ±
0.3 g/kg/day, p = 0.001, and 3.2 ± 0.5 vs 2.9 ± 0.5 g/dl, p = 0.03, re-
spectively) while other markers were comparable. The DPI alone
predicted patient survival with area under the curve (AUC) of 0.69.
A combined clinical model predicted survival with AUC of 0.78.
When adjusted for differences in albumin level, clinical severity
score (APACHEII and SOFA score), and serum creatinine at initiation
of CRRT, DPI still independently predicted survival (odds ratio 395.8,
p = 0.024). The serum levels of micronutrients in both groups were
comparable and unaltered following CRRT. Regarding renal out-
come, patients in the dialysis-independent group had higher serum
albumin level than the dialysis-dependent group, p = 0.01.
Conclusions In critically ill patients requiring CRRT, DPI is a good pre-
dictor of patient survival while serum albumin is a good prognosticator
of renal outcome.
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Introduction Hydroxyethylstarch (HES) was part of triple H-therapy
for prophylaxis and therapy of vasospasm in patients suffering
from subarachnoid haemorrhage (SAH). [1, 2] The EMA restricted
the use of HES 2013 based on studies showing significant increase
of renal failure in septic or critical ill patients receiving HES com-
pared to crystalloids as fluid therapy. [3] There's still a lack of data
examining the occurrence of renal insufficiency in non-septic
patient groups.
Objectives The purpose of our study was to evaluate the effect of
HES on renal function in SAH patients, who received large amounts
of HES in the context of triple H therapy.
Methods Medical records of all patients presenting between January
2009 and December 2013 with non-traumatic SAH were analysed.
Patients were divided in two groups based on the administration of
HES 6 % and/or 10 % (n = 183) vs. controls receiving crystalloids for
fluid therapy (n = 93).
Primary outcome was acute kidney injury (AKI) assessed using the RIFLE
criteria referring to increase of serum creatinine and/or oliguria. [4]
Results The study groups had similar baseline characteristics except
for SAPS scores, incidence of vasospasm and ICU LOS. Patients re-
ceiving HES fulfilled significantly more often sepsis criteria.
24.6 % (62/183) of patients in the HES group had AKI at any time dur-
ing their ICU stay compared to 23.6 % (25/93) in controls (p = 0.679).
Only few patients needed renal replacement therapy with no signifi-
cant difference between groups (4.3 % control group vs. 2.2 % in HES
group, p = 0.322).
Conclusions In non-traumatic SAH there was no association between
AKI and HES therapy. The use of HES as fluid replacement therapy
might be of less risk in non-septic critically ill patients.
References
1 Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, Quintel M,
Schmiedek P, Vajkoczy P: Effects of hypervolemia and hypertension on
regional cerebral blood flow, intracranial pressure, and brain tissue
oxygenation after subarachnoid hemorrhage. Crit Care Med 2007.
2 Sen, J., Belli, A., Albon, H., Morgan, L., Petzold, A., & Kitchen, N: Triple-H
therapy in the management of aneurysmal subarachnoid haemorrhage.
Lancet Neurology 2003.
3 Mayor, S.: EMA confirms that hydroxyethyl starch solutions should not be
used in critically ill, sepsis, or burns patients: BMJ (Clinical Research Ed.). 2013.
4 Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis
Quality Initiative: Acute renal failure - definition, outcome measures,
animal models, fluid therapy and information technology needs: theSecond International Consensus Conference of the Acute Dialysis Quality
Initiative (ADQI) Group. Crit Care 2004.
A328
Early and late acute kidney injury in burn patients
E.M. Flores Cabeza, M. Sánchez Sánchez, N. Cáceres Giménez, C.
Gutierrez Melón, E. Herrero de Lucas, P. Millán Estañ, M. Hernández
Bernal, A. Garcia de Lorenzo y Mateos
Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain
Correspondence: E.M. Flores Cabeza – Hospital Universitario La Paz,
Medicina Intensiva, Madrid, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A328
Objectives To study the prevalence and factors related with the de-
velopment of early AKI (before day 3) and late AKI (after day 3)
Methods 165 critical burn patients were studied over a period of 3 years.
All of them were resuscitated by a resuscitation protocol guided by
transpulmonary thermodilution and monitoring lactic acid levels. In re-
suscitation phase artificial colloids were used at low doses.The incidence
of AKI (according to AKIN criteria), early AKI (defined as before day 3),
recovery or progression and late AKI, and related factors with their
development: comorbidities, severity scores, need for mechanical
ventilation, development of shock and mortality were studied. De-
scriptive analysis and Kruskall-Wallis test was performed
Results The average total body surface area (TBSA) burned was 30 ±
15 %, mean age was 43 ± 16 years, mean ABSI score was 7.1 ± 2.1and
the median of the total volume needed in the first 24 hours was
4.01 ml/kg/% .
42 patients developed AKI (stage I: 20 , II : 5, III : 17). Of these, 12 pa-
tients (28 %) developed early AKI (stage I : 7, II 1 and III : 4). There were
no differences in comorbidities en no AKI, early AKI, and late AKI pa-
tients. There were differences between late AKI and no AKI patients;
the late AKI patients were older (55 vs 40 p < 0.001), had more TBSA
burned (27 vs 37 p < 0.001), presented worse severity scores (ABSI 6.7
vs 8.7 p < 0.001; SOFA day 0:2.1 vs 3.9 p < 0.001; SOFA day 3: 3.5 vs 6.5
p < 0.001), presented greater need for mechanical ventilation (43 % vs
80 % p < 0.001), had more prevalence of shock ( 37 vs 73 p < 0.0001),
and more mortality (4.9 % vs 39.2 % p < 0.0001) than the no AKI
patients. But there were no differences in the other study factors. There
were no differences between early and late AKI patients nor between
no AKI and early AKI patients (except for mortality 4.9 vs 25 % p <
0.008). 4 patients with early AKI returned to basal values at 7th day and
the other 8: 3 continued in AKIN I at 7th day, 1 increased to AKIN II level
and 4 to AKIN III): Only two patients (15 % of them),one alive and an-
other dead, did not recover basal values.
Conclusions The patients without AKI had similar characteristics to the
patients who developed early AKI but the patients who developed late
AKI were older, had more TBSA burned, , worse severity scores, greater
need for mechanical ventilation, presented more prevalence of shock
and higher mortality. One third of the early AKI patients recovered
normal values before the 7th day, and most of them recover this normal
values before discharge.
0329
HES (130/0.4) has no negative effect on kidney function and
microvascular perfusion in severe acute normovolemic
hemodilution in pigs
B. Ergin1, P. Guerci1, P.A.C. Specht2, Y. Ince1, C. Ince1
1Academic Medical Center, University of Amsterdam, Translational
Physiology, Amsterdam, Netherlands; 2Erasmus Medical Center,
Experimental Anesthesiology, Roterdam, Netherlands
Correspondence: B. Ergin – Academic Medical Center, University of
Amsterdam, Translational Physiology, Amsterdam, Netherlands
Intensive Care Medicine Experimental 2016, 4(Suppl 1):0329
Fig. 129 (abstract 0329).
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colloid such as starch solution is a common technique to reduce the
requirements for allogeneic blood transfusion but is controversial es-
pecially concerning renal function. Not much data exists about the
influence of starches in setting of hemodilution on renal function
and microvascular perfusion.
Objectives The present study was designed to investigate the impact
of ANH on renal cortex microcirculatory flow distribution and its short-
term functional consequences on the systemic, renal hemodynamics
and oxygenation.
Methods Fully instrumented 11 female Yorkshire pigs (27.5 ±
1,5 kg) were divided into two group; Hemodilution (n = 8)(ANH)
and a control (Ctr) group (n = 3). Hemodilution was performed
by replacing blood with HES solution (6 % Hydroxyethyl Starch
130/0.4, Voluven, Fresenius Kabi) till hematocrit levels reached
20 % (T1), 15 % (T2) and 10 % (T3). Cardiac output (CO), mean
arterial pressure (MAP), central venous blood pressure (CVP), pul-
monary arterial pressure (PAP), systemic vascular resistance (SVR)
and heart rate (HR) were monitored.The right kidney was exposed
and an flow probe (Transonic Systems Inc.) was placed around the
renal artery to measure renal blood flow (RBF). Renal cortex microcircu-
latory flow distribution was measured by Laser Speckle Imaging (Moor
Instruments, UK).)
Results Despite MAP and CVP being stable during the entire study,
we found that while HR (106+/-18 in ANH group vs. 76+/-7 in Ctr
group, p = 0.025) and CO (6.7+/-1.1 in ANH group vs. 3.9+/-0.1 in Ctr
group, p = 0.002) increased, PAP (17.6+/-2.3 in ANH group vs. 22
+/-4.3 in Ctr, p = 0.05) decreased significantly at Hct 10 % compared
to the Ctr. Oxygen delivery (DO2) did not change but SVR (704+/-128
in ANH group vs. 1259+/-128 in Ctr group, p = 0.001 at T3) and oxy-
gen consumption (VO2) (798+/-137 in ANH group vs. 1046+/-113 in
Ctr group, p = 0.02 at T2; 842+/-218 in ANH group vs. 1142+/-78 in
Ctr group, p = 0.05 at T3) were found to be lower than the Control.
RBF increased at T3 ( 255+/- 55 ml/min. in ANH group and 218
+/-42 ml/min. in the Ctrl group, p = 0.046) and was accompanied
with slightly right shifted histograms but no significant change in the
mean flux values of kidney was found (Figs. 128, 129). No differences
was found in creatinine clearance, tubular sodium reabsorption and
fractional sodium excretion of kidney between 10 % Hct of ANH and
Ctr group at T3.
Conclusions This study showed that ANH using HES can cause a
reduction of systemic oxygen consumption with sustained oxygen
delivery being maintained by an increase CO. ANH with HES also
caused an increase in RBF but did not change the microvascular
perfusion and flow heterogeneity in kidney. In the present study,
we demonstrated that there is no deleterious effect of HES on
renal function and microvascular perfusion in the setting of
severe ANH.
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Introduction The requirements for magnesium (Mg) supplementa-
tion increase under regional citrate anticoagulation (RCA) because
citrate acts by chelation of bivalent cations within the blood circuit.
The level of magnesium in commercially available fluids for continu-
ous renal replacement therapy (CRRT) may not be sufficient to pre-
vent hypomagnesemia.
Objectives To test dialysis/haemofiltration fluid with Mg concentra-
tion 1.50 mmol/l under various common settings of CRRT with RCA.
Methods Patients (n = 23 CVVH, n = 22 CVVHDF) on RRT dosage
2000 ml/h, blood flow (Qb) 100 ml/min, with RCA modality (4 % tri-
sodium citrate) using calcium free fluid with 0.75 mmol/l of Mg and
magnesium substitution were observed after switch to the calcium-
free fluid with magnesium level of 1.50 mmol/l (n = 42) and no extra
magnesium replenishment. All patients had renal indication to CRRT,
were treated with the same devices, filters and the same postfilter
ionized calcium endpoint (<0.4 mmol/l) of prefilter citrate dosage.
Under the high level Mg fluid the Qb, dosages of citrate and CRRT
were consequently escalated in 9 h steps to test various settings.
Results Median balance of Mg was -0.91 (-1.18 to -0.53) mmol/h with
Mg 0.75 mmol/l and 0.2 (0.06-0.35) mmol/h when fluid with Mg
1.50 mmol/l was used. It was close to zero (0.02 (-0.12-0.18) mmol/h)
with higher blood flow and dosage of citrate, increased again to 0.15
(-0.11-0.25) mmol/h with 3000 ml/h of high magnesium containing
fluid (p < 0.001). The arterial levels of Mg were mildly increased after
the change for high level magnesium containing fluid(p < 0.01).
Conclusions Compared to ordinary dialysis fluid the mildly hyper-
magnesemic fluid provided even balances and adequate levels
within ordinary configurations of CRRT with RCA and without a need
for extra magnesium replenishment.
Note: This abstract has been previously published and is available at
[2]. It is included here as a complete record of the abstracts from the
conference.
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Introduction Undetected decrease of blood flow is a known factor
for decreasing circuit lifespan of continuous veno-venous haemofil-
tration1 (CVVH).The connection of CVVH lines to a circuit of extracor-
poreal membrane oxygenation (ECMO) may allow for a more stable
blood flow and a possible increase of circuit lifespan compared to a
conventional CVVH realized using a central venous catheter (CVC)2.
Objectives To assess lifespan of CVVH connected to ECMO circuit
compared to conventional CVVH using central venous catheter.
Methods In this single-center prospective study, all patients requiring
CVVH for acute kidney injury were eligible for inclusion. A group of
patients without ECMO receiving CVVH through CVC (C group) was
compared to patients receiving ECMO (E group) in whom CVVH lines
were connected to the ECMO circuit. The circuit lifespan was mea-
sured from its connection to the session discontinuation. Reasons for
ending CVVH were classified as follows: effective session; primary clot-
ting of the circuit; unsuitable inflow or outflow line pressure; not CVVH-
related end of session (NRCES). All sessions for each patient were re-
corded and included. Data related to CVVH were recorded at the time
of initiation of CVVH (H0), then after 6(H6), 12 (H12), 24 (H24), 48 (H48),
and 72 hours (H72). Primary endpoint was lifespan of the circuit. Results
are presented as median and interquartile range (IQR) [25-75], and ab-
solute numbers or proportions. Statistical analysis used Mann-Whitney
U test and two way independent ANOVA for comparison of multiple
measures at different times. The time-to-event of both groups were es-
timated using Kaplan Meier analysis and log-rank test.
Results Between January 2014 and May 2015, 17 patients were
included in each group, 43 sessions of CVVH were recorded in the E
group and 56 in the C group. 16 sessions were interrupted prematurely
for NRCES leaving 34 and 49 episodes (respectively E and C group) for
analyzing circuit lifespan. Circuit lifespan was statistically increased in the
E group compared to the C group. Median lifespans of CVVH circuit were
respectively 48 H [21-72] vs 20 H [6-39] in E and C groups (relative risk of
session ending: 2.4, 95 % CI [1.41-3.9], log rank p = 0.0009 (Fig. 130). CVVH
blood flow was higher and more stable throughout sessions in the E
group (p < 0.001) (Fig. 131). Median heparin dose used for anticoagula-
tion was higher in the C group (p < 0.001) (Fig. 132) but without effect on
the activated partial thromboplastin time (aPTT) all over the session.
Conclusions In our experience, connection of CVVH lines to ECMO is
associated with an increased lifespan of the CVVH circuit, the direct
connection of CVVH circuit to ECMO allowing higher blood flow.
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Fig. 134 (abstract A333). amino acid losses per patient (mg/h)]
Table 103 (abstract A333). Estimated total amino acid loss (g/day)]
Amino acid loss Median (IQR)
Total 22 (18.3 - 23.8)
by Ultrafiltration 11.8 (10.3 - 12.9)
by Adsorption 10.3 (7.4 - 12.2)
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Introduction Continuous venovenous hemofiltration (CVVH) is
used for renal replacement in critically ill patients with acute
kidney injury (AKI). Unfortunately, substrate removal is aselective.
Previous studies have shown a substantial loss of amino acids
(AA) in the ultrafiltrate. However, none of the studies investigated
the loss of amino acids due to adsorption to the filter
membrane.
Objectives To quantify the total loss of amino acids during
predilution CVVH in critically ill patients, including the loss
by ultrafiltration (UF) and adsorption (Ads); and secondly, to
determine the sieving coefficients of the different amino
acids.
Methods Prospective observational study in 8 critically ill pa-
tients with AKI receiving predilution CVVH, blood flow180 ml/
min. Predilution flow of 2400 ml/h, Fresenius polysulfone mem-
brane (Ultraflux AV). Amino acids were measured in arterial
plasma, post-filter plasma and ultrafiltrate at baseline, 1-hour, 8-
hours and 24-hours after start of a new CVVH session, and were
measured by high performance liquid chromatography (HPLC).
Calculations:
 Total AA loss: AA filter in - AA filter out (g/hour) Loss by ultrafiltration (UF): [AA]UF (g/L) * QUF (L/h) Loss by adsorption (Ads): Total loss - Loss by UF
 Sieving coefficient: [AA]UF/{0.5 ([AA]pre-filter + [AA]post-filter
Results Mean age was 57 (±18) years, APACHE II score 27 (±6);
Nutrition was enteral in 6 patients, parenteral in 1; 1 patient
did not receive nutrition (shock). Total AA loss (mg/h), AA
loss by ultrafiltration (mg/h), and AA loss by adsorption (mg/
h) at 1-h, 8-h, 24-h after start of CVVH, are shown in Fig. 133.
Patient nr 8, with acute ischemic liver failure, had the great-
est loss of amino acids. The total amino acid loss (p = 0.276),
loss by ultrafiltration (p = 0.876) and loss by adsorption (p =
0.368) did not change during the course of CVVH. The esti-
mated median amino acid losses (g/day) are shown in
Table 103.
The sieving coefficients of most amino acids were near 1. Sieving co-
efficients of glutamic acid (0.60), taurine (0.83), tryptophan (0.84) and
ornithine (0.85) were lower.
Conclusion During CVVH with a modern polysulfone mem-
brane, the estimated amino acid loss is 22.0 g/day. Total loss
consists of loss by ultrafiltration for 56 % and of loss by ad-
sorption for 44 %. Loss by UF and adsorption is stable dur-
ing the first 24-h. Amino Acid loss is higher than reported
previously, because loss by adsorption was not measured
before.A334
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Introduction Volume resuscitation is the mainstay of treatment in most
types of shock, especially in hypovolemic, hemorrhagic and septic
shock [1, 2]. Although there has been an increasing amount of research
within the last decade in order to evaluate the optimal amount and
composition of fluids for volume resuscitation (e.g. colloids, crystalloids,
red blood cell transfusion, albumin, fresh frozen plasma), results remain
inconclusive and to some extent contradictive.
Objectives To evaluate the impact of amount and type of fluids ad-
ministered on the use of renal replacement therapy (RRT) and
outcome.
Methods Single-centred retrospective observational study analysing
patient charts on the medical and surgical ICU of the University Hos-
pital Basel from 2011 until 2015.
Results We retrospectively analysed type and amount of fluid adminis-
tered within the first 72 hours after ICU admission to patients receiving
continuous veno-venous hemodiafiltration (RRT) or hemodialysis in the
surgical or medical ICU at Basel University hospital during a 5-year
period. A total of 343 ICU patients underwent RRT from 1st January
2011 to 31st December 2015 (median duration of 3 days, interquartile
range (IQR) 1-7 days).
We found a significant difference comparing patient survival and
patient death among age (p < 0.001), SAPS II score, total volume
within the first 72 hours on the ICU, fluid balance in the second and
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(p < 0.001).
Out of 343 patients, 189 (55.1 %) died. The annual mortality varies from
65.6 % in 2011, 44.8 % in 2013 to 54.9 % in 2015 (average 55.1 %,
p(2011/2013) = 0.169). The number of RRT in the ICU did not change
during the study period. HES was administered to 75 patients (21.9 %),
the number of HES-receiving patients decreased from 64.1 % in 2011
to 6 % in 2013 and finally to 0 patients in 2015. Patients who were
given HES received more intravenous fluids within the first 72 hours
(p < 0.001), more noradrenaline (p = 0.033) and had significant
higher fluid balances at all measured time-points. The mortality of
patients without HES administration was lower than those who re-
ceived HES (51.2 % vs. 69.3 %, p = 0.005, Phi/Cramer V = 0.151).
Conclusions Contrary to our expectations, the rate of renal replace-
ment therapy did not decrease over the last 5 years despite abandon-
ing administration of HES solution. Nevertheless, the administration of
HES was associated with a higher mortality. Additional high fluid load
and a positive balance are highly associated with mortality. Further re-
search is needed to evaluate if the relationship between high mortality
and higher amount of administered fluids is based on correlation or
causation.
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2. Haase N, et al. BMJ. 2013 15;346:f839.Table 104 (abstract A334). Patient characteristics per Year
2011 2012 2013 2014 2015
Number 64 (48 - 16) 72 (43 - 29) 67 (43 - 24) 69 (48 - 21) 71 (41 - 30)
SAPS-II 71 (62 - 78) 69 (59 -
82.8)
73 (58 - 86) 81 (65 - 87) 73 (56 - 86)
HES used n(%) 41 (64) 29 (40) 4 (6) 1 (1.5) 0 (0)
Mortality n (%) 42 (66) 41 (57) 30 (45) 37 (54) 39 (55)
ICU LOS [d] 6 (3 - 14.8) 12 (3 - 21) 7 (3 - 13) 9 (3 - 19.5) 7 (3 - 14)
RRT length [d] 2.5 (1 - 7.8) 1 (3.5 - 8.8 3 (1 - 6) 4 (2 - 7.5) 3 (1 - 8)
Total fluids in
72h [L]
14.2 (7.2 -
22)
13.1 (5.5 -
24.5)
13.9 (5.2 -
26.2)
14.7 (6.1 -
23.4)
8.8 (3.3 - 16)
∑ Noradrenaline in
72h [mg]
27.5 (6.3 -
79.3)
26.3 (7.8 -
61.4)
12.0 (1.0 -
61.2)
12.1 (1.9 -
45.2)
9.0 (0.07 -
29.9)
Dialysis on discharge
n (%)
3 (4.7) 10 (4.2) 5 (4.5) 11 (4.4) 4 (4.2)
Table 105 (abstract A334). Impact on survival
Survivours Dead p-Value
Median (IQR) Median (IQR) Unpaired t-Test &
Pearson-Chi2
Number (m/f) 154 (99/55) 189 (124/65)
SAPS-II Score 69 (55.75 - 79) 77 (64 - 88) <0.001
Length of RRT [d] 4 (2 - 8) 2 (1 - 6)
∑ Volume in 72h [L] 10.4 (4.4 - 19.8) 14.6 (8.1 - 24.6) <0.001
HES received n (%) 23 (14.9) 52 (27.5) 0.005
∑ Ec, FFP, Tc in 72h [L] 0.6 (0 - 1.8) 1.2 (0.3 - 4.6) <0.001
∑ Noradrenaline in 72h [mg] 7.4 (0.05 - 38.4) 26.4 (6.6 - 55.4) 0.036
Balance first 24h [L] 2.6 (0.9 - 5.8) 4.4 (2.0 - 8.6) 0.001
Balance at 72h [L] 9.7 (4.2 - 17.0) 12.5 (6.9 - 21.1) <0.001
Exclusion LOS <72h (13 survival) (56 death)A335
Continuous renal replacement therapy prescription and dosing in
intensive care patients at the Queen Elizabeth University Hospital
Glasgow
N. Runciman, M. Ralston, R. Appleton
Queen Elizabeth University Hospital, NHS GG&C, Glasgow, United
Kingdom
Correspondence: N. Runciman – Queen Elizabeth University Hospital,
NHS GG&C, Glasgow, United Kingdom
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A335
Introduction Current continuous renal replacement therapy (CRRT)
guidelines recommend delivery of a dose of 20-25 ml/kg/hr 1. Previ-
ous studies have shown a tendency to higher intensity dosing than
required 2. The new Queen Elizabeth University Hospital Glasgow
(QEUHG) merged three intensive care units (ICUs), and practice at
the new unit had not yet been evaluated.
Objectives To determine the delivered dose of CRRT to patients in
the ICU, the number and length of breaks in delivery, and the choice
of filtration fluid.
Method 79 patients received CRRT in the ICU at the QEUHG be-
tween May and December 2015. A sample of 29 patients was ex-
amined. Effluent doses were collected from the electronic patient
record (EPR), normalised by the patients' weights and by time on
CRRT. Prescriptions, interruptions in delivery of CRRT (including
noted reasons for the break) and the choice of filtration fluid
were also retrieved.
Result Patients received 3333 hours of CRRT, or 158 24-hour periods
(8 am-7 am). Daily prescriptions were completed in 42 % of cases.
Prescriptions were completed in 56 % of cases in which CRRT was
required prior to review on a ward round. The median prescribed
dose was 25.5 ml/kg/hr. 29 % of days saw the recommended dose
delivered for patients. On 32 % of days studied, patients received a
dose lower than 20 ml/kg/hr, while on another 39 % of days, patients
received greater than 25 ml/kg/hr. The median delivered dose was
24.3 ml/kg/hr. Greater variation in prescription and delivery were
noted in the first 3 days of CRRT. Breaks in CRRT constituted 15 % of
total hours examined. The most frequent reason was for a clotted fil-
ter. The average filter lifespan was 18.6 hours, with 2.7 % lasting the
maximum 72 hours. Prismasol 4 % filtration fluid was used for 94.3 %
of the hours spent on CRRT.
Conclusions Rates of daily prescription are poor, at 42 %. Completed
prescriptions show reasonable adherence to recommended dosages.
This suggests there may be a role for prompting to complete/re-
assess prescriptions within the EPR. Only 29 % of days saw the cor-
rect dose of CRRT delivered. It may be that the breaks in CRRT are
not adjusted for in the prescribed dose, leading to under-dosing.
Higher prescription, in the context of anticipated disruption, may re-
duce under-dosing. However, this would worsen cases of higher-
intensity delivery. Further work is required to understand the reasons
for high-intensity prescription and delivery. Improved anticoagulation
may reduce breaks in CRRT delivery, and improve filter lifespan. This
could reduce workload, cut costs, and potentially improve patient
outcomes.
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Table 106 (abstract A335). CRRT Prescription in First Week
Day Median Dose (ml/kg/hr) Range [IQR]
1 25 25-60 [25-25]
2 25 25-67 [23-30]
3 30 25-40 [25-36]
4 25 25-35 [25-25]
5 25 25-25 [25-25]
6 25 25-25 [25-25]
7 25 25-25 [25-25]
Table 107 (abstract A336). Effects of HFNC on gas exchange
Facial mask
(12 L/min)
HFNC (30
L/min)
HFNC (45
L/min)
HFNC (60
L/min)
P-value
(ANOVA)
Fitting
(AIC) Linear
Fitting (AIC)
Non-linear
PaO2
(mmHg)
72.8±13.5 86.7±14.4* 92.4±11.3* 95.9±13.9* <0.001 228.1 231.2
PaCO2
(mmHg)
38.9±5.6 39.2±6.4 39.1±6.6 38.9±6.3 n.s. - -
pH 7.47±0.1 7.47±0.1 7.47±0.1 7.48±0.1 n.s. - -
* p<0.05 vs. facial mask by post-hoc Bonferroni test; no other between-phases
post-hoc comparison was significant
Table 108 (abstract A336). Effects of HFNC on ventilation pattern
Facial mask
(12 L/min)
HFNC (30
L/min)
HFNC
(45 L/
min
HFNC (60
L/min)
P-value
(ANOVA)
Fitting
(AIC)
Linear
Fitting (AIC)
Non-linear
RR (bpm) 21±5 19±4 17±5* 16±5* <0.001 204.7 206.9
Vt (mL) 499±371 481±376 487±377 482±368 n.s. - -
MV (L/min) 9.5±4.1 7.0±2.5* 7.5±3.2* 7.2±2.1* <0.01 228.2 225.7
MV corr (L/
min)
9.2±4.5 6.8±2.7* 7.2±3.4 6.9±2.4* <0.01 235.9 234.5
ΔEELV (mL) baseline 81±228 119±178 212±284* <0.05 425.2 428.1
PEF (L/min) 40.7±23.9 34.8
±21.1*
36.7
±21.3
36.6±17.6 <0.05 225.1 226.4
ΔPes
(cmH2O)
10.0±4.1 8.0±2.9* 7.7±2.9* 7.2±2.3* <0.01 203.9 202.8
PTPes
(cmH2O*s/
min)
228±74 178±55* 152±41* 143±44* <0.001 235.9 202.3
* p<0.05 vs. facial mask by post-hoc Bonferroni test; no other between-phases
post-hoc comparison was significant
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Introduction High Flow Nasal Cannula (HFNC) is a non-invasive re-
spiratory support that positively modifies clinical outcomes of hyp-
oxemic Acute Respiratory Failure (ARF) patients [1]. Available data
suggest that HFNC support induces a number of physiological ben-
efits over conventional oxygen therapy, however little is known
about the correlation between physiological effects of HFNC and
flow rates.
Objective Aim of this study was to disclose whether physio-
logical effects of HFNC linearly or non-linearly follow increased
flow rates.
Methods We performed a prospective randomized cross-over
study on 10 hypoxemic ARF patients with PaO2/FiO2 ≤ 300 mmHg
while on non-invasive oxygen support. FiO2 was set to obtain
SpO2 of 90-95 % by facial mask and left unchanged throughout
the study. Patients underwent four randomized steps, lasting
20 minutes each: facial mask (gas flow 12 L/min) vs. HFNC at 30,
45 and 60 L/min. During all phases we assessed gas exchange,
lung volumes by electrical impedance tomography and inspiratory
effort by esophageal pressure. Data measured during the 4 steps
were compared using one-way ANOVA while best fitting of linear
vs. non-linear correlations was assessed by lower Akaike´s informa-
tion criterion (AIC) value.
Results Patients were 61 ± 10 year-old, five were female and PaO2/
FiO2 at enrollment was 171 ± 44 mmHg. At higher flow rates
(Table 107): PaO2 improved (p < 0.001) while pH and PaCO2 didn't
vary; end-expiratory lung volume (ΔEELV) increased (p < 0.05) and
peak expiratory flow (PEF) decreased (<0.05) suggesting positive ex-
piratory pressure effect by increased expiratory resistance and/or
improved respiratory system compliance; respiratory rate (RR) de-
creased (p < 0.001) and tidal volume (Vt) didn't change (p > 0.05),
anyway yielding decreased minute ventilation (MV) (p < 0.01) and
corrected minute ventilation (MVcorr = MV*PaCO2/40 mmHg) (p <
0.01), indicating enhanced CO2 removal; finally, esophageal pres-
sure swing (ΔPes) and pressure-time product (PTPes) decreased (p
< 0.01 for both). AIC for linear correlation with flow rates was lower
for PaO2, RR, ΔEELV and PEF, as if improved aeration and its effects
on oxygenation constantly increase with flow; while non-linear AICwas lower for MV, MVcorr, ΔPes and PTPes, possibly suggesting that
most of the improvement in CO2 wash-out from upper airway dead
space and its consequences on patient's effort is already obtained
at 30 L/min.
Conclusions HFNC induces multiple beneficial physiologic effects
that might delay respiratory decompensation and improve clinical
outcomes. However, not all effects linearly increase with HFNC flow
so that its selection might be personalized to target the most clinic-
ally relevant physiologic derangement.
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Introduction CIP appears frequently in ICU and can occur in up to
25 % of patients. After extubation CIP causes poor airway clearance
due to respiratory muscle weakness and can lead to respiratory fail-
ure and reintubation. Reintubation, which increases severity of ill-
ness, is an independent risk of nosocomial pneumonia, increased
hospital stay and mortality. Currently, standard treatment includes
respiratory physiotherapy with manual assisted cough. However re-
spiratory failures still occurs in 30 % of patients within 48 hours
Table 109 (abstract A338).
Fig. 135 (abstract A338).
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in patients with CIP, the efficiency of MI-E device in the prevention
of respiratory failure during 48 hours after extubation. MI-E is a
non-invasive technic to assist respiratory physiotherapy which aims
to suction tracheal mucus. MI-E has been evaluated for neuromus-
cular disease patients, and it has been shown to increase peak ex-
piratory flow and to improve airway clearance.
Objectives
Primary outcome: Incidence of respiratory failure after extubation
Secondary outcomes:
– reintubation rate
– mean length of stay in ICU
– mortality at day 28
Methods In a medical ICU of a university hospital we conducted a
prospective randomized open study in two parallel groups. All intu-
bated patients were screened with a Medical Research Council (MRC)
muscular test. Patients were diagnosed CIP if the MRC score was
equal or under 48/60. All patients with CIP and without exclusion
criteria were randomized in the study. During the treatment period,
patients received two daily session of MI-E plus manually assisted
coughing or standard treatment (manually assisted coughing).
Results 123 patients were included in three years, 62 in the standard
group, and 61 in the MI-E group. There was no difference between
the two groups at baseline. The results show no difference for the
primary outcome (p 0,6022): 7/62 respiratory failures in the standard
group (11,5 %), 10/61 in the MI-E group (16,4 %). For the secondary
outcomes, we found no statistical difference concerning reintubation
(3.6 % vs 7 %), mean length of stay in ICU (6,5 vs 7,9 days) and mor-
tality at day 28 (14.8 % vs 18.3 %)
Conclusions The study demonstrated no superiority of the MI-E
device in the prevention of post-extubation respiratory failure for ICU
patients with CIP.
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Introduction The noise is associated with morbidity and mortality in
critically ill patients, related to sleep fragmentation and delirium pri-
marily (1-3). The ventilation devices can generate noise, with further
impact on the effectiveness of the technique. An example is the non-
invasive CPAP devices and high nasal flow, widely used in ICU (4).
Objectives To evaluate the intensity of the noise level as perceived
by the patient and to compare the difference in noise intensity be-
tween several different devices for non-invasive respiratory support
at different levels of assistance.
Methods Made in patients with acute respiratory failure, and pulmon-
ary dummy-simulator with spontaneous breathing, were connected to
differents device CPAP with 5, 10, 12.5, and 15cmH2O, as high flowsystem 35-110 L/min. We studied 3 models of noninvasive CPAP (Wis-
perflow/Vital Signs; Ventumask® HF, Starmed, Intersurgical; valve-
Boussignac®, Vigon); device of high flow: Optiflow®-MR850 with Whis-
perflow high flow generator, and Airvo2® Fisher & Paykel. The flow is
measured with Ohmeda 5410 Volume Monitor. The intensity of sound
is measured at ear level using Speedlink SL-8691-SBK-01 microphones.
The audio signal is recorded for 60 seconds in wav format (22,050 KHz).
Three measurements were performed for each level of assistance and
devices. The noise intensity was obtained from the spectral power
(PSD) of sound pressure waves, hanning windows and fast Fourier
transform was used. PSD is reported in decibels sound pressure level
(dB SPL)/KHz, where: dB SPL = 20 log(P/P0), P is intensity of the stimu-
lus, and P0 the reference's intensity at the threshold of human hearing
at the frequency of 1 kHz. Analysis was perfomed with software Matlab
R2008a of the maximum and mean (SD) spectral power/frequency of
each signal. The comparisons are performed by analysis of variance for
multiple samples.
Results The table below shows the measured noise intensity levels
from the devices and support leves studied. The figure shows the
power spectral (dB/KHz) of signals at level representative, from devices
CPAP with 12.5-15 cmH2O and high nasal flow. Boussignac CPAP and
HF Ventumask produced the highest levels of noise: 2.3 to -3.8 dB/KHz
at the high CPAP levels. The lowest noise levels are produced by high
flow nasal Airvo2 35 L/min (dB/KHz max: -48). The noise intensity in-
creasing in proportion to the flow.
Conclusions Our results suggest that the devices studied are the
noisiest valve-Boussignac and Ventumask. The noise intensity in-
creases in proportion to the flow, regardless of the level of applied
pressure. The less noisy device: Airvo2 35 L/min. The noise Optiflow-
MR850 can be relative to the flow generator used.
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Table 110 (abstract A339). Biomarkers at day 1 (median [IQR])
HFNC (n=23) MV (n=23) P value
RAGE (ρg/ml) 2164.57 (1000.46-3394.40) 1386.35 (972.75-2180.29) 0.18
SP-D (ηg/ml) 13.70 (5.85-18.95) 12.25 (4.11-19.19) 0.51
ANG-2 (ρg/ml) 7215.00 (3712.92-10875.42) 10243.75 (5978.54-15510.83) 0.17
sST2 (ρg/ml) 1506.87 (1130.77-3691.53) 1399.89 (1075.22-1837.99) 0.61
IL33 (ηg/ml) 0.87 (0.77-1.59) 0.94 (0.85-1.38) 0.45
IL-8 (ρg/ml) 37.29 (22.46-143.39) 83.68 (33.48-145.02) 0.28
IL-6 (ηg/l) 111.63 (84.29-135.73) 74.41 (52.61-113.93) 0.05
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Introduction High flow nasal cannula (HFNC) is emerging as a sup-
portive therapy for patients with acute respiratory failure. However,
according to the Berlin definition, it is unclear whether patients with
acute hypoxemia (PaO2/FIO2 ≤ 300) and bilateral opacities not fully
explained by cardiac failure and who are treated with HFNC should
be considered as acute respiratory distress syndrome (ARDS)
patients.
Objectives To examine whether HFNC patients with acute hypox-
emia and bilateral opacities treated with HFNC and ARDS patients
who were directly mechanically ventilated are similar in terms of
lung epithelial, endothelial and inflammatory biomarkers.
Methods Prospective multicenter study at three university tertiary
hospitals enrolling intubated and non-intubated patients admitted to
the ICU with acute hypoxemia (PaO2/FIO2 ≤ 300) and bilateral opaci-
ties. HFNC or mechanical ventilation was initiated at the discretion of
the attending physician. We measured plasma biomarkers of lung
epithelial (receptor for advanced glycation end-products [RAGE] and
surfactant protein D [SP-D]) and endothelial (Angiopoietin-2 [ANG-2])
injury and inflammation (interleukin [IL] 6, IL8, IL33 and soluble sup-
pression of tumorigenicity-2 [sST2]) within the first 24 hours of ARDS
onset. A propensity score matching was performed using 5 different
variables (APACHE II, SOFA, PaO2/FIO2, origin of ARDS and need for
vasopressors). Non-hypoxemic mechanically ventilated critically ill pa-
tients and healthy volunteers served as the controls.
Results Of the 102 enrolled patients, 71 (69.6 %) were intubated and
31 (30.4 %) were treated with HFNC at ARDS onset. Patients initially
treated with HFNC had lower APACHE II (20 [14-23] vs 21 [19-24]; p = <
0.01) and SOFA score (6 [4-8] vs 7 [5-10]; p = < 0.01) and were less likely
to develop shock during their ICU stay (48.4 % vs 83.1 %; p = < 0.01).
After propensity score matching (23 HNFC patients vs 23 MV patients),
no significant differences were observed in RAGE, SP-D, ANG-2, IL6, IL8,
IL33 and ST2 between matched patients who were treated with HFNC
at ARDS onset and those who were intubated.
After matching, no differences in mortality or length of stay were ob-
served. All biomarkers with the exception of IL33 were higher in both
groups of matched ARDS patients than in both control groups.
Conclusions Acute hypoxemic patients with bilateral infiltrates
treated with HFNC present a similar pattern of biomarkers of inflam-
mation and injury compared with those ARDS patients who were dir-
ectly mechanically ventilated. The results suggest that these HFNC
patients may be considered as ARDS patients.
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Introduction Critically ill patients with acute respiratory failure (ARF)
undergoing bronchoscopy have an increased risk of hypoxemia-
related complications. Previous studies have shown that in awake,
hypoxemic patients non-invasive ventilation is helpful in preventing
hypoxemia during bronchoscopic procedure. Recently, high-flow
nasal cannula (HFNC) therapy has been used to improve oxygenation
in patients with ARF. However, there are minimal data evaluating the
use of high flow nasal cannula undergoing bronchoscopy with bron-
choalveolar lavage (BAL).
Objectives This study investigated the feasibility and safety of high-
flow nasal cannula (HFNC) oxygen therapy for ARF in adult patients
undergoing bronchoscopy with BAL.
Methods We identified 19 patients with suspected pneumonia and
hypoxemic ARF (PaO2/FiO2 ≤ 300) who were admitted to a medical
intensive care unit and who received HFNC therapy undergoing
bronchoscopy with BAL between May 2014 and March 2016 at
Dankook University Hospital. Their medical records were reviewed
retrospectively.
Results The subjects included 13 men and 6 women, mean age 61 years
(range 23-86 y).
Of the 19 patients, 18 (94.7 %) successfully complete BAL on HFNC.
Only 1 patient required endotracheal intubation during BAL. Two pa-
tients required endotracheal intubation with mechanical ventilation 3
and 5 hours after BAL, respectively.
The etiologies of acute respiratory failure were bacterial pneumonia (8,
42.1 %), Influenza pneumonia (2, 10.5 %), pneumonia due to undefined
pathogen (7, 36.8 %), and diffuse alveolar hemorrhage (1, 5.3 %), acute
exacerbation of idiopathic pulmonary fibrosis (1, 5.3 %). HFNC was
initiated at a mean FiO2 of 0.56 (range 0.30 - 0.9) and flow of 44.3 L/min(-
range 30 - 50 L/min). Mean PaO2/FiO2 at baseline was 168 (range 77 -
260) mm Hg and at the end of procedure was 157.8 (range 54.5 - 266).
Changes in mean blood pressure, heart rate, respiratory rate and
PaO2/FiO2 values induced by the procedure did not reach signifi-
cance (P > 0.05).
Conclusions Application of the HFNC to be a safe and effective alter-
native to intubation for accomplishing bronchoscopy with BAL in pa-
tients with hypoxemic ARF.
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Introduction Although several approaches for providing supplemen-
tal oxygen have been suggested, the best option for patients with
acute respiratory failure remains unclear.
Objectives To study the effect of the HFNC with ARDS.
Methods We chose the 12 patients with ARDS in the study, average
67 years. The patients were all treated with the HFNC in the PLA 309
ICU. According the Berlin's standard , the patients were divided into
the mild to moderate ARDS group(7 cases)and the severe ARDS
group(5 cases).In order to detect the effect of the HFNC, we recorded
the respiratory frequency , Pa02/FiO2 ,PaCO2 in the 0 h,24 h,48 h,72 h
after the treatment of HFNC as well as the failure rate of each group.
Results The failure rate in the mild to moderate ARDS group is 14
percent,the HFNC don't cause the significant change in the PaCO2
of the group(P > 0.05); The respiratory frequency of the patients in
the group has been ameliorated in the 48 h due to the HFNC
treatment(20.57 ± 2.37vs.23.87 ± 2.64,P < 0.05)and the result can
be better in the 72 h.As long as the treatment of the HFNC, Pa02/FiO2
was significantly higher at 72 h(276.00 ± 108.15vs.177.75 ± 64.23, P<
0.05). In the severe ARDS group, the failure rate is 40 percent and there
is no statistics significance about Pa02/FiO2 before and after the
treatment of the HFNC.The respiratory frequency could be ameliorated
in the proceeding of HFNC treatment(48 h:19.25 ± 3.77vs.25.60 ±
2.50, P < 0.05;72 h 20.75 ± 3.59vs.25.60 ± 2.50,P < 0.05),but the PaCO2
has achieved to the normal level(39.75 ± 7.13vs.30.40 ± 6.98,P < 0.05).
Conclusions HFNC can ameliorate the symptom of the mild to mod-
erate ARDS, but the effect in the severe ARDS isn't certain. So, the
symptom of patients must have been monitored frequently in order
to avoid missing the chance of intubation.
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Introduction Oxygen therapy is one of the most popular treatments
in the ICU. We typically use oxygen masks to give oxygen to patients
who breathe spontaneously. However, ordinary oxygen masks have a
risk of CO2 rebreathing—especially at lower flow rates (less than 5 l/
min).
For our bench study, we investigated the use of an open face mask
(Atom Medical, Japan) in alleviating the risk of CO2 rebreathing while
still delivering a relatively high FIO2. The result showed that the open
face mask mitigated this safety concern. It provided a 10 % higher of
inspired oxygen (FIO2) and a lower inspired carbon dioxide (FICO2) as
60-100 % reduction than an ordinary mask (IMJ, Japan). That result
was presented in the congress of WFSICCM.
Objective We hypothesize that the use of an open face mask is better
for our spontaneous breathing patients who need oxygen than an or-
dinary mask because it can give patients better oxygenation and CO2
clearance.
Methods This study was performed among 22 ICU patients who suf-
fered from mild respiratory failure. We applied both masks (ordinary
and open face mask) with various flow rates: 5, 4, 3, 2, 1 and 0.5 l/
min for three minutes, respectively. First, we tried ordinary masks
with 5 l/min for 15 minutes and decreased the flow to 0.5 l/min
every three minutes. The patients whose SpO2 achieved 100 % with
5 l/min of oxygen were excluded. Respiratory parameters (SpO2, re-
spiratory rate: RR; FICO2, end-tidal CO2: EtCO2) were recorded at the
end of each flow rate.
FICO2 and EtCO2 were measured via Capnostream
TM (Medtronic, US).
Next, we investigated an open face mask in the same manner: applying
5 l/min of oxygen for 15 minutes. Finally, we checked patient satisfac-
tion with each mask using a visual analogue scale (VAS: 0-best, 5-worst)
at the end of each trial. We used the Wilcoxon matched-pairs signed-
ranks test to detect significant differences in the two groups.
Results Data from 12 patients were analysed. The median age was 66
(range: 50-87). Most of the patents (92 %) underwent an operation
(cardiovascular surgery: 67 %, orthopaedic surgery: 17 %, abdominal sur-
gery: 8.3 %). The patient who did not receive an operation had congest-
ive heart failure.
The group using open face masks showed higher SpO2 (Mean: 97.8
± 0.47 % vs 97.5 ± 0.71 %, p < 0.01) and lower FICO2 (0.76 ± 0.16 % vs
2.00 ± 0.77 %, p < 0.01) and EtCO2 (35.5 ± 0.36 % vs 37.0 ± 0.78 %, p
< 0.01). The respiratory rate did not reveal any significant difference
(20.19 ± 0.75/min vs 20.85 ± 0.68/min, p = 0.15). Patient satisfaction
with the open face mask was superior to an ordinary oxygen mask
(VAS 2.42 ± 1.08 vs 3.25 ± 1.14, p < 0.01).
Conclusion Open face masks can provide better oxygenation and re-
duce CO2 rebreathing for the ICU patients in comparison with ordin-
ary masks.
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Introduction The peak expiratory flow (PEF) is a strong predictor of
success or failure of extubation. The risk of extubation failure for PEF
< 60 L/min is to 6.3 times higher than PEF > 60 L/min (1,2).
Objectives To evaluate the impact on extubation outcome of
prophylactic noninvasive assistance at extubation of patients with
weak cough, and to identify optimal device for assistance.
Fig. 136 (abstract A344).
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 181 of 607Methods Prospective collected database was conducted of from De-
cember 2014 to April 2016. Weak cough was defined by PEF < 60 L/min.
The PEF was measured with Cosmed Pony Graphic® spirometer v.4.0 S-
CZ before extubation, for the patients mechanically ventilated > 24 h,
and without tracheostomy, who passed successfully a sponyaneus
breathing trial (SBT) at least of 30 min of pressure support at 5-8 cmH2O,
CPAP, or T-T. The patients were then extubated regardless the PEF. The
patients with PEF > 60 L/min conventional oxygen therapy was applied,
and groups at risk of extubation failure (PEF < 60 L/min) was applied ran-
domly prophylactic CPAP, noninvasive ventilation (VNI BiLevel), or hu-
midified high flow nasal cannula (HFNC). Extubation failure was defined
by the need of reintubation within 48 h following extubation. We com-
pared both groups of patients according to the PEF, and prophylactic as-
sistance on groups patients with weak cough, on outcome extubation.
Continuous variables were expressed as mean ± SD or median (IRQ) and
categorical variables as absolute value and percentage. The comparison
of continuous variables was performed by Student t test and Mann-
Whitney test and comparison between categorical variables was per-
formed by Fisher's exact test and Chi-square test.
Results 137 patients were studied, 89 males (65 %). The two groups
of patients according to the PEF, were similar regarding age, APACHE
II, underlying chronic disease and duration of mechanical ventilation
before extubation. Prophylatic assistance was effectively applied to
72,1 % of patients with PEF < 60 L/min and 87,2 % for PEF > 60 L/
min. VNI was applied at 51,2 % (CPAP 18,6 % and BiLevel 32,6 %),
Optiflow® 48,8 %. No significant differences were found between the
prophylactic devices of assistance at risk group of extubation failure.
In the patients with PEF > 60 L/min, extubation failure rate was
12,8 %. There were not differences between diagnosis and extuba-
tion failure. Not differences in total stay in ICU between both groups.
Conclusions Prophylactic non invasive assistance at extubation could
reduce the risk of extubation failure in patients with a weak cough
strength without increasing length of stay. It's could be applied to
any mode and device (HFNC, CPAP or VNI).
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Introduction Numerous studies have shown that a weak cough
strength, if evaluated objectively before extubation by the measure
of peak cough expiratory flow (PCEF), is a strong predictor of extuba-
tion failure. However, reported cut-off values depend on the device
used for the measure. Measuring PCEF on the screen of the ventilator
by its flow sensor seems easy to perform, without disconnecting the
patient from the ventilator, and could provide a method available
everywhere at the bedside.
Objectives This prospective study aimed to compare the measure of
PCEF on the screen of the ventilator Servo i (Maquet, Solna, Sweden)
to the measure obtained with an electronic flowmeter, the Piko-1
(Ferraris Respiratory, Hertford, UK), whose accuracy to predict extuba-
tion outcome has been previously reported, with an optimal cut-off
value of 35 l/min [1].
Methods The PCEF was measured by the respiratory therapist just
before extubation for the patients mechanically ventilated for more
than 24 hours and who passed successfully a spontaneous breathing
trial of 30 minutes of pressure support at 8 cm H2O. The order of the
measures with the two devices was changed after inclusion of half ofthe patients. The best value obtained from two measures was kept
for the analysis.
Results Over one year 87 patients were eligible for the study; the
measure of PCEF was impossible to achieve because of lack of un-
derstanding in 14 patients (16 %). Among the 73 patients in-
cluded for the analysis, there was a significant correlation
between the measures obtained with the Piko-1 and the Servo i
(rs = 0.831; p < 0.01) (Fig. 135). The linear regression line obtained
predicts a cut-off value of PCEF on the Servo i at 60 l/min, corre-
sponding to the value at 35 l/min previously determined with the
Piko-1 [1].
Conclusions The measure of PCEF just before extubation on the
screen of the ventilator Servo i is easy to perform and well cor-
related with the measure performed by an electronic flowmeter
Piko-1. This allows to propose a cut-off value of 60 l/min with
the ventilator, below which the cough strength may be judged
as weak.
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Introduction Non-invasive ventilation (NIV) is the first option for the
treatment of cystic fibrosis (CF) patients with acute exacerbation.
High flow nasal oxygen cannula (HFNC) is a heated humidified, high
flow oxygen delivery system that has demonstrated benefits in terms
of survival in patients with acute hypoxemic respiratory failure and in
preventing postextubation failure. This device may also have benefits
in patients with hypercapneic respiratory failure including CF pa-
tients. We hypothesize that HFNC would not be inferior to NIV in
terms of reducing work of breathing and improving breathing pat-
tern in CF patients requiring ventilator support.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 182 of 607Objectives To compare HFNC vs. NIV induced changes in inspiratory
work of breathing assessed by the thickening fraction of the dia-
phragm (TFdi), and breathing pattern, hemodynamics, dyspnea and
comfort.
Methods CF patients with acute exacerbation requiring ventilator
support were ventilated with HFNC and NIV for 30 minutes in
random order. TFdi was measured using ultrasound at baseline
and at 25 minutes with each device. Pulse oximetry (SpO2), trans-
cutaneous CO2 (PtcCO2) were continuously recorded and respira-
tory rate, tidal volume (VT) and minute ventilation (MV) measured
by bio-impedance techniques; hemodynamics, dyspnea and com-
fort assessed by visual analog scales were also recorded. Results
were compared using a Mann Whitney, 2 tailed test, and are
expressed as mean (SD) with each intervention compared to
baseline conditions.
Results 12 patients were enrolled (mean age 31.3 years, mean FEV1/
FVC 49.9 %, mean FEV1 28.4 % predicted). TFdi was similar with the
two techniques, but HFNC, compared to NIV, resulted in a significant
decrease in respiratory rate (-20.2 % (18.0) vs -0.2 % (18.7), p = 0.024)
and a lower mean arterial pressure (0.3 % (5.6) vs 5.8 % (4.9), p =
0.017). No significant differences were found in heart rate, SpO2,
PtcCO2, VT, MV, comfort and dyspnea (Table 111).
Conclusions HFNC was not inferior to NIV with respect to diaphrag-
matic work in CF patients who had an indication for ventilator sup-
port. These preliminary data suggest that HFNC may confer
physiological benefits by decreasing respiratory rate, and constitute
an interesting alternative to NIV.
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HFNC; Mean (SD) NIV; Mean (SD) p-value
Thickening fraction of the
diaphragm
-1.8 (32.7) -2.0 (32.8) 0.880
Respiratory rate -20.2 (18.0) -0.2 (18.7) 0.024
SpO2 1.5 (3.2) 0.3 (2.9) 0.450
PtcCO2 1.2 (4.7) 0.8 (4.0) 0.667
Minute ventilation -17.7 (33.2) -11.3 (23.1) 0.627
Mean arterial pressure 0.3 (5.6) 5.8 (4.9) 0.019
Heart rate -3.8 (5.7) -3.7 (4.4) 0.793
Dyspnea 11.1 (63.0) -11.1 (42.8) 0.338
Comfort -22.9 (13.9) -15.8 (27.6) 0.310A346
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Introduction The washout effect of HFNC has not been well evalu-
ated. Our prior study, presented at the ESICM congress 2014, evalu-
ated the reduction of PETCO2 with HFNC using a tracheal intubation
trainer and a test lung. Although we concluded that the washout ef-
fect is most effective with a relatively low flow, the model had a
large upper airway dead space of 200 mL, which was thought to
have influenced PETCO2. We also were not able to measure PEEP,
which is also thought to have interaction between HFNC flows.
Therefore, we developed a more sophisticated artificial respiratory
model using a 3D printer, and used a lung model equipped with a
pressure sensor to quantitatively evaluate the washout effect of
HFNC and the interaction with PEEP.
Objectives To quantitatively evaluate the washout effect and inter-
action with PEEP using different levels of HFNC flow.
Methods The airway model was made by a 3D printer using the
craniocervical CT data of a healthy 32-year-old male. The total
anatomical dead space was adjusted to 180 mL (3 mL/kg). The
model lung (LUNGOO : Air water safety service Inc., Kobe, Japan)
had the following settings: normal (Compliance (C) 50 ml/cmH2O,
resistance (R) 5 cmH2O/L/s, tidal volume (Vt) of 500 mL, respira-
tory rate (RR) 16 /min), obstructive (C 70, R 20, Vt 700, RR 10), re-
strictive (C 30, R 5, Vt 300, RR 30) with inspiratory time at
1 second, and residual volume of 1000 mL. CO2 was infused into
respiratory lung models to reach PETCO2 of 40 mmHg without
HFNC. After setting PETCO2 with each lung model, HFNC with
flows of 10 to 60 L/min were applied and the change in PETCO2
in the subglottic area and the inlet of the lung model was mea-
sured. PEEP inside the model was also recorded.
Results With the normal lung open-mouth model, 10 L/min of
HFNC flow decreased the PETCO2 of the subglottic area and the
inlet in a lung model to 30 mmHg. Increasing HFNC flow did not
decrease PETCO2 in either area. With the normal lung closed-
mouth model, PETCO2 of all sites required a HFNC flow of 40 L/
min to decrease, and reached 30 mmHg with HFNC flow of 60 L/
min. With the obstructive lung open mouth model, PETCO2 of all
sites had the same trends as the normal lung open-mouth
model. With the restrictive lung open mouth model, 20 L/min of
HFNC flow decreased the PETCO2 of the subglottic area and the
inlet to 25 mmHg, and did not decrease thereafter. As HFNC flow
was increased, PEEP gradually generated up to around 8 to 5 cm
H2O with open mouth models and up to 17 cmH2O with the nor-
mal lung closed mouth model.
Conclusions The washout effect of HFNC is thought to reduce the
PETCO2 enough to have a clinical effect. Contrary to the relation of
HFNC flow and generated PEEP, the HFNC reduced PETCO2 with a
relatively low flow in open mouth models. HFNC required more flow
to reduce PETCO2 with a closed mouth model, which is thought to
be due to a less efficient washing out of the dead space than in the
open model.
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Fig. 137 (abstract A346). Relation of PETCO2, PEEP and HFNC flows
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Introduction Clinical frailty is increasingly used and recognised to
predict mortality and functional dependence following critical admis-
sion1 although less is known regarding its impact on specific patient
groups. Bilevel noninvasive ventilation (NIV) is frequently used to
treat acute respiratory failure (ARF) of various aetiologies. Whilst NIV
is known to be beneficial in exacerbations of COPD2, acute cardio-
genic pulmonary oedema3 and other presentations of ARF, there is
scarce data available on the impact frailty may have on the success
of NIV in this patient group.
Objective We examined the impact of frailty score on outcomes in
patients receiving NIV for mixed aetiology of ARF within our critical
care (CC) unit.
Methods Case notes and electronic patient data records (Metavisio-
n,iMDsoft,MA,USA) were retrospectively reviewed for adult patients
with ARF who received NIV between December 2011 and April 2013.
Patients who received continuous positive airway pressure and those
with a primary surgical problem were excluded. Patient frailty score
was recorded on admission using the Rockwood frailty index in on
55 consecutive patients. Demographic data, body mass index (BMI),
primary cause of ARF and hospital mortality were recorded.Patients
were divided into two groups according to their frailty score: below
4 (very fit to vulnerable) and 5 and above (frail to severely frail).
Results 55 patients were identified. 44 % were male, mean age
63 years. Presenting diagnosis was pneumonia in 32 patients (58 %)
and acute exacerbation of COPD in 13 patients (23 %). The overall
CC survival rate was 84 % with 73 % surviving to hospital discharge.
31 patients had a frailty score of 5 or above (77 % male, mean age
66 years) and 24 patients had a frailty score of 4 or less (50 % male,
mean age of 62 years). Patients with a lower frailty score had a
higher overall survival rate (91 % on CC and 83 % to hospital dis-
charge) compared to those with a higher frailty score (70 % on CC
and 51 % to hospital discharge). The mean BMI for both groups was
identical (30.5 kg/m2). There were no differences in the mean lengthof stay in CC or in hospital or duration of NIV use between the two
groups.
Conclusion Our data suggests that a Rockwood frailty score of 5 or
above is associated with reduced CC and hospital survival in patients
with ARF requiring NIV. Use of a frailty index may be a useful predict-
ive marker in patients admitted to critical care and further work is
warranted to define the prognostic value of frailty scoring.
References
1. Le Maguet, P.et al. Prevalence and impact of frailty on mortality in elderly
ICU patients: a prospective, multicenter, observational study. Intensive
Care Med, 2014.4(5):p.674-82.
2. Roberts, C.M.et al. Acidosis, non-invasive ventilation and mortality in hos-
pitalised COPD exacerbations. Thorax, 2011.66(1):p.43-8.
3. Masip, J.et al. Noninvasive ventilation in acute cardiogenic pulmonary
edema: systematic review and meta-analysis. JAMA, 2005.294(24):p.3124-30.
A348
Has the high flow therapy changed our approach to the acute
respiratory failure?
J. Higuera Lucas, A. Blandino Ortiz, D. Cabestrero Alonso, R. De Pablo
Sánchez, L. Rey González
Hospital Universitario Ramón y Cajal, Unidad de Cuidados Intensivos,
Madrid, Spain
Correspondence: A. Blandino Ortiz – Hospital Universitario Ramón y
Cajal, Unidad de Cuidados Intensivos, Madrid, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A348
Introduction The use of high flow therapy in the critical care units
for adults is becoming more common from few years on. This ther-
apy approaches the patient with acute respiratory failure from a new
way of treatment.
Objectives Our goal is to analyze the impact and the results of the
application of high flow therapy in an intensive care unit of a tertiary
hospital. Evaluate if the use of such a therapy has avoided the use of
mechanical ventilation in the patients.
Materials and methods The study has summarized all the patients
that have been treated with the oxygen therapy treatment between
May 2013-October 2015. The reviewed data has been: SOFA, APACHE II,
SAPS II, tabulated diagnosis, etiology of the respiratory failure, length of
stay, use of high flow before or after the intubation, evaluate if the in-
tubation has been avoided, mortality and mortality in 30 days.
Results The study includes 113 patients, medium average age 58,
men 56.5 %,and women 43.5 %. The severity indexes of the study
are: SOFA 8,37 ± 4,44(1-19), APACHE II 19,68 ± 8,75(3-44), SAPS2
49,31 ± 20,59(11-95). The average stay of the patients is 14,70 days.
The origin of the disease is respiratory in the 55 % of the causes,
hematological 22 %, septic 14,5 %, cardiologic 3,8 % and miscellan-
eous in all the rest.
The cause of the ventilation decompensate has been:respiratory
77,1 %, septic 16,8 %, and miscellaneous in all the other cases. The
causes of the respiratory failure have been hypoxemic in the 75,6 % of
the cases, hipercapnic in the 1,5 % and mixed causes in the rest.
42,7 % of the times high flow therapy is provided before the mechan-
ical ventilation. 19,8 % of the times after the mechanical ventilation.
It is considered that avoids mechanical ventilation in 43,5 % of the
cases.
Applying non parametrical test the group of patients that needs
mechanical ventilation has a higher mortality (p < 0, 0001)
Conclusions The use of high flow therapy has changed the attitude
towards the patients with insufficiency respiratory diseases avoiding
in many cases the use of mechanical ventilation.
More controlled studies are needed showing which other patients
can be beneficed by the high flow therapy to prevent the delays in
the start of mechanical ventilation.
References
[1] Williams R, Rankin N, Smith T, Galler D, Seakins P. Relationes-hip between
the humidity and temperature of inspired gas and the function of the
airway mucosa. Crit Care Med.1996; 24:1920-9
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 184 of 607[2] Williams AB, Ritchie JE, Gerard C. Evaluation of a high-flownasal oxygen
delivery system: Gas analysis and pharyngeal presure. Intensive Care Med.
2006;32 (S1):S219
[3] Groves N, Tobin A. High flow nasal oxygen generates positive air-way
pressure in adult volunteers. Aus Crit. Care2007;20:126-31
[4] Sztrymf B, Messika J, Mayot T, Lenglet H, Dreyfuss D, Ricard JD. Impact of
high flow nasal cannula oxygen therapy on intensive care unit pacients
with acute respiratory failure: A prospective observacional study. J Crit.
Care.2012;27:324,e9-13
A349
Comparative evaluation of three full face masks for delivering NIV
R. Costa, G. Spinazzola, A. Pizza, G. Ferrone, M. Rossi, M. Antonelli, G. Conti
Catholic University of Rome, Department of Anesthesia and Intensive
Care, Rome, Italy
Correspondence: R. Costa – Catholic University of Rome, Department
of Anesthesia and Intensive Care, Rome, Italy
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A349
Introduction Full face masks have been proposed to improve patient
comfort during NIV and thus increase NIV success.
Objectives To compare three full Face masks (FF) (Dimax, Dimar,
Italy; Performax, Respironics,US and BiTrac, Pulmodyne, US).
Methods An adult mannequin, connected to an active lung simulator
(Compliance : 60 ml/cmH2O; Respiratory Resistances : 4 cmH2O/L/sec)
breathing at 20 and 30 breaths/minute was ventilated with the three
FF in Pressure Support (PS 10 and 15 cmH2O, PEEP 8 cmH2O) with a
fast pressurization ramp (100 %) and 2 expiratory triggers (25 %,
50 %). The data analysis evaluated Patient-ventilator interaction
(Delaytrinsp, Delaytrexp, Timesync) and masks performance (Swingtrig-
ger, PTPt, PTP300, PTP500 Index).
Results At RR 20, Timesync was longer with FF-Pulmo and FF-Dimar,
while, at RR 30, no significant difference was found between the
masks. FF-Dimar and FF-Respir significantly increased Swingtrigger and
PTPt at RR 20, but both FF showed a better performance in terms of
PTP300. No significant difference was found in terms of PTP500 Index.
Conclusions Independently from the setting, all FF guaranteed a
Timesync above 50 % of the neural inspiratory time. The different
shape and material of the FF significantly influenced our results:
softer flange and the need for less head-strips tightness required by
FF-Dimar caused an initial pressure dissipation with longer Delaytrinsp,
Swingtrigger and PTPt. Conversely, the need to strongly pull the head-
strips with FF-Pulmo to reduce leaks, explained its superior perform-
ance and interaction.
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Introduction Venous Thromboembolism encompasses deep venous
thrombosis (DVT) and pulmonary embolism (PE) and has a significant
impact on morbidity and mortality, being responsible for more than
370000 deaths every year in 6 European countries. Nowadays, clinicalscores and diagnostic non-invasive techniques have improved diag-
nosis and early treatment: anticoagulant and thrombolytic therapy.
Objectives To characterize patients admitted to Intermediate Care
Unit (ICU) due to PE and submitted to thrombolytic therapy.
Methods Retrospective observational study of patients admitted due
to PE in the ICU between January 2013 and December 2015. Data
was collected and analysed with SPSS and descriptive and analytic
statistic were performed. A value of p ≤ 0,05 was considered statisti-
cally significant.
Results During 3 years, 82 patients (51 female, median age 69,5, ran-
ging from 24 to 89, 48 with more than 65 years) were admitted due
to PE, more frequently from the Emergency Service (86,6 %).The
most common symptoms were dyspnea (61 %), chest pain (50 %)
and syncope (24,4 %) and 54 patients were classified as low probabil-
ity PE using Wells Criteria. Computed Tomography was positive in
97,6 % of patients. Using Pulmonary Embolism Severity Index (PESI)
Score, 9 patients had very low risk score (mean age 40,4 ± 7,1 years),
13 low risk (mean age 50 ± 16,9 years), 26 moderate risk (mean age
70,4 ± 10,3 years), 14 high risk (mean age 71,4 ± 12,6 years)and 18
very high risk score (mean age 72,6 ± 14,2 years). Age was different
between PESI Score classes (p < 0,001). The most common DVT risk
factors were age, peripheral venous insufficiency (24,4 %), obesity
(23,2 %), previous immobilization (17,1 %). In the ICU, 10 patients
were admitted due to massive PE, 23 submassive PE, 11 due to hyp-
oxemia and 23 for other reasons, more frequently due to the need
constant monitoring. DVT was confirmed in 17 patients. Thrombolytic
therapy was administered to 29 patients (13 submassive PE; 13
massive PE), 3 with registered complications (haemoptysis, haema-
turia and multiple hematomas and skin haemorrhage). Ventilation
and vasopressor support were needed in 7,3 %. One patient was
transferred to Intensive Care Unit; 1 died in ICU, 2 after discharge of
ICU and 2 in the next 6 months.
Conclusions Age is an important risk factor in patients admitted to
ICU. Although 21 patients were classified as low/very low risk patients
they were clinically unstable, had cardiac repercussion or needed con-
stant monitoring. These patients were younger, with less comorbidities
and with better physiological condition that may have underestimated
PESI Score. This study highlights the importance of individualized and
clinical evaluation, early therapy and the low rate of complications in
patients submitted to thrombolytic therapy.A351
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Introduction Complex factors in ICU survivors such as health literacy,
socioeconomic status and social environment may be predictive of ad-
verse outcomes following hospital discharge but are not well studied.
Objectives We hypothesized that Medicaid Insurance, a proxy for
individual low socioeconomic status, would be associated with
increased hospital readmission rates following hospital discharge.
Table 112 (abstract A352). Demographics & scores
LOS prior to ICU admission (days)
0–7 8–14 15–21 21–28 >28
Number of patients 3872 216 93 55 104
Age (years) 56.0 (sd 19.1) 62.8 (sd 15.5) 61.1 (sd 15.1) 60.5 (sd 16.0) 63.2 (sd 14.3)
APACHE II score 14.5 (sd 6.9) 17.5 (sd 7.4) 17.7 (sd 7.0) 18.1 (sd 7.7) 18.4 (sd 6.9)
APACHE II probability of death (%) 18.0 (sd 20.9) 24.1 (sd 22.3) 26.0 (sd 21.7) 24.2 (sd 24.1) 26.2 (sd 22.8)
ICNARC Score 13.9 (sd 8.7) 15.4 (sd 8.6) 15.4 (sd 9.1) 16.9 (sd 9.5) 15.5 (sd 8.5)
ICNARC mortality probability (%) 15.6% 20.9% 20.3% 24.3% 21.4%
Outreach involvement (%) 7.6% 26.4% 29.0% 43.6% 45.2%
LOS on ICU (days) 6.5 (sd 14.3) 8.2 (sd 16.0) 7.3 (sd 11.1) 10.8 (sd 22.3) 11.5 (sd 24.3)
LOS hospital (days) 20.9 (sd 27.1) 43.8 (sd 40.2) 51.3 (sd 41.6) 54.8 (sd 27.5) 108.7 (sd 70.3)
Fig. 138 (abstract A352). ICU Mortality vs Preceding ward Length
of stay
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 185 of 607Methods We performed a two center observational study of
patients treated in medical and surgical intensive care units in
Boston, Massachusetts. We studied 82,583 patients, age ≥ 18 years,
who received critical care between 1998 and 2012 and survived
hospitalization. The exposure of interest was Medicaid Insurance
status. The primary outcome was unplanned 30-day hospital re-
admission. Adjusted odds ratios were estimated by multivariable
logistic regression models with inclusion of covariate terms for
gender, race, Deyo-Charlson index, type (surgical vs. medical),
sepsis, acute organ failure, area deprivation index (proxy for area
socioeconomic status and social environment) and age as a re-
stricted cubic spline function. In a subset admitted to Spaulding
Rehabilitation Hospital following hospital discharge, (n = 4,232) we
evaluated the association of Medicaid Insurance status and re-
habilitation hospital length of stay utilizing a negative binomial
regression model.
Results The cohort patients were 58 % male, 20 % nonwhite and
51 % surgical. 10 % of the cohort had sepsis and the mean age was
61.2 years. Medicaid Insurance was present in 10 %. Those with
Medicaid Insurance were significantly younger, more frequently
non-white, with higher sepsis and acute lung injury rates. Un-
planned 30-day readmission rate was 14.1 %. 33.1 % were dis-
charged to a care facility. 90-day post-discharge mortality was
6.5 % in patients with Medicaid Insurance and 7.3 % in patients
without. Medicaid Insurance was a robust predictor of 30-day hos-
pital readmission and remained so following multivariable adjust-
ment. Patients with Medicaid Insurance have an adjusted OR of 30-
day readmission of 1.31 (95%CI, 1.22-1.41; P < 0.001) relative to
patients without Medicaid Insurance. Further, patients with Medic-
aid Insurance have an adjusted OR for discharge to a care facility of
1.34 (95%CI, 1.26-1.42; P < 0.001) relative to patients without
Medicaid Insurance. Finally, patients with Medicaid Insurance com-
pared to those without Medicaid Insurance, are expected to have a
1.2 fold times greater rehabilitation hospital length of stay [ad-
justed IRR = 1.21 (95%CI 1.11, 1.32) P < 0.001].
Conclusions In critical illness survivors, individual socioeconomic
status as reflected by Medicaid Insurance is a robust predictor of
hospital readmission, placement in a care facility and rehabilita-
tion length of stay. Disparities in ICU survivor outcomes are likely
multifactorial involving individual, acute illness, hospital, post-
hospital, and neighborhood-level factors that alter optimum post
ICU recovery.
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Introduction Prolonged hospital stay prior to admission to the inten-
sive care unit has been shown to be independently associated with
poorer outcome (1,2). Even a few hour delay in transfer from emer-
gency department to intensive care worsens outcome (3). This may
relate to an ongoing deterioration of physiological function while in
hospital, potentially influenced by the process or disease state that
culminates in admission to critical care.
We investigated whether common illness severity scores e.g. Acute
Physiology and Chronic Health Evaluation II (APACHE II) or Intensive
Care National Audit & Research Centre (ICNARC), are significantly dif-
ferent in patients admitted after a prolonged ward stay. We describe
mortality and ICU / hospital length of stay in said patients, in an
order to elucidate predictors for outcome.
Objectives Show higher length of stay before ICU admission as an in-
dependent predictor of outcome
· Identify whether ICU scoring systems predict outcome in our
population· Identify whether serum albumin or other surrogate marker of frailty
(e.g. Creatinine) can help predict outcome?
Methods Retrospective analysis of prospectively collected data of all
admissions in ICNARC database to 44 bed adult critical care unit in
University Associated London Major Trauma Centre over two-year
period (1st January 2013 - 31st December 2014).
Demographic data, APACHE II, ICNARC score, ICU mortality, and
length of stay on ward preceding ICU, within ICU and overall hospital
length of stay were collected. Data was analyzed using ANOVA tests,
according to preceding ward length of stay.
RESULTS. n = 4340
Mean APACHE 2 score for all admissions was 14.88 (sd 7.0)
P < 0.01 ANOVA comparing Length of ICU stay between 0-7 and
>28 days.
P < 0.01 ANOVA comparing APACHE2 across all ward LOS groups.
P < 0.01 ANOVA comparing serum albumin across ward LOS 0-7 days
vs >28 days, and non significant across other groups.
Conclusions Prolonged pre-ICU hospital admission is associated with
longer ICU and hospital admission and generally higher ICU mortal-
ity. APACHE2 scoring and serum albumin predict outcome.
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Introduction A historical cohort study of patients who received
Extra-corporeal membrane oxygenation (ECMO) in ICU of a regional
hospital.
Objectives To compare the clinical outcomes between in-house
ECMO patients and inter-hospital retrieval ECMO patients.
Methods Primary outcome was the ICU mortality rate between in-
house and inter-hospital retrieved ECMO patients. Mann-Whitney U
tests and Fisher's exact tests were used for comparisons of continu-
ous and categorical variables respectively. 2-tailed p-values < 0.05
represented statistical significance.
Results Between 2009 to 2015, 112 patients received ECMO. Among
them, 101 patients (77 VV-ECMO, 24 VA-ECMO) with complete data
for further analysis. Overall mortality rate was 40/101 (39.6 %). Mean
Acute Physiology and Chronic Health Evaluation (APACHE) II scores
were 30.03 for in-house ECMO vs. 30.80 for inter-hospital retrieval
ECMO (p = 0.774).
For those patients who received ECMO for respiratory support
(VV-ECMO, n = 77), their mean Respiratory Extracorporeal Mem-
brane Oxygenation Survival Prediction (RESP) score (3.64 vs. 3.03,
p = 0.060) and ICU mortality (34.8 % vs. 19.4 %, p = 0.199) were
not significantly different between in-house and retrieved cases.
Predicted hospital survival for RESP score risk classe II (score 3 to
5) was 76 %.
For those patients who received ECMO for circulatory support (VA-
ECMO, n = 24), their mean Survival After Veno-arterial-ECMO (SAVE)
score (-7.2 vs. -2.75, p = 0.304) and ICU mortality (86.7 % vs. 55.6 %,
p = 0.150) were not significantly different between in-house and re-
trieved cases. Predicted hospital survival for SAVE score risk class IV
(score -9 to -5) and class III (score -4 to 0) were 30 % and 18 %
respectively.
For in-house ECMO patients, higher proportions of non-infective aeti-
ologies for VV-ECMO (RESP score) and post-MI cariogenic shock for
VA-ECMO were observed. These conditions have poorer prognosis
and lower reversibility, which may account for the poorer RESP/SAVE
scores (though statistically insignificant) and higher predicted and
observed mortality.
Conclusions Our findings did not show a statistically significant dif-
ference in ICU mortality rate between in-house and retrieval ECMOgroups. Inter-hospital ECMO retrieval is feasible for further develop-
ment. The RESP score and SAVE score systems provides a tool for
monitoring of our centre´s performance in comparison to ECMO cen-
tres worldwide.
References
1. Schmidt M, et al.; Survival after Extracorporeal Membrane Oxygenation
for Severe Acute Respiratory Failure - The Respiratory Extracorporeal
Membrane Oxygenation Survival Prediction (RESP) Score. Am J Respir Crit
Care Med Vol 189, Iss 11, pp 1374-1382
2. Schmidt M, et al.; Predicting survival after ECMO for refractory
cardiogenic shock: the survival after veno-arterial-ECMO (SAVE) score.
European Heart Journal First published online: 1 June 2015
Grant acknowledgment
None.
A354
Evaluation of outcome from intensive care units in turkey: a
prevalence study
C. Kaymak1, N. Okumus2, A. Sari2, B. Erdogdu2, S. Aksun2, H. Basar1, A.
Ozcan1, N. Ozcan1, D. Oztuna3
1Ministry of Health, Ankara Training and Research Hospital,
Anesthesiology and Reanimation Department, Intensive Care Unit,
Ankara, Turkey; 2Ministry of Health, Departmant of Health Services,
Ankara, Turkey; 3University of Ankara, Faculty of Medicine, Medical
Biostatistics Department, Ankara, Turkey
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A354
Correspondence: C. Kaymak – Ministry of Health, Ankara Training and
Research Hospital, Anesthesiology and Reanimation Department,
Intensive Care Unit, Ankara, Turkey
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A354
Introduction The outcome in critically ill patients regarded with
prognosis has many background effects of risk factors. An aging
population and chronic diseases may also result in an increased
number of patients in intensive care unit (ICU). Clinical results have
revealed the need for outcome examination and guidance on the ef-
fective use of ICU.
Objectives The aim of this study was to evaluate mortality among
patients in Turkish ICUs. Regarding this, the present study analyzed
APACHE II databases in critically ill patients at secondary and tertiary
referral hospital ICUs in Turkey.
Methods During the study period, clinical data that were collected
concurrently for each patient contained demographic details, diag-
nostic category leading to ICU admission and APACHE II scores fol-
lowing ICU admission. Patients were followed up during ICU stay.
The equation coefficients for APACHE II were supplied by APACHE
Medical Systems. The mortality in intensive care units was analyzed
according to APACHE II scores. The other attempts performed during
ICU stay were also recorded.
Results 13.313 patients were enrolled in this study. The 69.9 % of pa-
tients were > 60 years old and 53.8 % of them were male. The mean
APACHE II score was 21.49. The ICU's mortality rate was 44.5 %. The
mechanical ventilation was determined as the most performed at-
tempt in ICU's with a ratio of 55.9 %. The ratio of central venous
catheterization was found 53.5 %. The ratios of systemic infection
and antibiotic administration were 63.6 % and 80.7 %, respectively.
Conclusion In the present study, the patients hospitalized in ICU's of
ministry, university, and private hospitals were analyzed all over
Turkey. Early identification of patients at risk, both before admission
and after discharge from ICU, may allow to prevent some of the
physiologic abnormalities contributing to the APACHE II score. There
was a wide difference in outcome for patients admitted to different
ICU's by using risk adjustment methods.
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Introduction Growing interest in the long-term effects after critical
care has formed investigator-led clinical research groups around the
world. Work aiming at standardizing core outcome measures and in-
struments for randomized clinical trials is ongoing. Whether these
outcome measures reflect the domains most valued by patients or if
important issues are missing from the existing scales is unclear. Com-
monly used tools like SF-36 and EQ-5D are too unspecific.
Objectives To develop and validate a questionnaire for patient-reported
outcome measures (PROM) after critical care.
Methods During a 24-months qualitative phase, 35 former ICU-patients
were interviewed in a semi-structured way, providing detailed informa-
tion on symptoms and difficulties in all areas of everyday life. Patients
were recruited from the post-ICU clinic at Sahlgrenska University Hos-
pital, covering both urban and rural areas. The interviews were recorded,
transcribed, and issues were categorized into 13 hypothesized domains:
cognitive, executive/fatigue, physical health, pain, mental health, daily
activities, sleep, food/drink/smoking, sexuality, hearing/visual/dysphagia,
intestinal and urinary problems, and return to work/financial situation.
After searching the literature and commonly used assessment tools,
additional issues were included. All issues were then rephrased into
questions, with care taken to maintain only one conceptual entity per
question, and with the recall period usually being the last month.
Adequate scales for frequency, intensity and duration were used. All
questions were validated face-to-face with another set of former ICU-
patients and with non-ICU-treated controls to make sure the wording
was easily understood and neither confusing nor upsetting.
Results The questionnaire contains 271 questions. It is currently be-
ing tested in a pilot study with 650 patients, recruited six months to
three years after discharge from the ICU, and 200 controls, matched
for age and gender. The questionnaire is sent by mail after an invita-
tion letter followed by a phone call, and returned in a pre-stamped
envelope. Returned questionnaires are being scanned and data digit-
ally imported into SPSS, where additional clinical data will be added.
After comparison with controls, item reduction will follow, resulting
in an ICU-specific PROM questionnaire.
Conclusions A patient-centred, ICU-specific questionnaire will be
available for long-term follow-up in the post-ICU clinic. Being a
postal document, the patients do not have to return to the hospital
to provide their information, making it and suitable for large-scale
studies.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A356Introduction Approximately 2000 oesophagogasterectomies are per-
formed each year, with a 5 year survival of 25 % and 30 day mortality
of 10 %1. Secondary analysis of ICNARC data has shown the median
length of stay to be 2.8 days, and a readmission rate of 12.2 %2. We
conducted a retrospective review of all post Oesophagogastrectomies
ICU admissions in our hospital between Jan 2014-15, as part of a quality
improvement project to reduce morbidity and length of stay (LOS).
Objective To analyse the electronic record and chest Xray of every
oesophagogastrectomy in order to compare our own LOS, patient
characteristics and identify factors affecting LOS and unit morbidity.
Method We analysed the electronic case record for each open or min-
imal access oesophagogastrectomy patient. Data was gathered on age,
gender, analgesic method, pain scores, analgesia failure, vasopressor
use, highest arterial lactate within 24 h, unit LOS and readmission rates.
Results 42 patients were identified; 77 % male and median age 64.4.
25/42 (58 %) of patients had a combination of epidural and paraverteb-
ral analgesia, 17/42 (40 %) epidural alone and 1/42 (2 %) paravertebral
alone. Median pain score on D1 was 1.4 (0-3). There was a 13/42 (30 %)
epidural failure rate, 10 disconnections and 3 never effective.
Vasopressors were used on D1 in 28/42 (67 %) patients. Median base
excess on D1 was -1 (0-5.1) and median lactate on D1 was 1.93 (0.1-5).
Unit LOS had a range of 3-52 days (median 6 days).
Combinations of collapse and atelectasis were identified in 26/42
(62 %) patients on review of CXR, with one apical pneumothorax.
Conclusion Epidural disconnection rate was very high, contributing
to a longer unit LOS than national average and higher pain scores.
We have introduced a training package on epidural care for our
nurses and encouraged the use of tunnelled epidurals in combin-
ation with paravertebral catheters.
The incidence of CXR changes after surgery in this cohort has not
been studied previously. A large proportion of our patients had
radiologically apparent collapse and even consolidation on arrival on
ICU. This may contribute to the development of pneumonia in this
setting if analgesia is imperfect as CPAP is relatively contraindicated
due to the oesophageal anastomosis. We now encourage a longer
period in recovery, with lung toilet and recruitment manoeuvres at
the end of one-lung ventilation.
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Introduction Placement of tracheostomy is commonly thought to
allow a more secure and manageable airway and to facilitate weaning
from mechanical ventilation. However, current literature suggests that
tracheostomy has no impact on survival in unselected ICU patients, and
it only transfers the mortality from the ICU to the ward. Moreover, in
many circumstances tracheostomies are placed in patients who are at
the end of their lives with little hope of meaningful recovery.
Objectives To describe main characteristics and outcomes of tra-
cheostomized patients discharged from ICU to ward in a public
hospital.
Table 113 (abstract A358). Results
Readmitted
(Group 1)
Not readmitted
(Group 2)
p value (NS =
Not significant)
Hospital mortality 100 (36.1) 1889 (26.4%) 0.008
Unit mortality 60 (21.6%) 1351 (18.9%) NS
Mech. Vent 144 (51.9%) 3433 (48.1%) NS
RRT 39 (14.1%) 1107 (15.5%) NS
MRSA 20 (7.2%) 243 (3.4%) 0.002
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 188 of 607Methods A retrospective descriptive study was conducted to analyze
data from the electronic medical record. The setting was four adult
medical-surgical ICUs (44 beds) in a tertiary care public hospital in
southern Brazil. Data from 71 adult subjects who underwent a
tracheostomy as part of their ICU management and were subse-
quently transferred to ward were obtained. Individuals who died at
ICU during first admission were excluded. Demographic data, diagno-
ses on admission, comorbidities, duration of mechanical ventilation,
ICU length of stay, end-of-life decisions and mortality were recorded.
Results From January to December 2015, 104 subjects received
tracheostomy. Thirty-two died during their initial ICU admission
(30.4 %) and therefore were excluded of analysis. Of the
remaining 73 individuals, twenty-eight died (38.3 %), and only
four of whom were readmitted to the ICU within 48 hours of dis-
charge. Mean age was 56.9 ± 17.7 years, 52.1 % were male and
mean APACHE II score was 21.6 ± 6.8 points. Chronic neurologic
disorders and cancer were main comorbidities (21.1 % and 14 %,
respectively). Most common diagnosis were sepsis (33.8 %) and
neurological emergencies (stroke, intracerebral hemorrhage,
meningitis) [23.9 %]. Length of ICU stay was 30.7 ± 17 days and
duration of mechanical ventilation was 23 (13 - 29) days. Life-
sustaining treatments were withheld or withdrawn in twenty-five
decedents. Seven subjects died in posterior hospitalizations at our
institution over the period recorded.
Conclusions Tracheostomy may represent a burden after ICU dis-
charge, requiring high resource use and low survival rate. Indication
for tracheostomy should be cautious, and efforts should be made to
recognize patients who might clearly benefit from this technique to
avoid unnecessary and unwanted prolonged mechanical ventilation.
All the decisions we make in the ICU do have an important impact
on future care needs. Knowledge of characteristics and outcomes
may assist in identifying interventions to reduce the need for trache-
ostomy or improve outcomes.A358
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Introduction Readmission to Intensive Care during the same hospital
admission has been shown to be associated with a higher risk of
mortality (1,2).
Objectives To determine the readmission rate over a ten year period
and subsequently analyse any effect this may have on mortality,
length of ICU stay and whether readmission to ICU requires higher
levels of care.
Methods Retrospective analysis of our electronic patient informa-
tion system for admissions from 2005 to 2016. Patients under
18 years old were excluded. Data collected included: mean age,
mean stay, proportions of ventilated patients, patients com-
menced on RRT, unit mortality, hospital mortality and MRSA sta-
tus. The two patient groups were compared: patients readmitted
to ICU within their hospital admission (Group 1), and those pa-
tients who were not readmitted (Group 2).
Results 7422 patients were identified in the 10-year period; 277 in
Group 1 (3.7 %) and 7145 in Group 2 (96.3 %). Mean age in Group 1
was 64 compared to 61 in Group 2. Mean stay was 7.1 days and
5.3 days respectively.
Conclusions Patients readmitted to ICU during their hospital stay
were at significantly increased risk of dying in hospital, but not ICU
itself. MRSA is more likely to be detected in patients who are re-
admitted to ICU. Further work should be carried out to investigate
patients readmitted more thoroughly, with an aim of identifying pa-
tients most at risk of readmission and strategies to prevent readmis-
sion and improve discharge planning.References
1. Patients readmitted to the intensive care unit during the same
hospitalization: Clinical features and outcomes. Chen LM et al. Critical
Care Medicine: Nov 1998. Volume 26(11). pp1834-1841
2. Critically ill patients readmitted to intensive care units—lessons to learn?
Metnitz PGH et al. Intensive Care Medicine. Feb 2003, Volume 29(2). pp
241-248A359
Pancreatitis in the west of Scotland intensive care population over
a 20 year period
G. Carroll, L. Gemmell, A. MacKay, C. Wright, J. Ballantyne
Queen Elizabeth University hospital, Anaesthetics and Intensive Care,
Glasgow, United Kingdom
Correspondence: G. Carroll – Queen Elizabeth University hospital,
Anaesthetics and Intensive Care, Glasgow, United Kingdom
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A359
Introduction Pancreatitis is a common precipitant of critical illness
and intensive care admission. Mortality from pancreatitis overall
should be under 10 % and in severe pancreatitis under 30 % (1).
Mortality risk is mulit-factorial but those at high risk are co-morbid,
elderly, develop SIRS or progress to pancreatic necrosis. We sought
to look at all of our pancreatitis admissions to ICU over a 21 year
period and identify the average demographics and difference be-
tween survivors and non survivors.
Objectives To identify patients admitted to ICU with a primary diag-
nosis of acute pancreatitis, and to compare predicted demographics
and features of systemic inflammatory response between survivors
and non survivors. We hypothesised that if you required Intensive
Care for the management of severe pancreatitis, death is likely to
occur at the beginning of your ICU stay due to overwhelming organ
failure. If you were to survive the initial insult, it was hypothesised
that you may survive to hospital discharge, although the length of
hospital stay would be prolonged. We sought to test this theory with
our patient group.
Methods A retrospective audit of patients admitted to ICU in the
Glasgow Victoria Infirmary, Southern General and Queen Elizabeth
University hospital from 1994 to 2015. Patients were identified on
Wardwatcher via a search of APACHE II diagnosis including pancrea-
titis. Data was collected from patient profiles on the Wardwatcher
and TrakCare CIS.
Results 182 patients were identified with an admission diagnosis of
pancreatitis from 12704 patients admitted giving an incidence of
1.4 % of all ICU admissions. Other results are as demonstrated below
with with all data being presented as mean and 95 % confidence in-
tervals with p-values from Student´s unpaired t-test where
applicable.
Conclusions As could be predicted, pancreatitis is a diagnosis of the
older male population in ICU, likely as a result of the concomitant
problem of alcohol abuse in the West of Scotland. These patients
have a higher than normal APACHE-II score and predicted mortality
compared with unit averages. All SIRS criteria were met when look-
ing at average data, hence why their likely admission to ICU.
When comparing survivors to non-survivors, survivors were signifi-
cantly more likely to be younger, with lower APACHE-II scores and
predicted mortality. There was no difference in length of stay be-
tween groups nor degree of derangement of any of the SIRS criteria.
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All patients
(n= 182)
Survivors
(n=95)
Non-survivors
(n=87)
p-value
Age (years) 57.4 +/- 2.2 53.8 +/- 3 61.2 +/- 3.1 <0.001
Male gender 58.8% 65.3% 51.7% 0.064
APACHE-II 21.8 +/- 1.1 18.4 +/- 1.2 25.6 +/- 1.7 <0.001
Predicted mortality 51.8 +/- 3.5 41.5 +/- 3.9 63.4 +/- 4.8 <0.001
Length of stay (days) 9.0 +/- 1.6 8.4 +/- 1.6 9.7 +/- 3.0 0.415
WCC in 1st 24hrs 16.5 +/- 1.8 17.4 +/- 3.0 15.5 +/- 1.8 0.298
HR in 1st 24hours (bpm) 130 +/- 3 129 +/- 4 131 +/- 6 0.483
RR in 1st 24hrs 29 +/- 1 29 +/- 2 29 +/- 2 0.943
Temp in 1st 24hrs (oC) 38.1 +/- 0.2 38.2 +/- 0.3 38.0 +/- 0.2 0.391
Table 115 (abstract A360). Patients with Adverse Outcomes by Quartile
Q1 Q2 Q3 Q4
No of patients per group 1143 1144 1143 1144
Median fluid administration per day (ml) 87.9 122.8 157.5 331.1
No of deaths 5 0 9 66
No staying over 72 hours 83 76 136 729
No requiring PV 4 0 0 172
No requiring PN 3 2 5 48
No with AKI (any) 120 68 100 426
No with AKI (stage III) 1 3 1 42A360
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Introduction Fluid resuscitation is a key part of patient management
after cardiac surgery. Intravenous (IV) fluids are used to replace lost
circulating volume and to maintain adequate perfusion to vital or-
gans, but the volume given to patients varies greatly. In the past, the
accepted practice was that the greater the volume of fluids a patient
was given, the better their chance of survival. However, recent litera-
ture shows that fluid overload could possibly lead to worse out-
comes for patients1,2 and suggests that clinicians should be cautious
when prescribing fluids.
Objectives To determine the association between IV fluid administra-
tion (FA) and patient outcomes in patients in a cardiothoracic inten-
sive care unit.
Methods A retrospective observational analysis was conducted of all
of the patients admitted to the cardiothoracic critical care unit (CCU)
at Papworth Hospital between 01/01/2014 and 31/12/15. Patient data
was extracted from the CCU electronic database and patients with
missing data were excluded, leading to the final patient cohort used
for the study. Parameters including IV FA, survival, need for a pro-
longed CCU stay (defined as >72 h), need for prolonged ventilation
(PV) (defined as >168 h), need for parenteral nutrition (PN) and AKI
score were collected. Patients were split evenly into four quartiles,
determined by daily IV FA. Relative risk (RR)and 95 % confidence in-
tervals (CI) were calculated for each adverse patient outcome by
comparing each of Quartile 2 (Q2), Quartile 3 (Q3) and Quartile 4
(Q4) to Quartile 1 (Q1).
Results 5519 patients were identified initially, but after excluding those
with incomplete data (n = 945), a total of 4574 patients were found to
be eligible for the study. Patient quartiles contained 1143 or 1144 indi-
viduals. A statistically significant association was found between high
FA and adverse patient outcomes in patients in Q4 compared to pa-
tients in Q1 for mortality (RR = 13.2 (CI 5.3-32.6)), need for prolonged
stay (RR = 8.8 (CI 7.1-10.8)), need for PV (RR = 43.0 (CI 16.0-115.4)), need
for PN (RR = 16.0 (CI 5.0-51.2)), AKI score (RR = 3.6 (CI 2.9-4.3)) and a
maximum AKI score of 3 (RR = 41.2 (CI 5.8-304.4)). These results are in
keeping with the findings in other studies1,2.
Conclusions High FA is associated with increased mortality and mor-
bidity, with the poorest patient outcomes consistently observed in
Q4 compared to Q1 across all complications. Being cautious whenprescribing IV fluids may help improve patient outcomes in critical
care.
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Introduction Lactate is a prognostic biomarker used commonly in in-
tensive care to detect tissue hypoxia. Lactate clearance has been
shown to be associated with improved outcomes in patients with
sepsis (1) and cardiac arrest (2). Whether elevations in lactate after
primary clearance (ie. secondary hyperlactataemia, SH) is associated
with outcomes in critically ill patients remains unknown.
Objectives We hypothesized that SH is an early marker for ICU mor-
tality and would be independently associated with mortality. In order
to test this hypothesis, we performed a retrospective observational
study to assess the relationship between SH and mortality.
Methods Retrospective analysis of the Multiparameter Intelligent
Monitoring Intensive Care III (MIMIC-III) database was performed.
MIMIC-III is an open access anonymised database comprising over
58,000 intensive care admissions from 2001-2012. All adult patients
demonstrating an initial lactate clearance (LC) to < 2 mmol/L from >
4 mmol/L were included. SH was defined by a rise in lactate >
4 mmol/L following an initial LC. Univariate and multivariable logistic
regression analysis was used to test the association between SH and
28-day mortality.
Results A total of 3390 patients were included, of which 341 (10 %)
showed a SH, the remainder belonging to the LC group. The average
age at admission was 63 (+/- 18) years, 58 % males and frequent co-
morbidities included hypertension, diabetes mellitus and congestive
cardiac failure. The median time of initial LC was 15 hours and the
delay between SH and death was 83 hours. The 28-day mortality rate
in the SH group was 42 % versus 12 % in the LC group. SH was asso-
ciated with 28-day mortality in unadjusted analysis (OR 5.41, 95 % CI
4.25 - 6.89; p < 0.001). After multivariable adjustments for patient
demographics, co-morbid disease, new organ dysfunction and la-
boratory data, SH remained independently associated with 28-day
mortality (OR 4.87, 95 % CI 3.70 - 6.41; p < 0.001).
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was associated with mortality in critically ill patients. The association
remained robust after multivariable adjustments. Secondary hyperlac-
tataemia may serve as an early signal for deterioration in critically ill
patients. Future studies should assess additional therapeutic options
for patients with secondary hyperlactataemia in the ICU.
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809 Liver Transplants (LT) made at Hospital Clínico Universitario de
Santiago de Compostela (Spain) in period 1994-2014, 4.25 % of all LT
performed in Spain (19005 cases, according to the Spanish Liver
Transplant Registry- RETH). Review and comparison of Cumulative
Survival Rates based on LT Indication over 20 Years Experience.
Materials and methods Retrospective and descriptive study of 809
LT cases performed from 1994 to 2014 at Hospital Clínico Universi-
tario de Santiago de Compostela (Spain) based in our local LT
Registration.
Results 809 LT cases,12 of which were Hepatorenal Transplanta-
tions,35 required a Re-Transplantation. Media of LT:36 LT/year.
Gender:79.35 % Male,20.64 % Female,Mean Age of 51 years old.-
Blood Group:A positive (49 %) and 0 positive (39 %).Most frequent
LT Indication Groups:Liver Cirrhosis (LC): 541 cases,Tumors (T):186
cases,Fulminant Liver Failure (FLF):50 cases and Re-Transplant
(RLT):35 cases.In the LC Group the most frequent: Alcohol-Related
(ARC): 64 %, Hepatitis Virus C Cirrhosis (HVC): 22 %, Primary Biliary
Cirrhosis (PBC): 5 % with Cumulative Survival Rate at 20 Years:
ARC: 50 %, HCV: 35 % and PBC: 48 %. In T Group the most fre-
quent indication: Hepatocarcinoma (HC): 90 %, Neuroendocrine
Tumor (NET): 4 %, Klatskin Tumor (KT): 3 % with Cumulative Sur-
vival Rate at 20 Years: HC: 59 %, NET: 50 % and KT: 30 %. In FLF
Group: Autoimmune/ Toxic/ Idiopatic (ATI): 72 %, Hepatitis B Virus
(HBV): 10 % and Post-traumatic (PT): 6 % with a Global Cumulative
Survival Rate at 20 years: 70 % in the total group. In RLT Group:
Hepatic Artery Thrombosis (HAT): 35 %, Primary Allograft Dysfunc-
tion (PAD): 29 % and Recurrence of Underlying Disease (RUD):
21 % with a Global Cumulative Survival Rate at 5 years (2008-
2013): 23 %.
Conclusions Liver Chirrosis is the most frequent indication towards
LT, followed by Tumors, with Hepatocarcinoma predominance and
Fulminant Liver Failure. Cumulative Survival Rate globally is similar to
the ones found out in other Transplantation Programs. In Liver Cir-
rhosis Group, Alcohol-Related Cirrhosis is the most frequent and withbetter Outcome as well as Hepatocarcinoma int the Tumor Group.
Autoimmune/Toxic/Idiopatic is the most frequent in Fulminant Liver
Failure Group and has the best Outcome of all LT Indications though,
poor Outcome at Retransplant Group leads to a more careful selec-
tion of cases to get better Survival Ratios.
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Introduction Why do patients with Spinal Cord Injury (SCI) stay in
Neuro ICU for a long time?
Objectives A survey about the reasons why SCI patients stayed lon-
ger in NICU between 2013 and 2015 and their outcome
Methods A local database (Wardwatcher) was used to search and
collection of data for patients admitted with SCI between 2013 and
2015.
Results Out of 3,539 admissions in NICU, 326 cases were related to
spinal injury and 137 were considered as spinal cord injury and 93 %
of admissions were related to trauma and 6 patients were readmitted
while in the hospital between 2013 and 2015. There was an increase
trend of admissions in NICU between 2013 and 2015 and the data
showed that the average length number of days of patient stay was
3.6 days while spinal patients were 8.6 days.
The Guidelines for the Provision of Intensive Care Services (2015) rec-
ommends a discharge from critical care to ward must be within
4 hours from the decision of the consultant, the data showed that
71 % of between 9 to 14 hours delayed discharges from NICU to
ward are mainly caused by shortage of ward beds followed by delay
on ward.
60-66 % of SCI patients required advance cardiac and respiratory
organ support and 36 % were on neurological support. 86 % of the
patients had tracheostomy.
Only 19 patients were qualified for SCI study called Injured Spinal Cord
Pressure Evaluation (ISCoPE) where the intraspinal pressure was mea-
sured in relation to traumatic spinal cord injury and this requires the
patient to be in the spinal monitoring pressure for at least 7 days.
On patients outcome, 75 % had improved, 13 % died and 12 % of
the patients remain unchanged. While the hospital patient outcome
on discharge, 83 % lived and 17 % died.
Conclusions Though there were not many SCI patients admitted in
the unit compared to other patients. SCI patients stayed longer by
5 days on average. Three main reasons were identified why they
stayed longer; one was because of ISCoPE research, the other one
was their dependency on advance organ support and lastly, the de-
layed discharges because of shortage of ward beds. The delayed dis-
charges could indicate that the hospital needs to increase the bed
capacity.
The patients' outcome appears encouraging with their improved
outcome.
A further audit is necessary to see any changes.References
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Introduction The risk of medical errors is high in intensive care medi-
cine. Errors in healthcare may occur due to an unintended act or by
omission. Errors of omission are more insidious and more difficult to
identify. Our group previously developed and validated a new tool:
the real time random safety audits (in Spanish: Análisis Aleatorios de
Seguridad en Tiempo Real, AASTRE). It was effective in detecting and
remedying errors of omission in real time.
Objective The purpose of this study was to investigate the AASTRE
impact in structure, process and outcome indicators through a multi-
center study.
Methods A prospective study was conducted over a period of
12 months in two adult patient ICUs. Safety rounds were conducted
three days a week ascertaining the 37 safety measures (grouped into
10 blocks). In each round, 50 % of the patients and 50 % of the mea-
sures were randomized. The impact of this safety tool was analysed in
indicators of structure (culture of safety, healthcare protocols), process
(improvement proportion related to tool application, IPR-AASTRE) and
outcome (mortality, average stay, rate of catheter-related bacteremias
and rate of ventilator-associated pneumonia, VAP).
Results 1241 patients-day were analyzed. Structure indicators: AAS-
TRE was associated with an increased climate of security and creation
/ modification of protocols (sedation/analgesia and weaning). Process
indicators: 12 of the 37 measures had an IPR-AASTRE > 10 %. Seven
mesures had an IPR-AASTRE > 10 % in the three quarters analyzed.
Six mesures showed a progressive decrease of the IPR over the study
period. Nursing workloads and patient severity on the day of analysis
were independently associated with a higher IPR-AASTRE in half of
the blocks of variables. Outcome indicators: AASTRE was associated
with a significant decrease in the rate of NAV.
Conclusions AASTRE was associated with improvement in structure,
process and outcome indicators. This tool also improved the care
process and adherence to the clinical practice guidelines and proved
to be most useful in situations of high care load and in patients with
more severe disease.
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Introduction Emergency laparotomy is associated with a high risk of
mortality and morbidity, which leads to significant financial expendituresfor the NHS. In a recent study, the Emergency Laparotomy Pathway
Quality Improvement Care (ELPQUIC) program has shown that a set of
sequential interventions have the potential to improve clinical outcome;
however related costs or savings remain unknown.
Objective This economic evaluation aims to evaluate costs and the
cost-effectiveness of a clinical pathway for patients undergoing
emergency laparotomy, compared to a historical cohort receiving
standard care.
Methods 299 consecutive patients in the control group were
compared with 427 patients directed into a predefined pathway. To
assess costs and cost-effectiveness, two decision models were con-
structed; the first model took hospitals management perspective, the
second model took a societal perspective and evaluated lifetime
costs and quality adjusted life years.
Results One time implementation costs of £23,406.7/hospital
(£1,399.0-£31,793.0) for training, supervision, purchase of equipment
and pharmaceuticals can be expected. However, these costs were
offset after treating 26 patients, mainly due to reduced LOS and
lower complication rates. The long-term model showed that the
intervention is both more effective (2.4 month) and leads to lower
costs to society (cost savings of £899.6/patient). The incremental
cost-effectiveness ratio is £-4,015.9, meaning the new pathway is the
dominant strategy and should be recommended to decision makers.
Conclusion A bundled pathway to improve clinical care for patients
undergoing emergency laparotomy has shown to reduce mortality,
seems cost-effective and has the potential to improve clinical out-
come and lower costs for society. Decision makers need to adopt a
long-term vision and be prepared to make one off investments to
lower future costs.
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Introduction Delayed admission from the emergency department
(ED) to intensive care unit (ICU) has been associated with increased
ICU/hospital mortality, length of stay and total cost of care1,2. How-
ever, there is little data to support the use of any particular time
frame as an indicator of quality of care.
Objectives We aimed to investigate the relationship between time in
ED and ICU mortality in a tertiary university affiliated hospital.
Methods We conducted a retrospective study of patients admitted
from 2011 to 2015. We included patients admitted directly from the
ED based upon administrative registries Transfers from other hospi-
tals including administrative passages through the ED and admis-
sions after emergency surgery were excluded. Primary outcome was
ICU mortality. Secondary outcomes included nosocomial infection,
ventilation time and hospital mortality. Statistical analysis included
univariate and multivariate logistic regression.
Results We included 555 admissions (548 patients) with a mean SAP-
SII level of 43.0 ± 18.8 and ICU mortality of 19.8 % (n = 110). Mean
age at the time of admission was 57.8 ± 18.2y, and 60.0 % were male.
Patients were admitted due to medical conditions (78.2 %) and
trauma with no need for emergent surgery (21.8 %). Mean time in
the ED was 8.4 hours (±5.7), with a skewed distribution to the left.
Significantly, there was a significant decrease of ED time during this
five year period (-1.9 (-3.5- -0.5, p = 0.009) hours in 2015 compared to
2011). In the univariate analysis, we found no association of time in
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 192 of 607the ED with ICU mortality (OR = 1.01; p = 0.73). This result was not
altered after adjusting for SAPSII, age, gender, trauma, acute kidney
injury or year of admission. Of relevance, there was also no associ-
ation with ICU mortality and an excess of 12 hours in the emergency
department. Finally, there was no association between time spent in
the ED and hospital mortality (OR = 1.2; p = 0.13), ventilation time
(p = 0.6) or nosocomial infection (p = 0.8).
Conclusions Unnecessary time spent in the ED has the potential to
adversely affect the care and to overwhelm crucial ED resources. In
our single-center retrospective study we did not find any association
between the absolute time spent in the ED and ICU mortality, and
we cannot recommend any clinically relevant specific time frame.
Meanwhile, patients should be transferred to the ICU from the emer-
gency department as soon as possible and further research is
needed to develop potential quality indicators.
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Objectives Several studies have demonstrated a decrease of mortal-
ity under mechanical protective ventilation with low tidal volumes
(6-8 ml per kilogram of predicted body weight) not only in patients
with acute respiratory distress syndrome (ARDS), but also in ICU pa-
tients without criteria of pulmonary injury, The aim of this study is to
evaluate the utility of a daily checklist applied to all the patients
under mechanical ventilation (MV) admitted to an ICU as well as to
identify the factors influencing the achievement of the goal to keep
the tidal volume at 6-8 ml per kilogram of predicted body weight
Methods A prospective study including all the patients admitted to an
ICU during a four-months study period. A daily-based register was im-
plemented for all the ICU patients under MV during the morning, the
afternoon and the night shifts. We analyse the degree of compliance
with the checklist, as well as the influence on the achievement of the
goal for tidal volume of the following factors: height, sex, type of MV
(Continuous Mandatory Ventilation-CMV, Pressure Control Ventilation-
PCV, Bi-level positive airway pressure-BiPAP, Synchronized Intermittent-
mandatory Ventilation-SIMV, Pressure Support Ventilation-PSV),
gaseous exchange (relation paO2/FiO2), pulmonary mechanics
(plateau pressure).
Results We registered 883 measurements (36 % in the morning
shifts, 31 % in the afternoon and 33 % in the night shift) for all the
patients with MV (either with ARDS or without criteria of pulmonary
injury). No patient developed ventilator induced lung injury (VILI).
The percentage of measurements outside the established goal of
tidal volume was 28,7 % (CI 95 % 23.9-33.9 %) without differences
between the shifts. The average tidal volume was of 443.9 ml (range
431-457) that corresponds to 7.5 ml per kilogram of predicted body
weight (IC 95 %: 7,35-7,66). In univariate analysis the factors associ-
ated to being outside of the goal for tidal volume were: female sex,
height and the Pressure Support Ventilation-PSV as opposite to
mandatory modes with no influence of the shifts of work, the rela-
tion paO2/FiO2 and the plateau pressure. The multivariate logistic re-
gression analysis showed that the factors independently associated
with being outside of the goal for tidal volume were female sex and
the Pressure Support Ventilation-PSV.Conclusions In almost 30 % of the ICU patients under MV the goal of
low tidal volumes is not achieved, especially in female patients and
in those under Pressure Support Ventilation. The establishment of a
daily checklist for patients under VM is feasible and could influence
in a low frequency of VILI in patients with ARDS and also in those
without criteria of pulmonary injury.
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Introduction Fostering a safety culture is one of the most important
landmarks when it comes to provide quality assistance in an Inten-
sive Care Unit (ICU). The detection and analysis of the incidents and
adverse events that affect our patients are the cornerstone for the
development of programs and protocols leading to safe health assist-
ance with high standards of quality.
Objectives Knowing the nature, casuistry and the underlying ele-
ments of adverse events (AE), rated as serious, according to the
Protocol on Adverse Events Reporting established in our Unit.
Methods 266 notified EA, reaching 201 patients, were analysed
through the Adverse Events Reporting System (AERS) established in
the Heart Surgery Intensive Care Unit (HSICU) from January 2014 to
January 2016. Among these, we rated as serious those that caused to
the patients a temporary or permanent damage, extending their
hospitalization, compromising their lives or needing surgery in order
to save their lives and contributing or causing their demises. In our
AERS, those rated as F-I according to the catalogue of the National
Coordinating Council for Medication Error Reporting and Prevention
(NCCMERP).
Results 21 AE rated as serious were notified. Among these, 13
were rated H category (incident that compromised the patient's
life and needed care to keep him alive) and 2 were rated I cat-
egory (the incident contributed or caused the patient's demise).
The last were related to surgery complications. All of them
needed medical attention, being the majority of them discharged
to ordinary ward hospitalization. There were not relevant differ-
ences as far as the urgency of the hospitalization, the clinical
profile and the assistance needed in the moment of the AE. In
30 % of the AE, the equipment and available resources were
pointed out as contributing factors; in 35 % of cases it was re-
lated to formation and training; in 40 % of cases it was due to
elements related to the patient and in 45 % of the cases it was
elements related to the performance. The most frequent serious
safety issues were surgery complications or damages related to
invasive procedures, three of them related to the handling of
breathing devices and two of them with reaction after blood
transfusions. In 75 % , according to professional advice, the AE
was deemed avoidable.
Conclusions The AE rated as serious were 7.7 %. The most common
feature ,was their avoidability and their relation with formation and
training in the techniques used during the assistance. Beyond the
cases of death, the serious AE involved an extension in the stay at
the hospital and a rise in the morbidity and mortality rate. According
to this, the intervention over factors capable of improvement, such
as formation and training of all the professionals involved in the
healing process, is compulsory.
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Introduction A well-defined briefing can help to improve the ex-
change of information among professionals in the shift change and
strengthens the safety culture.
Objectives General: To promote safety culture in the ICU of the HGB
of Motril.
Specific: Encourage communication between the interprofessional
team. Diminish the appearance of adverse effects (EAs). Implement
use of safety briefings to increase patient safety. Since 2008 daily
meetings are held in the morning shift among medical and nursing
professionals, and among nurses on each shift, for exchange of infor-
mation and communication regarding patients admitted, assessing
the risk of occurrence of AEs each patient.
Methods Description of briefing protocol designed in 2015 in our ICU
wich has 8 beds with a total income of 582 in 2015. The personnel that
make the interprofessional team are 7 doctors, 14 nurses and 10 assis-
tants.In 2014 a total of 18 EA were reported 33.33 % being derived
from a care or clinical procedure, 22.22 % resulting from an accident
patien, 16.67 % of medical equipment and 11.11 % patients´falls. The
rest was due to other causes.A working group was created to develop
and promote safety culture. In November 2015 implementing security
briefing was performed after consensus of all nursing professionals.
The variables were entered in the checklist (yes/no) three times a day
(in the morning, in the afternoon and at night) and were: mechanical
ventilation, vasoactive drugs, fasteners in the weaning, pressure ulcers,
drains, revision infusion rate, review alarms, repositioning, mobilization
endotracheal tube, nasogastric tube and urine probe, wristband.
Mandatory measures of pneumonia Zero program were included:
Ambu review and aspirator, strict hand hygiene before handling air,
headboard position 30°-40°, check neumotaponamiento pressure,
chlorhexidine mouthwash.
Results
– Regulated exchange of information among professionals.
– The number of EA reported has decreased by 60 % since the
introduction of the use of the new briefing protocol.
– Briefing accepted by 100 % of the professionals.
– 97 % of staff completed the checklist successfully.
Conclusions It has reduced the number of adverse effects in more
than a half, thus we have demonstrated the effectiveness of the proto-
col, it is also very important that it has been accepted by almost all of
the staff, this data shows that it is simple and easy to carry out.
With these data we have sensitized the staff of the importance of in-
formation for patient safety. We think that with this work we can
help other units.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A370Introduction Rapid response systems (RRS) may slightly reduce car-
diac arrest in the hospital. RRS has an efferent limb such as rapid re-
sponse team (RRT) and an afferent limb that has a process of timely
detection and activation. RRS activates mostly 24 hours/day and
7 days/week by a multidisciplinary team. In middle-income country,
unlike EU and USA the personal resources are limited. RRT call were
most common during working hours in Australian study1.
Objectives Daytime activation of RRT may reduce cardiac arrests
rates.
Methods From October 2015, Inha university hospital rapid response
team (INHART) had organized and activated. The INHART consisted
with three doctors (two were pulmonologist, one was cardiologist) and
one nurse who has experienced in intensive care unit. The activation
time was from 9 AM to 5 PM. We collected the numbers of hospital dis-
charge, cardiac arrest events (CAE) retrospectively for 2 years (before
INHART) and prospectively from October 2015 to February 2016 (after
INHART). CAE per 1,000 discharge were compared between before and
after INHART. Nonparametric test was performed.
Results Mean CAE per 1,000 discharge were 4.03 before INHART and
2.93 after INHART (p = 0.041). CAE was reduced by 27 % after INHART.
Conclusions Despite of short-term operation, daytime only activation
of RRT reduced cardiac arrests events. After long-term application,
RRT would ameliorate cardiac arrests and improve patient safety in a
general hospital.
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Introduction Patient safety in the ICU is the prevention of injury or
harm arising as a result of the process of care, rather than as a result
of the underlying disease process. The incidence of medical errors
and adverse events in ICU is surprisingly high1.
Systems to improve patient safety, such as checklists, are only effect-
ive when implemented within a receptive and positive safety climate.
A positive safety climate is associated with a measurable decrease in
error rates2.
Objectives To evaluate the safety climate across both critical care
units within Aneurin Bevan University Health Board (ABUHB).
Methods We conducted an anonymous online survey across all staff
in critical care within ABUHB. The survey consisted of questions vali-
dated by the Agency for Healthcare Research and Quality, part of the
United States Department of Health and our own questions regard-
ing staff's incident reporting behaviour. We ran the survey for a
month and aimed to get a 50 % return rate from the 180 staff work-
ing across both sites.
Results We received 114 responses and 101 completed surveys from
across the multi-disciplinary team.
Eighty eight percent rated overall patient safety as very good or
excellent.
The survey reported a supportive environment (83 %) where people
worked well together as a team (97 %), and treated each other re-
spectfully (90 %).
Generally patient safety was not sacrificed to get more work done
(66 %), and there was no pressure to take shortcuts to speed up
work rate (85 %).
"Crisis mode" was precipitated by an inability to discharge wardable pa-
tients (52 %), rather than lack of staff (27 %), or the unit being too full
(33 %).
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informally (85 %), and in many cases (63 %) implement a solution fol-
lowing this discussion.
Feedback as a result of adverse event reports was highlighted as a
deficiency with only 33 (31 %) staff feeling they received this, simi-
larly 39 (37 %) of staff did not feel they were adequately informed
about any errors that happened on the units.
Conclusions Whilst our results indicate a positive work environment,
there are areas for improvement, specifically feedback following ad-
verse events.
Designated nurses to attend morbidity and mortality meetings and
subsequent publication of patient safety bulletins will improve feed-
back to nursing staff.
We are going to instigate a designated patient safety board to publi-
cise patient safety events and resultant changes in practice.
Little is currently published regarding UK ICU safety surveys to allow
benchmarking of our results. The authors feel UK ICUs should con-
sider collection and publication of this data.
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Introduction Clinical safety has become on one side a quality stand-
ard and on the other side an ethical obligation in the daily work of
an Intensive Care Unit (ICU). The establishment of standardized
protocols and appropriate training in the area of safety have become
a must when it comes to its development. Also all professional cat-
egories have to be involved in this process.
Objectives Analysis of the incidents and adverse events (I/AE) re-
ported after the establishment of a report protocol (RPIAE) in a Heart
Surgery Intensive Care Unit (HSICU).
Methods The Clinical Safety Group of the Intensive Care Service, re-
sponsible for the design of the RPIAE, was created in January 2014.
Thus, the RPIAE was introduced in the HSICU in March 2014. This
methodology reviews the adverse events (AE) detected in every sin-
gle patient that was looked after in this unit between March 2014
and October 2015.AE: non-intentional damage caused during or as a
consequence of the medical attention received and non-related to
the evolution or eventual complications of the initial illness. The in-
formation was gathered in an Excel data base and the statistical ana-
lysis was performed through the SPSS and Epidat programs.
Results 254 AE's were reported on 189 patients, 67 % of which were
males. 2.7 % of them were admitted to hospital as a result of an AE.
90.9 % were discharged and 23 patients passed away. 50 % of them
were reported by the nursing staff; 39.8 % by doctors. 88.9 % took
place in the Intensive Care Unit., 44.9 % of which during the morning
shift. 79.9 % while the Unit was holding 100 % occupancy. 24 % of
the AE affected the patient in a way that they needed further moni-
toring and/or intervention in order to check that no damage had
been caused. 7.1 % compromised the patient's life and 1.6 % contrib-
uted or caused the demise of the patient. 57.9 % of them were
doubtlessly avoidable. 22.8 % had their origin in the unplugging/re-
moval of accesses/probes/catheters/sensors/tubes and 7.9 % had
their origin in the handling of breathing devices and mechanical ven-
tilation. In 43.75 % of the cases the lack of training and formationhad direct effect on the I/AE. The mean duration of hospitalization
stay before the AE was 7.68 days (statistic standard deviation, SSD,
30.1); the mean duration of hospitalisation was 16.45 days (SSD
25.26) and the mean stay in the Intensive Care Unit 8.69 days (SSD
13.48), (p < 0.05).
Conclusions The majority of the AE were deemed evitable and nei-
ther had they important effects on the evolution of the patient nor
extended the patient's stay in the ICU. A longer stay in the ICU was
related to a bigger incidence of AE. (p < 0.05). Formation and training
are key elements in order to avoid AE and they are part in the mea-
sures currently established in our ICU in order to avoid these I/AE.
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Introduction Medication errors are common in critically ill patients,
[1] and have the potential to adversely affect patient safety [2].
Whilst adverse events, including those caused by medications, have
a direct relationship with patient outcomes, [3] the potential clinical
impact of individual medication errors remain less clear. Moreover,
the complexity of critically ill patient care means frequent optimisa-
tion of medications is required to ensure effective therapy. Currently
the clinical impact grading of medication errors and optimisations re-
mains subjective in clinical practice and research methodologies.
Objectives To identify the reliability of clinical impact grading by
health professionals
(i) between professions (inter-rater) and
(ii) within professions (intra-rater)) of common prescribing errors
and optimisations in critical care patients; and
(iii)identify representative clinical impact grades for each example.
Methods 50 representative medication error and 55 optimisation
cases from the PROTECTED UK study, [4] were sent electronically to a
purposive sample of 30 healthcare professionals (10 ICU consultants,
specialist pharmacists and specialist nurses) in 5 UK sites. Each rater
graded the error or optimisation case for severity of clinical impact
using a 5-point categorical scale (no, minor, moderate, severe and life
threatening/saving clinical impact). Inter-rater reliability was tested
using a linear mixed model. Intra-rater reliability was tested using the
intra-class correlation (ICC) with a two-way random effects model
using absolute agreement.
Results The majority of errors and optimisations (both 76 %) had a
modal clinical severity grade of moderate or higher. Error cases: doc-
tors graded clinical impact significantly lower than pharmacists
(-0.25; p < 0.001) and nurses (-0.53; p < 0.001), with nurses signifi-
cantly higher than pharmacists (0.28; p < 0.001). Optimisation cases:
doctors graded clinical impact significantly lower than nurses and
pharmacists (-0.39 and -0.5; p < 0.001 respectively). There was excel-
lent intra-reliability (ICC) grading for pharmacists (0.882 & 0.887; p <
0.001) and doctors (0.794 & 0.829; p < 0.001)) but only fair to good
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 195 of 607for nurses (0.429 & 0.739; p < 0.001), for optimisations and errors
respectively.
Conclusions Over one hundred common prescribing errors and opti-
misations had modal clinical impact grades recorded for potential
application in clinical practice and research. The inter-professional
variability highlights the importance of multidisciplinary perspectives
in assessment of medication errors and optimisations in clinical prac-
tice and research.
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Introduction Adverse events (AE) are frequent in patients admitted
in intensive care unit (ICU) for different causes.
Objective To determine the incidence, characteristics and results of
adverse events in critically ill patients requiring mechanical ventila-
tion (MV).
Methods An observational, prospective and single-center study, con-
ducted in a medical-surgical ICU over a period of 12 months (2015),
in patients who require MV > 24 hours. The variables studied were:
demographic data, extubation unscheduled, severe obstructions air-
way, cardiac arrest, atelectasis, loss of medical devices, septic shock,
duration MV, ICU and hospital stay, and ICU and hospital mortality.
Statistical analysis: descriptive, bivariate (chi 2 and t-Student) and
multivariate logistic regression analysis.
Results 330 patients were included, with APACHE II score 23.5 ± 7,
age 61 ± 15 years, body mass index 28 ± 5, total SOFA on day 1, 8.9
± 3.5 pts, and 67 % were males. Renal replacement therapies were
14.6 %, duration of ICU stay 17 ± 18, hospital stay 26 ± 22 days, dur-
ation of MV 10.8 ± 11 days, cardiac arrest 4.9 %, septic shock 39.8 %,
airway obstructions 33.4 %, unscheduled extubation 9.1 %, loss of
medical devices 8.25 %. ICU mortality was 33.7 % and hospital mor-
tality 38.6 %. Total incidence of AE was 42.2 %. Predictive factors as-
sociated with hospital mortality were APACHE II score (OR 1.048,
95%CI 1.01 to 1.08), septic shock (OR 1.27, 95%CI 0.76 to 2.11), airway
obstruction (OR 0.81, 95%CI 0.49 to 1.35), unscheduled extubation
(OR 1.80, 95%CI 0.73 to 4.45), and loss of medical devices (OR 1.60,
95%CI 0.65 to 3.9).
Conclusion The occurrence of AE in critically ill patients is high. Strat-
egies to reduce the incidence of adverse events may eventually im-
prove outcomes in these patients.A375
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A375Introduction Sepsis survival rates have improved in recent years and
it becomes more and more important to asses long-term outcomes
in order to align treatment with what is important for patients. Qual-
ity of life (QoL) is an important patient-reported outcome (PRO) that
is commonly used as an endpoint in clinical studies. However, the
most frequently used instruments, eg. SF-36 and EuroQoL-5D, were
developed without input from intensive care survivors and may thus
lack validity in these populations. Quality of life domains which mat-
ter to sepsis survivors have not yet been elicited.
Objectives Identification of the domains of quality of life of sepsis
survivors according to their own perception and priorities.
Methods Open-ended face-to-face or telephone interviews were con-
ducted with sepsis survivors from interdisciplinary ICUs of a German
university hospital. Interviews were transcribed verbatim with a fixed
set of transcription rules and analyzed qualitatively with the inter-
pretative phenomenological analysis (IPA) approach. Codes and sub-
codes were applied to the data and a codebook was developed. A
second experienced researcher unfamiliar with the data evaluated
the codebook; differences were solved by discussion. Codes were
clustered into domains and evaluated for their importance by stake-
holders (survivors, relatives of survivors, intensive care physicians,
nurses, psychologists, rehabilitation physicians) through a Delphi
process.
Results Fifteen participants (7 female, 8 male) had a mean age of
62 years (range: 27 - 87 years) with mean time after onset of sepsis
of 11 months (range: 5 - 40 months). Mean interview duration was
68 minutes (range: 34 - 95 minutes). The final codebook comprised
16 codes and 99 subcodes; data saturation was already 95 % after 7
interviews. Initial agreement between the two researchers about the
codebook was 83 % and could be improved to 100 % after minor
changes. 10 core domains of quality of life could be identified. The
most relevant domain for sepsis survivors' quality of life is reintegra-
tion to normal living. Survivors reported that their quality of life
depended more on how much they could participate in everyday life
and less on each single persisting physical and psychological deficit.
Other domains include: ability to walk, fatigue, family and partner-
ship, self-perception and control over one's life.
Conclusions This study highlights the domains that are important for
the quality of life of sepsis survivors as assessed by the survivors'
own perception. Identified domains are only partly assessed by com-
monly used quality of life instruments. Reintegration as the most im-
portant domain from a patient' perspective is a novel concept in the
context of quality of life after sepsis. These domains will help to im-
prove quality of life questionnaires which provide patient-relevant
outcomes measures.
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Introduction Intercostal chest drain (ICD) insertion is a relatively
common procedure but can be associated with significant complica-
tions including bleeding and organ perforation. Indications for inser-
tion include management of hemothorax, pneumothorax and pleural
effusions. The "triangle of safety (TOS)" is an often quoted site as be-
ing appropriate for ICD insertion; including in trauma patients by
ATLS. The space is delineated by lateral border of the pectoralis
major, lateral border of the latismus dorsi, line of the 5th intercostal
space and the base of the axillaintercostal space. Although ultra-
sound (US) guidance has been recommended to aid insertion, its use
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 196 of 607is far from established practice and landmark techniques and the
TOS is still widely practiced.
Objectives To establish the safety profile of the TOS through the use
of US to delineate underlying anatomy including the position of
intercostal vessels.
Methods 50 consecutive patients on a general ICU underwent bilat-
eral US examination of their TOS. The position of liver, spleen and
heart in the respective TOS was noted. Doppler ultrasound was used
to identify intercostal vessels within the TOS.
Results Overall, the heart, liver and spleen were visible in 60 % of pa-
tients within the TOS. This percentage increased in the intubated
and ventilated patient population. Intercostal vessels where visible in
the minority of patients.
Conclusions The British Thoracic Society and the National Patient
Safety Agency UK has recommended ultrasound before inserting a
drain for fluid. Our study found that the TOS is a misnomer exposing
the patient to the risk of underlying organ perforation especially in
the patient who is intubated and ventilated. It is therefore not safe
and the practice should be abandoned. The routine use of real-time
US to guide ICD insertion should be recommended to improve pro-
cedural safety.
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Introduction Severe sepsis and septic shock are still the common
cause of death in ICU. The extracorporeal blood purification therapy
could provide a benefit in reduction the inflammatory mediators and
bacterial endotoxins.
Objectives To study the immunomoudation effect of Polymyxin-B
Hemoperfusion (PMX) in severe sepsis/septic shock
Methods The adult patients with severe sepsis/septic shock in inten-
sive care units (ICUs) of King Chulalongkorn Memorial Hospital were
tested with endotoxin assay. The patients with blood endotoxin level
≥0.6 were randomized into two groups, PMX hemoperfusion group
and standard treatment group. The 2-hour PMX hemoperfusion were
done in two consecutive days in PMX hemoperfusion group. Data for
hemodynamic parameters, Sequential Organ Failure Assessment
(SOFA) score, and blood sample were collected on first three day
after enrollment The primary outcomes were leukocyte expression of
CD11b, HLA-DR, chemotaxis function and blood endotoxin level on
day 3 after enrollment. The secondary outcomes were 28-day sur-
vival, APACHE II score, change in SOFA score, CVS SOFA score.
Results We have enrolled 36 participants into the study, 18 patients
for each group. The age, APACHE II score, endotoxin level were com-
parable between two groups. The percent change of EAA was
-19.8 % vs -10.6 % in PMX group and control group, respectively. The
APACHE II and total SOFA score was -14.8 % vs +1.5 % and -12.8 %
vs +6.1 %, in PMX group and control group, respectively. The CVS
SOFA score was -31.4 % vs +24.9 %, in PMX group and control group,
respectively. There was the trend increase in HLA-DR expression in
PMX group and no change in control group.HLA-DR expression on
day 3 in PMX group was significantly higher than control group,34.5 % vs 24.2 %, p = 0.03. 28-day survival rate was comparable be-
tween two groups.
Conclusions The PMX hemoperfusion seemed to improve hemodynamic
instability and improved immunoparalysis status in severe sepsis/septic
shock patients.
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Introduction Sepsis can induce rapid proteolysis and early exercise is
desirable to prevent loss of muscle mass. It is not known whether
early intervention is safe in critically ill patients with sepsis. Exercise
may also act to recruit the microcirculation.
Objectives To investigate the effect of 30 minutes of electrical muscle
stimulation and passive movements to major muscle groups on the
microcirculation in patients in the first 48 hours of sepsis.
Methods Changes in tissue oxygenation were assessed at baseline
and immediately post exercise using a] a near infrared oxygenation
device on the thenar eminence to assess percentage of oxygen in
the muscle (StO2) and percentage of muscle oxygen extraction rate
(MOER%) under both baseline and hyperaemic conditions. B] an
orthogonal polarization spectral imaging device was placed sublin-
gually to measure the microvascular flow index and capillary density
of the microcirculation.
Results All 20 patients completed the trial. There were significant ef-
fects post exercise on StO2 with hyperaemia [63.0 (±3.3)% to 66.2
(±5.3)%, p = 0.02], and an improvement in capillary density [2.45
(±1.01)% to 3.85 (±1.02)%, p = 0.04]. There were no adverse effects.
Conclusions Early exercise appears to have a beneficial effect on crit-
ically ill patients as tissue oxygenation improved. There was evidence
of recruitment of the microcirculation.
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Introduction Generalized vasodilation with nonresponding hypotension
is present in half death cases due to septicaemia. Methylene blue could
be used as a valuable complement in refractory hypotension treatment.
with septic shock.
Objectives The aim of this study was to determine the effectiveness
of methylene blue as contributory treatment in patients.
Methods A controlled, randomized, double blinded, clinical trial was
performed. 60 patients were divided in two groups. A Group re-
ceived a single dose of methylene blue calculated 2 mg/kg per body
weight diluted in 100 cc of 5 % dextrose infused in 60 min. and C
Group, (control) received 100 cc of 5 % dextrose infused in 60 min.
Basal measurements of study variables were taken (MBP, lactate,
base deficit, central venous saturation and CO2 delta) prior blue
methylene administration and every hour afterwards, until MBP
>65 mmHg without vasopressor or 72 hours passed after shock
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mechanical ventilation length and mortality was recorded.
Results MBP increased progressively first 6 hours after methylene
blue infusion in A Group 22 % and C Group 9.2 % (p:< 0.05), steadily
until 72 hour follow up. Noradrenaline dose decreased in the first
6 hours, on A Group an 86 %, C Group was 56 % (p:< 0.05). Lactate
clearance first 6 hours was 62 % in A Group, in contrast with C Group
with 33 % clearance (p:< 0.05). Mortality at ICU discharge on A Group
was 20.0 % and C Group was 36.6 % (p: < 0.05) without variation at
21 days.
Conclusions Methylene blue is effective as contributory in septic
shock treatment.
Note: This abstract has been previously published and is available at
[2]. It is included here as a complete record of the abstracts from the
conference.
References
1. Edmund S, Kwok M, Daniel H. Use of Methylene Blue in Sepsis: A
Systematic Review. Journal of Intensive Care Medicine 2006; 21(6):359-
363. 2. Alderton W, Cooper C, Knowles G. Nitric Oxide synthases:
structure, function and inhibition. Biochem. J. 2001; 357:593-615.
2. Lopez V, Aguilar Arzapalo M, Barradas L, Escalante A, Gongoro J, Cetina
M (2016) Methylene blue effectiveness as contributory treatment in
patients with septic shock. Critical Care 20(Suppl 2): 94.
Grant acknowledgment
Hospital "Agustin O´Horan".Fig. 140 (abstract A379). Mean pressure in the two groupsA380
Elimination of cytokines from blood of septic patients with lps
adsorber
R. Vlasenko1, E. Gromova1, S. Loginov2, M. Kiselevskiy1, Y. Dolgikova1
1NN Blokhin Russisn Cancer Research Center, Moscow, Russian
Federation; 2Moscow Botkin Clinic, Moscow, Russian Federation
Correspondence: R. Vlasenko – NN Blokhin Russisn Cancer Research
Center, Moscow, Russian Federation
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A380
Introduction In clinical practice LPS adsorbers are used on the
method of extracorporal detoxification to remove the excess of LPS
from the blood of the patients with sepsis. In recent years, there is
evidence of the ability of the hemosorption columnsto eliminate cy-
tokines and inflammatory mediators that trigger a cascade reaction
of irreversible pathological changes in organs and tissues of the pa-
tient [ 1].
Objectives Study of elimination of proinflammatory cytokines from
the blood of septic patients during the hemosorption procedureby
using the LPS adsorber Alteco
Methods The study included 20 patients with confirmed Gram-
negative sepsis. Sorption procedure was implemented on Alteco
columns (Sweden). Blood serum sampleswere taken before and im-
mediately after the procedure, column lavages were taken as well.
Samples were stored at - 70 ° C. The values of IL- 4 , IL- 6 , IL- 8 , IL-
10 , IL- 18 in serum and lavage was measured by ELISA.
Results Baseline level of serum proinflammatory cytokines was sig-
nificantly increased and the median was 380 pg/ml for IL-6; 122 pg/ml for IL-8; 350 pg/ml for IL-18; IL-10 was in the range of 50-400 pg/ml.
The level of IL-4 was not increased (2.6 pg/ml) and had no significant
difference. Levels of cytokines changed individually during hemosorp-
tion procedure and had no unambiguous correlation and did not show
a clear dependence on the baseline level or the number of the proce-
dures performed. The concentration median of interleukins from blood
serum obtained after hemosorption was 380 pg/mlfor IL-6; 165 pg/ml
for IL-8; 400 pg/ml for IL-18; 70 pg/ml for IL-10.During the analysis of
the results, patients were divided into two groups: those with a moder-
ately high value of IL-6 (250 pg/ml), and with ultra-high value (from
250 pg/ml) before hemosorption procedure. In the first group 70 % of
patients after hemosorption procedure showed no significant changes
in the concentration of IL6. 30 % of the second group showed a ten-
dency to decrease the level of serum IL-6. In the studied ofAlteco LPS-
adsorbers eluates sorbed cytokines were found, but significantly high
level was only for IL-8. There was an increase in serum IL-10 (33 %) and
IL-18 (35 %) after extracorporal detoxification procedure.
Conclusions These results indicate that the application of LPS-absorber
Alteco in patients with sepsis is not significantly affect of free cytokines
level in the systemic circulation. Reduction of IL- 8 and IL-6 observed
only in patients with moderate increase of these cytokines concentra-
tion (not higher than 250 pg / ml). The presence of significant amounts
of IL- 6 and IL-8 in Alteco LPS-adsorbers eluates with may indicate the
presence in the blood of patients with sepsis related forms of cytokines
capable of dissociation and adsorption on adsorber filter LPS-Alteco.
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Introduction Septic shock induced by gram-negative bacteria infec-
tion is a serious condition in intensive care unit (ICU), and endotoxin
plays an important role in their pathogenesis. oXiris filter is a polyac-
rylonitrile haemofiltration membrane treated with polyethyleneimine,
which provide a positive charged surface to enhance the absorption
of endotoxins and cytokines.
Objectives case series to determine oXiris haemodiafiltration could
improve the haemodynamic status in patients with gram-negative
bacteria related septic shock.
Methods Patients admitted to regional ICU with intra-abdominal sepsis
that required intervention, who developed severe septic shock required
inotropic support and acute renal failure required renal support, was
assigned to receive oXiris haemodiafiltration for 72 hours. Matched
patients with similar pathology and severity, who received ordinary
haemodiafiltration for acute renal failure, were identified for compari-
son. Primary outcome was the percentage of reduction of inotrope
dose within 96 hours after the start of renal replacement therapy,
which was calculated according to equivalent Noradrenaline dose (ug/
hr). Second outcomes including duration of MV, duration of CRRT, ICU
length of stay, and ICU mortality.
Results Three patients were assigned to receive oXiris haemodiafiltration,
and five matched patients were identified for comparison. ICU mortality
for patient receiving oXiris haemodiafiltration was 33 %, compare to
60 % for patient with ordinary haemodiafiltration. Patient received oXiris
haemodiafiltration shown a rapid reversal of inotrope dose compare to
the control, and the effect became obvious after 24 hours of treatment
(24 hr: 46.21 +/- 8.23 % drop for oXiris group, 24.93 +/- 9.22 % drop for
control group, 48 hr: 81.95 +/- 12.34 % drop for oXiris group, 54.85 +/-
15.24 % drop for control group, 72 hr: 93.98 +/- 2.05 % drop for oXiris
group, 65.61 +/- 11.47 % drop for control group, 96 hr: 97.28 +/- 1.85 %
drop for oXiris group, 42.29 +/- 36.27 % drop for control group). There
was no different between groups in terms duration of MV (10.28 +/-
Table 116 (abstract A383). Heparin Dosing Score
Score 0 1 2 6
(A) Platelet count (K/μL) (1000/mL) >80 50-80 20-49 <20
(B) INR <1.2 1.20-1.49 1.50-1.80 >1.8
(C) PTT(sec) <30 30-49 50-80 >80
Total score = A + B + C
Table 117 (abstract A383). Heparin Dosing Score
Score 0 1 2 6
(A) Platelet count (K/μL) (1000/mL) >80 50-80 20-49 <20
(B) INR <1.2 1.20-1.49 1.50-1.80 >1.8
(C) PTT(sec) <30 30-49 50-80 >80
Total score = A + B + C
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 198 of 6072.67 days in oXiris group vs 11.67 +/- 3.06 days in control group), dur-
ation of CRRT (4.55 +/- 1.7 days in oXiris group vs 5.72 +/- 2.55 days in
control group), and ICU length of stay (15.17 +/- 6.96 days in oXiris group
vs 14.49 +/- 2.33 days in control group).
Conclusions oXiris haemodiafiltration shown a rapid reversal of
shock and lower mortality in patient with intra-abdominal sepsis and
septic shock, while there was no difference in terms of duration of
MV, duration of CRRT, and ICU length of stay.
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Introduction Direct hemoperfusion with Polymyxin-B-immobilized
fiber column (PMX-DHP) has been successfully used to treat patients
with septic shock
Objectives The aim of this study was to report clinical experience of
PMX-DHP in septic shock patients in a single center, and identifying
subgroup of patients who may benefit from this treatment.
Methods From July 2014 to March 2016, we performed 56 cases of
PMX-DHP in septic shock and severe acute respiratory distress syn-
drome (ARDS) patients. Among these, septic shock patients who re-
quired vasopressor and lactic acid level was more than 2 mg/dl after
fluid resuscitation were analyzed.
Results We performed 47 cases of PMX-DPH treatment in 31 septic
shock patients. Two session of PMX-DPH were performed in 16 pa-
tients (51.6 %). Median age was 64 years old (IQR 51-69) and 54.8 %
(17/31) was male. When PMX-DHP treatment started, median SOFA
score was 17 (IQR 14-20), median lactic acid level was 9.72 mg/dl
(IQR 6.47-20.42), and median inotropic score (IS) was 105 (IQR 65-
300). Major infection focus was intra-abdominal (22/31, 71.0 %) and 5
patients (16.1 %) treated due to respiratory tract infection. The 28-
day mortality was 48.4 % (15/31), and 90-day mortality was 54.8 %
(17/31). SOFA score at PMX-DHP treatment day, infection site, source
control, and lactic acid level were associated with 28-day mortality.
Cox-regression analysis shows a significant association of SOFA score
(OR, 1.33; 95 % CI, 1.095-1.616, p = 0.004) and infection site (OR
0.264; 95 % CI, 0.083-0.845, p = 0.025) in overall survival.
Conclusions PMX-DHP application for septic shock patients could be
considered as an adjunctive therapy.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A383Introduction In recent decades, more and more studies have re-
ported that treatment with polymyxin B-immobilized hemoperfusion
cartridge may have beneficial effects on hemodynamics and mortal-
ity in patients with severe sepsis or septic shock.(1, 2) Premature cart-
ridge clotting is a common problem during polymyxin B
hemoperfusion, and it may decrease therapeutic efficacy and in-
crease cost of therapy. However, excessive anticoagulation in
patients with severe disseminated intravascular coagulation or in
intra-abdominal infection patients after operation may increase the
risk of bleeding. Currently, nafamostat mesilate is used dominantly in
Japan,(2) but the experience of using heparin for anticoagulation for
polymyxin B hemoperfusion therapy in other countries is less and
need further investigation.
Objectives We aimed to investigate the effectiveness and safety of a
heparin dosing score protocol for anticoagulation during polymyxin
B-immobilized cartridge hemoperfusion.
Methods This was a retrospective study in 6 ICUs in National Taiwan
University Hospital. The medical records of polymyxin B hemoperfu-
sion in 23 septic shock patients from October, 2013 to February,
2016 were reviewed. The heparin dosing score was modified from
the instruction of heparin dosing from Toray Industries, Inc.
The primary aim was to investigate the completion rate of 2-hour
session of hemoperfusion without premature cartridge clotting or
any event of significant bleeding. The secondary aim was to investi-
gate the effect of polymyxin B hemoperfusion on hemodynamics
and disease severity scores.
Results Among the 23 enrolled patients, 34 sessions of polymyxin B-
immobilized hemoperfusion were administered.
The completion rate of 2-hour session of hemoperfusion was 97 %. In the
only one case of premature cartridge clotting, the hemoperfusion time
was 94 minutes. There was no any documented significant bleeding.
For surgical patients, the mean time to initiate hemoperfusion was
16.3 ± 15.2 hours after operation. The 28-day mortality of these en-
rolled patients was 24 %. Significant hemodynamic improvement
and reduction of disease severity scores were noted after polymyxin
B hemoperfusion.
Conclusions Our results support that our heparin dosing score proto-
col provides effective and safe anticoagulation during polymyxin B
hemoperfusion in septic shock patients.
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Table 118 (abstract A383). Patient Characteristics and Outcomes
23 patients (34 sessions
of hemoperfusion)
Age (years, mean(SD)) 64.6(14.1)
Gender (male/female) 12/11
Body weight (kg, mean(SD)) 65.6(18.3)
Management prior to hemoperfusion (operation/
intervention /medical treatment only)
16 /2 /5
Mortality (%) 24
SOFA score (baseline/24 hours after hemoperfusion,
mean(SD))
12.4(3.9)/11.9(5.3)
APACHE II score (beseline/24 hours after
hemoperfusion, mean(SD))
24.4(6.8)/21.4(9.0)*
Inotropic equivalent score (baseline/6 hours after
hemoperfusion/24 hours after hemoperfusion,
mean(SD))
48(62)/34(48)*/23(40)*
Hemoperfusion initiation time(hours after operation,
mean(SD))
16.3(15.2)
Table 119 (abstract A383). Heparin Dosing Protocol and Session
Distribution
Heparin dosing score 0-1 2-3 4-5 ≥6
Heparin Loading 3000 IU 1500 IU 1000 IU 0 IU
Heparin maintenance 20 IU/kg/h,
MAX=2000 IU
10 IU/kg/h,
MAX=1000 IU
0 IU 0 IU
Session Number 5 15 9 5
Platelet count
(K/μL, mean(SD))
240(106) 217(161) 60(39) 123(64)
INR (mean(SD)) 1.07(0.03) 1.36(0.15) 1.42(0.20) 2.26(0.61)
PTT (sec, mean(SD)) 26.7(10.3) 45.8(12.5) 53.2(9.1) 74.2(12.9)
Duration (minutes,
mean(SD))
120(0) 128(16) 125(25) 121(2)
Event of premature
cartridge clotting
Nil Nil 1 Nil
Event of significant
bleeding
Nil Nil Nil Nil
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Introduction Argatroban (ARG) is a synthetic direct thrombin inhibi-
tor, effective against free, fibrin and clot bound thrombin. It has been
approved for HIT. ARG is hepatically metabolized and has a half-life
elimination of 45'. Pharmacokinetic of ARG does not depend on renal
function. It's anticoagulant effect declines within 2-4 hours.
Objectives The aim of our study is to investigate ARG as anticoagulant
during PMB hemoperfusion in septic patients with thrombocytopenia
possibly related to HIT, to prevent the circuit clotting.
Methods From September 2014 to October 2015 five septic patients
with thrombocytopenia needed hemoperfusion with PMB were en-
rolled and nine hemoperfusion sessions were performed. The entrycriteria were: severe sepsis or septic shock requiring PMB hemoperfu-
sion, thrombocitopenia (<100.000). The exclusion criteria were: ser-
ious liver dysfunction, recent surgical operation (<12 h), recent head
trauma or cerebral bleeding (<10 days), hemorrhagic diseases.
Patients requiring PMB hemoperfusion followed the standard proto-
col recommended by Estor.
The patients received ARG at a dose of 250 mcg/kg as single bolus
injection, 30 min before the beginning of the treatment.
The monitoring of anticoagulation was achieved by systemic aPTT
and thromboelastography assessment (TEG), before the beginning of
hemoperfusion session (T0), at 1 h (T1), 2 h (T2) and at 4 h (T3) after
the start of the treatment. The TEG was performed to identify R
values that can be used for a routine evaluation of anticoagulant
regimen in clinical setting, compared with aPTT values. The anticoa-
gulation target was to achieve aPTT values between 1,5 and 2 times
the reference values.
Results All patients received two hemoperfusion sessions except one
patient that died prematurely. The media aPTT were at T0 37 s
(±5,8), at T1 60,8 s (±14,9), at T2 61,4 s (±22,9) and at T3 58,3 s
(±14,6).
The media TEG-R time were at T0 8,2 m (±2,1), at T1 19,5 m (±6,2) at
T2 17,5 m (±5,1) and at T3 19,1 m (±5,8).
Conclusions The ARG loading dose of 250 mcg/kg has demonstrated
to be effective to maintain cartridge patency during PMB hemoperfu-
sion. No cartridge clotting events occurred. The aPTT test demon-
strated an adequate anticoagulation. In contrast the TEG-R time
shows a greater variability of their values and a more severe patient
anticoagulation than reported by aPTT sampling. This suggests that
lower ARG doses could be sufficient to ensure an adequate anticoa-
gulation. Nevertheless no adverse events were recorded. The dur-
ation of ARG anticoagulation effect appears to be longer than
described by pharmaceutical company, always exceeding 4 hours.
Further investigations are necessary to introduce ARG in clinical prac-
tice as anticoagulant during PMB hemoperfusion.
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Introduction Recent clinical studies have shown that the reduction
of toxic levels of cytokines from blood with the use of a new extra-
corporeal sorbent, Cytosorb (Cytosorbents), could be useful to regain
control during a complicated inflammatory condition in patients with
sepsis and septic shock [1].
Objectives The aim of this observational study was to evaluate the
course of patients with septic shock admitted to our ICU and treated
with the new sorbent, Cytosorb. Primary outcomes were the influ-
ence of this new sorbent in hemodynamics, evaluating mean arterial
pressure (MAP) and vasopressors need, whereas secondary outcomes
were the improvement in inflammatory condition and renal function,
studying procalcitonin (PCT) and creatinine.
Methods We enrolled 8 patients until now (4 f, 4 m): 2 severe sepsis
and 6 septic shock. Patients data are reported in the table (median,
lower and upper quartile). All patients were non-responding to the
Standard of Care for the treatment of sepsis/septic shock. Therefore,
Cytosorb was used as adjunctive therapy in combination with con-
tinuous renal replace therapy (CRRT), in order to control the cyto-
kines storm and improve the hemodynamic stability of patients, and
it was installed in series connection after the dialyser in the CRRT cir-
cuit for 24 h. Clinical parameters were collected before, during and
at the end of Cytosorb treatment.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 200 of 607Results 6 treated patients survived and during the treatment
there was an overall improvement of MAP from 83 (73,5-89) to
88 (82-89,5) mmHg, with a rapid reduction in inotropes need:
noradrenaline decreased from 0,33 (0,15-0,46) to 0,13 (0,10-
0,18) while dopamine from 7,5 (6-8) to 3 (1,5-5) Y/kg/min.
Moreover, there was a markedly decrease of PCT levels from
14,53 (7,64-67,5) to 3,90 (1,62-23,05) ng/dl and an improvement
in renal function, thanks to the combination of CytoSorb with
CRRT; in fact creatinine decreased from 3.3 (1.05-4.42) to 1.15
(0.5-1.57) mg%. In 2 non-survivors, MAP was hard to stabilize
and decreased from 89,5 (77,75-101,25) to 69,5 (63,25-73,75)
mmHg and there was an aggravation in overall patients'
conditions.
Conclusions These are preliminary data, indicating that a timely
use of Cytosorb, in combination with the standard therapy, could
have benefits in improving hemodynamics and helping a more
rapid stabilization of patients. These results are promising, show-
ing how Cytosorb might help in many conditions of organs dys-
function. However, more in vivo studies are needed to confirm
these results.
Note: This abstract has been previously published and is available at
[2]. It is included here as a complete record of the abstracts from the
conference.
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sorbent. Critical Care 20(Suppl 2): 94.Table 120 (abstract A385). Characteristics of Patients
Age, years 65,5 (52,25-67,25)
Type of patient 6 Surgical/2 Medical
ICU stay, days 17 (9,5- 27,5)
Vasopressors need, days 5 (3,25-10,5)
Fig. 141 (abstract A386). Plasma concentrations of (A) tumor
necrosis factor (TNF)ɑ, (B) interleukin (IL)-6, (C) IL-8, (D) IL-10 and (E)
IL-1 receptor antagonist (IL-1RA) during endotoxin-elicited systemic
infalmmation. Data are expressed as means with SEM. Effects of
study treatment on the cytokine response were evaluated by com-
paring 2 groups with a 2-ways ANOVA. Significant differences be-
tween groups are displayed in the figure with a p-value. P: placebo,
PA: placebo and acetylsalicylic acid, TA: ticagrelor and acetylsalicylic
acid, CA: clopidogrel and acetylsalicylic acidA386
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Introduction Platelets play a pivotal role in the host immune re-
sponse, and antiplatelet therapy is associated with a beneficial
outcome in sepsis patients1. Antiplatelet therapy may therefore,
besides prevention of cardiovascular disease, also affect inflam-
matory processes and outcome in infections. Theoretically,
modulation of prostaglandin production, adenosine metabolism,
and attenuation of platelet reactivity may account for these
effects2.
Objectives To evaluate the effects of clinically relevant doses and
combinations of antiplatelet therapy on the innate immune
response in a human model of systemic inflammation and to
evaluate putative mechanisms of immunomodulation by these
antiplatelet agents.
Methods We performed a parallel randomized controlled study in
40 healthy male volunteers, who were randomized to a sevenday treatment course with either placebo (P), placebo with
acetylsalicylic acid (ASA) (PA), ticagrelor and ASA (TA), or clopido-
grel and ASA (CA), n = 10 per group. On the seventh day, a sys-
temic inflammatory response was elicited by intravenous
administration of a bolus of 1 ng/kg purified E. Coli endotoxin,
followed by 1 ng/kg/h for 3 hours in all subjects. We evaluated
plasma levels of cytokines, prostaglandins, and adenosine, and
measured platelet reactivity during endotoxemia.
Results Treatment with ASA resulted in a profound augmentation of
plasma levels of the pro-inflammatory cytokines TNFα, IL6, and IL8
during endotoxemia (Fig. 140), but did not affect anti-inflammatory
cytokines IL-10 and IL-1RA. Although the addition of ticagrelor, but
not clopidogrel, attenuated the ASA-induced increase in TNFα, these
P2Y12 antagonists did not affect the concentration of other pro-
inflammatory cytokines (Fig. 140). There was no difference in cyto-
kine response between ticagrelor- and clopidogrel-treated subjects.
Treatment with ASA lowered plasma levels of thromboxane B2.
Plasma adenosine increased during endotoxemia, without differences
between groups. Platelet reactivity was reduced in ticagrelor and clo-
pidogrel treated subjects, without any correlation with cytokine
responses.
Conclusions A seven day course with low dose ASA resulted in a
profoundly enhanced pro-inflammatory immune response in an
in vivo model of systemic inflammation in humans. Although
addition of ticagrelor but not clopidogrel significantly attenuated the
TNFα response, ticagrelor or clopidogrel did not affect IL6, IL8, IL10,
and IL1RA responses.
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Introduction Sepsis induced cardiomyopathy is a complication of se-
vere sepsis. It is characterized by left ventricular dilatation and de-
pressed ejection fraction. Recent meta-analysis suggested that the
mortality depends on the heart hyperkinetic. However, the crucial
mechanism of sepsis induced cardiomyopathy and the treatment are
still unknown. It has been reported that telomere length has inverse
correlation to severity of heart failure and infectious disease. In
addition, telomere dysfunction decreases mitochondrial function by
affecting downstream gene expression of cell energy regulators such
as p53 and peroxisome proliferator-activated receptor gamma coacti-
vator 1-alpha (PGC-1α). It is suggested that dysfunction of “telomere-
p53-PGC axis” reduces a mitochondrial function, and as a result, it
develops to heart failure. Beta-blockers have a possibility to improve
the morbidity and mortality of sepsis by regulating sympathetic
nerve system and metabolism. Carvedilol has antioxidant properties
and widely used for patients with heart failure.
The present study was conducted to investigate the therapeutic po-
tential of carvedilol which improves prognosis in preclinical models
of severe infection, the murine cecal ligation and puncture (CLP)
model to induce peritonitis.
Methods CLP procedure was performed using 10 weeks male C57BL/
6 mice. After operation, mice were divided into beta blocker group
(BB) and control group (CT). 1 mg/kg carvedilol or normal saline was
administered every day for each group. We isolated left ventricle of
the hearts and obtained blood sample from survived individuals on
postoperative day 14. We estimated survival rates, cardiac function
by echocardiography, blood pressure measured by indirect tail-cuff
method, telomere length in heart tissue and white blood cell were
evaluated by quantitative fluorescence in situ hybridization (Q-FISH)
analysis.
Results Kaplan-Meier analysis showed that the 14 days mortality was
reduced in BB group. 14 days after surgery, BB group reduced heart
rate (440 ± 100 BB vs. 580 ± 41 bpm CT, p = 0.029) while there was
no significant difference in mean arterial pressure (68.5 ± 17.4 vs.
66.7 ± 15.3 mmHg, p = 0.34). BB group also improved cardiac function
such as E/e'(18.0 ± 7.3 vs. 27.0 ± 4.0, p = 0.027), LVEF(57.0 ± 4.8 vs. 46
± 5.2 %, p < 0.01) and LVEDV(56.9 ± 13.4 vs. 46.3 ± 10.5ul, p = 0.02) as
compared to CT group. Q-FISH analysis revealed that telomere length
of white blood cells was significantly longer in BB group (68.9 ± 45.0
vs. 48.0 ± 29.6, p < 0.01; Telomere Fluorescence Units; TFU = 1 kb).
Quantitative PCR analysis revealed that BB showed higher expression
of telomerase reverse transcriptase (tert), PGC-α which promote mito-
chondrial biogenesis and lower expression of p53 in heart tissue as
compared to CT group.
Conclusions Carvedilol improved sepsis-induced cardiomyopathy
through the attenuation of telomere shortening by regulating gene
expression of energy metabolism and reducing mortality resulting
from sepsis.
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Intensive Care Medicine Experimental 2016, 4(Suppl 1):A388In CORTICUS trial, hydrocortisone therapy did not improve outcomes
among patients with septic shock (onset within 72 hours), although
it did shorten the duration of vasopressor dependence. In this study
we investigated the role of the hydrocortisone therapy, at the very
early phase of sepsis, when combined to hyper-fluid therapy. The
purpose was to examine the protective role of corticoid and of
hyper-fluid therapy on microcirculatory dysfunction progression dur-
ing the early phase of sepsis.
Methods Adult Wistar rats (200-300 g), under general anesthesia,
were submitted to sepsis {iv. 2 mL E. coli 108 (S8), DL60 in
26 hours}. The intervention started 30 minutes after sepsis induc-
tion. The SBH group (n = 2) was treated with basal-fluid reposition
(iv. 8 ml saline/kg/h). The SHH group (n = 2) was treated with
hyper-fluid therapy (i.v. 20 ml saline/kg/during 1 h and main-
tained with basal fluid further). The SBH + Cort group (n = 2) was
treated similar to SBH, however treating with the Hydrocortisone
(i.v. 100 mg/kg, diluted in 0,5 ml Milli-Q water before the fluid
therapy). The SHH + Cort group (n = 2) was treated with Hydrocor-
tisone and hyper-fluid therapy. The microcirculation of mesentery
was monitored by Intravital microscopy during the first 3 hours
of sepsis. The microcirculation of renal cortex area and the liver
were monitored by Sidestream Dark Field Imaging (SDF) video-
microscopy, at 3 hours after sepsis.
Results The intravital monitoring showed that, in sepsis treated
with basal-fluid therapy (SBH), there was an important microcircu-
latory dysfunction, including an intense leucocyte adhesion and
transmigration, leading to vessels' congestion and focal hemor-
rhages. These alterations were decreased in all the other groups,
even though the ones treated with hyper-fluid (SHH) or hydrocor-
tisone associated (SHH + Cort) resulted in lesser leucocyte
adhesion and transmigration than the group treated with hydro-
cortisone with basal-fluid (SBH + Cort). Interestingly, the combined
HH + Cort therapy determined the lowest leucocyte adhesion
whereas the HH therapy alone lowered the leucocyte transmigra-
tion. The SDF monitoring revealed that, in sepsis treated with
basal-fluid therapy (SBH), there was a greater microcirculatory
dysfunction at both liver and kidney, presenting numerous areas
of heterogeneity. The HH or corticoid alone or in combination
seems to minimize the sepsis's effects on the microcirculation,
however, further histological and biochemical studies are needed
to better elucidate these findings. The overall data demonstrated
that hyper fluid therapy and corticoid therapy, alone or com-
bined, given in the very early phase of sepsis might bring poten-
tial benefits in the control of the exacerbated inflammatory
response of sepsis.
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Introduction Sepsis still represents major health issues, with per-
sisting high mortality rate in critically ill patients. Organs dysfunc-
tions1 occur frequently during sepsis and are related to the
magnitude of the inflammatory response. Erythropoietin (EPO)
has emerged as a major tissue protective cytokine in the setting
of stress2.
Objectives To determine 1) the effects of EPO on inflammatory
state and oxidative stress of organs, and 2) to analyze the func-
tional benefit of EPO in the heart and the vessels in a model of
sepsis.
Methods Sepsis was induced by cecal ligation and puncture
(CLP)3 performed in rats, sham had only abdominal surgery.
EPO (10000 UI/kg) was injected intraperitoneally at the time of
surgery. Groups of animals (>10/group) allowed the following
indexes to be analyzed: survival of animals, invasive blood pres-
sure (BP), lactate rate, heart function and cytokine profile using
plasma, organs (heart, kidney, lung, liver and brain) and RT-PCR
18 hours after surgery. Oxidative stress was assessed using
DHE.
Results and discussion Survival, 18 h after the onset of surgery,
was 0 %, 83 % and 42 % for sham, CLP and CLP-EPO rats (p <
0.0001), respectively. The whole inflammatory response (pro- and
anti-inflammatory cytokines) was prevented by EPO in organs
and plasma (see figure). Hence, the increases in cytokines as
TNFα, Il-6 and Il-10 in the CLP-EPO heart were -50, -75 and -25 %
lower than those observed in CLP ones (p = 0.0103 ; 0.0037 and
0.0031 respectively).
At the protein level, p62, an inflammatory marker, was increased
in the CLP hearts when compare to sham, whereas no difference
was seen between sham and CLP-EPO rats (p = 0.0162). There
was less oxidative stress in the CLP-EPO hearts when compared
to sham and CLP groups (p < 0.05) 18 hours after the onset of
sepsis. Regarding function indices, EPO did not prevent systolic
dysfunction, but completely prevented tachycardia (p = 0.0248)
and the decrease of BP (p = 0.0455).
Conclusion During sepsis in rats, EPO prevents inflammatory re-
sponses and oxidative stress in organs and plasma.
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Introduction Extracorporeal therapies are considered as an option to
modulate cytokine levels in the circulation in systemic inflammatory
syndromes. The technologies based on high cut-off (HCO) mem-
branes with larger pore-size and effective clearance of middle mole-
cules are most promising [1, 2].
Objectives Aim of this study was to conduct in vitro experiments in
order to compare the Ultraflux® AV 1000S high-flux haemofilter to
the Ultraflux® EMiC®2 HCO filter (both from Fresenius Medical Care,
Bad Homburg, Germany) regarding cytokine elimination.
Methods In these experiments, 2 x 1000 ml human plasma was spiked
with IL-6, IL-8, IL-10 and TNF-α and dialyzed with the AV 1000S filter or
the EMiC®2 filter. The experiments were conducted using two Fresenius
4008H haemodialysis machines with a plasma- and dialysate flow of
300 ml/min. Samples for clearance measurements were taken at 15, 30,
60, 120, 180 and 240 min. Sieving coefficients were determined at a fil-
trate flow of 10 % of the plasma flow. All experiments were carried out
in triplicates and cytokines were quantified by ELISA.
Results The results show that IL-8 is efficiently removed by both
filters. Larger cytokines, such as IL-6 and TNF-α were removed only
by the EMiC®2 filter with a clearance rate of 4.7 and 2.4 ml/min, re-
spectively. For IL-10, the EMiC®2 shows much higher clearance rates
than AV 1000S.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):27 Page 203 of 607Conclusions Compared to high-flux dialyzers, HCO filters offer sig-
nificantly higher removal rates for middle molecules such as cyto-
kines and other target molecules with similar molar mass.
Therefore, HCO filters should be preferred in extracorporeal ther-
apies for the supportive treatment of systemic inflammatory
syndromes.
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